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DIRECTOR'S
REPORT
I have now been closely associated with Cold Spring Harbor Laboratory for more
than 45 years. During this almost half-century interval, the Lab has both stayed
the same and changed itself radically. What initially made me so admire, if not
love, the Lab was the beauty of its harbor and buildings, then populated by indi-
viduals such as Barbara McClintock and Alfred Hershey, who had extraordinarily
high intellectual objectives and standards. There was then, as still today, no
snobbery or hypocritical obeisance to age or authority. Instead, what mattered
was the truth or falsity of the facts and ideas of genetics. As a 20-year-old sum-
mer student, I felt both liked and needed for wanting passionately to unravel the
essence of the gene, the master unit of heredity that we now know to be com-
posed of DNA.
This preoccupation with genetics, which for so long made Cold Spring Harbor
Laboratory so unique, goes back to the turn of the century. It was then that
Mendel's laws, effectively lost for 35 years, were rediscovered independently by
the European plant breeders Correns, de Vries, and Tschermak. In 1904, Cold
Spring Harbor became one of the first sites to take on the challenge of the new
genetics when money from Andrew Carnegie's steel fortune was used to create a
Station for Experimental Evolution here. It was headed by the Harvard-trained
zoologist Charles B. Davenport, who was already in charge of a summer teach-
ing program at The Biological Laboratory. This neighboring institution had been
started in 1890 by the Brooklyn Institute of Arts and Sciences and supported by
the local Jones family, one of whose houses adjacent to the Lab was the largest
on Long Island until its destruction by fire in 1861. Initially, the main preoccupa-
tion of the Station, later to be renamed the Department of Genetics of the
Carnegie Institution of Washington, was to extend the validity of Mendel's laws to
a large variety of plants and animals including our own human species.
To carry out these studies, which soon made Cold Spring Harbor a world-
class leader in genetics, several new buildings in Italianate style were con-
structed using designs from leading architects of the time. Initially, these new
structures must have seemed discordant with the more traditional New England
style buildings along the western shore of the inner harbor, where the whaling in-
dustry of the Jones family had been located from the 1830s until the start of the
Civil War. Particularly stark and ungraceful in early photographs was Blackford
Hall. This residence and dining hall was built in 1907 from reinforced concrete at
the suggestion of the Lab's early patron William John Matheson, a founder of
Allied Chemical, whose massive, brick, Tudor style home, "Fort Hill," graced the
entrance from Long Island Sound into Cold Spring Harbor. But by the time I first
arrived here some 40 years later, the various buildings worked well together
nestled amidst the trees that had grown up between them. I remember well one
particular early June day at sunrise when, already exposed to the magnificent
buildings of the old world Cambridge, I thought Blackford to be one of the world's
most beautiful buildings.
But these buildings from the past were not equal to the next phase of
genetics, whose objective was to understand the gene at the chemical level. The
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director at that time, Milislav Demerec, rose to the challenge by selling off Lab-
owned land along both sides of Stewart Lane to build, in 1953, the box-shaped,
concrete laboratory that today bears his name. Seen at night from across the har-
bor, its long regular rows of windows conveyed a commercial feeling that jarred
with the sylvan feeling of the inner harbor then dominated by the Moorings
Restaurant, whose red leather interior long graced Long Island's fabled Gold
Coast. Also strange must have seemed the new Scandinavian style auditorium
that later was to be named after Vannevar Bush, who then led the Carnegie In-
stitution of Washington. This 250-seat edifice was sorely needed to maintain the
viability of the annual June Symposium when attendance was routinely creeping
beyond 100 and thus impossible to accommodate in the Fireplace Room of
Blackford. No one, however, then protested its appearance, since it gave to the
Symposium a home appropriate for its ever-growing reputation as the world's
most influential meeting in biology.
These 1950s additions soon blended with those of the past, with motorists
driving along route 25A always much less conscious of the Lab than of the
elegant 1836 Jones family church, St. John's, and the adjacent Fish Hatchery,
whose 1881 founding by John D. Jones and E.G. Blackford just preceded that of
The Biological Laboratory in 1890. Even when I became the director in 1968, the
Lab's existence was unknown to many nearby residents who, if asked, would
most likely have said that the buildings stretching northward along Bungtown
Road were connected to the Fish Hatchery. Equally at variance with reality were
the perceptions of those biologists who only knew the Lab indirectly through its
yearly Symposium volumes and from the growing reputation of its summer
courses in which the experimental techniques of the new DNA-based molecular
biology were taught. It was presumed that such prestigious activities very likely
had to emerge from up-to-date laboratories and auxiliary buildings. But all in-
siders knew that except for two relatively new buildings dating from the 1950s,
virtually all of the other buildings on the 95-acre waterfront campus bordered on
the derelict. If such decay was not attended to soon, high-level science at Cold
Spring Harbor would soon disappear.
The thought that Cold Spring Harbor Laboratory might vanish obviously
worried its many friends, and it was to prevent that from happening that I became
director in 1968. Key to that decision was the reassurance from Harvard Univer-
sity that I would remain a salaried professor there as long as I continued to give
my lectures and oversee those graduate students doing their Ph.D. thesis work
under my supervision. So I could worry about the future of the Lab without fear
that my salary might vanish along with the Lab. My decision to take on the task of
saving science at Cold Spring Harbor was not, however, an entirely selfless act.
As the director here, I would have the ability to start a major effort focused on
using tumor viruses to work out the genetic basis of cancer, an intellectual objec-
tive that increasingly dominated my thoughts after 1966. By then we knew the
main features of how RNA is involved in protein synthesis, my main intellectual
goal since finding the double-helical structure of DNA in 1953. From the start, I
saw that the task of understanding cancer would require large team efforts in-
volving many senior scientists with highly different backgrounds and so beyond
my resources as a professor at Harvard. There my research space linked me to a
research group of at most ten students and postdocs. In contrast, there would be
no limitation of available laboratory space at Cold Spring Harbor provided I could
obtain the funds to upgrade the unoccupied but dilapidated structures.
Ordinarily, incoming directors of research institutions inherit significant num-
bers of scientists appointed by previous directors and whose continued
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presence inhibits the new director from moving swiftly in new intellectual direc-
tions. But the poor physical condition of most of our laboratories coupled with the
lack of any long-term fiscal stability had led many previous staff members to
move to more stable academic positions. At least initially, we had all the space
we needed as long as I could find the funds to renovate preexisting laboratories
into acceptable facilities for molecular work on cancer-causing viruses.
Fortunately, this proved to be an easy task, since in 1968 there was far more fed-
eral money available for research on cancer than could be used effectively by
the scientists then working on this disease. At that time, cancer was thought to be
deadly not only for its unfortunate victims, but also for the careers of those
scientists who invariably failed to understand its underlying diabolically complex
molecular mechanisms. Most first-class biochemically oriented scientists in the
prime of their careers thus stayed away from work on cancer.
But the public did not know this, and each year Congress could be counted
on to vote even more money for cancer research, and so the money was there.
Soon after I became director, the National Cancer Institute was asked for funds
both to renovate James Laboratory, parts of which remained virtually unchanged
since its construction in 1929 as a concrete shell for biophysics research, and to
bring to the Lab some top-level younger scientists already trained to work on
tumor viruses. Key to our getting the grant was Joe Sambrook's decision to move
here from the still almost new Salk Institute. At the Salk, Joe was one of the
younger stars working in Dulbecco's DNA tumor virus group. With his arrival, we
instantly had the potential to soon become one of the world's best cancer re-
search laboratories. But I worried about the disparity between the facilities here
and those in the magnificent Louis Kahn-designed Salk laboratories and soon
was out seeking funds for an annex to James that would allow the scientists to
have offices from where they worked with viruses as a library
seminar room where experiments could be discused over coffee. Then only
$200,000 was needed to build the imaginative wooden structure that had been
designed by the talented New York architect Harold Edelman. But even this rela-
tively small sum greatly exceeded any funds at our disposal, and so it was to our
great good fortune that retired Pfizer executive John Davenport decided to make
the major gift that allowed the Annex to be completed early in 1971. By design,
the unpainted cedar boards of the Annex blended nicely into the hill behind it,
and the grand Norway spruce in front of it made it virtually invisible from across
the harbor, except at night when its large windows reflected the fact that science
here goes on until very late in the evening.
The James Annex was not the first new building of my directorship. Upon ac-
cepting the directorship, I and Liz, whom I had just married, decided to live in
Osterhout, then an older building dating from just before 1800. Feeling flush with
the royalties from my just published, best-selling book The Double Helix, I gave
the Lab the funds to totally renovate Osterhout and expand it to the designs of
Harold Edelman. When construction started in the summer of 1968, however, the
builder quickly told us that Osterhout had decayed beyond saving, but he offered
to build a completely new structure for the price agreed upon for the renovation.
Everyone liked the final result, which still had early New England features, and no
one complained that we had given up part of our whaling-era identity.
Happily, we were able to save the 1830-era Wawepex, despite its advanced
decay which had required us to abandon its use. Using monies from Manny Del-
bruck, who with her husband Max had been a summer visitor here for 25 years,
Wawepex was converted from a primitive laboratory to a year-round residence
capable of housing 16 students during the summer teaching intervals. By then,
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the crisis atmosphere that had enveloped Cold Spring Harbor
for more than a
decade had passed, and our scientists could worry about their experiments with
tumor viruses rather than about whether they would have jobs over the foresee-
able future. The Lab thus looked very alive when we learned in the summer of
1972 that our neighbor Charles S. Robertson, whose large estate in Lloyd Harbor
bordered on Cold Spring Harbor, was seeking an institution to make use of the
land and buildings on Banbury Lane that he no longer wished to keep after the
unexpected death that spring of his beloved wife Marie.
A visit was soon arranged for him to tour the Lab and to have lunch at Oster-
hout, whose large picture windows on the harbor side revealed the summer
beauty of Cold Spring Harbor at its best. Within days, we knew we had won his
support to a degree that we had never anticipated. Not only would he deed to us
his wonderful Lloyd Harbor property, but even more important, he also planned
to give us an endowment of 8 million dollars to support research at the
Laboratory. Gifts like this generally go only to distinguished universities whose
elegant buildings convey the fact that they will live forever. The fact that both the
James Annex, in which by then my office was situated, and Osterhout were ar-
chitecturally elegant had to have been a factor in convincing Charles Robertson
to choose us as beneficiaries of his great philanthropy. The message was clear:
Whenever possible, we should design attractive buildings appropriate for the fu-
ture of an elite institution.
The means were thus available to expand further the research done at the
Lab by additional renovations to preexisting spaces. At the same time, ever-
increasing community support for the Lab, marshaled by Edward Pulling's firm
leadership of the Long Island Biological Association (LIBA), allowed us to sys-
tematically renovate the other buildings on the Lab grounds, in particular to con-
vert many from summer-only to year-round use. In this ac-
quired the heating system that lets this dining hall function year-round. It was also
LIBA's help that let us buy the circa 1885 Takami House (now Olney) that was
surrounded by Lab grounds and that by then included the field to the north which
had once been owned by Charles Davenport. Several years later, thanks again to
LIBA support, a new Williams House modeled after the original unsalvageable
1830 "tenement" gave us five new apartments for visiting scientists and course in-
structors.
My decision to give up our house near Harvard and move full-time to Cold
Spring Harbor led to the 1973-1974 renovation of Airs lie, the director's residence
since 1943. This 1806 former Jones family farmhouse had been purchased in
1943 from Mrs. de Forest following the death of her noted philanthropic and capi-
talist husband and the subsequent breakup of their large estate at the end of
Bungtown Road. Their specimen-tree-covered property adjacent to the Lab
stretched up over Ridge Road, extending northward to virtually contact the estate
of their close friend Louis Comfort Tiffany. Following the acquisition of Airs lie, the
Lab did not have the monies to renovate it properly, and its north-facing rooms
remained largely unheatable during the severe cold of the winter. But by 1973 we
had the resources to carry out a clever renovation scheme proposed by the al-
ready celebrated architect Charles W. Moore, who then headed the School of
Design at Yale. Moore's plan left the 1806-1850 exterior virtually unchanged but
radically changed the inside space, in particular by creating a three-storied
entrance hall that went to the top of the house. When so renovated, Airs lie was a
major architectural triumph, photos of which later graced architectural books and
magazines.
I had to feel highly privileged living in such an exciting yet so livable house,
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whose renovation costs totaled almost $200,000 for its 6600 square feet of
space. My intent, however, was to raise all of our housing to such standards, and
we later spent roughly the same sum to renovate the by then totally derelict Vic-
torian house located at the Bungtown Road entrance to the Lab. Now called
Davenport House, it was built in 1884, and since the 1930s has continually
served as a large residence for postdoctoral fellows and graduate students. Most
important, my wife Liz, who oversaw the renovation project, had the house
repainted in its original six Victorian colors which now give continuous pleasure
to the thousands of motorists who drive past it on route 25A each day.
With the renovation of Davenport, virtually all of the previously derelict build-
ings had been restored to functional use. Our gamble that we could do first-class
research on tumor viruses using preexisting space more than paid off, with Cold
Spring Harbor already acknowledged by the mid 1970s as one of the world's
leaders in this area. Admittedly, a 1000-square-foot west annex to James had to
be built in 1973 to provide special rooms for the growth of viruses, but that we
could so quickly leap-frog scientifically ahead of the Salk shows that the heart of
success depends much more on the esprit and competence of specific scientists
than on the grandeur of the facilities in which they work. Certainly the 1970s
represented one of the best decades in the Lab's history, with last year's Nobel
Prize in Medicine or Physiology awarded to Richard Roberts for research done
here between his arrival in 1972 and the historic discovery of RNA splicing in
1977
The challenge of the 1980s was completely different with the world of
molecular biology exploding because of two new important methodological de-
velopments of the 1970s-that of recombinant DNA (1973) and that of
monoclonal antibodies (1975). Effective utilization of recombinant DNA proce-
dures was held up for several years because
potential biohazards, but no such inhibitions held up work on monoclonal
antibodies. This technique had already been brought here in 1978 when David
Lane arrived from London to use monoclonal antibodies to study the T antigen,
the SV40 tumor virus protein at the heart of the cancer-causing potential of this
virus. The making of such antibodies required the facilities for a mouse colony,
and the tiny "mouse house" that we had placed in the former sheep shed next to
McClintock Laboratory was inadequate for the tasks ahead. Using funds from the
Kresge Foundation and the National Cancer Institute, a modern, barn-like, animal
facility, the Harris Building, was finished in 1982 on the sitewhere a woolen-mill-
era building had existed since the early nineteenth century.
At the same time, to create the additional laboratories needed to properly use
monoclonal antibodies for cancer research, a major addition to James Laboratory
was finished in 1985. Its planned existence allowed us in 1983 to recruit the
American-born and -educated Ed Harlow from London, where his Ph.D. thesis re-
search had involved monoclonal antibodies. In retrospect, the building of this tur-
reted wooden-clad north annex, now known as Sambrook Laboratory, was a cru-
cial step in the Lab's development since it let Ed make one of the great dis-
coveries of all tumor virus research. To our amazed delight, in 1987 he showed
that the key adenovirus E1A protein binds to a normal cellular protein that func-
tions to inhibit cell growth-a tumor suppressor protein. Without the opportunity
the Sambrook Labortory gave to Harlow to form his own lab group, the discovery
that capped some 30 years of worldwide research on DNA tumor viruses would
most likely have occurred elsewhere. Instead, our leading position in cancer re-
search was retained.
There also arose the need to build two successive additions to the 1926
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waterfront "Long Island Colonial" style building just off Bungtown Road that I first
knew as Davenport Laboratory. Robertson Research
Funds had permitted it to be
upgraded into a heated year-round facility in 1973 so
that it could function as the
home of our tiny but intellectually powerful Yeast Genetics group.
The aim of this
group was to determine a molecular genetic mechanism
for how yeast cells can
suddenly switch from one sex to the other. Using the new procedures of recom-
binant DNA, Jim Hicks, Amar Klar, and Jeff Strathern hoped to establish the
validity of their "cassette model," which time has shown to
be a revolutionary step
forward in understanding how genetic information is moved from one
chromosomal site to another. But they had to do so in the context of routinely
losing their labs when the summer courses were taught. To solve this dilemma, a
modest addition, designed to look from across the harbor like a separate
whaling-era house, was made to the south in 1981. The same architectural trick
was used six years later when a slightly larger north addition was added that let
us seriously move back into plant genetics to exploit Barbara McClintock's jump-
ing genes idea, which by then had widespread implications for both pure
science and commercial plant breeding.
During the same period, we made two additions to the by then 30-year-old
Demerec Laboratory to let it function more effectively as a center for the further
development of recombinant DNA technology, particularly in the area of protein
and nucleic acid chemistry. Of these, the first addition, made in 1982, was the
largest, being built using monies from Exxon for facilities needed for our joint pro-
gram to introduce advanced recombinant DNA technologies into our respective
research programs. Before we signed this major agreement with Exxon, which
was to provide us with 7.5 million dollars over five years, we had reason to worry
that Cold Spring Harbor would become an increasingly marginal player in
science as recombinant DNA techniques more and more dominated biological
research. Happily, Exxon's help came just in the nick of time to let us compete
successfully with major institutions doing biomedical research, virtually all of
which were adding large new facilities for DNA-based research. Now, in
retrospect, the 1980s were every bit as successful scientifically as the 1970s,
with the computerized citation indices, which track the key scientific articles that
are quoted by other scientists, now revealing us as the most influential research
institution in the world doing biomedical research over this two-decade interval.
A major contributing factor to this success has been our advanced courses
and meetings which set out the important challenges and dilemmas of biology.
During the spring, summer, and fall sessions, we function, in effect, as the inter-
national center for DNA-based research. By the middle 1980s, however, these
teaching and conference activities were coming under increasing strain as they
continued to grow in size and number. Not only was Bush Auditorium much too
small for meetings attended increasingly by more than 300 scientists, but also
our dining and on-site housing could no longer handle a meeting schedule that
now stretched into summer months when the rain could no longer be counted on
to feel warm. Closed-circuit TVs, long food lines, dining tents, and massive
busing to not always near motels could no longer be the norm if we were to have
a future for disseminating important biological facts and techniques.
The first challenge we faced was to build a bigger home for our world-
famous Symposium, which we did in the shape of the strikingly elegant, brick-
faced, Oliver and Lorraine Grace Auditorium. This 360-seat almost-square struc-
ture embodies both modern and traditional features, with its dormer-windowed
south-facing facade warmly compatible with neighboring multicolored Davenport
House. Upon its completion in 1986, we possessed for the first time a building
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more appropriate for our increasingly year-round, as opposed to summer-camp-
like, existence. That our new auditorium enhanced, not diminished, our always
cherished sense of history led to a complete change in our thoughts as to how
we should further develop our "middle campus" land on the hill to the west of
Blackford Hall. In the mid 1950s, part of this hill had been flattened for the Page
Motel and its companion parking space to provide additional housing for summer
visitors. Three decades later, we began to think about replacing this by then very
dilapidated relic with a much larger Adirondack style year-round lodge. It was to
be adjacent to a modest new laboratory for neurobiology, also designed to look
like a component of a summer camp but also suitable for winter use.
That we needed to expand in the area of neurobiology had been obvious ever
since the Sloan Foundation had given us the funds in 1970 to initiate a program
of advanced courses on nerve cells and how they underlie perception, memory,
and thinking. Understanding the brain was very likely to be the ultimate frontier
for biology, an undertaking soon to be populated by many of the brightest and
most courageous minds in science. Increasingly obvious to virtually all percep-
tive biologists was the fact that the brain would be to the twenty-first century what
the gene was to the twentieth century- the place where the real action lies.
Moreover, especially after the onset of the recombinant DNA revolution, genetic
methodologies were likely to prove indispensable to understanding how the brain
develops and functions. Much useful synergism would develop by promoting
neurobiology at institutions with strong genetic heritages. So in the late 1970s,
the recently created Marie H. Robertson Fund for Neurobiology helped us attract
several young neurobiologists to use our summer neurobiology teaching labs for
their year-round research, retreating during the summer course season to the for-
mer mouse house now converted to a tiny laboratory. The research they did was
first-class, but, for lack of appropriate research space, all too soon they were
recruited away to institutions where they could properly exploit their new ad-
vances.
In 1985, when Sue Hockfield, our last remaining talented young neuro-
biologist, had left us for Yale, we decided to seek the funds for a modest
neurobiology laboratory in which both advanced teaching and research would
occur. Our planning, however, necessarily only became focused when we knew
that we had a realistic chance of raising the required multimillion-dollar sums.
That moment came in the summer of 1987 when the Howard Hughes Medical In-
stitute made a gift of 7 million dollars toward the building, its equipment, and staff
support. By then the success of Grace Auditorium led us to decide on an "aca-
demic" as opposed to "rustic" design. So we asked our architects, Centerbrook of
Essex, Connecticut, the descendant of Charles W. Moore's original firm, to de-
sign a building complex in which the neurobiology laboratory is separated by a
courtyard from a 60-room residence for visitors to our meetings and courses. Par-
ticularly appealing in their resulting design was an imaginative bell tower that
also functioned as smoke stacks.
No building anywhere near the size of the 1991-completed 65,000-square-
foot Neuroscience Center had ever existed on our Bungtown Road site, and natu-
rally concerns were voiced as to whether its existence would fundamentally
change the way we do science at Cold Spring Harbor. But these worries
vanished as soon as some of us had moved into Beckman Laboratory and the
summer courses had been successfully run in its labs. Much more sophisticated
experiments could be done in the new teaching laboratories than in the older
facilities in James and Jones Laboratories, totally justifying the decision of the
Howard Hughes Medical Institute to fund the new teaching laboratories. Although
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we deliberately retained a hillside layer of deciduous trees that would make the
Neuroscience Center effectively invisible from across the harbor in the summer,
there was no way to keep it invisible during the winter, and its massive size upset
some neighbors who would have preferred us to remain perpetually old-
fashioned. But the planting of appropriate conifers eventually will give the
Neuroscience Center the appearance of a lower building and, with time, I'm sure
that its clever architectural details will begin to be appreciated in their own right
as more and more of our neighbors accept the fact that we should look like the
major academic institution that we in fact are.
Less attention will also be drawn to the Neuroscience Center because of
alterations more recently made elsewhere on our grounds. To do away with the
need for tents to feed attendees at the Symposium and other similar size meet-
ings, a major addition to Blackford Hall, largely to its east, was finished in 1992. It
effectively doubled its size, creating in particular the elegant new Clarkson Dining
Room on the ground floor. Although its appearance from Bungtown Road has
hardly changed, Blackford looks different from the harborside, with the new stair-
case to lower floors topped by our second bell tower.
Also presenting a larger facade to the western shore is the newly renovated
McClintock Laboratory, which had a third, penthouse-like floor added to it to
make it over into a very effective facility for cancer research. Ever since I became
the director, I saw the eventual need to give McClintock proper offices and semi-
nar space through adding a tastefully designed upper floor. Without such an ad-
dition, McClintock, perhaps the most historic of all our buildings through the
Nobel prize winning research done within it by Barbara McClintock and Alfred
Hershey, was increasingly too small for the complexities of modern science. Hap-
pily, the upper floor further enhances the Italianate elegance of the original 1914
design while providing breathtaking views of the inner harbor.
Although we take much deserved pleasure from the way we propelled Cold
Spring Harbor Laboratory into a world-leading role in science while simultaneous-
ly preserving the flavors of its historic past, our rapid growth of the past decade
worries some of our nearby neighbors. They say we have already grown too
much and want to take legal steps that will restrict how we grow in the future.
That such fears exist should not surprise us, since rapid change is invariably un-
settling to those comfortable with the present and who would like their environ-
ment to present only the challenges that they had faced in preceding years.
Moreover, we share the concerns of those who wish to preserve forever the great
intrinsic beauty of Cold Spring Harbor. It greatly enhances the value of the
houses of those fortunate, like me and my family, to live in our vicinity as well as
the quality of the commuting lives of those whose work necessitates driving daily
along route 25A. No one, in fact, has a greater vested interest in the beauty and
ambiance of our site than the Lab and its residents.
Had we not been located on such an idyllic site, I'm sure that the Laboratory
would have gone under during the financial crises of the 1960s. Moreover, the
chief reason why we have functioned so well as a meeting and teaching center is
the almost rural feeling that still characterizes our buildings along Bungtown
Road, as well as the inner harbor itself. The desire to keep this atmosphere is
what led us in the still fiscally tricky early 1970s to buy the Whaler's Cove Marina
that lies across from us on the eastern shore of the inner harbor. If we had not so
acted, its size would have soon doubled to 100 slips, its owner having just won a
lengthy legal battle for the expansion. Such a move would have radically
changed our inner harbor, paving the way for the awful congestion that already
characterized nearby Huntington Harbor. We saw our purchase of the property to
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be totally for the public good, but we did displease a tiny minority who felt that we
should close down the marina instead of letting it continue to operate at its cur-
rent size. But we did not want to upset those who had their boats there, since
they did not seriously disturb us or even their closer neighbors. In addition, the
rent paid to us by the marina, then and still now, each year covers the stipends of
several young postdoctoral fellows. Finally, the small, quiet marina preserves the
bucolic ambience of Cold Spring Harbor that we love.
More recently, we have taken the equally important step of successfully work-
ing to see that the main Laboratory grounds and those of our neighboring Fish
Hatchery were in January 1993 nominated to the State and National Registers of
Historic Places. Toward this recognition, my wife Liz, assisted by Nathaniel Com-
fort and Susan Cooper, diligently documented our achievements as one of the
major founding sites for American science. By being on the register, we will have
to demonstrate that future major changes to our campus do not have a negative
impact on its historic flavor. This designation, however, in no way means that we
cannot make additions to clearly historic structures like those just done to
McClintock Laboratory and Blackford Hall. Nor does this designation inhibit us
from building the new laboratories that we will need to continue to be a major re-
search and educational establishment. Such changes, however, must be done in
ways that respect Cold Spring Harbor's unique environment for science and its
teaching. Since this is the way we have proceeded over the past 25 years, I do
not see our freedom to act imaginatively being seriously restricted. During all this
time, we have always instructed our architects to design structures compatible
with their preexisting neighbors. This does not mean, however, that invariably
their resulting designs will please everyone, since often many years, if not
decades, must pass before a new building finds general acceptance. We must
thus always take care that we do not fall into the trap of perpetuating architectural
styles long past the time when they are the best solution for a given era. Imagine
Yale or Princeton slavishly burdened by the need to build perpetually in Gothic
Revival styles.
Our freedom to continue to build imaginatively upon the past is aided by the
fact that we still utilize only a small fraction of our 95-acre site in Laurel Hollow,
with nearly all our science and conference activities done on land at the south
end of our property. Moreover, within this region, which comprises less than a
quarter of our land, there remains much room on our middle-campus slopes to
expand these activities further when the need arises. So we should never have
reason to change the basic rural character of the land along the northern reaches
of Bungtown Road. Future visitors to our meetings and courses should perpetual-
ly have the pleasure of walking along Bungtown Road, which has the feeling of a
narrow country lane. Of course, there will be subsequent changes along it, but
we hope that they will further add to its charm, for example, by the construction
near our tennis courts of a small, barn-like athletic building containing a squash
court and a modest exercise room. When we find the funds, we plan to replace
the split-level former residence of the Kurahara family with a hillside, barn-like
building for our Buildings and Grounds Department, which is now crowded into
inadequate facilities along the waterfront below Blackford Hall.
Even within our more built-up region at the head of the harbor, we should
have the ability to expand our research and educational activities without sig-
nificantly increasing the number of individuals working on our main campus. This
can be done by moving certain programs to nearby
off-campus sites. We, in fact,
began this process in 1976 when we were given the 45-acre Lloyd Harbor estate
of Charles S. Robertson to use as a site for small
conferences where some 30-40
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individuals come together for several days. From the start, a scenic easement
was attached to the land preventing us from ever building upon the fields
that still
convey the character of past days when it was farmed. So the estate-like am-
biance that now makes our Banbury Conference Center so
successful should be
forever preserved and help Lloyd Harbor keep some of the
atmosphere of 50
years ago, when it was largely covered by the magnificent
properties of many of
New York's best-known families.
We likewise were able to restart a serious program in plant genetics by utiliz-
ing land and farm buildings, purchased from the Nature
Conservancy, on the for-
mer 90-acre estate of Mrs. George Nichols, less than a
half mile away from us to
the east on Lawrence Hill Road. By sharing the maintenance
of its buildings, we
helped the Nature Conservancy keep intact what was once one
of Long Island's
finest estates maintained for agricultural purposes.
We have helped the village of Cold Spring Harbor preserve the handsome
Georgian style school building located on Main Street at the foot of Goosehill
Road. By purchasing it from our local school district for use as our DNA Learning
Center, we prevented its transformation into commercial office space that would
have destroyed its academic flavor. It was built in 1925 using funds provided by
Mrs. Walter Jennings, whose Standard Oil fortune husband had built in 1906 the
magnificent Burrwood mansion at the top of Snake Hill Road. Sadly, Burrwood it-
self has just been demolished, having served as a residence for the blind long
since the end of World War II following the deaths of its original owners. For years
I had dreamed of finding the funds to renovate Burrwood as a residence for our
increasing number of graduate students who now number some 50. But a
multimillion-dollar sum would have been necessary to restore it properly, and I
never seriously shared this hope with others, knowing it to be unrealistic.
But now that Burrwood is gone, our community has lost an important expres-
sion of its fabled past. We should work to see whether further opportunities exist
whereby we could save remaining historic properties through utilizing them for
our current needs. In particular, we now desperately need more residences for
our younger scientists, few of whom have the resources to live within our well-to-
do local neighborhoods. Although we possess hilltop land off Moore's Hill Road
in Laurel Hollow suitable for such residences, we would prefer now to keep that
land vacant, both to maintain a buffer space between us and our nearby neigh-
bors and to retain the future possibility of devoting some of this land to scientific
uses. Thus, I believe, it would be in the best interests of both ourselves and our
neighboring villages if we can acquire additional off-ground sites whose historic
flavor we can maintain by our occupancy.
I am thus optimistic that the Cold Spring Harbor Laboratory will continue to
serve well both its own scientists and those working outside it while at the same
time further enhancing the quality of life for those citizens who live nearby. We
must always remember that only by continuing to do science at its best will we
maintain the financial strength needed to allow us to design and maintain build-
ings that our neighbors can forever take delight in. So we must necessarily al-
ways look more to the future than to its past. What we look like must reflect the
way we need to be to do the science that the world wants.
I will always remember our sage neighbor Amyas Ames remarking that if it
were not for the Lab, Cold Spring Harbor would be no different from the Green-
wich that lies just across Long Island Sound. We will not let it go that way.
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HIGHLIGHTS OF THE YEAR
A Nobel for Splicing: The Tumor Virus Program Bears Fruit
Beginning in 1969, Joe Sambrook and I began assembling a tumor virus group at
Cold Spring Harbor. After the successes of the 1960s in understanding the ge-
netic code and the way genetic information was translated into proteins, a next
logical step was to apply this new knowledge to understanding cancer. Tumor
viruses seemed to be an ideal model system. These tiny packages of proteins
and genes somehow contained the necessary information to generate cancer. In
addition, the National Cancer Institute was soon to embark on its "War on Cancer"
and so funding for cancer research was readily available. So I began to recruit
the best scientists I could find to tease out the functions of the handful of genes
in DNA viruses such as simian virus 40 (SV40) and the somewhat larger
adenovirus 2, which Ulf Pettersson brought from Sweden to Cold Spring Harbor
in 1971. That year, a young postdoc named Phillip Sharp came from Caltech to
work with Joe Sambrook, and the next year Richard Roberts, an expert DNA
chemist from England, came to set up his own research group in Demerec
Laboratory. Soon, both of them turned their attention to the wide-open adenovirus
field, which was relatively unpopulated at the time. As with the discovery of a new
continent, the first job to be done is the cartography. In genetics, this means
mapping out the locations of the genes. So Roberts and Sharp collaborated on
an early paper on adenovirus gene mapping.
Sharp accepted a job offer from the Massachusetts Institute of Technology in
1974, where he took his postdocs and set up shop to continue working on
adenovirus. Roberts stayed at Cold Spring Harbor and pursued among other
projects his own adenovirus research. Soon his laboratory began identifying
novel restriction enzymes, proteins discovered in the 1960s that are used by host
cells to defend themselves against invading viruses by cutting up their DNA.
Each one of these enzymes recognizes a specific DNA sequence and cuts the
DNA at each occurrence of that sequence. Roberts realized that many such en-
zymes were likely to exist and quickly developed techniques for seeking them out
and purifying them. Here he saw, perhaps more than anyone else, their immense
potential as tools for molecular biologists. Not only could these enzymes break
up a long DNA sequence into manageable pieces, but they would cut a genome
the same way every time. Moreover, if you knew what sequence a given enzyme
cut, you therefore knew the sequence at each cut it made in novel DNA.
Soon Roberts effectively set up a restriction enzyme clearing-house in his
laboratory, with bottles and flasks and a line out the door of scientists from all
over the country wanting to borrow a little EcoRl or BamHI. This project was his
bread and butter, allowing him to pursue riskier projects with adenovirus.
With his talented postdoc Richard Gelinas, who had come from Harvard,
Roberts began in 1975 to try to identify the sequences of adenovirus promoters,
the DNA sequences used to turn on gene transcription. No one had yet se-
quenced a promoter from an organism higher than a bacterium, and Roberts rea-
soned that a virus which infected a higher cell would likely have promoters similar
to that of its host. Furthermore, they reasoned that each
of the 20 or so viral
genes would have its own promoter. To find them, Roberts and Gelinas devel-
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oped a way to isolate just the left-hand (5 ' ) end of the RNA messages for some
20 different adenovirus proteins. But when they did the experiment, they only got
one sequence, an 11-nucleotide-long string. This seemed certainly to be an
artifact, since they expected some 20 different sequences, one for each protein.
When they repeated the experiment, however, they got the same result. Two con-
clusions were possible: Either the same 11-base sequence was repeated
throughout the adenovirus genome at the beginning of every gene or it only oc-
curred once in the genome and was somehow tacked onto each RNA message
during transcription. The latter possibility was unheard of, but it turned out to be
correct.
Dr. Richard Roberts (left) receiving 1994 Nobel Prize for Physiology or Medicine from King
Carl XVI Gustaf of Sweden
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It was easy enough to check whether a given sequence occurred with un-
usual frequency in the adenovirus genome, and when they looked, they found
that it did not. At the same time, another postdoc in Roberts' laboratory, Sayeeda
Zain, unexpectedly found another piece of the puzzle. She had been looking at
recombination between SV40 and adenovirus. A recombination event happened
to occur at a spot just in front of one of the adenovirus genes that Gelinas and
Roberts had been studying. A natural assumption was that Zain would therefore
encounter a DNA sequence complementary to the now-notorious 11-base se-
quence in the RNA, but she did not. The DNA complement to that 11-base se-
quence therefore had to lie somewhere "upstream" in the genome. The gene, in
other words, had to be in at least two parts, which were somehow joined during
transcription to make a single messenger RNA.
At this point, late in 1976, Roberts and Gelinas began to suspect the exis-
tence of what we call today split genes. A key paper they coauthored in January
1977 suggested that the DNA complement to the 11-base message fragment
might not lie adjacent to the DNA for the rest of the RNA message. Roberts and
Gelinas then began to design and carry out experiments to show that this 11-
base message fragment was not a contaminant or other artifact. One Saturday
morning in the early spring of 1977, Roberts conceived the key experiment dur-
ing one of his regular meetings with Gelinas. It would use electron microscopy to
show that a DNA fragment from upstream in the adenovirus genome would bind
to the end of the RNA message from the downstream gene. Neither Roberts nor
Gelinas knew electron microscopy, but fortunately right downstairs in Demerec
Laboratory were Louise Chow and Tom Broker, who knew the specific tech-
niques needed to do the experiment. Roberts and Gelinas explained to Broker
and Chow what they wanted to do. Chow said she thought it sounded possible
and to do the experiment. 3 days, they had the result, and it
looked almost exactly as Roberts had drawn it on the blackboard the previous
Saturday.
Chow, however, had a good microscopist's eye for detail, and she explained
to Roberts and Gelinas that her pictures showed that the RNA was a composite
of more than two distinct regions of DNA. The adenovirus gene was instead
made up of four separate regions that were spliced together to make a single
RNA message.
Over the next few months, many people contributed to fleshing out the final
picture of split genes. Dan Klessig, from Ray Geste land's laboratory, had been
applying the techniques Gelinas had been using to specific RNA messages, and
he showed much more detail in terms of how splicing occurred. He also articu-
lated the probable mechanism by which the splicing of RNA message
fragments
from different regions of the genome could occur. Other scientists at Cold Spring
Harbor had results that in fact could only be adequately
explained by splicing.
John Hassell and Ashley Dunn, from Joe Sambrook's
laboratory, and Jim Lewis,
Carl Anderson, and John Atkins, from Ray Geste land's laboratory, reinterpreted
their results in terms of RNA splicing, making a very strong case indeed. Roberts
coordinated a group of four papers that were shipped off to the journal Cell and
were published back-to-back in the October 1977 issue.
At the same time up at MIT, Phil Sharp and Sue
Berget had made the same
discovery. A slightly different approach to the same
electron microscopy experi-
ment had led them directly to the conclusion that the adenovirus messenger
RNA
molecules were coded by four discrete regions
of the DNA. Their results were
published in the August 1977 issue of Proceedings
of the National Academy of
Sciences.
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If some scientific discoveries are like time
bombs, lingering in the literature for
years until they become widely accepted or
their generality to all life becomes
clear, this was a land mine. As soon as Roberts
and Sharp stepped on it, it blew
up the entire field of eukaryotic gene structure.
At the Cold Spring Harbor
Symposium in June, 1977-still 3 months before the first publication-the papers
by Sharp and Tom Broker reporting on the discovery of splicing were followed by
another on splicing in adenovirus and two more on
splicing in SV40. Soon every-
one discovered that RNA splicing explained
results they had been getting for
months. It was almost instantly accepted.
This year in October, 16 years after the discovery,
RNA splicing was recog-
nized by the Nobel Committee, and Roberts and Sharp
shared the Nobel Prize in
Physiology or Medicine. The week after the announcement from Stockholm, we
held a party for Rich that was attended by many of the Laboratory staff who
wanted to celebrate this most glorious of all prizes awarded for scientific achieve-
ment. Our pleasure in the occasion was tempered by the omission of those other
Laboratory scientists who contributed to the discovery. The Nobel Committee's
"Rule of Three" has often precluded acknowledgement of all who shared in the
burden of research, most notably in this case the vital contributions of Louise
Chow and Richard Gelinas. Last year, Rich concluded 20 years at Cold Spring
Harbor and moved to the Boston area to head research at New England Biolabs,
the premier source for restriction enzymes. He continues his ties with the
Laboratory, however, not least through his exciting collaboration on DNA
methylases with staff scientist Xiaodong Cheng.
The phenomenal growth of the splicing field, now with its own subdisciplines,
such as the exciting field of alternative splicing, is proof of the value of basic re-
search and yet another reminder that most real scientific innovations come from
"pure" investigations, undertaken for their own intrinsic interest. Splicing has clini-
cal interest as well-dozens of diseases, including 13-thalassemia, Tay Sachs, and
some forms of cystic fibrosis and muscular dystrophy, have been shown to result
from defects in RNA splicing.
A Good Year for Cancer Research, Crystallography, Plant Genetics
In 1981, in Demerec Laboratory, Mike Wig ler was one of the first scientists to dis-
cover a human oncogene, called ras. The Ras protein, made by the ras gene,
plays a key role in telling a cell when to grow and divide. When genetically
damaged, the ras gene's respective protein product can become stuck in the
"on" position, sending the cell into uncontrolled growth. This discovery began
what has become a worldwide effort to understand exactly how the Ras protein
functions, how it is activated, and what it in turn activates to initiate cell growth.
This year saw large advances in our understanding of the Ras pathway, and
several laboratories at Cold Spring Harbor contributed significant pieces to this
large jigsaw puzzle. We now have a nearly complete molecular pathway, from the
extracellular signal all the way down to the DNA.
The Ras pathway begins at the cell membrane, with a receptor protein such
as the epidermal growth factor (EGF) receptor. The EGF receptor receives a
molecule of growth factor, which circulates in the blood, to trigger the Ras path-
way and at least one other pathway called SIF. The SIF pathway has fewer steps
to the DNA than the Ras pathway, and it activates a different set of genes. In
James Laboratory, Mike Gilman's group showed that the EGF receptor's SIF
pathway activity is independent of its Ras pathway activity. By mixing cell mem-
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branes, cytoplasm, and EGF, they reconstituted the activity of the EGF receptor
in a beaker and showed that they could recover SIF activity.
In the Ras pathway, the EGF receptor becomes activated when EGF binds to
it. It can then bind a complex of two proteins, GRB2 and Sos. Dafna Bar-Sagi,
working in Demerec Lab, showed that GRB2 binds the EGF receptor, and when
Ras is in the activated state binds Sos. Mike Wigler's laboratory furthermore
showed that activated Ras in turn binds a protein called RAF. The RAF protein is
the first in a bucket brigade of protein kinases, each one activating the next by
phosphorylating it, that results in the activation of a protein such as AP-1, which
binds DNA to turn on genes. Also essential to controlling cell growth is
deactivating the proteins in this pathway. Nick Tonks' laboratory isolated a
protein that deactivates MAP kinase, the last step in the kinase bucket brigade.
The protein, called a tyrosine phosphatase, is one of the first such proteins to be
purified and understood functionally in the cell.
In our Keck Laboratory of Structural Biology, David Barford has just worked
out the three-dimensional structure of the first tyrosine phosphatase. Equally ex-
citing has been the achievement of Xiaodong Cheng, who produced a high-
resolution three-dimensional map of Hhal methylase. This project, part of a col-
laboration between Xiaodong and Rich Roberts, promises to elucidate the func-
tion of an enigmatic kind of enzyme. Methylases attach a small chemical group
called a methyl group (CH3) to DNA. Some researchers hypothesize that
methylation blocks other proteins from binding to the DNA. Thus, if a promoter or
an enhancer region were heavily methylated, the gene might be "silenced."
Methylation is at the center of a hot debate over how gene activity is controlled in
the cell.
DNA-binding proteins have specific "domains" that recognize a particular
DNA sequence. Some bind to a gene's promoter, which directly turns on the
gene, whereas others bind to an enhancer, which, as its name implies, enhances
the activity of the promoter, providing another level of regulatory control. Winship
Herr's group, in James Laboratory, helped determine the structure of the DNA-
binding domain for a protein that binds to an SV40 enhancer. The structure of this
DNA sequence, called the POU-specific domain, is strikingly similar to that of the
DNA-binding domain of the repressor of bacteriophage X, a bacterial virus. To-
gether with other results, this revealed that human dwarfism can occur by defects
similar to those that affect X replication-an amazing similarity between such dis-
tantly related organisms.
Laboratory scientist David Beach is one of the world leaders in the cell cycle
field. This year, his group in McClintock Laboratory identified two new genes and
their proteins, which are key players in regulating cell growth. One, called p21,
interacts with the nearly ubiquitous tumor suppressor protein p53. In response to
DNA damage, p53 activates p21, which then interacts with a variety of other
proteins to halt cell growth. The p21 protein functions by blocking the activity of
cyclin-dependent kinases, which are proteins that have a key regulatory role in
the cell cycle. If p21 is damaged, this check on growth could be removed, lead-
ing to tumor formation. The other gene, which they
called p16, inhibits a major
cycle protein complex called cyclin D/Cdk4. This protein
complex inhibits yet an-
other protein called Rb, which inhibits cell growth. Through this triple negative,
the p16 protein holds cell growth in check. Early
in 1994, scientists in Utah found
a gene that was damaged in a large proportion of cancers, including cancers
of
the lung, brain, bladder, breast, blood, and
skin. The discovery that this gene
was the same as p16 marks the most direct
link to date of cancer to the genes
that control the cell cycle.
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James D. Watson
Formation of the Dana Consortium on Manic Depressive Diseases
An exciting new collaborative research project was
begun this year to identify the
genetic underpinnings of manic depressive illness
(MDI). The project is funded
by the Charles A. Dana Foundation and involves
research teams at Cold Spring
Harbor, Johns Hopkins, and Stanford. The team at
Johns Hopkins is selecting
very carefully families with manic depressive illness for genetic
analysis, and this
analysis is being carried out at both Johns Hopkins and Stanford. The
Laboratory's contribution is to develop an integrated
database that will have at its
core programs for linkage analysis but will as well
incorporate information on all
aspects of the diagnoses and laboratory analyses
of these families. This data-
base is being designed in Tom Marr's Computational
Biology group, using a pro-
gram developed by Marr called Genome Topographer. An especially exciting
feature of this approach is that the database will be useful
for genetic research
on other disorders. We are also promoting research on manic depressive illness
through meetings being held at Banbury Center and through courses intended to
train psychiatrists in basic molecular genetics.
Double Helix Turns 40
The year 1993 marked the 40th anniversary of the discovery of the double helix.
The Laboratory celebrated with a special 3-day meeting entitled DNA and
Biotechnology, which spanned both the history and the future of DNA science.
Among the audience were leading scientists from the now almost 40
pharmaceutical, diagnostic, and biotechnology companies that are the corporate
sponsors of our meetings programs. On the opening night, Francis Crick gave a
thoroughly engaging public evening lecture to a packed Grace Auditorium, after
which I presented him with a minature golden helix to celebrate the occasion.
The next day featured talks by many of the pioneers in DNA science, including
Paul Doty, Tom Maniatis, James D. Watson, and Wally Gilbert at celebration of
40th anniversary of the double helix
16
Mahlon Hoagland, Rich Roberts, Wally Gilbert, Stanley Cohen, and Mark
Ptashne. Kary Mullis' talk on his discovery of the polymerase chain reaction, for
which he won the Nobel Prize in Chemistry this year, was a colorful and entertain-
ing highlight of that afternoon. Then after a banquet, I talked about how I have
tried to adapt to the various stages of my life as a student, a scientist, a profes-
sor, a writer, an administrator, and a bureaucrat. As befits the central role played
by DNA, talks on future developments in biotechnology covered a wide range of
topics. We can now control gene expression (Peter Dervan), design proteins (Jim
Wells), and study how the brain works (Sol Snyder). New strains of plants can be
made with special characteristics (Robert Fraley) and human proteins can be
produced in both animals and plants (Alan Colman). Genetic disorders can be
diagnosed (Tom Caskey) and, most spectacularly, gene therapy is being used to
help those afflicted (French Anderson). The whole meeting was a testament to
the extraordinary power of molecular genetics and to the work of thousands of
scientists over the past 40 years.
Symposium LVIII
This year's Symposium was on DNA and Chromosomes, a further tribute to the
40th anniversary of the double helix. Forty years after the 1953 Symposium on
Viruses where I first presented our model for the structure of DNA, Bruce Alberts
of the University of California, San Francisco, and Bruce Stillman put together a
first-class program featuring sessions on some of the most interesting new re-
search areas, such as silencing, imprinting, and chromosome domains, as well
as productive mainstream areas such as transcription and regulation. Eric
Lander, of the Whitehead Institute and MIT, gave the annual Dorcas Cummings
public lecture, which occurs midway through each Symposium. Lander is one of
the world's leading genome scientists, and his talk was entitled "Mapping Genes
and Genomes." Lander is adept at accurately simplifying complex issues, and he
outlined with elegance the arguments for mapping and sequencing the human
genome. A highlight of the event was a gift from Laboratory employees and many
of my friends and colleagues of a 15-foot bronze sculpture of a double helix,
crafted by local artist Charles Reina. "Bronze Helix" has become the focal point of
the Grace Auditorium lobby and is a fitting tribute to four decades of excellent
science as well as the world's prettiest molecule.
A Rich Program at Banbury Center
Banbury Center continues to hold exciting meetings, ranging from "hard" science
to social issues affecting the way modern research is pursued. An outstanding
meeting in 1993, and one typical of the Banbury style, was that on Apoptotic Cell
Death: Functions and Mechanisms. This is a topic that has changed beyond
recognition in recent years, and cell death is now seen to be a normal and essen-
tial process in the lives of cells, including cancer cells. For this meeting, we
brought together scientists working on cell death in diverse biological systems,
who find now that their research has converged on common molecular pathways.
All of us hope that the new knowledge coming from the Human Genome Pro-
ject and other research can be put to use to help people. For disorders like
Duchenne muscular dystrophy, we want methods to treat boys afflicted by this
disorder, and Banbury Center was the site of a meeting to examine a novel
strategy to do this. Molecular studies suggest that it may be possible to turn on a
gene for a protein called utrophin, which might substitute for the protein
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dystrophin that is missing or damaged in boys with Duchenne muscular
dystrophy. We must now see whether this can be
achieved in practice.
With each passing year, federal funding for research
becomes more difficult
to obtain, and so we must turn increasingly to private
sources. But close associa-
tions between academic institutions and the corporate
world are fraught with
potential conflict of interest problems. In a very interesting
and important meeting
at Banbury Center held in May, the benefits and
problems were reviewed and as-
sessed by scientists, institutions, and politicians. No
definitive conclusions were
reached, but at least the complexities of the situation were appreciated.
Baring Brothers Executive Meeting
For the eighth year of our October meetings for senior executives in the worlds of
pharmaceuticals and biotechnology, we turned to the topic of Human Molecular
Genetics, a field that we drew attention to in our first executive conference held in
1986. The advances that have been made since then have been quite astound-
ing. The major successes up to 1986 were locating the gene for Huntington's dis-
ease and cloning the gene for Duchenne muscular dystrophy. But in 1993, our
speakers were able to discuss the trinucleotide repeat genes, including the gene
for Huntington's disease, the hunting of genes involved in breast cancer and
other complex disorders, approaches to developing new genetic diagnostic
techniques, progress in genome research, and, far in advance of our expecta-
tions, gene therapy for inherited diseases and cancer. The recent meetings in
this series have been supported by Baring Brothers of London together with Dil-
lon Read of New York. I would like to pay a special tribute to Robin Broad ley of
Baring Brothers, London, who has been such an enthusiast for bringing together
the worlds of commerce and biology.
Robertson Research Fund Marks 20th Anniversary
This was a year of milestones. In addition to the 40th anniversary of the double
helix, we celebrated the 20th anniversary of the Robertson Research Fund. The
more than generous gift in May 1973 from Charles Robertson and his family of $8
million and their family estate instantly secured the Laboratory's future as a con-
tinuing leader in molecular biology research. Until then, the Laboratory did not
have a meaningful endowment. Today, thanks to prudent, conservative manage-
ment, the original Robertson sum has grown to over $48 million. The Robertson
estate, originally endowed with its own $1.5 million endowment that now has risen
to $7.8 million, has become our Banbury Conference Center, home to an eclectic
and engaging series of meetings and workshops on biology and social topics. In
early June, we feted the Robertsons with a special evening featuring talks by
some of our scientists and a brief but moving acknowledgment from Bill Robert-
son, a leather-bound booklet outlining the history and achievements of the Fund,
and a wonderful dinner in Blackford Hall. A bronze plaque on the wall in Grace
Auditorium lobby now commemorates the Robertson Fund.
Major Gifts
The Laboratory received a number of major gifts in 1993 from corporations, foun-
dations, and private individuals. Major gifts are an important part of our ability to
support young scientists. Many of these were gifts to the Cancer Research Fund,
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which supports all aspects of cancer research at Cold Spring Harbor. Nearly two
thirds of the research done at Cold Spring Harbor has implications for under-
standing cancer. The Cancer Research Fund now stands at $4.1 million, thanks
to a number of substantial recent gifts. Among these are gifts of $100,000 from
the Booth Ferris Foundation, $94,000 from Sherburn Becker, $25,000 from the
David Koch Foundation, $150,000 from William and Irene Miller, $55,000 from Dr.
David Pall, $50,000 from the Perkin Fund, and $10,000 each from the Daphne
Seyboldt Culpeper Foundation and Oncor, Inc. The Fannie E. Rippel Foundation
has made a challenge grant of $250,000 to raise the $750,000 needed to cover
the $1 million equipment budget for the Cancer Research Fund. We are particu-
larly grateful to George and Mary Lindsay for the $250,000 unrestricted gift.
The Infrastructure Fund was concluded this year with great success. It raised
a total of $4,124,000 that will be used to build and improve facilities and support
research. The Fund is being named in honor of William Miller, in recognition of his
leadership. Research Support Funds will continue to target the pharmaceutical
industry, but the focus will now shift to program support. Henry Wendt and Max-
well Cowan were the first contributors to this fund, with pledges of $150,000 and
$25,000, respectively, for neuroscience fellowships.
This year, we also launched the Genetic Diseases Fund, which will be used to
support research into the biology of hereditary illness with initial emphasis on
muscular dystrophy. Inaugurating this fund were gifts from John Cleary and his
family, Owen Smith, the Daphne Seybolt Culpeper Foundation, and myself. The
Fort Hill Foundation provided $500,000 toward the William J. Matheson Chair,
and the Banbury Fund contributed $50,000 for the Charles S. Robertson Chair.
We received Planned Gifts this year from Townsend and Elise Knight, Robert
Gardner, the Taggert Whipple estate, Charles Henry Leach II, and Ed Palmer.
The Annual Fund, made up of contributions from the nearly 900 members of the
Cold Spring Harbor Laboratory Association, continues to be strong and vigorous.
The 100 new members of the Laboratory helped bring the Annual Fund total to
$526,241.
McClintock Remodeled, Reinhabited
Renovations to the 1912 McClintock Laboratory were completed this year, and
David Beach and Dick McCombie moved in. The main externally visible change
is the addition of a mostly glass third floor, topped with an already-patinaed cop-
per roof, set atop the flat roof of the original structure. The third floor houses of-
fices and the William and Eleanore Everdell Seminar Room. Interestingly, a third
floor was first considered for the building in 1937, but it was thought to be ar-
chitecturally impossible. Indeed, even today it would have been cheaper and
easier to raze the historic structure and build a new, larger facility. But the old
Animal House is a Laboratory landmark; both Barbara McClintock and Al Her-
shey did their Nobel-winning research there. So we brought in the ever-talented
Bill Grover and Centerbrook Architects to remodel the interior, design a tasteful
third-floor addition, and plan out the structural strengthening that would be
needed to turn the 80-year-old building into a modern cancer and gene-
sequencing laboratory. The old Animal House is now very much a yeast house.
Upstairs, David Beach uses the yeast Schizosaccharomyces pombe to probe the
genes and proteins that control the cell division cycle. Downstairs, Dick McCom-
bie is mounting the "Pombe Genome Project," a large-scale effort to sequence all
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Lita Annenberg Hazen and James D. Watson
of the yeast DNA. The two laboratories are
complementary and further collabora-
tions take place with Tom Marr's computer
laboratory across the road in Hershey
building.
On the second floor, the two main laboratories for cancer research now have
plaques acknowledging the great generosity of the late Charles Leech II and the
Farish Fund. The ground floor is the gene laboratory made possible by a gift from
Lita Annenberg Hazen, who long has been one of the Laboratory's most devoted
supporters. So it was with great pleasure that we have attached her noted name
to our Gene Sequencing Laboratory. Early in October, we formally dedicated the
new McClintock Laboratory in the presence of the major donors who made pos-
sible this latest facility for modern science at Cold Spring Harbor.
A Great Architect Passes
Charles Moore, founder of Centerbrook Architects and one of the great architects
of the 20th century, died of a heart attack on December 15 at his Austin, Texas,
home. Born in 1925 in Benton Harbor, Michigan, Moore took a Bachelor of Ar-
chitecture degree at the University of Utah in 1947 and a Ph.D. at Princeton in
1957. He accepted an associate professorship at the University of California,
Berkeley, in 1959. Three years later, he became chairman of the Berkeley ar-
chitecture department and formed a partnership with three colleagues, Dorilyn
Lyndon, William Turnbull, and Richard Whitaker (MLTW). Moore first achieved na-
tional recognition with the development of the popular Sea Ranch Condominiums
on California's North Coast. Over the next 8 years, MLTW designed many promi-
nent structures in California, including several at the new University of California
campuses at Santa Barbara and Santa Cruz. In 1965, Moore took the chair of the
architecture department at Yale. He began a solo practice in 1970, after the
MLTW partners separated, and in 1975, he formed Moore Grover Harper in Es-
sex, Connecticut-the forerunner of Centerbrook Architects.
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It was during June 1972 that the Laboratory first became acquainted with
Moore. On a trip to California, my wife and I drove north of San Francisco where,
after spending a night at the Sea Ranch Lodge, we toured the extraordinary col-
lection of new homes that surrounded it, including Moore's now famous Condo-
minium. Upon returning East, we realized that Charles Moore was also active on
Long Island, being responsible for the design of the Whitman Village Apartments
in Huntington Station. So we asked him to visit the Lab with the thought that he
would help renovate Airs lie, the director's house into which my wife and I were
soon to move. Soon he and his talented collaborator, Bill Grover, gave an elegant
design to the interior of Airs lie. Two years later, they also gave us super plans for
remodeling the Robertson family carriage house to create the Banbury Meeting
Center. In 1981, when his Palladian-styled Sammis Hall residence at the Banbury
Center was dedicated, Moore was again on the West Coast, a professor of ar-
chitecture at the University of California, Los Angeles. In 1985, he moved again,
this time to Austin, Texas, where he took a professorship and opened a new
practice with Arthur Andersson. Throughout his long career, Moore showed style,
imagination, respect for tradition, and dissidence from current fashions in ar-
chitecture. He won the most prestigious awards in his field, including the
AIA/ACSA Topaz Medallion for architectural education and the AIA Gold Medal.
Beyond that, he was simply one of the great minds in architecture. We are proud
to have his stamp on our institution.
DNA Learning Center Renovates, Goes Multimedia
The DNA Learning Center underwent an extensive set of renovations, designed
by Centerbrook of Essex, Connecticut, that left it with a new exhibit space,
sophisticated computer lab, and, most spectacularly, a state-of-the-art
auditorium, complete with a multimedia show about Long Island.
Sponsored by Cablevision Systems Corp., the Stone Foundation, Inc., Edwin
S. Webster Foundation, and the Weezie Foundation, the renovations included
more than $600,000 worth of work and affected 90% of the building's 7600
square feet. A new computer lab is linked to the "wet" lab next door, enabling
classes to do experiments and then go into the next room to work computer
simulations that explain the biology. A new exhibit space features an elaborate
mural of the inside of a cell, painted by art students at Cooper Union and New
York Tech.
The highlight of the new Learning Center is the auditorium. Located in what
was once the Cold Spring Harbor elementary school's gymnasium, the 104-seat
hall now features a bank of 5-foot by 7-foot video screens, 36-inch monitors, and
12 sets of speakers. The hall can accommodate nearly any type of presentation,
from "chalk talk" to slides to computer-generated movies. The showpiece of the
hall, though, is "Long Island Discovery," a 28-minute multimedia presentation
sponsored by Cablevision Systems Corporation and developed for the Learning
Center. The movie uses the multiple screens and surround-sound capabilities of
the auditorium to give a rich picture of the history and diversity of Long Island.
The DNA Learning Center staff encourage local teachers to use the show as a
teaching tool and to draw classes to the other features of the Learning Center.
Nick Tonks Wins Colworth Medal
Nick Tonks received a high honor when he was awarded the Colworth Medal this
year. This prestigious award is given to the "top British biochemist under the age
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Nick Tonks
David Beach
Bruce Stillman signing
in as FRS as wife Grace
watches
of 35." Nick's exciting work on tyrosine
phosphatases, a vital but poorly un-
derstood class of regulatory enzymes,
makes him a leader in today's cohort of
hot young molecular biologists.
David Beach Honored with
Lilly Award
Senior Staff Scientist David
Beach was honored with
the Eli Lilly and Company
Research Award, given by the American
Society of Microbiology. The award,
given for work "of unusual merit for an
individual on the threshold of his or her
career," is among the most
prestigious in microbiology.
Previous winners include
Joshua Lederberg (1953), Matthew
Meselson (1964), and David Baltimore
(1971). Established in 1936, the
Award was first given to
Harry Eagle, a
Laboratory trustee from 1962 to
1991 and chairman of
the board of trustees from
1974 to 1979.
Bruce Stillman, Fellow of Royal
Society
In March of this year, Bruce Stillman
was elected a Fellow to the Royal Society,
one of the most prized honors for
scientists of British or Commonwealth
citizenship. Bruce, an Australian citizen,
joins an elite group of scientists stretch-
ing back to the sixteenth century.
Bruce will be the second director to have been
elected to the Royal Society, the first
being my predecessor John Cairns who
was elected to the Society in
1974 soon after his return to England.
A Boom Year for the Press
The Press continued an ambitious publishing
program by adding 15 new books
and 2 new videotapes, bringing its total
titles in print to more than 120, doubling
the frequency of both its current journals, and announcing
plans for the launch of
a third journal in 1994. Sales increased by 16% to over
$4.3 million, and the
balance after expenses, including significant
one-time charges, rose by 25%.
New titles were added in all categories of the catalog. Sales
of laboratory
manuals continued to flourish, particularly the perennial bestsellers
Molecular
Cloning, Antibodies, and the recent success A
Short Course in Bacterial
Genetics. There were new manuals on molecular
probes of the nervous system
and fission yeast biology. The Symposium volume on
The Cell Surface, published
in the 60th anniversary year of the Symposium's
founding, was a worthy and
colorful addition to this prestigious series. The second volume of the authoritative
monograph Transcriptional Regulation was published, and
the entire book was
almost immediately reprinted in paperback in response to the strong demand for
an edition affordable by graduate students. A
paperback edition of the widely ap-
preciated memoir of Barbara McClintock, The Dynamic Genome, was released,
featuring the elegant cover that won a national design award.
Two new books made a dramatic impact both visually and scientifically. The
RNA World revisited a prebiotic era in which evolution may have depended on
replicating RNA, not DNA, and reviewed current ideas about the structure and
function of this ancient molecule. A notable feature of this book is the
frontispiece-an RNA hologram. Even more arresting is the lavish artwork in The
Development of Drosophila melanogaster, a monograph on the molecular analy-
sis of fruit fly embryology. This book set includes 114 color plates and a separate
stunning 50-page atlas created entirely with computer graphics.
22
It was a year of expansion for our journals. Genes & Development was again
listed as the most cited journal in genetics and in developmental biology and, as
in previous years, had a steady increase in circulation. Because of rising demand
to publish in the journal, the decision was taken to produce issues semi-monthly
in 1994. The success of PCR Methods and Applications, launched in 1991,
necessitated an acceleration from quarterly to bimonthly publication with the start
of Volume 3 in August. The growing tide of interest in the molecular analysis of
mental function prompted the decision to launch a new journal, Learning &
Memory, in 1994. A distinguished group of editors and advisors was readily as-
sembled, attracted by the idea of a journal devoted exclusively to papers on this
broad and fascinating topic.
Undergraduate Research Program
This year's cohort of promising undergraduates included 19 students from nine
states and four countries. Like their predecessors of the last 24 years, these stu-
dents spent 10 weeks during the summer in the laboratories of Cold Spring Har-
bor scientists. They learned the fundamental techniques of molecular biology,
carried out semi-independent research projects, and, most important, were im-
mersed in the culture of science. The program is highly competitive; this year, we
received 176 applications. Thirteen of the successful applicants were women.
Research projects undertaken by this year's students included RNA splicing,
plant molecular biology, genetics of the yeast cell cycle, DNA sequencing, and
Drosophila learning and memory. This highly successful program would be im-
possible without the sponsorship of the National Science Foundation, Burroughs-
Wellcome, the Robert P. Olney Fund, Hanson Industries, Bio-Rad Laboratories,
the Phillips Petroleum Foundation, Libby, Zeneca, and the Cold Spring Harbor
Fund.
Partners for the Future
This was the fourth year for our Partners for the Future program. Born in 1990 out
of the Laboratory's centennial celebration, Partners for the Future extends the Un-
dergraduate Research Program to the level of high school seniors. Local
businesses support five talented Long Island students in a 6-month after-school
research effort, undertaken with the guidance of a Laboratory scientist "Mentor."
These students spend at least 10 hours per week from October through March,
learning new techniques and concepts as well as something about what the day-
to-day life of a scientist is like. This year's Partners, followed by their school and
Mentor, were: Edwin Yoo, Half Hollow Hills High School West (Dr. James
Pflugrath); Olivia Cheng, Plainview-Old Bethpage JFK High School (Dr.
Venkatesan Sundaresan); Seema Gupta, Syosset High School (Dr. Jerry Yin);
Jason Kass, Oceanside High School (Dr. Daniel Marshak); Joann Romano, Great
Neck South High School (Drs. Tim Tully and Mike Regulski).
Long-term Service
Seventeen Laboratory staffers celebrated big anniversaries of employment.
Celebrating 15 years with the Lab were Katya Davey, Banbury Hostess; Gus
Dulls, Mechanical Technician; Jim Garrels, Senior Staff Scientist; Patti Maroney,
Payroll Administrator; Chris McEvoy, Assistant Grounds Foreman; Charlie
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Employees celebrate 15- and 20-year anniversaries at the Lab: (Top, left to right) Jim Car-
rels, Chris McEvoy, Carol Caldarelli, Dorothy Youngs, James D. Watson. (Middle) Patti
Maroney, Gus Dulis, Bea To liver, Mike Wig ler, Charlie Schneider. (Bottom) Laura Hyman,
Nancy Ford, Katya Davey, Elizabeth Watson
Schneider, Estimator/Draftsman; Bea To liver, Banbury Administrative Assistant;
Mike Wig ler, Senior Staff Scientist; Jeanne Wiggins, Laboratory Technician; and
Dorothy Youngs, Head Housekeeper. Celebrating 20 years of service were Carol
Caldarelli, Housekeeper; Nancy Ford, Managing Editor, CSHL Press; Laura
Hyman, Administrative/ Business Manager, Library; and Hans Trede, Grounds
Foreman.
Changes in Scientific Staff
We said good-bye to Drosophila neurobiologist and Senior Staff Scientist Ronald
Davis, who returned to Baylor College of Medicine in Houston, where he was of-
fered an endowed chair. Several of his laboratory group accompanied him, in-
cluding Staff Associate Jim Cherry. Senior Staff Investigator Elizabeth Moran left
to take a joint appointment at Temple University's School of Medicine in Philadel-
phia, as Associate Professor of Biochemistry and Director of the Fels Institute for
Cancer Research and Molecular Biology's program in molecular genetics. Betty
got her start at Cold Spring Harbor as a postdoc in Mike Mathews's laboratory in
1983, where she began working on oncogenes in adenovirus. Senior Staff Inves-
tigator Tom Peterson will pursue his maize transposon work in the heart of corn
country, Iowa State University, in Ames, where he has an endowed chair in Plant
Genetics. Tom came to Cold Spring Harbor in 1987, from CSIRO, Division of
Plant Industry, in Canberra, Australia.
Staff Investigator Roymarie Ballester has left Mike Wigler's laboratory for a
faculty position at the University of California, Santa Barbara. Michael Laspia, a
Staff Investigator in Mike Mathews' laboratory, has taken a position at Dartmouth
Medical School, in Lebanon, New Hampshire. Scott Patterson, a Staff Investigator
in the 2D gel facility, has taken a research position at AMgen, Inc., in Thousand
Oaks, California. Gil Morris, a Staff Investigator under Mike Mathews, has taken a
job at Tulane Medical Center in New Orleans.
Graeme Bolger, a Staff Associate in the Wig ler laboratory and a postdoc here
from 1985 to 1990, has moved to the University of Utah Medical Center in Salt
Lake City. Susan Lobo, Staff Associate with Nouria Hernandez, has moved to the
University of Alabama in Birmingham as an assistant professor.
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Montage presented to J.D. Watson by staff members. Photos represent long-time employ-
ees who worked at Cold Spring Harbor Laboratory between 1968, when Watson became
Director, and 1993, his 25th anniversary.
Several visiting scientists have completed their work here and returned to
their home institutions. These include: Jacques Camonis, from Mike Wigler's
laboratory, who returned to Centree Hospitalier Lariboirere, Paris; Javier Diaz-
Nido, who came from the Universidad Autonoma de Madrid to Dan Marshak's
laboratory; Igor Galkavtsev, from the Medical Genetics Center in Moscow, who
spent time in David Beach's laboratory; Nicholas Muzyczka, who took sabbatical
leave from SUNY Stony Brook to work in Bruce Stillman's laboratory; Kikuo Sen, a
member of Shinshu University, Faculty of Agriculture, in Nagano, Japan, who
worked in the Wig ler laboratory; Huan Ran Tan, visiting from the Beijing Medical
University, Department of Pharmacology, to work with Bob Franza; Robert West,
Jr., from SUNY Health Science Center in Syracuse, who worked with Ron Davis;
and Daisuke Yamamoto, from Mitsubishi Kasei Institute of Life Sciences, in
Tokyo, who also worked with Ron Davis.
New Staff Members
A large number of visiting scientists came to the Laboratory this year. Peter
Barker, from the German Cancer Research Center in Heidelberg, is working with
Mike Wig ler. Brian Cox, from Oxford University, is working with Bruce Futcher.
William Eckberg, from Howard University in Washington, D.C., is working in Nick
Tonks' laboratory. Alexandre Melnikov, from the State Control Institute of Stan-
dardization of Medical and Biological Preparations in Moscow, is working with
Dick McCombie. Carol Prives is on sabbatical from Columbia University and
working in Bruce Stillman's laboratory. John Scott is also on sabbatical from the
University of Hawaii at Hilo to work in Bruce Stillman's laboratory. Tokio Tani, from
Kyushu University in Fukuoka, Japan, is working in David Spector's laboratory.
Rui-Ming Xu, from SUNY Stony Brook, is working with Jeff Kuret.
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Promotions
Senior Staff Investigators Mike Gilman
and Nouria Hernandez were promoted to
Senior Staff Scientist in July. Mike came
to Cold Spring Harbor in 1986, following
a fruitful postdoc at the Whitehead
Institute with ras co-discoverer Bob Weinberg.
His work now focuses on signal transduction,
the set of chemical reactions that
relay growth messages from outside the
cell into the nucleus. Nouria also arrived
in 1986, from Alan Weiner's laboratory
at Yale. Her field is gene transcription. She
focuses her efforts on two systems: small
nuclear RNAs (molecules that function
within the nucleus to carry out RNA splicing) and transcription
of genes of the
AIDS virus, HIV.
Two scientists were promoted to Senior
Staff Investigator this year. Grigori
Enikolopov, who came in 1988 as a visiting
scientist from the Institute of
Molecular Biology at Moscow's Academy of Science,
has found several surpris-
ing functions of the increasingly remarkable gas nitric
oxide, including the ability
to initiate gene transcription. Jacek Skowronski,
promoted from Staff Investigator,
came to Cold Spring Harbor in 1986 from the
National Institutes of Health, in
Bethesda, Maryland. Jacek studies the effects and function
of the HIV gene nef
in mice.
Postdoc Harriet Feilotter was promoted to Staff Investigator in November. As
liaison for the Laboratory's collaborative effort into the genetic basis of manic
depressive illness, Harriet will coordinate efforts among scientists at Cold Spring
Harbor, Johns Hopkins, and Stanford.
Postdocs Eric Chang, from Mike Wigler's laboratory, Erich Grotewold, in the
plant genetics group, Shobha Gunnery from Mike Mathews' laboratory, Misha
Jung in the structural biology group, as well as Stevan Marcus, Akila Mayeda,
and Linda Van Aelst from Mike Wigler's laboratory were promoted to Staff Associ-
ate. Visiting scientist Natalia Peunova was also appointed to Staff Associate.
Postdoctoral Fellows
A large number of postdoctoral fellows moved on to other positions this year.
Cyril le Alexandre, a postdoc with Mike Gilman, has moved to the ICRF in London.
Also from Gilman's laboratory, Ricardo Attar has moved to Princeton, New Jer-
sey, for a position with Bristol-Meyers Squibb. Prasanna Athma, from Tom Peter-
son's laboratory, has left for New York Medical College, in Westchester County.
Kanagasabapathi Balendran, a postdoc with John Anderson, has moved to the
Fels Cancer Institute at Temple University, in Philadelphia. James Bischoff has
left David Beach's laboratory for a job with Onyx Pharmaceuticals, in Richmond,
California. Christian Brandes, a postdoc with Tim Tully, has moved to Brandeis
University, in Waltham, Massachusetts. Paul Clarke, a postdoc with Mike Math-
ews, has returned to the UK, to the Institute of Cancer Research Royal Marsden
Hospital, Sutton, Surrey. Simon Green, also from Mathews' laboratory, has gone
to Ribogene Inc., in Hayward, California. Mubasher Dar, from Betty Moran's
laboratory, has left for Georgetown University. Brigitte Dauwalder, Kyung-An Han,
Victoria Meller, and Efthimios Skoulakis have accompanied Ron Davis to the
Baylor College of Medicine, Houston. Salah Ud Din, who worked under Jim Car-
rels and Bruce Stillman, has gone to pursue other activities. Ahmed Ebrahim,
from Betty Moran's laboratory, is now at home in Bayville. Ian Fitch, who worked
with Bruce Futcher, has moved to the University of California, San Francisco,
while Michael Tyers, also from Futcher's laboratory, has taken a faculty position
at the University of Toronto. Kyuhyung Han, a postdoc with Ron Davis, has gone
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to Hallym University, South Korea. Chris Hardy left Bruce Stillman's laboratory for
a position at Washington University in St. Louis, and John Ruppert went on to a
position at Johns Hopkins University School of Medicine, in Baltimore. Luis
Jimenez-Garcia, from David Spector's laboratory, has gone to the National
Autonomous University of Mexico, in Mexico City. Betty Leichus, a postdoc with
Jeff Kuret, has moved to the University of Iowa, in Iowa City. Maarten Linskens,
from Bruce Futcher's laboratory, and Karen Prowse, from Carol Greider's
laboratory, have taken research positions at Geron Corporation, in Menlo Park,
California. Karen Lundgren and Nancy Walworth, who worked with David Beach,
have both moved on to other jobs: Karen took a position at Glaxo, in Research
Triangle Park, North Carolina, while Nancy went to the Netherlands Cancer Cen-
ter, Amsterdam. Alan Nighorn finished his postdoc with Ron Davis and took a job
at the University of Arizona, Tucson. Arne Ostman, who worked with Nick Tonks,
went to the Ludwig Institute for Cancer Research in Uppsala, Sweden. Gian-Luigi
Russo, a postdoc with Dan Marshak, has moved across the ocean to the Univer-
sity of Naples, while Anthony Rossomando, also from Marshak's laboratory, has
moved across the Sound to Miles Pharmaceuticals, in West Haven, Connecticut.
Robert Swanson, from Mike Wigler's laboratory, has taken a position at
Pharmacopeia, Inc., Monmouth Junction, New Jersey. Ales Vancura has left Jeff
Kuret's laboratory for St. John's University, in Jamaica, New York, while Pi-Chao
Wang has moved to the National Taiwan University, in Taipei. Heidi Wang left
Betty Moran's laboratory for a research job with Bristol-Myers Squibb
Pharmaceutical Institute, in Wallingford, Connecticut. Peter Yaciuk also finished
up his work in Betty's laboratory and moved to an assistant professorship in mi-
crobiology and immunology at St. Louis University Medical Center. Both Yue
Xiong, from David Beach's laboratory, and Qing Yang, from Nick Tonks'
laboratory, took positions at the University of North Carolina, Chapel Hill.
Graduate Students
Several graduate students have moved on. Jill Crittenden and Kwok Hang Wu
have followed Ron Davis to Baylor. Fred Bunz, from Bruce Stillman's laboratory,
has left to complete his M.D. at SUNY Stony Brook. Lea Harrington finished up
her degree under Carol Greider and took a postdoctoral fellowship at the Univer-
sity of Toronto. Jiann-Shiun Lai, from Winship Herr's laboratory, has begun a
postdoctoral fellowship with David Baltimore at The Rockefeller University. Robert
Nash finished his degree under Bruce Futcher and headed for California, for a
postdoc at the University of California, San Francisco. Michael Sheldon left
Nouria Hernandez's laboratory for a postdoc at Rutgers University. Wei Guo fin-
ished her degree with David Helfman and continues as a postdoctoral fellow.
John Connolly, a visiting graduate student with Tim Tully, came from Dr. C.P.
Kyriacou's laboratory at the University of Leicester in England. He has since
returned to England, but may return as a postdoctoral fellow.
A Rock-solid Board of Trustees
After the major turnover in our board of trustees in 1992, it was a relief to have
few changes this year. We did bid a sad farewell to two members, however.
Retiring were George Cutting, whose board membership started in 1986 when he
became president of LIBA, and David Pall, the renowned Long Island scientist
and corporation founder, who has served since 1987. Both have long been close
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personal friends and I will miss
much the invaluable advice
and help they have
given to our board. Charles Dolan,
Shirley Tilghman, and Owen Smith were re-
elected to the board this year following
their first three-year term. The officers of
the board remain David Luke,
Chairman; Mary Lindsay, Vice Chairman; John
Reese, Treasurer; Wendy Hatch,
Secretary; and Townsend Knight, Assistant Sec-
retary.
On Friday night before the annual
trustees meeting, the Laboratory Trustees
held a special lection in honor of my 25 years as
Director. Trustees and guests
were treated to a wonderful talk by my
friend Hanna Gray, the University of Chi-
cago's President Emeritus. After the talk,
David Luke and Mary Lindsay present-
ed Liz and me with a beautiful handpainted
tray-table emblazoned with a
landscape of the Laboratory.
George Cutting Turns Over Presidency of the Cold Spring
Harbor
Association to Mary Lindsay
For the past 7 years, we were extraordinarily fortunate in
having George Cutting
as President of the Long Island Biological
Association and its successor organi-
zation, the Cold Spring Harbor Laboratory Association.
During his leadership, he
played an essential role in the success of the Second Century Campaign, as well
as in turning the Association's annual fund-raising
objective toward providing re-
search support for the younger scientists of the Laboratory. In every way,
George's presidency was an unqualified success, with especially important his
decision to create the donor category of Associate to designate those donors
who annually contribute $1000 or more to the Association. Such Associates now
provide more than 75% of the Association support, allowing it in this year's an-
nual drive to raise more than $530,000. It was thus to our great regret that
George decided that the time had come to retire, his term ending at the Associa-
tion Annual Meeting, January 20, 1993. Then David Luke and I gave tribute to the
vital role he has played in ensuring the Laboratory's healthy scientific future.
Succeeding George as President is Mary Lindsay, also a long-time neighbor of
the Laboratory with her home in Laurel Hollow nearby on Ridge Road. I now have
known Mary and her husband, George, since the summer of 1967 and look for-
ward to even greater Lindsay roles in providing vital leadership skills to the
Laboratory.
I Make the Transition from Director to President
This past year marked my final year as Director, my appointment occurring in
February of 1968. My tenure of slightly more than 25 years has brought me many
moments of happiness as I watched the Laboratory become an even more im-
portant instrument for science than it was when I arrived from Harvard, newly
married, and just turned 40 years of age. Leading our research meetings and
teaching programs has constantly renewed my mind both through the excitement
of important new ideas and facts and through intellectual interactions with so
many talented individuals, many of whom have become lifelong friends. Equally
wonderful has been the opportunity to live on the Laboratory grounds, which
surely must be one of the most attractive sites for conducting science anywhere
in the world.
I am thus very grateful to our Board of Trustees not only for creating the new
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position of President for me, but also for acquiring the adjacent parcel of land
that is enabling the Laboratory to build a new President's House which we hope
will be completed by the early fall of 1994. The costs of the house will be covered
by me as a way of expressing my faith in the continued importance of Cold
Spring Harbor for the promotion of biomedical research and education. Upon the
occupancy of the President's House by my wife Liz and me, the Director's House,
Airs lie, will be further renewed to suit its future occupancy by our new Director
Bruce Stillman and his family. We shall be leaving Airs lie after almost exactly 20
years of contented dwelling. Before we moved in, a year had been spent totally
renovating this 1806 Jones family farmhouse according to the inspired plans
given to us by Charles W. Moore and his talented colleague, William Grover.
Airs lie remains an extraordinarily fine home to occupy, and I anticipate that Bruce
and his family also will take great pleasure from its beautiful lawns and specimen
trees.
April 15, 1994 James D. Watson
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ADMINISTRATION
1993 was a remarkable year to be at Cold Spring Harbor Laboratory with a ring-
side view of the stunning progress driving the fields of molecular biology and
genetics. There were breakthrough discoveries at the Laboratory, some receiving
much attention in the national media, and most everything new and interesting
from other places was being discussed at our meetings, taught in our courses, or
published by the Cold Spring Harbor Laboratory Press. Against this background
of extraordinary science, it should not be surprising that other aspects of
Laboratory operations were very satisfactory as well.
Financial results were good with revenues at a new high of $39 million. For
the fifth consecutive year, there was a surplus from operations after provision for
depreciation and reserves for future contingencies. During the last 5 years, oper-
ations have provided nearly $12 million of cash flow for investment in new and
improved facilities and programs. Final 1993 results were more than $1 million
better than projected at the beginning of the year due to higher than expected
meetings attendance, a strong level of government grants, higher royalty and in-
terests receipts, and careful cost control by administrative departments. Environ-
mental Health and Safety, under the effective leadership of Art Brings, saved
some $240,000 through innovative programs for managing and disposing of
radioactive and hazardous waste.
The Cold Spring Harbor Laboratory Press, Banbury Center, and the DNA
Learning Center, which operate as individual cost centers, each improved their
financial results over the previous year. The Press, with its successful journal pro-
gram and increased new book publications, has become reliably self-sufficient,
which is important for the Laboratory at this time when Federal grants for science
are difficult to obtain. Both Banbury and the Learning Center conduct innovative
and consistently first-rate programs with broad national significance. They are
successful in attracting the funding they require and operate at a modest surplus
before depreciation.
The Laboratory's endowment, consisting of the Robertson and Cold Spring
Harbor funds, ended the year at a new high level of approximately $92 million.
The investments include a balanced mix of domestic and foreign equities, fixed
income securities, and short-term liquid instruments. The endowment represents
the Laboratory's primary internal source of funding for science and also provides
important support for $30 million of outstanding tax-exempt civic and research fa-
cility development bonds. Over the years, the drawdown from endowment has
been maintained at a conservative level, averaging about 3.5% per year. This al-
lows for substantial reinvestment of income to protect against inflation and to pro-
vide for future programs. The endowment enjoys excellent investment manage-
ment from Miller, Anderson, and Sherrerd and from the U.S. Trust Company. In
1993, the Robertson and Cold Spring Harbor funds had a total return of about
13.5% compared with a benchmark index of 10.5%. The Cold Spring Harbor
Fund also benefited from new gifts of $2.9 million, which included $500,000 from
the Fort Hill Foundation to establish the William J. Matheson Chair and an addi-
tion of $50,000 from the Banbury Fund for the Charles S. Robertson Chair.
The Trustees of the Laboratory have set as a goal to increase the endowment
to a level of $100 million, net of outstanding debt, by the year 2000. At their No-
vember annual meeting, the Trustees established a new program entitled The
Next 100 Years, which seeks new funds for the endowment in the form of
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planned giving. Such gifts, which include various forms
of trusts, bequests, and
outright donations of property, are regarded by most
institutions as the largest
potential source for future endowment funds.
Much discussion has occurred in recent years
concerning the rates of in-
direct cost recovery that institutions receive on government
research grants and
use to pay the cost of overhead incurred in
providing support and facilities for
science. There has been pressure from Congress to
correct a few much
publicized cases of abuse and for a broad reduction
in such rates. We are
pleased that in 1993, the government accepted the Laboratory's
past procedures
without adjustment and negotiated with us a new 5-year predetermined rate in-
corporating a reduction of about 5%. This removes considerable uncertainty and
greatly facilitates future planning. Bill Keen, our Controller,
deserves much credit
for his very competent past and present handling of this important subject.
Particularly noteworthy during 1993 were the ongoing efforts by John
Maroney, Director of Commercial Relations, to match up the discoveries of
Laboratory scientists with pharmaceutical and biotech companies interested in
providing research support in return for various rights to existing intellectual
property and also with venture capitalists looking to fund new start-ups. The
Laboratory's Trustees in 1992 established the Science Fund as a permanent part
of the endowment into which are placed all of the Laboratory's royalties and equi-
ty shares from such relationships, to be used for the exclusive support of
science. Last year, royalty income exceeded $1 million for the first time, and al-
ready the Science Fund includes equity holdings in new biotech names such as
ICOS, Geron, Mitotix, Pharmacopeia, and Oncor. Soon Amplicon and
PathoGenesis will be added to this list.
1993 marked a watershed year for the Laboratory's Meetings Department
with the retirement of Barbara Ward in October. Barbara began her career at
Cold Spring Harbor some 25 years ago as secretary to Edward Pulling, who then
personified the Long Island Biological Association, now the Cold Spring Harbor
Laboratory Association. In recent years, as Meetings and Courses Manager, Bar-
bara has led the very competent Meetings staff in caring for the needs of our
nearly 6000 visiting scientists per year. We shall miss her a great deal. Fortunate-
ly, we were successful in recruiting Dr. David Stewart from a biotech and aca-
demic science background at Cambridge, England; he joined the Laboratory as
Director of Meetings in September. Arriving at a time of record meetings at-
tendance, David moved quickly to modernize the department's computer system
to better handle the increased registration and established a small computer
center for visiting scientists.
For the future, David is thinking about adding new meetings, perhaps in the
normally dormant months of late fall, winter, and early spring. These, for example,
might involve academic retreats or meetings sponsored by members of the
pharmaceutical or biotech industry to discuss applied uses of basic research.
The only caveat would be that such meetings be scientifically interesting and
conform to the tradition here of excellence. In this manner, more year-round use
can be made of our facilities.
In the interest of improving the overall quality of food service at Blackford
Hall, we recruited in November a new chef, Ron Padden, who has extensive
restaurant experience. Laboratory employees benefited first at winter meals, and
this spring, our meetings visitors confirmed the improvement.
An important change during the year was consolidation of the Development
and Public Affairs Departments into a new Department of Public Affairs and De-
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velopment with Susan Cooper as Director. There is much overlap between the
functions of these areas, and already there is clear improvement in effectiveness
and efficiency. The change enables Gordon Hargraves, appointed to the new
position of Director of Planned Giving, to devote his efforts to the success of the
very important "The Next 100 Years" effort.
The effective functioning of the Buildings and Grounds Department, under the
leadership of Jack Richards, has always been of critical importance to the
Laboratory. In 1992, Jack delegated the responsibility for maintenance of
grounds and the renovation of laboratories, offices, and other facilities to Peter
Stahl, and Peter and his staff have responded with skill and dedication. This has
enabled Jack to devote the major portion of his time to new construction, and
once more, we are in awe of what has been accomplished. The 2-year project to
completely gut and rebuild the more than 80-year-old McClintock Laboratory as a
state-of-the-art cancer research laboratory was completed on time and on
budget of approximately $4.6 million. With the major assistance of subcontractor
Bill Baldwin, the entire structure was strengthened and equipped with new me-
chanical systems, a third floor was added, and the classically detailed brick and
stucco exterior was restored to its former beauty.
In the spring of the year, the Laboratory purchased the previously leased
DNA Learning Center building in Cold Spring Harbor Village from the Cold Spring
Harbor Central School District. Immediately thereafter began a thorough renova-
tion of the building, including a new front entrance, handicap accessibility fea-
tures, and a new sprinkler system. A computer laboratory was added, and thanks
to generous support from Cablevision, Inc., a new multimedia-equipped 100-seat
auditorium was built that may well be the finest installation of its type on Long Is-
land.
The year also witnessed the start of construction of a new President's House,
which has a spectacular view of Cold Spring Harbor and far-off Connecticut from
the northernmost corner of the campus. Paid for entirely through Jim Watson's
generosity to the Laboratory, the new structure will be home to Jim and Liz for
many years and also house the Watson archives and other important papers
dealing with the history of molecular biology and genetics.
Less interesting, but very important, was the completion of all the necessary
engineering and approvals for the start of construction at year end of a new
sewage force main and pumping station that this spring replaced our nearly 25-
year -old sewage treatment plant. For an investment of $1.6 million, the
Laboratory is now connected to Nassau County's sewage line in Syosset and
then to the Cedar Creek treatment plant on the South Shore. The need to dis-
charge treated effluent into the inner harbor has been ended forever. The as-
sistance of the Trustees of the Village of Laurel Hollow in approving and support-
ing this project is much appreciated, and we thank the residents of Stewarts
Lane and Laurel Hollow Road for their patience during the winter construction.
Every year, other key administrators such as Barbara Wang, Assistant Con-
troller; Susan Schulz, Grants Manager; Sandy Chmelev, Purchasing Manager;
and Cheryl Sinclair, Human Resources Manager play key roles in running our
complex and larger institution. Roberta Salant deals with all the requirements of
our very active and interested Board of Trustees and is of immeasurable help to
John Maroney and myself. The administrative departments and their staff do
much to provide the facilities and support that make the Laboratory a leader in its
field, and they should all feel great satisfaction in what they have accomplished.
Looking to the future, we are concerned by a small but important cloud on an
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otherwise potential-filled outlook. For perhaps the
first time in the Laboratory's
more than 100-year history, a significant number
of neighbors in the Village of
Laurel Hollow are disturbed by various matters
relating to the Laboratory. Some
are concerned by "dollars and cents" issues
such as the cost of scientists' chil-
dren attending local schools while living in
tax-exempt housing. Others question
the degree of Laboratory support for the Village
budget and use of Village ser-
vices. Such concerns are understandable at this
time when school budgets
everywhere are under pressure and with Village taxes
here among the highest on
Long Island. It should be possible to resolve these
questions by reasoned dis-
cussion, better communication, and a willingness to
be fair. More difficult is con-
cern by some residents about the growth of
the Laboratory and future use of the
property. In recent years, the Laboratory has become
substantially larger in num-
ber of buildings and employees, but so too has the
Village of Laurel Hollow. The
Laboratory has managed its growth with great care and concern for the environ-
ment, and today the campus grounds and architecture are widely regarded as
among Long Island's most beautiful. It is hard to imagine anyone having a
greater vested interest than the Laboratory itself in the continuation of that beauty
over the next 100 years for the enjoyment and inspiration of our staff, our visitors,
and our many neighbors who support us so generously.
Some believe, however, that the Village should limit future use of the campus,
and at their behest, a temporary moratorium has been instituted on new non-
residential construction. Renovation of the ground floor of the De Forest Stables
as a day-care center for children of Laboratory employees has been put on hold
after 2 years of study and planning with consultants and the appropriate state
and local agencies. The Village has required a site-specific and generic environ-
mental impact study; meanwhile, there is much disappointment and in-
convenience for those who have been counting on the availability of child care.
To remain at the forefront of its field, the Laboratory must maintain its legal
right to use its property in a manner consistent with its role as a world class re-
search and education institution. Hopefully, reason and dialogue will prevail, and
it will be possible to proceed into the next century with the spirit of cooperation
and mutual respect that has benefited both the Laboratory and the Village for so
long.
G. Morgan Browne
BUILDINGS AND GROUNDS
The Buildings and Grounds Department was again kept busy in 1993. With major
projects from the previous year nearing completion and new projects started, the
Buildings and Grounds staff could hardly catch its breath. The first half of the
year was the busiest; the McClintock renovation was coming to completion and
the DNA Learning Center was being renovated. The last half of the year was
marked by many minor alterations and by the retrofitting of the sewage treatment
plant and installation of a sewage pipeline two and a half miles long.
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McClintock Laboratory
As 1993 opened, the Mcclintock renovation was moving along with the installa-
tion of the third-floor penthouse, all new interior walls, and new mechanical
equipment. The next step was to install the laboratory benches, desks, fume
hoods, shelves, etc., and to complete the mechanical system, which included the
cooling tower for the air-conditioning system and a building to house the system
north of the Cairn Laboratory. The last stage was to complete the trim, hang
doors, install computers and telephone wires, clean the building, and landscape
the exterior. David Beach's laboratory, with all of its equipment, was moved from
the Beckman building to the completed McClintock building. McClintock now has
a wonderful third-floor office area with a spectacular view of Cold Spring Harbor.
We moved a very large boulder to the entrance of McClintock Meadows to be
used for a plaque in memory of Barbara McClintock.
DNA Learning Center
Major changes during the first half of 1993 were carried out at the DNA Learning
Center after the Smithsonian Exhibition, which had occupied most of the building
since 1987, was removed. We gutted the interior of the entire main floor and
removed the main entrance steps. We then built some new exhibit rooms, along
with a state-of-the-art auditorium in the east wing for the multimedia program
donated by Cablevision Corporation. The auditorium became a highly technical
room complete with multiple projectors, videos, and sound equipment, all com-
puter coordinated. The west wing now holds a new computer laboratory which is
linked to the "wet" laboratory next door. We also installed a fire sprinkler system
and completely rebuilt the main entrance, including a ramp for the handicapped.
Sewage Treatment Plant
For 18 years, the Laboratory has maintained a sewage treatment facility in the
middle of the Laboratory grounds, and the staff has always operated the plant in
full compliance with all regulations. However, as the plant aged and the mechani-
cal equipment became in constant need of repair, it became painfully clear that
soon the plant would have to be completely rebuilt. The Laboratory therefore ex-
plored the possibility of pumping all of the sewage to Nassau County's Cedar
Creek Treatment Plant. After an engineering study and numerous applications,
the Laboratory received permission from the Department of Conservation and
Nassau County to construct a pump station and pipeline to connect to the county
sewer system. In October, contracts were signed to install both the pipeline and
pump station, and both contractors set to work planning and ordering materials.
As the year ended, the two and half mile long pipeline was started and the exist-
ing treatment plant saw the beginnings of its conversion. Work will proceed
through the winter of 1994, with completion scheduled for April 1, 1994.
Renovations, Alterations, and Other Projects
Throughout the year, numerous projects keep the Buildings and Grounds staff
moving ever forward, from alterations to renovations to new and old construc-
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tions. These projects can be as small as moving a
desk or as large as demolish-
ing a house.
Bronze Helix: In May, a 15-foot sculpture of the
double helix was presented to Dr.
Watson during the Symposium meeting. We had
the privilege of assisting Charles
Reina, the artist, transport Bronze Helix" from
his home and install it in the lobby
of Grace Auditorium. This beautiful sculpture
is so huge that we had to anchor it
to the wall!
The President's House: As April rolled around, we
began demolishing the
Northview house to prepare the site for the
President's House. By June, the foun-
dation was in and construction of the house was
under way. As 1993 came to a
close, the building was up, the windows were
installed, and the roofing and
stucco work were started. We also started the
300 linear feet of riprap seawall.
We hope to complete all interior work on the
house during the winter and start the
exterior work in the spring.
Demerec Laboratory: As soon as the McClintock Laboratory was finished, many
scientist's laboratories were relocated there. Demerec
experienced most of the
changes. The rooms on the ground floor of the south wing became support
rooms, as the cell culture area was moved to a
larger laboratory, and the old cell
culture laboratory became a microinjection room. A number of the laboratories on
the second floor were refurbished, and three of the cold rooms were completely
updated with new mechanical equipment.
Hershey: Fiberoptic cabling was installed, and one of the offices was reworked
into a computer laboratory.
Delbruck Laboratory: An energy management computer system came to Del-
bruck in 1993. This ongoing project is making its way throughout the Laboratory
and is now showing results in both energy savings and fewer mechanical fail-
ures. Some structural roof repair was also done to Delbuck's teaching laboratory.
A combination of age and type of construction had caused the roof to sag to a
great extent. After the structural repairs were completed, we installed a new roof.
Beckman Laboratory: Two mechanical systems were improved. The first was the
addition of a plate heat exchanger that uses free outdoor cooling and eliminates
the need for costly mechanical cooling during the winter months. The second im-
provement was the addition of supplemental heat to enhance comfort levels in
some of the office areas.
Olney Barn: The barn became the headquarters for the Grounds Department and
will be used year-round. Some of the improvements included the addition of heat-
ing and bathroom facilities and an office for the Grounds Foreman. We also
repaired the exterior in preparation for painting in the spring of 1994.
Hooper House and the Firehouse: The years had taken their toll on the roofs of
these two buildings as evidenced by falling tiles and unsightly appearance. We
installed new roofs on both buildings and look forward to years of trouble-free
service.
Upper Cabins: We built a stairway from the lower set of cabins to the upper cabin
site. We also constructed a spacious, round wood deck for our visitors at the top
of this stairway.
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Uplands Farm: Scientists at the farm use corn and Arabidopsis as scientific tools,
and they need to grow the Arabidopsis in an enclosed growth room. Buildings
and Grounds therefore designed and built a growth room 24 feet long and 12
feet wide specifically for these plants. Timed fluorescent lighting and a climate-
controlled environment provide these plants with all they need for healthy growth.
Credit for the success of this complex room goes to our tradesmen, who spent
many weeks in its construction.
Banbury Center: Dan Miller, with the aid of one full-time helper and one part-
timer, does a great job maintaining the 40 acres comprising the Robertson
Estate. This team keeps moving right along without too much help from the main
Buildings and Grounds office.
In March of 1993, the Laboratory experienced a fierce storm out of the north-
east, which caused only minor damage. However, the round houseboat an-
chored in the harbor for more than 20 years lost its moorings and drifted onto
Laboratory property. After spending numerous hours making many phone calls,
the owner reluctantly agreed to dismantle the craft and haul it away. We can
honestly say, Good riddance!
As the year comes to a close, the Buildings and Grounds Department can
look back at all of its accomplishments and be very proud of its work. Our staff
has worked very hard and with great skill to maintain the working environment of
the Laboratory.
Jack Richards
PUBLIC AFFAIRS AND DEVELOPMENT,
AND THE LIBRARY
Combined Effort
So often had the efforts of the Public Affairs and Development Departments
dovetailed that in 1993 they were merged to align functions and provide a new
environment to deal with the challenge of a project-oriented fund-raising effort.
Raising funds for the clearly defined Second Century Capital Campaign, which
had a monetary goal, a beginning, and an end, is much different from the day-to-
day fund-raising needs of this complex organization. Funding plans and events
must be coordinated with the already packed Laboratory-wide calendar. We also
must prepare for the return of our chief fund-raiser, Jim Watson, from sabbatical
in July 1994. As Laboratory president, he will concentrate on the various funding
priorities set forth for the new department. We all look forward to the challenge.
This year of completion, expansion, and transition has been punctuated by
great successes. The Infrastructure Fund, begun during the Second Century
Campaign, was completed and will be named in honor of Trustee William R. Mil-
ler, who so successfully led this effort. The annual contributions grew, an
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achievement largely attributable to the efforts of the Cold Spring
Harbor
Laboratory Association (CSHLA) and its volunteers,
led enthusiastically and tire-
lessly by Mary Lindsay. Similarly, the fledging
Corporate Advisory Board, chaired
by Douglas Fox, broadened its base of Long
Island corporate support for the
Laboratory's DNA Learning Center and sharply
increased the amount of un-
restricted funds raised this year.
DEVELOPMENT
The William R. Miller Infrastructure Fund
The Infrastructure Fund, one of the last remaining
funds established during the
Second Century Campaign and spearheaded by
Trustee William R. Miller, com-
pleted the arduous task of raising over $4 million, enabling the Laboratory to
complete the buildings and facilities needed for our
meetings program. The
kitchen and dining areas in Blackford Dining Hall were
modernized and the
visitor cabins were completed. Fund-raising is difficult;
finding funding for the un-
derpinnings of an organization is nearly impossible-but not for Bill Miller, who
rallied pharmaceutical industry support for the expanded facilities so that we
might better serve our meetings attendees.
Major Gifts
Several major gifts were received in 1993. Generous gifts from William and Irene
Miller, the David Koch Foundation, Dr. David Pall, the Perkin Fund, Sherburn Bec-
ker, the Daphne Seyboldt Culpeper Foundation, Fannie E. Rippel Foundation,
Booth Ferris Foundation, and Oncor, Inc. provided over $4 million toward the
Cancer Research Fund.
We were also fortunate to have received other major gifts during the year.
John and Rita Cleary, Dr. James Watson, and Owen Smith, Esq., contributed to
the Genetic Diseases Fund with a specific emphasis on muscular dystrophy.
George and Mary Lindsay contributed unrestricted funds, and Henry Wendt and
Dr. Maxwell Cowan gave for program support in Neurobiology. The Fort Hill
Foundation provided funds toward the William J. Matheson Chair and the Ban-
bury Fund supported the Charles S. Robertson Chair.
We also received several planned gifts in 1993. Bob Gardner established a
Charitable Remainder Trust (CRT) which named the Laboratory and two other in-
stitutions as equal beneficiaries; the trust was funded with appreciated securities.
Townsend and Elise Knight established a CRT naming the Laboratory as the sole
beneficiary; this trust was funded with proceeds from the sale of a house owned
for many years by the Knights and donated to the Laboratory. In both cases, the
donors added significantly to the Laboratory's endowment while creating a high-
yield life income for themselves, avoiding capital gains taxes on the transfer of
appreciated property, receiving a charitable deduction, and reducing estate
taxes. In a similar fashion, Edward Palmer named the Laboratory as beneficiary
of a life insurance policy he had received as a corporate director, and William
Osborn, who sadly died in November, made a bequest of an insurance policy to
be paid at a date in the future. Two other bequests were received from the
estates of Taggart Whipple and Charles Henry Leach II. All of these gifts add to
the Laboratory's endowment, helping to ensure the future of the science program
at the highest level.
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Annual Contributions
The Laboratory's Annual Fund consists of several programs: the CSHL Associa-
tion Annual Fund, the Corporate Sponsor Program, the Student Scholarship
Funds (which include both the Undergraduate Research Program and Partners
for the Future), and the DNA Learning Center Annual Fund. Miscellaneous annual
contributions also come from memorials and a few restricted annual gifts. These
programs contributed a total of $1,468,093 to the Laboratory in 1993.
The CSHLA Annual Fund, the major source of unrestricted gifts to the Laboratory,
reached a new high in 1993 at $526,241. Membership in the Cold Spring Harbor
Laboratory Association rose to 889 members. Through the hard work of Mary
Lindsay, Carol Large, and the other Association officers, directors, and members,
the CSHLA's contribution to the Annual Fund was increased by $100,000 over
the 1992 level. Two successful benefits, the Blue Hill Troupe and the "Secret of
Life" garden party, raised $43,980. The "Secret of Life" party also added 140
people to the Association's membership.
Association dollars are well spent. Dwindling federal funds make it in-
creasingly difficult for the scientists to find complete funding for their laboratory's
operating costs. The Annual Fund provides fellowships for young scientists, start-
up funding for new laboratories, equipment, and supplies, and other unrestricted
monies to ease the budget burden. Providing these funds directly affects the
success of basic research into the causes of cancer, the nature of learning and
memory, the understanding of neurodegenerative diseases such as Alzheimer's,
aging, and other genetic diseases such as muscular dystrophy.
The Corporate Sponsor Program, which supports the meetings program at the
Laboratory and at the Banbury Center, generated $737,750 from 30 companies
in 1993.
Corporate Advisory Board DNALC Annual Fund, composed of outstanding busi-
ness and professional leaders from the Long Island business community, grew
significantly during 1993. Led by Douglas Fox of Times-Mirror, members raised
$66,650 in unrestricted funds in 1993, an increase of more than 200% from the
previous year. Members also contributed their time and ideas to the Corporate
Advisory Board, and three committees were formed to support future outreach
and fund-raising efforts. The Education Committee, focusing on genetics work-
shops and seminars for the nonscientific community, is co-chaired by Gary
Frashier of Oncogene Science and Rocco Barrese of Dilworth and Barrese. The
Golf Tournament Committee will plan and execute the first Cold Spring Harbor
Laboratory Golf Tournament in spring 1994.
In the fall, Advisory board members were proud to show off the newly ex-
panded and renovated DNA Learning Center at Education Night, where they
treated close friends and business associates to a hands-on visit in both the
teaching and computer laboratories and to a viewing of Long Island Discovery; a
Cablevision-sponsored multimedia presentation about Long Island. A delicious
harvest meal capped the evening.
Undergraduate Research Program/Partners for the Future are highly selective
programs that make up the Laboratory's Student Scholarship Funds. The Un-
dergraduate Research Program (URP) is a 10-week intensive summer program
that encourages college juniors and seniors to consider careers in basic re-
search. Each student from the international group of about 20 works on a specific
project with a mentor from senior Laboratory staff. Similarly, each Long Island
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high school may nominate a single senior to
be one of five Partners for the Fu-
ture. These youngsters spend 10 hours a
week after school, between October
and March, working with a scientist/mentor.
Funds for these two programs have
been received from a variety of sources and total $119,771 in
1993. The lion's
share of these funds were raised for the
34-year-old URP program, which started
its own endowment effort in the Second
Century Campaign. The Shakespeare
URP internship became the first to be fully endowed this
year when its donor
added $50,000 to his original gift of that amount. More funds
must be found to
ensure the continuation of the vital Partners
for the Future program.
Reorganization and Staff Changes
Following the completion of the Second Century
Campaign, jobs were realigned
to reflect the new organization of the development effort.
Gordon "Skip"
Hargraves became Director of Planned Giving to
reflect the Department's em-
phasis on planned giving as the major mechanism for increasing the Laboratory's
endowment. Jill Clark, who came to us from the
Foundation for Child Develop-
ment with a background in nonprofit financial
consulting, was appointed Associ-
ate Director of Development with responsibility for
Foundations and Corporate re-
lations. In her short time here, Jill's handiwork can be seen in the professional
preparation of formal foundation proposals, the establishment and successful be-
ginning of the new President's Council, and her initiative in planning a variety of
departmental projects. Joan Pesek continues as the Associate Director of the
CSHL Association Annual Fund. This year, Joan developed the new array of As-
sociation materials for the membership drive. Claire Fairman has responsibility for
raising funds for the Student Scholarship Funds and coordinating most of the
events for the Department. Deb Mullen, administrative assistant, on whom we all
rely, keeps our lives in order with a can-do willingness seen in very few. Deb took
responsibility for creating our fundraising database using the new software,
Raiser's Edge from Black Baud. Gisela Jennings will continue to assist Deb until
her temporary appointment ends in March 1994.
Plans for 1994 include continued emphasis on planned giving with the prepa-
ration and direct mailing of a planned giving brochure. Every effort will be made
to further the success of the Association by developing marketing tools that ex-
pand the demographics of membership and broaden the base of annual un-
restricted support. Foundation support will be sought to sustain the various pro-
grams that must be funded; these include the Cancer Research Fund, scientific
program support, Student Scholarship Funds, the Education Fund, the Child
Care Center, fiber optic cable system for high-speed computer networking, and
the Library Fund. We hope to expand the role of the Corporate Advisory Board
whose efforts presently go to raise unrestricted annual funds for the DNA Learn-
ing Center.
PUBLIC AFFAIRS
Major Events
Each year brings an increased number of events, and each year we imagine
there could never be more. Certainly that could be said for 1993, a year that
marked so many passages for Cold Spring Harbor Laboratory. Celebrations were
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held to mark the 40th anniversary of the discovery of the double helix, Dr. Wat-
son's 25th year as organizer of the Symposium, and his 25 years as director. We
lauded 20 years of Robertson Research Fund support, applauded our newest
Nobel Laureate, Richard Roberts, and rededicated two of our oldest buildings,
Blackford Dining Hall and McClintock Laboratory.
The Public Affairs Department joined forces with Jan Witkowski to plan every
aspect of the DNA 40th Anniversary celebration, March 1-3, 1993. We prepared
a reprint of the original articles printed in Nature in 1953, which announced one
of the most important scientific discoveries of our time. Sculptor Charles Reina
was commissioned to design small double helix models; a gold one was present-
ed to Francis Crick who was here for the 40th Anniversary. At the same time, we
rededicated an expanded Blackford Hall with the preparation of a brochure that
documented the history of the Hall from its inception in 1907 to its present mod-
ernization. At the dedication, a silver model of the double helix was given to Wil-
liam R. Miller, who led the fund-raising effort that, among other things, supported
the Blackford expansion. A dinner was held in Clarkson Dining Hall for the con-
tributors and special guests.
The last 20 years have been the most secure in the Laboratory's more than
100 years, and the Robertson Research Fund, established in 1973, formed the
original endowment. On June 11, the Robertson family and friends were feted
with a presentation by one of the Robertson Fund-sponsored Outstanding Junior
Fellows, Carol Greider, and by David Beach, both of whom described their
cutting-edge research. Dr. Watson extolled the virtues of this important gift and
presented the members of the family with a leather-bound commemorative
volume charting the history and success of the fund. Bill Robertson spoke
thoughtfully on behalf of the family. A wonderful dinner capped the evening.
The rededication of the McClintock building drew an interesting assemblage.
Barbara McClintock's niece, Marjorie Bhavnani, and nephew, Scott McClintock,
joined contributors, members of 1 in 9 from the Long Island Breast Cancer Coali-
tion, and staff to hear Al Hershey describe sharing this laboratory with Dr.
McClintock in the 1950s. The keynote address was given by David Beach, who
discussed his work using yeast to understand control in the cell cycle. The day
was marked by a dedication brochure featuring a reproduction of Eleanor
Ma lamed's towering portrait of Barbara McClintock and an intriguing history of
the building and its occupants.
Other Events
Many other events rounded out our year. The three Lloyd Harbor Seminars were
introduced by village trustee George Toumanoff. In the spring, Dr. Francis
Roberts, Superintendent, District 2, presented a talk on American schools in the
21st Century, and Meg Cleary of the Nature Conservancy spoke on the Conser-
vation Initiative on Long Island. A seminar on eugenics was presented in the late
fall by David Mick los, Director of the DNA Learning Center. Twice yearly, during a
spring and fall meeting, performers from Young Concert Artists International
come to the Laboratory to delight our meeting attendees. In 1993, Alex
Slobodyanik, pianist, and Scott St. Johns, violinist, performed.
A new series of clinical lectures for the public, arranged in conjunction with
Huntington Hospital, was presented in Grace Auditorium. Topics discussed in-
cluded stroke, heart disease, and colon, prostate, and breast cancer. The
popularity of these programs has encouraged us to continue them in 1994/1995.
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Again we held our four quarterly
Saturday morning public tours, introducing
117 visitors to the magic of Cold Spring Harbor.
Special talks and tours were ar-
ranged for various groups throughout the year.
Some of these groups included
SPLIA; the New York Institute of Technology; Lion's
Club; SUNY Stony Brook
science forum, Nassau Community College;
and the Association of University
Women. These tours and talks are successful because
our scientists are willing
to meet with visitors and outside groups.
The Association kept us busy arranging
more than a dozen different events,
including art exhibits, concerts, an operetta,
garden parties, lectures, and meet-
ings. We produced new stationery which
includes two sizes of letterhead, thank
you and note cards, donor and memorial
cards, and the annual fund brochure.
The Association President's report appears on
page 407.
Our involvement with holiday parties is
kept to a minimum because of the
good offices of Art Brings, who, along with his energetic staff,
installs giant
Christmas trees, wraps Christmas gifts,
designs coffins for Halloween, arranges
magic shows, and generally makes this a better
place to be. This year's staff
events included the first Lab-wide summer
staff picnic on the sandspit, a wel-
come get-together for staff and their families.
Seventy staff and their families sat down
together for a shared Thanksgiving.
Blackford Hall staff prepared turkey and trimmings,
and the families provided the
side dishes and dessert. After a game of football on
the lawn, everyone enjoyed
the international food and extended family. At the
children's holiday party, Santa
presented 114 kids from the laboratory with gifts selected by helpers Joan Pesek
and Grace Stillman. At our annual tree lighting, Old Bethpage Village Brass Band
accompanied our caroling, and Jim Hope prepared great holiday treats for staff
and neighbors.
It should be noted that events do not happen without the cooperation of many
people. Safety and security handle the parking and crowd control with
tremendous skill. The carpenters hang artwork and install brass plaques and are
always on hand to fix something at the last minute. The computer staff makes
light work of our mailing lists and in-house printing needs. The electricians work
tirelessly to fix phones, install wiring, and ensure lighting. The custodial staff is
called on to set up and take down tables and chairs daily. They keep the facilities
clean and offer the human power necessary to move an event. The grounds are
beautifully groomed. The Meetings office arranges housing for our overnight
visitors, and the Blackford staff prepares all the food and drink.
Printed Materials
Harbor Transcript continues to expand its content. This year, our summer issue
was a whopping 16 pager featuring special coverage of the very special events
held this year by the CSHL Association. Each issue in 1993 recorded the many
milestones of the Laboratory. We are distributing this newsletter to nearly 7000
scientific alumni, foundations, contributors, association members, neighbors, and
friends. Rising costs will make it necessary to pare our mailing list in the future
and offer it long-term to only those who are members of the Laboratory's ex-
tended family.
Production of materials for the Laboratory is a cooperative effort of science
writer Nathaniel Comfort and our multitalented art director, Margot Bennett. The
addition of a new computer with design software makes the work faster and more
efficient. We can now see what a piece will look like, color and all, directly on the
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monitor, and this allows us to make minor changes instantaneously. With the ca-
pacity to work more efficiently, we have been called on to produce more material
with no increase in staff. We prepared 11 formal invitations, 6 event programs, 11
pieces for the Association, a brochure for the new President's Council, and, as al-
ways, the 3 meetings posters and the Nature Study brochure. Margot Bennett's
tasteful design of the dedication pieces, the Robertson book, and our new
brochure, A Closer View (due early 1994), deserves special mention. Each de-
sign fit the occasion and each uniquely represents the Laboratory. Additionally,
Margot Bennett, ably aided by Ed Campodonico, Herb Parsons, and Scott
McBride, succeeds in keeping up with the growing demand for photographic
services.
Nathaniel Comfort researched and wrote the three important brochures that
have eloquently contributed to the documentation of the Laboratory's history: The
Blackford Dedication, the McClintock Dedication, and the Robertson Research
Fund 20th Anniversary. He also wrote many press releases, foundation applica-
tions, and the text for A Closer View. Certainly, Nathan's year could be character-
ized as one of change and commitment. He married, began his Ph.D. in the his-
tory of science, bought a home, completed the science history portion of a spe-
cial research project for the Laboratory's application to the National Register of
Historic Places, prepared by Elizabeth Watson, and contracted with the CSHL
Press to co-author a book with Dr. Bentley Glass on the Laboratory's scientific
history. It is our pleasure to find that Nathan's career path has been influenced by
the rich history of this institution.
Partners for the Future
Along with handling the day-to-day operation of a very busy Public Affairs office,
Lynn Hardin is the administrator for the Partners program. Each year in March,
the 151 schools on Long Island are asked to submit their candidates for the fol-
lowing school year. The applications are narrowed to ten candidates by a com-
mittee of scientists; in June, the committee interviews each of the finalists and the
five successful Partners are notified on July 1. The fact that this program runs
flawlessly can be attributed to Lynn's adherence to timetables and execution of
the rules for this competitive program. The 1993/1994 students are profiled in the
Highlights section of this report.
Donor Recognition
Brass plaque recognition of our donors is also Lynn Hardin's responsibility. Five
major plaques were put in place in 1993. Among these were the giant Second
Century Campaign plaque and the plaque marking the first 20 years of the
Robertson Research Fund, each installed in Grace Auditorium lobby. In 1993,
Lynn found a Long Island vendor who was able to do work of better quality for
half the price and in half the time required by the previous vendor.
Media
The Department handled press questions that resulted in nearly 400 mentions in
the print media, television, and radio. Two big events, the 40th Anniversary of
DNA and the receipt of the Nobel prize by two former staff members, Richard
Roberts and Phillip Sharp, dominated the coverage. The Department got special
support from intern Elizabeth Cooper, who gave her Columbus Day weekend to
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reproduce all the materials for the Press.
Additionally, we had requests regarding
other Nobel recipients who have been
participants in the Laboratory's meetings
and courses, and questions relating
to the promotions of Jim
Watson to president
and Bruce Stillman to director.
Likewise, there were other
notable features in
1993. The Economic Times of Long
Island, in its series "Women in Technology,"
profiled Carol Greider and her telomeres
research. Bob Cooke of Newday wrote
an excellent companion piece
to the announcement of
this year's Nobel prize
characterizing the Laboratory as "a
fertile seedbed for biological research." The
Long Islander wrote "CSH lab sends
experiment to space," discussing the fact
that the space shuttle Discovery
carried a protein payload from David Barford's
laboratory. The experiment examined
the effect of growing crystals under micro-
gravity conditions.
Audiovisual
Ever present and willing to meet all
the audiovisual needs of the Laboratory, Herb
Parsons and Ed Campodonico bring new
meaning to personal service and atten-
tion to detail. These men and their able
student aides provide all audiovisual ser-
vices for the meetings and courses,
Banbury Center programs, and all special
events inside and out. It is their
responsibility to keep all seminar rooms in work-
ing order. We cannot ask more of this small dedicated
staff.
LIBRARY SERVICES
Under are the Library and its staff, who
continue to serve and
port the information needs of their many
constituencies. The scientists receive
prompt service and up-to-date bibliographic support of their projects through the
availability of a variety of computer resources. Public
Affairs requires major sup-
port when preparing the history or design for
projects ranging from dedication
booklets to commemorative reprints. The Development
Department is provided
with a range of services from art curation, commissioning,
and framing to the ac-
quisition of commemoratives. The Library also maintains Development's collec-
tion of foundation and corporate annual reports and reference materials.
The Library staff continues to operate efficiently in ever-deteriorating condi-
tions. Materials, machines, and machine readables contribute to the growth,
whereas water problems, crowding, and noise weaken the resolve.
Reference and Bibliography
Patron access of MEDLINE, Current Contents, and Science Citation Index on
computers increased 94% in 1993. Computer-based reference capability has
grown to include Linscott's Manual and Grolier's Encyclopedia on CD. Patrons
are assisted in discovering resources on the Internet, such as American Type
Culture Collection catalog (ATCC), FlyBase, and the Arabidopsis Research Com-
panion. Continuing problems with the CD-ROM towers computer, which is heavily
used, put us out of commission for a while, but free searching was done by the
staff to mitigate the inconvenience to researchers. These mechanical problems
should be resolved early in 1994 with an upgrade of the system.
Seventy-one scientists use the Library's table of contents service, which pro-
vides desktop access to the contents of 81 journals. The number of interlibrary
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loans processed for the scientific staff increased 78% over last year. Wanda
Stolen, senior library assistant, obtains articles quickly and efficiently using on-
line access while keeping costs down by utilization of our membership in the
New York State Hospital Program which supplements regional libraries.
A survey of the use of journal titles held by the Library and its branches pro-
duced excellent results when it revealed that 11 titles were not being used and
could be canceled and replaced by 11 new titles required by the scientific staff.
Inactive journals and accumulated duplicates were sold to make room for our ex-
panding collection of books, journals, and tapes.
New Equipment
A new Xerox photocopier has replaced the tired, old IBM. The new copier does
reduction and enlargement and has a photo mode, auto contrast, margin shift,
stapler, and other special features. The use of the Library's photocopy service
has increased 73% this year. As has been done in a growing number of buildings
on grounds, a security access system has been installed to provide after-hours
access by authorized personnel.
Service with a Smile
Superlative service to growing numbers of scientists in overcrowded conditions
can only be achieved by a willing and dedicated staff. Margaret Henderson and
her staff meet this challenge with great patience and intelligence. Wanda Stolen,
Kelly Kasso, and Leigh Johnson ably handled the Library during Margaret's sum-
mer maternity leave.
Archives and Art
The Library archives were exploited in 1993 because of the convergence of
several landmark events occurring at the Laboratory. Clare Bunce has made an
indelible mark on archive service, accomplishing volumes of work for the torrent
of requests. Not only does archives provide research and photographic service,
but it also handles artistic reproduction and framing Lab-wide.
Research and photographs were provided for the Robertson Research Fund
20th Anniversary book, the McClintock Laboratory's rededication brochure, and
the current forthcoming Laboratory overview, A Closer View. Photographs were
also provided for the Annual Report and Harbor Transcript.
Outside use of the archival collection came from a diverse clientele consisting
of book publishers, film producers, newspapers, museums, and educational
facilities. Students of all ages are visitors to the archives for class projects on the
history of molecular biology and genetics. Biographical information on and pho-
tographs of our Nobel Laureates, Alfred Hershey, Barbara McClintock, James
Watson, and now Richard Roberts and Phillip Sharp, are routinely requested.
There was heightened interest in James D. Watson when the 40th anniversary
of the discovery of the structure of DNA coincided with his 25th year as director
of the Laboratory. Along with the original drawing of the double helix, archives
provided various illustrations as the inspiration for the 15-foot "Bronze Helix,"
which stands in the lobby of Grace Auditorium. In addition, photographs were
provided for the montage that hangs in the lobby. Both of these were gifts from
colleagues of Jim Watson and were presented during the annual Symposium
marking his first 25 years at the Laboratory.
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Special Skills and Financial Support
Laura Hyman, marking her
20th year with Cold
Spring Harbor Laboratory, is my
greatest asset. She lends
support to all aspects of my many-faceted
department.
Among her many 1993 accomplishments,
Laura identified the artists, commis-
sioned the works, and monitored
the progress of the "Bronze
Helix," the portrait of
Dr. McClintock that hangs on
the top floor of the laboratory
building that bears
Barbara's name, and the
tray-table for Dr. and Mrs.
Watson. Laura selects
frames, commemoratives, artwork,
photography, and furnishing for myriad
projects Lab-wide. Her artistic
talent and eye for excellence enable her to put
many finishing touches on the
Laboratory's aesthetic landscape.
As business manager, Laura is
responsible for preparing the preliminary
budgets for all three departments, overseeing
expenditures throughout the year,
and handling special projects. In 1993, she
managed the records retention corn_
mittee, determining needs, finding
appropriate space, and planning the move. By
the summer of 1994, the Records
Center of the Laboratory will move into a
permanent, long-term storage space
in the basement of Sammis Hall. During
these 20 years, no one has served the
Laboratory any better or more willingly.
She has my respect and gratitude.
It is gratifying to review the year of accomplishments
and know that many
people contributed to the success of
the newly combined department. It is my
pleasure to team-build with a dedicated
staff, cooperative departments, and
energetic volunteers.
Susan Cooper
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RESEARCH
Top row: T. Koothan; P. Kearney; C. Huang; K. Mc Cloy
Center: M. Delay (President of Axon Institute), R. Malinow, A. Shirke
Bottom row: H. Zhou; S. Waga; M.-S. Jung, M. Regulski; C. Bautista
TUMOR VIRUSES
The Tumor Virus Section continues to use a variety of viruses to study the me-
chanisms of gene replication and expression. These studies follow the central
dogma of biology, extending from control of DNA replication and transcription to
mRNA processing and translation. In earlier years, research in this section relied
heavily on DNA tumor viruses, especially adenovirus, papillomavirus, and SV40.
More recently, the research has expanded to include other viruses such as
herpes simplex virus and human immunodeficiency virus and nonmammalian
organisms, in particular yeast. This diversification, however, has not weakened
the network of interactions that have been a mainstay of this section. Indeed, the
reports that follow attest to the vitality of this program now in its 23rd year.
DNA SYNTHESIS
B. Stillman N. Muzyczka S.-U. Din J.M. Ruppert
C. Prives C. Hardy S. Waga
J. Scott C. Liang M. Weinrich
M. Akiyama T. Melendy K. Fien
S.P. Bell C. Mirzayan K. Gavin
G. Cullman
During the past year, our studies on the replication of
DNA in eukaryotes have progressed on many impor-
tant fronts. The primate virus, simian virus 40, can
replicate its DNA in human cells and has been the
mainstay of our efforts toward understanding the en-
zymology of DNA replication in eukaryotes. This
vigorous experimental system has been valuable
primarily because of the ability to replicate SV40
DNA in a cell-free extract from human cells. In this
past year, we have achieved a long-term goal of
being able to replicate DNA containing the SV40
replicator with highly purified and characterized
DNA replication proteins. This has resulted in a
detailed understanding of the mechanism of DNA
replication. Concomitant with studies on SV40 DNA
replication, we continue to study the replication of
chromosomal DNA using the yeast Saccharomyces
cerevisiae as a model system. Progress during the last
year in this rapidly expanding area has been substan-
tial, including the recognition that initiation of DNA
replication and transcriptional regulation are inti-
mately connected.
Y. Marahrens
J. Mitchell
H. Rao
L. Borzillo
C. Dreissens
SV40 DNA Replication
L. Borzillo, F. Bunz, T. Melendy, C. Prives, J.M. Ruppert,
S. Waga, B. Stillman
One of the key events in the control of DNA replica-
tion is the binding of an initiator protein to a
replicator located in the template DNA. The
replicator is a genetically defined element in the
DNA that controls the initiation of DNA replication
and contains the binding site for the initiator protein.
SV40 encodes its own initiator protein, the SV40 T
antigen. This protein functions not only to recognize
the replicator, but also as a DNA helicase and to load
DNA polymerase a/DNA primase (pola/primase)
onto the DNA at the replication origin. The binding
of the initiator protein promotes initiation of DNA
replication at the SV40 ori.
In collaboration with Dr. Daniel Simons and his
colleagues (University of Delaware), we have studied
the activities present in mutant forms of T antigen
and have found that the DNA-binding domain con-
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tributes to many of the T-antigen-associated DNA- laboratory,
Memorial Sloan-Kettering Cancer Cen-
replication activities. In particular, some mutants of T ter); it also
contains an extensive similarity to a small
antigen distinguish between the ability of T antigen region in the
bacterial DNA ligases and mammalian
to bind to the replicator sequences at the SV40 on poly(ADP)-ribose
polymerase. The common feature
and its ability to initiate unwinding and subsequent between these
proteins is their ability to recognize
DNA synthesis functions. One of these functions may DNA in a
structure-specific manner. We have also
be a primosome-loading function of T antigen. SV40 cloned cDNA
encoding a portion of the MF1 5' to
T antigen promotes the assembly of the pola/primase 3' exonuclease
and have discovered that it is identi-
complex onto single-stranded DNA coated with the cal to a recently
characterized endo- and exonuclease
single-stranded DNA-binding protein RPA (replica- characterized by Dr.
Micheal Leiber and his col -
tion protein A). In many ways, this function of T leagues (Stanford University).
antigen is analogous to that of the primosome as- Because the human
cell proteins required for
sembly proteins that load DNA primase onto the replication of SV40
DNA in vitro have been purified,
template DNA during replication of the bacterial the role of these
proteins in DNA replication can now
chromosome, and thus we have designated T antigen be studied. In the
last year, we have shown that three
as a primosome-loading protein. new DNA
replication factors, MF1, DNA ligase I,
T antigen from SV40 supports DNA replication and ribonuclease
H1 (the latter is required as
from the SV40 on in primate cells but not in murine demonstrated by Dr. R.
Bambara and his colleagues,
cells. Other investigators have shown that a correla- University of Rochester) are required for complete
tion exists between the ability of SV40 T antigen to replication of SV40 DNA,
particularly for completion
support DNA replication in these various cells and of the discontinuously
synthesized lagging strand. In
the ability of T antigen to bind to the pola/primase previous years, characterization
of the mechanism of
complex. In the past year, in collaboration with Dr. J. DNA replication has
demonstrated that pola/primase
Kadonaga and R. Kamakaka (University of Califor- primes DNA synthesis at the SV40 ori, and then
nia, San Diego), we have demonstrated DNA repli- DNA polymerase 8, together with the proliferating
cation in cell extracts prepared from Drosophila cell nuclear antigen (PCNA) and RFC, produces the
melanogaster embryos and tissue culture cells that is continuously synthesized leading strand at the DNA
SV40-T-antigen- and SV40-ori-dependent. Further- replication fork.
more, initiation of DNA replication can occur at the Now that complete replication of both strands at
SV40 ori in the presence of highly purified T antigen, the replication fork can be reproduced in vitro, we re-
Drosophila pola/primase, and Drosophila RPA. In examined the role of the various DNA replication
this case, the human RPA cannot support DNA proteins. When either pol8, PCNA, or RFC was
replication, further emphasizing the role of protein- omitted from the complete DNA replication reac-
protein interactions between SV40 T antigen, RPA, tions, as expected, synthesis of the leading strand was
and pola/primase in correctly initiating DNA replica- prevented, but surprisingly, replication of the lagging
tion. strand at the fork was also abnormal. This and other
As noted in last year's Annual Report, a number results suggested that polo and its accessory proteins
of new DNA replication proteins have been identi- PCNA and RFC are required for synthesis of the
fied, and the replication of DNA from the SV40 ori Okazaki fragments on the lagging-strand template.
can occur with highly purified human proteins and The idea was examined by constructing a synthetic
SV40 T antigen. To characterize these proteins more lagging-strand DNA template and testing the require-
thoroughly and to facilitate production of large ment for various DNA replication proteins in the
amounts of these proteins, we have cloned several completion of Okazaki fragment synthesis and liga-
cDNAs encoding human DNA replication proteins. tion of the fragments. The results demonstrated that
cDNAs encoding the large subunit of replication fac- PCNA and RFC cooperate to prevent pola/primase
for C (RFC) have been isolated from human and from extensively elongating a DNA primer and that
mouse cells (the latter in collaboration with Dr. they load pol8 onto the primer DNA to complete the
Gunter Schutz and his colleagues, Cancer Center, Okazaki fragment. Thus, there is a switch from pola
Heidelberg, Germany). A region in the human RFC to polo during the synthesis of every Okazaki frag-
140-kD subunit has extensive similarity to the other ment (see Fig. 1). We have previously demonstrated
human RFC subunits (cloned in Dr. J. Hurwitz's that a similar switch from pola to pol8 occurs at the
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RNA previous Okazaki
RPA primer fragment
1 3'1:::::)C):)1W%-----11' 35: Lagging strand template
pol a/primase
3,
5' by pol a /primase
Priming and DNA synthesis
RFC
3 3, RFC binding
Displacement of pol a/primase
PCNA 1 8
4 ;:
6 5'
Assembly of pol 5 complex
RNase H / MF1
3, Elongation
5' Removal of RNA primer by
RNase H and MF1
3' Gap-filling
5
DNA ligase I
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5'
DNA ligase I
RNase H
MF1 exonuclease
primase
helicase
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3' PCNA
FIGURE 1 Mechanism of DNA synthesis at a eukaryotic cell
DNA replication fork. (Top) Model for a DNA polymerase
switching mechanism during lagging-strand replication.
(Bottom) Model for a multi-protein complex at a eukaryotic
cell DNA replication fork, including one molecule of
polymerase a/primase complex which is about to synthesize
an initiator RNA-DNA on the lagging-strand template. Two
molecules of polymerase 8; one of them on the lagging-
strand template is elongating the DNA strand from the in-
itiator DNA that had been synthesized previously by
pola/primase; the other on the leading-strand template is
continuously replicating the leading strand. During SV40
DNA replication, the DNA helicase at the fork is SV40 T
antigen. (Reprinted, with permission, from Waga and
Stillman 1994.)
RPA
SV40 on during initiation of leading-strand synthe-
sis. These studies suggest that a eukaryotic DNA
replication fork has two molecules of DNA pol
synthesizing DNA on both the leading and lagging
strands (see Fig. 1). In contrast, polcc/primase seems
to function only during synthesis of a primer
RNA/DNA both at the replication origin and for in-
itiation of every Okazaki fragment.
Cell Chromosome
Replication
M. Akiyama, S.P. Bell, G. Cullmann, K. Fien, K. Gavin,
C. Liang, Y. Marahrens, C. Mirzayan, J. Mitchell, J. Scott,
B. Stillman, H. Rao, M. Weinrich
In parallel with the studies on the replication of SV40
DNA, we have for quite some time worked on the
replication of cell chromosomal DNA in the yeast S.
cerevisiae. A number of DNA replication proteins
have been purified from this yeast and the genes en-
coding them have been identified. Most recently, the
five genes encoding the S. cerevisiae RFC subunits
have been cloned. One of these genes that encodes
the large subunit of RFC is related to the large sub-
units of human and mouse RFC and contains sim-
ilarity to the DNA ligase and poly(ADP)-ribose
polymerase mentioned above. Furthermore, the gene
encoding the large subunit of S. cerevisiae RFC is
identical to the CDC44 gene. Mutations in this gene
have a cell division cycle (cdc) arrest phenotype that
is consistent with a role for this protein in DNA me-
tabolism; in addition, there appears to be an effect of
the mutations in this gene on the entry into mitosis,
suggesting that the RFC might have a role in linking
DNA replication and/or repair to mitosis controls.
The dependence of the SV40 system on the many
functions of T antigen precludes insight from this
system into the mechanism of initiation of cell
chromosome replication. To begin to study this im-
portant problem, we have focused our attention on
the DNA sequences that are required for initiation of
DNA replication and the proteins that interact with
these sequences.
The DNA sequences in the ARS1 and ARS307
replicators that are required for supporting auton-
omous replication of an artificial plasmid chromo-
some have been defined. Each replicator contains an
essential A domain that contains within it a match to
an 11-base-pair consensus sequence found in every
yeast replicator. In addition, these two replicators
contain B1 and B2 elements that are functionally
conserved, even though there is little sequence
similarity between them. ARS1 also contains a B3
element that is the binding site for the Abfl protein.
Other investigators have demonstrated that only a
subset of yeast sequences that function as replicator
sequences in a minichromosome (plasmid) context
actually function in the chromosome in their natural
location to initiate DNA replication. For this reason,
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we have investigated whether the four DNA elements
required for ARS1 function in a plasmid context func-
tion in the chromosome. Linker scan or point muta-
tions were introduced into the ARS1 locus on
chromosome IV, and the presence or absence of an
origin of DNA replication was assayed by two-
dimensional electrophoresis. As expected, mutations
in the A element abolished replicator activity. Muta-
tions in any one of the three B elements had a small
effect on the activity of the replicator, but double and
triple mutations in the B element severely reduced or
eliminated initiation of DNA replication at the ARS1
locus. These results are similar to those obtained
employing the plasmid-based assay and demonstrate
that a chromosomal replicator consists of a modular
array of DNA sequence elements, some of which are
in large part not absolutely necessary when mutated
individually.
In the course of these experiments, a yeast strain
was constructed that contained two copies of the
ARS1 sequences separated by 4.6 kb of DNA. Inter-
estingly, only one of these replicators (left) was func-
tional in producing a replication origin and the other
(right) was inactive. Thus, sequences outside the
replicator DNA can influence the selection of identi-
cal replicators. The dominance of the left replicator
over the inactive right replicator depended, however,
on the active replicator. When the essential A ele-
ment in the active left replicator was mutated, the
right replicator was fully active. This suggests that
the dominance of one replicator over another requires
initiation of DNA replication.
In two previous Annual Reports, we have de-
scribed the purification and characterization of the
origin recognition complex (ORC). This protein com-
plex contains subunits of 120, 72, 62, 56, 53, and 50
kD in mass. ORC binds in an ATP-dependent manner
to the essential A element in the replicator and pro-
tects from nuclease digestion the A and B1 region of
ARS sequences. We have demonstrated that the B1
element also contributes to the specificity of ORC
binding to the replicator since mutations in the B1
element, but not the B2 or B3 elements, affect ORC
DNA binding in vitro.
To characterize the ORC protein complex further,
peptides from the ORC proteins were sequenced in
collaboration with Dr. R. Kobayashi (Protein Chem-
istry Laboratory), and this information was used to
obtain the genes encoding all six subunits. All of
these gene products are essential for yeast viability.
The peptide sequences derived from the ORC2 and
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ORC6 proteins were found to be encoded by genes
that had been characterized by other investigators.
Drs. J. Li and I. Herskowitz (University of California,
San Francisco) cloned the ORC6 gene using a genetic
screen for proteins that interact with the ARS con-
sensus sequence. They demonstrated that over-
production of the ORC6 protein did not affect a wild-
type strain, but in cdc6 and cdc46 mutant strains,
overproduction of ORC6 was incompatible with cell
viability. This suggested that ORC interacts with the
CDC6 and CDC46 proteins, both of which are re-
quired for entry into S phase of the cell cycle.
In collaboration with Dr. J. Rine and his col-
leagues (University of California, Berkeley), we have
identified temperature-sensitive mutants in the ORC2
and ORC5 genes that arrest at the nonpermissive
temperature with a cdc phenotype, consistent with a
role for these proteins in the initiation of DNA
replication. Furthermore, these strains cannot
maintain plasmids that contain only one replicator,
even at the temperature where the cells are viable.
Analysis of the DNA content by fluorescence-acti-
vated cell sorting suggests that ORC is required for
correct initiation of DNA replication, but the data
also suggest a role for ORC in preventing in-
appropriate DNA synthesis.
An unexpected finding from characterization of
these orc2 and orc5 mutants was the observation that
they are defective for transcriptional silencing of the
silent mating-type loci on chromosome III in S. cere-
visiae. At the permissive temperature, both mutants
failed to keep the normally silent HML and HMR
genes from being transcribed. We have demonstrated
that ORC binds to the DNA sequences that flank
these silent genes that act as cis-acting silencer se-
quences. Within these silencers, the ORC-binding
site cooperates with the binding sites for the Abfl
and Rap proteins. These results demonstrate a direct
relationship between the initiation of DNA replica-
tion and the initiation or maintenance of a transcrip-
tional state that is inherited to daughter cells.
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MOLECULAR BIOLOGY OF BOVINE PAPILLOMAVIRUSES
A. Stenlund M. Berg J. Sedman
T. Sedman R. Kluttig
The papillomaviruses infect and transform the basal
epithelium in their hosts, inducing proliferation of the
cell at the site of infection. The resulting tumors are
in most cases benign and will usually regress after
some time, but certain types of human papilloma-
viruses (HPVs 16, 18, 31, 33, and 39) give rise to
tumors that are prone to progress toward malignancy,
especially frequently cervical carcinoma. In total,
HPV DNA can now be found in biopsies from ap-
proximately 80% of all cervical carcinomas.
This very good correlation between papilloma-
virus infections and human carcinomas has in-
tensified the research on the biology of these viruses
over the past decade. One of the key impediments to
this work has been the inability to define a simple in
vitro cell culture system for HPVs, largely due to the
fact that these viruses normally require specialized
differentiating cells that only with great difficulty can
be generated in cell culture. One way to circumvent
this problem has been to study related animal viruses
where at least a part of the viral life cycle can be
reproduced. In particular, a bovine papillomavirus
(BPV-1) has become something of a prototype virus
for the papillomavirus group since a convenient cell
culture system exists for this virus, where viral gene
expression, oncogenic transformation, and viral DNA
replication can be studied. To date, more than 60 dif-
ferent papillomavirus genomes have been character-
ized and cloned, and all of these show a remarkable
degree of similarity in their genome organization.
This similarity originally formed the basis for the as-
sumption that what was learned from one virus could
be applied to another. This assumption has largely
been verified; many of the phenomena that originally
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were described for BPV have subsequently been
found also in the human viruses.
The DNA replication properties of these viruses
show some unique and interesting characteristics. As
part of their normal life cycle, papillomaviruses can
exist in a state of latency which is characterized by
maintenance of the viral DNA as a multicopy plas-
mid in the infected cells. The copy number of the
viral DNA appears to be tightly controlled, and the
viral DNA is stably inherited under these conditions.
This system therefore provides a unique opportunity
to study plasmid replication in mammalian cells.
In previous years, we have reported the develop-
ment of a short-term replication assay that has
enabled us, for the first time, to define the viral com-
ponents that are required for viral DNA replication
and to initiate detailed studies of the viral DNA
replication properties of this group of viruses. In the
past year, we have continued this work with most of
our effort directed toward detailed biochemical anal-
ysis of the replication process, with specific emphasis
on the respective function of the viral and cellular
proteins that take part in this process. To this end, we
have refined the expression and purification of the
two viral proteins (El and E2) that are required for
viral DNA replication, as well as continued the analy-
sis of the initiation complexes that are formed on the
Ori. We have also adapted and modified a cell-free
replication system that was originally developed in
M. Botchan's laboratory. In addition, we have begun
(in collaboration with T. Melendy in B. Stillman's
laboratory) to identify the cellular factors that are re-
quired for viral DNA replication.
Formation of Initiation
Complexes
T. Sedman, A. Stenlund
The minimal Ori sequence that is required for
replication in vivo is approximately 60 nucleotides
long and contains three sequence elements. Two of
these elements have known functions, consisting of
binding sites for the viral El and E2 proteins. The
third element has been termed the A+T-rich region.
Our earlier genetic experiments have demonstrated
that the presence of these elements is necessary for
replication activity. However, the position and se-
quence of one of these elements, the E2-binding site,
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is not critical for replication activity of the Ori. The
sequence of this site is not important per se and can
be changed as long as these changes still allow bind-
ing of E2. Furthermore, the E2-binding site can func-
tion from various positions relative to the El-binding
site and A+T-rich region. During the past year, we
have developed a series of assays to study the binding
of El and E2 to the Ori sequence to determine the re-
quirements for binding and for formation of produc-
tive replication complexes. By a combination of
DNase protection assays, interference assays, and
gel-retardation assays, we have been able to establish
that El is capable of binding to the Ori in at least two
different forms: either together with E2 to form an
Ori+E 1+E2 complex or by itself to form an Ori+El
complex. The Ori+E 1 +E2 complex is formed by
cooperative binding of El and E2 to Ori and can
form at low concentration of El provided E2 is pres-
ent. The formation of this complex also requires the
presence of an E2-binding site adjacent to the El-
binding site. The Ori+El complex requires higher
concentrations of El and forms on the same Ori se-
quence but does not require E2 or E2-binding sites
for its formation. Results from interference analysis
indicated that overlapping but not completely identi-
cal sequences are involved in binding of the two
complexes. To determine which of these complexes
is important for replication in vivo, we have genera-
ted mutations designed to affect the formation of the
two complexes differentially. Mutations in the E2-
binding site reduce the ability to form the E1 +E2
complex and also reduce replication. Mutations that
increase the spacing between the El- and E2-binding
sites concomitantly reduce the ability to form the
El+E2 complex and the ability to replicate. The sum
of these results indicates that the ability to form the
El+E2 complex is essential for replication activity in
vivo, whereas the ability to form the El complex is
not. However, the ability to form the El complex
clearly is sufficient for replication in vitro (see be-
low), indicating that more than one pathway exists to
generate functional replication complexes.
DNA Replication In Vitro
J. Sedman, A. Stenlund
A major effort during the past year has been to per-
fect the overexpression and purification of the two
viral proteins involved in viral DNA replication. The
El and E2 proteins have been expressed in soluble
form in Escherichia coli and have been purified to
apparent homogeneity by a combination of conven-
tional chromatography and affinity chromatography.
Both proteins are site-specific DNA-binding proteins,
and this activity can readily be measured in vitro. El
has several additional biochemical activities. A num-
ber of analyses have been carried out to characterize
the biochemical functions of the El polypeptide. In
addition to site-specific DNA-binding activity, the
protein also has a DNA-dependent ATPase activity
and a 5' to 3' DNA helicase activity. El can also
function to unwind a supercoiled plasmid that con-
tains the Ori sequence. Thus, El appears to have the
required activities associated with other known in-
itiator proteins such as SV40 large T antigen. The
presence of the E2 polypeptide in these assays has
little or no effect on the activities of El. During the
past year, we have adapted an in vitro replication sys-
tem that was developed in M. Botchan's laboratory at
Berkeley. This system, which consists of a whole-cell
extract from the mouse cell line FM3A, initiates
DNA synthesis from the BPV origin of replication. In
agreement with the original studies, the presence of
viral El protein is sufficient for Ori-specific replica-
tion activity. These results are consistent with the
biochemical activities observed for the El protein.
The in vitro system thus displays several important
differences compared to replication in vivo. First, al-
though the E2 protein is absolutely required for
replication in vivo, in the cell-free system, only a
moderate stimulation is seen upon addition of E2
(Fig. 1). Second, in vivo replication is also absolutely
dependent on a binding site for the E2 protein at the
Ori. In vitro, neither El-dependent replication nor
slight E2 stimulation is dependent on the presence of
an E2-binding site. Third, the A+T-rich region, which
is essential for replication in vivo, appears to be com-
pletely dispensable for replication in vitro. The basis
for these differences between replication in vivo and
replication in the cell-free system is not clear; how-
ever, it is obvious that in vitro replication fails to
reproduce certain aspects of replication in vivo (Fig.
2). Several possible explanations for this difference
can be envisioned. One is that the in vitro and in vivo
systems in fact represent different types of replica-
tion. Another perhaps more likely possibility is that
the two types of complexes are present on the same
pathway, eventually leading to the same funcjonal
initiation complex. The modification of this cell-free
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FIGURE 1 Replication in a cell-free system is stimulated by
E2 but does not require an E2-binding site. A cell-free
replication system based on extracts from the mouse cell
line FM3A was used to determine the replication activity of
various templates diagrammed below. Replication reactions
were carried out using standard conditions, and the prod-
ucts were separated on agarose gels under native condi-
tions and visualized by autoradiography. Both the SV40 Ori
and the Xho linker insertion into the BPV Ori serve as nega-
tive controls demonstrating Ori specificity. The two tem-
plates Msp and Msp/15 differ only by the presence or ab-
sence of an E2-binding site. Replication of these templates
is dependent on the addition of E1. Addition of E2 in both
cases results in an approximately threefold increase in
replication at all levels of E1, demonstrating that the
stimulatory effect of E2 is not dependent on the presence of
an E2-binding site.
system continues in order to generate a system that
corresponds more closely to the requirements for
replication in vivo.
Cellular Factors Required for
Replication of BPV In Vitro
J. Sedman, A. Stenlund [in collaboration with T. Melendy
and B. Stillman, Cold Spring Harbor Laboratory]
The SV40 system has for a number of years served as
the paradigm for DNA replication in mammalian
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Requirements for replication in vivo.
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FIGURE 2 Schematic figure illustrating the requirements for
replication in vivo and in vitro. The contrasting requirements
for viral proteins and cis-acting sequences in the two
replication systems are listed. The composition of the two
complexes is inferred from indirect measurements in various
binding assays.
cells. This system relies on the viral initiator large T
antigen for Ori recognition, Ori unwinding, and
helicase activity. By using this system, a number of
cellular factors involved in DNA synthesis have been
purified and characterized. A minimal purified sys-
tem, which contains all of the cellular factors that are
required for SV40 replication, has been developed by
B. Stillman and co-workers. Although all of these
factors are clearly involved in cellular DNA
synthesis, it is unclear whether additional cellular
replication proteins exist. To determine if BPV uses
the same set of cellular replication factors that are
utilized for SV40 replication, we have tested the re-
quirement for each of these factors in a BPV in vitro
replication system. Preliminary data indicate that all
of the factors identified in the SV40 system are also
required for BPV replication. However, the degree of
dependence on a given factor appears to be different,
indicating that differences exist between the two sys-
tems.
Interaction between the
El and E2 Proteins
M. Berg, A. Stenlund
Transcription factors have been implicated as having
an auxiliary role in a number of different replication
systems, but the actual function of these transcription
factors in initiation of DNA replication is not clear.
In most well-studied systems, including SV40,
polyomavirus, and ARS elements from Saccha-
romyces cerevisae, the requirement for transcription
factors generally shows a low degree of specificity,
i.e., activity can be supplied by a variety of trans-
criptional trans-activators provided the cognate bind-
ing site is present. From our previous work, it is clear
that the requirement for the transcription factor E2 in
the BPV system differs from that in these other sys-
tems in several aspects: The E2-binding site at the
Ori cannot be replaced by various enhancers that
function as replication enhancers in other systems.
Replacement of the trans-activation domain of E2
with the activation domain from the herpes simplex
virus activator VP16 yields a trans-activator that fails
to function for BPV replication, demonstrating a re-
quirement for a high degree of specificity in the BPV
system. As we have previously demonstrated, the re-
quirement for E2 in replication of BPV is consistent
with a requirement for interaction between the El
and E2 proteins at the origin of replication. This in-
teraction can be detected as a cooperative binding of
the two proteins to the Ori, when the respective bind-
ing sites are located in the correct position relative to
each other (see above). To further study this interac-
tion, we have adopted an approach using chimeric
proteins. The E2 proteins are quite well conserved
between different papillomaviruses and are likely to
have a conserved structure. For example, the se-
quence specificity for DNA binding is identical for
E2 from all papillomaviruses tested so far. However,
when tested for their ability to bind cooperatively
with BPV El, some E2 proteins from other papil-
lomaviruses fail to interact with El even though
binding to the E2-binding site can be detected. To an-
alyze what regions of El and E2 are required for this
interaction, we have initiated construction of
chimeras between BPV E2, on the one hand, and
interaction-defective E2 proteins from other papil-
lomaviruses, on the other hand. These chimeras can
then be tested for their ability to interact with BPV
El, and regions of the protein important for the inter-
action can be defined. This approach has the distinc-
tive advantage that the overall structure of the protein
can be maintained.
The results from these experiments so far indicate
that multiple regions both from the amino-terminal
trans-activation domain of E2 and from the carboxy-
terminal DNA-binding/dimerization domain co-
operate to generate a strong interaction with El.
These results serve to indicate that the interaction
PROTEIN CHEMISTRY
D.R. Marshak
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E. Araya
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G. Russo
M. Vandenberg
The members of the Protein Chemistry laboratory
conduct research on signal transduction and cell
growth using advanced methods of analytical and
preparative biochemistry. These methods include
automated protein sequence analysis, high-per-
formance liquid chromatography (HPLC), amino acid
analysis, preparative electrophoresis, mass spec-
trometry, and peptide synthesis. The use of such pro-
cedures allows us to deduce chemical structures of
proteins and to synthesize structural and functional
domains. In addition, physical analysis of proteins by
mass spectrometry, in conjunction with chemical
studies, permits the determination of posttranslational
modifications of proteins, such as phosphorylation
and acylation. Our goal is to attack biological prob-
lems of the control of cell growth by using an arsenal
of state-of-the-art biochemical methods. Often, this
requires the development of new methods when ex-
isting procedures are not adequate to solve the cell
biological question. This chemical approach to cell
biology is highly complementary to genetic ap-
proaches in many of the other laboratories at Cold
Spring Harbor, and analytical biochemistry is an es-
sential part of a multidisciplinary approach to prob-
lems of normal and abnormal cell growth, as in can-
cer.
surface may be composed of determinants from
several domains, presumably brought together by
protein folding.
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Synthetic Peptide Substrates
for Protein Kinases
D.R. Marshak, N. Carpino, N. Poppito, M. Vandenberg
Protein kinases are enzymes that catalyze the transfer
of phosphates from the y-phosphate position of ATP
to a hydroxyl moiety (serine, threonine, or tyrosine)
on proteins. The recognition sequences for protein
kinases are surprisingly short; usually only four to six
amino acid residues in linear sequence are required
for specifying the substrate. Therefore, synthetic pep-
tide substrates have been quite useful as model sub-
strates for protein kinases. Such peptides, usually 10-
20 residues in length, can be synthesized by solid-
phase methods using automated instrumentation.
They are constructed as protected molecules on
polystyrene supports and then deprotected and
cleaved from the support by treatment with acid. In
our laboratory, rigorous purification and characteriza-
tion are carried out to assure purity and identity of the
material. We have documented evidence that prod-
ucts of the side reactions of peptide synthesis can
alter the measured kinetic properties of the substrate.
Therefore, we use mass spectrometric measurements
to assess the molecular weight of the product to elim-
59
inate unwanted, modified side products that arise
from incomplete removal of protecting groups or
other modifications.
Combined with HPLC and amino acid analysis,
mass spectrometry has allowed us to prepare peptides
with excellent characteristics as kinase substrates, in-
cluding low KM values.
During the past year, we have introduced new
chemistry to our laboratory that allows the synthesis
of phosphorylated peptides. This is accomplished in a
four-step process. First, they are assembled on solid
supports using FMOC-protected N-a-amino acids.
Since the FMOC group is labile to base, acid treat-
ment of the peptide is unnecessary during assembly.
The hydroxyl moiety of the amino acid to be
phosphorylated is left unprotected.
Second, the assembled peptide-resin is treated
with a protected phosphoramidite compound that
leads to the production of the peptide-resin phosphite.
Third, the phosphite is oxidized to the phosphate
using an organic peroxide. Cysteinyl sulfhydryl
groups are protected from oxidation by steric
hindrance of the S-trityl derivative. Fourth, the pep-
tide is deprotected and removed from the resin using
trifluoroacetic acid. The solubilized peptide is
purified to homogeneity by multiple rounds of HPLC
under different conditions. The availability of this
chemistry has permitted the production of several
phosphopeptides that can be used to prepare
antibodies specific to phosphorylation sites on
proteins. In addition, some kinases require target sites
that are already phosphorylated at a site nearby the
substrate hydroxyl, and these synthetic phosphopep-
tides can be used as quantitative probes of activity
and as substrates for such kinases.
Molecular Cloning and
Expression of Casein
Kinase II Subunits
N. Chester, M. Vandenberg, J. Kass, D.R. Marshak
The enzyme casein kinase II (CKII) is a protein
serine/threonine kinase found in all eukaryotic cells.
Its ubiquitous distribution among species and tissues
implies a function central to all nucleated cells. The
enzyme consists of two subunits, a and 0, with
molecular masses of 37-44 kD and 24-28 kD,
respectively, and an apparent subunit composition of
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a2132. The a subunit is found in two different forms,
known as a and a' , that arise from separate genes.
To answer questions about the mechanism of enzyme
regulation, we have cloned and expressed DNA
molecules coding for the full-length forms of the a
and p subunits, using an innovative variation of the
polymerase chain reaction (Chester and Marshak
1993). This cloning has allowed us to insert the
coding sequences for the CKII subunits into various
expression vectors. Using these constructs, we have
expressed the proteins in large amounts in bacteria.
The purified, recombinant catalytic subunits are en-
zymatically active, and the activity is increased by
the regulatory subunit, p. The catalytic and regulatory
subunits combine in a functional complex whether
they are mixed in vitro or coexpressed in the same
bacterial cells. We have purified large amounts of the
regulatory subunit for structural analysis. In col-
laboration with J. Horton and J. Pflugrath (CSHL),
we have crystallized the 3 subunit of CKII in forms
that appear to diffract X-rays. We are now attempting
to produce larger crystals to solve the three-
dimensional strucure of this protein. Although the
catalytic subunits of CKII are homologous to other
known protein serine/threonine kinases, the p subunit
is unique. We expect that the structure of this
regulatory subunit will be a novel contribution to the
field.
Cell Cycle Regulation
of Casein Kinase II
G. Russo, M. Vandenberg, D.R. Marshak
During the past year, we have continued to study the
cell cycle regulation of CKII and its effect on cyclin-
dependent kinases in the control of cell division. The
enzyme p34cdc2 is a cyclin-dependent kinase that is a
key regulator of the G2/M transition in the cell cycle,
and it appears to have a role in the G1 /S transition as
well. We previously reported that human p34cdc2 is
phosphorylated on Ser-39 during the G1 phase of the
HeLa cell division cycle. The enzyme apparently
responsible for this phosphorylation event is CKII,
based on in vitro phosphorylation data, substrate
specificity, and correlation of the activities in vivo.
To evaluate the functional role of this phosphoryla-
tion event in eukaryotic cells, we turned to the bud-
ding yeast, Saccharomyces cerevisiae, in which we
genetically manipulated the homolog of mammalian
p34cdc2, known as Cdc28. In collaboration with A.
Sutton (CSHL), we have demonstrated that the
homologous serine is phosphorylated on Cdc28 in
yeast as on p34cdc2 in mammalian cells. To test the
functional role of this site in yeast, we constructed a
yeast carrying a mutation that results in the substitu-
tion of an alanine residue for the serine. The mutant
plasmid was intruduced into a yeast defective for
wild-type Cdc28. The phenotype of the mutant is a
small cell size, indicating a premature entry into S
phase. This result suggests that the phosphorylation
of the serine on Cdc28 in yeast (and by analogy on
p34cdc2 in human cells) allows the cell to extend GI.
Further genetic and biochemical experiments are un-
der way to demonstrate the mechanistic details of this
process.
Subcellular Pools of
Casein Kinase II
N. Chester, D.R. Marshak
The CKII enzyme activity is found both in cytosol
and in nuclei, and substrates have been identified in
both locations. Cytosolic substrates include proteins
involved in translational control (eIF-2, -3, -4B, -5),
metabolic regulation (glycogen synthase), and the
cytoskeleton (nonmuscle myosin heavy chain, (3-
tubulin). Substrates found in the nucleus include
DNA topoisomerase II, RNA polymerases I and II,
oncoproteins such as Myc, Myb, and SV40 large T
antigen, and transcription factors such as serum
response factor. The extraordinary range of substrates
for this enzyme supports the contention that CKII has
a significant role in cell physiology. We have devel-
oped a large set of specific antibodies to synthetic
peptide antigens that react with the individual sub-
units of CKII. These antibodies allowed us to con-
tinue our studies of the subcellular localization of the
subunits of the enzyme during the cell division cycle
of He La cells. Nick Chester has used the antibodies
developed in the laboratory to do detailed im-
munoprecipitation and immunoblots of the CKII sub-
units. First, he found that the synthetic rate for the
CKII 13 subunit is significantly longer than that of the
catalytic subunits, whereas the degradation rates for
all of the subunits appear to be similar. Second, using
steady-state metabolic labeling, he identified dif-
ferent pools of CKII that vary in subunit stoi-
chiometry and activity. He is currently attempting to
see if the different pools of CKII are localized in dif-
ferent subcellular compartments and if they change
their characteristics during the cell division cycle in
He La cells.
Structural Analysis and
Phosphorylation of
Nuclear Proteins
D.R. Marshak, M. Vandenberg, G. Binns
ZEBRA PROTEIN
The Epstein-Barr virus protein Zebra has been char-
acterized in collaboration with G. Miller's group at
Yale (Kolman et al. 1993). The Zebra protein is
phosphorylated at a unique site by CKII. This
phosphorylation results in the inability of the Zebra
protein to bind DNA. This suggests that physiologi-
cally, phosphorylation of Zebra may control its func-
tions in controlling viral gene transcription and
replication. Because of the structural similarity to c-
Jun, the phosphorylation of Zebra may parallel other
mechanisms in human cells.
FOS AND JUN PROTEINS
Our analysis of the phosphorylation of the c-Fos and
c-Jun proteins were done in collaboration with T.
Curran's group at the Roche Institute (Abate et al.
1993). This year, we found that the phosphorylation
of Fos and Jun proteins changes depending on
whether they are dimerized and bound to DNA. The
direction of the change in activity of the proteins as
substrates is different for different protein kinases.
The enzymes tested were CKII, p34cdc2/cyclin B,
double-stranded, DNA-dependent protein kinase, and
protein kinase C. The results provide some insight
into the complex mechanism of regulation of these
transcription factors. In a separate project in col-
laboration with G. Landreth at Case Western Reserve
University in Cleveland, we identified a novel
phosphorylation site on Fos. The phosphorylation of
this site is increased upon nerve growth factor treat-
ment of rat pheochromocytoma cells in culture
(Taylor et al. 1993).
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Protein Chemistry
Core Facility
R. Kobayashi, G. Binns, N. Poppito, D.R. Marshak
The Protein Chemistry Core Facility provides high-
technology methods, equipment, and expertise for
use by all of the scientists at Cold Spring Harbor
Laboratory. The services provided include protein se-
quencing, peptide mapping by HPLC, peptide
synthesis, HPLC and electrophoretic purification of
proteins, mass spectrometry, and amino acid analysis.
These methods can be used for structural analysis of
the amino acid sequence and composition of a
protein, as well as for determining posttranslational
modifications. Peptide synthesis remained approxi-
mately constant, whereas amino acid analysis
returned to levels of 1990. Protein sequencing and
peptide mapping have been aided by the addition of
new equipment to the laboratory. In the past year, we
have used funds from a shared instrumentation grant
to obtain an Applied Biosystems 477 protein se-
quencer and a new Hewlett Packard 1090M HPLC,
with the new workstation based on DOS operating
software. This instrument is networked with the ex-
isting 1090M HPLC and is complementary to another
1090L HPLC used by R. Kobayashi. The equipment
in the Core Facility is sufficient for isolating and se-
quencing peptides in the 0.2-2-pmole range. Next
year, we hope to make modifications that will extend
this range below 100 fmole. R. Kobayashi has pro-
duced an enormous amount of useful protein se-
quence information in collaboration with several
groups at Cold Spring Harbor Laboratory. A sum-
mary of these projects appears in the Structure and
Computation Section.
Our facility is active in the Association of
Biomolecular Resource Facilities (ABRF). The pur-
poses of the ABRF are (1) to promote and facilitate
discussion and cooperation among facilities; (2) to
provide research mechanisms for evaluation and im-
provement of the capabilities of facilities; and (3) to
promote the education of facility staff, users, ad-
ministrators, and interested members of the scientific
community regarding facility functions. The ABRF
exists because facilities have demanded an organiza-
tion that will provide them with a mechanism for
sharing information, maintaining state-of-the-art pro-
cedures, evaluating performance, and expanding to
new areas.
D. Marshak has completed a 2-year term on the
peptide synthesis research committee of the ABRF.
During that period, the committee performed a series
of studies to evaluate the performance of peptide
synthesis facilities. During 1993, Marshak has been
appointed to a 3-year term on the Executive Board of
the ABRF, and he will host next year's winter Board
meeting. Involvement with the ABRF helps to
maintain communication with other facilities around
the world and improves our ability to maintain high
standards of work.
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Gene expression in human cells is controlled at a va-
riety of levels. In our research, we continue to ex-
plore regulatory processes that operate at the levels of
RNA and protein synthesis, concentrating in particu-
lar on three systems in which viruses participate in
the regulatory events.
The first system operates at the translational level.
Its key component is a cellular protein kinase that
phosphorylates an initiation factor (as well as other
proteins, less well understood), thereby affecting the
rate of this critical step in protein synthesis. The
kinase is part of the antiviral defense mechanism that
is induced by interferon, and many viruses have elab-
orated countermeasures that at least partly neutralize
it and ensure their survival.
The second system, which operates at the tran-
scriptional level, concerns the relationship between
oncogenesis and DNA replication. Synthesis of a
replication protein known as PCNA (proliferating
cell nuclear antigen) is stimulated by one of the
adenovirus oncogenes, and this induction is mediated
through a number of cellular components and PCNA
promoter elements.
The third system involves the human immuno-
deficiency virus, HIV-1, the causative agent of AIDS.
Synthesis of viral RNA is dependent on a viral
protein called Tat, which exerts a novel type of con-
trol over the efficiency of RNA polymerases trans-
cribing the viral genome. During the year, Stephen
Brand, Michael Greenberg, and Benjamin Lee joined
the laboratory; Christian Schmedt completed his Dip-
lomarbeit for the University of Konstanz and returned
to Germany as a graduate student; Paul Clarke and
Simon Green finished their postdoctoral training and
moved to independent positions; and two senior
members of the group, Michael Laspia and Gilbert
Morris, left for faculty positions at Dartmouth Col-
lege and Tulane University, respectively.
Translational Control
Y. Ma, D. Taylor, P. Clarke, C. Schmedt, S. Green,
S. Brand, L. Manche, M.B. Mathews
Like many biological pathways, protein synthesis can
be controlled by the phosphorylation of enzymes that
mediate the process. One of the key regulatory steps
in translation is catalyzed by the eukaryotic initiation
factor eIF-2. Phosphorylation of this enzyme on its a
subunit leads to the entrapment of a second initiation
factor, GEF or eIF-2B, that is required for continued
eIF-2 activity. Three kinases are known that are able
to phosphorylate the critical Ser-51 residue of eIF-
2a, one in yeast and two in mammals. One of the
mammalian kinases, DAI, has an important role in
combating viral infection and has recently been im-
plicated in processes such as growth control and
tumorigenesis. An acronym for the double-stranded
RNA (dsRNA)-activated inhibitor of translation, DAI
(also known as PKR, p68, P1, etc.), is widespread in
cells and tissues. It is normally present at a low level
and in an inactive state; its synthesis is increased by
treatment with the antiviral interferons, and its activa-
tion is accompanied by autophosphorylation which
takes place in the presence of dsRNA. Viruses have
responded to this threat to their propagation by devel-
oping numerous countermeasures. One of these is the
production by adenovirus of a short (160-nucleotide)
RNA called VA RNA', which blocks DAI activation
by dsRNA.
Our objective is to understand the molecular
switches that are thrown by dsRNA and VA RNA so
as to control the activity of the kinase. To this end,
we have studied the nature of the RNAs that activate
and inhibit DAI, the structure of the enzyme itself,
and the interaction between the protein and the
RNAs. Earlier studies had indicated that activation
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requires a dsRNA containing at least 30-80 base
pairs of perfectly matched duplex, whereas VA RNA
is highly structured but only partially duplexed. Ac-
cordingly, we anticipated that the genomic RNA of
the hepatitis delta agent might also inhibit DAI ac-
tivation. This RNA is circular, predominantly single-
stranded but base-paired such that it forms a linear
structure resembling a collapsed rubber band. To-
gether with Dr. H. Robertson (Cornell University
Medical School), we found that delta agent RNA
forms complexes with DAI, interacting specifically
with the enzyme's RNA-binding domain. Surprising-
ly, however, the consequence of binding is activation
of the enzyme rather than the opposite. Consistent
with the structure of delta RNA, this activation was
sensitive to digestion with a single-strand-specific
RNase but was resistant to treatment with a dsRNA-
specific nuclease. RNase III cleaves RNA molecules
that contain stretches of duplex exceeding 20 base
pairs in length but is unable to act on delta agent
RNA, indicating that dsRNA contaminants are not
responsible for the activation. These results suggest
that DAI (or possibly another cellular protein with
similar RNA-binding properties) may contribute to
hepatitis delta pathogenesis, and they show that some
RNAs that are not formally double-stranded can ac-
tivate the enzyme, emphasizing the subtleties of the
nucleic acid-protein interactions involved.
VA RNA/ serves to protect adenovirus against in-
terferon by preventing DAI activation. Its action rests
on two elements of structure: an extended stem, the
apical stem, containing about 40 imperfectly paired
nucleotides, and a complex structure, the central
domain, containing paired and unpaired regions.
Mutagenic analysis shows that the apical stem and
central domain are both involved in the binding of
VA RNA to DAI and that the central domain is criti-
cal for inhibition of DAI activation. These conclu-
sions have been extended by a direct examination of
the sites of interaction, using the protein to protect
the RNA from attack by nucleases or chemical
probes. The regions of VA RNA influenced by DAI
are illustrated in Figure 1, superimposed on a new
model of the RNA's secondary structure.
The new structure takes into account recent data
from three sources: mutagenesis, chemical probing,
and phylogenetic comparisons. Previous comparative
studies with seven VA RNAs suggested that two
pairs of conserved tetranucleotides might have a part
in maintaining base pairing in VA RNA. One pair
(GGGU/ACCC), located in the central domain, led
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FIGURE 1 The DAI-binding-site in VA RNA. Superimposed
on the new secondary structure model for Ad2 VA RNA, are
the sites that are protected by DAI from chemical and en-
zymatic attack. The protected sites are in the central domain
and adjacent stretch of the apical stem. To locate the GG-
GU/ACCC tetranucleotide pair described in the text, note
that the U residue is at position 40.
us to suggest a revision of the previous adenovirus 2
(Ad2) VA RNA/ model. This year, we have taken
three steps to test this prediction. First, we used more
physiological conditions to probe VA RNA structure.
This resulted in changes in the sensitivity of certain
nucleotides, supporting the new model. Second, we
made a set of mutations of these tetranucleotides,
changing GGGU to GUCU and ACCC to AGAC.
The double mutant, containing both changes, should
be a compensatory mutant if the new structure is cor-
rect. Indeed, this mutant was more active in a CAT
expression enhancing assay than either of the single
mutants alone. Third, we extended the phylogenetic
analysis to cover all of the human adenoviruses.
Using degenerate oligonucleotides complementary to
conserved adenovirus genes that flank the VA RNA
sequences, we amplified the VA RNA gene region
and sequenced the amplified polymerase chain reac-
tion (PCR) fragments. The GGGU/ACCC tetranu-
cleotide pair was highly conserved in all of the VA
RNAs, confirming the importance of the proposed
base pairing.
Despite its opposite responses to dsRNA and VA
RNA, no DAI mutations have been isolated so far
that distinguish between the binding of these two
ligands. The RNA-binding domain contains two
divergent copies of a repeated sequence about 65
amino acids in length, which is also characteristic of
some other dsRNA-binding proteins. We have ex-
plored the roles of the two copies of the motif
through mutagenesis and direct analysis of protein
overexpressed in Escherichia coli. Mutagenic studies
showed that the first motif has a more important role
than the second motif, although both are required for
efficient RNA binding. The two motifs do not seem
to be equivalent, however, because mutations of equi-
valent amino acids do not necessarily produce equi-
valent effects on RNA binding. Physical bio-
chemistry studies are under way to define the interac-
tions in detail. Further investigations, carried out with
Drs. S. Lee and M. Esteban (SUNY, Brooklyn) have
identified a region adjacent to the RNA-binding
domain as having an important role in DAI function.
Like the RNA-binding motifs, this region is highly
basic in nature, but it does not appear to influence
RNA binding. Nevertheless, its deletion eliminates
kinase function in assays based on a vaccinia virus
system. Although the function of this region is not
yet understood, it may be significant that it contains
some autophosphorylation sites.
DAI is a serine/threonine kinase and its activation
as an eIF-2 kinase is correlated with its auto-
phosphorylation. We have begun to identify the loca-
tion of the autophosphorylation sites and the mech-
anism of autophosphorylation of DAI. In collabora-
tion with Dr. D. Marshak and G. Binns (Protein
Chemistry Core section), the locations of several
autophosphorylated sites have been identified
through peptide mapping and sequencing. These sites
may define an autoregulatory region, separating the
enzyme's RNA-binding and kinase domains. We
have also identified phosphorylated serine and
threonine residues located with the spacer region of
the RNA-binding domain. This region is likely to be
accessible to phosphorylation, as it is not contained
within either of the two predicted a helices. It will be
interesting to see if these sites affect kinase function
through RNA binding. We are currently using site-
directed mutagenesis to determine which of the
autophosphorylation sites are important for the ac-
tivation of the enzyme. We have also begun to inves-
tigate the mechanism of autophosphorylation. Pre-
liminary data indicate that some sites on truncated
forms of DAI can be phosphorylated intermolecular-
ly, consistent with the view that such a mechanism is
used by full-length DAI, but further studies are re-
quired to prove this point with the intact protein.
Regulation of PCNA
G.F. Morris, C. Labrie, B. Lee, S. Brand, R. Packer,
M.B. Mathews
Activation of the DNA replication machinery is cen-
tral to the process of neoplastic transformation. The
protein PCNA, the proliferating cell nuclear antigen,
was originally discovered as an antigen in the
autoimmune disease SLE (systemic lupus ery-
thematosis). As the auxiliary factor of DNA
polymerase 8, it functions in both leading and
lagging-strand DNA synthesis during DNA replica-
tion. In accord with this function, cellular PCNA
levels increase during the oncogenic transformation
of rodent cells by the adenovirus ElA gene. The goal
of this project is to explore the relationship between
transformation and gene activation by elucidating the
mechanism of E1A-mediated induction of PCNA
gene expression.
The El A 243R protein (243 residues long), trans-
lated from the El A 12S mRNA, is able to stimulate
PCNA transcription and to activate the PCNA
promoter in the absence of other viral genes. Last
year, we showed that trans-activation of the human
PCNA promoter by El A 243R is mediated through
an element termed the PERE (PCNA E1A-re-
sponsive element) and that multiple domains of the
El A' protein are required to induce expression of the
wild-type PCNA promoter. We also showed that the
p300 and p107/cyclin A-binding function of El A
correlates most closely with its ability to activate the
PCNA promoter.
To further elucidate the function of El A, we have
developed a simplified assay for activities of El A
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mutants by preparing a construct, G5PCNA-CAT, in
which the PERE and sequences upstream in the
PCNA promoter are replaced by five sites cor-
responding to the DNA sequence bound by the yeast
GAL4 protein. With the G5PCNA-CAT construct,
the transcriptional activator is specified by the GAL4
fusion protein, thereby obviating effects of El A on
the components that bind the PERE. In contrast to
our earlier results with the wild-type PCNA
promoter, we found that an El A mutant with a dele-
tion of conserved region 2 can cooperate with a
weakly activating fusion protein to trans-activate
G5PCNA-CAT as effectively as wild-type EIA
243R. An EIA mutant with a deletion of the amino
terminus failed to trans-activate G5PCNA-CAT,
however. These data suggest that the p300-binding
function of El A is associated with its ability to trans-
activate transcription and that the p107/cyclin A re-
quirement for trans-activation of the wild-type
promoter is associated with PERE function.
The PERE contains an activating transcription
factor (ATF)-binding site, together with an adjacent
sequence that does not correspond to any known
protein-binding site. We have made good progress
toward identifying the cellular transcription factors
that associate with the PERE and presumably mediate
trans-activation of the PCNA promoter by El A
243R. Through a combination of Southwestern analy-
sis and UV light cross-linking experiments, we have
identified five proteins in crude HeLa cell nuclear ex-
tracts that interact with the PERE. On the basis of the
size of one of these polypeptides, we suspected that
one of the PERE-binding proteins might be ATF-1
and have now proven this contention. Antibodies
raised against ATF-1 specifically disrupt PERE-
protein complexes in gel-retardation assays. More-
over, ATF-1 synthesized in vitro can bind to the
PERE in a gel-shift assay. We are currently in the
process of identifying the other PERE-binding
proteins by biochemical methods.
All of the above studies were conducted in HeLa
cells, a human cervical carcinoma cell line. Paradoxi-
cally, in contrast to the HeLa cell results, ElA
represses expression from the PCNA-CAT promoter
in two types of rodent cells, baby rat kidney (BRK)
and cloned rat embryo fibroblasts (CREFs). We have
now shown that removal of sequences between posi-
tions -234 and -213, upstream of the transcription
initiation site, relieves E1A-mediated repression of
PCNA-CAT expression in these rodent cells. Within
this sequence is an 18 out of 20 match to the con-
sensus sequence bound by the tumor suppressor
protein p53. Several observations suggest that this se-
quence in the human PCNA promoter can function as
a p53-responsive element. First, a construct (-249)
with the site intact bound a protein antigenically re-
lated to p53 in cell extracts from yeast that express
wild-type, but not mutant, human p53, whereas a
construct (-213) with the site deleted did not. Sec-
ond, cotransfection of a construct encoding wild-type
p53 activated CAT expression from the -249 PCNA-
CAT construct in a cell line that fails to express p53
(SAOS-2 cells) but represses CAT expression from
-213 PCNA-CAT. Third, as with the wild-type
PCNA promoter, El A repressed CAT expression in
BRK cells from a PCNA-CAT construct with a well-
characterized heterologous p53-binding site sub-
stituted for the related sequence in the PCNA
promoter (Fig. 2).
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FIGURE 2 EIA 243R repression of the PCNA promoter via
p53-binding sites. The constructs (top) were cotransfected
into BRK cells with a plasmid that expresses EIA 243R or a
control plasmid. Transcription from the mutant PCNA
promoters was measured in CAT units (bottom). The data
show that removal of sequences between -249 and -213
abolished EIA repression, which was restored by insertion of
a heterologous p53-binding site from the ribosomal gene
cluster (RGC 213).
Finally, we have also been examining the struc-
ture and antigenicity of PCNA itself. In a collabora-
tion with Dr. R. Bernstein (University of Manchester,
U.K.), we defined two classes of antibodies against
PCNA found in serum from SLE patients. The major
class was highly conformation-dependent, tolerating
only minor changes in protein structure; the minor
class was less conformation-dependent and could
react with PCNA lacking about half of its sequence
from the amino terminus. We went on to use gel fil-
tration and glycerol gradient sedimentation to analyze
the native structure and size of PCNA. PCNA from
three sources was studied-from He La cells, purified
following its overexpression in bacteria, and pro-
duced in the wheat-germ cell-free translation sys-
tem-as well as mutant forms of PCNA translated in
vitro. In each case, full-length PCNA behaved as a
trimer. Analysis of mutant proteins revealed a cor-
relation between their ability to adopt the trimeric
form and binding to the common type of human anti-
PCNA autoantibody, suggesting that the antibodies
are specific for the active form of the protein. These
findings are consistent with the idea that auto-
antibodies are generated as a response to native
antigen and provide experimental support for the
hypothesis that PCNA serves its processive function
in DNA replication as a trimeric ring structure.
Transcriptional Regulation
by the HIV-1 Tat Protein
A. Lozeau, P. Wendel, L.A. Sheldon, M. Laspia
The genome of HIV-1 contains, in addition to the
structural genes gag, pol, and env, several novel
regulatory genes. One of these, Tat, is essential and
encodes a powerful trans-activator that greatly stimu-
lated HIV-1 gene expression. It does so by binding to
an RNA element, known as TAR, present in the 5' -
untranslated region of all HIV mRNAs. This causes
an increase in transcription directed by the promoter
located within the long terminal repeat (LTR) of the
virus. Previous studies showed that, in the absence of
Tat, the level of HIV-directed transcriptional initia-
tion is low and transcriptional elongation is ineffi-
cient, such that the number of transcriptional com-
plexes declines with increasing distance from the site
of initiation. We found that Tat works through TAR
to increase initiation of transcription by RNA
polymerase II and also improves the efficiency of
elongation. Thus, Tat appears to be a unique tran-
scriptional activator in that promoter binding is via a
structured RNA, as well as in its ability to stimulate
both transcriptional initiation and elongation. We
wish to understand the mechanism by which Tat acts
to stimulate HIV transcription, both as a paradigm for
regulation of eukaryotic gene expression and because
approaches that interfere with trans-activation may
have therapeutic potential for the treatment of AIDS.
The molecular mechanism by which Tat produces
these dual effects on HIV-1 transcription is unclear.
In particular, little is known about the role of cellular
factors in trans-activation. A detailed understanding
of the mechanism of trans-activation is most likely to
emerge from the identification and purification of
cellular components of the transcriptional machinery
that interact with Tat. Therefore, we have pursued
our analysis of trans-activation by Tat in a cell-free
system. In an in vitro transcription system consisting
of a DNA template and HeLa cell nuclear extract, the
addition of purified, bacterially expressed Tat stimu-
lates transcription from the HIV-1 promoter but not
from heterologous promoters nor from the HIV-1
promoter when TAR is mutated. An examination of
the effects of Tat on HIV-1 transcription rates in vitro
has indicated that Tat increases promoter-distal tran-
scription rates without similarly increasing promoter-
proximal transcription rates, suggesting that in vitro,
Tat principally stimulates transcriptional elongation.
TAR is the only promoter element known to be
absolutely required for trans-activation by Tat. TAR
RNA folds into a structure consisting of a 60-nucleo-
tide paired stem with a trinucleotide bulge (+23U
CU+25) and an apical loop (+30CUGGGA+35). Tat
binding to TAR RNA in vitro is abolished by muta-
tions in the bulge, but mutations in the apical loop do
not reduce the binding of Tat to TAR RNA. On the
other hand, mutations that disrupt the stem or change
the sequence in either the bulge or the loop greatly
reduce trans-activation in vivo. To assess the struc-
tural requirements of TAR RNA in trans-activation,
we examined the ability of Tat to stimulate transcrip-
tion from HIV templates containing mutations in
TAR. Deletion of the trinucleotide bulge or alteration
of the loop sequence from +31UGGG+34 to CAAA
greatly diminished trans-activation in vitro. Inter-
estingly, a +23U to A transversion, which abolishes
the ability of Tat to bind to TAR RNA in gel-shift ex-
periments, supported stimulation by Tat in transcrip-
tion assays at a reduced level.
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We further analyzed the role of TAR RNA in
trans-activation by Tat by examining the ability of
synthetic competitor TAR RNA to inhibit trans-
activation by Tat in vitro. Wild-type and mutant TAR
RNAs were synthesized in vitro and purified. The ad-
dition of 1 mm wild-type TAR RNA, corresponding
to nucleotides +1 to +83, strongly inhibited trans-
activation by Tat, whereas the addition of 8 mm
mutant TAR RNA containing a deletion of nu-
cleotides +35 to +38 failed to inhibit trans-activation.
In addition, synthetic TAR RNA with a mutation in
either the bulge or the apical loop failed to inhibit
trans-activation. These results indicate that TAR
functions as an RNA element and that the integrity of Activation of HIV-1
transcription, which is depen-
the stem and the sequence of both the trinucleotide dent on the viral
Tat protein and its target RNA -
bulge and apical loop are essential for TAR RNA to binding sequence,
TAR, is indispensable for the virus
inhibit trans-activation by Tat. Thus, the trinucleotide to exit from
latency and initiate a productive infec-
bulge is necessary but not sufficient for competitor tion. This suggested
that the proximity of the in-
TAR RNA to inhibit trans-activation, suggesting that tegrated HIV provirus to a
DNA replication origin
Tat may bind to TAR cooperatively with a cellular may affect viral
promoter activity and pathogenicity.
protein that has specificity for the apical loop. We are To explore this possibility, we have examined the in-
examining whether inhibition of Tat responsiveness fluence of replication origins on the transcriptional
by synthetic TAR RNA is due to competition for the activity of the HIV-LTR promoter, using transient
binding of Tat or a cellular protein(s). Preliminary expression assays, and have begun to investigate the
studies indicate that synthetic TAR RNA does not activity of the HIV-LTR promoter integrated into the
function as a competitive inhibitor of Tat since in- human chromosomal DNA.
hibition cannot be overcome by increasing the con- In transient expression assays, the transcriptional
centration of Tat. Thus, inhibition by TAR may re- activity of the HIV promoter is influenced by the
quire the binding of a cellular protein, and we are origin of SV40 DNA replication. When the SV40
currently addressing this possibility using nuclear ex- origin was situated immediately upstream or
tracts fractionated by conventional and affinity ap- downstream from an LTR-CAT reporter cassette, the
proaches to overcome inhibition. basal transcription rate increased severalfold. More-
An additional approach we are utilizing is to at- over, the origin enhanced the effects of HIV-Tat,
tempt to identify cellular proteins that bind to Tat that which were an increase in transcription initiation rate
may be involved in trans-activation. Utilizing and elongation processivity. A deletion in the core
purified, bacterially expressed, "epitope-tagged " Tat, origin, which disrupts the SV40 T antigen binding
we have preliminary evidence that a cellular and abolishes replication, abrogates the origin's ef-
protein(s) that binds to Tat is required for activated fects on HIV-LTR promoter activity. The DNA
but not basal levels of transcription in vitro. This is replication inhibitor hydroxyurea, which terminates
based on the finding that immunoprecipitation of Tat nascent DNA chains without blocking initiation,
from nuclear extracts incubated with wild-type reduced the effects of the origin but did not eliminate
epitope-tagged Tat renders the extracts incapable of them. These studies suggest that the increase in DNA
supporting trans-activation in vitro. We are currently template number due to replication is not the only
attempting to reconstitute the activity of extracts factor contributing to increased basal HIV-LTR
depleted by Tat with nuclear extracts fractionated by promoter activity and the enhancement of transcrip-
conventional and affinity approaches. We are also tion initiation and elongation by Tat. Possibly, in-
using the two hybrid system, a genetic selection in complete replication of the DNA template containing
yeast, to identify human proteins that interact with the LTR-CAT, as achieved in the presence of
Tat in vivo. Through characterization of the interac- hydroxyurea, imparts similar effects, albeit at a
tions between Tat and the cellular transcriptional ap- reduced level.
paratus, we should come to a greater understanding To address the second objective, we are exploit-
Tat which hopefully willwaisthsisHtHIV
-thlegdeenve
of the biochemistry of transcriptional activation by
e lexpression f
strategies that interfere
in patients with AIDS.
Regulation of HIV
Gene Expression
P. Nahreini, S. Gunnery, M. Greenberg, P. Wendel,
B. Hofmann, M.B. Mathews
ing the ability of recombinant adeno-associated virus
(AAV-1) to transfer and stably integrate a reporter
gene cassette into human chromosome 19 in a site-
specific fashion. We have constructed several chi-
meric AAV vectors containing the LTR-CAT re-
porter cassette. In some of these vectors, a selectable
marker gene (for neomycin resistance) was inserted
to facilitate the isolation of clones containing the in-
tegrated HIV gene cassette. The recombinant AAVs
were used to infect He La cells; in some instances, the
recombinant virus was coinfected with wild-type
AAV to provide rep function and impart site-specific
integration of the recombinant virus. Thus far, we
have isolated 25 independent clones of He La cells
containing the integrated LTR-CAT recombinant and
have monitored the activity of the chromosomally in-
tegrated HIV-LTR promoter using CAT enzyme and
RNase-protection assays.
In the absence of the HIV Tat protein, few clones
expressed CAT activity. In the presence of HIV-Tat,
however, CAT activity was detected in most of these
clones. The level of CAT activity differed sig-
nificantly among the Tat-responsive clones, and a
few clones showed no CAT activity even though the
linked neomycin resistance gene was biologically ac-
tive. We plan to determine the integration site of the
recombinant proviral DNA and to assess whether the
flanking chromosomal DNA might account for the
observed variation among these clones. In future
studies, we hope to examine the influence of cellular
replication origins on the activity of the integrated
HIV-LTR promoter.
To explore the mechanism whereby Tat activates
transcription from the HIV-1 promoter, we have ex-
ploited a cell-free transcription system that faithfully
reproduces Tat stimulation. Together with D.
Ostapenko (Weizmann Institute, Israel), we showed
that the level of trans-activation increased sig-
nificantly when transcription was measured at later
times during the reaction as a result of two distinct
processes. First, preincubation reduces the level of
basal transcription for reasons that are not yet un-
derstood. Second, when the addition of Tat to prein-
cubated reaction mixtures was delayed, the level of
trans-activation decreased markedly, indicative of a
lag in the formation of Tat-activated transcription
complexes. Pulse-chase analysis revealed that this lag
is not due to the rate-limiting binding of Tat to the
TAR element. Rather, it seems that preincubation of
Tat with nuclear extract is required for the assembly
of Tat with a cellular cofactor whose nature we are
currently investigating. We have also developed a
solid-phase transcription system, in which a template
bearing the HIV-1 promoter is immobilized on
agarose beads through a biotin-streptavidin bridge.
Tat stimulated transcription in this solid-phase sys-
tem as in the soluble reaction. Although washing of
the immobilized pre-initiation transcription com-
plexes did not affect basal transcription, it abolished
Tat-mediated stimulation, indicating that a cellular
cofactor of Tat is removed by the washing. These
results suggest that the immobilized transcription sys-
tem will enable further analysis of cellular proteins
which participate in trans-activation.
We have also exploited the Tat/TAR system to
show that RNA polymerase III is capable of produc-
ing RNA that can be translated as messenger RNA.
Eukaryotic cellular mRNA is synthesized by pol II,
whereas pol I produces long rRNAs and pol III pro-
duces 5S rRNA, tRNA, and other small RNAs. To
determine whether this functional differentiation
reflects an underlying mechanistic specialization,
such that each polymerase is restricted as to the kind
of RNA that it produces, we examined the transla-
tional potential of a pol III transcript. The coding
region of the HIV-1 Tat gene was placed under the
control of the adenovirus-2 VA RNA' gene promoter,
a strong pol III promoter. The resultant plasmid,
pVA-Tat, was transcribed in vivo and in vitro to gen-
erate the predicted RNA, which was insensitive to
low concentrations of a-amanitin as expected for a
pol III transcript. Its translational activity was exam-
ined by cotransfection of pVA-Tat with a reporter
construct, pHIV-LTR-CAT, which is trans-activated
by the Tat protein. pVA-Tat elicited an 80-fold in-
crease in CAT activity, showing that it generates
functional mRNA (Fig. 3). Neither a control plasmid
pVA that lacks the Tat-coding region nor pVA anti-
Tat that contains the coding region in an antisense
orientation elicited any effect in the trans-activation
assay.
To verify that the translated RNA is indeed pro-
duced by pol III, we produced a series of mutations in
pVA-Tat sites that are specific for pol III transcrip-
tion. Site-directed mutations in the essential elements
of the pol III promoter, the A and B boxes, down-
regulated VA-Tat RNA production both in vivo and
in vitro and dramatically reduced CAT trans-
activation. Furthermore, the insertion of a pol III
termination signal within the Tat-coding sequence led
to the production of truncated RNA and reduced
trans-activation.
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FIGURE 3 Synthesis of Tat from a pol III chimera. The HIV-LTR-CAT reporter
plasmid was cotransfected into HeLa cells with the pVA-Tat chimera (lane 5), in
which the VA RNA promoter drives Tat RNA synthesis. As a positive control, Tat
RNA was produced from a pol II promoter (pCMV-Tat, lane 6). Negative controls
include cells lacking the reporter plasmid (lane 1), containing this plasmid alone
(lane 2), or cotransfected with plasmids expressing VA RNA (pVA, lane 3) or a
partial antisense copy of Tat (pVA-anti Tat, lane 4). The plasmids are shown
schematically (top) and results of CAT assays are shown below.
As expected for a pol III transcript, VA-Tat RNA
was neither polyadenylated at its 3' end nor capped at
its 5' end. Like mRNA, the uncapped VA-Tat RNA
was associated with polysomes in a salt-stable man-
ner. We conclude that the Tat activity is generated by
translation of an RNA produced by pol III. These
findings imply that functional mRNA synthesis is not
restricted to pol II, that pol III transcripts can be
transported within the cell and assembled with the
translational components, and that the 5' cap struc-
ture is not obligatory for translation. The implications
of these findings for the transcription and translation
processes are being explored further, for example, to
determine whether a pol III transcript can be spliced
and to study the initiation of protein synthesis on an
uncapped mRNA.
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MECHANISMS OF MAMMALIAN PRE-mRNA SPLICING
AND SPLICE SITE SELECTION
RNA splicing is a required step in the expression of
most eukaryotic protein-coding genes. Alternative
pre-mRNA splicing is a widespread mechanism for
generating structurally and functionally distinct
protein isoforms from single genes, often in a tissue-
specific, developmentally regulated, or physiological-
ly controlled manner. Both constitutive and alterna-
tive splicing mechanisms involve multiple protein
components as well as RNA components that are part
of small nuclear ribonucleoprotein (snRNP) particles.
RNA-RNA base-pairing interactions among snRNAs
and between snRNAs and pre-mRNA are important
determinants of splice site recognition and, in addi-
tion, probably participate in the formation of the ac-
tive sites for catalyzing the trans-esterification reac-
tions within the spliceosome. The role of spliceo-
somal proteins is not well understood, although
protein-RNA and protein-protein interactions are also
essential for pre-mRNA splicing. Several required
protein-splicing factors are thought to have important
roles in spliceosome assembly, splice site selection,
and conformational rearrangements coupled to ATP
hydrolysis. Other possible roles include regulation of
active site accessibility, turnover of snRNPs, and pos-
itive and negative regulation of alternative splice site
selection, for example, through posttranslational
modification. Some protein factors might also con-
tribute chemical groups to the trans-esterification ac-
tive sites. Our laboratory has focused on the identi-
fication, purification, and molecular characterization
of protein factors that are necessary for the catalysis
of splicing and/or for the regulation of alternative
splice site selection in vitro.
STRUCTURE, FUNCTION, AND EXPRESSION OF
HUMAN SPLICING FACTORS SF2/ASF AND hnRNP Al
Human pre-mRNA splicing factor SF2/ASF has an
activity required for general splicing in vitro and
promotes utilization of proximal alternative 5' splice
sites in a concentration-dependent manner. The latter
activity results from antagonistic interactions with the
protein heterogeneous nuclear RNP (hnRNP) Al,
which stimulates use of distal 5' splice sites. J.
Caceres introduced selected mutations in the amino-
terminal RNA recognition motif (RRM) and the
carboxy-terminal arginine/serine (RS) domain of
SF2/ASF and assayed the resulting recombinant
proteins for constitutive and alternative splicing in
vitro and for binding to pre-mRNA and mRNA (Figs.
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1 and 2). Mutations were designed on the basis of
known RRM tertiary structures in such a way as to
minimize structural or folding perturbations. These
experiments showed that mutant proteins inactive in
constitutive splicing continued to affect alternative
splice site selection, demonstrating that these ac-
tivities involve distinct molecular interactions.
Specific protein-RNA contacts mediated by solvent-
exposed Phe-56 and Phe-58 in the RNP-1 submotif of
the SF2/ASF RRM were found to be essential for
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FIGURE 1 Effect of SF2/ASF mutations on constitutive splic-
ing in vitro. The constitutive splicing activity of purified wild-
type (wt) and mutant SF2/ASF proteins expressed in Es-
cherichia coli was assayed by biochemical complementa-
tion with a HeLa S100 extract that contains all other general
splicing factors. Pre-mRNA containing the first two exons
and first intron of wild-type human 13-globin was spliced in
vitro with HeLa nuclear extract (NE) or with HeLa cytoplas-
mic S100 extract and recombinant SF2/ASF proteins; 0.2 [ig
of wild type or mutant SF2/ASF in 5 µl was used to comple-
ment 7 [LI of S100 extract. The products were analyzed by
urea-PAGE and autoradiography. The structures and rela-
tive mobilities of the pre-mRNA and spliced mRNA are indi-
cated at left. The band just above spliced mRNA is the
lariat-exon 2 intermediate. (PP-RG) Mutation of Pro-54/Pro-
55 in the RNP-1 submotif of the RRM to the consensus Arg-
Gly; (FF-DD) mutation of solvent-exposed Phe-56 and Phe-
58 in the RNP-1 submotif to Asp residues; (loop3) replace-
ment of the variable loop sequence preceding RNP-1
(RGGPP) with the loop from a different RRM (GSGKKRG);
(Octa) replacement of the octapeptide EFEDPRDA, which is
conserved between several SR proteins and U1-70K
polypeptide, by the uncharged sequence TFQNPANV. The
next four mutants consist of replacements of the Arg/Ser
dipeptide repeats within the carboxy-terminal 50-amino-acid
RS domain: substitution of all Ser residues by Thr (RT) or
Gly (RG) or of all Arg residues by Gly (GS) or Lys (KS).
(ARS) Deletion of all Arg/Ser dipeptides within the RS
domain.
constitutive splicing, although they are not required
for RRM-mediated binding to pre-mRNA. The RS
domain is also required for efficient constitutive
splicing activity, and both arginine and serine
residues are important for biochemical activity. Anal-
ysis of domain deletion mutants demonstrated strong
synergy between the RRM and a central degenerate
RRM repeat in binding to RNA. These two domains
are sufficient for alternative splicing activity in the
absence of an RS domain (Fig. 2).
A related mutagenic analysis of hnRNP Al struc-
ture and function was carried out by A. Mayeda in
collaboration with Steve Munroe (Marquette Univer-
sity). The ability of hnRNP Al to promote use of
certain distal alternative 5 ' splice sites requires
specific protein-RNA contacts mediated by pairs of
conserved phenylalanine residues (analogous to those
of SF2/ASF) in the RNP-1 submotifs of each of the
two RRMs, although these residues are not required
for general RNA binding. The glycine-rich carboxyl
terminus of hnRNP Al is also essential for alterna-
tive splicing activity. These mutants were also an-
alyzed for their effects on the RNA annealing activity
of hnRNP Al. Previous work on hnRNP Al showed
that it binds single-stranded nucleic acids in a
sequence-independent fashion and in a cooperative
manner due to protein-protein interactions between
carboxy-terminal domains. However, in crude ex-
tracts, distinct binding preferences for 3 ' splice sites,
as well as changes in the ability to cross-link this
protein to pre-mRNA depending on the integrity of
snRNAs, have been shown in other laboratories.
More recently, intrinsic high-affinity binding sites for
hnRNP Al have been identified by G. Dreyfuss and
colleagues. A. Hanamura and I. Watakabe are cur-
rently identifying high-affinity SF2/ASF-binding
sites by selection and amplification from random
RNA libraries. The functional significance of binding
to sites of different affinities by wild-type and mutant
SF2/ASF and hnRNP Al proteins will then be
evaluated.
Collaborative experiments between I. Eperon's
laboratory (University of Leicester) and our labora-
tory showed that U1 snRNP can bind simultaneously
to two alternative 5' splice sites on a single pre-
mRNA molecule. When this occurs, the downstream
5' splice site is selected, and the effect of SF2/ASF
appears to be to enhance multiple 5' splice site oc-
cupancy by UI snRNP. Ongoing experiments will
address the role of hnRNP Al and the mechanism by
which SF2/ASF stabilizes Ul snRNP binding.
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FIGURE 2 Summary of the effects of SF2/ASF mutations. The structures of the wild-type and mutant proteins
are shown schematically at the left. The X symbolizes mutation of Phe-56 and Phe-58 in the RNP-1 submotif to
Asp residues. The 0 represents each of three mutations of the RNP-1 submotif and/or adjacent residues,
which have similar phenotypes: PP-RG, loop3, and Octa (see Fig. 1). The closed ellipse denotes each of four
mutations of the Arg/Ser repeats within the RS domain, which have similar phenotypes: RT, RG, GS, and KS. ip
RRM refers to a central atypical RRM. The effects of single and double mutations and domain deletions of
SF2/ASF on constitutive splicing, alternative 5' splice site selection, UV cross-linking to RNA, and retention of
RNA on nitrocellulose filters are indicated. ND indicates not determined.
We have proposed that the intracellular ratios of
SF2/ASF and hnRNP Al may control the specificity
of splice site selection and that in vivo regulation of
one or both of these activities may have an important
role in the tissue-specific or developmental regulation
of alternative splicing. A. Hanamura measured the
levels of SF2/ASF and hnRNP Al polypeptides in
different rat tissues by quantitative immunoblotting
with a monoclonal anti-SF2/ASF antibody (generated
in collaboration with C. Bautista and M. Falkowski,
CSHL Monoclonal Antibody Facility) and a mono-
clonal anti-hnRNP Al antibody (provided by G.
Dreyfuss). Substantial variation in the molar ratio of
SF2/ASF to Al was observed, well above the range
required to elicit splice site switching in vitro.
Altered electrophoretic mobilities that would reflect
differences in posttranslational modifications were
not observed in rapidly lysed samples. In addition,
small but reproducible changes were also observed
among different cell lines, for example, in response
to transformation (in collaboration with J. Caceres
and with R. Franza Jr., CSHL), which might explain
some of the alterations of alternative splicing patterns
that are commonly seen in transformed cells.
ROLE OF SF2/ASF IN SPLICING REACTIONS
DEPENDENT ON EXONIC SPLICING ENHANCERS
A novel function for SF2/ASF was uncovered in col-
laborative studies with F. Rottman and colleagues
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(Case Western Reserve University). Their laboratory
had previously identified a purine-rich cis-acting ele-
ment in the last exon of bovine growth hormone
(bGH) pre-mRNA which activates alternative splic-
ing of the bGH last intron in vivo and in vitro. A 35-
kD protein factor that interacts specifically with the
exonic splicing enhancer (ESE) turned out to be iden-
tical to SF2/ASF. UV cross-linking followed by im-
munoprecipitation with an SF2/ASF-specific mono-
clonal antibody confirmed that SF2/ASF binds to the
ESE in splicing extracts. Competition experiments
showed that sequence-specific binding of SF2/ASF to
the ESE is an intrinsic property of the protein and can
occur in the absence of other components. Addition
of purified SF2/ASF enhanced in vitro splicing of the
last intron in wild-type bGH pre-mRNA but not in
mutant bGH pre-mRNA lacking the ESE. A related
SR protein, SC35, failed to bind to the bGH ESE and
did not activate splicing of the last intron. Thus,
SF2/ASF functions as a sequence-specific exonic en-
hancer recognition factor to activate the splicing of
the preceding intron. hnRNP Al counteracted the
SF2/ASF-mediated enhancement of bGH splicing, al-
though it bound the ESE only in a nonspecific man-
ESE - dependent splicing
Stimulate
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ESE - independent splicing
PY 3'ss
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Functional binding site?
by py 3'ss
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FIGURE 3 SF2/ASF activation of enhancer-dependent and
-independent splicing events. (Top) Based on the bGH sys-
tem, SF2/ASF binds sequence-specifically to a purine-rich
exonic splicing enhancer (ESE). The resulting complex ac-
tivates splicing of the preceding intron. Splicing is depen-
dent on the ESE because of the presence of weak splicing
signals in the intron. (Bottom) Constitutively spliced pre-
mRNA with strong intronic splicing signals. Although
SF2/ASF, or another SR protein, is required for splicing of
this substrate, the nature and location of the functionally
relevant binding site(s) are presently unknown. The 5' and
3' splice sites (ss), branchpoint (bp), and poly-pyrimidine
tract (py) are indicated.
ner. The relative levels of SF2/ASF and hnRNP Al
influence the excision or
retention of this intron in
vitro and may be the underlying mechanism of
alternative bGH pre-mRNA processing in vivo.
SF2/ASF and hnRNP Al, or related proteins, may
also control the function of other purine-rich exonic
splicing enhancers, such as those recently identified
in IgM, troponin, fibronectin, and tropomyosin. Fu-
ture experiments will address
the mechanistic
similarities and differences in the involvement of
SF2/ASF in ESE-dependent and ESE-independent
splicing (Fig. 3).
OTHER ESSENTIAL PROTEIN SPLICING FACTORS
We are continuing to purify and characterize addi-
tional protein factors that are essential for one or both
RNA cleavage-ligation reactions. Using selective in-
activation and biochemical complementation strat-
egies, D. Horowitz identified two novel activities re-
quired for cleavage at the 5' splice site and lariat
formation. These activities have been chromato-
graphically separated, and their purification is in
progress. T.-L. Tseng is searching for proteins with
RS domains in budding and fission yeast, with the
ultimate goal of studying the structure and function
of RS domain-containing splicing factors by genetic
methods. The rationale is based on our previous ob-
servation that very few known proteins in the data-
bases contain significant repeats of interspersed
arginine and serine residues, and virtually all of these
proteins have been directly or indirectly implicated in
constitutive or regulated splicing.
B. Dong purified a 54-kD HeLa cell polypeptide,
initially based on cross-reactivity with antibodies
raised against a yeast splicing factor, although this
cross-reactivity turned out to be fortuitous. This
protein is in the nuclear fraction and can be cross-
linked to RNA and was therefore termed p54nrb (for
nuclear RNA binding). The sequence of p54nrb
cDNA clones revealed the presence of two RRMs
and significant sequence similarity to a number of
RNA-binding proteins and mammalian splicing fac-
tors. In particular, the 471-amino-acid-long p54nrb
shares a 320-amino-acid central region of 71%
identity with the 712-amino-acid-long human splic-
ing factor PSF (Fig. 4). The same region is 42%
identical to a central region of a 700-amino-acid-long
Drosophila protein known as NONA, DISS, or BJ6.
Previous work in other laboratories showed that this
fly protein is ubiquitously expressed and has pleio-
P54
PSF
BJ6
54
277
282
P54 110
PSF 333
BJ6 338
P54 166
PSF 389
BJ6 394
P54 222
PSF 445
BJ6 450
P54 278
PSF 501
BJ6 506
P54 334
PSF 557
BJ6 562
POPE EPVEV
FKAN SLUR
K
GFGF IRLET
GFGF I KLE
NFTF K
EAFS
EAFS
FK
B
S
C:
E
PGEKTFTQRS
PGEKTEITORC
PTETKF GRN
TLAEIAKV
ALAE I AKA
PNREKAKRA
ELD
ELD
LD
VFGQVERAVVIVDDRGR
QFGP I ERAVV I VDDRGR
I FGP I ERAS I TVDDRG
VEPMDQLDDEEGLPEK
VEPPIEOLDDEDGLPEK
V PMEVNDD DGLPEK
ME KOOODO V I
MEKOQ Qvg M
K ,40DALK ELL F
M
OKRK
QKRKEM
EM
Q L
RE KQA E
E
D
A
A
RLFVGNLP
RLFVGNLP
RL VGNL
NM
DI
GSMR
PS
ST
KHM
L
M
VI
AQ
A FNK
RE
MEE
KLE
DKLE
DKLE
T
PDITEEE
ADITEDE
NDITDDE
RGKOLRVRFA
RGROLRVR FA
GROLRVRFA
GKG I VEFS
GKG I VEFA
GEG I VEFA
KN
KNP
KMP
S
AQ
EME
EME
ME
ELROEEERRRREEEM
QLROEEERRRREEEM
RKREEETMRR TEMH
QQH
MYQ
DrINQ
MDK E
F K RllgA
LEIEM KP
CHSA
THAA
PNAT
S
A
GKPAARKAL
SKPAARKAF
KKSSASACL
KERE
KERE
ER S
AARHEHQ
DAIIIHEHO
YARYEQE
RRQQE
M I ROR
QSHMNRQ
EM
EMEE
DEEE
H
S
KYG
KYG
YGE
KAGEVFI KDK
PGEVFINKMK
ISE FSNLDK
VRNL
VRNL
VSNL
DRCSEG
RCSEG
RMCNEK
PQYVSNELLE
SPYVSNELLE
TPFVSNELLY
SFLLTTF
VFLLTTT
CFFLTAS
OP PGS F EY E
T PP R F AQMGMF EYEY
I GPRFADPNSFE EY
VM
AN
TE
AM
SQ
GS
RWK
RWK
RWK
PRP
PRP
RPL
109
332
337
165
388
393
221
444
449
277
S D 500
Q HN 505
LMRQDLMRROE E LRRME E LHNQ
LLRODLMRROEELRRMEELHNO
L LRO L REVDNER EWE M
MRRQQEG F KGQQ R E S
L
REI
RQQ
333
556
561
374
597
602
FIGURE 4 Sequence homology between central domains of human p54nrb, human PSF, and Drosophila NONA/BJ6.
Identical residues are indicated by black background, and conservative substitutions are highlighted in gray. Amino
acid residues in each protein are numbered on both sides. Part of the alignment comprises the two adjacent RRMs
in each protein (positions 75-148 and 150-232 of the p54nrb sequence). The RRMs from these proteins have a
much higher degree of sequence similarity than expected for otherwise unrelated RRMs (see Fig. 5).
tropic functions in the nervous system, such that
mutations in its gene impair normal visual acuity and
male courtship song and give rise to abnormal elec-
troretinograms. On the basis of the significant homol-
ogy with known and putative splicing factors, we
have suggested that NONA may affect alternative
splicing of pre-mRNAs encoding ion channels or
other proteins in such a way as to affect the expres-
sion of one or several isoforms that function in
specific neural tissues. A variety of approaches is
being used to study the RNA-binding properties of
p54nrb, its likely involvement in pre-mRNA splicing,
and its functional relation to PSF.
CONSERVED MOTIFS IN PROTEIN SPLICING FACTORS
E. Birney (now at Balliol College, Oxford), and S.
Kumar (in R.J. Roberts' laboratory at New England
Biolabs) carried out a detailed sequence analysis of
conserved motifs in metazoan protein-splicing factors
and related RNA-binding proteins. This analysis in-
cluded the characterization of RRMs, the construc-
tion of a comprehensive RRM database, and statisti-
cal analysis of arginine-serine and glycine-rich
repeats found in RNA-binding proteins. An align-
ment of 70 RRMs (Fig. 5) was constructed placing
special emphasis on tertiary structural requirements,
modeled after two available structures. The most con-
served positions in this alignment correspond precise-
ly to residues that form the hydrophobic core of the
U1 -A RRM1 tertiary structure, as previously noted
by J. Keene and colleagues. Analysis of the RRM
alignment and the model tertiary RRM structure led
us to propose the following consensus structural core
sequence for RRMs: UxUxxLxxx[x0_6]Z[x]xxxLxxx
Fxxx[x]GxUx[x]Zxxxxxx[x0_21,]UxVxF[x]xxxxxx
ZxxA, where x = any residue; U = uncharged resi-
dues, L,I,V,A,G,F,W,Y,C,M; Z = U + S,T; and + in-
dicates that loop 3 may be expanded further.
This is a degenerate consensus that is too permis-
sive to be used as the sole criterion to identify RRMs,
but which should be matched by all RRMs with the
correct tertiary fold, including those with atypical
RNP-1 submotifs.
Using profile analysis based on an alignment
slightly larger than that in Figure 5, an RRM-
enriched database was generated. Examination of
each entry for a match to the above structural con-
sensus yielded a comprehensive RRM database. The
RRM database is periodically updated by E. Birney
and is accessible through the Internet (send E-mail to
RRM@molbiol.ox.ac.uk with the words SEND RRM
in the body of the message). As of this writing, the
database contains 151 proteins with 289 RRMs. 17
proteins were found to contain 22 previously un-
reported RRMs, which strongly suggests that they are
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FIGURE 5 Alignment of 70 selected RRMs. Selected RRMs were aligned manually with special empha-
sis on tertiary structural requirements modeled after two available structures.
Alignment gaps are indi-
cated by dashes. For sequences with more than one RRM, each one is numbered from the amino
terminus, with the number given in parentheses after the sequence name. Beginning and ending residue
positions within the parent protein are given for each RRM at the left and right of the alignment. The
alignment positions are numbered above and below; conserved positions are given sequential numbers,
and positions that are not present in all RRMs are alphabetized. The positions of conserved residues are
highlighted by vertical shading. Black shading indicates positions in which a single residue occurs in at
least 75% of the sequences. Gray shading at the same positions represents conservative substitutions.
Elsewhere, gray shading indicates positions in which residues belonging to a single conservative group-
ing are present in at least 50% of the sequences. When a single conservative grouping represents at
least 75% of the sequences, this is denoted by gray shading in boxed columns. Acceptable conserva-
tive groupings were I=V=L,F=Y=W,Q=N,R=K,D=E,S=T. Three additional positions at which the con-
sensus is split between two residues are also shaded: positions 6 and 53g (G=N) and position 36
(A=G). The consensus structural core residues are shown below the alignment (U = uncharged
residues: L,I,V,A,G,F,W,y,C,M; Z = U + S,T), along with the position of the RNP-1 and RNP-2 submotifs.
Secondary structure, modeled primarily after the humU1A(1) tertiary structure except for a1, which was
based on the humHNRNPC secondary structure, is given above the alignment. In humU1A(1), a1 ex-
tends another two residues toward the amino terminus. Most positions of the RRM lack a firm consensus.
The range of sequence similarity between two otherwise unrelated RRMs is 10-20% identity.
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RNA-binding proteins. Additional homologies with
known splicing factors were also found. One example
of this analysis is the finding of striking homology
between metazoan SR proteins that contain a central
atypical RRM and the Saccharomyces cerevisiae
protein NPL3/NOP3. NPL3 mutants have pleiotropic
phenotypes, but this protein so far is not known to be
involved in splicing. The homology includes a per-
fectly conserved heptapeptide, SWQDLKD, which is
an invariant signature for SR proteins that contain a
central atypical RRM and is not found in any other
proteins in the databases. Another finding from the
above analysis is the presence of two unreported
RRMs in Schizosaccharomyces pombe mei2, a pro-
tein involved in meiosis. The presence of these
RRMs strongly suggests that RNA binding is in-
volved in the function of mei2.
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We study the mechanisms of transcriptional regula-
tion in eukaryotes. To probe these mechanisms, we
use both cellular and viral regulatory factors, in par-
ticular two cellular POU-domain proteins, Oct-1 and
Oct-2, and a herpes simplex virus (HSV) protein,
VP16. Although the cellular proteins Oct-1 and Oct-2
possess the same intrinsic DNA-binding specificity,
their transcriptional regulatory properties are dif-
ferent. For example, both proteins recognize the oc-
tamer sequence ATGCAAAT found in a variety of
promoters, but the efficiencies with which they ac-
tivate such promoters differ. These differences result
from the activities of promoter-selective transcrip-
tional activation domains that can discriminate
among promoters. The viral protein VP16 is a com-
ponent of the HSV virion that, after infection, associ-
ates with Oct-1 and a second cellular factor we refer
to as HCF to form a multiprotein-DNA regulatory
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complex. By its association with Oct-1, VP16 alters
the transcriptional regulatory properties of Oct-1
in
two ways: It recruits Oct-1 to new DNA sites that are
not recognized effectively by Oct-1 alone,
and it pro-
vides a potent transcriptional activation domain to
ac-
tivate the HSV immediate early promoters, a type
of
promoter that is normally resistant to activation
by
Oct-1.
This year, our studies focused on three issues: (1)
How does a eukaryotic transcription factor recognize
a diverse and yet specific set of DNA sequences? (2)
How is a DNA site-specific multiprotein-DNA regu-
latory complex, as exemplified by the VP16-induced
complex, assembled? (3) What are the rules for how
transcriptional activation domains and the basal tran-
scriptional apparatus communicate with one another?
Additionally, we study promoter structure by analyz-
ing the natural variation that occurs in the human im-
munodeficiency virus (HIV) promoter isolated from
infected individuals.
Below are descriptions of accomplishments we
made during the past year.
Crystal Structure of the Oct-1
POU Domain Bound to an
Octamer Site: DNA
Recognition with Tethered
DNA-binding Modules
R. Aurora [in collaboration with J. Klemm, M. Rould,
and C. Pabo, Massachusetts Institute of Technology]
Oct-1 and Oct-2 are members of the POU subfamily
of homeodomain proteins. These proteins are dis-
tinguished by a bipartite DNA-binding domain, con-
sisting of an amino-terminal POU-specific (POUs)
domain linked to a carboxy-terminal homeo (POUH)
domain by a hypervariable linker. We showed last
year, in collaboration with N. Assa-Munt, R.
Mortishire-Smith, and P. Wright (The Scripps Re-
search Institute), that the POUs domain is structurally
similar to the DNA-binding domains of the bac-
teriophage X and 434 repressors and 434 Cro protein.
These DNA-binding domains, like homeodomains,
contain a helix-turn-helix (HTH) motif; unlike
homeodomains, however, which contain a single a
helix in addition to the HTH structure, the POUs and
bacteriophage DNA-binding domains contain two ad-
ditional a helices.
Although the POUs and bacteriophage DNA_
binding domains are structurally
very similar, they
differ in the region that is normally most highly con-
served, the HTH structure
itself. In the POUs struc-
ture, the first helix
and turn of the HTH structure are
both extended. These extensions compensate for one
another such that glutamines that lie at the beginning
of the two HTH a helices in these proteins are identi-
cally positioned in relation to one another. In the bac-
teriophage DNA-binding domains, these glutamines
were known to make critical sequence-specific con-
tacts. The structural similarity between the POUs and
bacteriophage DNA-binding domains led us to sug-
gest that the POUs domain glutamines contact DNA
in a similar manner. The crystal structure of the Oct-1
POU domain bound to an octamer site shows that this
prediction was indeed correct.
Figure 1 shows a schematic of the Oct-1 POU
domain bound to DNA. The most striking feature of
the structure is the structurally independent associa-
tion of the two POU subdomains with the DNA. The
POUR and POUH domains bind on opposite sides of
the DNA, without evident contacts between them.
This "independent" association highlights the impor-
tance of the linker that tethers the two domains: By
apparently increasing their relative concentration, the
linker is largely responsible for the interdependence
of the two DNA-binding domains. The linker, how-
FIGURE 1 Illustration of the Oct-1 POU domain bound to the
human histone H2B octamer site.
ever, is likely to be structurally flexible, because it
could not be seen in the cocrystal structure. The
structure of the DNA-bound Oct-1 POU domain sug-
gests how this DNA-binding domain is well suited to
recognize a degenerate set of DNA sequences, be-
cause the two domains should be able to bind to dif-
ferently oriented half sites, and to associate with a
protein like VP16, because the two domains are very
accessible.
Flexible DNA Sequence
Recognition by the Oct-1
POU Domain
M. Cleary
The Oct-1 POU domain is capable of binding to a
number of sites that bear little octamer similarity. For
example, the TAATGARAT sequence, which is
found in the promoters of the HSV immediate early
genes and which serves as a target of activation by
VP16, is a weak but specific binding site for the Oct-
1 POU domain in the absence of VP16.
We have studied the mechanisms by which the
POU domain achieves sequence recognition
flexibility by focusing on the contribution of the
POU domain to the overall binding ability of the
entire POU domain. By analyzing the separate and
combined effects of amino acid substitutions in the
POU domain and base changes in the Oct-1-binding
sites, we have uncovered two mechanisms for DNA-
binding flexibility. First, an amino acid side chain in
the POU DNA recognition helix that makes critical
DNA contacts can adapt to DNA sequence alterations
at its sites of interaction. Alanine substitution of this
residue, an arginine, greatly destabilizes the POU
domain on DNA; base changes at the DNA contact
sites of the arginine, however, only have a minor dis-
ruptive effect. This finding suggests that although the
arginine is necessary for DNA contact, its DNA se-
quence requirements are not rigid, allowing the Oct-1
POU domain to recognize sites that diverge from the
octamer sequence. In the second mechanism, the two
subdomains of the POU domain can apparently
reorient themselves on different sites to accom-
modate differential positioning of the POU and
POUH domain-binding sites. Our studies indicate that
binding of the Oct-1 POU domain to the TAAT-
GARAT site involves a translocation of the POU
domain from the left-hand side of the POUH domain,
as it is shown in Figure 1, to the right-hand side.
VP16-induced Complex Formation
J.-L. Lai, C. Huang, M. Cleary
After HSV infection, transcription of the HSV im-
mediate early genes is activated by a multiprotein-
DNA complex containing one viral and two cellular
proteins. The viral component is the virion protein
VP16 and the cellular components are Oct-1 and a
less-well understood cellular factor we refer to as
HCF. Figure 2 shows a cartoon of this VP16-induced
complex. The complex forms on specific sites within
the immediate early promoters that conform to the
concensus sequence TAATGARAT (R = purine).
These VP16-responsive sites are sometimes associa-
ted with an overlapping octamer sequence, which
serves as a binding site for Oct-1, but other TAAT-
GARAT sites lack any strong similarity to an oc-
tamer sequence; these sites, called (OCTA-)TAA-
TGARAT, are low-affinity binding sites for Oct-1 on
their own.
When VP16 is first delivered to the cell, it forms
a heterodimeric complex with HCF. This complex is
then able to associate with Oct-1 on TAATGARAT
sites, through interactions with the Oct-1 homeo-
domain and the GARAT segment of the TAATGA-
RAT motif. Although Oct-1 and Oct-2 are very close-
ly related, Oct-2 fails to associate effectively with
VP16 because of a single-amino-acid difference on
the exposed surface of the DNA-bound Oct-1 and
Oct-2 homeodomains.
We have extended our studies on the sequence re-
quirements within both Oct-1 and VP16 for VP16-
induced complex formation. Previously, our studies
FIGURE 2 VP16-induced complex. See text for a descrip-
tion.
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have focused on the involvement of the Oct-1
homeodomain in VP16-induced complex formation;
the contribution of the POUs domain has not been
evident. By testing the activity of a series of Oct-1
POUs domain mutants, we have found that the POUs
domain contributes to complex formation by stabiliz-
ing Oct-1 on the DNA. There are residues in the
POUs domain, however, that contribute more directly
to VP16-induced complex formation; mutation of
these residues has a more dramatic effect on forma-
tion of the VP16-induced complex than on Oct-1
binding to a TAATGARAT site on its own.
Analysis of VP16 has revealed multiple regions
involved in complex assembly. These studies have
been aided by the recent elucidation by other investi-
gators of the sequence of VP16 homologs in other
herpesviruses. Sequence comparison reveals at least
five conserved regions, and mutations within these
regions affect VP16-induced complex formation. One
small region of VP16, near the carboxy-terminal tran-
scriptional activation domain, is of particular interest
because individual mutations within this region dis-
rupt complex formation by alternatively affecting
VP16 association with either HCF, Oct-1, or DNA.
The interaction of a small region of VP16 with all of
the other components of the VP16-induced complex
suggests that, unlike the structure of the VP16-
induced complex shown in Figure 2, VP16, Oct-1,
HCF, and the DNA are all in close proximity to one
another in the complex.
Molecular Analysis of the
VP16-Accessory Protein HCF
A. Wilson, R. Freiman, D. Aufiero, W. Herr [in collaboration
with K. La Marco and G. Peterson, Tularik, Inc.]
HCF, the second cellular factor in the VP16-induced
complex, has unusual properties in stabilizing the
VP16-induced complex. It binds to VP16 and enables
it to associate more effectively with Oct-1 on TAAT-
GARAT sites. The normal cellular function of HCF
is unknown, although it is likely to be important, be-
cause HCF activity is found in animals as diverged
from humans as nematodes and insects.
Last year, we described the purification of HCF
and the isolation of cDNA clones encoding HCF.
Figure 3A shows samples of purified human HCF; it
is a collection of polypeptides ranging in size from
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FIGURE 3 Structure of the VP16-accessory protein HCF. (A)
Pattern of HCF polypeptides in purified human HCF after
polyacrylamide gel electrophoresis. (B) Illustration of the
2035-codon HCF open reading frame. The hatch marks
identify the positions of 19 HCF peptides that were se-
quenced to identify and isolate HCF cDNAs. The HCF
repeats are shown as arrowheads and regions enriched for
particular amino acids are highlighted. (C) HCF repeat con-
sensus sequence. Invariant residues are underlined, and
more highly conserved residues are shown in uppercase
letters.
110 to 300 kD. The cDNA clones revealed that HCF
is encoded by a 2035-codon open reading frame and
is initially expressed as a large precursor protein of
about 300 kD. Figure 3B shows a schematic of HCF,
highlighting elements observed in the deduced HCF
amino acid sequence. HCF bears little resemblance to
other known proteins, but centrally located within the
HCF sequence is a prominent repeat of a 26-amino-
acid sequence that we refer to as the HCF repeat. A
consensus sequence of the HCF repeat is shown in
Figure 3C.
In the cell, the 300-kD primary HCF translation
product is processed into smaller amino- and
carboxy-terminal halves, which remain noncovalently
associated with each other. The HCF repeats direct
this unusual form of proteolytic processing. The pur-
pose of the proteolytic processing of HCF is not
known. The amino-terminal segments, however, are
sufficient to associate with VP16 and induce complex
formation with VP16 and Oct-1.
To investigate the cellular function of HCF, we
have analyzed, in collaboration with B. Trask (Uni-
versity of Washington) and J. Parrish and D. Nelson
(Baylor College of Medicine), the genomic location
of the HCF gene and its expression patterns. The
gene encoding HCF, HCF-1, is located within the
q28 region of the X chromosome. This region of the
human genome contains many genes and is associa-
ted with many human diseases such as hemophilia
and color blindness. We have not as yet, however,
identified a human disease that might correspond to
mutations in the HCF-1 gene. The HCF-1 gene is
highly expressed in fetal tissues and tissue culture
cells, but in adult tissues, it is generally not highly
expressed, suggesting a role in cell proliferation.
HCF is, however, highly expressed in the adult kid-
ney where it may be involved in a function separate
from cell proliferation. Curiously, the brain, the site
of HSV latency, contains very little HCF protein.
Regulatory Mechanisms of
Transcriptional Activation
Domains
G. Das, C. Hinkley, W. Tansey
Little is known about how transcriptional activation
domains stimulate transcription or about their struc-
ture. Activation domains rarely display high levels of
sequence similarity, such as that observed among
DNA-binding domains, suggesting less stringent
structural requirements. We have taken three ap-
proaches to study the structural and functional
properties of activation domains: (1) We have per-
formed an "alanine-scanning" mutagenesis of a small
18-amino-acid activation domain; (2) we have as-
sayed the influence of basal promoter elements on the
activity of activation domains; and (3) we have
studied the role of sequences on the surface of the
TATA-box-binding protein TBP in responding to ac-
tivators.
We have previously described a multimerization
approach, developed by M. Tanaka, to analyze the
structure and function of transcriptional activation
domains. In this approach, a short, otherwise inactive,
segment from within an activation domain is
reiterated in tandem, creating a larger and now func-
tional activation domain. In this manner, two separate
18-amino-acid segments from within a 66-amino-acid
glutamine-rich activation domain in Oct-2, called
Q18II and 01811i -L7 were shown to possess activation
domain potential.
This approach is well suited to dissect activation
domain structure and function by mutagenesis, be-
cause the effects of mutations are amplified by the
multimerization process. We therefore mutated indi-
vidually all 17 nonalanine residues in the 018111 seg-
ment to alanine and assayed their effects on transcrip-
tional activation. To our surprise, most of the muta-
tions disrupted activation. Thus, although not dis-
playing strong sequence similarity to other activation
domains, this 18-amino-acid activation domain ap-
parently possesses important structural properties that
are easily disrupted by point mutagenesis.
The activation domains of Oct-1 and Oct-2 dis-
play different abilities to activate transcription from
snRNA and mRNA promoters. To explore the dif-
ferent activities of promoter-selective activation
domains in more detail, we have assayed the activity
of a large collection of activators, all carrying dif-
ferent activation domains fused to the same yeast
GALA DNA-binding domain, in different promoter
contexts. Figure 4 shows three of the promoter con-
Fos
U6
U2 AM>
FIGURE 4 Structure of the c-Fos mRNA, and U6 and U2
snRNA promoters, showing a generic activator and basal
factor complexes.
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texts we have tested: an mRNA promoter (c-Fos),
along with two snRNA promoters, one directing tran-
scription by RNA polymerase III (U6) and one
directing transcription by RNA polymerase II (U2).
The major difference among these three promoters is
the architecture of the basal elements situated near
the transcriptional start sites. These elements direct
formation of different DNA-bound TBP-containing
complexes. The TATA box found in mRNA pro-
moters, such as that in the c-Fos promoter, binds the
TBP-containing TFIID complex, whereas in snRNA
promoters, a conserved proximal sequence element,
the PSE, binds a TBP-containing complex called
SNAP. One snRNA promoter, that for the U6
snRNA, directs RNA polymerase HI transcription
and contains, in addition to a PSE, a TATA box that
binds TBP.
Among the activator collection tested were the
very potent and acidic transcriptional activation
domain from the herpesvirus protein VP16 and a
glutamine-rich activation domain from the well-
characterized transcription factor Spl. As with acidic
activation domains in general, the VP16 activation
domain can activate mRNA promoters in all
eukaryotic species tested, including such diverse
species as yeast and human cells. In contrast, the hu-
man Spl activation domain is not active in yeast
cells. Although not active in as many species, how-
ever, the Spl activation domain we tested is more
universally active with respect to promoter type than
the VP16 activation domain; whereas the snRNA
promoters did not respond to the VP16 activation
domain, the Spl activation domain was active on
both the mRNA and snRNA promoters tested, al-
though it displayed considerably more activity on the
snRNA promoters. These results suggest that activa-
tion domains discriminate among factors bound to
different sets of basal elements and emphasize the
importance of the composition of basal elements in
defining the activity of activators.
To study how basal factors respond to activators,
we have assayed the ability of mutated human TBP
molecules to activate transcription in vivo. To bypass
the activity of endogenous human TBP, we adapted
to human cells the altered TBP DNA-binding
specificity strategy developed by K. Struhl and col-
leagues (Harvard University) in yeast cells. In this
strategy, the activity of a mutant TBP molecule with
relaxed DNA-binding specificity can be measured on
a promoter containing a mutated TATA box that is
not recognized by the wild-type endogenous TBP. By
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use of this assay, we have made two important find-
ings. First, although Spl does not activate transcrip-
tion in yeast cells, yeast TBP responds to Spl in
mammalian cells, indicating that the defect in yeast is
not due to TBP itself. Second, individual sets of
mutations on different surfaces of TBP do not inter-
fere with the ability of TBP to respond to activators
in vivo, but combinations of these mutations can have
dramatic effects. These results suggest that separate
surfaces of TBP cooperate in responding to activators
and that these surfaces of TBP can compensate for
each other's defects. Thus, although TBP has been
very highly conserved during evolution, it is very
resistant to mutagenesis for response to activators of
RNA polymerase II transcription in vivo.
Analysis of VP16 Activation
Domain Subsegments
in Yeast
M. Tanaka
Transcriptional activators often contain multiple and
separable activation domains that cooperate with one
another to activate transcription. To identify an
elementary unit for this synergistic action, the VP16
activation domain was analyzed in the yeast Sac-
charomyces cerevisiae using a multimerization ap-
proach. I chose multiple 12-13-amino-acid-long seg-
ments within the 78-amino-acid-long acidic VP16 ac-
tivation domain, individually reiterated as two to six
tandem copies and fused them to the GAL4 DNA-
binding domain. They were tested for the ability to
activate transcription of a GAL4-responsive reporter
gene in yeast cells.
Among the segments tested, all of which con-
tained abundant acidic and hydrophobic amino acid
residues, two strongly activated transcription; even
subsegments as short as four or eight amino acids ac-
tivated transcription when reiterated. Their transcrip-
tional activity increased dramatically with an increas-
ing number of reiterations. Thus, an activation do-
main can be reconstituted from an extremely small
repetitive module, which cooperates to function effi-
ciently.
Analysis of these GAL4-VP16 fusion activators
expressed in yeast cells has identified the hsp60
chaperonin as a factor that can interact with func-
tional but not with nonfunctional VP16-derived ac-
tivation domains. Indeed, the relative level of associ-
ation with hsp60 correlates directly with the relative
level of activation domain activity. Although it
remains to be determined if hsp60 is involved in
nuclear transcription, the observation that it specifi-
cally associates with functional activation domains is
intriguing, because hsp60 is thought to interact with
exposed hydrophobic surfaces of folding intermedi-
ates of a number of proteins. Therefore, an important
feature of an activation domain may be a hydro-
phobic surface being exposed in folded proteins,
whereas acidic amino acid residues may be required
to expose the region to solvents while avoiding inter-
molecular aggregation. The interaction between a
transcriptional activation domain and a chaperonin
also suggests that a target molecule of an activation
domain during activation process can, like
chaperonins, interact with divergent sequences, not
containing specific secondary or tertiary structures.
Sequence Rearrangements in
the HIV-1 LTR Isolated from
Infected Individuals
B. Lee, D. Aufiero [in collaboration with A. Wiznia,
Bronx-Lebanon Hospital, New York]
We have an ongoing project to study the structure of
transcriptional regulatory sequences in the HIV-1
long terminal repeat (LTR) isolated from infected in-
dividuals. We have previously described a region of
the HIV-1 LTR that is a hot spot for the appearance
of tandem sequence duplications or TSDs. This TSD
hot-spot region lies just upstream of the HIV-1 en-
hancer core sequences that bind the transcription fac-
tor NF-KB. We originally identified these rearrange-
ments in lymphocytes from infected adults, but viral
LTRs containing the rearrangements were always ac-
companied by unrearranged forms. This year, we an-
alyzed samples from infected children in the Bronx
and found that, in contrast to the earlier results, many
of these infected individuals only carried rearranged
LTRs with TSDs. These results show that TSD-
containing viruses on their own can produce produc-
tive infections. We are currently studying the nature
of the trans-acting factors that recognize the TSD
elements.
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MOLECULAR GENETICS OF EUKARYOTIC CELLS
Laboratories in this section study various aspects of eukaryotic cell biology, particularly those
relating to disease, cell signaling, transcription, and structure.
Dr. Skowronski's laboratory (Accessory Genes of Human Immunodeficiency Virus) is focused
on the mechanisms by which HIV, the virus responsible for AIDS, causes immunodeficiency.
They have determined that expression of the nef gene down-regulates CD4 antigen in T
cells. CD4 antigen is required for normal T-cell function. Mechanisms for this down-
regulation are being explored.
Dr. Franza's laboratory (Quantitative Regulatory Biology) has continued their studies of HIV
and has laid groundwork for the inhibition of certain viral proteins with oligonucleotides.
Dr. Garrels' laboratory (Quest Protein Database Center) has continued software development
to allow more convenient and widespread use of 2D gel analysis and protein databases.
They have expanded their application to the yeast Saccharomyces cerevisiae in order to en-
rich the effort, ongoing elsewhere, to sequence the genome of that organism.
Dr. Wigler's laboratory (Mammalian Cell Genetics) studies signal transduction in yeasts and
mammalian cells, concentrating on the RAS pathway and associated protein kinases, such
as RAF. Both RAS and RAF are oncoproteins, capable of inducing malignant transformation
in normal cells. Additionally, they are in the midst of discovery of genetic lesions in malignant
cells.
Dr. Bar-Sagi's laboratory (Transmembrane Signaling) studies signal transduction through the
RAS pathway in mammalian cells, in particular its mode of regulation by growth factor recep-
tors and its interaction with the RAF serine/threonine protein kinase. These studies build
upon evidence gathered in her laboratory that receptor activation leads to a reorganization
of the subcellular localization of components of the RAS pathway through SH2 and SH3
protein motif domains.
Dr. Tonks' laboratory (Protein Tyrosine Phosphatases and the Control of Cellular Signaling
Responses) has produced the first X-ray crystal structure of a protein phosphatase in a col-
laboration with David Barford. In addition, this laboratory has identified a protein
phosphatase that dephosphorylates MAP kinase and blocks its signaling.
Dr. Gilman's laboratory (Nuclear Signal Transduction) explores the mechanisms whereby
cellular signaling by growth factors and hormones leads to alterations in gene transcription.
In a seminal series of experiments, this group has demonstrated that growth factor receptor
activation leads to the tyrosine phosphorylation and subsequent activation of a set of tran-
scription factors. This pathway is distinct from the pathway that alters gene expression
through the participation of RAS, demonstrating a redundancy in signal transduction cir-
cuitry. Other work in this laboratory is directed to understanding how the same signal elicits
different responses in different cells.
Dr. Spector's laboratory (Cell Biology of the Nucleus) has addressed questions about func-
tions within the nucleus using predominantly microscopic techniques. His laboratory has
recently demonstrated the recruitment of splicing factors from nuclear storage sites to sites
of active transcription.
Dr. Helfman's laboratory (Molecular Cell Biology) continues the study of tropomyosins and
tissue-specific splicing. Over 16 different forms of tropomyosins, derived from four different
genes, are found distributed in a tissue-specific manner. This diversity arises in part from
tissue-specific differential splicing.
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ACCESSORY GENES OF HUMAN IMMUNODEFICIENCY VIRUS
J. Skowronski R. Mariani
S. Salghetti
AIDS immunodeficiency is invariably associated
with depletion of a regulatory subset of T cells that
express CD4 antigen on the cell surface. These CD4+
T cells are preferentially infected by human im-
munodeficiency virus (HIV), but neither the mechan-
ism(s) that subverts the normal function of the in-
fected cells nor the identity of viral genes involved is
clear. Besides the gag, pol, and env genes, found in
all retroviruses, immunodeficiency viruses encode
several additional "accessory" proteins. Some of
these accessory genes are not required for the viral
life cycle in established cell lines, and their function
has been difficult to assess. Remarkably, several lines
of evidence indicate that these "nonessential" genes
have an essential function in vivo, or in primary cells,
for efficient virus replication and pathogenesis. Re-
search in this laboratory focuses on the function and
mechanism of action of these accessory proteins of
immunodeficiency viruses.
Our recent work has focused on understanding
the function and mechanism of action of the HIV-1
nef gene. nef is dispensable for the viral life cycle in
vitro, but it is strictly required for high viral load and
CD4+ T-cell depletion in animal models for AIDS.
Our laboratory has been using approaches in vivo, in
transgenic mice, and in vitro to address the con-
sequences of Nef expression on normal cellular func-
tions and its interaction with cellular regulatory me-
chanisms. We have shown previously that (1) HIV-1
Nef alleles isolated directly from peripheral blood of
HIV-1-infected individuals decrease expression of
CD4 antigen on the surface of human T cells and (2)
HIV-1 Nef alters activation and blocks development
of a CD4+ T-cell subset when expressed in T cells in
transgenic mice. These effects of Nef expression in
transgenic T cells correlated with abnormally low
CD4 antigen expression on the cell surface. These
results have broad implications, because CD4 antigen
is involved in many aspects of biology of CD4+ T
cells and also is a cell-surface receptor that mediates
HIV infection. During the last year, we have focused
on cellular mechanisms impacted by nef. We have
also taken the first step toward elucidation of
molecular interactions between Nef and CD4.
CD4 DOWN-MODULATION BY NEF REQUIRES A
MEMBRANE PROXIMAL REGION IN THE CD4
CYTOPLASMIC TAIL
CD4 is an integral membrane glycoprotein expressed
primarily on immature thymic T cells and mature hel-
per T lymphocytes. The extracellular domain of CD4
binds to a nonpolymorphic region of major histocom-
patibility complex (MHC) class II molecules ex-
pressed on antigen-presenting cells. These events are
associated with activation of a nonreceptor Src-like
protein tyrosine kinase p56", associated with CD4
via its cytoplasmic tail, which couples CD4 to cel-
lular signaling (Fig. 1). CD4 is required for the
normal ontogeny of the regulatory helper subset. In
mature T cells, CD4 is involved in T-cell activation.
In addition, under some experimental conditions,
CD4 is involved in specifying programmed cell death
and/or G1 block in the cell cycle progression of CD4+
T cells.
As a first step to address the interaction between
Nef and CD4-p56" complexes, we defined the
region in CD4 that is required for down-modulation
by Nef. We constructed a set of mutant CD4 proteins
that were subsequently expressed in the 171.22 T-cell
hybridoma that does not express the endogenous CD4
genes. These derivative cell lines were transduced
with NA13 nef or with a control vector, and CD4
antigen expression on the cell surface was analyzed
by flow cytometry. A summary from this analysis is
shown in Figure 1. Results from initial experiments
with wild-type and mutant CD4 proteins, where the
cytoplasmic tail was either deleted or replaced with
that of the CD8 transmembrane protein which is not
responsive to Nef, indicated that down-modulation by
Nef requires the intact cytoplasmic domain of CD4.
Subsequent experiments with a set of carboxy-
terminal deletions in the cytoplasmic tail of CD4 in-
dicated that the last 15 amino acids of the cytoplas-
mic tail of CD4, including C420 and C422, which
that are essential for CD4-p56" association, had no
detectable effect. In contrast, more extensive trunca-
tions past T419 almost completely abolished Nef-
induced CD4 down-modulation. The observation that
the region membrane-proximal to the T419 was criti-
cytoplasmic
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FIGURE 1 CD4 down-modulation by HIV-1 Nef required a membrane proximal region in the CD4
cytoplasmic tall. Compilation of results from flow cytometry analysis of mutant CD4 proteins. Amino
acid sequences of the cytoplasmic tails of mutant CD4 proteins are aligned on the left with that of
the wild-type human CD4. Dots indicate amino acid identities with the wild-type protein, dashes indi-
cate the extent of internal deletions, and letters identify amino acid substitutions in a single-letter
code. Following staining with Leu3A a-CD4 monoclonal antibody, the fluorescence of cells express-
ing various CD4 proteins was 50-60 channels (on the 256-channel logarithmic scale) higher than
that of the parental 171.22 cells that do not express CD4. The extent of change in CD4 expression
following treatment of cells with phorbol ester (PMA), or following transduction with HIV-1 NA13 Nef
expression vector (Nef), is indicated by (+++), (++), (+), (+/-), and (-), which reflects a decrease in
the fluorescence intensity of 35-55, 20-35, 10-20, 5-10, and less than 5 channels, respectively.
cal for interaction with nef was further confirmed in
experiments with CD4 mutants bearing internal dele-
tions in the CD4 cytoplasmic tail. Deletion of amino
acids 403-418 completely abolished Nef responsive-
ness, and a small deletion spanning positions
403-406 had no detectable effect, suggesting a criti-
cal role of amino acids 407-418. Indeed, deletions
spanning residues 407-412 and 411-416 reduced
CD4 down-modulation by Nef by more than 95%. In-
terestingly, residues 407 through 418 are also re-
quired CD4 endocytosis induced by phorbol esters,
suggesting that Nef may activate. We are currently
analyzing additional, more subtle mutations in the
Nef-responsive domain to address this possibility.
NEF DISRUPTS CD4 ASSOCIATION WITH THE P56Ick
PROTEIN TYROSINE KINASE
In T cells, CD4 is associated with the p56" protein
tyrosine kinase via its cytoplasmic tail, and this inter-
action is required for signal transduction via CD4.
The region required for Nef-induced modulation
(positions 407 through 418) is in a close proximity to
cysteines 420 and 422, which are required for CD4
association with p561ck. Therefore, it seemed plau-
sible that Nef may interfere with CD4 association
with p561ck . The ability of p56" to remain in a com-
plex with CD4 in the presence of Nef was analyzed
by immunoprecipitating CD4 from detergent lysates
prepared from 171.22 cells coexpressing human CD4
and NA13 Nef, and the immune complexes were im-
munoblotted with the p56" antiserum for determina-
tion of CD4-associated p56" and, as a control, with
CD4 antiserum. Two additional sets of controls were
used in these experiments: (1) CD4 immune com-
plexes were prepared directly from the parental cells
expressing the respective CD4 proteins but not Nef
and (2) CD4 immune complexes were also isolated
from both the parental and Nef-expressing cells fol-
lowing treatment with phorbol ester, which induces
CD4 endocytosis and disrupts CD4-p56" associa-
tion.
As shown in Figure 2, coexpression of wild-type
CD4 and NA13 Nef resulted in an approximately
two- to threefold lower steady-state level of total
CD4 (compare lanes 8 and 10 with lanes 1 to 6, lower
panel). This decrease most likely reflects the pre-
viously observed increased rate of the CD4 turnover
and lysosomal degradation induced by functional
HIV-1 and SIV nef alleles. The CD4 detected by im-
munoblot analysis must reflect the intracellular pool,
because no detectable staining with anti-CD4
antibody was detected by flow cytometry analysis of
Nef-expressing cells. A similar reduction of the
steady-state level of CD4 was also observed follow-
ing treatment of cells with phorbol ester (Fig. 2, lane
9). Immunoblot analysis with p56" antiserum
revealed an approximately 20-fold decrease in CD4-
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FIGURE 2 Effect of HIV-1 NA13 Nef or phorbol ester on the
association of p56Ick with CID4 protein in 171.22 T cells. 171
cells expressing the wild-type human CD4 (lanes 8,9) and
from a derivative population transduced with HIV-1 nef
(lanes 10,11) were incubated for 1 hr in the presence (lanes
9,11) or absence (lanes 8,10) of 50 ng/ml PMA. For each ex-
periment, lysates were prepared from 2 x 107 cells and im-
munoprecipitated with OKT4 a-CD4 monoclonal antibody.
Western blots of immune complexes were probed with
antiserum specific for p56ick (a-lck) or human CD4 (a-CD4).
Twofold serial dilutions of protein extracts prepared from
COS7 cells transiently expressing p56Ick or human CD4
were used as standards for quantitation, respectively (lanes
1-6). Aliquots of an extract prepared from COS7 cells that
were not transfected were used as a negative control for
specificity of immunoblot analysis (lane 7).
associated p56" in Nef-expressing or phorbol-ester-
treated cells (compare lanes 8, 9, and 10 with lanes 1
to 6, lower panel). Thus, the intracellular pool of
CD4 is by and large not complexed with p56".
Additional experiments have shown that disruption
of p56" complexes by Nef does not involve activa-
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tion of the tyrosine kinase
activity of p56iek, More
over, Nef affects only CD4-p56" complexes but not
other pools of non-CD4-associated
p561ck . We there-
fore expect that in primary
T cells, where approxi-
mately 70% of total cellular p56" is sequestered by
CD4, Nef expression would cause redistribution of
p56" to the cytoplasmic pool on the expense of that
bound by CD4 on the cell surface. This would likely
result in sensitizing T cells to antigenic stimulation
and may provide an explanation for the elevated
mitogenic responses of HIV-1 Nef-expressing T cells
observed by us before in transgenic mice. Currently,
we are testing this possibility directly.
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Our laboratory has been involved in three distinct ac-
tivities: studying aspects of signal transduction; de-
veloping methods for the discovery of small mol-
ecules with desirable chemical properties; and apply-
ing a new system for genomic analysis for the dis-
covery of genetic lesions in human cancers. This year
has witnessed important progress emerging from four
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breakthroughs that were described in last year's An-
nual Report: the discovery of RAS targets; the defini-
tion of a conserved protein kinase signal transduction
cascade; the development of a molecular indexing
system for complex combinatorial chemical synthe-
sis; and the invention of a powerful method for com-
parative genomic analysis. We have used heavily the
two-hybrid genetic system developed by Fields and
Song (Nature 340: 245 [1989]) that allows the detec-
tion of complex formation between any two proteins
expressed in the yeast Saccharomyces cerevisiae.
RAS in Yeasts
R. Ballester, H.-P. Xu, E. Chang, L. Van Aelst, S. Marcus,
V. Jung, K. Sen, A. Polverino, M. Barr
RAS homologs in the budding yeast, S. cerevisiae,
and the evolutionary distant fission yeast, Schizosac-
charomyces pombe, have highly diverged functions.
In the budding yeast, RAS proteins are essential for
growth. They regulate adenylyl cyclase and probably
another as yet unidentified target. In the fission yeast,
rasl is required for sexual differentiation and pher-
omone-inducible responses as well as an elongated
cell shape. As we previously described, one of the
target effectors for rasl in S. pombe is the byr2
protein kinase required for mediating pheromone
responses. Complex formation between RAS and
byr2 was detected using the two-hybrid genetic sys-
tems of Fields and Song (Van Aelst et al. 1993).
Mutations in the effector loop of RAS abrogate this
interaction. The byr2 protein kinase is part of the
conserved MAP kinase module, described in last
year's Annual Report and in more detail below. Ad-
ditional regulators of byr2 have been found (see later
section).
byr2 does not mediate the effects of rasl on cell
morphology (Wang et al., Mol. Cell. Biol. 11: 3554
[1991]), and hence rasl must have additional medi-
ators. Mutant hunts unearthed two, scdl and scd2,
both required for elongated cell shape and conjuga-
tion. scdl and scd2 are homologs of S. cerevisiae
CDC24 and BEM1, respectively, each involved in
morphogenic events in that organism, as is RSR1, a
RAS homolog (Miyamoto et al., Gene 54: 125
[1987]; Bender and Pringle, Proc. Natl. Acad. Sci.
86: 9976 [1989]; Miyamoto et al., Biochem. Biophys.
Res. Commun. 181: 604 [1991]; Chenevert et al., Na-
ture 356: 77 [1992]). In the budding yeast, the
CDC42 protein, a member of the RHO family of
small GTPases, is also functionally linked with
CDC24 (Bender and Pringle, Proc. Natl. Acad. Sci.
86: 9976 [1989]; Zheng et al., J. Biol. Chem. 269:
2369 [1994]). Likewise, we found that the S. pombe
CDC42 homolog, cdc42sp, is functionally linked
with rasl, scdl, and scd2. Genetic studies led to the
conclusion that rasl and scd2 act in concert upon
scdl, which interacts with cdc42sp. Biochemical
studies indicate that scdl and scd2 interact directly.
Studies with the two-hybrid system confirm this and
further indicate that scdl, scd2, cdc42sp, and rasl can
all form a complex: scd2 binds cdc42sp; rasl, in its
GTP-bound state, induces scdl to bind cdc42sp; and
scd2 induces scdl to bind rasl. It seems likely that
the morphogenic module we have described in fission
yeast will have been conserved in evolution, perhaps
even in metazoans.
We have continued our studies of the new inter-
fering mutants of RAS found in S. pombe, first men-
tioned in last year's Annual Report. In collaboration
with Dan Broek's group at the University of Southern
California, we have confirmed that these mutants
(raslTyr62 and HRASTYr57) block nucleotide ex-
change function by binding virtually irreversibly to
exchange factors of the CDC25 type. ras1TYr62 blocks
all rasl function, beyond that dependent on the ste6
exchange factor, which is required for conjugation
but not cell shape (Jung et al. 1994). We therefore in-
fer that ras1TYr62 blocks other regulatory molecules
involved in morphogenesis. One candidate protein
has been identified through two hybrid interactions
and is now being characterized genetically.
RAS in Mammalian Cells
L. Van Aelst, M. White, A. Polverino
As reported last year, we detected complex formation
between RAS and RAF in the yeast two-hybrid ge-
netic system (Van Aelst et al. 1993). RAF is itself an
oncoprotein (Rapp et al., Proc. Natl. Acad. Sci. 80:
4128 [1983]), a protein kinase capable of activating
MAP kinase through a MAP kinase kinase (Dent et
al., Science 257: 1404 [1992]; Howe et al., Cell 71:
335 [1992]; Kyriakis et al., Nature 358: 417 [1992]),
and able to bypass dominant negative mutants of
RAS to transform mammalian cells (Bonner et al.,
Nucleic Acids Res. 14: 1009 [1986]; Cia et al., Mol.
Cell. Biol. 10: 5314 [1990]). Genetic evidence for the
direct interaction of RAS and RAF comes from muta-
tional studies. We first made a mutagenized library of
RAS and then screened for mutations of RAS that
could not complex with RAF, yet still formed com-
plexes with byr2. One, HRASG1Y37, was chosen for
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further study. We reasoned that if RAS and RAF in-
teract directly, we could find mutants of RAF that
Regulation of the Conserved
restored interaction with HRASGIY37. Several mu-
MAP Kinase Module
tants were found. The compensating mutations in H. P. Xu, L. Van Aelst, S. Marcus, A. Polverino, M. Barr
RAF all mapped to the conserved CR2 domain in the '
RAF regulatory domain. These studies give evidence
We described in last years Annual Report the
of direct physical contact between the effector loop
realization that a cascade of protein kinases, Which
of RAS and this domain of RAF.
we call the MAP kinase module, was conserved in
The mutant HRASGIY37 was activated to an evolution.
The first examples
in
from the
HRAsvali2,Gly37 double mutant. The double mutant pheromone signaling
pathways yeasts: in S.
failed to induce transformed foci in NIH-3T3 cells.
cerevisiae, STE11, STE7, and FUS3; in S. pombe,
bHowever, when the RAFs with mutations in the CR2
yr2, byrl, and spkl (Neiman et al. 1993). These
domain were cotransfected with HRASVa112,G1 Y37,
protein kinases are now known to have homologs in
vertebrates: FUS3 and spkl are homologous to the
transformed foci were readily observed. The mutant
RAFs were unable to induce foci on their own but mitogen-activated
protein kinases (MAPKs or
synergized with the mutant HRASGY37 greater than
ERKs); STE7 and byr1, to the MAP kinase kinases
tenfold better than did wild-type RAF. These are the
(MEKs); and STE1 1 and byr2, to MEK kinases
first studies to show that interaction between RAS
(MEKKs) (Neiman et al. 1993). In addition, this
kinase cascade motif is repeated multiple times
and RAF is necessary for transformation.
Evidence has been presented in previous Annual within other signaling pathways
within yeasts (Errede
Reports, and in this one as well, that RAS has multi- and Leven, Curr. Opin.
Cell Biol. 5: 254 [1993]), and
ple target effectors in yeasts. We have long specu- one has to presume
that this module is a "good ap-
lated, therefore, that RAS would have multiple target
proximate solution" to some recurring problem of
effectors in mammalian cells. To test this idea, a sec- adaption. Our interest in this cascade began when we
and other investigators discovered evidence for the
and type of mutant RAS was sought, one that bound
iRAF but failed to bind byr2. We reasoned that such a involvement of RAS in its regulation in S. pombe and
mutant might fail to bind other effectors essential for in mammalian cells (see Nieman et al. 1993; Van
RAS transformation of mammalian cells. Such a Aelst et al. 1993). We have been interested in the
mutant, HRASSer35, was found. As expected from its control and integration of the MAP kinase module,
failure to interact with byr2 in the two-hybrid assay, both in S. pombe and in S. cerevisiae (even though, in
HRASSer35 fails to replace rasl function in S. pombe. the latter, RAS does not appear to be involved).
This in itself is rather astonishing since serine is a byr2 and byrl are required for the basal level ex-
conservative substitution for threonine, the wild-type pression of the pheromone receptor gene mam2 (Xu
residue at position 35. Gratifyingly, HRASVa112,Ser35 et al. 1994). Interestingly, spkl is not required for
fails to transform NIH-3T3 cells but efficiently in- this, either because the kinase cascade branches prior
duces transformed foci when cotransfected with to activation of spkl or because spkl has redundant
HRAsva112,G1y37 This result argues very strongly kinase function. The latter is a distinct possibility,
that HRAS transforms cells by interacting with two given that multiple genes encoding MAP kinase
different target effectors. homologs are found in other organisms, but spkl is
Using the two-hybrid system again, we have essential for many aspects of sexual differentiation.
screened mammalian cDNAs for those encoding We conclude that it is probable that byrl has func-
proteins capable of interacting with RAS. Among tions other than the activation of spkl.
those so found were cDNAs encoding members of The S. pombe kinase module appears to require
the RAF family of protein kinases, a guanine both rasl and the pheromone sensing apparatus
nucleotide exchange protein for RAL (Albright et al., (Neiman et al. 1993). Disruption of rasl or gpal, en-
EMBO J. 12: 339 [1993]), and a number of other as coding the a subunit of the heterotrimer mediating
yet unidentified cDNAs. We should be able to receptor occupancy, abolishes basal level expression
determine which of these candidates are actually re- of mam2 in h90 (homothallic) S. pombe. Epistasic
quired for the transforming potential of RAS by studies indicate that rasl and gpal act in concert
utilizing the type of approach we have already taken upon mam2 expression. High-level expression of
for RAF. gpal can induce mam2 even in the absence of rasl;
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yet disruption of rasl produces a depression of mam2
expression even in the absence of gpal in heterothal-
lie S. pombe strains. From these results, we infer that
the MAP kinase module is under independent but co-
operative regulation by rasl and the upstream mating
pheromone response pathway (Xu et al. 1994).
We have identified a new component of the S.
pombe MAP kinase module: ste4. ste4 was found in a
two-hybrid screen of a library of S. pombe cDNAs
encoding proteins capable of binding to byr2. It was
previously known that ste4 was essential for conjuga-
tion and encoded a leucine zipper protein (Okazaki et
al., Nucleic Acids Res. 19: 7043 [1991]). Using the
two-hybrid system, we demonstrated that ste4 indeed
forms dimers, binds to the regulatory domain of byr2,
and causes byr2 to dimerize. Hence, we propose that
ste4 has a role in activating byr2 by inducing auto-
phosphorylation through dimerization. We suspect
that a ste4 homolog may exist in S. cerevisiae, since
we find that STE11 dimerizes in that organism. Al-
though rasl does not bind directly to ste4, over-
expression of the byr2 regulatory domain induces
complex formation between rasl and ste4 detectable
with the two-hybrid system. Hence, ste4 and rasl oc-
cupy separate sites on the regulatory domain of byr2.
We are investigating whether this binding is coopera-
tive. If so, this may partly explain the regulatory
function of rasl.
One of the proteins of S. cerevisiae that partici-
pates in pheromone signaling is STE5. Genetic
studies have placed STE5 upstream of the MAP
kinase module (Hasson et al., Mol. Cell. Biol. 14:
1054 [1994]). Using the two-hybrid system, we
demonstrated that STE5 binds all three of the protein
kinases that comprise the MAP kinase module,
STE11, STE7, and FUS3. The binding between
STE11 and STE7 is not apparent unless STE5 is pres-
ent. Hence, we have proposed that STE5 is a scaf-
folding protein that promotes interactions between
the members of the cascade. In addition to possibly
activating the pathway thereby, STE5 may serve to
"insulate" the pathway from cross talk with other
MAP kinase modules within the same cell that are
dedicated to other signal transduction functions. We
feel it likely that scaffolding proteins like STE5 may
exist for other MAP kinase cascades given that we
cannot detect interactions between MEKK and MEK
and between byr2 and byrl with the two-hybrid sys-
tem.
Finally, we have found that the S. cerevisiae
STE20 protein kinase (Leberer et al., EMBO J. 11:
4815 [1993]) may be a conserved element of the
MAP kinase cascade. STE20 functions weakly in S.
pombe as a suppressor of rasl null cells. Moreover,
STE20 protein can induce the phosphorylation of
MAP kinase in Xenopus oocyte cell-free extracts. We
therefore sought homologs of STE20 in S. pombe and
mammalian cells. In collaboration with Dr. M.
Cobb's laboratory at the University of Texas South-
western Medical School, we identified several clear
STE20 homologs in both fission yeast and mam-
malian cells. Their properties are currently under in-
vestigation.
Combinatorial Chemistry
R. Swanson
As we began to describe in last year's Annual Report,
we have collaborated with Clark Still and Michael
Ohlmeyer of the Department of Chemistry at Colum-
bia University to develop a general method for the
molecular tagging of solid-phase synthesis beads
used in "split" synthesis to generate chemical librar-
ies of great complexity. In split synthesis, solid-phase
synthesis beads are used as substrates to build
molecules by iterative synthetic steps (Furka et al.,
Int. J. Pept. Protein Res. 37: 487 [1991]; Lam et al.,
Nature 354: 82 [1991]). By consecutive batching and
segregating into different reaction vessels, huge li-
braries of diverse compounds are created, with each
bead bearing a single predominant moiety according
to its particular reaction history. We have devised a
method of using tags to record the reaction history of
each bead (Ohlmeyer et al. 1993). After beads con-
taining a desirable moiety are identified, the com-
position of the moiety is inferred by reading the reac-
tion history of the bead encoded by the tags. The tags
are read, after detachment from the bead, by gas
chromatography and electron capture. We have util-
ized this system to tag a combinatorial library of
oligopeptides of greater than 105 complexity and
demonstrated the correct identification of peptide
epitopes reactive with a monoclonal antibody. Many
conserved amino acid substitutions were allowed
within the epitope, but to our surprise, we found that
certain very conservative substitutions reduced the
binding of the epitope to the antibody by several or-
ders of magnitude. The tagging method is perfectly
general and can be applied to libraries of organic
molecules created on beads by virtually any synthetic
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route. In this vein, Dr. Still and co-workers have used
the method to tag libraries of nonlinear peptidic
moieties containing structures that would be difficult
to elucidate by other means (Borchardt and Still, J.
Am. Chem. Soc. 116: 373 [1994]). In collaboration
with other investigators, we are testing the applica-
tion of this method for the discovery of chemical
agonists and antagonists of components of signal
transduction pathways.
Comparative Genomic
Analysis
N. Lisitsyn, H.-P. Xu
We have developed a method for genomic difference
analysis that we call representational difference anal-
ysis, or RDA, and are applying the method to clone
probes that define genetic lesions occurring in cancer
cells or are linked to inherited disease loci. This
method allows the detection and cloning of specific
DNA sequences ("difference" sequences) present in
one population of DNA molecules ("tester") that are
not equivalently present in a highly related second
population of DNA molecules ("driver"). The RDA
procedure is composed of two parts. In the first part,
we make a reductive sampling of the two DNA popu-
lations that are to be compared, thereby deriving two
new populations of DNA molecules, called represen-
tations. The sequence complexity of the representa-
tion is considerably lower than that of the DNA pop-
ulation from which it derived. In the second part, we
utilize "sequence subtraction" and "kinetic enrich-
ment" to clone the difference sequences. A detailed
description of this powerful method was presented in
last year's Annual Report and recently published in
Science (Lisitsyn et al. 1993). At its core, our method
detects small restriction fragments in one DNA popu-
lation that are not present in another.
The method can be used to find probes linked to
inherited disease in animals that can be bred (Lisitsyn
et al. 1994). In collaboration with Eric Lander's
group at MIT, we designed two protocols that exploit
the ability of RDA to detect polymorphic differences
between individuals or groups of individuals. The
first protocol requires the use of congenic strains, in
which a strain carrying an inherited disease is
repeatedly back-crossed into a polymorphic strain.
The second protocol, which is more general, merely
requires the generation of F2 progeny from the cross
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of a disease-carrying strain to one
that is disease-free.
It is possible to generate thereby polymorphic probes
linked to the disease locus for any experimental
animal that can be bred. Preexisting genetic maps are
not needed. Similar strategies may be applicable to
humans.
The method can be applied to define the lesions in
cancer cells in either of two ways. Using DNA from
normal cells as tester and DNA from cancer cells as
driver, we can isolate probes that are homozygously
lost in cancers or that detect restriction endonuclease
polymorphisms that are heterozygously lost in can-
cers. To be applied in this way, the cancer and
normal must be from the same individual and the
cancer DNA (driver) must be nearly free of con-
taminating normal DNA (tester). As starting material,
we have used paired normal and cancer cell lines,
derived in the main from renal cell carcinomas or
colon cancers. We have also successfully imple-
mented the protocol on cancer biopsies using nuclei
fractionated by flow cytometry into aneuploid (can-
cer) and diploid (normal) fractions. In this manner,
we have identified seven loci that undergo
homozygous deletion in at least one cancer sample.
Two of these loci were observed to undergo very fre-
quent loss. Presumably, these are the sites of genes
the loss of which contribute to the initiation or prog-
ression of cancer.
When cancer DNA is taken as tester, probes aris-
ing from several types of lesions can, in principle, be
detected: point mutations, genetic rearrangements,
gene amplifications, and pathogens. In practice, we
have observed point mutations and amplifications.
We can calculate that on the order of 1/5000 point
mutations should create a detectable tester fragment.
The presence of such fragments may indicate an in-
creased frequency of point mutation in the cancer.
The application of RDA to the detection of amplifica-
tions may be of substantial value, since amplification
is a useful prognostic indicator for the disease. We
have not yet documented examples of RDA probes
that detect the other types of lesions.
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Our work continues to focus on the mechanisms of
signal transduction by Ras proteins. Ras proteins are
members of a large superfamily of low-molecular-
weight proteins that bind guanine nucleotides. They
are essential for the transduction of diverse ex-
tracellular signals that control cell growth, and ab-
normal activation of Ras proteins is thought to con-
tribute to the development of several types of human
cancer. Signal transduction through Ras proteins is
tightly controlled by several cellular proteins whose
function is to up-regulate or down-regulate Ras ac-
tivity. Much of our effort during the past year has
been directed at the functional characterization of
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these proteins. Our findings provide the first
molecular description of the pathway by which cell-
surface receptors activate Ras proteins. We have
shown that the critical components of this pathway
include the small adaptor protein GRB2 and the Ras
guanine nucleotide exchange factor Sos. In addition
to the mechanisms involved in the regulation of Ras
activity, we are interested in understanding how Ras
proteins interact with target molecules to induce a
cellular response. Our work on this subject involved
the biochemical characterization of the interaction
between Ras and the serine/threonine kinase Raf.
During this year, Nick Gale completed his Ph.D. re-
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search, and Roberto Buccafusca and Todd Pulerwitz
worked for three productive months as summer stu-
dents.
Activation of Ras by Receptor
Tyrosine Kinases
N. Gale, T. Pulerwitz
It is well established that Ras proteins are critical in-
termediates in the signaling pathways initiated by
receptor tyrosine kinases. The role of Ras proteins in
transducing signals from receptor tyrosine kinases
has been highly conserved: In Drosophila, activation
of the sevenless receptor tyrosine kinase is required
for the proper specification of R7 in the Drosophila
eye, and activation of Ras is a crucial early event in
this signaling pathway. Similarly, in Caenorhabditis
elegans, it has been shown that a receptor tyrosine
kinase encoded by the let-23 gene and a Ras protein
encoded by the let-60 gene are required for the induc-
tion of vulval cell fate. Biochemical data from mam-
malian cells have shown that stimulation of receptor
tyrosine kinases leads to an increase in the fraction of
active GTP-bound Ras molecules. Work carried out
in several laboratories including our own has indi-
cated that stimulation of guanine nucleotide exchange
is the predominant mechanism by which receptor
tyrosine kinases control Ras activation. This sug-
gested the presence of a coupling mechanism be-
tween receptor tyrosine kinases and a guanine
nucleotide exchange factor for Ras. Until recently,
identity of the guanine nucleotide exchange factor for
Ras was unknown. Genetic studies in Drosophila
have indicated that the protein encoded by the Son of
sevenless gene (Sos) functions as a guanine nucleo-
tide exchange factor for Ras.
Homo logs of Sos have been identified in mam-
malian cells, and last year, we demonstrated by both
genetic and biochemical techniques that the mam-
malian Sos protein is a specific guanine nucleotide
exchange factor for Ras. The carboxy-terminal region
of Sos contains several proline-rich sequence motifs.
The crucial insight into the mechanism by which
receptor tyrosine kinases may communicate with Sos
came from the identification of a similar proline-rich
motif in a protein termed 3BP-1. In 3BP-1, the
proline-rich motif was shown to constitute the bind-
ing site for the SH3 domain of c-Abl. This observa-
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tion, combined with our earlier findings concerning
the role of the SH2 and SH3 domain-containing
protein GRB2 in linking receptor tyrosine kinases to
the Ras pathway, prompted us to investigate the pos-
sibility that the proline-rich sequences in the carboxy-
terminal of Sos mediates its interaction with the SH3
domain of GRB2. Using the coimmunoprecipitation
approach, we have demonstrated a physical interac-
tion between Sos and GRB2. This interaction was
detected both in resting cells and in growth-factor-
stimulated cells. We utilized the two-hybrid system
to characterize this interaction further and to show
that the Sos-GRB2 association is mediated by the
carboxy-terminal domain of Sos and the SH3
domains of GRB2. Upon growth factor stimulation,
the GRB2-Sos complex has been shown to bind to
the activated growth factor receptor. This interaction
has been shown to be mediated by the direct binding
of the SH2 domain of GRB2 to a specific phospho-
tyrosine residue on the activated receptor. However,
we detected no changes in the guanine nucleotide ex-
change activity of Sos after epidermal growth factor
(EGF) stimulation. On the basis of these observa-
tions, we have proposed the following mechanism for
the coupling of receptor tyrosine kinases to Ras ac-
tivation (Fig. 1): Receptor activation induces the
GRB2
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FIGURE 1 Transduction of signals from receptor tyrosine
kinases to Ras. GRB2 binds to the activated receptors via
the SH2 domain and to Sos via the SH3 domain. Thus, Sos
is recruited to the activated receptor in the plasma mem-
brane where Ras activation takes place. Activated Ras trig-
gers a cascade of serine-threonine kinases that send sig-
nals to the nucleus.
translocation of a constitutive complex between
GRB2 and Sos to the activated receptor.
This translocation could link receptor activation
to an increase in the guanine nucleotide exchange on
Ras by increasing the local concentration of the ex-
change factor in the plasma membrane where Ras is
located.
Regulation of the Sos
by Phosphorylation
K. Degenhardt, N. Gale, R. Buccafusca
Upon growth factor stimulation, the Ras guanine
nucleotide exchange factor Sos becomes phosphory-
lated on serine and threonine. To understand the
functional significance of this phosphorylation event,
we sought to identify the kinase responsible for this
phosphorylation event. The carboxy-terminal region
of Sos contains 16 potential MAP kinase sites. There-
fore, we have investigated the possibility that MAP
kinase is involved in the phosphorylation of Sos. To
this end, we initially tested the ability of MAP kinase
to phosphorylate Sos polypeptides in vitro using Sos
immunoprecipitates from serum-starved cells or from
growth-factor-stimulated cells. We reasoned that if
growth-factor-induced phosphorylation of Sos occurs
at MAP kinase sites, then Sos immunoprecipitated
from growth-factor-stimulated cells would be a poor
substrate for MAP kinase relative to Sos derived
from serum-starved cells. Indeed, we found that
recombinant MAP kinase efficiently phosphorylated
Sos from serum-starved cells. In contrast, Sos derived
from growth-factor-stimulated cells was a poor sub-
strate for MAP kinase in vitro. These results are con-
sistent with the idea that Sos is phosphorylated by
MAP kinase in response to growth factor stimulation
(Fig. 2). To prove directly the role of MAP kinase in
Sos phosphorylation, we compared the patterns ob-
tained from tryptic phosphopeptide mapping of Sos
phosphorylated by growth factor in vivo or by MAP
kinase in vitro. We have found that the growth factor
stimulation results in the appearance of five major
phosphorylated species, four of which correspond to
phosphopeptides generated by MAP kinase phos-
phorylation of Sos in vitro (Fig. 2). We have
determined that all of the MAP kinase sites are con-
tained within the carboxy-terminal domain of Sos and
studies are under way to identify the exact sites of
MAP kinase phosphorylation. On the basis of these
analyses, we plan to generate Sos mutants lacking the
MAP-kinase phosphorylation sites. These mutants
should enable us to investigate the functional sig-
nficance of Sos phosphorylation. Specifically, it will
be interesting to examine whether Sos phosphoryla-
tion has a role in regulating Sos catalytic activity, the
interaction with GRB2, and Sos subcellular localiza-
tion.
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FIGURE 2 Phosphorylation of Sos by MAP kinase. (A) Phosphorylat. on in vivo was determined using Sos immunoprecipitates
isolated from serum-starved or EGF-stimulated 32P-labeled cells. For the in vitro phosphorylation, Sos was im-
munoprecipitated from unlabeled serum-starved or EGF-stimulated cells, and the immunoprecipitates were incubated with
purified recombinant MAP kinase in the presence of [y- 32P]ATP for 30 min. Mock reactions (minus) were performed under
the same conditions but without the kinase. (B-D) Tryptic phosphopeptide maps of Sos after phosphorylation in vivo (B and
C) and in vitro (D).
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Functional Differences
among Sos Proteins
S.-S. Yang
Mammalian cells contain two related but distinct Sos
genes designated Sos] and Sos2. It has been shown
that these genes are widely expressed during develop-
ment and in adult tissues, consistent with their role as
positive regulators of the ubiquitously expressed ras
genes. Alignment of the two Sos genes shows that
they share a high degree of similarity (65% overall
amino acid identity). However, at their carboxy-
terminal ends, the homology between Sos 1 and Sos2
is scattered and the conserved regions are mostly
restricted to the proline-rich motifs. Since the
carboxy-terminal region has been implicated in the
regulation of Sos function, it is enticing to speculate
that Sosl functions in a regulatory capacity different
from that of Sos2.
Using the two hybrid system, we have found that
the interaction between GRB2 and the carboxy-
terminal region of Sos2 is significantly tighter than
that observed for GRB2 and the carboxy-terminal
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region of Sos]. Moreover, we have found that the
carboxy-terminal tail of Sos/ interacts with Nck, an
SH2- and SH3-domain containing protein implicated
in mitogenic signaling via the EGF and platelet-
derived growth factor (PDGF) receptors. These
results suggest qualitative and/or quantitative dif-
ferences between Sosl and Sos2 in terms of their in-
teractions with SH3 domain-containing proteins. The
physiological significance of these differences is cur-
rently being investigated.
Regulation of Ras-Raf
Interactions
S. Kaplan [in collaboration with T. Polverino and
M. Wigler, Cold Spring Harbor Laboratory]
The stimulation of cell growth and differentiation by
a variety of extracellular signals frequently involves
the Ras-dependent activation of the mitogen-acti-
vated protein kinase (MAPK) cascade (Fig. 1). More-
over, it has been recently shown, using a combination
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FIGURE 3 Activation of Raf reduces its affinity to Raf. Serum-starved L6 cells were
incubated with 10 ng/ml PMA and 1 [thi insulin for 15 min prior to the preparation of
lysates. Aliquots of equal amounts of lysates were incubated for 90 min with increas-
ing concentrations of GST-Rasg1Y12 (WT) complexed with GTPy. Proteins bound to
beads were subjected to SDS-PAGE and Western blot analysis with anti-Raf
antibody. (Top) Autoradiogram of the immunoblot; (bottom) densitometric scan of
the Raf band from respective samples on the autoradiogram shown at the top. The
amount of Ras used in each incubation is indicated in micromolars.
of biochemical and genetic techniques, that this acti-
vation is probably mediated through the direct inter-
action of Ras with the MAP protein kinase kinase
kinase Raf. To characterize further the interactions
between Ras and Raf, we have established an in-
vitro-binding assay that is based on the ability of Raf
proteins present in cell extracts to interact with im-
mobilized GST-Ras fusion protein. The amount of
Ras-bound Raf is determined by immunoblotting
using specific anti-Raf antibodies. In agreement with
earlier studies, the binding of Raf to Ras in our assay
system required the Ras proteins to be in the active
GTP-bound form. We have found that agonist-
induced activation of Raf results in the significant
reduction in its binding affinity for Ras (Fig. 3). In
addition, Raf proteins display a dramatically reduced
affinity for the oncogenic form of Ras protein
(Rasva112) in comparison with the normal form of the
protein (RasglY12).
Finally, we have observed that treatment of cells
with agents that increase the intracellular concentra-
tion of cAMP results in the inhibition of Raf activa-
tion and a concomitant reduction in the affinity of
Ras for Raf. These observations suggest that a reduc-
tion in the affinity of Raf for Ras may constitute a
negative feedback mechanism to prevent the over-
stimulation of the Ras pathway in the presence of
agonists. Additionally, the modulation of the affinity
of Raf for Ras may provide a mechanism by which
Ras or Raf would be able to interact with other target
molecules. The identity of these mole-cules is cur-
rently being investigated.
Identification of Exploitable
Phenotypic Changes Associated
with Abnormalities in the
NF1 Gene in B Lymphocytes
M. Boyer [in collaboration with D. Gutmann, Washington
University, St. Louis]
von Recklinghausen neurofibromatosis type 1 (NF1)
is a common autosomal dominant disorder affecting
approximately 1 in 3500 individuals. The NF1 locus
has been identified, and all of the mutations identified
so far within the NF1 gene are consistent with an in-
activation mechanism, indicating that NF1 may func-
tion as a tumor suppressor gene. The protein product
of the NF1 gene, neurofibromin, was shown to share
a region of homology with negative regulators of Ras
(GAPs). Moreover, it has been shown that the GAP-
related domain of NFl can function as a Ras-GAP,
suggesting that neurofibromin may function as a
tumor suppressor gene by virtue of its ability to
modulate Ras negatively. We have been studying the
role of neurofibromin in B lymphocytes. In these
cells, surface immunoglobulin receptors (slg) are
rapidly redistributed following exposure to antibody
or other multivalent ligands. This receptor redistribu-
tion event, termed slg capping, initiates signals that
lead to the activation of a B cell. Previously, we had
demonstrated that Ras proteins co-cap with slg in B
lymphocytes. More recently, we have found that
neurofibromin also co-caps with slg. If the redistribu-
tion of neurofibromin is functionally significant, then
a testable prediction can be made that cellular events
linked to slg redistribution will be affected by ab-
normalities in the NF1 gene. We are using two model
systems to test this prediction: (1) B cells derived
from mice heterozygous for targeted mutations in
NF1 and (2) Epstein-Barr virus (EBV)-immortalized
lymphoblast cell lines derived from NF1 patients. In
both systems, we find that the level of expression of
neurofibromin is approximately 50% reduced com-
pared to normal cells. We are characterizing the NF1-
deficient cells with respect to several Ig-mediated
signaling events, including the induction of tyrosine
phosphorylation, the kinetics of slg capping and in-
ternalization, and cytoskeletal reorganization. If we
find that these cells are quantitatively different from
normal cells with respect to any of these aspects, we
plan to utilize this difference toward the establish-
ment of a quantitative assay for differentiating be-
tween normal and NFl- deficient B cells. This assay
will constitute, we hope, the foundation for the devel-
opment of a diagnostic test for NFL The clinical
manifestations of the NF1 disorder are extremely var-
iable, even within the same family. At present, no ap-
proach exists that enables the molecular diagnosis of
NFl in patients who fail to meet the common diag-
nostic criteria of the disease. Thus, the availability of
a diagnostic test that reflects a partial functional loss
of neurofibromin would have a profound impact on
the ability to diagnose patients with NF1 who lack a
family history or in whom diagnostic criteria are not
met.
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Functional Analysis of SH3
Domain-mediated
Protein-Protein Interactions
D. Bar-Sagi [in collaboration with D. Rotin,
University of Toronto]
SH3 domains are noncatalytic protein modules of ap-
proximately 50 amino acids. We have recently shown
that the SH3 domain of PLCy mediates the localiza-
tion of this protein to the actin cytoskeleton. We have
also shown that the SH3 domains of GRB2 are
responsible for its specific localization in membrane
ruffles. On the basis of these findings, we suggested
that SH3 domain-mediated interactions could have a
role in specifying the subcellular location of proteins.
To examine the generality of this concept, we have
extended our analysis to the role of SH3-mediated in-
teraction in the differential localization of the amil-
oride-sensitive Na+ channel in epithelial cells. Earlier
studies have demonstrated that this channel is local-
ized at the apical membrane of epithelial cells. This
localization is essential for proper channel function in
Na+ transporting epithelia. The molecular mech-
anisms that determine the selective localization of the
channel to the apical membrane have not been
defined. The a subunit of the channel was recently
cloned and has been shown to contain two proline-
rich sequences resembling the SH3-binding motifs
found in Sos and 3BP-1. Biochemical binding studies
have indicated that these proline-rich motifs can bind
to SH3 domains of several proteins. When a recom-
binant fusion protein containing the proline-rich se-
quences was microinjected into polarized epithelial
cells, the protein localized exclusively to the apical
area of the plasma membrane as determined by con-
focal microscopy (Fig. 4). In contrast, a recombinant
fusion protein corresponding to a region within the a
FIGURE 4 Cellular localization of microinjected GST-fusion proteins in polarized epithelial cells. (a,b)
Cells were injected with a fusion protein lacking the proline-rich sequences; (c,d) cells were injected
with a fusion protein containing the proline-rich motifs of the Na+ channel. Proteinswere localized by
indirect immunofluorescence using anti-GST antibodies and subcellular distribution as determined
by confocal microscopy. (a,c) X-Y confocal image of an optical section through the center of two
typical cells; (b,d) X-Z confocal images of one of the two cells shown in panels a and c, respectively.
Note that the fusion protein containing the proline-rich motifs (c and d) is localized exclusively at the
apical side of the plasma membrane.
subunit that lacks the proline-rich sequences re-
mained diffuse in the cytoplasm when microinjected
into these cells (Fig. 4). These results suggest that the
SH3-binding region in the a subunit of the Na+ chan-
nel is a critical determinant in the apical localization
of this channel.
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NUCLEAR SIGNAL TRANSDUCTION
M. Gilman C. Alexandre
R. Attar
K. Brennan
D. Grueneberg
J. lafrate A. Ryan
G. Lee H. Sadowski
T. Nahreini K. Simon
S. Natesan M.-L. Vignais
Our interest is in how extracellular signals are com-
municated to the nucleus to control the growth and
differentiation of eukaryotic cells. Cells are presented
with a complex spectrum of signals, in the form of
soluble hormones and growth factors and direct cell-
cell and cell-matrix contacts. They must be able to
distinguish among these signals and to translate each
signal into the pattern of gene expression required to
execute the appropriate biological program. Our work
focuses on two major aspects of how cells receive
these signals, process them, and interpret them into
specific patterns of gene expression.
First, we are interested in the mechanics of signal
transduction: How are signals passed from cell-
surface receptors to nuclear transcription factors?
Recent progress in this area has allowed at least two
distinct signal transduction pathways to be traced
nearly in their entirety from membrane to nucleus.
Our current effort focuses on one of these pathways,
which leads to the direct tyrosine phosphorylation of
a latent cytoplasmic transcription factor.
Second, we are interested in the specificity of
these signaling pathways: How do cells know what
signal they are receiving and how are they pro-
grammed to respond to a signal at the level of tran-
scription? Here, we have gained our major insight
from genetic and biochemical studies of proteins of
the homeodomain family, which we believe function
to route signal transduction information to cell-type-
specific target genes.
Our principal experimental focus is the proto-
oncogene c-fos, which is rapidly and transiently ac-
tivated at the transcriptional level within minutes of
exposure to a spectrum of extracellular signals. c-fos
transcription is activated by multiple intracellular sig-
nal transduction pathways. In the past, our work has
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focused on identification of the cis-acting regulatory
elements in the c-fos gene that are connected to each
of these pathways and on the DNA-binding proteins
that interact with these elements. This year, we have
concentrated on one of these nuclear signal transduc-
tion pathways, a pathway mediated by a family of
DNA-binding proteins regulated by direct tyrosine
phosphorylation. In addition, we have extended our
analysis on the role of homeodomain proteins in
targeting these nuclear signal transduction pathways
to specific target genes. We have also begun to move
our studies into more complex biological systems, in-
cluding Drosophila and mice.
The Serum Response
Element as a Focus
for Incoming Signals
M. Gilman, C. Alexandre, G. Lee, H. Sadowski
The serum response element (SRE) is required for the
response of the c-fos gene to at least three distinct
signal transduction pathways, one dependent on
protein kinase C (PKC) and at least two that are inde-
pendent of PKC. In addition, the SRE is the target for
the rapid repression of c-fos transcription that follows
induction. The SRE is bound by a ubiquitously ex-
pressed 67-kD phosphoprotein, serum response factor
(SRF). Extensive mutagenesis of the SRE indicates
that binding of SRF to the SRE is absolutely required
for all functions of the element, but increasingly we
have come to realize that SRF binding is not suffi-
cient for many-and perhaps all-of these functions.
SRF DNA-binding activity is not detectably in-
fluenced by signaling events, nor does the pattern of
proteins bound to the SRE in living cells change, sug-
gesting that SRF is always bound at the SRE. Instead,
we believe that SRF works principally by recruiting a
set of different accessory proteins, each of which
connects SRF and the SRE to a distinct signal trans-
duction pathway.
One well-characterized group of SRF accessory
proteins is a small family of Ets-domain proteins col-
lectively termed ternary complex factor (TCF). TCF
does not display strong binding affinity for either free
SRF or SRE DNA. Rather, it specifically recognizes
and binds to the SRF-SRE complex. Previously, we
found that we could make mutations in the SRE that
did not affect the binding of SRF but prevented the
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recruitment of TCF. These mutant SREs lost the
ability to respond to PKC-dependent signals but
retained wild-type response to PKC-independent sig-
nals. Thus, the PKC pathway targets the ternary com-
plex of SRF and TCF. Indeed, recent work in several
laboratories indicates that TCF is a direct physical
target for these signals: TCF is phosphorylated by
MAP kinase, and this phosphorylation switches on its
transcriptional activation potential.
What is the target for the PKC-independent sig-
nals that continue to function in the absence of TCF?
One target, we believe, is another small family of
DNA-binding proteins, collectively designated SIR
These proteins, which we describe in more detail be-
low, become activated at the level of DNA binding
within seconds of growth factor treatment and bind to
a sequence, the SIE, located approximately 25 by up-
stream of the SRE. When mutations are introduced
into the SIE, the remaining TCF-independent
response of the c-fos gene to platelet-derived growth
factor (PDGF) is eliminated. Thus, we can dis-
tinguish two nuclear signals transmitted by the PDGF
receptor, one that reaches c-fos via TCF and one that
arrives via SIF. Mutations that abolish the binding of
SRF interrupt both signals, again suggesting that the
functions of TCF and SIF are dependent on the bind-
ing of SRF.
When a doubly mutant promoter unable to bind
either TCF or SIF is assayed following stimulation
with whole serum, a complex cocktail of growth fac-
tors and hormones, it retains a reduced ability to
respond. This observation suggests the existence of at
least one additional pathway dependent on SRF. This
signal either targets SRF alone or requires an as yet
unidentified accessory factor. Thus, we believe that
SRF works principally as a landing pad for other
proteins, which are the actual physical targets for dis-
tinct signal transduction pathways. The c-fos gene,
and presumably other immediate early genes, can
thus be independently connected to these signal trans-
duction pathways. The ability of each of these
proteins to interact at the c-fos gene depends on the
presence of two elements in the gene: a DNA se-
quence that is recognized directly by each protein and
a DNA-bound SRF molecule. This model has two
important ramifications. First, it suggests that the
specification of which signal transduction pathways a
gene can sense is directly encoded in regulatory
DNA. Second, by determining where SRF is allowed
to bind, a cell can exert global control over which
genes are connected to signal transduction pathways.
Regulation of c-fos Transcription
by Tyrosine Phosphorylation
of a Latent Cytoplasmic
Transcription Factor
H. Sadowski
Signal transduction to the nucleus by growth factor
receptors with protein-tyrosine kinase activity is
complex. The initial event in activation of these types
of receptors is the cross-linking of receptors by
ligand, resulting in the rapid and concerted trans-
phosphorylation of the receptors on multiple tyrosine
residues. Phosphorylation on tyrosine is absolutely
required for receptor signaling. The next step is the
recruitment of a series of cytoplasmic and membrane-
associated adaptor/signaling proteins to the receptor
where they may or may not be phosphorylated on
tyrosine. Many of these proteins associate with
phosphotyrosine residues on the receptor via protein
domains termed SH2 (src homology region-2)
domains. Each of these SH2-domain proteins is
thought to elicit an independent intracellular signal
transduction pathway.
Among these SH2-domain proteins involved in
growth factor signal transduction is the family of
DNA-binding proteins termed SIF. SIF proteins are
members of a larger family, termed signal trans-
ducers and activators of transcription (STATs). These
proteins undergo rapid phosphorylation on tyrosine in
cells treated with a variety of polypeptide growth fac-
tors and cytokines. Phosphorylation of the STATs in-
duces protein dimerization, DNA-binding activity,
and nuclear translocation.
Using A431 cells as a model system, we have ex-
amined the mechanism of SIF activation by epider-
mal growth factor (EGF). Activation does not involve
the well-characterized signal transduction pathways
utilizing PKC, calcium, or cAMP but clearly requires
tyrosine kinase activity as it is inhibited by cell-
permeable tyrosine kinase inhibitors. SIF activation is
extremely rapid at 37°C, detectable within 20 sec-
onds of EGF addition, peaking within 4 minutes, and
persisting for at least 30 minutes. Three distinct
mobility-shift complexes (SIF A, B, and C) rapidly
appear in nuclear extracts, whereas only the two more
rapidly migrating complexes (SIF B and C) appear in
the cytoplasm. When activations are performed at
0°C, where internalization of receptors and nuclear
transport of proteins is inhibited, SIF activation is
still readily apparent within 30 seconds, with appar-
ent accumulation over time of the two faster-
migrating complexes in the cytoplasmic fraction rela-
tive to the nuclear fraction. Together, these data sug-
gest that latent SIF exists in the cytoplasm where it is
rapidly activated by a receptor proximal event (kinet-
ics just behind receptor tyrosine phosphorylation),
after which DNA-binding-competent SIF is translo-
cated to the nucleus.
Since the activation of SIF by EGF in A431 cells
is quite robust and a receptor proximal event, we
have used fractions from unstimulated A431 cells to
develop a cell-free assay for SIF activation. In this
assay, we observe time- and ligand-dependent activa-
tion of SIF, with a requirement for detergent-treated
A431 membranes, cytoplasm (from virtually any cell
line), ATP, Mg++, and Mn++. Antibody depletion ex-
periments indicate that activation is absolutely depen-
dent on the EGF receptor. Activation is blocked by
antibody to phosphotyrosine, recombinant SH2 do-
mains, and free phosphotyrosine, indicating that at
least one phosphotyrosine-SH2 domain interaction is
required.
The addition of either phosphotyrosine antibody
or a highly purified protein tyrosine phosphatase to
nuclear extracts from EGF-treated cells inhibits
formation of SIF-DNA complexes. Thus, SIF poly-
peptides contain phosphotyrosine, and this phosphor-
ylation is required for DNA-binding activity. Using a
combination of UV cross-linking, and DNA-affinity
precipitations of [35S]methionine-labeled cell ex-
tracts, we have detected four polypeptides in the
80-94-kD range that specifically bind to the SIE after
treatment of A431 cells with EGF.
Several of the characteristics of SIF, including
subunit size, DNA-binding specificity, and mechan-
ism of activation, resemble those of the interferon
(IFN)-activated transcription factors, particularly the
91K subunit selectively activated by IFN-y (Statl).
Using a variety of experimental approaches, we have
shown that the IFN-y-activated factor complex
(GAF), which contains only tyrosine phosphorylated
Statl, is identical to SIF-C and phosphorylated on the
same tyrosine residue. In contrast, SIF-A does not
contain the Statl protein, does not form on a GAS
probe, and is not activated by IFN-y. The SIF-A com-
plex contains a distinct SH2-domain protein, Stat3.
SIF complex B behaves as a composite of A and C,
and it appears to be a heterodimer of Statl and Stat3.
Statl and Stat3 differ in their DNA-binding specifici-
ties and in the ligands that activate them. Stat 1 is
preferentially activated by IFN-y and binds selective-
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ly to regulatory elements in IFN-y-inducible genes.
Stat3, in contrast, is preferentially induced by poly-
peptide growth factors, such as EGF and PDGF, and
by certain cytokines, such as interleukin-6. Stat3 ex-
hibits weak affinity for IFN-y-inducible sites and
binds preferentially to the SIE in the c-fos gene.
Recently, we have focused on the mechanism of
SIF activation by polypeptide growth factors. Using a
bank of cell lines expressing wild-type and mutant
human B-PDGF receptors (constructed by Adam
Keshishian and Jonathan Cooper, Fred Hutchinson
Cancer Research Center), we are examining which
portions of the PDGF receptor are required for SIF
activation. At the same time, various phosphotyro-
sine-containing peptides and SH2 domains from dif-
ferent signaling proteins are being tested as competi-
tive inhibitors in the in vitro activation assay. And, as
detailed below, we are also trying to identify the
protein tyrosine kinase responsible for phosphorylat-
ing the SIF proteins.
Regulation of SIF Activity by
Tyrosine Phosphorylation
M.-L. Vignais
The c-sis-inducible element (SIE) of the c-fos pro-
moter is the target for the two STAT proteins, Statl
and Stat3. These two proteins undergo rapid
phosphorylation on a single tyrosine residue when
cells are exposed to polypeptide growth factors such
as EGF and PDGF. Phosphorylation of Tyr-701 of
Statl is required for protein dimerization, DNA-
binding activity, and translocation of the protein to
the nucleus. The SH2 domain of Statl is also re-
quired for activation. Statl and Stat3 can bind DNA
as either homodimers or heterodimers, generating the
three distinguishable DNA-protein complexes on an
SIE probe (SIF A, B, and C) in gel-shift assays. Statl
and Stat3 proteins are also activated by a number of
cytokines, whose receptors, unlike those of EGF and
PDGF, do not harbor intrinsic protein tyrosine kinase
activity. Signaling by these receptors relies on non-
covalently associated protein tyrosine kinases of the
JAK family.
We are interested in establishing the mechanism of
activation of Statl and Stat3 proteins by growth fac-
tor receptors. Three different models could account
for how the STAT proteins become tyrosine phos-
phorylated. First, they could be recruited to the ac-
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tivated growth factor receptor via their SH2 domains
and directly phosphorylated by the receptor kinase.
Second, the STAT proteins could be phosphorylated
by the same JAK kinases that apparently mediate
their activation by cytokine receptors. Third, a dis-
tinct class of protein tyrosine kinases, such as the Src
family, could be involved.
We have begun to address these questions in two
ways. First, we have shown that Stat 1 protein-
produced reticulocyte lysate from a cDNA clone can
be activated in vitro by EGF in the presence of A431
membranes. No cyotosolic components beyond those
supplied by the reticulocyte lysate are required. We
can now exploit this assay to investigate the struc-
tural and functional domains of the STAT proteins
required for various aspects of their regulation by
tyrosine phosphorylation. The next step is to repeat
these activation experiments with STAT proteins pro-
duced in Escherichia coli. If activation of bacterially
produced protein can be achieved, then we will use
conventional biochemical approaches, such as frac-
tionation and depletion, to identify the membrane
and/or cytosolic components required for STAT ac-
tivation. The ultimate goal of these experiments is to
reconstitute STAT activation with purified proteins.
Our second approach is genetic. We have obtained
a number of cell lines that lack individual protein
tyrosine kinases of the JAK and Src families and are
testing these cell lines for the ability to support SIF
activation by PDGF. In some cases, this has required
the transfer of functional PDGF receptors into the ap-
propriate cell lines. Using these cell lines, we will
determine if any of these protein tyrosine kinases are
required for STAT activation by PDGF in vivo.
Dual Modes of Control of c-fos
Transcription by Calcium in T Cells
G. Lee
Many extracellular stimuli elevate intracellular cal-
cium, and calcium ions can be potent second mes-
sengers. Cytoplasmic calcium pulses are particularly
important in T lymphocytes, where they mediate one
component of the activation signal triggered by the
antigen receptor. A second signal activated by the
antigen receptor results in the activation of protein
kinase C (PKC). Neither signal is sufficient for T-cell
activation, but together, activators of PKC and cal-
cium ionophores cooperate synergistically to elicit
activation. This synergy between PKC activators and
calcium ionophores is also evident at the level of c-
fos mRNA induction. Neither stimulus alone sig-
nificantly elevates c-fos mRNA, but both together
yield significant c-fos induction.
We have investigated the mechanisms by which
calcium interacts synergistically with PKC activators
to induce c-fos mRNA. Induction of c-fos transcrip-
tion by phorbol ester requires the serum response ele-
ment (SRE). Mutagenesis of the SRE indicates that,
as we have observed previously in fibroblasts, induc-
tion by phorbol ester requires the ternary complex of
SRF and TCF. Calcium cooperates with phorbol ester
in two distinct ways. First, calcium induces the ac-
tivity of the c-fos promoter, as measured in reporter
gene assays and by nuclear run-on analysis of endog-
enous c-fos transcription. Induction of promoter ac-
tivity by calcium requires a conserved AP-1/CRE-
like element located immediately 3' to the SRE. Sec-
ond, calcium greatly enhances the efficiency with
which nascent c-fos transcripts are elongated to com-
pletion. In the absence of a calcium signal, transcripts
initiated at the c-fos promoter in response to phorbol
ester appear to terminate near the boundary of the
first exon and intron. In nuclear run-on assays, little
transcription of downstream portions of the gene is
observed. In the presence of a calcium signal, how-
ever, these transcripts proceed through the gene with
greatly enhanced efficiency. The strong synergy be-
tween phorbol ester and calcium ionophore thus
arises because these agents affect discrete steps in the
production of c-fos mRNA: Phorbol ester promotes
initiation of transcription, whereas calcium promotes
elongation. Only when both signals are present do
mature c-fos mRNAs accumulate. Furthermore, the
enhanced elongation induced by calcium occurs for a
very short period of time following signaling, even
while the enhanced initiation of transcription persists.
Thus, control of transcript elongation is the principal
form of control over both the kinetics and the extent
of c-fos mRNA accumulation under these treatment
conditions.
Role of 'YY1 in the Organization
of Protein-DNA Complexes on
the c-fos Promoter
S. Natesan
YY1 is a zinc-finger-containing protein that can ac-
tivate or repress transcription depending on the pro-
moter context. YY1 is indistinguishable from a pre-
viously characterized SRE-binding protein termed
p62DBF. YY1 binds to at least three sites in the
mouse c-fos promoter including the SRE and sites
positioned near -255 and -55. The -55 site is
situated between the TATA box and the cAMP
response element (CRE), which is also a major basal
element of the promoter. The presence of YY1 sites
within or adjacent to these essential promoter ele-
ments suggests that YY1 may have an important role
in the regulation of c-fos expression. At each of these
sites, YY1 binding induces DNA bending. Thus,
YY1 has the potential to induce significant three-
dimensional structure in the mouse c-fos promoter,
suggesting that YY1 may facilitate interactions
among proteins bound to different sites in the
promoter.
To test this hypothesis, we carried out a series of
transfection experiments with a simplified c-fos
promoter carrying sequences from -71 to +109 fused
to the bacterial CAT gene. These experiments sug-
gest that YY1 binding to the -55 region represses
promoter activity but that repression is not an in-
trinsic property of YY1 in this context, because its
ability to repress transcription requires an intact CRE
at -65. Repression by YY1 is also alleviated by
changing the relative phasing of the factor binding
sites on either side of YY1. Moreover, when the
orientation of the -55 YY1 site is reversed, YY1 ac-
tivates the promoter. These data suggest that the prin-
cipal function of YY1 in this promoter context is to
bend DNA to regulate contact between other
proteins. In support of this view, we have shown that
the product of male sex determination gene SRY en-
codes a protein that can bind to YY1 sites and induce
DNA bending. In transfection assays, SRY can par-
tially mimic the function of YY1. Therefore, YY1,
and perhaps SRY as well, belongs to a novel class of
transcription factors that affect promoter function by
affecting DNA structure, rather than directly contact-
ing the transcriptional machinery.
We are currently investigating the role of YY1 in
the regulation of SRE function. Our data suggest that
both affinity-purified DBF and bacterially expressed
YY1 enhance the binding of SRF to SRE. Enhance-
ment of SRF-binding activity requires the binding of
YY1 to SRE. Given that YY1 bends DNA, including
the SRE, we imagine that YY1 may enhance the
binding of SRF to the SRE by inducing a DNA con-
formation that is favored by SRF. Furthermore, under
certain assay conditions, we can detect stable corn-
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plexes in which YY1 and SRF co-occupy the SRE.
Interestingly, both the enhancement of SRF binding
and co-occupancy of the SRE with YY1 appear to re-
quire regions outside the DNA-binding and dimeriza-
tion domain of SRF.
How can YY1 and SRF simultaneously occupy
overlapping binding sites? YY1 is a member of the
C2H2 class of zinc finger proteins. On the basis of es-
tablished structures of related proteins, it is rea-
sonable to assume that YY1 contacts the SRE pre-
dominantly in the major groove. The structure of the
SRF-SRE complex is unknown, but modifica-
tion/interference assays have been interpreted as evi-
dence for major groove binding as well. To test
whether these proteins indeed make major groove
contacts in regions of the SRE in which their binding
sites overlap, we made SRE probes in which adenine-
thymine base pairs have been replaced with inosine-
cytosine base pairs. These substitutions change
protein contact groups in the major groove while
leaving the minor groove essentially unchanged. We
find that YY1 is unable to bind this substituted SRE,
consistent with the hypothesis that it recognizes the
SRE primarily in the major groove. In contrast, SRF
does bind the substituted SRE, suggesting that SRF
does not make major groove contacts, at least in the
central region of the SRE. SRF may make minor
groove contacts in this region or it may make no con-
tacts at all. To distinguish between these possibilities,
we tested distamycin, a drug that binds to the minor
groove of AT-rich DNA, for its ability to function as
a competitive inhibitor of SRF binding. Distamycin
effectively inhibited the binding of SRF to the wild-
type SRE, whereas it did not affect the binding of
YY1. Thus, at least in the central AT-rich core of the
SRE, SRF binds predominantly in the minor groove
and YY1 in the major groove, making co-occupancy
possible.
SRF-Homeodomain
Interactions and
the Specificity of Signal
Transduction to the Nucleus
D. Grueneberg
How do cells interpret incoming signals into an ap-
propriate pattern of gene expression? This question
has become particularly important with the observa-
tion that different growth factor receptors share a
small number of common signal transduction path-
ways. For example, in the Drosophila eye, the seven-
less receptor tyrosine kinase (RTK) transmits an in-
ductive signal that specifies the development of the
R7 photoreceptor cell. Genetic analysis of the sev sig-
naling pathway indicates that this signal uses the
ras/MAP kinase pathway. But other receptors in
Drosophila, including the EGF receptor and the
torso-encoded RTK, utilize the same signaling ma-
chinery and elicit completely distinct biological
responses. Thus, these signals must be generic, and
the unique biological response of an individual cell to
such a signal must be due to intepretation of the sig-
nal at the transcriptional level into a cell-type-specific
pattern of gene expression. We have proposed that
this interpretation is carried out by complexes of
proteins of the MADS box family, such as SRF, and
proteins of the homeodomain family. Our work this
year has focused on devising assays to test this
hypothesis.
Earlier, we had used a genetic screen in yeast to
identify potential accessory factors for SRF. From
that screen, we isolated cDNAs encoding a novel hu-
man homeodomain protein, Phox1. Biochemical
studies, using recombinant proteins produced in E.
colt, confirmed that Phox1 interacts with SRF in
vitro. Furthermore, we found that Phox1 enhanced
the binding of SRF to the SRE. This activity resides
within the homeodomain of Phox1 and is shared with
closely related homeodomain proteins, such as the
Drosophila Paired and Orthodenticle proteins, but not
with more distantly related homeodomain proteins.
The observation that proteins of the homeodomain
family, with clearly documented roles in assigning
cell identity, could interact physically with proteins
like SRF, which connect genes to signal transduction
pathways, suggested a simple model for how these
processes might be linked. We speculated that one
way in which homeodomain proteins impart identity
to a cell is by routing incoming signals to cell-type-
specific genes and that they do this by recruiting SRF
to these sites.
To test this model, we have devised an assay to
study the interaction between Phoxl and SRF in vivo.
In He La cells, a simplified reporter gene carrying a
single SRF-binding site is not responsive to serum
growth factors. However, upon cotransfection of an
expression vector producing the Phox1 homeodo-
main, the reporter becomes serum-inducible. As we
observed in our in vitro assays, this activity is shared
with related homeodomains, such as Prd, but not
more distantly related homeodomains. Thus, homeo-
domain proteins have the ability to link a gene to the
cellular signal transduction machinery. Moreover, the
ability of Phoxl to impart serum inducibility of the
reporter gene requires cooperation with endogenous
cellular proteins, presumably including SRF, because
a reporter gene carrying mutations that prevent the
binding of SRF is not responsive to Phoxl. There-
fore, although we cannot form stable SRF/Phoxl
complexes in vitro using purified proteins, we believe
that this in vivo assay provides a measure of the
formation of such complexes on the reporter gene.
We have used this assay is several ways. First, to-
gether with Ken Simon, we have extensively
mutagenized the Phoxl homeodomain to determine
which parts of the protein are required for this ac-
tivity. We find that the ability of Phoxl to impart
serum inducibility to the reporter gene requires the
DNA-binding activity of the homeodomain. In addi-
tion, as described in more detail below, Phoxl ac-
tivity also requires amino acid residues on the
solvent-exposed surfaces of homeodomain helices
one and two. This observation indicates a require-
ment for direct protein-protein interactions between
Phoxl and some other component(s) in the complex
at the SRE.
Second, together with Keith Brennan, we have ex-
amined the DNA sequence specificity of Phoxl in
vivo. By randomly mutagenizing the AT-rich core of
the SRE, we have derived sets of SRF-binding sites
that differ dramatically in their abilities to be ac-
tivated by Phoxl in vivo. This observation suggests
that Phoxl can recruit SRF to only a subset of poten-
tial binding sites, consistent with the hypothesis that
homeodomains recruit SRF to cell-type-specific
genes. Interestingly, the ability of Phox 1 to impart
serum inducibility to these SRF-binding sites does
not strictly correlate with the simple affinities of ei-
ther Phoxl or SRF for these sites in vitro. Thus, the
specificity of action of the SRF/Phoxl complexes in
vivo is distinct from the DNA-binding specificity of
the individual partners in vivo. This observation is
consistent with a large body of data concerning the
specificity of action of homeodomain proteins: Their
exquisite biological specificity in vivo contrasts
dramatically with their rather weak affinity and
degenerate sequence specificity for DNA in vitro.
Mutagenesis of the Homeodomain-SRF
Interface
K. Simon
Homeodomain proteins, first characterized in the fruit
fly Drosophila melanogaster, have important regula-
tory roles in embryonic development. Among these
functions is the ability to specify the identity of indi-
vidual body segments in the fly and presumably of
the individual cell types within each segment. This
ability of homeodomain proteins to assign cell
identity appears to be conserved in metazoans, as
well as in fungi. Homeodomain proteins bind DNA
and act as transcription factors, but their DNA-
binding specificity is generally poor and is not suffi-
cient to explain their high degree of specificity in
vivo. It is widely believed that the homeodomain
must have additional activities, including perhaps the
ability to interact with other proteins. As described
above, we have amassed considerable evidence that
certain homeodomain proteins have the ability to in-
teract with SRF and other proteins of the MADS box
family. To understand this interaction, we have begun
a mutagenic analysis of the Phoxl homeodomain
protein to determine which amino acid residues of the
homeodomain are required for interaction with SRF.
To begin, we have systematically substituted
amino acid residues predicted to reside on the
solvent-exposed surfaces of Phoxl homeodomain
helices one and two with alanine residues. Mutant
proteins were assayed in the HeLa cotransfection as-
say described in the previous section. Many substitu-
tions in helices one and two had little detectable ef-
fect on the ability of Phoxl to recruit SRF to the SRE
reporter gene. Several substitutions did, however.
These included residues on both helices one and two
and in the loop joining these helices. We are continu-
ing this analysis by testing the effect of different
amino acid substitutions at these positions and by
testing the mutant proteins in other assays.
Our goals for the upcoming year include a muta-
genic analysis of SRF to determine what residues in
this protein are required for interaction with Phoxl.
In addition, we plan to undertake a more detailed
analysis of the structural organization of the SRF/
Phoxl complex, focusing on the stoichiometry of the
complex, the nature of the DNA contacts, and
whether other proteins are present in the functional
complex in vivo.
Isolation and Characterization
of a Drosophila Homo log of SRF
A. Ryan
To test our hypothesis that SRF (and other proteins of
the MADS box family) cooperates with homeo-
domain proteins to impart cell type specificity to sig-
nal transduction pathways, we would like to be able
to study this interaction in an intact animal. One at-
tractive choice is Drosophila. Embryogenesis in
Drosophila has been actively studied at the genetic,
morphological, and molecular levels. The role of
homeodomain proteins in key regulatory events in the
fly embryo is relatively well understood. In addition,
powerful molecular tools are available for monitoring
and manipulating embryonic development. As a first
step in studying the role of potential SRF/homeo-
domain interactions in fly development, we have iso-
lated an SRF homolog from Drosophila.
Using a partial sequence provided to us by Ron
Prywes and Michael Levine, we isolated a polymer-
ase chain reaction (PCR) product from reverse-
transcribed Drosophila mRNA that encodes a protein
closely related to human SRF. With this probe, we
have isolated both genomic and cDNA clones cor-
responding to this gene. The gene encodes a protein
very closely related to human SRF in the DNA-
binding domain; amino acid identity is greater than
90% in this region. We find that this protein binds
DNA with specificity essentially indistinguishable
from that of the human protein. Moreover, the fly
protein interacts readily with the human SRF acces-
sory protein, Elk-1. Thus, the biochemical properties
of the fly SRF protein are highly conserved.
The SRF gene maps to region 60C on the right
arm of chromosome 2. We have identified two defic-
iencies in this region of the genome. A number of
recessive lethal genes map to this area, one of which
may correspond to SRF. By in situ hybridization of
an SRF probe to developing fly embryos, we find that
SRF mRNA is provided to the embryo maternally. It
is ubiquitously distributed throughout early develop-
ment. This ubiquitous distribution is consistent with
the possibility that SRF is a cofactor for homeo-
domain proteins active in the early embryo. After
germ-band extension, however, SRF mRNA disap-
pears from most tissues and is found at high levels in
a relatively small number of cells scattered through-
out the embryo. This pattern of expression suggests
that the function of SRF at later stages of embryonic
development is restricted to a subset of cell types.
To complement our studies
of SRF, we have gen_
erated a series of lacZ reporter genes under the con-
trol of a portion of the mouse c-fos promoter. This
region, which includes the binding
sites for SRF and
several accessory factors, is sufficient to mediate a
transcriptional response to receptor tyrosine kinases
in mammalian cells. We are introducing these
reporters into transgenic flies by P-element-mediated
transformation. We hope to find that this reporter
gene is expressed in regions of the embryo in which
signal transduction pathways are active. We would
then use such fly lines for studying the role of SRF,
its accessory proteins, and homeodomains in deter-
mining the pattern of expression of the reporter gene.
Role of Nuclear Signal Transduction
Pathways in Tumorigenesis in a
Transgenic Mouse Model
J. lafrate
Our studies of c-fos regulation have allowed us to
identify nuclear proteins that are the recipients of the
signals generated by growth factor receptors. We be-
lieve it is likely that these proteins must also have a
significant role in transmitting proliferative signals
from activated oncogenes in tumors. We plan to test
this hypothesis in transgenic mice expressing ac-
tivated oncogenes under the control of the mammary
tumor virus long terminal repeat (MTV LTR). These
animals reproducibly develop mammary tumors, with
varying degrees of latency and penetrance, depending
on the oncogene. Our experiments are being carried
out in collaboration with Dr. William Muller,
McMaster University.
Our first goal will be a simple biochemical analy-
sis of nuclear signal transduction proteins in cell lines
derived from transgenic mouse tumors. We will ex-
amine the ternary complex factors to determine if
they are constitutively phosphorylated by MAP
kinase. In addition, we will examine the SIF proteins
to determine if they are constitutively activated and
phosphorylated on tyrosine. To verify the activation
state of these proteins, we will transfect appropriate
reporter genes into these cell lines to determine if
they exhibit elevated transcriptional activity.
If we find that these proteins are activated in
tumors, we will then determine whether they con-
tribute functionally to tumorigenesis by expressing
mutant proteins in transgenic mice under the control
of the MTV LTR. We expect that gain-of-function
mutants might function as oncogenes in these
animals, either alone or in cooperation with other on-
cogenes. We expect that dominant-negative mutants
should inhibit or retard tumor development in
animals bearing transgenic oncogenes.
In addition, we plan to explore the role of
homeodomain proteins in mammary tumorigenesis.
In much the same way that we think homeodomain
proteins interpret incoming signals by routing them to
the appropriate genes, we believe that homeodomains
should also be responsible for routing signals from
activated oncogenes to target genes required for cell
proliferation. Thus, we predict that mammary tumors
from transgenic animals must express homeodomain
proteins that are normally expressed only early in the
development of the mammary epithelium, during its
proliferative phase, or tumors may ectopically ex-
press homeodomain proteins that are not normally
expressed in mammary cells. Therefore, we plan to
isolate homeodomain cDNAs from libraries prepared
from transgenic tumors, examine their expression
patterns during development of the mammary gland,
and test them for the ability to act as oncogenes in
transgenic mice.
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PROTEIN TYROSINE PHOSPHATASES AND THE CONTROL OF
CELLULAR SIGNALING RESPONSES
N.K. Tonks S.M. Brady-Kalnay
R.L. Del Vecchio
W.R. Eckberg
A.J. Flint
A.J. Garton
P.M. Guida, Jr.
Y.F. Hu
K.R. La Montagne
The phosphorylation of tyrosyl residues in proteins is
a key component of the control of many fundamental
physiological processes. Our laboratory is particular-
ly interested in the role of tyrosine phosphorylation in
transducing an extracellular signal into an in-
tracellular response, such as proliferation or differen-
tiation. Protein phosphorylation is a reversible,
dynamic process in which the net level of phosphate
observed in a target substrate reflects not only the ac-
tivity of the kinases that phosphorylate it, but also the
competing action of protein phosphatases that
catalyze the dephosphorylation reaction. We study
S.N. Mamajiwalla
C.A. Ostman
A.A. Samatar
H. Sun
Q. Yang
S.H. Zhang
the expanding family of protein tyrosine phos-
phatases (PTPs) that, like the kinases, comprise both
transmembrane, receptor-linked forms and non-
transmembrane, cytosolic species. The structures of
the PTPs indicate important roles in the control of
processes such as cell adhesion, cytoskeletal func-
tion, and the cell cycle.
During the last year, Qing Yang left to take a
position in the Gene Therapy Center at the University
of North Carolina, Chapel Hill, and Arne Ostman
returned to a position in the Ludwig Institute for Can-
cer Research in Uppsala, Sweden. Yan-Fen Hu,
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Salim Mamajiwalla, and Shao-Hui Zhang joined the
laboratory as postdoctoral fellows, and Bill Eckberg
came to the laboratory in September to begin a year
of sabbatical leave from Howard University, Wash-
ington D.C.
Receptor-like PTPs and
Cell-Cell Contact
S.M. Brady-Kalnay, S.N. Mamajiwalla, C.A. Ostman,
Q. Yang, N.K. Tonks
A characteristic feature of the extracellular segment
of many receptor-like PTPs is the presence of im-
munoglobulin (Ig)-like and/or fibronectin type III
(FNIII) domains. These are motifs that are commonly
found in cell adhesion molecules. We have focused
on two such enzymes, PTPli and DEP-1.
PTPIA is characterized by an extracellular seg-
ment containing one Ig-like and four FNIII domains
and thus displays structural similarity to members of
the Ig superfamily of cell adhesion molecules that in-
cludes neural cell adhesion molecule (NCAM). There
is a single transmembrane domain and a large in-
tracellular segment containing two PTPase domains
preceded by a juxtamembrane segment that is 70
residues longer than the equivalent segment in other
receptor-like PTPs and which displays homology
with the intracellular domain of members of the cad-
herin family of cell adhesion molecules. Such homol-
ogy is unique among both the receptor-like PTPs and
members of the Ig superfamily.
On the basis of the structural similarity between
the extracellular segments of PTPILt and NCAM, one
would predict that this receptor PTP may participate
in homophilic binding interactions. We have tested
this prediction using an overexpression system,
reconstitution of the binding reaction in vitro, and
cells in which PTPI,t is normally expressed. Using the
baculovirus system, expression of full-length PT1311,
or mutant forms with an intact extracellular segment,
induced Sf9 cells to aggregate. In addition, we have
demonstrated that homophilic binding between
molecules of PTP[t can be reconstituted in vitro. Flu-
orescent beads linked to baculovirus-expressed PT1311
were able to bind to the surface of petri dishes coated
with GST/PTPli (a GST fusion protein containing the
extracellular segment of PTP1.1 purified following ex-
pression in Escherichia coli) but did not bind to GST
alone. In addition, beads coated with the GST/PTP[t
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fusion protein self-aggregate, whereas
those coated
with GST alone do not. The PTP11-induced aggrega-
tion was found to be independent of calcium and
glycosylation. Furthermore, phosphatase
activity and
the adhesive function are not
mutually dependent.
We also demonstrated that
PTPtt, as it is expressed
endogenously on the surface of MvLu cells, retains
the capacity to interact with baculovirus-expressed
PT131,1, linked to beads. The binding of PTPti-coated
beads to the MvLu cell surface is blocked by
antibody to the extracellular segment of PTP but not
by a control pre-immune antibody. These data estab-
lish homophilic binding between molecules of PTP1A,
thus indicating that the ligand for PTPIA, is another
PTPli molecule on the surface of an adjacent cell. We
are currently trying to define the sequences in the ex-
tracellular segment of PT131,t that mediate homophilic
binding interactions and to examine the effect of
perturbing these interactions on cell growth and de-
velopment.
As far as we can tell, aggregation, i.e., ligand
binding to the extracellular segment, had no detec-
table direct effect on the activity of the intracellular
PTP domains. Nevertheless, it is possible that such an
interaction could serve a tethering role, controlling
the activity of the PTP indirectly by restricting its
spatial distribution on the membrane and thus
restricting the spectrum of substrates with which it
may interact. Preliminary immunocytochemical anal-
ysis has localized PTI3p, to particular junctional com-
plexes at points of cell-cell contact under physiologi-
cal conditions of expression. We are characterizing
the components of these junctional complexes that
bind to PTPti and examining the consequences of
such interactions with respect to the function of this
enzyme.
Our data with PTPti, reinforce the concept that
receptor PTPs may have a role in transducing signals
initiated by cell-cell contact. For example, normal
cells display density-dependent arrest of cell growth.
Thus, as cultures approach confluence, and adjacent
cells touch each other, growth is inhibited. Since
tyrosine phosphorylation, triggered by growth factor
receptor PTKs, has been implicated in promoting cell
growth and proliferation, PTPs, as the natural
antagonists of PTK function, may exert a negative ef-
fect on such growth-promoting signals. We have iso-
lated cDNA encoding a novel receptor-like PTP from
a He La cell library. The cDNA predicts an enzyme
consisting of an extracellular segment containing
eight FNIII repeats, a single transmembrane segment,
and a single intracellular PTP domain. We have pro-
posed the name DEP-1 (high-cell-density enhanced
PTP) for this enzyme. Following expression of DEP-
1 cDNA in COS cells, a glycoprotein of 180 kD was
detected, and PTP activity was demonstrated in im-
mune complexes using a carboxy-terminal peptide
antiserum. Endogenous DEP-1 was detected in WI38
lung fibroblasts by immunoblotting, immuno-
precipitation of metabolically labeled cells, and im-
mune complex PTP assays. Immunoblot analysis of
DEP-1 expression in WI38 revealed dramatically in-
creased levels and activity of the PTP in dense rela-
tive to sparse cultures. In addition, DEP-1 activity,
detected in PTP assays of immune complexes, was
increased in dense cell cultures. In contrast, the ex-
pression levels of PTP-1B, a ubiquitously expressed
cytoplasmic enzyme that is the major PTP in many
tissues and cell lines, did not change with cell
density. This enhancement of DEP-1 expression with
increasing cell density was also observed in another
fibroblast cell line, AG1518. The increase in levels of
DEP-1 occurs gradually with increasing cell contact
and is initiated before saturation cell density is
reached (Fig. 1). These observations suggest that
high-cell-density-induced expression of DEP-1,
which is broadly distributed, may contribute to the
mechanism of contact inhibition of cell growth by
promoting net dephosphorylation of proteins in the
membrane and countering the effect of growth-
promoting PTKs. We are currently examining the
link between cell contact and expression of DEP-1
and testing directly the ability of this PTP to
antagonize cell growth.
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FIGURE 1 Analysis of DEP-1 expression at various cell
densities. DEP-1 expression was analyzed by immunoblot-
ting of lysates of W138 cells. Photomicrographs of cultures at
varying cell densities from which the lysates were derived
are shown below.
MKP-1, a Tyr/Thr Phosphatase
That Dephosphorylates, and Blocks
Signaling Downstream from, MAP Kinase
H. Sun, N.K. Tonks [in collaboration with C.H. Charles
and L.F. Lau, University of Illinois, and D. Bar-Sagi,
Cold Spring Harbor Laboratory]
Recently, progress has been made by many
laboratories in defining signaling pathways initiated
by mitogenic stimuli. Growth-factor-induced auto-
phosphorylation of tyrosyl residues in receptor-PTKs
induces the formation of multiprotein complexes in
the membrane that trigger conversion of Ras from an
inactive GDP-bound form to an active GTP-bound
state. Activated Ras then initiates a cascade of se-
quential phosphorylation events in which the
serine/threonine kinase Raf phosphorylates and ac-
tivates MAP kinase kinase (also known as MEK),
which is a dual specificity kinase that in turn
phosphorylates both Thr-183 and Tyr-185 in p42
MAP kinase. Phosphorylation of both tyrosine and
threonine regulatory sites is essential for activation.
The MAP kinase family of enzymes has been impli-
cated as common and essential components of signal-
ing pathways induced by diverse mitogenic stimuli.
Once activated, MAP kinase can phosphorylate a
number of substrates, including transcription factors,
that are essential for triggering the expression of
genes required for the mitogenic response. Therefore,
growth factor binding initiates a complex network of
protein phosphorylation events that leads a quiescent
cell to enter the cell cycle, undergo DNA replication,
and ultimately divide. One of these immediate early
genes that is activated rapidly and transiently in
quiescent fibroblasts treated with serum growth fac-
tors is 3CH134, which encodes a dual specificity
(tyrosine/threonine) phosphatase termed MKP-1.
MKP-1 possesses intrinsic phosphatase activity that
is highly specific for both the tyrosine and threonine
regulatory sites in MAP kinases. In serum-stimulated
fibroblasts, the kinetics of inactivation of MAP
kinases coincides with the appearance of newly
synthesized MKP-1 protein, and the protein synthesis
inhibitor cycloheximide leads to persistent activation
of MAP kinases. Expression of the phosphatase in
COS cells leads to selective dephosphorylation of
MAP kinases from the spectrum of phosphotyrosyl
proteins visualized by immunoblotting with an
antiphosphotyrosine antibody. MKP-1 blocks phos-
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phorylation and activation of p42maPk-mediated by
serum, oncogenic Ras, or activated Raf. Most striking
is the observation that a catalytically inactive mutant
of the phosphatase, Cys-258-->Ser, augments MAP
kinase phosphorylation under similar conditions. The
mutant phosphatase forms a physical complex with
the phosphorylated form of p42maPk and p44maPk
(Fig. 2). Therefore, our findings suggest that MKP-1
is a physiological MAP kinase phosphatase that may
feed back on the growth factor signaling pathway to
dephosphorylate and inactivate MAP kinase, prevent-
ing uncontrolled growth and proliferation. To exam-
ine the effect of expression of MKP-1 on signaling
responses downstream from MAP kinase, we em-
ployed a transcription assay in which MAP kinase ac-
tivation was measured by its ability to trans-activate
a promoter containing a serum response element
(SRE). We have observed that the induction of SRE
is mediated through the MAP kinase pathway and is
sensitive to the expression of MKP-1. We have also
established a microinjection assay to measure MAP
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FIGURE 2 Physical association between the Cys-.Ser
mutant of MKP-1 and endogenous p42maPk in COS cells.
COS cells expressing the inactive Cys--,Ser mutant of MKP-
1/3CH134 were serum deprived, metabolically labeled with
[35S]methionine, and then either restimulated with serum for
10 min (lanes 2 and 3) or left untreated (lane 1) . The
phosphatase (labeled 3CH134CS) was immunoprecipitated
in the absence (lanes 1 , 2) or presence (lane 3) of competi-
ng antigen. Arrows indicate the positions of dephospho-
MAPK (lane 4) and phospho-MAPK (lane 5). Lane 2 il-
lustrates the serum-dependent association between the
mutant phosphatase and its substrate, the phosphorylated
activated form of MAPK.
kinase activation in single cells
with use of the SRE
reporter. We found that microinjection of either
purified MKP-1 protein or MKP-1 expression plas-
mid blocks SRE induction mediated by TPA, EGF,
and oncogenic Ras. We are currently using MKP-1 as
a tool to define the role of MAP kinase activation in
Go/Gi-S-phase
transition of the cell cycle in response
to growth stimuli or oncoproteins such as Ras.
Analysis of the Structure, Regulation,
and Function of PTP1B
A.J. Flint, K.R. La Montagne, N.K. Tonks [in collaboration
with David Barford and Bob Franza, Cold Spring
Harbor Laboratory]
PHOSPHORYLATION OF PTP1B
PTP1B is a nontransmembrane PTP, the first member
of the family to be isolated in homogeneous form. Its
cDNA predicts a protein of 435 amino acids, of
which the carboxy-terminal 114 residues have been
implicated in controlling both the localization and
function of the enzyme. Neel's group (Beth Israel
Hospital, Boston) has shown that the extreme
carboxy-terminal 35 amino acids, which are of a
highly hydrophobic nature, are both necessary and
sufficient for targeting the enzyme to the cytoplasmic
face of membranes of the endoplasmic reticulum.
Upon inspection of the sequence of the preceding 80
amino acids, which are predominantly hydrophilic,
we noted several potential sites for phosphorylation
by serine/threonine kinases. We have now confirmed
that PTP1B is phosphorylated in a cell-cycle-de-
pendent manner in vivo. In asynchronously growing
HeLa cells, PTP1B is phosphorylated predominantly
on Ser-378 by PKC and at two other minor sites. In
mitotically arrested cells, these interphase sites are
dephosphorylated, and PTP1B becomes phosphory-
lated instead on Ser-386 by p34cdc2 and on Ser-352
by a "proline-directed" kinase. These mitotic phos-
phorylation events coincide with a 30% inhibition of
PTP1B activity. The interaction between these
phosphorylation sites has now been examined in
greater detail following expression of point mutants
in which individual serine residues were converted to
alanine. The results suggest that (1) the phosphoryla-
tion of Ser-386 by p34cdc2 occurs independently of
phosphorylation at another site, and (2) phosphoryla-
tion of Ser-352 promotes the dephosphorylation of
the interphase sites, including Ser-378, that occurs in
mitotic HeLa cells.
A number of approaches have been taken to iden-
tify the kinase responsible for phosphorylating Ser-
352, and current data point to a MAP kinase-like en-
zyme. However, the precise identity of this kinase
remains to be defined.
DETERMINATION OF THE CRYSTAL STRUCTURE
OF PTP1B
The families of receptor-like and nontransmembrane
PTPs are related through a conserved catalytic core
structure of approximately 240 residues. PTP1B was
the first PTP to be isolated in homogeneous form. It
was purified from human placenta as a 321-residue
protein of 37 kD that primarily comprises the cat-
alytic domain and which is derived from the full-
length protein by proteolytic removal of the regula-
tory carboxy-terminal segment. In collaboration with
David Barford, from the crystallography group at
Cold Spring Harbor, we have determined the crystal
structure of this 37,000 form of PTP1B which we
hope will serve as a model for understanding
structure-function relationships and the catalytic me-
chanism of the PTPs. The enzyme was expressed in
E. coli in a stable and soluble form, the activity of
which is indistinguishable from that of the molecule
purified from human placenta. The structure was
determined by single isomorphous replacement and
anomalous scattering methods using sodium tungstate
as the heavy atom derivative. This was important be-
cause sodium tungstate is an effective inhibitor of
PTP1B (IC50 = 10 [tm) that binds at the catalytic site
and presumably functions as an analog of phosphate.
Thus, the structure of the PTP1B-tungstate complex
provides information about the interactions between
the enzyme and its substrate.
The structure of PTP1B has been determined to
2.8 A resolution. It is composed of a single domain
with the polypeptide chain organized into 8 a helices
and 12 p strands with a 10-stranded mixed 13 sheet,
which adopts a highly twisted conformation, span-
ning the entire length of the molecule. The structure
illustrates that the sequence motif [IN]HCXAGXX
RIS/TIG, which contains the catalytically essential
nucleophilic cysteinyl residue and uniquely defines
the PTP family of enzymes, forms the phosphate
recognition site and is located at the base of a cleft.
The hydrogen bonding interactions that are important
for phosphate binding are illustrated in Figure 3.
Specificity for phosphotyrosine-containing substrates
FIGURE 3 View of the catalytic site of PTP1B to illustrate binding of tungstate (phosphate). (Open
lines) Main chain bonds; (closed lines) side chain bonds; (dotted lines) hydrogen bonding interac-
tions.
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probably results from the depth of the cleft since the
smaller phosphoserine and phosphothreonine re-
sidues would not reach down to the phosphate-bind-
ing site. In addition, the surface of the protein sur-
rounding the cleft is relatively open and contains a
high density of basic residues. This would permit
numerous modes of peptide binding, consistent with
the poor discrimination between PTyr-proteins, and
would explain the apparent preference for acidic
residues adjacent to the phosphotyrosine in target
substrates. We are currently generating mutants of
PTP1B for structural determination to test the role of
particular amino acid residues in the catalytic me-
chanism and also looking at the binding of substrate
in detail through cocrystallization of PTP with ei-
ther phosphotyrosine or phosphopeptide substrates.
In addition, we are expanding our studies to en-
compass other members of the family, in particular
MKP-1. We hope to elucidate the structural basis for
both the selectivity of MKP-1 and its dual specificity.
PTP1B AND CHRONIC MYELOGENOUS LEUKEMIA
Chronic myelogenous leukemia (CML) is a clonal
disorder of the hematopoietic stem cell characterized
by the Philadelphia chromosome, in which the c-abl
proto-oncogene on chromosome 9, encoding a PTK,
becomes linked to the bcr gene on chromosome 22.
This results in the production of a fusion protein
termed p210 bcr:abl, the PTK activity of which is en-
hanced relative to c-Abl generating abnormal patterns
of tyrosine phosphorylation in CML cells. Although
much effort was focused on the p210 bcr:abl PTK
and the role of tyrosine phosphorylation in the dis-
ease, we are looking from the perspective of the PTPs
as potential antagonists of p210 bcr:abl function. We
have found that the levels of PTP1B, both mRNA
and protein, are increased as a result of constitutive
expression of p210 bcr:abl in Mo7 cells. An increase
in the half-life of PTP1B also contributes to the en-
hanced levels of this enzyme. Furthermore, PTP1B
appears to be phosphorylated on tyrosyl residues in
the p210 bcr:abl-expressing cells. What makes these
results exciting is that TCPTP, which is a very close-
ly related homolog of PTP1B (75% identity in the
catalytic domain), is also expressed in Mo7 cells but
is apparently not altered in its expression level, half-
life, or tyrosine phosphorylation state as a con-
sequence of p210 bcr:abl expression. We are current-
ly trying to establish whether PTP1B is a specific
antagonist of p210 bcr:abl function, i.e., does the cell
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respond to this aberrantly activated PTK by trying to
produce a natural inhibitor? Through the identifica-
tion of PTPs with the ability to antagonize p210
bcr:abl, we hope to be able to characterize the signal-
ing events that underlie the role of this kinase in
CML. In collaboration with Dr. Bayard Clarkson
(Memorial Sloan-Kettering Cancer Center, New
York), we are also investigating whether the changes
we observe in PTPs in model cell systems for CML
also apply to cells from patients afflicted with the dis-
ease.
Regulation of PTP Activity
R.L. Del Vecchio, W.R. Eckberg, A.J. Garton,
P.M. Guida, Jr., Y.F. Hu, A.A. Samatar, Q. Yang,
S.H. Zhang, N.K. Tonks
The activity of members of the PTP family may be
regulated at several levels. In the case of the receptor-
like enzymes, there is obviously the potential for
modulation of activity by ligand binding to the ex-
tracellular segment. In addition, it appears that many
of the members of this family will be responsive to
regulation by reversible phosphorylation, intracellular
targeting, and association with other proteins.
PTP-PEST
The protein tyrosine phosphatase PTP-PEST is an 88-
kD cytosolic enzyme that is ubiquitously expressed in
mammalian tissues. We have expressed PTP-PEST
using recombinant baculoviruses and purified the
protein essentially to homogeneity in order to investi-
gate phosphorylation as a potential mechanism of
regulation of the enzyme. PTP-PEST is phosphory-
lated in vitro by both PKA and PKC at two major
sites, which we have identified as Ser-39 and Ser-
435. PTP-PEST is also phosphorylated on both Ser-
39 and Ser-435 following treatment of intact He La
cells with TPA, forskolin, or IBMX. Phosphorylation
of Ser-39 in vitro decreases the activity of PTP-PEST
by reducing its affinity for substrate. In addition,
PTP-PEST immunoprecipitated from TPA-treated
cells displayed significantly reduced PTP activity
compared to enzyme obtained from untreated cells.
Our results suggest that both PKC and PKA are
capable of phosphorylating, and therefore inhibiting,
PTP-PEST in vivo, offering a mechanism whereby
signal transduction pathways acting through either
PKA or PKC may directly influence cellular pro-
cesses involving reversible tyrosine phosphorylation.
These data again emphasize the interplay between
serine/threonine and tyrosine phosphorylation events
in signal transduction in vivo.
PTPX1 AND X10
We have isolated the complete coding sequences for
two distinct PTPs, PTPX1 and X10, from a Xenopus
laevis ovary cDNA library. The X1 cDNA encodes a
protein (PTPX1) of 693 amino acids (-79 kD); the
X10 cDNA encodes a protein of 597 amino acids
(-69 kD). Both PTPX1 and PTPX10 lack potential
membrane spanning sequences and therefore can be
classified as nontransmembrane/cytoplasmic PTPs.
Although the overall structures of these PTPs are
similar, sharing segments of 95% amino acid identity,
they differ in that PTPX1 contains a unique 97-
amino -acid insert between the amino-terminal seg-
ment and carboxy-terminal catalytic domain. The ab-
sence of complete identity between PTPX1 and
PTPX10 suggests that these two sequences are the
products of separate genes and not the result of
alternative splicing. This conclusion is confirmed by
polymerase chain reaction (PCR) analysis of Xenopus
genomic DNA. Both PTPs share sequence identities
in their amino-terminal segments with two lipid bind-
ing proteins, cellular retinaldehyde-binding protein
and SEC14p, a phospholipid transferase. In addition,
the unique insert sequence of PTPX1 shares identity
with PSSA, a protein involved in phosphatidylserine
biosynthesis. Sequence comparison suggests that
PTPX10 is the Xenopus homolog of the human PTP
Meg-02, whereas PTPX1 is a structurally related yet
distinct PTP. Intrinsic PTP activity of PTPX1 and
PTPX10 was demonstrated in lysates of Sf9 cells in-
fected with recombinant baculovirus encoding either
enzyme. PTPX1 can associate with membranes in
Xenopus oocytes, and this association is accompanied
by a fourfold increase in PTP-specific activity. We
are currently trying to establish the mechanism by
which PTP activity is enhanced by membrane associ-
ation and to determine whether these enzymes are
targeted to specific membrane fractions.
PTPH1
PTPH1 is a nontransmembrane PTP of 913 residues,
characterized by the presence of an amino-terminal
domain of 320 residues that has homology with the
cytoskeleton-associated proteins, band 4.1, ezrin, and
talin. This domain defines a family of proteins that is
targeted to interfaces between the plasma membrane
and the cytoskeleton. For example, band 4.1, which
promotes the association of actin and spectrin in
erythrocytes, interacts through this domain with the
transmembrane protein glycophorin. We propose that
PTPH1 may be similarly restricted in its intracellular
localization. In the past year, we have expressed
PTPH1 in Sf9 cells and characterized its enzymatic
activity. It appears that the amino-terminal segment,
containing the band-4.1 homology domain, exerts a
negative influence on catalytic activity. Using the
purified protein in affinity chromatography ap-
proaches, we have identified two proteins that bind to
PTPH1. We are in the process of characterizing these
proteins and their effect on the activity of PTPH1.
CD45
CD45 is the prototypical receptor PTP. It is expressed
exclusively on cells of the hematopoietic lineage, and
its expression is essential for normal signaling
through T- and B-cell receptors. Several reports have
indicated that CD45 may be recovered from cell
lysates as part of a multiprotein complex. In particu-
lar, it has been proposed that CD45 functionally in-
teracts with the PTK p56", an as yet unidentified
p32 protein and cell surface proteins such as CD4 or
CD8. We also detect association between CD45 and
proteins of 50,000 and 30,000 in human spleen and in
cell lines including Jurkat. We are currently testing
the regulatory significance of these apparent associa-
tions. In particular, we are looking at the possibility
that these polypeptides may in fact be derived from
CD45 by a proteolytic processing event.
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CELL BIOLOGY OF THE NUCLEUS
D.L. Spector S. Huang
S. Henderson
R.T. O'Keefe
A. Chi
R. Derby
S. Kaurin
L.F. Jimenez-Garcia
T. Tani
Studies in our laboratory are focused on the
structural-functional organization of the mammalian
cell nucleus. Our research program evolves around
understanding the nuclear organization of factors as-
sociated with pre-mRNA splicing and the RNA sub-
strates with which these factors interact. The micros-
copy core facility has been used extensively over the
past year, and numerous collaborations are under way
with the excellent technical expertise of Robert
Derby.
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In Vivo Analysis of the Stability
and Transport of Poly(A),- RNA
S. Huang, D.L. Spector [in collaboration with
Mark H. Ellisman and Thomas J. Deerinck,
University of California at San Diego,
San Diego Microscopy and Imaging Resource]
Previous studies from our laboratory have shown that
a variety of pre-mRNA splicing factors are localized
to a subnuclear speckled domain when mammalian
cells are immunolabeled with antibodies against these
pre-mRNA splicing factors. At the electron micro-
scopic level, the speckled pattern is composed of both
interchromatin granule clusters and perichromatin
fibrils. A large body of evidence has accumulated
from both our laboratory and other laboratories which
has suggested that the perichromatin fibrils represent
nascent transcripts and the interchromatin granule
clusters represent storage and/or assembly sites for
pre-mRNA splicing factors. The majority of sub-
strates for these splicing factors are pre-mRNAs
which contain a poly(A) tail of approximately
200-300 nucleotides. During the past year, we have
studied the distribution of poly(A)+ RNA in the
mammalian cell nucleus and its transport through
nuclear pores by fluorescence and electron micro-
scopic in situ hybridization. Poly(A)+ RNA was
FIGURE 1 Transport of poly(A)+ RNA through the nuclear pore complexes is directly visual-
ized in He La cells by electron microscopic pre-embedding in situ hybridization with photo-
oxidation. Poly(A)+ RNA labeling appears to taper into confined regions as it reaches the
nuclear pore complexes (arrowheads in A). In addition, a buildup of RNA is observed at the
cytoplasmic side of the pore complex (arrows in A). In grazing section, poly(A)+ RNA is ob-
served to be localized to all of the nuclear pore complexes (B), suggesting that poly(A)+ RNA
is transported through all of the nuclear pores. The poly(A)+ RNA appears to be concentrated
around the periphery of the pore complexes. Bars: (A) 1µm; (B) 0.5 1.4.m.
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detected in the nucleus as a speckled pattern that to-
tally colocalized with pre-mRNA splicing factors to
interchromatin granule clusters and perichromatin
fibrils. When cells were fractionated by detergent and
salt extraction as well as DNase I digestion, the ma-
jority of the nuclear poly(A)+ RNA was found to
remain associated with the nonchromatin RNP-
enriched fraction of the nucleus. After inhibition of
RNA polymerase II transcription for 5-10 hours, a
stable population of poly(A)+ RNA remained in the
nucleus and was reorganized into fewer and larger in-
terchromatin granule clusters along with pre-mRNA
splicing factors. This stable population of nuclear
RNA may have an important role in nuclear function
other than in the formation of pre-mRNA or mRNA.
Furthermore, we have observed that, in actively
transcribing cells, the regions of poly(A)+ RNA that
reached the nuclear pore complexes appeared as nar-
row concentrations of RNA, suggesting a limited or
directed pathway of movement (Fig. 1A). All of the
observed nuclear pores contained poly(A)+ RNA
labeling (Fig. 1B), suggesting that they are all
capable of exporting RNA. In addition, we have
directly visualized, for the first time in mammalian
cells, stages in the transport of poly(A)+ RNA
through the nuclear pore complexes. Ongoing studies
are attempting to determine whether transcripts from
individual genes are transported through all or a sub-
set of nuclear pores. If only a subset of the pores are
involved in transport of certain transcripts, as has
been suggested by the gene gating hypothesis
(Blobel, Proc. Natl. Acad. Sci. 82: 8527 [1985]), it
will be interesting to determine the spatial rela-
tionship of the localization of the gene to the nuclear
pores involved in the transport of its RNA.
A Possible Role of the Yeast
Nucleolus in mRNA Transport
T. Tani, R.J. Derby, D.L. Spector
Transport of mRNA from the nucleus to the
cytoplasm plays an important role in gene expression
in eukaryotic cells. The process of mRNA transport
can be dissected into several stages: release of the
mRNA from transcription and processing sites,
movement of the mRNA to the nuclear pore complex
and docking at the pore complex, translocation
through the nuclear pore complex, binding of the
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mRNA to cytoskeletal elements, and movement to
the proper cytoplasmic location for translation. How-
ever, knowledge of the mechanisms involved in each
of these processes remains limited.
We have examined the effects of heat shock on
mRNA transport in the fission yeast Schizosac-
charomyces pombe. As an assay system, we have
utilized in situ hybridization with an oligo(dT) probe
that hybridizes to the poly(A) tail of mRNA. In
normal cells grown at 30°C, poly(A)+ RNA is
uniformly distributed in the cytoplasm and nuclei
(Fig. 2A). We found that a severe heat shock at 42°C
results in accumulation of bulk poly(A)+ RNA in the
nuclei with little to no cytoplasmic labeling, suggest-
ing that the mRNA transport pathway is blocked in
the heat-shocked cells (Fig. 2B). Pretreatment of cells
with a mild heat shock prior to a severe heat shock
protects the mRNA transport machinery and allows
mRNA transport to proceed unimpeded. The protec-
tive effect of the pretreatment is eliminated when
cycloheximide is administered before the pretreat-
ment. However, cycloheximide does not block pro-
tection of mRNA transport if it is added after
pretreatment, suggesting that the induction of heat
shock proteins is involved in the protection of the
mRNA transport pathway. In situ hybridization using
a probe to the intronless alcohol dehydrogenase RNA
showed that alcohol dehydrogenase transcripts are
also accumulated in the nucleus after a severe heat
shock. This result suggests that the accumulation of
poly(A)+ RNA in nuclei is not simply due to the
retention of unspliced precursor mRNAs after heat
shock due to the inhibition of pre-mRNA splicing.
Upon heat shock, the nucleolar crescent-shaped
region of the nucleus condensed into a few compact
structures. Triple-label staining with the oligo(dT)
probe, an antibody to the nucleolar protein fibrillarin,
and the DNA fluorochrome DAPI, revealed that
poly(A)+ RNA accumulates predominantly in the
condensed nucleolar regions of the heat-shocked cells
(Fig. 2B). High-resolution electron microscopic in
situ hybridization confirmed that poly(A)+ RNA is
distributed in both the nucleolar region and the DNA-
enriched region of wild-type cells and that upon heat
shock, RNA accumulates in the condensed nucleolar
components of the S. pombe nucleus. On the basis of
these results, we propose that the crescent-shaped
"nucleolar" region of the yeast nucleus may contain
functional domains that are involved in mRNA trans-
port in addition to those domains involved in
ribosomal RNA synthesis and packaging.
FIGURE 2 Localization of poly(A)+ RNA in control and heat-shocked S. pombe cells.
Wild-type S. pombe cells grown at normal temperature (A,C,E) and cells exposed to
heat shock for 60 min (B,D,F) were subjected to triple labeling with an oligo(dT) probe
(A,B), an antibody to the nucleolar protein fibrillarin (C,D), and DAPI (E,F). In control
cells, poly(A)+ RNA is diffusely distributed throughout the cytoplasm and nucleoplasm
(A). In heat-shocked cells, poly(A)+ RNA concentrates in the nucleolar portion of the S.
pombe nucleus (B). Magnification, 1050x.
Organization of the Double-stranded
RNA-activated Protein Kinase
DAI and Virus-associated VA
RNA1 in Adenovirus-infected Cells
L.F. Jimenez-Garcia, D.L. Spector [in collaboration with
M.B. Mathews and S.R. Green]
In a previous study, we examined the localization of
total adenovirus-2 (Ad2) RNAs in infected He La
cells. We found that these RNAs are concentrated in
a series of ring-shaped inclusions and dots in infected
cell nuclei and are diffusely distributed in the
cytoplasm. Since translational control in adenovirus-
infected cells involves the participation of the cellular
kinase DAI (double-stranded RNA-activated in-
hibitor of translation) and the small viral VA RNA1,
we have examined the cellular distribution of DAI in
Ad2-infected and uninfected He La cells. In unin-
fected He La cells, DAI was found to be concentrated
in the cytoplasm. In addition, DAI was localized in
the nucleoli and diffusely distributed throughout the
nucleoplasm (Fig. 3a). Cells treated with a-interferon
displayed a pattern of distribution similar to that for
10 pm
FIGURE 3 Immunofiuorescent localization of DAI in
uninfected control and a-interferon-treated He La cells.
Cells untreated (a) or treated with a-interferon (b) both display
cytoplasmic and nucleolar localization of
DAI.
DAI (Fig. 3b). When RNA polymerase I activity was
inhibited by the drug actinomycin D, nucleoli
segregated and DAI was found to colocalize with the
dense fibrillar region of the nucleoli. During mitosis,
the distribution of DAI paralleled that of rRNA. In
adenovirus-infected cells, the localization of DAI was
similar to that in uninfected interphase cells. VA
RNA1 was detected in Ad2-infected cells by 10-14
hours postinfection as fine dots in the nucleoplasm.
By 18-24 hours postinfection, VA RNA1 appeared in
bigger and more abundant dots in the nucleoplasm,
and the cytoplasm was intensely labeled (Fig. 4a).
Transient expression of the VA RNA1 gene in
uninfected cells resulted in a similar localization of
the RNA. Our results are consistent with a role for
DAI and VA RNA1 in protein synthesis and suggest
FIGURE 4 Localization of VA RNA1 in He La cells infected with Ad2 for 24 hr, using in situ hybridiza-
tion. (a) VA RNA1 appears to be localized in abundant small round dots in the nucleus (arrowheads)
as well as being diffusely distributed in the cytoplasm. (b) Corresponding differential interference
contrast image. The hybridization signal (dots) are still observed after DNase I pretreatment (c) but
are not observed after RNase A pretreatment (c).
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that DAI may have an early role in ribosome
biogenesis in the nucleolus in addition to its cytoplas-
mic role in translation.
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QUANTITATIVE REGULATORY BIOLOGY
B.R. Franza Y. Li M. Neumann
B.-C. Ma J. Scheppler
G. Mak A. Wilisch
During the past year, we continued to study specific
interactions of cellular macromolecules that occur in
temporally constrained responses of the cell to its en-
vironment.
Drs. M. Neumann and A. Wilisch joined the lab
to demonstrate highly specific alterations in the
regulatory protein, Rel, as cells are stimulated by the
cytokines, interleukin 1, interleukin 3, tumor necrosis
factor a, and the retinoid, all-trans retinoic acid. The
cell system they were investigating permitted the
comparison of the effect of constitutive expression of
an altered tyrosine kinase on the response to addition
of each cytokine or/and retinoid to the growth en-
vironment. The results indicated that Rel can be used
as a meter of the differential effects of each cytokine
and all-trans retinoic acid, that the meter is funda-
mentally re-set when a constitutive, disregulated
tyrosine kinase is present in the cell, and that interac-
tions between Rel and other macromolecules repre-
sent additional meters of changes in the growth en-
vironment of the cell, as well as expression of in-
tracellular regulatory components like tyrosine
kinases (manuscript submitted).
Dr. J. Scheppler demonstrated conclusively that
specific cellular and viral (in this case, human im-
munodeficiency virus type 1, HIV-1) proteins do in-
teract with single-strand, specific sequence oligo-
nucleotides. In doing so, she uncovered a novel ap-
proach to the disruption of a critical HIV-1 regulatory
protein, p32 integrase, and set in place (with our col-
laborators at ISIS Pharmaceuticals) a strategy for
deducing an optimum structure for inhibiting the en-
zyme. The context of her discovery was substantial
because she uncovered certain low-abundance cel-
lular proteins that interacted with the same
oligonucleotide. The implications include cellular
proteins with integrase-like activity or/and complexes
of proteins, one of which happens to recognize the
single-strand oligonucleotide in a sequence-specific
manner, with the others coming along for the ride.
Dr. Y. Li continued her work on the regulation of
expression of HIV-1 by demonstrating contributing
interactions between various structures that reside
within the HIV-1 transcription control region (manu-
script submitted). She also brought a substantial
amount of work on the promoter of the human cell
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cycle control gene, cdc2, to completion. In the cdc2
study, she elucidated a more comprehensive under-
standing of promoter structures that apparently con-
tribute to the stringent transcriptional control of cdc2
and a clearer indication of regions within the cdc2
promoter that are responsive to disregulators like the
cellular-transforming adenoviral gene product, E1A-
12S (manuscript submitted).
We continued our excellent collaboration with
Nick Tonks on aspects of regulation and activity of
the cellular tyrosine phosphatase, PTP1B. Similarly,
in two collaborations, Dr. M. Neumann completed
further analysis of the tyrosine phosphorylation of
Rel in fully differentiated, normal human myelocytes
with Brian Druker and extended our understanding of
Rel (and the related cellular protein, p65 NF-KB) in-
teraction with the KB site in response to activation of
protein kinase A in normal human T lymphocytes
with Edgar Serf ling and colleagues (manuscript sub-
mitted).
MOLECULAR CELL BIOLOGY
D.M. Helfman C. Casciato G. Mulligan
W. Guo M. Pittenger
J. Horwitz M. Selvakumar
J. Kazzaz S. Stamm
We are interested in two fundamental problems in
molecular and cell biology: (1) the mechanisms
responsible for cell-type-specific and developmental-
ly regulated patterns of gene expression and (2) the
functional significance of cell-type-specific protein
isoform expression. In particular, we have been
studying the regulation and function of tropomyosin
gene expression in muscle and nonmuscle cells.
Tropomyosins are among the major components of
the thin filaments of skeletal and cardiac muscle and
the microfilaments of nonmuscle cells. These fila-
ments are involved in a number of cellular processes,
including muscle contraction, cell movement, mito-
sis, and the generation of cell shape. Of interest to
our laboratory is the observation that different forms
of tropomyosin are expressed in different cell types
and tissues. Distinct isoforms are present in striated
muscle (skeletal and cardiac), smooth muscle, and
nonmuscle cells. We now know that at least 16 dif-
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Through all of this work, the contributions of Ms.
G. Mak and B.-C. Ma have been
extensive.
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ferent tropomyosin isoforms are expressed from four
separate genes in rat. The a-TM gene encodes nine
isoforms, the (3 -TM gene encodes two isoforms, the
TM-4 gene encodes a single isoform, and a newly
identified fourth TM gene, referred to as the a skele-
tal muscle slow-twitch gene, encodes at least four
distinct isoforms. We have been studying the expres-
sion of these genes with particular attention to under-
standing the mechanisms of their regulation at the
posttranscriptional level, i.e., tissue-specific alterna-
tive RNA splicing. The expression of a diverse group
of tropomyosin isoforms in a highly tissue-specific
manner via alternative RNA processing strongly sug-
gests that each isoform is required to carry out
specific functions in conjunction with the actin-based
filaments of various muscle and nonmuscle cells. The
function of these different isoforms is not known and
is under study. In addition, we have also continued to
study the molecular basis for neuron-specific alterna-
tive splicing using the rat clathrin light-chain B gene
as a model system. Below is a summary of our
studies.
Cis-Elements Involved in Alternative
Splicing of the Rat p-Tropomyosin
Gene: The 3' Splice Site of the
Skeletal Muscle Exon 7 Is the Major
Site of Blockage in Nonmuscle Cells
W. Guo
We have been using the rat P-tropomyosin (13-TM)
gene as a model system to study the mechanism of
alternative splicing. The I3-TM gene spans 10 kb with
11 exons and encodes two distinct isoforms, namely,
skeletal muscle 13-TM and fibroblast TM-1. Exons 1-
5, 8, and 9 are common to all mRNAs expressed
from this gene. Exons 6 and 11 are used in fibro-
blasts, as well as in smooth muscle cells, whereas ex-
ons 7 and 10 are used exclusively in skeletal muscle
cells. Our previous studies localized the critical ele-
ments for regulated alternative splicing to sequences
within exon 7 and the adjacent upstream intron. We
also demonstrated that these sequences function, in
part, to regulate splice site selection in vivo by inter-
acting with cellular factors that block the use of the
skeletal muscle exon in nonmuscle cells. We have
further characterized the critical cis-acting elements
involved in alternative splice site selection. Our data
demonstrate that exon 7 and its flanking intron se-
quences are sufficient to regulate the suppression of
exon 7 in nonmuscle cells when flanked by hetero-
logous exons derived from adenovirus. We have also
shown by both in vivo and in vitro assays that the
blockage of exon 7 in nonmuscle cells is primarily at
its 3' splice site.
Role of the Polypyrimidine Tract
Binding Protein in RNA Splicing
G. Mulligan
The I3-TM transcript contains a mutually exclusive
internal cassette, in which exon 7 is spliced into
mRNA in skeletal muscle, whereas in all other tis-
sues, exon 6 is used. Our studies demonstrated that in
nonmuscle cells, exons 6 and 7 do not compete for
splice site recognition, but instead there are cellular
factors that block the use of exon 7. We recently
found that the polypyrimidine tract binding protein
(PTB) specifically interacts with sequences involved
in alternative splicing of f3-TM pre-mRNA. Having
identified that PTB can bind to specific regulatory
regions, we are studying how these interactions con-
tribute to splice site selection. One approach to test
the role of PTB is to determine if depletion or addi-
tion of PTB to nuclear extracts affects the use of the
skeletal muscle exon 7 in He La cell nuclear extracts.
Two methods are being used to deplete nuclear ex-
tracts of PTB: (1) passage of nuclear extract over a
poly(U) affinity column and (2) immunodepletion.
We have prepared both polyclonal and monoclonal
antibodies to PTB. We now have 16 monoclonal
antibodies and have determined that they bind to
epitopes located throughout the length of the protein.
We have used the antibodies to inhibit PTB function
by adding them to in vitro splicing assays of various
pre-mRNAs. Four of the monoclonal antibodies in-
hibited the in vitro splicing of intron 6 in the (3 -TM
intron yet have no effect on the splicing of introns 5
and 7. It is worth noting that the latter two introns
were previously shown not to bind well to PTB in
direct binding assays (Mulligan et al., J. Biol. Chem.
267: 25480 [1992]). In addition, we found that splic-
ing of intron 2 in the a-TM gene (which also contains
a strong PTB-binding site) was also inhibited by
antibodies to PTB, whereas splicing of an intron from
13-globin was not. Collectively, these data suggest
that PTB is required for splicing of certain introns.
Functional analysis of cellular factors involved in
exon 7 blockage had previously been hampered by
the lack of an extract that uses the skeletal muscle
exon to significant levels. We have now developed a
modified procedure for nuclei isolation that allows us
to obtain nuclear extracts from both He La cells and
293 cells which utilize the 3' splice site of exon 7.
This modification alters the distribution of cellular
factors between the nuclear and cytoplasmic frac-
tions. These extracts contain significant levels of
PTB, and addition of more PTB did not reduce exon
7 splicing. Affinity chromatography and immuno-
depletion with PTB antibodies are both being used in
attempts to reduce PTB levels such that possible ef-
fects on exon 7 usage can be observed. We are also
using this extract as the basis for a complementation
assay to detect factors blocking exon 7 usage. Addi-
tion of a HeLa cell nuclear extract that inefficiently
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uses exon 7 indicates the presence of general and
specific inhibitory activities. We have obtained a par-
tially purified fraction that specifically reduces exon
7 usage without inhibiting splicing of control pre-
mRNAs. Work is in progress to purify this specific
inhibitory activity in order to understand both the
mechanism and specificity of exon 7 blockage.
Multiple Cis-elements Can
Contribute to the Use of the
5' and 3 Splice Sites of the
Nonmuscle/Smooth Muscle
Exon 6 in [3 -TM Pre-mRNA
C. Casciato
We previously found that the splicing of exon 5 to
exon 6 in the rat 13-TM gene required that exon 6 first
be joined to the downstream common exon 8 (Genes
Dev. 2: 1627 [1988]). Pre-mRNAs containing exon 5,
intron 5, and exon 6 are not normally spliced in vitro.
We have carried out a mutational analysis to
determine which sequences in the pre-mRNA con-
tribute to the inability of this precursor to be spliced
in vitro. We found that mutations in two regions of
the pre-mRNA led to activation of the ' splice site
of exon 6, without first joining exon 6 to exon 8.
First, introduction of a nine-nucleotide poly(U) tract
upstream of the 3 ' splice site of exon 6 results in the
splicing of exon 5 to exon 6 with as little as 35
nucleotides of exon 6. Second, introduction of a con-
sensus 5 ' splice site in exon 6 led to splicing of exon
5 to exon 6. Thus, three distinct elements can act in-
dependently to activate the use of the 3 ' splice site of
exon 6: (1) the sequences contained within exon 8
when joined to exon 6, (2) a poly(U) tract in intron 5,
and (3) a consensus 5 ' splice site in exon 6. Using
biochemical assays, we have determined that these
sequence elements interact with distinct cellular fac-
tors for 3 ' splice site utilization. Although HeLa cell
nuclear extracts were able to splice all three types of
pre-mRNAs mentioned above, a cytoplasmic S100
fraction supplemented with SR proteins was unable
to splice efficiently exon 5 to exon 6 using precursors
in which exon 6 was joined to exon 8. We also
studied how these elements contribute to alternative
splice site selection using precursors containing the
mutually exclusive, alternatively spliced cassette
composed of exons 5 through 8. Introduction of the
poly(U) tract upstream of exon 6, and changing the
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5' splice site of exon 6 to a consensus sequence, ei-
ther alone or in combination, facilitated the use of
exon 6 in vitro, such that exon 6 was spliced more ef-
ficiently to exon 8. These data show that intron se-
quences upstream of an exon can contribute to the
use of the downstream 5 ' splice and that sequences
surrounding exon 6 can contribute to tissue-specific
alternative splice site selection.
Identification of Cis-acting Elements
and Cellular Factors Required for
the Use of Certain 3' Splice Sites
M. Selvakumar
As described above, our experiments have revealed a
number of features involved in the alternative splic-
ing of 13-TM pre-mRNA, including the fact that the
splicing of exon 5 to exon 6 requires that exon 6 first
be joined to exon 8. These experiments demonstrated
that sequences within exon 8 contain a cis-acting ele-
ment (referred to as exon recognition element or
ERE), which is required for the 3 ' splice site of exon
8. Within exon 8, there are three copies of a purine-
rich motif that has been shown in other systems to
function as a site enhancer for certain 3 ' splice sites.
Interestingly, exon 6 contains two copies of a purine-
rich motif and exon 8 contains three copies. Whether
all these repeats are functionally required for splicing
remains to be determined. For example, we previous-
ly found that pre-mRNAs containing only one repeat
from exon 8 joined to exon 6 were still able to splice
in vitro. We are currently undertaking a systematic
analysis of the different purine-rich motifs to de-
termine which are required for pre-mRNA splicing
using both in vitro and in vivo systems. In addition,
using a biochemical complementation assay, we are
in the process of purifying the factor(s) involved in
pre-mRNA splicing.
Alternative Splicing of
[3-Tropomyosin Pre-mRNA
in a Myogenic Cell System
Y. -C. Wang
Studies in our laboratory on alternative splicing of 13-
TM pre-mRNA have indicated that use of the
skeletal-muscle-specific exon (exon 7) in nonmuscle
cells (such as He La cells) is subject to negative
regulation, due to the presence of an inhibitory ac-
tivity or factor in nonmuscle cells. It remains to be
determined whether skeletal muscle cells lack this
negative activity or express a muscle-specific factor
that overcomes the negative activity, thereby result-
ing in the use of exon 7. To address this question, we
are developing an in vitro splicing system from the
myogenic cell line BC3H1 cells. To test whether the
nuclear extracts made from BC3H1 cells have an ef-
fect on splicing of exon 5 to exon 7 (skeletal-muscle-
type splice), fractions from BC3H1 extracts were
added to nonmuscle cell nuclear extracts (made from
He La or 293 cells) and splicing reactions were
carried out. The results revealed that BC3H1 cells
contain an activity that can stimulate the inclusion of
exon 7 when added to nonmuscle cell extracts. Ex-
periments are under way to determine whether this
activity is due to a general splicing factor or a
muscle-specific factor.
Since it has been reported that alternative RNA
splicing might be achieved by changes in the levels
or activities of general splicing factors, we have
begun to analyze the protein levels of a variety of
factors that are known to have effects on alternative
splicing in other gene systems. Previous studies in
our laboratory have shown a correlation between the
activation of the splicing of exons 5 to 7 in non-
muscle cells and reduced binding of the poly-
pyrimidine tract binding protein (PTB) to an intron
regulatory element immediately upstream of exon 7
(Mulligan et al., J. Biol. Chem. 267: 25480 [1992]).
Studies with other genes have also shown that
changes in the relative amounts of certain splicing
factors may have a role in regulating alternative
splicing of their pre-mRNAs. For example,
antagonistic effects on splice site selection were
demonstrated in vitro between the essential splicing
factor SF2/ASF and hnRNP Al (Mayeda et al. 1993),
as well as interactions between U2 auxiliary factor
(U2AF) and the Drosophila sex-lethal gene product
(Valcarel et al., Nature 362: 171 [1993]). Therefore,
we examined the levels of these factors in BC3H1
cells during differentiation using Western blot
analyses. The levels of PTB, U2AF, SF2, and hnRNP
Al all remained constant throughout the differentia-
tion process. Therefore, changes in the levels of these
factors per se are not likely involved in the regulation
of alternative splicing of exon 7 in the 13-TM pre-
mRNA.
RNA-Protein Interactions Involved
in Alternative Splicing of
13- Tropomyosin Pre-mRNA
J. Horwitz, Y.-C. Wang
We have begun to identify proteins that interact with
the pre-mRNA during spliceosome assembly. One
approach is using biotin-RNA probes to detect pro-
teins that interact with the different segments of the
pre-mRNA. This method has been used to identify
proteins that are associated with pre-spliceosome and
spliceosome complexes, as well as snRNPs associa-
ted with the pre-mRNA. Using both wild-type and
mutant RNAs, we were able to detect a number of
specific interactions with proteins in HeLa cell
nuclear extracts. In agreement with the results de-
scribed above, among the associated proteins, we
detect binding of PTB to sequences within intron 6.
In addition, we detect a number of other polypeptides
ranging in size from 30 to 100 kD. We are currently
studying the interaction of proteins obtained from
myoblasts and myocytes to determine if there are
cell-type-specific factors that interact with distinct
regions in the pre-mRNA. Such factors would be can-
didates for tissue-specific splicing factors.
Role of Brain-specific
Tropomyosin Isoforms
TMBr-1 and TMBr-3
A. Watakabe
The rat a-TM gene expresses at least nine distinct
isoforms, including a unique set of isoforms found in
the rat brain, named TMBr-1, TMBr-2, and TMBr-3,
and are 281, 251, and 245 amino acids in length with
apparent molecular weights on SDS-PAGE of
36,000, 31,000, and 31,000, respectively. Last year,
we reported on the expression of TMBr-1 and TMBr-
3 using an isoform-specific antibody specific for se-
quences contained within exon 9c of TMBr-1 and
TMBr-3 (Stamm et al. 1993). Western blot analysis
reveals that the two isoforms are differentially ex-
pressed in development, with TMBr-3 appearing in
the embryonic brain at 16 days of gestation, followed
by the expression of TMBr-1 at 20 days after birth. In
addition, although TMBr-3 was detected by Western
blot in all brain regions examined (brainstem,
cerebellum, cortex, hippocampus, midbrain, olfactory
123
bulb, striatum, and thalamus), TMBr-1 was detected
predominantly in brain areas that derive from the
telencephalon (cortex, hippocampus, olfactory bulb,
striatum, and thalamus). Immunocytochemical stud-
ies on mixed primary cultures made from rat em-
bryonic midbrain indicate that expression of the
brain-specific epitope is restricted to neurons, and
this was confirmed by the lack of immunoreactivity
when immunocytochemistry was performed on glial
cultures of the same origin.
The functions of TMBr-1 and TMBr-3 in neurons
are not known. What role TMBr-2 has in brain also
remains to be investigated. We have prepared recom-
binant TMBr-1, TMBr-2, and TMBr-3 using Es-
cherichia coli and insect cell expression systems. The
recombinant proteins are being used to study the
biochemical properties of the individual isoforms, in-
cluding the ability to bind to F-actin and interactions
with other proteins. In addition, we are currently
labeling these proteins with various fluorescent com-
pounds or chomophores. The labeled proteins will be
introduced into living cells by microinjection. By so
doing, we will determine whether the different iso-
forms exhibit a differential localization or incorporate
into different microfilament structures associated
with the neuronal cytoskeleton.
Functional Differences among
Tropomyosin Isoforms
M. Pittenger
Although much is known about the function of TMs
from striated muscle, relatively little is known about
the isoforms from nonmuscle cells. This is in large
part due to the difficulty in isolating the individual
isoforms from cells and tissues. By expressing cDNA
clones in bacteria and insect cells, we have been able
to obtain the individual TMs for in vitro and in vivo
studies. During this past year, we have made sig-
nificant progress in understanding the products of the
13-TM gene. In particular, we have found that TM-1 is
a major target for the actions of caldesmon. The latter
protein promotes the binding of TM to F-actin, which
has a key role in stabilizing microfilaments. The ob-
servation that the Cdc2 protein kinase phosphorylates
caldesmon during mitosis suggests a mechanism for
regulating actin filament disassembly during cell
division. In addition, although TM-1 alone was able
to bind to F-actin, the binding of TM-1 was enhanced
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in the presence of TM-2.
These results demonstrate
that different TM isoforms can
act cooperatively to
bind to actin filaments.
Experiments are in progress
to study the cooperative
interactions of the different
isoforms in vitro.
To determine whether the functional
significance
of the multiple fibroblast TM isoforms may be re-
lated to differences in their intracellular localization,
each of the recombinant TMs was fluorescently
labeled and introduced into cultured fibroblasts by
microinjection. Each isoform was labeled in separate
reactions with amine-reactive fluorophores, fluo_
rescein-5-isothiocyanate (FITC) and Lissamine rho-
damine B sulfonyl chloride (LRB). Well-spread cul-
tured rat embryo fibroblasts (REF 52 cells) were mi-
croinjected with the fluorescently labeled TMs. Thus
far, we have found by double-label immunofluores-
cence microscopy that the distribution of the micro-
injected TM-1, TM-2, TM-3, or TM-5b was coinci-
dent with endogenous actin in that areas which con-
tained endogenous actin or TM also contained the in-
jected protein. Because these results showed that the
distribution of each microinjected TM was similar to
the distribution found by antibody localization for
endogenous TM, it appears that the distribution of the
microinjected fluorescently labeled TM accurately
reflects the distribution of endogenous TM in living
cells. Thus far, at the level of fluorescence micros-
copy, we have found that each isoform appeared to
label the same actin filaments uniformly, without a
preference for a particular subset of filaments or
region of the cell. Our studies to date have been
limited to fixed interphase cells. Experiments are in
progress to study the dynamic distribution of the dif-
ferent isoforms in living cells during cell spreading,
mitosis, and cell movement. In related experiments
using polarized epithelial cells, we have found dif-
ferences in the localization of some TM isoforms (see
below).
Partial Reversion of the Transformed
Phenotype by Stable Expression
of Specific Tropomyosin
Isoforms in Transformed Cells
J. Kazzaz, M. Pittenger
One of the classic features of transformed cells in
culture is their morphologic appearance. Transformed
cells often exhibit a rounded morphology with few
identifiable microfilament bundles or stress fibers. A
number of studies have documented a decrease in the
expression of specific tropomyosin (TM) isoforms in
transformed cells, although it remains to be deter-
mined if the suppression of TM synthesis is essential
in the establishment and maintenance of the trans-
formed phenotype. As a model system, we are using
a Kirsten-virus-transformed cell line (ATCC NRK
1569) to investigate the role of TM expression in
transformation. In contrast to normal fibroblasts, the
Kirsten transformants contain reduced levels of TM-1
and undetectable levels of TM-2 and TM-3. These
cells have a rounded morphology and are devoid of
microfilaments. We prepared cDNA expression vec-
tors for TM-2 and TM-3, and stable cell lines were
established from the NRK 1569 cells that constitu-
tively express TM-2 or TM-3. We have found that in-
creased expression of these isoforms led to cell
spreading and flattening and formation of identifiable
microfilaments but did not effect density-independent
or anchorage-independent growth. However, expres-
sion of TM-2 in these transformed cells altered the
serum requirements of these cells. Both the parental
cell line and cells stably expressing TM-3 can grow
in both high serum and low serum, whereas the cells
expressing TM-2 can grow only in high serum. These
data demonstrate that different TM isoforms can have
distinct effects on cell growth and suggest that the
suppression of TM expression in transformed cells
has a role in the transformed phenotype.
Characterization of Microfilament
Proteins in Epithelial Cells
C. Temm-Grove
Among nonmuscle cells, brush-border-type cells
have one of the most structured cytoskeletons. Typi-
cal brush-border-type cells are found lining the in-
testine and the proximal convoluted tubule of the
mammalian kidney. Although epithelial cells and
fibroblasts both exhibit stable arrays of microfila-
ments, epithelial cells also contain two additional
actin-filament structures: an adhesion belt and on
their apical surface microvilli. In collaboration with
Brigitte Jockusch (Bielefeld, Germany), we have
begun to study the components of the epithelial
cytoskeleton in order to understand the basis for these
different cytoskeletal structures. As a model system,
we have been using the porcine renal cell line LLC-
PK1. These cells have been reported to retain many
functional properties characteristic of renal proximal
tubular cells. Using a combination of molecular,
biochemical, and immunological approaches, we
have begun to study the LLC-PK1 cells, as well as
primary intestinal brush border cells and a human cell
line CaCO2(BBE). Our studies demonstrate that LLC-
PK1 cells synthesize villin, fimbrin, ezrin, and a 110-
kD protein (myosin I), all of which are incorporated
into the microvilli, as is characteristic for typical
brush border cells. We also observe not only the
presence of spectrin and myosin in a terminal web-
like structure, but a differential localization of high-
and low-molecular-weight TM isoforms in different
microfilament structures. Collectively, these studies
demonstrate that LLC-PK1 cells, although an im-
mortalized cell line, retain much of the normal brush
border cytoskeletal structure. Work is currently under
way to determine which isoforms of tropomyosin are
located in the adhesion belt, terminal web, and stress
fibers of the brush-border-type epithelial cells. In ad-
dition, preliminary experiments indicate that specific
forms of TM might be expressed in differentiated
epithelial cells whose expression appears to be sensi-
tive to transformation.
Isolation and Characterization
of cDNA Clones Encoding a
Low-molecular-weight
Fibroblast Tropomyosin TM-5
W. Guo
Previous work from our laboratory revealed that rat
contains at least three tropomyosin genes: a, 13, and
the TM-4 gene. The a gene is known to encode at
least nine distinct isoforms, including skeletal muscle
fast-twitch a-TM, smooth muscle a-TM, three
isoforms found in brain (TMBr-1, TMBr-2, and
TMBr-3), and four isoforms found in fibroblasts and
other nonmuscle cells (TM-2, TM-3, TM-5a, and
TM-5b). The 1 gene encodes two isoforms, namely,
skeletal muscle n -TM and fibroblast TM-1. The latter
form is also expressed in smooth muscle where it cor-
responds to smooth muscle 13-TM. The TM-4 gene
encodes a single isoform that corresponds to fibro-
blast TM-4 and is expressed in a variety of cells and
tissues. A fourth TM gene has been reported in a
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number of vertebrates including human, mouse, and
chicken. Utilizing cDNA clones to mouse fibroblast
TM-5 (kindly provided by Peter Gunning), we have
isolated and characterized the rat homolog. The rat
fibroblast TM-5 contains 248 amino acids and is en-
coded by a 1.7-kb mRNA. Interestingly, TM-5 comi-
grates on one- and two-dimensional gels with fibro-
blasts TM-5a and TM-5b. Northern blot and RNA
protection analyses revealed that the gene encoding
fibroblast TM-5 encodes at least three other isoforms,
including a skeletal muscle isoform that corresponds
to the skeletal muscle slow-twitch a isoform. The
full-length cDNA has been used to produce recom-
binant TM-5 to study its actin-binding properties in
vitro. In addition, experiments are under way to fluo-
rescently tag the protein for microinjection studies in
order to determine the localization of TM-5 in living
cells.
Regulation of Neuron-specific
Alternative RNA Splicing
S. Stamm
We are using two approaches to understand the
molecular basis for neuron-specific alternative RNA
splicing: (1) analysis of model pre-mRNAs derived
from the clathrin light-chain B gene to identify cis-
acting elements and cellular factors involved in
alternative splice site selection and (2) computational
analysis of genes that are alternatively spliced in
neurons. Clathrin light chains are components of
clathrin-coated vesicles which are involved in
endocytosis and membrane recycling. The light-chain
B (LCB) gene encodes two isoforms, termed LCB2
and LCB3, via alternative RNA splicing. The neuron-
specific LCB2 isoform is generated by the inclusion
of a single exon, termed EN. We analyzed the cis ele-
ments involved in splice site selection by transfecting
minigene constructs in primary neuronal and He La
cell cultures. Both the 5' and 3 ' splice sites of exon
EN deviate from the vertebrate consensus sequences.
Changing the 5' or 3 ' splice site of exon EN into the
consensus sequence leads to the use of exon EN in
HeLa cells. If both splice sites are converted into the
consensus sequence, exon EN is constitutively used
in HeLa cells. To investigate general mechanisms in-
volved in neuron-specific splicing, we generated in
collaboration with Mike Zhang and Tom Marr
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(CSHL) a database containing all known neuron-
specific alternatively spliced exons (Stamm et al.
1994). Splice site analysis of this database shows that
about 20% of alternatively spliced exons in neurons
have a suboptimal 3 ' splice site similar to that of
exon EN, revealing that an A at the -3 position is an
important feature of these 3 ' splice sites. In addition,
we found that neuron-specific exons can be divided
into two subgroups according to their splice site qual-
ity. One subgroup has relatively suboptimal splice
sites, whereas the second subgroup has the same
quality as constitutively spliced exons. Using se-
quence analysis of this database, we noticed sequence
identity between exon EN and other neuron-specific
exons. We found that exon 9c of the a-TM gene also
contains the same sequence motif as in exon EN of
clathrin light-chain B. We demonstrated that use of
exon 9c is neuron-specific and follows a pattern of
developmental regulation identical to that of exon EN
(Stamm et al. 1993). Changing this sequence element
eliminates the use of exon EN in neurons. RNA gel-
shift experiments detect specific RNA-binding pro-
teins in brain nuclear extracts that bind specifically to
exon EN. To determine if SR-type proteins might
have a role in alternative splicing of exon EN, in col-
laboration with J. Caceras and A. Krainer (CSHL),
we co-transfected the LCB minigene with SF2 in
HeLa cells and observed an increase in EN usage.
This effect suggests that exon EN inclusion is regu-
lated in neurons by factors similar to SF2. We
propose that the use of exon EN is regulated as fol-
lows: exon EN is not spliced in nonneuronal cells be-
cause its 5' and 3 ' splice sites differ from the con-
sensus. In neurons, a protein factor binds to se-
quences within the exon and promotes its use. We
postulate that a developmentally regulated neuron-
specific exon-binding factor is responsible, in part,
for the regulation of a variety neuron-specific exons,
such as clathrin light-chain exon EN and a-TM exon
9c.
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QUEST PROTEIN DATABASE CENTER
J.I. Garrels G.I. Latter
B.R. Franza
S.D. Patterson
B. Futcher
R. Kobayashi
T. Boutell
P.J. Monardo
N. Bizios
N. Sareen
B. Schwender
T. Volpe
The QUEST Protein Database Center moved into
new areas in 1993. The software development effort
reached its goal of producing a version of the QUEST
software for 2D gel analysis and database construc-
tion that is suitable for distribution to other sites. A
course was held in April to introduce the new soft-
ware package to prospective users. While the effort to
support and improve the software system continues, a
new effort to distribute databases via Internet was
begun. The completed rat database has been made
available in graphic form via Internet, and our yeast
database is next to be made available on the Internet.
A new focus on the yeast database was initiated in
1993. With the genome sequencing effort for the
yeast Saccharomyces cerevisiae going on throughout
the world, we have concentrated our efforts on build-
ing a 2D gel yeast protein database. The current
thrust of this effort is protein identifications. With so
much knowledge available from yeast genetics, our
2D gels of normal and mutant yeast strains under var-
ious growth conditions (as reported in prior years)
gain in significance in proportion to the number of
proteins identified. Two CSHL researchers, Dr.
Bruce Futcher and Dr. Ryuji Kobayashi, have joined
the QUEST program for this effort, and as detailed
P. D'Andrea
J. Horwitz
G. Neporanny
S. Bayern
below, we are engaged in three complementary pro-
grams for protein identification.
While Dr. Futcher and Dr. Kobayashi joined ef-
forts with the QUEST center in 1993, two of our col-
leagues, Dr. Scott Patterson and Dr. Robert Franza,
ended their affiliation for other pursuits. Dr. Patterson
moved to California in May to take a new position at
Amgen, and Dr. Franza is in transition to a new
biotechnology venture. Both Scott and Bob were
stimulating influences at QUEST, and both will con-
tinue their interest in protein databases in their new
positions.
A Yeast Protein Database of Known
Protein Properties
J.I. Garrels
A good starting point for a 2D gel database of the
yeast proteins is to gather as much information as
possible from the literature and from the protein se-
quence databases about the known properties of the
yeast proteins. More than 2000 protein sequences
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from yeast are now known. Using the sequence data
to calculate molecular weight, isoelectric point, and
codon bias, we can greatly narrow the number of pos-
sible identifications for each spot on a 2D gel. Other
relevant information from the literature includes
amino- and carboxy-terminal modifications, informa-
tion on protein phosphorylation and glycosylation,
and the identification of precursor peptides for
secretory pathway or mitochondria] proteins. Further-
more, knowing the expected subcellular localization
and regulators of expression of each protein can help
greatly for identification and for understanding of
function.
A yeast protein database, called YPD, has been
compiled that contains one entry for each known
yeast protein. For each protein, the gene name and its
synonyms have been determined, and when multiple
entries are available in the sequence databases, the
sequence most likely to be correct for strain S288C is
used. The YPD database is available as a table
40000
1 000 0
1 000 0
4000
suitable for spreadsheet analysis.
The fields provided
for each protein include calculated molecular weight,
calculated isoelectric point, codon bias, subcellular
localization, molecular environment (association with
membrane, DNA, RNA, cytoskeleton, or soluble),
and functional categories (protein kinases, phospha-
tases, heat shock, proteases, tRNA synthetases, GTp..
binding proteins). Other fields report known amino..
terminal modifications (acetylation or myristylation),
carboxy-terminal modifications (prenylation or addi-
tion of GPI anchors), and the lengths of any precursor
peptides. Finally, the amino acid composition of the
mature protein and a brief description are given. All
of this information has great relevance to the charac-
terization of proteins on 2D gels. The database will
be made available on Internet as part of our yeast
database project.
An image of the entire yeast protein map is shown
in Figure 1. This map represents the expected size
and charge of the mature form of each protein, after
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FIGURE 1 A 'theoretical 2D gel plot' for all known yeast proteins. Each spot is positioned by its calculated molecular
weight and isoelectric point, taking into account removal of precursor peptides and amino- and carboxy-terminal
modifications. The spot size is determined by codon bias.
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FIGURE 2 Major proteins of yeast. Only proteins with codon bias greater than 0.25 are shown for an enlarged region of the gel.
Proteins that are known or tentatively identified on 2D gels are underlined.
compensating for the effects of precursor peptide
cleavage and amino-terminal modification. The
plotted spot size is a function of codon bias, which is
a good predictor of the level of maximal gene expres-
sion. The enlargement in Figure 2 shows a section of
the map with gene names for the major proteins.
Those with known or probable identification on our
2D gel maps are underlined. Each of the identified
spots has been checked for consistency with pre-
viously run 2D gels, which show the location of heat
shock proteins, ribosomal proteins, acetylated
proteins, and proteins coded from spliced genes (see
work in collaboration with C. McLaughlin and J.
Warner reported in prior years).
Protein Identification by
Double-labeled Amino
Acid Analysis
J.I. Garrels, G.I. Latter
To identify proteins that are products of sequenced
genes, one method is to compare amino acid com-
positions. The relative amino acid compositions of
proteins on 2D gels can be obtained by labeling cells
with different 35S and 14C amino acid precursors.
This information, coupled with expected size, charge,
codon bias, and other information provided by the
YPD (see above), can allow many of the spots on 2D
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gels to be identified. We have been employing this
approach, using yeast cells double-labeled with one
35S amino acid and one 14C amino acid.
The relative incorporation of two amino acids can
be determined for each spot on 2D gels by the rate of
isotope decay. We have exposed our gels every 2
weeks for up to 4 months, and the images have been
analyzed by a special version of our image analysis
software. After detailed alignment of the multiple im-
ages, the rate of decay for each pixel of the image can
be calculated, and the average rate of decay for each
spot can be calculated. Spots that contain more of the
14C amino acid will decay slowly, and spots that con-
tain more of the 35S amino acid will decay more
rapidly, approaching the half-life of 35S which is 3
months.
Using the rate of decay for known proteins, we
create a standard curve for each gel. A standard curve
for a gel containing [35S]methionine and [14C]his-
tidine is shown in Figure 3. About 24 known proteins
follow closely on the line, which relates isotopic ratio
to amino acid ratio. We have analyzed gels so far
from about ten different double-labeled amino acid
combinations.
The analysis of the data for several hundred spots
of each gel is carried out on a spreadsheet. For each
spot from a 2D gel, the program selects the proteins
from the YPD within the expected range of molecular
weight, isoelectric point, and codon bias and then
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gives the candidate a score from each gel, based on
the number of standard deviations from the expected
amino acid ratio. When a spot emerges with a score
much better than all the others, it is in most cases the
correct identification. The method has identified
more than 30 spots so far, and more identifications
are coming clear as more data are analyzed. Each
new identification, from any one of our three meth-
ods (protein sequencing, expression from multicopy
plasmids, and amino acid composition), improves the
quality of the standard curves and aids in making fu-
ture identifications. Addition of new protein entries
to the YPD database, as new gene sequences appear
in the sequence databases, also improves the number
of identifications that can be made.
Yeast 2D Gel Protein Database:
Protein Identification
by Overexpression
B. Futcher, T. Volpe
One method for identifying yeast proteins on 2D gels
is to overexpress a known protein from a high-copy-
number plasmid and see which spot on the gel be-
comes darker. This method has been tried with
several dozen proteins. In cases where the codon bias
was less than 0.2 (suggesting a relatively rare pro-
0.00 % 21.50 1.00 1.50
Isotope ratio
FIGURE 3 Identification of proteins from double-labeled 2D gels. A sample of yeast
cells was labeled simultaneously with [35S]methionine and [14C]histidine, and
known proteins from the 2D gel are plotted. A linear relationship exists between the
isotopic ratio, as determined experimentally, and the amino acid ratio, as deter-
mined from the known protein sequences.
tein), the method did not work, presumably because
even the overexpressed protein was too rare to be
seen. However, in all cases so far when the codon
bias was greater than 0.4 (and in some cases between
0.3 and 0.4), an extra-dark spot was seen at about the
expected mobility. In most cases, there were also one
or two extra nearby spots that may represent post-
translationally modified forms. We are now collect-
ing high-copy plasmids so that we can use the meth-
od to identify all of the abundant proteins. Our initial
goal is 200 identifications.
We have also begun to study the phosphorylated
proteins. In vivo labeling with 32P or 33P gives a pat-
tern containing several hundred spots. Many proteins
appeared to have multiple phosphates. Perhaps sur-
prisingly, cell cycle position has very little effect on
the pattern.
Finally, we have done pulse-chase experiments
with [35S]methionine to examine half-lives. Most of
the proteins in the 2D gel are stable, but a few turn
over rapidly.
Identification of S. cerevisiae
Proteins after 2D Gel Electrophoresis
by Protein Sequencing
R. Kobayashi, B.J. Schwender
To construct a protein database of S. cerevisiae on
2D gels, we have been identifying proteins in each
spot by protein sequencing. The 2D gel elec-
trophoresis was performed at the Cold Spring Harbor
Laboratory 2D gel laboratory core facility. Each gel
was loaded with several hundred micrograms of
protein. We applied the technique for internal amino
acid sequence analysis of protein after SDS-PAGE,
which is currently used lab-wide at Cold Spring Har-
bor Laboratory. The method is carried out as follows:
After the gel electrophoresis, proteins are stained by
Coomassie brilliant blue G and the excised protein
bands are transferred to a microfuge tube. The gel is
soaked in 1 ml of 50% methanol twice for 20 minutes
at room temperature to remove SDS. Achromobacter
protease I (lysylendopeptidase) is then added to
digest the protein in the gel. After digestion for 24
hours, the peptide fragments are extracted by 0.1%
TFA in 50% acetonitrile. The digest is then separated
by reverse-phase HPLC using a C18 microbore
column, and the purified peptides are sequenced by
using an automated protein sequencer. This technique
usually allows us to obtain sequence information for
proteins in the amount of 1-2 lig for 50 kD. After ob-
taining sequence information, each sequence is
searched for homology in the protein database
through the computer network. So far, we have ob-
tained good sequencing data to identify nine proteins
and two unknown proteins. The nine proteins and
their gene names are aldolase (FBA1), heat shock
protein 70K (SSB1), tripose-phosphate isomerase
(TPI1), posttranslationally modified form triose-
phosphate isomerase (TPI1), alchohol dehydroge-
nase (ADH1), enolase 1 (ENO1), enolase 2 (ENO2),
pyruvate decarboxylase 1 (PDC1), and inorganic
pyrophosphatase (PPA1). Two other proteins had no
match from the yeast protein sequence database, al-
though one of these has homology with an initiation
factor in B. subtilis. We will continue this work to
identify as many proteins as possible in the 2D gel
map.
QUEST II Software for
2D Gel Analysis
P.J. Monardo, T. Boutell, J.I. Garrels, G.I. Latter
The QUEST II software for analysis and construction
of protein databases has been released and delivered
to several sites. A number of users who attended our
course entitled Two-Dimensional Gel Analysis and
Protein Database Construction now have the software
at their own sites. The architecture has proven espe-
cially successful for a networking environment, and
at the QUEST center, the client-server architecture is
allowing multiple users to interact to build new data-
bases.
This QUEST II software system has many new
features that make the construction and analysis of
databases quicker and easier. The most time-consum-
ing part of database construction in the previous sys-
tem was the detailed editing of the spot data. Most of
this is now done automatically. The combination of
the QUEST II software as a database building tool
and our 2D Gel Network Publishing system as a pub-
lishing tool is proving to be very powerful.
The QUEST II software was chosen as a nominee
for the Computerworld Smithsonian Software Award
in the category of Scientific Achievement for 1993
and was then chosen as a finalist.
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2D Gel Network
Publishing Project
T. Boutell, G.I. Latter
We have completed the first phase of a project to
make 2D gel data available via the Internet using a
system called World Wide Web. The gels are dis-
played over the Internet and allow biologists to point
and click on the identified protein spots to obtain in-
formation about the protein. This information in-
cludes the protein name and other annotations, the
molecular weight, the isoelectric point, and the Swiss
Protein Database Accession number. The links pro-
vided in the database allow direct access to Swiss Prot
and other molecular biology databases simply by
clicking on a spot on a 2D gel image. The annotative
data from the REF52 database is the first database
that we have made available. We are now adding
more annotations for protein sets, such as the nu-
clear, cytoskeletal, mitochondrial, mannose-labeled,
or phosphorylated proteins from the rat database.
A system has been constructed that automatically
accesses the QUEST II databases and prepares data
for publication via World Wide Web if the data have
been marked to be published. Additionally, a hyper-
text tutorial on the QUEST II software and general
information about the QUEST Protein Database Cen-
ter have been made available for Internet users.
2D Gel Laboratory Core
Facility
S.D. Patterson, J.I. Carrels, G.I. Latter, N. Bizios, N. Sareen
The 2D gel laboratory in the Demerec building has
provided 2D gel services for 14 different groups here
at the Laboratory and for 6 outside researchers. Near-
ly all of the 2152 gels run in 1993 were detected
using phosphorimaging, and the images were ar-
chived on tape. The computer storage for 2D gels has
been enhanced, and Jerry Latter has helped to auto-
mate the image handling aspects. A high-quality laser
image of each gel is now routinely printed and sent to
the user. Other services include silver and Coomassie
staining, including the use of a special high-purity
Coomassie stain that has been very successful for
protein sequencing from 2D gels.
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GENETICS
In the last century, Cold Spring Harbor Laboratory began its life as a biological
institute as an adjunct to the local whaling fleet. With the collapse of the whaling
industry, the laboratory was reinvented, and even from these earliest beginnings,
an interest in genetics was apparent. This interest took an unfortunate turn with
short-lived leanings toward eugenics. The best debunking of the pursuit of
eugenics came not from the outcries of moralists but from the unwitting comment
of the playwright George Bernard Shaw. The inveterate bachelor was ap-
proached one day by a most attractive woman who propositioned Shaw with the
following suggestion. "Just imagine what our child would be like with your brains
and my looks." The playwright is reputed to have replied laconically, "but my
dear, what if the unfortunate child were to have your brains and my looks." De-
scribed below are the results of the genetic excursions undertaken at Cold
Spring Harbor during the last year.
EUKARYOTIC CELL CYCLE CONTROL
D. Beach S. Allan
M. Caligiuri
D. Casso
T. Connolly
S. Davey
D. Demetrick
H. Feilotter
K. Galaktionov
I. Garkavtsev
C. Gawel
G. Hannon
J. Hofmann
J. Hudson
N. Kaplan
D. Lombardi
K. Lundgren
S. Matsumoto
T. Matsumoto
B. Nefsky
During the course of the year, Harriet Feilotter left to
take a staff position at Cold Spring Harbor (Hershey
Building) with the Manic Depression Program, and
Igor Garkavtsev took a position at the University of
Calgary. Karen Lundgren became a Staff Scientist at
Glaxo in North Carolina, Yue Xiong accepted a posi-
tion as Assistant Professor at the University of North
Carolina at Chapel Hill, and Nancy Walworth went to
the Netherlands Cancer Center. We were joined by
one new postdoc, Doug Conklin, and a lab tech-
nician, Gretchen Hannon.
Checkpoint Controls
N. Walworth, D. Beach
Cell cycle progression in eukaryotic cells is con-
trolled by the activity of complexes of proteins con-
K. Okamoto
M. Serrano
A. Tesoro
N. Walworth
Y. Xiong
H. Zhang
sisting of a protein kinase catalytic subunit and a
regulatory subunit called a cyclin. In fission yeast, a
complex between p34cdc2 and p56cdct3 regulates the
transition from G2 to mitosis. The p34cdc2 subunit it-
self is regulated through phosphorylation. The kinase
tyrosine residue is maintained by the products of the
weel and mikl genes. Phosphorylation of p34cdc2 on
tyrosine is required to prevent cells from entering
mitosis prematurely. Simultaneous loss of function of
wee] and mikl results in advanced progression into
mitosis and leads to cell death. Mutations in the cdc2
gene itself can compensate for the loss of function of
weel and mikl. These particular alleles of cdc2 are
cold-sensitive and cause G2 arrest at the restrictive
temperature. The proteins encoded by the mutant al-
leles have low kinase activity at any temperature.
A number of genes were isolated that allow the
cold-sensitive alleles of cdc2 to grow at the restric-
tive temperature. One of these genes encodes a novel
protein kinase which has been called chkl. The chkl
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gene product is not required for cell viability during
normal vegetative growth. However, under certain
conditions, the chkl gene product is required for cell
survival. Characterization of the chkl protein kinase
suggests that it is required for the checkpoint in G2
that causes temporary cell cycle arrest when DNA is
damaged; chkl encodes a checkpoint kinase.
Cells that have been exposed to DNA-damaging
agents normally arrest the cell cycle to repair the
damage in order to avoid the accumulation of muta-
tions or errors in the segregation of chromosomes.
Cells lacking chkl function fail to arrest the cell cycle
in G2 when DNA is damaged by irradiation or when
unligated DNA is generated upon inactivation of
DNA ligase. The chkl protein kinase is not required
for the physical repair of damaged DNA nor is it re-
quired to prevent entry into mitosis when DNA
replication is blocked. It is likely that the kinase is in-
volved in arresting the cell cycle in response to sig-
nals generated by damaged DNA. Since chkl was
isolated as a multicopy suppressor of a cdc2 mutant,
it is likely that chkl has the ability to influence the
activity of p34cdc2. Indeed, overexpression of chkl
inhibits cell cycle progression. Identification of the
targets of the chkl protein kinase and of the signals
that activate it will aid in the understanding of the
mechanism of cell cycle arrest in response to DNA-
damaging agents.
pl6INK4: A Specific Inhibitor of the
CDK4/Cyclin D Kinase
M. Serrano, D. Beach
The complexes formed by CDK4 and the D-type
cyclins have been implicated in the control of cell
proliferation during the 01 phase of the cell cycle. In
normal proliferating cells, CDK4 associates with D-
type cyclins and with a protein with a molecular mass
of 16 kD, p16INK4 (inhibitor of CDK4). In human
cells transformed with viral oncoproteins that in-
activate the Rb tumor suppressor protein, p16INK4 is
overexpressed, being the main, if not exclusive, part-
ner of CDK4. We have isolated a human cDNA clone
encoding p16INK4 by using the two-hybrid screening
system in yeast with CDK4 as the target protein.
p16INK4 specifically associates with CDK4 in vitro
and in vivo but not with other CDKs. We have
reconstituted active CDK4-cyclin D kinases in insect
cells and have found that p16INK4 specifically in-
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hibits the kinase activity
of CDK4. In normal cells,
the balance between
p16INK4 and D-type cyclins
could determine the level of
CDK4 kinase activity.
Inactivation of Rb during
the mid-G1 phase is
thought to be fulfilled by CDK4 associated with D-
type cyclins. In transformed
cells expressing viral on-
coproteins, such as T antigen, El A, or E7, Rb is con..
stitutively inactivated and the
GI/S control is, at least,
partially disrupted. We think that the disruption of the
Gi/S control is sensed by a signaling pathway that
up-regulates the expression of pl6INK4, resulting in
the inhibition of CDK4 activity; however, this nega-
tive loop would be unable to restore the Rb-depen-
dent Gi/S control because Rb function in these cells
is constitutively abrogated.
Target Genes of the Cell-cycle-regulated
Transcription Factor cdc10
J.F.X. Hofmann, D. Beach
The fission yeast cdc10 gene product is required for
cell cycle progression at the GI/S boundary. Recent-
ly, we isolated two novel target genes of the cdc10
transcription factor, cdtl and cdt2. Gene disruption
experiments have shown that cdtl is an essential gene
whose function is required for the entry into S phase.
Surprisingly, although cdtl null mutants do not
synthesize DNA, they enter an abnormal mitosis.
cdtl is therefore required for the normal dependency
of mitosis on the previous S phase.
Mutations in two other cell cycle genes, cdc18
and cut5, express essentially identical phenotypes
like cdt1. We have thus examined the possibility of
genetic interaction between these genes. Indeed,
elevated gene dosage of either cdtl or cdc18 can sup-
press the lethal phenotypes of cut5 mutations. This
and other observations suggest that cdtl, cdc18, and
cut5, in addition to their requirement for DNA
synthesis, act in an essential checkpoint control path-
way to inhibit the premature entry into mitosis. We
also conclude that the activation of mitotic pathways
is intrinsically completely independent from S phase.
The cell-cycle-regulated expression of both
cdc18 and cdtl, which is dependent on cdc10, ap-
pears to be essential for cell cycle progression under
certain conditions. Ectopic expression of both cdtl
and cdc18 is lethal under conditions where the entry
into S phase is rate-limiting for cell cycle progres-
sion. This suggests that the expression of cdtl and
cdc18 must be properly controlled within the cell
cycle.
The other novel target gene of cdc10, the cdt2
gene, also is an essential gene. The construction of a
null allele has shown that cdt2 is surprisingly not re-
quired until the latest landmark event in the cell
cycle, namely cytokinesis. Mutant cells arrest as
binucleate septated cells with each nucleus contain-
ing a IN complement of DNA. Eventually, these
nuclei continue to replicate DNA followed by a nor-
mal mitosis and cell septation. However, cytokinesis
does not occur, which results in the formation of
elongated multinucleate cells. These observations
suggest that Start is coupled with cytokinesis in a
pathway that involves the function of the cdt2 gene.
The GTPase Signaling Cascade
Prevents Premature Mitosis
T. Matsumoto, D. Beach
A checkpoint functions during each cell cycle to
ensure that DNA synthesis is complete before mitosis
is initiated. In fission yeast, loss of piml +, a homolog
of RCC1, disrupts this checkpoint, resulting in
premature entry into mitosis. Mutation in RCC1 in
hamster BHK cells results in similar phenotype, sug-
gesting functional as well as structural conservation
of this gene between species.
spil+, a multicopy suppressor of piml, encodes a
ras-like GTPase, which binds to piml+. The
piml/spil complex dissociates in the presence of
GTP and Mg++, suggesting that pim 1 acts as a
guanine nucleotide exchanger on spil GTPase.
On the basis of the assumption that piml+ ac-
tivates spil GTPase, we hypothesize that piml+
senses the chromatin state during the cell cycle and
changes its activity as a guanine nucleotide ex-
changer. The activity might be higher during G1 and
S phases to prevent cells from entering into mitosis
prematurely. As a collaboration with Dr. Bruce
Stillman's laboratory, we have demonstrated that
bacterially expressed piml can bind in-vitro-
assembled chromatin. We are currently examining
whether the activity of piml+ is altered when bound
to chromatin.
We are also studying two additional genes that
may have a role at the piml /spil checkpoint. Muta-
tions in espl+, which encodes a protein phosphatase,
can suppress the piml mutation. Another mutant,
pim2, shows a phenotype similar to that of piml, and
the double mutant piml pim2 is a synthetic lethal,
suggesting a close relationship between the two gene
products. pim2+ could possibly encode a factor acting
downstream from piml+ or spil+, such as an effector
of the GTPase.
Reconstitution and Characterization
of p21/PCNA/Cyclin/CDK
Quaternary Kinase Complexes
H. Zhang, D. Beach
The mammalian cell cycle is controlled by multiple
cdc2-like kinases. Differences exist between normal
and transformed cells in their ability to respond to
various growth conditions and external stimuli during
the cell cycle. We have established that these dif-
ferences appear to be reflected in the changes in the
basic composition of the cell cycle kinases. In normal
cells, the majority of various cell cycle kinases exist
in the form of quaternary complexes of cyclin/CDK
associated with two universal components, PCNA
and p21. In many transformed cells, the majority of
the kinases are in the form of cyclin/CDK binary
complexes which sometimes associate with other
proteins. In the past year, we have focused on the iso-
lation and characterization of these proteins. We have
cloned the gene for p21 through its association with
cyclin Dl. Using a baculovirus expression system,
we have reconstituted the cyclin/CDK/PCNA/p21
quaternary complexes in vitro. Biochemical analysis
indicated that p21 is a universal inhibitor of cell cycle
kinases that exerts its effect by association with the
kinases. p21 is also capable of forming an indepen-
dent complex with PCNA. No effect of PCNA on the
kinases has been observed. However, since in normal
cells, the majority of cell cycle kinases are in the
form of cyclin/CDK/p21/PCNA quaternary com-
plexes, how do these cells divide at normal rate,
whereas most kinases are in inactive form? Our study
suggested that p21-containing kinases can exist in
both active and inactive states. The single p21-
containing kinases are catalytically active. The bind-
ing of multiple p21 is required for the inhibition of
the kinases. The p21 inhibition of the kinases appears
to be cooperative. These results suggest that in vivo,
the p21-containing kinases can transit between active
and inactive forms, depending on the level of p21
protein.
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In viral oncogene-transformed cells such as
He La
or 293 cells, p21 and PCNA disappear from the
cyclin A/CDK2 kinase. Instead, another protein, p19,
associates with cyclin A/CDK2 kinase. p19 has been
isolated through its association with cyclin A and its
gene has been cloned. The cloned p19 shows no
homology with p21 and thus is a new type of protein
that interacts with the cyclin/CDK kinase. The char-
acterization of p19 is in progress.
p21, a Potential Effector of the
p53 Cell Cycle Checkpoint
G. Hannon, H. Zhang, D. Casso, R. Kobayashi, D. Beach
A wide variety of genetic alterations can contribute to
neoplastic transformation. However, one feature
common to most transformed cells is their ability to
execute the cell division cycle under conditions that
would prevent or slow the proliferation of normal
cells. This suggested that one of the ultimate effects
of alterations in oncogenes or tumor suppressors must
lie in at least a partial derangement of cell cycle con-
trol.
The pathways that oversee cell cycle progression
have been termed "checkpoints." It has recently be-
come clear that the tumor suppressor protein, p53,
functions in a cellular checkpoint that responds to
damaged DNA. Upon DNA damage (e.g., by ionizing
radiation), p53 levels increase, and the cell cycle ar-
rests, allowing the damage to be repaired. p53 is a
transcriptional activator, and this property is critical
to its function both as a checkpoint protein and as a
tumor suppressor. We have recently demonstrated
that one of the targets of the p53 transcription factor
is the 21-kD subunit of cyclin kinase complexes
(p21).
The passage of a mammalian cell through the cell
cycle is controlled by a family of related protein
kinases known as the cyclin-dependent kinases or
CDKs. The activation of specific members of this
family is required for the execution of each cell cycle
phase. CDKs are regulated posttranslationally by
phosphorylation and by complex formation with
regulatory subunits. In particular, CDKs require the
association of a positive regulatory subunit known as
a cyclin for activity. Studies from a number of
laboratories suggested that the binary complex of a
cyclin and a CDK formed the core enzyme that con-
trols cell cycle progression. This view persisted until
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these enzymes were examined in normal fibroblasts,
rather than in the many oncogenically transformed
cell types that had been previously investigated
(Xiong et al. 1993).
In normal fibroblasts, the major population of
cyclin kinases exists in quaternary complexes con-
sisting of cyclin, CDK, PCNA, and a protein of 21
kD. In vitro, reconstitution using cyclin kinase ex-
pressed in baculovirus-infected insect cells revealed
that p21 is a universal inhibitor of cyclin kinases,
though the affinity of p21 varied for each cyclin/
CDK pair.
Previous analysis of cyclin kinase complexes in a
large number of cell lines indicated that the presence
of p21 correlated with the presence of functional p53.
For example, p21 was absent from cells expressing
p53-inactivating viral oncoproteins (e.g., Hpv_16
E6) or from cells containing inactive, mutant p53
(e.g., Li-Fraumeni fibroblasts). These observations
prompted us to test the possibility that p21 might be a
target for the p53 transcription factor. Both p21
mRNA and p21 protein are rapidly induced upon ac-
tivation of the p53 checkpoint pathway. p21 message
levels increase approximately 10-fold upon irradia-
tion of ML-1 cells which contain wild-type p53. Fur-
thermore, primary fibroblasts derived from p53
"knockout" mice (kindly supplied by Tyler Jack,
Massachusetts Institute of Technology) contain ap-
proximately 50-fold reduced levels of p21 as com-
pared to fibroblasts from their wild-type siblings.
Finally, genomic sequences upstream of the human
p21 gene contain sites capable of binding to p53.
Considered together, our observations suggest
that p53 imposes cell cycle arrest through its regula-
tion of the cyclin kinase inhibitor, p21. Thus, our
results form one of the few concrete links between
the basic machinery of cell cycle control and a
genetically identified tumor suppressor protein.
Role of sctl in the Regulation
of Start in the Fission
Yeast Cell Cycle
M. Caligiuri, D. Beach
In the fission yeast Schizosaccharomyces pombe, pas-
sage through Start and subsequent commitment to the
mitotic cell cycle requires the function of the Cdc2
protein kinase (p34cdc2) and the Sctl and CdclO tran-
scription factors (p72sct1 and p85cdclo, respectively).
Strains defective in any one of these genes will con-
jugate from the point of arrest. The Sctl protein is
unique, however, in that it functions in a dual capac-
ity to negotiate passage through the G1 /S -phase
transition. Cells that carry the sctl null allele arrest in
G1 as highly elongated cells that are capable of
mating under conditions normally inhibitory to this
process. This suggests that p72sctl functions as a pos-
itive regulator of the mitotic cell cycle and as a nega-
tive regulator of the cells' alternate developmental
fate leading to sexual differentiation.
p72sct1 and pascdcio share amino acid sequence
similarity with the budding yeast Swi4 and Swi6
transcription factors. The p72set1 and p85cdci
proteins associate to form a complex that is involved
in the regulation of the cdc18, cdc22, and cdtl genes
whose transcripts are periodically expressed, peaking
in late G1 /early S phase. Genetic evidence suggests
that p72scr1 and p85cdcl 0 do not, however, perform
equivalent functions and that perhaps p72sct1 is re-
quired for an additional essential function(s). We
have initiated a genetic analysis of the sctl gene in
order to elucidate these activities and to identify addi-
tional proteins which interact with and perhaps regu-
late sctl. The basis of this genetic screen exploits the
observation that overexpression of the wild-type sctl
gene can rescue mutants carrying temperature-sensi-
tive alleles of cdc10 (cdclOts-). We therefore envi-
sioned that conditional alleles of sctl could be ob-
tained by transforming a cdclOts- strain with a li-
brary of mutagenized sctl plasmids and screening
these transformants for temperature-sensitive growth.
Plasmids from strains incapable of growth at the
restrictive temperature were recovered and trans-
formed into a strain heterozygous for the sctl disrup-
tion to identify those capable of supplying sctl func-
tion under permissive conditions by complementation
of the sctl disruption. With this screen, we have ob-
tained a collection of sctl mutants that display a vari-
ety of cell cycle defects. Most interesting are two
classes represented by mutants that display a classic
cell-cycle-arrest phenotype, some of which mimic the
null phenotype (i.e., cell cycle arrest and de-
repression of the mating pathway), and those that dis-
play defects in the meiotic pathway. Members of this
later group initiate the mating pathway and undergo
conjugation but apparently fail to execute functions
required to activate the meiotic pathway. These
strains will be used in a classic suppressor analysis,
as well as in a screen to identify downstream targets
of the p72sctl transcription factor by seeking cDNAs
capable of rescuing the sctl mutant when expressed
ectopically under a heterologous promoter.
Interaction between the RAN1
Protein Kinase and PUC1 in
the Fission Yeast Cell Cycle
T. Connolly, D. Beach
The mechanism by which S. pombe cells recognize
nutritional conditions and respond either by arresting
in G1 at Start to initiate mating and subsequent
meiotic functions or by maintaining the haploid
mitotic cycle is not well understood. We have cloned
a CLN-type cyclin in fission yeast, pucl, by its
ability to complement the loss of the CLN-type
cyclins in Saccharomyces cerevisiae. We have shown
that p4Opuc1 associates with p34cdc2 to activate its
histone Hl kinase activity and defines a G1 form of
the p34cdc2 protein kinase in fission yeast. We have
begun to investigate the function of the p4OPuc1
protein complex in the cell cycle by attempting to
identify proteins that associate with the p40Puc1/
p34cdc2 protein complex.
We have identified the p52ranl protein kinase as a
substrate of the p4OPuc1 /p34cdc2 protein kinase. The
transition from the vegetative cell cycle to meiosis
and sporulation in the G1 phase of the cell cycle is
controlled in part by the rant + gene product. The
rani gene encodes a 52-kD protein kinase that is es-
sential for the vegetative cell cycle and functions as a
negative regulator of sexual conjugation and meiosis.
Immunoprecipitation and Western blot analysis have
revealed that p52ranl and p4OPue1 are associated in
vivo. A 52-kD protein that comigrates with autophos-
phorylated p52ran1 is coimmunoprecipitated with
p40Puc1 and becomes phosphorylated in in vitro
p4opuc i/p34cdc2 kinase reactions. We have deter-
mined that the phosphorylated product identified in
the p40Puc1 immunoprecipitates is in fact p52ranl by
partial protease mapping of this 52-kD phosphory-
lated product against autophosphorylated p52ran1. In
addition, the overproduction of pucl rescues a
temperature-sensitive rani mutant. These observa-
tions support a model in which these two proteins in-
teract to promote G1 /S -phase progression. The
biochemical consequences of the interaction between
the p52ranl and p4OPuc1 proteins are under current in-
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vestigation. Specifically, we are interested
in
determining if the phosphorylation of p52ranl by
p4 opuc /1)34 cd c2 affects its catalytic activity. To date,
no substrates of the p52ranl kinase have been identi-
fied; however, we have detected an allele-specific in-
teraction between the p72sctl transcription factor and
p52ranl. This suggests that p72scil may be a substrate
of the p52ranl kinase, a possibility that is under cur-
rent investigation.
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Last year, we reported on the development of an
enhancer-trap/gene-trap mutagenesis system, using
maize transposons in Arabidopsis. This approach to
insertional mutagenesis, which has been used with
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spectacular success in Drosophila, allows the identi-
fication and cloning of genes by their expression pat-
terns. It is particularly advantageous in identifying
genes whose mutant phenotypes can mask an essen-
tial function or are unrevealing, e.g., genes with mul-
tiple essential functions (early as well as late) or
genes that are partially or completely redundant. We
have utilized the Ac-Ds transposon system discovered
by McClintock, engineered for our purpose as fol-
lows. The Ds elements carry a GUS reporter gene
with either a minimal promoter (enhancer-trap) or a
multiple splice acceptor sequence (gene-trap) fused
to the 5' end of the gene. Expression of the reporter
gene depends on the element inserting within or close
to a chromosomal gene. The gene-trap element (DsG)
must insert within the transcribed region of a gene in
the correct orientation in order to get GUS expres-
sion, whereas insertions of the enhancer-trap element
(DsE) in either orientation, or into the nontranscribed
region, can also result in GUS expression. Enhancer-
trap insertions are more likely to result in reporter
gene expression, but gene-trap insertions that gener-
ate expression patterns are more likely to result in
mutant phenotypes. Furthermore, cDNA cloning of
the gene by RACE-polymerase chain reaction (PCR)
is feasible for gene-trap insertions (as described in
the following section; Springer et al.), and gene trap
insertions can result in translational fusions that pro-
vide information about the intracellular localization
of the gene product. Details of the construction of
these elements are given in the 1991 and 1992 An-
nual Reports.
A major limitation with the Ac /Ds transposon sys-
tem is the preferential transposition of the elements to
closely linked sites. To overcome this limitation, we
have designed a novel selection scheme that selects
against closely linked transpositions. This selection
scheme has been described in detail in the 1992 An-
nual Report and is summarized briefly here. The
donor Ds element is linked to the IAAH (indole
acetic acid hydrolase) gene which confers sensitivity
to the auxin analog NAM (naphthalene acetamide).
The Ds element also carries an NPTII gene that con-
fers kanamycin resistance. The Ac element that we
use is a fusion of the 35S promoter to the Ac
transposase gene; this element cannot transpose since
one end has been deleted. The Ac element is linked to
both an NPTII gene and an IAAH gene. The Ds ele-
ment is mobilized by crosses of Ds homozygous
plants to Ac homozygous plants. The transpositions
occur in the F1 plants, and the progeny of these plants
are selected for resistance to both kanamycin and
NAM. Therefore, we select against the donor site of
the Ds element, as well as against the Ac element,
and transposed Ds elements that are not linked to the
donor site will be preferentially recovered. Last year,
we described results showing that the selection
scheme could be successfully implemented and that
plants containing new independent transposed Ds ele-
ments (transposants) can be generated using this
scheme. By crossing transposants back to plants that
carry the donor Ds, it is possible to estimate their
linkage to the donor site. In three cases examined so
far, we find that two of the transposed Ds elements
are unlinked to the donor site and the third showed
loose linkage (about 25 cM). A more detailed analy-
sis of the linkage of the transposed Ds elements is un-
der way, but these preliminary data are further evi-
dence that the selection scheme is working as
planned. We have initiated large-scale mutagenesis of
Arabidopsis by crossing Ac lines to the DsG and DsE
lines. From about 100 crosses, approximately 7500
F1 progeny have been generated, of which about 3000
have been selfed. The selection for transposed Ds ele-
ments has been carried out on 1282 of these F2
families, and 496 independent transpositions have
been recovered. Therefore, approximately 39% of the
F1 progeny from the crosses of Ac to Ds give rise to
transpositions that are selected for in our scheme (i.e.,
transpositions that are unlinked or loosely linked to
the donor site). This encouragingly high frequency
suggests that generation of large numbers of indepen-
dent transposition events is feasible starting with a
relatively small number of crosses. Currently, we are
scaling up our efforts with the aim of generating 4000
transposon insertions in the coming year.
The plants carrying transposon insertions (trans-
posants) are maintained as individual lines by selfing.
These lines will then be screened for patterns of
reporter gene expression and for mutant phenotypes
due to the insertion. In a preliminary screen, 151 of
the gene-trap insertion lines and 23 of the enhancer-
trap insertion lines were examined for GUS expres-
sion in seedlings, leaves, and flowers. About 18% of
the gene-trap insertions and 40% of the enhancer-trap
insertions were found to result in GUS expression in
this screen. The lower frequency observed with gene-
trap insertions is expected from the requirement that
the gene-trap DsG element must insert within the
transcribed region of a gene and in the correct
orientation in order to get GUS expression, whereas
insertions of the enhancer-trap DsE element outside
the transcribed region and in either orientation can
result in GUS expression. Many different GUS ex-
pression patterns were observed in transposant lines
using both DsG and DsE. The seedling patterns in-
cluded expression restricted to the cotyledons, ex-
pression in the shoot and root meristematic zones,
and expression in the hypocotyl (see below). The leaf
patterns included expression in leaf primordia and ex-
pression restricted to the vasculature and hydathodes.
The floral patterns included expression in the whole
flower, expression restricted to the outer two whorls
of the flower, expression restricted to the filaments of
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the stamens, expression only in the anthers,
expres-
sion in the carpels and the vasculature of the
sepals,
expression only in the carpels, and expression
restricted to the zone of fusion of the carpels. The
number of diverse patterns observed is extremely
en-
couraging and suggests that many different genes can
be identified even in the relatively small number of
lines examined. In addition, a preliminary screen for
new mutations was carried out using about 100 inser-
tion lines, and two visible mutations were identified.
One of these mutations affects the vasculature of the
hypocotyl in the seedlings, and specific GUS staining
of the hypocotyl is observed in this line, consistent
with the mutant phenotype. This mutation is currently
being characterized further. The other mutation was
identified as a gametophyte lethal and is discussed in
detail below (Springer et al.).
Analysis of indeterminate
Gene Function in Maize
J. Colasanti, V. Sundaresan
A maize plant is normally programmed to make a
particular number of vegetative structures (e.g.,
leaves), followed by the reproductive structures
(flowers), and eventual senescence of the plant.
Plants that are homozygous for the indeterminate (id)
mutation are defective in the execution of this pro-
gram and exhibit several developmental phenotypes:
(1) The vegetative to reproductive transition is altered
such that the vegetative phase is prolonged, resulting
in plants with an extensive (or indeterminate) life
span; i.e., they flower much later than normal plants,
or not at all. (2) The vegetative phase expands into
the reproductive phase of development and causes
abnormal flower development; i.e., the female flower
(ear) exhibits vegetative characteristics and is usually
sterile, and the male flower (tassel) often undergoes a
complete developmental reversion such that new
vegetative shoots emerge from tissues that begin to
develop as floral tissue. In the latter case, terminally
differentiated cells that comprise floral tissue redif-
ferentiate into vegetative tissue and resume prolifera-
tive growth. These phenotypes suggest that the func-
tion of the normal Id gene is to suppress vegetative
growth and signal the beginning of reproductive
growth at a specific time during the life cycle of the
plant. Loss of Id function results in the failure to
140
demarcate this transition and causes prolonged
tative development.
In an attempt to understand better the vegetative
to reproductive transition in plants, we are using
transposon tagging to isolate this gene from maize,
The Id gene maps near the kernel pigmentation gene
Bz2, on chromosome 1. A mutable allele of the Bz2
gene, bz2-m2, results from the insertion of a Ds2
transposon at this locus. (Ds2 is a defective derivative
of the Ac-Ds family of transposable elements and is
able to transpose only in the presence of an Ac ele-
ment which provides transposase.) Taking advantage
of the proximity of Id to bz2-m2, and the fact that
Ac/Ds elements often transpose to linked sites, We
selected for id mutants from germinal revertants in
the bz2-m2 population; i.e., by selecting for com.
pletely purple kernels that resulted from germinal ex-
cision of the Ds2 element (i.e., bz2-m2 to Bz2), an F1
population with the Ds2 excised and inserted else-
where was generated. From an F2 population of these
revertants, one id mutant was isolated from 600
families examined and designated id *. Crosses of id*
to known alleles of id confirmed that it is allelic to
the id mutation of chromosome 1.
Through several generations of out-crosses and
back-crosses, the id* allele was introduced into genet-
ic backgrounds with or without active Ac elements,
Preliminary data suggest that id* plants with active
Ac elements have a less severe phenotype than those
with no Ac; i.e., they exhibit fewer vegetative nodes
and have near normal flower development. This
result is expected if the Ac element mediates somatic
excision of the Ds2 element from the id* gene during
growth. Excision would restore Id function and result
in partial restoration of normal development. Further-
more, the observation that these plants do not show
patterns of defined sectoring (i.e., a sharp demarca-
tion of normal tissue juxtaposed next to mutant tis-
sue) suggests that Id is non-cell-autonomous. This
result implies that the Id gene product is a diffusible
factor or that it is involved in the regulation of a dif-
fusible factor.
Southern blot analysis using the Ds2 element as a
probe shows that a 4.5-kb Sad fragment cosegre-
gates with the id* allele in more than 50 outcross
progeny tested so far. This fragment is absent in
plants that do not carry the id* allele. The cosegrega-
tion of this fragment with the id* allele is evidence
that this gene is tagged with the Ds2 transposable ele-
ment. In future work, the Ds2-containing fragment
cosegregating with the mutation will be cloned in or-
der to isolate the sequence flanking the Ds2 element.
Confirmation of the identity of this flanking sequence
as part of the Id gene will be possible through the
comparison of this region in normal plants with that
of plants in which the Ds2 element has excised and
restored the phenotype to normal (germinal rever-
sion). Isolation of the Id gene from maize will allow
us to characterize an important developmental func-
tion that mediates the transition from vegetative to
reproductive growth in plants.
Cell Division in Plants:
Higher Plants Have Three
Structurally Distinct Groups
of Mitotic Cyclins
J.-P. Renaudin, J. Colasanti, Z. Yuan, V. Sundaresan
[in collaboration with H. Rime, Universite P. et M. Curie,
Paris, France]
There are many significant differences between
plants and animals in the control of cell division dur-
ing development. These include the reversibility of
the terminally differentiated state, control by
phytohormones, regulation of the planes of cell divi-
sion, and persistence of meristematic lineages
through development. Although there has been con-
siderable focus on the molecular biology of cell divi-
sion control in animals and yeasts, comparatively
little is known at the molecular level about the ma-
chinery that regulates cell division in plants. For ex-
ample, it is not known how the plane of cell division
is controlled during division of plant cells. This con-
trol is very precise in plant development, since plant
cells cannot migrate and are fixed in their relative
positions following division. Previously, we have
cloned a gene for p34cdc2 from maize, generated
antibodies specific to the protein, and studied its in-
tracellular localization. We have shown that it is
nuclear in interphase and associates with the division
site prior to mitosis, suggesting that it is involved in
establishment of the division site. In particular, we
found that the p34cdc2 kinase is targeted to the divi-
sion site by the preprophase band of microtubules,
and we proposed that it modifies sites on the cortex
by phosphorylation that subsequently attract the ex-
panding cell plate at telophase.
In animal cells, the distribution of p34cdc2 kinase
and its substrate specificity depends on the associated
cyclin and is markedly different for cyclins A and B.
To study the mechanism by which the plant p34cdc2
kinase may be targeted to the division site and to
identify the cortical substrates of this kinase, we have
conducted an exhaustive search for homologs of
mitotic cyclins in maize. We used degenerate primers
to conserved regions of mitotic cyclins A and B (pro-
vided by I. Fitch and B. Futcher, CSHL) to amplify
cDNA from maize meristems. The PCR products
were cloned, and 21 clones were sequenced from two
maize inbreds. The sequences were found to belong
to four distinct types, representative of four different
cyclins, all related to the A and B cyclins. One PCR
product of each type was used to probe a maize im-
mature ear library (B. Veit and S. Hake, USDA), and
several cDNA clones corresponding to each type
were isolated and sequenced. The longest clones
from each type were called IaZm, IbZm, IIZm, and
IIIZm (Zm = Zea mays). The designations are based
on their relationships to each other as well as to other
plant mitotic cyclins as discussed below. All four
cyclins were shown to be functional for driving the
G2/M transition, since they could induce oocyte
maturation, following microinjection of the cor-
responding RNAs into immature oocytes. The ex-
pression pattern of the cyclins was analyzed by
Northern blots. All four cyclins showed a similar pat-
tern of expression, with the mRNA levels correlated
to cell division activity of the tissue. The expression
of the maize cyclins appears to be more tightly asso-
ciated to mitotic activity than expression of the cdc2
gene. For example, there is cdc2 expression, but no
detectable cyclin expression, in fully differentiated,
nondividing plant tissue. Since fully differentiated
cells in many plant species can be induced to divide
(and in some cases to regenerate new plants), our
results suggest that the control of proliferation in ful-
ly differentiated plant cells is in part effected by turn-
ing off transcription of cyclins while maintaining a
basal level of cdc2 transcription.
The sequences of the four maize cyclins showed
that they were clearly related to those of the A and B
cyclins but that none of the maize cyclins can be clas-
sified as either A or B cyclins, based on sequence
homologies or consensus motifs. While this work
was in progress, five additional mitotic cyclin genes
have been cloned from other plant species; one each
from soybean, Arabidopsis, and carrot, and two
closely related cyclins from alfalfa (Hata et al.,
EMBO J. 10: 2681 [1991]; Hemerly et al., Proc.
Natl. Acad. Sci. 89: 3295 [1992]; Hirt et al., Plant
Cell 4: 1531 [1992]). These plant cyclins also could
not be assigned as either A- or B-type cyclins. The
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partial homologies of the plant cyclins
with both A-
and B-type consensus motifs suggest the separate
evolution of the plant cyclin group. For this reason,
we propose, instead of the A and B designations,
to
use the Roman numeral system to
describe the dif-
ferent structural groups of plant cyclins
that we have
been able to define using data from these
studies. The
nine plant cyclins for which sequence data are avail-
able fall into three groups: I, II, and III.
Since at least
one cyclin from each group can be found in maize,
it
is likely that all higher plants have these three types
of mitotic cyclins. Although the amino-terminal do-
mains of the cyclins are highly variant, consensus
motifs typical to the groups of plant cyclins, and ab-
sent in animal and yeast cyclins, can be identified in
this region, as shown in Figure 1. Maize has two re-
lated homologs of group I cyclins, which we have
called cyclin IaZm and cyclin IbZm. They are most
homologous to the cyclins from soybean and
Arabidopsis. Group I cyclins have a conserved motif
KKXXXTLSSVLSARSKAAC located upstream of
the cyclin box (Fig. 1). They also share with group III
cyclins a motif HRPITRSF located close to the cyclin
destruction box (Fig. 1). Group II of plant cyclins en-
compasses cyclin IIZm in maize and the carrot
cyclin, which share some short motifs in the amino-
terminal region (Fig. 1), and have an overall high de-
gree of homology with each other (not shown).
Group III of plant cyclins includes the maize cyclin
IIIZm and the alfalfa cyclins. In addition to the
HRPITRSF motif that they share with group I
Ms 1
IIIZm
IaZm
IbZm
lAt
S13-6
IIZm
C13-1
Ms 1
Ms 2
IIIZm
IaZm
IbZm
1 At
S13-6
cyclins, the three cyclins of group Ili have a con-
served EMEDI motif in the amino-terminal region
(Fig. 1).
To summarize, mitotic cyclins in higher plants do
not belong to either A or B types, but we have shown
that they form three distinct structural groups that
have been conserved in both monocotyledonous and
dicotyledonous species. Cyclins from all three groups
are present in maize and probably in all other plant
species as well, suggesting that they specify different
essential functions. We are currently generating anti-
bodies to the three types of cyclins in order to study
their intracellular locations in dividing plant cells and
to determine which cyclin is involved in the localiza-
tion of p34cdc2 with the division site. Future work
will be aimed toward characterizing cyclin-associated
proteins in order to identify factors that are required
for division site localization, as well as identification
of cortical substrates that are phosphorylated during
the establishment of the division site.
Gene Trap Tagging of a
Semisterile Mutation
in Arabidopsis
P. Springer, V. Sundaresan, R. Martienssen
[in collaboration with R. McCombie, Cold
Spring Harbor Laboratory]
During preliminary screening of enhancer- and gene-
trap transposant lines, one insertion line containing a
MKESEEKNVSNNPTNFEGGLDSRKVGENRRALGVINQNLVVEGRPYPCVVNKRALSERNDVCEKKQADPVHRP I TRRFAAK I ---
MENLRSQNCHQGVAMEGVKFAPEKANTNRRALSD/RNI IGGP HQHLAVSKRALSEKPAAAAAANAKDQAGFVGHRP VT RKFAAT L
PMNRRAPLGDIGNLVSVRPAEGSLSCRSRSIAPITRSFGAQLVKNVQANAAIKNAAILP---
MATRNHRAAAAPQPANRGAARVAGKQKAAAAGTRRALGDIGNVVSDALD RA IKLP EG I HRP I TRSFGAQ LMKAALANKNADAAVAP AQPV
MMTSRSIVPQQSTDDVVVVDGKNVAKGRNRQVLGDIGNVVRGNYPKNNEPEKINHRPRTRSQNP TLLVEDNLKK
MASRIVQQQQARGEAVVGGGKQQKKNGVADGRNR/CALGD /GNL ANVRGVVD AKP NRP I TRS FGAQLLANAQAAAAADNSKRQACAN
RASVGSLGNVTAPTSSAKLNPTVPLKKP S LAT SARS VS SS I RGSADKP AS I KP AP P VARHGSATQRHNNVPPPKVP
AP SMTTP EPASKRRVVLGE/SNNS SAVSGNEDLLCREFEVPKCVAQKKRKRGVKE
AARAV
ASTKTSNAEGTTKRSNLAKSS SNGFGDFIFVDDEHKPVEDQpVPMALEQTEpMHSESDQMEEVEMED IMEEPVMDIDTPDANDPLAV
NSNEFGNF IAIDDE LKLP EDQP EPMT LEHTEPMH SDP LEMEEVEMED I EGEMI LD IDSCSANNSLAV
ATQPTVALLDP IGSERLKRNADTAFHTPADMESTKMTDDSPLPMVSEMDEMMSPELKE I EMED I E- EAAPD IDSGDAGNSLAV
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PVVKRNAVPKpKKVAGNPKVVDVIE I S SDSDEELGLVAAREKKATKKKAT T YT S VLTARS KAACGLEKKQK- -EKIVD IDSADVENDLAA
VAGp pAVANEGVAVAKRAAPKPVSKKVIVKPKP SEKVTD IDASPDKKEVLKDKKKEGDANp KKKSQHT LT S VLTARS KAACG I TNKpK- -EQ1 ID IDAsDvDNELAA
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C13-1 DVGVDFGEKFDDP QMC S
FIGURE 1 Comparison of the amino-terminal sequences of the plant mitotic cyclins. Amino acid sequences of the maize
cyclins laZm, IbZm, IIZm, and IIIZm have been aligned with each other and with cycMsl and cycMs2 from alfalfa, cyc1At from
Arabidopsis, S13-6 from soybean, and C13-1 from carrot. Only the amino-terminal region of the alignment is shown here. The
putative destruction box is in boldface and italicized. Residues conserved in one or several groups of plant cyclins have been
aligned and underlined. Dashes indicate positions of spaces required to align the sequences maximally. cycMs2, cyclin IaZm,
cyclin IIZm, and cyclin C13-1 are incomplete open reading frames from cDNAs truncated at their 5' ends, and the cycMsl se-
quence is truncated at its carboxy-terminal end.
gene-trap transposon was chosen for further charac-
terization. This transposant (GT148) shows GUS ex-
pression throughout embryos and very young seed-
lings; expression is later localized to lateral root and
leaf primordia, young floral buds, and, eventually,
ovules (see Fig. 2). A partial cDNA clone was ob-
tained corresponding to the chromosomal gene dis-
rupted by the gene-trap insertion in this line. RACE-
polymerase chain reaction (PCR) products were gen-
erated using nested primers from the GUS gene (Fig.
3) and cloned into M13. Sequencing revealed that
they contained a fusion of GUS sequences and
chromosomal exon sequences joined at the second
splice acceptor site. The cDNA clone was used to
probe Northern blots of RNA from different tissues
of wild-type plants, as well as plants heterozygous for
the gene-trap insertion. In each case, a 3.0-kb tran-
script was detected in roots and flowers but not in
B
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E
FIGURE 2 Reporter gene expression in plants heterozygous for the gene-trap insertion, GT148. Plant tis-
sues were stained with X-gluc and cleared in 70% ethanol. (A) Late heart/early torpedo-stage embryo
showing subcellularly localized reporter gene activity; (B) uniform staining in lateral root primordia; (C)
staining in proximal domain of immature leaves; (D) inflorescence with staining in flower buds, carpels,
and ovules; (F) unfertilized mature flower with staining in ovules.
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GTGCCAGGCAGTTTTAACGATCAGTTCGCCGATGCAGATATTCGTAAT
FIGURE 3 A scheme for generating RACE-PCR products from gene-trap insertions. (A) First-
strand cDNA is synthesized from primer 2 within the GUS gene. A poly(dA) tail is added with ter-
minal transferase, and the second strand is synthesized using a hybrid adapter-poly(dT) primer.
cDNA products are then amplified using nested primer 1 within the GUS gene and a primer from
the adapter sequence. (Stippled boxes) Exons within the target gene. Both spliced and unspliced
products are recovered using this approach. (B) The sequence of a RACE-PCR product cor-
responding to a spliced fusion RNA from the gene-trap line GT148.
mature leaves. In addition, a 5.0-kb transcript was
detected in plants heterozygous for the DsG insertion.
This larger transcript hybridized to a probe specific
for the GUS gene, indicating that it was derived from
a transcriptional fusion with the gene-trap reporter
gene. A cDNA library made from flower RNA (pro-
vided by D. Weigel, Salk Institute) was screened
using the partial cDNA clone as a probe, and several
additional clones were obtained.
The DNA sequence of these clones was de-
termined by R. McCombie, and database searches
revealed strong homology with the MCM3 family of
proteins (which includes MCM2, MCM3, and CDC
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46/MCM5 in Saccharomyces cerevisiae, CDC21 of
Schizosaccharomyces pombe, and the mammalian P1
protein). In the conserved region, the Arabidopsis se-
quence is 65% identical to that of the mammalian P1
protein. These proteins are involved in site-specific
initiation of DNA replication and are encoded by es-
sential genes in yeast (Tye, Trends Cell Biol. 4: 160
[19941).
The GT148 insertion line carries a mutation af-
fecting fertility: Plants heterozygous for the DsG ele-
ment are semisterile, having about 50% seed set. The
DsG insertion carries a kanamycin resistance gene,
and progeny from the self-pollination of a plant
heterozygous for the insertion segregate 1:1 kana-
mycin-resistant:kanamycin-sensitive. These segre-
gation ratios suggest that the insertion results in
gametophytic lethality (in contrast, a 2:1 ratio would
be predicted for embryo lethality). Outcrosses to
wild-type plants (carrying no insertion) show 75%
transmittance through the male and 32% through the
female. These ratios were even more exaggerated in
individual plants, suggesting that the insertion pri-
marily affects the female gametophyte. Early embryo
lethals were also observed in self-pollinated siliques,
suggesting that the few homozygotes that escape
gametophytic selection abort early during embryo-
genesis.
The Ds element in GT148 cosegregates with
semisterility in heterozygous plants, suggesting that
disruption of the MCM3-like gene is responsible for
the mutation. In the absence of Ac, the semisterile
phenotype is completely stable, but when Ac trans-
posase is re-introduced by crossing, the phenotype
becomes unstable: Most siliques from plants carry-
ing the DsG insertion and Ac are semisterile, but oc-
casional siliques are fully fertile, suggesting that the
mutation has reverted to wild-type in these flowers.
Analysis of these apparent revertant events is under
way.
Mutagenesis in plants is complicated by the ex-
tended haploid phase of the plant life cycle (the
gametophyte generation). Studies using chromosomal
deficiencies indicate that many mutations are lethal to
the male and/or the female gametophyte, resulting in
poor transmission and semisterility. For example,
mutants blocked in DNA replication would be ex-
pected to fall into this class. Enhancer-trap and gene-
trap transposon mutageneses are uniquely suited to
identifying these genes: In the absence of expression
data, mutations causing early lethality form a non-
descript class, but with our approach, we can deter-
mine the expression pattern in viable heterozygotes.
This allows those genes with additional functions
later in development to be identified.
The lojap (Ij) Protein Is Associated
with 50S Chloroplast Ribosomal
Subunits in Maize
C.-D. Han, R. Martienssen
Plants homozygous for the iojap (if) mutation have
patterned white stripes on their leaves (Jenkins, J.
Hered. 15: 467 [1924]) and give rise to albino seed-
lings in their maternal progeny when pollinated by
wild-type plants (Rhoades, Cold Spring Harbor
Symp. Quant. Biol. 11: 202 [1946]). The degree and
extent of striping, and the maternal transmission of
the if- affected plastids, are largely dependent on ge-
netic background (Jenkins, J. Hered. 15: 467 [1924];
Coe et al., Am. J. Bot. 75: 634 [1988]). These prop-
erties have made iojap a genetic paradigm for
cytoplasmic inheritance and nuclear-organellar inter-
actions, and many models have been proposed to ac-
count for them.
We cloned the Ij gene by transposon tagging, but
the sequence of the Ij protein showed no homology
with proteins in current databases (Han et al., EMBO
J. 11: 4037 [1992]). To characterize further the role
of the Ij protein in chloroplast and leaf development,
antibodies were raised against Ij fusion proteins and
purified by APT membrane affinity purification. By
using in situ immunolocalization, we found that most
cells in immature leaves expressed the Ij protein,
which appeared to be concentrated in the plastids of
each cell type.
On the basis of ribosomal RNA profiles of mutant
and wild-type plants, Walbot and Coe (Proc. Natl.
Acad. Sci. 76: 2760 [1979]) proposed that iojap
plants suffered a programmed loss of plastid
ribosomes that could account for the maternal trans-
mission of 4-affected plastids. We therefore analyzed
plastid subfractions to determine whether Ij was asso-
ciated with plastid ribosomes or with other macro-
molecular structures. In chloroplast lysates, most of
the protein was found in high-speed pellets, but it
was found in the soluble fraction in the presence of
20 mm EDTA. This suggested that the Ij protein was
associated with an EDTA-sensitive complex. Whole
seedling lysates were further fractionated by pelleting
through a sucrose cushion, followed by sucrose gra-
dient sedimentation in the presence of nonionic
detergents (polysome gradients). Sedimentation pro-
files were determined by UV absorption (not shown)
and by Western blotting (Fig. 4) using anti-Ij and
anti-50S ribosome antibodies. The Ij protein was
found in the same fractions as the 50S ribosomal
proteins under these conditions (Fig. 4).
Direct association of Ij with 505 subunits was ex-
amined by immunoprecipitation with affinity-purified
anti-Ij antibodies. Immunoprecipitates were frac-
tionated by SDS-PAGE, and Western blots were
probed sequentially with anti-Ij, anti-50S ribosomal
proteins and control anti-LHCPII (light- harvesting
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FIGURE 4 Western blots of lj and 50S ribosomal proteins fractionated by sucrose gradient sedimentation.
Plastid lysates were pelleted through 0.75 mm sucrose cushions, resuspended in 0.5 mm NH4CI and 2% PTE,
and loaded onto a 10-50% sucrose gradient. The gradient was centrifuged at 150,000g for 16 hr and fractions
were collected. Proteins from each fraction were analyzed by SDS-PAGE and by Western blotting using either
affinity-purified anti-Ij antibody (top panel) or anti-spinach 50S plastid ribosomal protein antibodies (lower
panel), respectively.
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FIGURE 5 IP-Westerns using anti-lj antibodies. Samples pelleted through sucrose cushions (Fig. 4)
were resuspended in 50 mm Tris (pH 8), 5 mm MgCl2, 20 mm KCI and were used for im-
munoprecipitation with affinity-purified antibodies. The immunoprecipitates and supernatants wereanalyzed to detect lj protein, 50S ribosomal proteins, and LHCPII membrane proteins, respectively,by sequential probing of the same blot. (Lane 1) Sample before immunoprecipitation; (lanes 2, 3,and 4) immunoprecipitation with 0, 5, and 25 [1.1 of anti-lj antibody; (lanes 5, 6, and 7) supernatantsfrom immunoprecipitates loaded in lanes 2, 3, and 4, diluted fivefold relative to the precipitates. Thelast lane was loaded with protein A beads alone.
complex membrane protein) antisera (Fig. 5). Ij
protein was quantitatively precipitated by increasing
amounts of anti-Ij antibody (first panel). 50S
ribosomal proteins were also specifically recovered
in the anti-Ij immunoprecipitates (second panel, I.P.),
although most of the proteins remained in solution
(second panel, sup.). LHCPII proteins were not
recovered in the precipitates (third panel), demon-
strating that the coimmunoprecipitation was specific
and did not reflect contamination with residual
membrane-bound ribosomes. We are currently de-
termining which ribosomal proteins are specifically
bound to Ij.
Association with 50S ribosomal subunits suggests
a role for the Ij protein in the regulation of plastid
translation and supports the model first proposed by
Walbot and Coe for the programmed loss of plastid
ribosomes in ij mutants: Some ribosomal proteins are
encoded by plastid genes, so that loss of plastid trans-
lation due to homozygous nuclear mutation could
lead to the loss of plastid-encoded ribosomal pro-
teins. Restoration of the nuclear components of the
plastid translational apparatus in heterozygous ma-
ternal progeny would not be expected to restore
plastid ribosomal function if the plastid-encoded
components were no longer present. Heritable
ribosome-deficient plastids would result.
Lineage Analysis of
iojap Maize Plants
R. Martienssen
Maize plants homozygous for the nuclear mutation
iojap have variegated leaves. Typically, the margins
of each leaf are albino, whereas the middle of the leaf
is variegated, comprising a mixture of white, yellow,
and green stripes. The pattern of striping changes
from leaf to leaf but is remarkably uniform within a
given inbred variety. However, in extreme cases,
iojap plants can be solid white, or mottled green in
different inbred varieties. The variegated pattern
found in most inbreds resembles the patterns found in
periclinal chimeras in linear-leaf monocotyledons,
such as Chlorophytum comosum (spider plants). This
pattern reflects the contribution made by LI cells of
the shoot apical meristem to the inner photosynthetic
tissues of the leaf. LI cells are restricted to the out-
ermost layer of the shoot apex by stereotypical
anticlinal divisions (i.e., divisions in the plane of the
cell layer). Cells from this lineage give rise to the
epidermal, primarily nonphotosynthetic, tissues of the
leaf. However, some cells from the LI lineage un-
dergo periclinal divisions in the leaf and so contribute
to the underlying photosynthetic tissues. These con-
tributions occur primarily at the leaf margins, but
they also occur in "stripes" elsewhere in the leaf.
These stripes are descended from groups of cells that
divided out-of-plane early in the initiation of leaf
primordia. Coe et al. (Am. J. Bot 75: 634 [1988]) pro-
posed that the pattern of variegation observed in
iojap plants might be accounted for if the stripes of
albino tissue were derived from cells from the LI
lineage of the shoot apex.
To test this model, plants of the genotype ij /ij;
B /b; PI Ipl; Bz /bz were constructed and irradiated with
y-rays to induce chromosome breakage. The irradia-
tion was performed at the Brookhaven National La-
boratory with the help of Rich Sautkilis. The genes B
(booster), PI (purple), and Bz (bronze) are required
for accumulation of purple anthocyanin pigments in
the epidermal and certain subepidermal tissues of the
maize leaf. A cell in which the functional allele of
any of these genes has been lost by chromosome
breakage gives rise to a clone of cells in which the
pigments fail to accumulate. When this clone arises
in a given lineage in the shoot apex, its contribution
to mature tissues of the leaf can be readily followed
by anthocyanin pigmentation. Of 761 ij /ij plants, 125
sectors were examined. Sectors were chosen that
passed through at least two leaves, so that they must
have arisen in the shoot apex prior to leaf develop-
ment. Twenty-two sectors were restricted to sub-
epidermal tissues of the leaf: All but one of these
were in green leaf tissue and had no effect on
chloroplast development. Nine sectors were com-
pletely restricted to the epidermal layer, and, as ex-
pected, these had no effect on chlorophyll accumula-
tion in the underlying tissue. Ninety-four sectors
were found that, at some point in the sector, were
present in both the epidermal and the subepidermal
layers; 89 of these became white or mottled in ap-
pearance in the subepidermal layer. In 36 of these 89
sectors, the sector was restricted to one or the other
layer for part of its length, so that it was possible to
determine whether the sector was derived from the LI
of the shoot apex and later contributed to the sub-
epidermal layer, or vice versa. In all the cases in
which the sector moved from LI to LII, it was white
in appearance. In both of two cases in which the sec-
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for had moved in the opposite direction
(LII to LI), it
was unchanged in pigmentation.
Seventy-nine
anthocyaninless sectors were observed on 470
control
ij /+ heterozygous plants that were phenotypically
wild type. All but one of these sectors were green.
Molecular analysis revealed that the one exceptional
white sector had lost both the Ij gene and the B gene
in successive cell divisions, so that the white sector
was entirely contained within hemizygous ij /- tissue.
These results show that chloroplasts in ij mutant
plants fail to differentiate in cells derived from
the LI
lineage of the shoot apical meristem when these cells
contribute to the subepidermal tissues of the leaf. In
contrast, chloroplasts in wild-type plants develop
normally regardless of their origin in the meristem.
Cells in higher plants typically adopt specific fates
relatively late in development, independent of cell
lineage. However, in ij mutant plants, chloroplast dif-
ferentiation depends on cell lineage, so that LI cells
must retain their clonal history. This suggests that the
lack of lineage restriction in wild-type plants is
mediated by specific gene products and may be
amenable to mutational analysis.
Isolation of a Derivative
Allele in Maize by PCR
Screening
L. Das, R. Martienssen
The hcf106 mutation in maize is caused by the inser-
tion of a Mul transposable element into the promoter
region of a gene required for chloroplast develop-
ment. The hcf106 mutant phenotype depends on
transposon activity, and as a result, the phenotype is
leaky and difficult to maintain in new genetic back-
grounds. To obtain stable alleles, we used a PCR
screening strategy to select plants that had suffered a
deletion flanking the Mul element at the 14706
locus; 1500 seedlings from the cross hcf706I+ x +I+
were germinated in the greenhouse in x-y grids to fa-
cilitate pooling. Mu activity was monitored using a
second independent mutation (Les28), and calcula-
tions showed that the 1500 seedlings represented a
collection of about 400 Mu-active hcf106 chro-
mosomes. DNA was prepared from pools of 32 seed-
lings from each row (x) and column (y) of the grids.
The DNA was digested with an enzyme that cuts
uniquely in the hcf106 gene at the initiator ATG
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codon. DNA from the he f106 locus was then
amplified using a primer from the promoter and
primer from the second exon of the hcf106 gene.
gestion ensured that only alleles that had lost the in
itiator ATG codon via deletion would be amplified
subsequent PCR. Three seedlings were identified by
cross-referencing x and y pools that had PCR prod .
ucts of the predicted size. DNA was made from these
seedlings individually, and they were found to have
suffered a 200-bp deletion, and two more compli-
cated rearrangements, respectively, that had removed
or interrupted the translational reading frame as
desired. These heterozygous plants have been self.
pollinated, and the progeny will be examined for
mutant phenotypes this summer.
This method provides a powerful way to identify
deletion (null) derivative alleles without phenotypic
selection. The plants were recovered as heterozy.
gotes, so that even if the deletion alleles are lethal,
they can still be propagated and studied. Sequencing
of the PCR products can be used to define precisely
the derivative alleles before their phenotype is
known, so that this technique is ideal for studying
genes with lethal phenotypes or those for which only
dominant, gain-of-function alleles are known.
DNA Methylation-deficient
Mutants in Arabidopsis
L. Das, R. Martienssen [in collaboration with E. Richards,
formerly at CSHL, now at Washington University,
St. Louis; and with M. Stammers and C. Dean,
John Innes Institute, Norwich UK, and K. Edwards,
Zeneca Seeds, UK]
Last year, Eric Richards reported the isolation of a
new class of mutants in Arabidopsis that are deficient
in cytosine methylation (Vongs et al. 1993). These
ddm mutants (for decrease in DNA methylation) were
isolated by direct screening of mutagenized popula-
tions for mutants whose repetitive DNA was sensitive
to restriction digestion using enzymes normally in-
hibited by DNA methylation. These mutants have
about 25-30% of wild-type 5-methylcytosine levels,
but no obvious morphological phenotypes. However,
they may have altered genetic properties (Vongs et al.
1993). We have backcrossed three different ddm
mutants into the Landsberg ecotype over six genera-
tions, so that we can study recombination between
polymorphic DNA markers in crosses with multiply
marked strains of the ecotype Columbia. In the com-
ing year, we will quantify genetic recombination in
an interval between phenotypic markers on chromo-
some 4 that has been cloned in overlapping YAC and
cosmid clones by Caroline Dean's group in the UK.
Holliday (Science 238: 163 [1987]) suggested the
possible link between methylation and recombination
based on studies in prokaryotes, and it will be of in-
terest to determine whether recombination in Arab-
idopsis is affected in methylation-deficient mutants.
Differential Transcriptional
Regulation Mediated by Two
Maize Myb-domain Proteins
E. Grotewold, T. Peterson [in collaboration with
B. Drummond and B. Bowen, Pioneer
Hi-Bred International]
The c-myb proto-oncogene is the cellular homolog of
the transforming v-myb oncogene of the avian myelo-
blastosis virus. This virus causes acute myeloblastic
leukemia in chickens and transforms myelomono-
cytic cells in vitro. The product of the transforming
v-myb gene is a truncated version of its cellular
progenitor, c-myb. Both c-myb and v-myb encode
sequence-specific DNA-binding proteins that activate
transcription. Most likely, c-Myb controls erythroid
cell growth and differentiation through the transcrip-
tional regulation of specific genes. Several proteins
have been described in a variety of organisms that
share high homology with c-Myb in the amino-
terminal DNA-binding domain, the Myb domain. In
no case, however, have the mechanisms by which
Myb-domain proteins regulate transcription been
elucidated.
In maize, two Myb-domain proteins, P and Cl,
regulate flavonoid biosynthesis: P regulates the ac-
cumulation of 3-deoxy flavonoids and derived pig-
ments by activating transcription of three genes of the
flavonoid biosynthetic pathway, C2, CHII, and Al.
Cl regulates 3-hydroxy flavonoid and anthocyanin
biosynthesis through the activation of the P-regulated
genes (C2, CHII, and Al), in addition to genes only
responsive to Cl (A2, Bzl, and Bz2). Cl, however, is
not able to achieve this regulation by itself and re-
quires the basic helix-loop-helix (bHLH) protein R.
The interaction between Cl and R has been shown by
two-hybrid analysis to occur through the highly con-
served Myb domain of Cl and the amino-terminal
region of R (which does not contain the bHLH
domain).
This system provides us with the first opportunity
to study the mechanism by which two Myb-domain
proteins direct distinct patterns of gene expression,
probably not only by different DNA-binding prefer-
ences, but also through specific interactions with the
co-activator R.
Our studies have shown that a protein expressed
from a cloned P cDNA (Grotewold et al., Proc. Natl.
Acad. Sci. 88: 4587 [1991]) activates the Al promo-
ter, but not the Bzl promoter, in transient expression
experiments. Our system for transient expression
analysis consists of co-bombarding maize em-
bryogenic callus cells (in which P, Cl, and R are not
normally expressed) with the activator protein (P, R,
or C1) expressed from a plant constitutive promoter
(the CaMV 35S promoter) and the reporter luciferase
gene controlled by the Al or Bzl promoter fragments.
The differential activation of Al and Bzl by P is in-
dependent of R: R is not required for the activation of
Al, nor does R enable P to activate Bzl. Cl, in the
presence of R, is able to activate both the Al and Bzl
gene promoters.
We have determined that 220 by of the Al
promoter are sufficient for both P and Cl regulation
of A1. Gel mobility-shift experiments using Escher-
ichia coli-expressed P and Cl proteins indicated that
these proteins bind to this promoter fragment in vitro,
in the absence of other maize proteins. Footprint ex-
periments showed that the P and Cl proteins bind to
a region 60 nucleotides upstream of the Al start of
transcription which contains the sequence ACCTAC-
CAACC. Gel mobility-shift experiments using
oligonucleotides with specific mutations in this se-
quence confirmed that, indeed, this sequence is
recognized by P and that it consists of two overlap-
ping P- and Cl-binding sites, ACCTACC and AC-
CAACC.
To test whether the sequences recognized by both
P and Cl in vitro had a role in the regulation of Al in
vivo, mutant and wild-type Al promoters were tested
for trans-activation by P and Cl in our transient ex-
pression system. Mutations that prevent the binding
of P and Cl in vitro decreased the activation by P or
R+Cl four- to fivefold. When the wild-type P and Cl
binding sites were placed upstream of a minimal
promoter, normally not regulated by P or R+Cl,
regulation by P and R+Cl was obtained. These obser-
vations indicate that the P- and Cl-binding sites pres-
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ent in the Al promoter are not only necessary, but
also sufficient, for regulation by P and Cl (Grote-
wold et al., Cell 76: 543 [1994]).
Since the P- and C1-binding sites present in the
Al promoter are very different from sequences to
which c-Myb and v-Myb bind, we performed parallel
binding selection experiments with E. coli-expressed
P and v-Myb proteins. Our results showed that the
two proteins have different binding preferences in
vitro, although P and v-Myb have highly related Myb
domains. The binding consensus deduced for P was
ACCA/TACCA/cm, whereas the deduced v-Myb
DNA-binding consensus was G/j/cAACGGT/c/A
(Grotewold et al., Cell 76: 543 [1994]). The two P-
binding sites in Al (CCTACC and CCAACC) match
the deduced P consensus binding site, and as ex-
pected from the binding selection experiments, v-
Myb does not bind to the P-binding sites of the Al
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gene, nor does P bind to the Myb-binding sites in the
mim-1 gene, the only gene so far described as directly
regulated by Myb (see Fig. 6). These results provide
the first evidence that two members of the Myb fam-
ily of transcriptional activators bind different se_
quences.
P does not regulate Bzl, and consistent with this
pattern of regulation, we did not detect any binding
of P to Bzl promoter sequences. Surprisingly, how-
ever, there is also no binding of Cl to the Bzl
promoter, and yet, Cl is required for Bzl regulation.
One possibility is that R is required for binding of Cl
to the Bzl promoter. When the Myb domain of Cl
(residues 1-121) is fused to activation domains of
VP16 or GALA, activation of the Al or Bzl pro-
moters is only achieved in the presence of R, indicat-
ing that R is probably required for binding in vivo to
both Al and Bzl. Surprisingly, the Myb domain of P
Summary of Selected Seauences
I
Selected by P
-4 -3Position
G 4
A 25 2
4 3
C 3 28
Consensus A C
I 2 3 4 5 6 7 8
I II
GATCCGCGTCAGTGTACCTACCAACCTTAAACAC
GCCCAGTCACATGGATGGTTGGAATTTGTGC TAG
GATCCGGGTCAGTGTACCCACCAACCTTAP.ACAC
GCCCAGTCACATGGgTGGTTGGAATTTGTGCTAG
GATCCGGGTCAGTGTACCTACCAATCTTAAACAC
GCCCAGTCACATGGATGGTTAGAATTTGTGC TAG
GATCCGGGTCAGTGTACCACCAATCTTAAACAC
GCCCAGTCACATGGGTGGTTAGAATTTGTGCTAG
mim-1 wt TCGACACATTATAACGGTTTTTTAGC
GTGTAATATTGCCAAAAAATCGAGCT
Al site IAl site II
A
A
Selected by v -Mvb
-2 -1 0 +1 +2 +3 +4
:7 76
5 19
sl
C A/T A C C A/C(T) X
A
Position -4 -3 -2 -1 0 +1 +2 +3 +4
6 9
A 3 4 29 29
T 11 3 16
C 8 13 13
Consensus Y(R) G/C TIC A A C G G C /T /A
T A T
mim-1 m TCGACACATTATAg_AGGTTTTTTAGC
GTGTAATATGTCCAAAAAATCGAGCT
FIGURE 6 Gel mobility-shift experiments using wild-type (APB1) or mutant (APB2-4) oligonucleotides containing the P-binding
sites present in the Al gene promoter or the Myb-binding sites present in the mim-/ gene promoter. A summary of the se-
quences preferentially bound by P and v-Myb is shown.
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fused to the activation domain of VP16 does not ac-
tivate the Al promoter. This could indicate that P,
like Cl, requires an accessory factor. There is no ge-
netic evidence, however, to suggest that such a factor
exists.
The study of the mechanisms by which the Myb-
domain proteins P and Cl regulate transcription of
overlapping sets of genes thus provides us with a
unique opportunity to study how Myb-like proteins
can differentially regulate gene expression through
different binding specificities and combinatorial in-
teractions with accessory factors.
Cloning and Characterization
of a P-regulated Maize
Chalcone Isomerase
E. Grotewold, T. Peterson
Flavonoid-derived pigments are found almost univer-
sally in the plant kingdom, providing color to flow-
ers, fruits, leaves, and storage organs. Their bio-
synthesis is probably the best described biochemical
pathway in plants and therefore presents a very con-
venient system to study regulation of gene expres-
sion. The most commonly found flavonoid-derived
pigments, the anthocyanins, are derived from 3-
hydroxy flavonoids. However, pigments lacking the
3-hydroxyl group characteristic of the anthocyanins
(the 3-deoxy flavonoids) exist in some species, in-
cluding sorghum and maize. Besides being involved
in plant pigmentation, flavonoids have important
roles in protection from the damaging effects of UV
radiation, in response to attack by phytopathogens, as
signal molecules for the induction of nodulation
genes, and as stimulants for the development and
germination of pollen and for pollen tube growth.
Chalcone, the first flavonoid in the pathway, is
synthesized by the enzyme chalcone synthase, which
has been characterized in several plants, and in
maize, it is encoded by the C2 locus. Chalcones can
be converted into the corresponding flavonones by an
intramolecular reaction in which the C ring is closed
by the enzyme chalcone isomerase (CHI). Although
mutations have been found in genes encoding several
regulators and structural enzymes of the maize
flavonoid biosynthetic pathway, no mutations affect-
ing the activity of CHI have been identified. The ex-
istence of a functional CHI gene in maize has been
inferred from biochemical analysis of flavonoids and
the similarity in the flavonoid biosynthetic pathways
of maize and other plants. Because we are interested
in understanding the mechanisms by which flavonoid
biosynthesis is regulated, we decided to isolate puta-
tive maize CHI genes.
Using polymerase chain reaction (PCR) based on
conserved regions of the CHI genes of Petunia,
Antirrhinum, and bean, we cloned a fragment of a
maize CHI cDNA. This fragment was used to obtain
cDNA clones from a P-rr pericarp-specific cDNA li-
brary and genomic clones from a maize genomic li-
brary.
The analysis of the sequence of the cDNA clones
and the structure of the genomic clones indicated that
two to three CHI genes are present in most maize in-
bred lines, only one gene (CHI1) being regulated in
the pericarp by P, a Myb-domain protein (see above).
By RNase A and S1 protection experiments, together
with primer extension, we determined the start of
transcription of CHIl. The intron/exon structure of
CHI1 is identical to the structure of the CHIb gene
from Petunia, and CHI] encodes a 24.3-kD protein,
very similar in size and about 56% identical in se-
quence to that of the Petunia CHI proteins (Grote-
wold and Peterson 1994).
We analyzed 850 by of the CHI1 promoter se-
quence for high-affinity P-binding sites (Grotewold
et al., Cell 76: 543 [19941), and none were found.
Furthermore, E. coli- expressed P protein does not
bind to these CHI1 promoter sequences. These obser-
vations could indicate (1) that CHI1 is not regulated
directly by P, (2) that P has a different binding
specificity in vivo and in vitro, or (3) that an acces-
sory factor could be responsible for recruiting P to
the CHI1 promoter. This situation is similar to what
is found in the regulation by Cl: The Myb-domain
protein Cl regulates Al and Bzl only in the presence
of the bHLH protein R. However, only the Al gene
promoter has C1-responsive elements, whereas the
Bzl promoter does not. We believe that the analysis
of the mechanisms by which P regulates transcription
of promoters with P-responsive elements (like Al)
and without P-responsive elements (like CHI1) will
provide us with important information about the me-
chanisms involved in gene regulation by the maize
Myb-domain proteins P and Cl.
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ARABIDOPSIS SIGNAL TRANSDUCTION AND
FLOWER DEVELOPMENT
H. Ma J. Carruthers
C. Flanagan
Y. Hu
H. Huang
D. Kostic
Y. Mizukami
K. Mukai
P. Rubinelli
M. Tudor
C. Weiss
Research in our laboratory addresses two problems of
plant biology: (1) the function(s) of G protein(s) in
plant signal transduction pathways and the
molecular mechanisms controlling flower develop-
ment, especially the roles of members of a conserved
gene family (the MADS-box genes).
Plant cells respond to a variety of external signals,
including light, gravity, temperature, moisture, patho-
gens, and physical touch. In addition, in multicellular
plants, cells respond to molecules generated by other
plant cells, such as hormones and nutrients. Because
plants and individual plant cells are generally immo-
bile, the kinds of reactions that plant cells generate in
response to a stimulus are often different from those
of animals. It is therefore of fundamental importance
to study the molecular mechanisms of the plant signal
transduction pathways. It is well established that, in
animals and simple eukaryotes, heterotrimeric G
proteins have important roles in signal transduction.
However, the function of G proteins in plants is not
known. To study the function of plant G proteins, and
to test their possible involvement in plant signaling
processes, we have continued the analysis of a pre-
viously isolated Arabidopsis gene (GPAI) encoding a
G protein subunit (Ma et al., Proc. Natl. Acad. Sci.
87: 3821 [1990]). In addition, we have isolated a new
Arabidopsis gene that encodes a G protein p subunit.
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Much progress has been made in recent years
toward the understanding of the molecular mechan-
isms controlling flower development. In particular, a
number of Arabidopsis floral homeotic genes have
been characterized (Coen and Meyerowitz, Nature
353: 31 [1991]; Ma 1994). Mutations in one of these
genes, AGAMOUS (AG), cause double-flower pheno-
types, where the stamens are converted to extra petals
and the ovary is replaced by a new flower. The AG
DNA sequence (Yanofsky et al., Nature 346: 35
[1990]) indicates that it encodes a protein with strong
similarity to the DNA-binding domains of transcrip-
tion factors from humans (SRF) and yeast (MCM1),
suggesting that the AG protein is a transcription fac-
tor. This domain is also found in another floral
homeotic gene, DEF A from Antirrhinum majus
(Sommer et al., EMBO J. 9: 605 [1990]), and has
been referred to as the MADS-box, for MCMI -AG-
DEFA -SRF (Schwarz-Sommer et al., Science 250:
931 [1990]). Additional MADS-box genes were iso-
lated using AG as a probe, and these were designated
AGL1 through AGL6 for AG-Like. We have focused
our efforts on AG, AGL1 , AGL2, and AGL3 . To iden-
tify new genes required for flower development, we
have collaborated with Drs. V. Sundaresan and R.
Martienssen (see this section) to establish an enhan-
cer trap/gene trap transposon insertional mutagenesis
system, and we have continued our efforts to generate
lines carrying new insertions. In an alternative ap-
proach to isolate new genes that function during
flower development, we have begun a new project
aimed at identifying genes specifically expressed in
carpels.
In 1993, in addition to the people already here,
Peter Rubinelli came from SUNY Stony Brook,
where he is a graduate student in the Molecular and
Cellular Biology Program; Matt Tudor, an un-
dergraduate student at Cornell, returned for a second
summer, studying with Hai Huang the in vitro DNA-
binding properties of AG and AGLs; Julie Car-
ruthers, an undergraduate at the University of Cali-
fornia, Santa Cruz, spent the summer with us as an
URP, working with Cathy Flanagan on the analysis
of AG expressed in yeast; Kanae Mukai, who attends
Bronx School of Science, worked with Catherine
Weiss during the summer to isolate a G protein 13
subunit gene from Arabidopsis; and Dusan Kostic has
recently completed his studies at the University of
Utah and started his postdoctoral training in the fall.
Isolation and Characterization of
Plant G Protein 13 Subunit Genes
C. Weiss, K. Mukai, Y. Hu, H. Ma [in collaboration with
C. Garnaat, Pioneer Hi-Bred Seeds]
Heterotrimeric G proteins consist of three subunits a,
13, and y. Upon interaction of the inactive GDP-bound
G protein with an activated receptor, the GDP is re-
placed with a GTP and the Py complex dissociates
from the GTP-bound a subunit, thus liberating two
complexes. Until recently, the GTP-a subunit com-
plex was thought to be the only component interact-
ing with downstream effectors, whereas the role of
the Py complex in signal transduction, if any, was
controversial. However, a number of reports indicate
that the py complex is also able to interact directly
with effectors, such as adenylate cyclase, K+ chan-
nels, phospholipase A2 and the isoform 132 of
phospholipase C, and receptor kinases (Clapham and
Neer, Nature 365: 403 [1993]). Furthermore, it has
recently been shown that in some cases, the (3y com-
plex is involved in receptor recognition. In plants,
biochemical studies have suggested G protein in-
volvement in a number of pathways such as the con-
trol of K+ channel opening in guard cells and
mesophyll cells or the transmission of signals such as
red and blue light, stress, and auxin (Terryn et al.,
Plant MoL Biol. 22: 143 [1993]). Furthermore, we
have demonstrated the existence of heterotrimeric G
proteins in plants by isolating a G protein a subunit
gene from Arabidopsis and its homolog from tomato
(Ma et al., Gene 107: 189 [1991]). To obtain addi-
tional tools to study G protein functions in plants, it is
important to isolate and characterize gene(s) encod-
ing G protein p subunits.
Recently, a maize cDNA was isolated from a sub-
tracted tassel library, and it was found to encode a
peptide homologous to a portion of known G protein
p subunits. Further analysis of longer cDNAs with a
complete open reading frame indicates that the pre-
dicted protein is indeed a homolog of known G
protein (3 subunits. The gene represented by the
cDNA was designated ZGB1. Using ZGB1 cDNAs as
probes, we isolated the Arabidopsis homolog, AGB1,
from a cDNA library. The predicted amino acid se-
quences of the maize and Arabidopsis G protein 13
subunit homologs are 76% identical to each other and
more than 42% identical to animal G protein 13 sub-
units. Furthermore, both predicted sequences contain
seven repeats of the so-called WD-40 motif (contain-
ing a tryptophan-aspartate dipeptide and about 40
amino acids long), which is repeated seven times in
all known G protein p subunits. In addition to G
protein P subunits, a number of other proteins contain
WD-40 repeats. Although the function of the WD-40
motif is not known, it is thought to be involved in
protein-protein interaction. Two plant genes have
been isolated, from Chlamydomonas (Chlp; Schloss,
Mol. Gen. Genet. 221: 443 [1990]) and tobacco
(arcA; Ishida et al., Proc. Natl. Acad. Sci. 90: 11152
[1993]), that encode proteins with several copies of
the WD-40 motif; their amino acid sequences are
66% or more identical to each other and to that of a
chicken WD-40 protein (C12.3; Guillemot et al.,
Proc. Natl. Acad. Sci. 86: 4594 [1989]), suggesting
that they may have similar functions. However, these
proteins share only low levels (about 25%) of se-
quence identity to animal G protein l subunits; there-
fore, they are probably functionally distinct from the
G protein 13 subunits. Several other WD-40 proteins
have been identified in animals and yeast; these
proteins are not functionally related to G proteins and
are involved in a number of processes, such as RNA
splicing, cell cycle control, cytoskeleton organiza-
tion, and transcriptional repression.
Hybridizations to genomic DNA indicate that
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ZGBI and AGB1 are single -copy genes
and that this
G protein subunit homolog is conserved among
other plant species. Northern analysis
indicates that
ZGB1 mRNA is present in the root, leaf,
and tassel
and that AGBI mRNA is expressed in
the root, leaf,
and flower. The isolation of AGB1 and ZGB1 pro-
vides further indication that a heterotrimeric G
protein functions in plants, and it will be very impor-
tant to learn what role these genes may
have in plant
signaling pathways. In particular, it will be of interest
to investigate whether the a and 1 subunits encoded
by the GPA1 and AGB1 genes, respectively, interact
with each other directly.
Expression of the AGL2 Gene
in Wild-type and Mutant
Arabidopsis Flowers
C. Flanagan, H. Ma, Y. Hu
To obtain clues about AGL2 function in flower devel-
opment, we have carried out a detailed analysis of the
expression patterns of AGL2 in wild-type and mutant
flowers using RNA in situ hybridizations. AGL2 ex-
pression begins early in flower development (at stage
2), after the floral meristem has emerged, but before
any floral organ primordia appear. AGL2 expression
is uniformly high in floral primordia and floral organ
primordia between stages 2 and 7. However, the ex-
pression of AGL2 becomes organ-specific during
later stages of flower development. At stage 8, AGL2
expression begins to wane in the sepals but remains
high in the other organs. Later, during stages 9-10,
AGL2 expression remains high in the carpel, petals,
and (to some extent) in the filaments, whereas ex-
pression is reduced in the sepals and anthers. By
stage 12, AGL2 expression is localized primarily to
the ovules. After fertilization, the expression of AGL2
remains detectable in the developing seed coats, but it
diminishes gradually. Interestingly, AGL2 is also ex-
pressed in developing embryos. The AGL2 expres-
sion pattern suggests that AGL2 functions in the flo-
ral meristem, and in all floral organs during early
flower development, and that its function is required
to a different extent in different organs, with carpels
(ovules) requiring AGL2 function for the longest peri-
od. The presence of the AGL2 message in embryos
suggests that it may also have a role in embryo devel-
opment.
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Since the floral organs that exhibit different late
AGL2 expression patterns not only arc of distinct
identities sepals or petals), but also occupy dif-
ferent (cpositions (first or second whorls), it Was not
known whether late AGL2 expression is regulated by
the identity or the position of the floral organs. We
therefore tried to distinguish between these pos.
sibilities by examining AGL2 expression in floral
mutants, ag, ap2, and ap3, which have floral organs
occupying positions different from those in wild type
(e.g, the ag flower has petals in the third whorl, the
ap2 flower has carpels in the first whorl, and the ap3
flower has sepals and camels in the second and third
whorls, respectively). The patterns of AGL2 expres-
sion are altered in the mutant flowers in ways that are
consistent with the organ identities but not their posi-
tions. In ag mutant flowers, the outer two whorls are
normal, as is AGL2 expression in these organs. The
third whorl of an ag flower has petals instead of
anthers, and the AGL2 expression pattern in the third
whorl is the same as that in the second whorl petals.
The ag flower produces a secondary flower instead of
the ovary, and AGL2 expression in the secondary
flower follows the pattern in the primary flower, both
spatially and temporally. In ap2 and ap3 mutant
flowers, AGL2 expression is also altered such that the
patterns are consistent with the type of organs,
regardless of their positions. Therefore, AGL2 is
regulated (directly or indirectly) by the floral
homeotic genes such that the pattern of expression is
in agreement with wild-type AGL2 expression in
terms of organ types but not organ positions.
Characterization of AGL1, AGL2,
and AGL3-binding Sequences
H. Huang, M. Tudor, Y. Hu, H. Ma
AGL1, AGL2, AND AGL3 ARE SEQUENCE-SPECIFIC
DNA-BINDING PROTEINS
AGL1, AGL2, and AGL3 share a conserved motif,
the MADS-domain, with known transcription factors
(SRF and MCM1) and floral homeotic gene products
(e.g., AG and DEFA); however, it was not known
whether the AGL proteins are indeed DNA-binding
proteins. To test for DNA binding, we expressed the
AGL proteins using the T7 expression system in Es-
cherichia coli and used the proteins for in vitro
studies. We have recently shown (Huang et al. 1993)
that the Arabidopsis AG protein can bind sequences
resembling the target sequences (with a core con-
sensus of CC[A/1]6GG, or the CArG box) of SRF
and MCM1. We therefore tested whether the AGLs
can bind to an 80-bp oligonucleotide (oligoA) con-
taining a sequence (CCATTAATGG) to which AG
binds (Huang et al. 1993). Our results showed that
AGLI, AGL2, and AGL3 all can bind to oligoA but
not to another oligo (oligoB) differing only at six
nucleotides (GGATGCATCC) within the putative
binding sequence. Furthermore, nonradioactive
oligoA but not oligoB, competes for binding with
AGLI, AGL2, and AGL3, indicating that the binding
is sequence-specific.
AGL1-, AGL2-, AND AGL3-BINDING SEQUENCES ARE
SIMILAR BUT NOT IDENTICAL
With active proteins and both a positive and a nega-
tive control at our disposal, we next asked what the
spectra of sequences to which AGLI, AGL2, or
AGL3 bind are, since SRF, MCM1, and AG are
known to bind a number of similar but different se-
quences. We used the in vitro procedure that we used
for AG (Huang et al. 1993) to select for sequences
that bind to AGLI (AGL2 or AGL3) from a pool of
random sequences (flanked by known invariant se-
quences for polymerase chain reaction [PCR]). Se-
quences bound to AGL1 (AGL2 or AGL3) were
separated from free DNA using a polyacrylamide gel
mobility-shift assay, amplified by PCR, and used for
the next round of selection. We observed an enrich-
ment of sequences that bind AGLI (AGL2 or AGL3)
following each round of selection and amplification.
After four rounds of selection, the DNA was ligated
to a plasmid vector for cloning and sequence analy-
sis. Several dozens of the selected DNAs were se-
quenced and the consensus sequences were deduced,
as shown in Figure 1.
The AGLI target consensus is very similar to that
of AG, consistent with that fact that the MADS-boxes
of these two proteins are nearly identical (3 conserva-
tive replacements out of 56 residues; Fig. 1). Since
these three differences are within the carboxy-
terminal one fourth of the MADS-box, this region
may not be involved in determining sequence
specificity, in agreement with the finding that the
amino-terminal half of the MADS-box is needed for
the sequence specificity of SRF and related mam-
malian proteins. The AGL2- and AGL3-binding con-
sensus sequences are very similar to each other but
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FIGURE 1 Comparison of AG/AGLs MADS-domain se-
quences and binding consensus sequences. (A) Percent-
age of amino acid sequence identity between the AG,
AGLs, SRF, and MCM1 MADS domains (56 amino acids).
(B) Binding consensus sequences; the sequence in bold-
face is the CArG box. The consensus sequences for SRF
and MCM1 are from Pollock and Treisman (Nucleic Acids
Res. 18: 6197 [1990]) and Wynne and Treisman (Nucleic
Acids Res. 20: 3297 [1992]), respectively.
are somewhat different from those of AG and AGLI,
possibly because there are ten (nine) amino acid re-
placements in the MADS-box between AGL2
(AGL3) and AG or AGLI. Six (five) of the ten dif-
ferences are in the amino-terminal half of the MADS-
box; it is possible that these amino-terminal residues
may be important for sequence specificity.
Although AG and AGL1 have a similar binding
sequence consensus, their expression patterns suggest
that they have different functions. AG is expressed in
stamens and carpels, whereas AGLI is found only in
carpels. It is possible that AG and AGLI regulate dif-
ferent genes by interacting with different factors,
since they have quite different carboxy-terminal
regions. Such interactions could potentially enhance
binding of the proteins to some binding sites but not
to other binding sites, as is the case for MCM1. In ad-
dition, interactions with some accessary factors may
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modulate the transcriptional activity
of AG or AGLI
proteins, even though the interactions may
not affect
binding of these proteins to DNA. AGL2 and AGL3
are also expressed very differently; AGL2
is specific
to flowers, but AGL3 is expressed in flowers
and
vegetative organs. Since some of the plant MADS-
domain proteins that share common
regions of ex-
pression (e.g., AG and AGL2) show different se-
quence specificities, one of the
mechanisms by which
they might have different functions is by regulating
different genes. Our results on the AG- and AGL-
binding consensus sequences should also facilitate
the identification of potential target genes for these
presumptive transcriptional regulators.
Analysis of AG Function Using
Ectopic Expression in Transgenic
Arabidopsis Plants
Y. Mizukami, H. Ma
We have previously studied AG function in specify-
ing organ identity by ectopically expressing AG in
transgenic plants using the cauliflower mosaic virus
35S promoter and found that such ectopic expression
of AG results in phenocopies of the ap2 mutant
(Mizukami and Ma, Cell 71: 119 [1992]), which have
flowers with floral organ conversions opposite to
those in the ag mutant. Using the transgenic plants
carrying the 35S-AG construct, we have continued to
probe AG function in flower development.
ECTOPIC EXPRESSION OF AG AFFECTS SEED
DEVELOPMENT
We have previously observed that some of our 35S-
AG transgenic plants are sterile. To learn more about
AG function, we have characterized the phenotypes
of the AG transgenic plants after pollination and
found that the AG transgenic plants have ab-
normalities in seed development. First, in the trans-
genic seedpod, many seeds fail to desiccate and con-
tinue to develop precociously into seedlings
(vivipary), which can develop to maturity if trans-
ferred onto a defined culture medium. Second, al-
though some embryos develop normally at the begin-
ning of embryogenesis, they become overgrown ma-
ture seeds even though they have desiccated and be-
come dormant. Third, the transgenic seed coat is ab-
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normal. Fourth, mature seeds exhibit reduced
sensitivity to the exogenously provided hormone
ABA. Finally, the levels of 12S seed storage proteins
(cruciferins) in the transgenic seeds are reduced corn.
pared to those in normal seeds. We have also exam.
fined the seeds of ap2 mutant plants and observed that
ap2 mutant plants have seeds with phenotypes similar
to those seen in 35S-AG transgenic plants. Since AP2
was shown to regulate AG expression negatively, it is
possible that AG is ectopically expressed in seeds of
the ap2 mutants, leading to the abnormal phenotypes.
Our results show that ectopic expression of AG using
the 35S promoter produces a phenocopy of ap2
mutants not only with respect to floral organ identity,
but also in terms of seed development.
AG FUNCTIONS IN THE MAINTENANCE OF FLORAL
MERISTEM IDENTITY
The ag mutant flowers are indeterminate, with a
repeating pattern of a flower within a flower (Fig.
2B), suggesting that normal AG function is needed to
maintain the floral meristem. This is supported by the
observation that when the plants are grown under
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FIGURE 2 Schematic representation of wild-type, ag
mutant, and 35S-AG antisense transgenic flowers. (A) Wild-
type; (B) ag mutant, and severe AG antisense; (C [external]
and D [internal]) mild AG antisense phenotypes. (Se) Sepal;
(Pe) petal; (St) stamen; (Ca) carpel; (PS) primary stamen;
(PC) primary carpel; (PO) primary ovule; (SS) secondary
stamen; (SC) secondary carpel; (SO) secondary ovule.
;hort-day conditions, the ag floral meristems are con-
verted to indeterminate inflorescent meristems,
vvhereas wild-type floral meristems are determinate.
To test the possible AG function in floral meristem
further, we examined the phenotypes of the 35S-AG
transgenic plants in several ways. We found that the
transgenic plants flower much earlier than wild-type
plants and that the apical (inflorescence) meristem
terminates growth with a cluster of sessile ap2-like
flowers at its apex, resulting in a determinate in-
florescence with a much lower number of flowers
compared to that of wild type. On the other hand, ec-
topic expression of a defective AG transgene does not
cause either floral homeotic changes or inflorescent
phenotypes. The defective AG transgene encodes a
truncated AG protein lacking regions carboxy-
kik terminal of the MADS-domain. Therefore, ectopic
expression of a functional AG protein is needed for
the early flower and inflorescent phenotypes. It is in-
triguing that the early flowering and terminal flower
phenotypes are very similar to those of terminal
flower (tfll) mutants, in which the inflorescent
meristems are converted to floral meristems. It will
be interesting to determine whether AG is ectopically
expressed in the tfll mutant. Our results suggest that,
in addition to controlling floral organ identity, AG
also regulates floral meristem identity. It is possible
that the ectopic expression of AG causes premature
formation of the determinate floral meristem, result-
ing in early flowering, and the ectopic AG expression
at the apical meristem leads to the terminal flowers.
Dose-dependent Functions of AG
in Transgenic Arabidopsis Plants
Expressing Antisense RNA
Y. Mizukami, H. Ma
AG functions in two aspects of flower development
after the floral meristem is established: (1) specifying
stamen and carpel identity and (2) regulating
determinate growth of floral meristems. However,
little is known about how AG functions in these two
floral developmental processes. To begin to dissect
the AG functions, we have generated transgenic
Arabidopsis plants expressing a constitutive antisense
AG RNA under the control of the 35S promoter and
analyzed how different AG mRNA levels affect the
floral phenotype, All independent transformants dis-
play a range of abnormal floral phenotypes; they all
exhibit meristem indeterminacy but not always floral
organ homeotic conversion, suggesting that one of
the AG functions is separable from the other. Further
analysis of AG mRNA levels in the transgenic plants
reveals that partial reduction of AG expression results
in flowers that exhibit only meristem indeterminacy;
these flowers contain within their gynoecia another
flower (Fig. 2C,D). Further reduction of AG expres-
sion is necessary to produce an ag-1 phenocopy (Fig.
2B). These results suggest that the two AG functions
are modulated in a dose-dependent fashion during
flower development. Because AG likely encodes a
transcription factor, the proposed concentration-
dependent AG functions could be explained if the
critical amount of AG activity required to regulate
those AG target genes specifying organ identity is
different from the amount of AG needed to regulate
genes that are necessary for regulating a determinate
floral meristem.
Isolation and Initial Characterization
of Two Mutants with Altered
Floral Organ Number
H. Huang, H. Ma
ISOLATION AND PHENOTYPES OF fonl AND fon2
MUTANTS
Among the more than 300 Arabidopsis transformants
carrying various GPA1 constructs, two were observed
to segregate for plants that have abnormal number(s)
of floral organ(s). They were designated fonl and
fon2, respectively, for floral organ number. Both of
the mutations were heritable, because the progeny of
the mutants continued to exhibit the same phenotypes
as the parents. A fonl mutant plant was crossed to the
wild type, and the F1 plants have normal phenotypes,
indicating that the fonl mutation is recessive. Fur-
thermore, the progeny of the F1 heterozygotes
segregated 3 to 1 (74 to 20 plants) for normal to
mutant flowers, indicating that the phenotype was
due to a single gene defect. For fon2, the progeny of
the original transformant (normal phenotype) segre-
gated 3 to 1 (38 to 13 plants) for normal to mutant
plants, suggesting that the mutation is also in a single
gene and recessive to wild type. We have crossed
fon2 to wild type and the progeny will be examined
to confirm this in the near future.
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The overall floral phenotypes
of these mutants are
quite normal, with all four types
of floral organs pres-
ent: sepals, petals, stamens, and carpels.
Although the
number of sepals and petals are
normal (four each) in
both mutants, fonl plants have
flowers with an in-
creased number of stamens and carpels,
and fon2
plants produce flowers with a
reduced number of
stamens. Compared to the
wild-type flowers, which
have six stamens and two carpels
(n = 20), the fonl
flowers have six to ten stamens (n = 52, the average
is 7.08) and three to four carpels (average 3.44). In
addition, fonl flowers that appear early
tend to have
more stamens (for 11 #1-3 flowers, the average is
8.09), and fonl flowers that appear late tend to have
slightly fewer stamens (for 25 #7-12 flowers, the
average is 6.31). The stamen number in fon2 flowers
ranges from four to six (n = 57, average is 4.86),
whereas the carpel number in most fon2 flowers is
normal (5 of the 57 flowers counted have three car-
pels, the rest have two), and the shape of the fon2
seedpod is normal. Phenotype variations among flow-
ers of the same mutant plants have been observed for
many other floral mutants, including ap2, ap3, ag,
and lfy.
COMPLEMENTATION TEST BETWEEN fonl AND 00
Although the increase in stamen and camel numbers
of the fonl mutant is similar to that of a previously
identified floral mutant, c/v/ (Leyser and Furner, De-
velopment 116: 397 [1993]; Clark et al., Development
119: 397 [1993]), there are several significant dif-
ferences between fonl and ay/ mutants. First, c/v/
mutants have fasciated (flat but not round) stems,
whereas the stems of fonl plants appear to be normal.
Second, c/v/ mutants have an increased number of
organs in all four whorls. Third, c/v/ mutants have
club-shaped ovaries and seedpods, whereas fonl
ovaries and seedpods have about the same diameter
from one end to the other. Nevertheless, because fonl
and c/v/ both have an increased number of stamens
and carpels, we tested for complementation between
them. We observed that the progeny of crosses be-
tween homozygous fonl and c/v/ plants produce
normal flowers with normal numbers of organs.
Therefore, fonl and c/v/ are in different genes.
THE fonl MUTATION IS TIGHTLY LINKED TO A T-DNA
INSERTION
Cosegregation studies indicate that fon2 is a mutation
that probably arose during T-DNA transformation,
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but it is not due to a T-DNA insertion. Similar
studies, however, found that the fonl mutation is
tightly linked to a T-DNA insertion. This insertion
apparently has more than two copies of the T-DNA.
We isolated DNAs from 94 F2 progeny from the
cross between fonl and wild type and found that all
20 mutant plants contain the same two expected T-
DNA bands; 53 of the normal plants also have these
bands, indicating that they are heterozygotes. Indeed,
when the progeny from one of these heterozygotes
was grown up, they segregated 39 to 10 for normal to
mutant plants, very close to the expected 3 to 1 ratio.
Although the T-DNAs contain a copy of the CPA/
cDNA fused to the 35S promoter, several lines of
evidence indicate that GPA1 is not responsible for the
phenotype. First, fonl is the only transformant with
this phenotype among 53 transformants with the
same T-DNA. Second, fonl is recessive, whereas
transgenes are generally dominant. Third, Western
analysis indicates that the level of GPA1 protein in
flowers and leaves of the fonl mutant is the same as
that in several other transformants, which have no
floral abnormalities.
The isolation of fonl and fon2 mutants provides
new genetic materials to study a different aspect of
flower development, the control of organ number
about which we know very little. analysis of the
fonl and fon2 mutant phenotypes, and the isolation
and characterization of the FON1 gene, should un-
cover some of the mechanisms regulating floral organ
number and contribute to our understanding of flower
development.
Subtractive Hybridization
between Wild-type
and ag cDNAs
P. Rubinelli, H. Ma
Considerable progress has been achieved in the un-
derstanding of factors controlling floral organ identi-
ties. The ag-1 mutant flowers exhibit homeotic con-
version of stamens to petals and conversion of the
carpels to another ag flower, which lacks stamens
and carpels. Thus, the ag mutant has neither stamens
nor carpels. The sequence of AG suggests that it is a
transcription factor that specifies the identity of
stamens and carpels. However, little is known about
the genes whose functions are responsible for the
proper differentiation of each organ type. In an at-
tempt to identify genes that are involved in the
stamen and carpel developmental "pathways," we
have performed subtractive hybridizations between
cDNAs derived from the mRNAs of wild-type and ag
mutant inflorescences. Through several subtraction
steps, it should be possible to eliminate most of the
common cDNAs and greatly enrich for cDNAs
representing genes expressed in wild-type but not in
the ag mutant flowers. These cDNAs should be
stamen- and/or carpel-specific and should have a role
in the development of these organs.
In this method, cDNAs from wild-type inflores-
cences are hybridized with a 20-fold excess of
biotinylated cDNAs from ag mutant inflorescences.
The hybrid duplexes are then removed by addition of
streptavidin, which binds very tightly to the biotin
groups (KD = 10-15 M), followed by phenol/chloro-
form extractions to remove the streptavidin/DNA
complexes. The remaining cDNAs are amplified by
PCR and two additional rounds of subtraction are
performed. The resulting subtracted cDNAs are then
cloned into a plasmid vector and clones are screened
with both wild-type and ag cDNAs as probes to iden-
tify clones that are expressed in wild-type but not in
the ag mutant. These clones can be further screened
using cDNA probes from the ap3 mutant, which
lacks stamens but has carpels. Thus, the stamen-
and/or carpel-specific clones can be further dis-
tinguished as either stamen- or carpel-specific. With
this accomplished, selected clones can be further ana-
lyzed by DNA sequencing and other methods.
So far, the subtraction has been performed and
verified using marker cDNAs as probes of Southern
blots containing the amplified, subtracted cDNAs at
each step during the subtraction. One marker for sub-
traction, GPAI, is ubiquitously expressed throughout
the flower. We have observed a gradual loss of GPAI
sequences over the course of the subtraction steps,
culminating in a loss of the GPAI signal to below
detection levels in the final subtracted cDNA. A
similar result was found using AGL2, which is also
expressed throughout the flower, as a probe. Another
marker cDNA, AGLI , is normally expressed only in
the carpels; in ag mutant flowers, AGL1 expression is
drastically reduced. We expected that AGL1 cDNA
should be preferentially retained, compared to GPAI
We found that the amount of AGL1 cDNA was
maintained after early subtractive hybridizations but
reduced slightly after the third round of hybridiza-
tion. These results suggest that the subtraction meth-
od eliminates much of common cDNAs (e.g., GPAI),
reduces the amount of cDNAs (e.g., AGL1) expressed
at low levels in ag mutant, and presumably enriches
inner-whorl-specific cDNAs.
A Northern blot containing both wild-type and ag
poly(A)+ RNAs was hybridized with the final sub-
tracted cDNA as probe. This Northern blot showed
that there are still some common cDNAs remaining
in the subtracted cDNA, indicating that the subtrac-
tion was not complete. We are presently analyzing in-
dividual plasmid clones containing cDNA inserts
from the subtracted cDNAs by Southern blot analysis
of plasmid DNA, probing with wild-type and ag
cDNAs to identify inner-whorl-specific cDNAs.
Those cDNAs that are specifically expressed in the
wild-type but not in the ag mutant will be further an-
alyzed, including the isolation and characterization of
full-length cDNAs.
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CELL CYCLE CONTROL IN SACCHAROMYCES
CEREVISIAE
B. Futcher B. Cox
B. Elliott
L. Littlepage
B. Schneider
W. Seufert
B. Steiner
F. Stincone
G. Tokiwa
M. Tyers
Q.-H. Yang
Our main interest continues to be regulation of Start
and mitosis in Saccharomyces cerevisae. We are
most interested in the tethering of division to cell
growth and in the generation of the basic cell cycle
oscillation. Many key cell cycle events are regulated
by protein kinase complexes formed between Cdc28
and a cyclin. There are now nine known cyclins with
cell cycle roles and probably more to come. These
fall into two broad groups: the G1 cyclins Clnl, Cln2,
and C1n3 (which regulate Start) and the mitotic, B-
type cyclins Clbl, C1b2, Clb3, and Clb4. Two other
cyclins, C1b5 and C1b6, are very important for DNA
replication, but they also have roles at Start and per-
haps also in early mitosis.
The highlight of the past year was collaborative
work with A. Amon and K. Nasmyth (IMP, Vienna)
which showed that the G1 cyclins and the mitotic
cyclins regulate each other. This interaction may
largely explain the autoregulatory cell cycle oscilla-
tion.
Autoregulation of Cell
Cycle Oscillation
A. Amon, K. Nasmyth (IMP, Vienna), M. Tyers, B. Futcher
In a normal cell cycle, the G1 cyclins shut off just as
the mitotic cyclins are coming on. Perhaps this is be-
cause the mitotic cyclins repress the G1 cyclins. This
turns out to be the case: a clbl clb2 clb3 clb4 mutant
cannot turn off the G1 cyclins. The mechanism of the
repression of G1 cyclins by Clbs seems to be that the
Clbs interact directly with Swi4, presumably inhibit-
ing it in some way. Swi4 is a necessary transcription
factor for the G1 cyclins, and thus, with Swi4 in-
hibited, the G1 cyclins turn off.
Another finding is that the CLBs have a positive
feedback loop for their own transcription. CLB tran-
scription seems to require cyclin-Cdc28 kinase ac-
tivity. Initially, this is probably provided by the G1
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cyclin complexes. Later, the Clbs themselves provide
the kinase activity needed for their own expression.
These findings led to a model of how the cell
cycle oscillation might work (Fig. 1). In early G1,
cells are small, and CLN3 is on. In a size-dependent
manner, CLN3 activates Swi4 and Swi6, and thereby
up-regulates transcription of CLN1, CLN2, and other
G1 cyclins. When the Cln-Cdc28 kinase is sufficient-
ly active, Start occurs. Passage through Start (and
Cln-Cdc28 kinase activity) allows expression of the
CLBs. Perhaps the Cln kinases directly phosphorylate
and activate a transcription factor for CLB expres-
sion. The Clbs, once on, repress transcription of
CLNI and CLN2 by inactivating Swi4. This destroys
the CLN-Swi positive feedback loop and so leads to a
loss of G1 cyclins (except for CLN3). Thus, the cells
have moved from a G1 state (CLNs on, CLBs off)
through an intermediate state (CLNs on, CLBs on) to
a G2 state (CLN1 and CLN2 off, CLBs on). High Clb
levels lead to mitosis. Completion of anaphase some-
G1, Growth
CLN3
SWI4, SWIG
0
CLN1, CLN2, etc
START
CLB2
Mitosis
G1, Growth
FIGURE 1 Model for cell cycle oscillation.
0
how triggers proteolysis of the Clbs. As the level of
Clb declines, the positive feedback loop for CLB
transcription collapses, amplifying the effect of
proteolysis on loss of the Clbs. Soon, all Clb protein
has been lost because of proteolysis and weakening
transcription, so Clb-Cdc28 kinase activity is lost,
and the mitotic spindle depolymerizes. Cells go
through cytokinesis and enter G1. Now that Clbs are
gone, Swi4 protein is no longer inactivated. Swi4 can
therefore be re-activated by the ever-present Cln3,
leading to transcription of CLN1 and CLN2 and the
next round of Start, and so on.
Mechanism of Cln3 Action
B. Cox, L. Littlepage (URP program)
Genetically, CLN3 is the most important G1 cyclin
gene, and yet biochemically, the Cln3 protein is rarer
than either Clnl or Cln2, and the associated protein
kinase is much weaker. The main role of CLN3
seems to be to activate the Swi4 and Swi6 transcrip-
tion factors, which allow transcription of CLN1 and
CLN2. Clnl and Cln2 proteins, although more
abundant than Cln3, are poor activators of Swi4 and
Swi6.
To look for proteins associated with Clnl, Cln2,
and Cln3, we attempted to use the two-hybrid screen
developed by S. Fields and co-workers. However, all
the Cln-Gal4 fusions tested were strong transcrip-
tional activators. Perhaps this reflects the normal role
of Cln3: Perhaps Swi4 and Swi6 bind Cln3-Cdc28
and bring the complex to the promoters of CLN1 and
CLN2, and Cln3-Cdc28 is the ultimate transcriptional
activator. We are testing this possibility by asking
whether Cln3 can be found in a complex with a
synthetic CLN2-like promoter.
Size, Growth, and Start
G. Tokiwa, M. Tyers, B. Schneider
The mRNAs and protein for the G1 cyclins CLN1,
CLN2, and CLN3 are extremely unstable. This poses
a problem for cells growing slowly under poor condi-
tions. If the G1 cyclins are being made slowly, but
still degraded rapidly, how does enough cyclin ac-
cumulate to trigger Start? We are examining G1
cyclin expression under different growth conditions
to address this question.
One finding is that CLN1 and CLN2 expression is
partly controlled by the Ras/cAMP pathway, which is
known to respond to nutrient conditions. Better
nutrients up-regulate the cAMP pathway, and this
leads to down-regulation of CLN1, and to some ex-
tent CLN2. Evidence for this is that (1) addition of
glucose to a culture growing on a poor carbon source
represses CLN1, (2) CLN1 fails to respond to glucose
in a strain lacking an intact cAMP signaling pathway,
and (3) the effect of glucose can be mimicked by ad-
dition of cAMP to a cAMP-permeable strain.
We think that this is a balancing mechanism.
When cells synthesize G1 cyclin rapidly, G1 cyclin
gene expression can be low. When protein synthesis
is slow, gene expression is de-repressed to com-
pensate. Consistent with this, cells lacking an intact
cAMP signaling pathway have difficulty adapting to
slow-growth conditions and must grow to extra-
ordinarily large sizes before going through Start, just
as if they were having difficulty accumulating suffi-
cient G1 cyclin.
What Is Start, Anyway?
Q.-H. Yang
Originally, Start was defined as a unique "point" in
the cell cycle at which cells become committed to
division. Operationally, cells have passed through
this "point" if they have budded and initiated DNA
synthesis and become resistant to mating pheromone.
It seems that passage through Start depends on
achieving a critical level of Cln-Cdc28 protein
kinase activity. Presumably, this kinase phosphory-
lates one, or several, key substrates that commit the
cell to division. Then it is this phosphorylation or
phosphorylations that constitute Start: Start may be
an event, or several events, rather than a point.
If there are several substrates, one important for
budding, one for DNA synthesis, one for pheromone
resistance, etc., then it should be possible to complete
some of these events but not others; i.e., perhaps Start
can be dissociated into its component events.
We have started to do this using a clnl cln2
GAL-CLN3 cdc34 strain. According to current
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dogma, the CLNs are needed only for Start. A cdc34
mutant arrests as a budded cell that has not initiated
DNA synthesis; i.e., it is past the "point"
of Start
(since it has budded), but its mutant defect prevents
DNA replication. In our experiment, we grow
the
clnl cln2 GAL-CLN3 cdc34ts strain in galactose
me-
dium (to provide CLN3 from the GAL promoter) at
23°C (the permissive temperature for cdc34). The
cells are shifted to 37°C (restrictive), and the cells ar-
rest with buds (i.e., past Start, and so by definition
"committed" to division). While at the arrest, the
galactose medium is washed away and replaced by
raffinose medium. CLN expression ceases, and Cln3
protein is lost by rapid proteolysis. The cells are now
shifted back to permissive temperature. However,
they do not progress in the cell cycle; they still do not
replicate DNA. This indicates that the cells were not
in fact irreversibly committed to DNA replication
even though they had budded. Either there was a re-
versible commitment or budding and DNA replica-
tion are due to two separate events.
Cib Proteolysis
W. Seufert
Mitotic cyclins are destroyed at the end of anaphase.
This cyclin destruction is needed for the loss of
Cdc28 kinase activity, which is needed for spindle
depolymerization and exit from mitosis. As shown in
Figure 1, loss of mitotic cyclin is a key re-setting step
in the cell cycle, not only allowing mitotic exit, but
also allowing re-expression of CLN G1 cyclins in the
next G1 phase.
All known mitotic cyclins, including Clbl, 2, 3,
and 4 in S. cerevisiae, have amino-terminal signals
called "destruction boxes" which target the cyclin for
ubiquitination and proteolysis. We have been investi-
gating this proteolysis. Previously, it had been found
by W. Seufert and S. Jentsch that the ubiquitin-
conjugating enzyme Ubc9 was important for Clb
destruction. Now, we have found that another
ubiquitin-conjugating enzyme, Ubc1, is also in-
volved. Strangely, the destruction of at least two dif-
ferent Clbs with rather similar destruction boxes is
regulated independently. In our system, the destruc-
tion box alone does not seem to lead to cell-cycle-
regulated proteolysis. Perhaps there are other signals
for proteolysis somewhere else in the cyclins, and
these are responsible for the timing of destruction.
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Mechanisms of Heat Shock
Resistance
B. Elliott
Although many proteins are induced by heat shocks,
it is not clear how these induced proteins are involved
in heat shock resistance. In most cases, mutational in-
activation of a heat-shock-induced gene does not
cause cellular heat shock sensitivity. Heat shock
sensitivity can be caused by mutations in the
Ras/cAMP pathway, suggesting that it is a major
regulator of resistance. To find out about mechanisms
of heat shock resistance, we looked for mutants that
lacked induced heat shock resistance. One mutant is
of particular interest because it controls heat shock
resistance independently of the Ras/cAMP pathway.
This mutant lacks the function of a gene called
TPS2, which is thought to be involved in synthesis of
trehalose, a storage carbohydrate. Our tps2 null
mutant, however, does make trehalose, and therefore
lack of trehalose does not seem to be the cause of
sensitivity. There must be alternative pathways for
trehalose synthesis. TPS2 is a very large gene, and it
has two close homologs in yeast. Different alleles of
these genes cause a bewildering array of defects in
growth, glycolysis, carbohydrate and phosphate me-
tabolism, and, as we now know, heat shock resis-
tance. How these are all tied together is unclear.
Yeast Telomerase
B. Steiner
Telomerase is an enzyme that adds repeats (in this
case, G1_3T) to the ends of chromosomes to com-
pensate for the loss of terminal sequences during
DNA replication. It is possible that somatic mam-
malian cells lack this enzyme, and this may be one of
the causes of cellular senescence.
Because the enzyme is rare and biochemical char-
acterization has been difficult, we are taking a genetic
approach to finding the genes involved. We have
constructed a circular plasm id that can be linearized
in vivo upon expression of the HO endonuclease. The
linearized plasmid has very short telomeres at its
ends and will only survive in the cells if these proto-
telomeres can be lengthened. We are using this
aproach to screen for mutants that cannot lengthen
the plasmid telomeres; these may be telomerase
mutants.
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TRANSCRIPTION AND CELL CYCLE REGULATION IN YEAST
K.T. Arndt A. Sutton C. Devlin
M. Luke F. Lin
F. Della Seta A. Doseff
T. Zhong
C.J. Di Como
H. Chang (URP)
Our research focuses on the regulation of the G1
phase of the cell cycle. For most eukaryotic organ-
isms, it is during G1 that decisions are made as to
whether or not to initiate the cell cycle and divide.
For these studies, we use the model organism Sac-
charomyces cerevisiae, which is commonly called
budding yeast. Budding yeast cells that have ex-
ecuted the late G1 event(s) termed "Start" are com-
mitted to initiate DNA synthesis, form a bud, and di-
vide. Start is the point where growth signals and
mating factors control entry into the cell division
cycle. The execution of Start seems to require some
threshold level of G1 cyclin/CDC28 kinase activity,
which is determined in large part by the rate and
levels at which the G1 cyclin RNAs accumulate dur-
ing late G1. However, very little is known about the
mechanisms that determine if G1 cyclin RNAs ac-
cumulate and the rate at which G1 cyclin RNAs ac-
cumulate.
Many cell cycle events are controlled by the
regulation of the phosphorylation of certain key cell
cycle substrates. We have found that the SIT4 protein
phosphatase, which removes phosphate groups from
phosphoserine and phosphothreonine residues, is re-
quired during late G1 for the execution of Start, for
bud formation, for the initiation of DNA synthesis,
and for spindle pole body duplication. Our major
goals are to determine the signals that control the
ability of SIT4 to promote Start and the mechanisms
by which SIT4 regulates Start and late G1.
SIT4 Is Required for G1
Cyclin Accumulation
K. Arndt, C.J. Di Como, H. Chang
SIT4 is required for the execution of Start because it
is required for the expression of the CLN1 and CLN2
G1 cyclin genes. CLNI and CLN2 proteins bind to
CDC28, thereby activating the kinase activity of
CDC28. When some threshold level of CLN/CDC28
kinase activity is reached, Start is executed and the
cells are committed for DNA synthesis and the com-
pletion of the cell cycle. During early G1, the levels
of CLN1 and CLN2 RNAs are very low. During late
G1, the levels of CLN1 and CLN2 RNAs increase at a
very rapid rate. The rate at which CLN1 and CLN2
RNAs accumulate is determined in part by the ac-
tivity of the CLN3 gene. Hyperactive alleles of CLN3
cause a more rapid rate of increase of CLN1 and
CLN2 RNA accumulation, whereas loss-of-function
alleles of CLN3 cause a slower rate of increase.
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Much evidence shows that CLN3 and SIT4 pro-
RNAs during late G1 at extremely slow rates and low
vide additive pathways for the activation of
CLNI levels. Moreover,
the strong growth defect of a Abck2
Acln3 SSD1-v strain is completely cured by low-level
and CLN2 expression. In fact,
mutation of both SIT4
expression of CLN2 from a S/T4-independent pro_
and CLN3 causes a near lethal effect that is
due sole-
moter. In addition, expression .of BCK2 from the
ly to a defect in CLN1 and CLN2
expression. Like a
pGAL promoter, in a CLN3 strain or a Acln3 strain,
sit4 mutation, a mutation in any gene required in the
SIT4 pathway for the activation of CLNI and CLN2
induces CLN1, CLN2, and SCB:lacZ expression (to
expression should also be lethal in combination with
levels slightly higher than expression of the hyperac-
a Acln3 mutation. Therefore, to identify
genes tive CLN3-1
allele from the pGAL promoter). There_
functioning in the SIT4 pathway for the activation of
fore, BCK2 and CLN3 provide parallel activation
CLN1 andCLN2 expression, we used a
colony sec- pathways for CLNI, CLN2,
and SCB-dependent ex_
toring assay to isolate mutants that could not grow in
pression during late G1. In the absence of either
CLN3 or BCK2, the other gene provides a good path-
the absence CLN3. These mutants, termed ctr (for
CLN three requiring), fell into 12 complementation
way for the cell-cycle-dependent expression of CLN1
groups that were divided into two classes: class A,
and CLN2 via SWI4-dependent SCB promoter ele-
where (like sit4 mutations) the synthetic lethality ments. In the absence
of both CLN3 and BCK2, ex-
with Acln3 is cured by expression of CLN2 from a
pression of CLNI and CLN2 is extremely low. We
SIT4-independent promoter, and class B, where the suggest that BCK2
functions in the SIT4 pathway for
synthetic lethality with Acln3 is only partially cured reason -
by
and CLN2 expression by the following reason
 heterologous expression of CLN2. We predict that
ing (see Fig. 1): BCK2 and CLN3 provide parallel
pathways for the activation of G1 cyclin expression
CTR genes of class A function for CLNI and CLN2
expression, whereas CTR genes of class B might and a Abck2
Acln3 SSD1-v strain grows very slowly
function downstream from CLNI andCLN2 (they re- due to a defect in CLN1 and CLN2 expression.
Lquire higher than normal levels of CLN2) or might ikewise, SIT4 and CLN3 provide parallel pathways
function in a pathway parallel to that of CLN3, but for the activation of G1 cyclin expression and a Asit4
that is not involved directly in CLN1 or CLN2 expres- Acln3 SSD1-v strain grows extremely slowly due to a
sion. Therefore, we have concentrated on the analysis defect in CLNI and CLN2 expression. However, a
of the class A group. Abck2 Asit4 SSD1-v strain grows at a rate identical to
So far, we have analyzed ctrl in the most depth. that of a Asit4 SSD1-v strain, and both strains have
The CTR7 gene is the same as the BCK2 gene, pre- the same slow rate of CLN1 and CLN2 accumulation
viously identified in David Levin's laboratory by its during late G1. These findings, and others (e.g. unlike
ability, when overexpressed, to suppress partially the a Acln3 Aswi6 SSD1-v strain which is viable, but like
temperature-sensitive cell lysis defect (due to a defect a Asit4 Aswi6 SSD1-v strain which is inviable, a
in polarized cell growth) of pkcl mutants (PKC1 en- Abck2 Aswi6 SSD1-v strain is inviable), suggest a
codes a protein kinase C homolog) and mpkl mutants model where BCK2 functions within the SIT4 path-
(MPK1 encodes a MAP kinase homolog that func- way for G1 cyclin expression. Our future experiments
tions downstream from PKC1). In summary, the fol- will be directed toward determining the mechanism
lowing are our findings: Deletion of BCK2, like dele- of BCK2 function and how BCK2 relates to SIT4
tion of CLN3, causes no obvious growth defect but (the sequence of BCK2 provides no clues for its func-
causes the cells to be more sensitive to a factor and tion).
to execute Start at a larger than normal cell volume.
Overexpression of BCK2, like hyperactive alleles of
CLN3, causes the cells to be more resistant to a fac-
tor and to execute Start at a smaller than normal cell Characterization of the In Vitro
volume. At the level of CLNI and CLN2 expression, Phosphatase Activity of SIT4
a Abck2 strain or a Acln3 strain still has cell-cycle- M. Luke
dependent expression of CLN1, CLN2, and a SCB-
driven lacZ gene (the rate of accumulation is slightly In vitro, we have not been able to detect any SIT4 ac-
delayed). However, a Abck2 Acln3 SSD1-v strain tivity toward para-nitrophenol phosphate or a protein(like a Asit4 Acln3 SSD1-v strain) has a severe phosphorylated on tyrosine residues. However, using
growth defect and accumulates CLNI and CLN2 RCM-lysozyme phosphorylated by protein kinase A
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FIGURE 1 A model for BCK2 function.
(a gift from J. Kuret) as an artificial substrate, the
SIT4 phosphatase activity is readily detectable in
vitro. In this assay, the SIT4 phosphatase activity is
optimal at pH 6 and does not require monovalent or
divalent cations. The SIT4 phosphatase activity is
similar to that of mammalian type-2A protein phos-
phatases in that it is inhibited by nanomolar con-
centrations of okadaic acid. Type-1 protein phospha-
tases require higher concentrations of okadaic acid
for inhibition. This is consistent with the fact that
SIT4 is more similar to the catalytic subunit of type-
2A phosphatases than to that of type-1 phosphatases.
This in vitro phosphatase assay has also been used to
show that the activity of the SIT4-102 protein (a sit4-
102 strain is temperature sensitive and arrests in late
G1) is lower than that of wild-type SIT4 protein at
24°C and (unlike wild-type SIT4 which is more ac-
tive at 37°C) is not detectable at 37°C. Therefore,
sit4-102 strains arrest in late G1 because of the ab-
sence of SIT4 activity. In the future, we hope to use
substrates for the in vitro assay that are true in vivo
substrates of SIT4.
Identification of SIT4-interacting
Proteins by the Two-hybrid Approach
F. Della Seta
To identify the cellular substrates and regulatory sub-
units of SIT4, we used the two-hybrid technique (de-
veloped by Stan Fields) to identify SIT4-interacting
proteins. We have prepared fusions of SIT4 to lexA
(a bacterial DNA-binding factor, with no eukaryotic
activation domain) and the DNA-binding domain of
GAL4 (residues 1-147). The lexA-SIT4 fusion was
transformed into a strain that contains the HIS3 and
lacZ ((3-galactosidase) genes driven by promoters
containing lexA DNA-binding sites as UAS se-
quences. Similarly, the GAL4(1_147)-SIT4 fusion was
transformed into a strain that contains the HIS3 and
lacZ ((3-galactosidase) genes driven by a promoter
containing GAL4 DNA-binding sites as UAS se-
quences. Neither the lexA-SIT4 protein nor the
GAL4(1-147)-SIT4 protein activated transcription
from the lexA or GAL4 DNA-binding site containing
promoters, respectively. These strains were trans-
formed with libraries containing yeast DNA se-
quences fused to the GALA transcriptional activation
domain (which does not have DNA-binding function
on its own). If the yeast sequences encode a protein
that interacts with SIT4, then the GALA transcrip-
tional activation domain should be tethered to the
lexA-SIT4 or GAL4 (1-147)-SIT4 fusions, resulting in
the activation of transcription from lexA and GALA
DNA-binding sites, respectively.
We have used the two-hybrid system to screen
more than 107 transformants from yeast genomic and
cDNA libraries. We have obtained 20 unique library
plasmids (many isolated multiple times) that pass all
the tests of specificity to SIT4. Our next step will be
to determine which of the 20 library plasmids encode
proteins that physically and/or functionally interact
with SIT4. We hope that the analysis of the proteins
interacting with the SIT4 will allow us to better
define the in vivo SIT4 substrates and the functions
of SIT4.
Function and Regulation of the
SIT4 Phosphatase in the
Yeast Cell Cycle
M. Luke, F. Della Seta
During most of G1, SIT4 exists mostly as monomeric
uncomplexed SIT4. Very close to the time SIT4 is re-
quired for the execution of Start and for bud forma-
tion, SIT4 associates in separate complexes with two
high-molecular-weight proteins, p155 and p190 (the
complexes dissociate at about mid-mitosis). We
propose that p155 and p190, like the high-molecular-
weight targeting subunits of type-1 phosphatases,
may target SIT4 to specific substrates during late
In this model, we propose that growth signals cause
the association of p155 and p190 with SIT4, thereby
activating the SIT4-dependent processes of G1 cyclin
expression and bud formation.
To date, our genetic approaches have not identified
the genes encoding p155 and p190. To determine the
function of p155 and p190, we need to obtain these
genes. Therefore, we purified p155 and p190 to ob-
tain partial peptide sequence and for antibody pro-
duction. More than 100 ps each of p155 and p190
were purified by multiple large-scale immunoprecipi-
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tations of HA epitope-tagged SIT4
followed by SDS-
PAGE. The sequences of the p155
and p190 peptides
are being determined by R.
Kobayashi (see Structure
and Computation Section). Thepartial sequences
of
six peptides for each of p155
d p190 have been
generated and show that the genes
encoding p155 and
p190 are not in the current
databases. Using the p155
and p190 partial peptide sequences, we
have prepared
degenerate oligonucleotide primers.
The cloning of
the p155 and p190 genes by
polymerase chain reac-
tion is in progress. With the p155 and
p190 genes in
hand, we will prepare mutations in the p155
and p190
genes and determine the separate
functions of p155
and p190.
Identification of Genes
Functioning in the SIT4
Pathway for Bud Initiation
A. Doseff
In certain strain backgrounds, deletion of SIT4 is not
lethal but instead results in very slow growth with a
greatly expanded G1 phase. The ability to live in the
absence of SIT4 is due to a single genetic locus,
which we term SSD] (suppressor of sit4 deletion).
SSDI -v alleles allow viability in the absence of SIT4,
whereas ssdl-d alleles give death in the absence of
SIT4. The SSD] locus is polymorphic in that some
strain backgrounds have a SSD1 -v allele and other
strain backgrounds have a ssdl-d allele.
Deletion of SSD1 in a wild-type SIT4 strain
results in only subtle phenotypic alterations (especial-
ly in G1 regulation). It seems that whatever SIT4 can
do, SSDI-v can do as well. For instance, SSD1 -v pro-
vides a pathway to CLN1 and CLN2 expression that
is independent of SIT4. However, the SIT4 pathway
is the major pathway to G1 cyclin expression, where-
as the SSD1-v pathway is a minor pathway.
If CLN2 is expressed from a SIT4- independent
promoter, the cells can initiate and complete DNA
synthesis in the absence of both SIT4 and SSD1 -v
function. Therefore, SIT4 and SSDI-v are required for
CLNI and CLN2 expression, which is required for
Start and the initiation of DNA synthesis. However,
independently of CLN2 expression, SIT4 and SSD1 -v
are also required for bud formation. Again, SIT4 pro-
vides the major pathway and SSDI-v provides the
minor pathway leading to bud formation.
Very little is known about the factors that regu-
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late bud emergence and polarized cell growth. That
blocking protein synthesis in cells released from a
Start arrest allows actin polarization to the site of fu..
ture bud emergence but prevents bud emergence
raises the possibility that some factor required for
bud emergence does not pre-exist at Start but must be
expressed during late G1 at some time post-Start.
Could SIT4/SSD1 be required for the expression of
this factor? Unfortunately, there are too many un-
known processes involved in bud emergence to de-
sign experiments to address these questions directly.
Therefore, we have initiated a screen that should
identify genes that function in the SIT4 pathway for
bud emergence.
We used a synthetic lethal screen to identify
genes that function in the SIT4 budding pathway by
isolating mutations that (like sit4) are lethal in the ab-
sence of SSDI -v. From this screen, we isolated 75
mutants (termed LAS, for lethal in the absence of
SSD1) that fell into six complementation groups.
That we isolated mutations in SIT4 four times con-
firms the design of the screen. LAS1 (defined by the
major complementation group) is a previously
unidentified essential gene that encodes a predicted
64-kD protein with no strong similarity to known
proteins. Overexpression of LAS1 (from the pGAL
promoter) causes a remarkable phenotype: Up to five
extra small buds are formed in addition to the main
bud (Fig. 2; the main bud of the cell is not visible in
this slice). These projections are buds because actin
cables extend into the projections and because SPA2
protein (which is localized to normal buds in wild-
type cells) is localized to each small projection.
These small buds remain small and do not get larger,
suggesting that overexpression of LAS1 promotes
emergence of the bud, not continued growth of the
bud. In addition, that these extra small buds occurred
only on the mother cell suggests that the cells might
have to execute Start to obtain the extra small buds.
These findings (combined with the finding that HA
epitope-tagged LAS1 fractionates with nuclei) raise
the possibility that LAS1 is a positive regulator of
bud emergence. Database searches showed that LAS1
has weak similarity to the E2F transcription factor
and that this similarity is better than that between
E2F and SWI4 (which has been proposed to be re-
lated to E2F). However, the significance of the weak
similarity of LAS1 to E2F is not known.
Although mutations in LAS1 interact genetically
with mutations in SIT4, we do not yet know if LAS1
and SIT4 function within the same pathway for bud
FIGURE 2 Overexpression of LAS1 causes the formation of
extra small buds. Thin-section electron microscopy (freeze
substitution; performed by Bob Derby) of a pGAL:LAS1
strain grown on galactose medium; 50-60% of the cells had
three to five extra small buds in addition to a main bud
(which gives rise to the daughter cell). The main bud is not
visible in this slice.
formation. Future experiments will be directed
toward identifying how the function of LAS1 is re-
lated to the requirement of SIT4/SSD1-v for bud
formation.
Isolation of Mutations That
Cause Lethality in Combination
with a sit4 Mutation
A. Sutton
One way to identify genes functioning downstream
from SIT4 (within the SIT4 pathway) or in a pathway
parallel to the SIT4 pathway is to identify mutations
that cause inviability in the absence of SIT4 function.
We obtained mutations in eight different com-
plementation groups that cause lethality in the ab-
sence of SIT4 function. These genes are called PDL1
through PDL8, for phosphatase deficient lethality. So
far, we have initiated the characterization of PDL1
and PDL3.
The PDL1 gene is the same as the previously
identified CHS1 gene. CHS1 encodes one of three
known chitin synthase enzymes in budding yeast.
Chitin synthase is required for cell wall chitin
synthesis at specific stages of the cell cycle. Unlike
the pd11-1 mutation, which causes lethality in the ab-
sence of SIT4, deletion of CHS1 does not cause
lethality in the absence of SIT4. This finding suggests
that the pd11-1 allele is not simply a loss-of-function
mutation. Although there are no readily observable
phenotypic alterations associated with the poll -1
mutation in a wild-type SIT4 cell, the pattern of chitin
deposition in the pd11-1 cell walls is aberrant: There
is a very pronounced punctate staining throughout the
mother cell and daughter bud. The poll -1 mutation
may alter the localization and/or enzymatic activity
of CHS1. Experiments ar?, currently under way to
distinguish between these possibilities. In any case,
that the poll -1 mutation results in lethality in the ab-
sence of SIT4 suggests a role of SIT4 in cellular mor-
phogenesis or cell wall biosynthesis.
The PDL3 gene encodes P previously unidenti-
fied essential protein with sequence similarity to
serine/threonine protein kinases. We have made sev-
eral mutations in PDL3 that separately alter residues
which are highly conserved among protein kinases
and are known to be required for catalytic activity.
These mutations result in sharply reduced PDL3 -
dependent kinase activity in vitro. The pdB mutation
causes an aberrant cell morphology (the cells are con-
siderably longer than wild-type cells), implicating the
PDL3 kinase in polarized cell growth. The pdB
mutation also causes a delay in the G2 or M phase of
the cell cycle. Northern analysis reveals that pdB
mutant cells have a defect in their ability to accumu-
late mitotic cyclin RNAs during G2. Therefore, the
PDL3 protein kinase may be involved in mor-
phogenesis and may be required for activation of the
CLB/CDC28 kinase. We have previously obtained
evidence suggesting that SIT4 may have a direct role
in budding. The fact that we have identified genes in-
volved in budding and polarized cell growth in a
synthetic lethal screen with a sit4 mutation provides
further support for this hypothesis.
Overexpression of SIS2 Increases
the Growth Rate of sit4 Mutants
C.J. Di Como
Yeast strains containing a mutation in the SIT4 gene
have a very slow growth rate. SIS2 was isolated as a
gene that, when present in high copy number, dra-
matically increased the growth rate of sit4 mutants.
Moreover, loss-of-function mutations in SIS2 cause
lethality when combined with a sit4 mutation. Addi-
tional genetic tests show that SIS2 functions in a
pathway parallel to the SIT4 pathway (but not in the
SSD1-v pathway).
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functions of the SISI gene, we isolated an extragenic
The SIS2 gene predicts a protein of 562 amino Ts+ suppressor of the temperature-sensitive sis1-85
acids and a molecular mass of 62 kD. The
SIS2
mutant strain. This suppressor mutation occurred in
terminalregion where within a stretch of 59 amino
protein contains an extremely acidic
carboxy-
the gene encoding a 60S ribosomal subunit protein
acids, 51 residues are either glutamate or aspartate.
These results led to the finding that SISI is required
Strains containing a deletion of SIS2 are
viable and for the initiation
of translation and associates with
have a normal growth rate, are not temperature sensi-
ribosomes. Recently, we found that SISI may have an
al role: r of the heat shock
five for growth, accumulate normal
levels of ad
Wditionne d ot current
ulation response.
know if the heat shock regula-
glycogen, have no obvious mating defects, and have tion role of SISI is related to the role of SISI for the
a normal cell size.
Because sit4 mutants have a defect in G1 cyclin
initiation of translation.
RNA accumulation, we examined if overexpression
Heat shock normally results in the rapid transcrip-
tional activation of heat shock genes and the prefer-
of SIS2 can stimulate the rate of CLNI and CLN2
RNA accumulation during late G1 in a sit4 mutant.
ential translation of heat shock messages. The tran-
We found that overexpression of SIS2 greatly in-
scription and translation of nonheat shock genes are
creased the rate of CLNI and CLN2 RNA accumula-
repressed. We examined the levels of SISI RNA in
tion in sit4 mutants. In addition, we looked at a CLN1
wild-type SISI strains and in sill mutant strains. In-
cln2 cln3 (wild-type SIT4) strain, which accumulates
terestingly, at 24°C with no heat shock, the levels of
CLNI RNA at slower rates due to the absence of
SIS] RNA are fivefold higher in the sis/ mutant
CLN2 and CLN3. We found that overexpression of
strains than in a wild-type SISI strain. Addition of
SIS2 greatly increased the rate of CLN1 RNA ac-
wild-type SISI to the sis/ mutant strains represses the
cumulation for a CLN1 cln2 cln3 strain. The ability sis/ RNA levels. Therefore, the cells can sense a
of overexpressed SIS2 to stimulate G1 cyclin expres- defect in SISI and induce the transcription of SISI.
sion suggests that overexpression of SIS2 increases Because the levels of sis/ RNA are induced in sis/
the growth rate of sit4 mutants by stimulating the mutants, we examined the effect of sis/ mutations on
transcription of certain genes whose RNA levels are the RNA levels of other heat shock genes, including
present at low levels due to the sit4 mutation. the HSP70 (DnaK homolog) and HSP90 gene
To determine the mechanism by which SIS2 is families.
able to stimulate transcription, we performed The SSA4 gene is one of four highly related
biochemical fractionation experiments. SIS2 frac- genes encoding a particular class of yeast HSP70
tionates with nuclei. In addition, SIS2 is released protein. In a wild-type strain, heat shock causes a 5-
from the nuclear fraction upon treatments (DNase I fold induction of SSA4 RNA levels. The SSA4 gene
or micrococcal nuclease) that digest DNA within has no sustained heat shock response: By 90 minutes
chromatin but not by other treatments (RNase A). after the heat shock of a wild-type strain, SSA4 RNA
These results raise the possibility that SIS2 might decreases to very low levels. In contrast, in an sis/
physically interact with chromatin. Indeed, strains mutant strain, heat shock causes an 18-fold induction
with lower histone gene dosage of histone H2A and in the level of SSA4 RNA and after 90 minutes, the
H2B are sensitive to higher levels of SIS2 protein level of SSA4 RNA is about 60% of the maximal heat
(due to even a single extra copy of the SIS2 gene). shock level. Elevated expression of the SSA4 gene
has also been seen in ssal ssa2 mutant strains. The
increase in the level of SSA4 RNA under conditions
The SISI Protein: An Essential DnaJ of reduced SISI function suggests a negative regu-
Homo log Required for the Initiation of latory model of the control of the heat shock
Translation and for Normal Regulation response. We also looked at the effect of sis/ muta-
of the Heat Shock Response tions on the expression of the two yeast HSP90 genes(termed HSC82 and HSP82). Importantly, the expres-
T. Zhong sion of the constitutively expressed HSC82 gene and
the expression of the heat-shock-inducible HSP82
The budding yeast SISI gene encodes an essential gene were not altered in sis/ mutants. Therefore, sis/
heat shock protein with similarity to the bacterial mutations selectively alter the heat shock response of
DnaJ heat shock protein. To understand the cellular only certain heat shock genes. Future studies will be
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directed at the determination of the SIS1-responsive
promoter elements present in the SIS1 and SSA4
promoters.
Role of Type-2A Protein
Phosphatase for Entry
into Mitosis
F. Lin
Budding yeast has two type-2A protein phosphatase
genes, PPH2a and, PPH213. Disruption of either gene
has no detectable effects, but deletion of both genes
results in a slow growth phenotype. Only triple dele-
tions of PPH2a, PPH2r3, and a third type-2A-related
gene, PPH3, are lethal. To investigate how type-2A
protein phosphatases function for the cell cycle, we
prepared a temperature-sensitive mutation in PPH211,
in a strain deleted for PPH2a and PPH3. For sim-
plicity, we call this strain pph2(3-102. When shifted
to 36°C, the pph213-102 cells accumulate budded
cells with a 2n DNA content and with a defect in
mitotic spindles. These findings suggest that a major
requirement for type-2A phosphatase is for advance-
ment into mitosis.
A key factor required for progression from G2
into mitosis is the B cyclin/CDC28 kinase. Because
CLB2 is the major B cyclin in budding yeast, we ex-
amined the CLB2/CDC28 kinase activity (for histone
H1) in wild-type and pph213-102 mutant cells. When
released from a hydroxyurea arrest (which gives large
budded cells with a 1 n DNA content) and shifted to
36°C, wild-type cells are able to double the cell num-
ber and finish one cell cycle within 2 hours. In addi-
tion, the CLB2/CDC28 kinase activity increased
dramatically as the cells entered and progressed
through mitosis. In contrast, the pph213-102 cells
completed DNA synthesis but failed to increase in
number and failed to increase the CLB2/CDC28
kinase activity (in fact, the CLB2/ CDC28 kinase ac-
tivity decreased) even though the levels of CDC28
were normal and the levels of CLB2 protein were
normal. One known pathway for the activation of B
cyclin/CDC2 complexes (CDC2 is a homolog of
CDC28) is via the dephosphorylation of a phospho-
tyrosine in the ATP-binding pocket of CDC2. How-
ever, changing the Tyr-19 residue of CDC28 (in the
presumed ATP-binding pocket) to a phenylalanine
residue did not cure the G2 block and did not restore
the kinase activity of the CLB2/ CDC28 complexes
isolated from a pph213-102 strain shifted to 36°C.
Therefore, in budding yeast, the type-2A phos-
phatases are required, by a mechanism other than
Tyr-19 dephosphorylation, to activate CLB2/CDC28
complexes.
Alterations in GMP Synthase
Can Increase HIS4 Transcription
in the Absence of the Normal
Activators of Transcription
C. Devlin
GCN4, BAS1, and BAS2 are transcription factors
that bind to the HIS4 promoter to activate HIS4 tran-
scription. In the absence of GCN4, BAS1, and BAS2,
the yeast cells have a His- phenotype due to insuffi-
cient transcription of HIS4 (which encodes an en-
zyme required for biosynthesis of histidine). We iso-
lated sit mutations (suppressors of the initiation of
transcription) that confer the ability of a gcn4 basl
bas2 strain to increase HIS4 transcription and become
His+. The sit/ and sit2 mutations occurred in the
largest and second largest subunits of RNA poly-
merase II. Mutations in the SIT7 gene, which encodes
GMP Synthase, were also isolated as His suppres-
sors of a gcn4 basl bas2 strain. Primer extension
analysis showed that the HIS4 RNA in the sit7 strain
initiated at four sites: One of the start sites was at the
wild-type initiation site, and three of the start sites
were upstream of the wild-type HIS4 transcription in-
itiation site. HIS4 RNAs initiating at the site immedi-
ately upstream of the wild-type site were the most
abundant. A sit7-1 mutant strain has a slow-growth
phenotype, is temperature sensitive for growth at
37°C, and is a partial inositol auxotroph. Addition of
guanosine to the culture medium stimulated the
growth rate of the sit7-1 strain and reversed the His+
suppression effect. Therefore, limitation of guanine
nucleotides can alter transcription of HIS4 in the ab-
sence of the normal DNA-binding transcriptional ac-
tivators. This effect is specific to guanine nucleotides
because limitation for adenine nucleotides does not
alter HIS4 transcription. The mechanism by which
limitation for guanine nucleotides alters transcription
is under investigation.
PUBLICATIONS
Zhong, T. K.T. and Arndt. 1993. The yeast SIS1 protein, a
DnaJ homologue, is required for the initiation of transla-
tion. Cell 73: 1175-1186.
169
INITIATION AND TERMINATION OF
TRANSCRIPTION IN
HUMAN snRNA GENES AND HIV-1
N. Hernandez R.W. Henry
S.M. Lobo
R. Mital
D.B. Morrison
P.S. Pendergrast
F.C. Pessler
C.L. Sadowski
M. Sheldon
M.L. Sullivan
SMALL NUCLEAR RNA GENES
As a step toward understanding the determinants
of RNA polymerase specificity in snRNA gene tran-
The human small nuclear RNA (snRNA) genes form scription, we are identifying the factors involved in
a unique family containing both genes
transcribed by transcription of the Ul, U2, and U6 snRNA genes. In
RNA polymerase II (e.g., the U1 and U2 genes) and particular, we have examined whether transcription
genes transcribed by RNA polymerase III (e.g., the of these genes requires TBP- or TBP-containing corn.
U6 gene). Yet all snRNA genes have very similar plexes.
promoters that consist of an essential proximal se-
quence element (PSE) located around position -55
and an enhancer referred to as the distal sequence ele-
ment (DSE) located around position -215. The RNA
polymerase III snRNA promoters contain in addition Characterization of the
a TATA box located around -28. Curiously, the TFIIIB Fraction
TATA box is the determinant of RNA polymerase III
specificity. When the U6 TATA box is mutated, the S.M. Lobo, M.L. Sullivan, N. Hernandez
RNA polymerase III U6 promoter becomes tran-
scribed mainly by RNA polymerase II, and when the Figure 1A shows the assembly of transcription fac-
U6 TATA box is inserted into the U2 promoter, the tors on a typical RNA polymerase III promoter, the
RNA polymerase II U2 promoter becomes tran- VAI promoter. Like the promoters of tRNA genes,
scribed by RNA polymerase III. Because the RNA the VAI promoter consists of an A box and a B box
polymerase II and III snRNA promoters are so located downstream from the start site of transcrip-
similar, they offer a unique model system to identify tion. These elements are recognized by the transcrip-
the determinants of RNA polymerase specificity. tion factor IIIC, a large factor composed of at least
Tremendous progress has been achieved in identi- five polypetides. The binding of TFIIIC allows the
fying and cloning genes corresponding to transcrip- recruitment of TFIIIB to the DNA, and this in turn al-
tion factors involved in RNA polymerase I, II, and III lows the recruitment of RNA polymerase III. In
transcription. One of the key advances has been the yeast, it has been shown that after the recruitment of
realization that several of the factors that had been TFIIIB, TFIIIC can be stripped off the DNA by treat-
refractory to purification by standard chromatography ment with high concentrations of salt or heparin,
are in fact large complexes that contain a common leaving only TFIIIB on the DNA. TFIIIB on its own
subunit, the TATA-box-binding protein (TBP). Thus, is then capable of directing several rounds of tran-
TFIID, which recognizes the TATA box in promoters scription by RNA polymerase III. Thus, at least in
of mRNA-encoding genes and is also required for yeast, TFIIIC is an assembly factor whose main role
transcription from TATA-less mRNA promoters, is a is to recruit TFIIIB to the DNA, whereas TFIIIB
large TBP-containing complex consisting of TBP and recruits RNA polymerase III, presumably by direct
eight to ten associated polypetides. SL1, a factor re- protein-protein contacts.
quired for transcription of the rRNA genes by RNA Since TFIIIB is a key RNA polymerase III tran-
polymerase I, is a TBP-containing complex consist- scription factor in yeast, we wanted to characterize
ing of TBP and three associated polypeptides. In ad- mammalian TFIIIB and evaluate its role in transcrip-
dition, TFIIIB, a factor involved in RNA polymerase tion of the VAI and U6 genes. Mammalian TFIIIB
III transcription from TATA-less RNA polymerase consisted of a crude phosphocellulose fraction (B
III promoters such as the 5S and tRNA promoters, is fraction). We further fractionated TFIIIB by chroma-
also a TBP-containing complex. tography over a Mono-Q column and could show that
the activity separates into two components designated
0.38 M- TFIIIB and 0.48 tvi-TFIIIB, which are both re-
quired for transcription of the VAI gene. 0.38 tvi-
TFIIIB is a TBP-containing complex, whereas 0.48
tvi-TFIIIB is uncharacterized. Thus, as shown in Fig-
ure 1B, we can now represent the TFIIIB fraction as
consisting of two components, one of which (0.38 M-
TFIIIB) is a TBP-containing complex.
An important question is whether the VAI and U6
promoters, which have completely different struc-
tures, recruit the same TFIIIB components. We have
shown previously that transcription from the U6
promoter requires TBP bound to the U6 TATA box
in addition to the TFIIIB fraction. As illustrated in
Figure 1C, transcription reconstitution experiments
indicate that U6 transcription requires only the 0.48
tvi-TFIIIB component in addition to TBP. The 0.38 IA-
TFIIIB TBP-containing complex is dispensable. This
A
VAI
B
0.38M TFIIIB
VAI
C
U6
0.48M TFIIIB TFIIIC
7
PSE
FIGURE 1 TFIIIB is composed of two separable activities,
only one of which is required for U6 transcription. (A) TFIIIC
binds directly to the A and B boxes that constitute the VAI
promoter and this event allows the recruitment of TFIIIB. (B)
Purification of the TFIIIB fraction reveals that TFIIIB consists
of two separable entities, 0.38 M- TFIIIB and 0.48 M- TFIIIB.
0.38M- TFIIIB is a TBP-containing complex. (C) On the U6
promoter, TBP can bind directly to the TATA box, and the
TBP-associated factors in 0.38 M- TFIIIB are dispensable for
transcription.
observation suggests that the role of the TBP-
associated factors (TAFs) in the 0.38 M- TFIIIB com-
plex is to bring TBP to the promoter through protein-
protein interactions with TFIIIC and perhaps also
through protein-DNA interactions. In the case of the
U6 promoter, TBP can be recruited to the promoter
by direct binding to the TATA box, and the 0.38 to-
TFIIIB TAFs are therefore dispensable.
Characterization of the
0.38 M- TFIIIB Factor
R. Mital, N. Hernandez
To identify the exact components of the 0.38 NA-
TFIIIB TBP-containing complex, we are using a
functional transcription assay coupled with im-
munoprecipitations. In the functional assay, we fol-
low purification of the 0.38 M- TFIIIB complex by
testing fractions for their ability to reconstitute VAI
transcription when combined with a crude phospho-
cellulose fraction (C fraction) that provides RNA
polymerase III and TFIIIC, as well as a crude phos-
phocellulose B fraction depleted of TBP-containing
complexes by passage over an anti-TBP monoclonal
antibody column. This depleted B fraction provides
0.48 M- TFIIIB but is largely devoid of 0.38 M -IIIB.
To visualize polypeptides specifically associated with
TBP in the 0.38 NA-TFIIIB complex, we perform non-
denaturing immunoprecipitations with different anti-
TBP monoclonal antibodies from fractions at dif-
ferent stages of purification. After purification of the
0.38 M- TFIIIB activity over three columns, the non-
denaturing immunoprecipitations consistently bring
down TBP and a doublet of two polypetides with ap-
parent molecular masses of about 85 and 90 kD. This
doublet is absent from denaturing immunoprecipita-
tions, suggesting that it is not due to direct cross-
reaction with the antibodies. This is confirmed by the
observation that the doublet is observed in non-
denaturing immunoprecipitations performed with dif-
ferent anti-TBP monoclonal antibodies that recognize
different epitopes in TBP. The doublet is not seen in
immunoprecipitations performed with an irrelevant
antibody. We are therefore confident that this doublet
is associated with TBP as part of the 0.38 M- TFIIIB
activity. We are scaling up the purification to obtain
sufficient amounts of material for protein sequencing.
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The PSE-binding Factor Is a
TBP-containing Complex Required
for Transcription of snRNA Genes
by RNA Polymerases II and III
C.L. Sadowski, R.W. Henry, S.M. Lobo, N. Hernandez
The U6 TATA box binds TBP and, in the context of
the U6 promoter, is a dominant determinant
for RNA
polymerase III specificity. Since the RNA poly-
merase II snRNA promoters are recognized by RNA
polymerase II by virtue of the absence of a TATA
box, an interesting question is whether these pro-
moters recruit TBP. To address this question, we
depleted an extract of TBP by passage over an anti-
TBP or an irrelevant monoclonal antibody column
and asked whether Ul and U2 transcription was af-
fected. We found that depletion of TBP specifically
inhibited UI and U2 transcription, suggesting that
TBP is indeed required for RNA polymerase II tran-
scription of these genes. Intriguingly, efficient tran-
scription could be restored by addition of a fraction
enriched in the snRNA-activating protein (SNAP), a
PSE-binding activity (see below). Thus, either the
SNAP fraction was contaminated with TBP or TBP is
in fact part of the SNAP factor. We could show that
the SNAP factor is indeed a TBP-containing
by disrupting SNAP binding to a PSE-containing
probe in a gel mobility shift assay with different anti-
TBP monoclonal antibodies. Thus, the TBP-associ-
ated proteins in SNAP essentially reprogram the
DNA-binding specificity of TBP and allow its
recruitment to a new sequence, the PSE. As shown in
Figure 2A, we imagine that the binding of SNAP to
the Ul PSE allows the subsequent recruitment of at
least some of the general factors involved in RNA
polymerase II transcription of mRNA-encoding
genes.
The RNA polymerase II and III snRNA pro-
moters have exchangeable PSEs, suggesting that the
same factor may be involved in transcription by the
two RNA polymerases. We therefore tested in a
reconstitution experiment whether U6 transcription
required the SNAP fraction. We found that SNAP is
indeed required for U6 transcription and cannot be
replaced by TBP. This and other observations suggest
that, as shown in Figure 2B, the U6 initiation com-
plex contains at least two molecules of TBP-one
bound to the TATA box and the other bound to the
PSE as part of the SNAP complex. Consistent with
this possibility, we can show that TBP and SNAP can
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FIGURE 2 SNAP is a TBP-containing complex present in the
RNA polymerase II and Ill initiation complexes formed
on
snRNA promoters. (A) SNAP binds to the U1 PSE and
presumably recruits some of the general RNA polymerase II
transcription factors. (B) SNAP binds to the U6 PSE, and
TBP binds to the U6 TATA box. As a result, the U6 initiation
complex contains at least two molecules of TBP. We im-
agine that the protein surface resulting from interactions be-
tween TBP bound to the TATA box and SNAP mediates the
specific recruitment of 0.48 M- TFIIIB.
general Pol
transcription
factors ?
co-occupy their respective binding sites on a probe
corresponding to the U6 promoter. We are presently
performing experiments to confirm the presence of
two molecules of TBP in the U6 initiation complex.
Purification of SNAP and Isolation
of cDNA Clones Encoding Components
of the SNAP Complex
R.W. Henry, C.L. Sadowski, N. Hernandez
We have used a gel mobility shift assay to purify the
SNAP complex. The purification consists of an am-
monium sulfate cut followed by four columns and a
glycerol gradient. We have obtained protein se-
quences for all the major polypeptides that peak with
DNA-binding activity in the final glycerol gradient
and are in the process of generating polymerase chain
reaction (PCR) probes and obtaining corresponding
cDNAs.
HUMAN IMMUNODEFICIENCY VIRUS
Transcription from the human immunodeficiency
virus type-1 (HIV-1) promoter is regulated in part by
a viral trans-activator referred to as Tat. Tat acts
through the TAR element, an RNA target encoded
between positions +18 and +44 downstream from the
start site of transcription. The mechanism of Tat ac-
tion has been controversial. In transfection experi-
ments, the HIV-1 long terminal repeat (LTR) directs
the formation of a large number of short transcripts
and a small number of full-length transcripts in the
absence of Tat. In the presence of Tat, the number of
short transcripts decreases, and the number of long
transcripts increases. This and other observations
prompted the hypothesis that Tat is an antiterminator
that functions by promoting elongation of the short
transcripts. However, in other systems, Tat seems to
act by increasing the levels of initiation, as transcrip-
tion close to the promoter is increased in the presence
of Tat as measured in run-on experiments.
We have described the identification of a tran-
scriptional element, the inducer of short transcripts
(IST), which activates transcription from the HIV-1
and other promoters. However, the RNA molecules
resulting from this activation of transcription are all
short. This suggests that IST functions by directing
the formation of transcription complexes that are un-
able to elongate efficiently and therefore give rise to
prematurely terminated RNAs. As described below,
we have located IST precisely and examined whether
IST activity is required for Tat trans-activation.
Characterization of the Inducer
of Short Transcripts
M. Sheldon, F.C. Pessler, M.L. Sullivan, N. Hernandez
IST is located between positions -5 and +82 relative
to the HIV-1 start site of transcription. Analysis of a
series of mutations encompassing the region from +1
to +82 defines IST as a bipartite element, located at
positions -5 to +26 and +40 to +59. The most impor-
tant region for activity is that proximal to the
promoter, but the +40 to +59 region contributes to
maximal activity. The RNA secondary structure is
not important for IST function, and IST can be in-
verted without loss of activity, strongly suggesting
that, unlike TAR which is an RNA element, IST is a
DNA element.
Most of the IST does not overlap with the region
encoding the TAR element. As a result, it is possible
to debilitate IST with mutations that leave TAR in-
tact. Such mutations reduce the formation of short
transcripts to barely detectable levels in the absence
of Tat, yet they do not inhibit Tat trans-activation.
This suggests that (1) Tat can function by binding to
TAR present on a long transcript and (2) Tat does not
function by promoting elongation of short transcripts
into long transcripts, since in an IST- mutant, there
are few or no short transcripts to elongate. These ob-
servations strongly suggest that Tat does not act on
an RNA polymerase paused around position +60 but
rather on an RNA polymerase at the promoter. The
effect of Tat on this polymerase could be either to in-
crease the rate of initiation or to improve the elonga-
tion properties of the enzyme, or both. To confirm
these conclusions, we are in the process of testing an-
other mutation in IST which should completely
abolish the formation of short transcripts. If this
mutation does not inhibit Tat trans-activation, the
antiterminator model can be definitively ruled out.
Identification of Trans-acting
Factors Involved in 1ST Function
F.C. Pessler, N. Hernandez
We have identified a putative IST factor that in a
mobility shift assay binds to probes containing an in-
tact IST but not to probes containing a debilitated
IST. This factor differs from previously identified
factors that bind downstream from the HIV-1 start
site, such as LBP-1 and TFII-I. So far, the factor has
been purified over three successive chromatographic
columns. We are pursuing the purification of the fac-
tor to be able to identify the polypeptides that com-
pose it.
Identification of TBP Domains
Required for Tat Trans-activation
and 1ST Activity
P.S. Pendergrast, D.B. Morrison, M. Sheldon,
N. Hernandez
The observation that HIV-1 constructs carrying
severe mutations in the IST element can still be
trans-activated by Tat strongly suggests that Tat acts
on an initiation complex located at the promoter to
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increase either the initiation rates
or the elonation
properties of the RNA polymerase. This raisegs
the
question of whether Tat is comparable to other well-
studied trans-activators that bind to DNA
targets in
different promoters. To approach this
question, we
are examining which domains of the TATA-box-
binding protein TBP are required for trans-activation
by Tat. For this purpose, we have modified the HIV-1
TATA box to the sequence TGTAAA. This sequence
is recognized by an altered specificity TBP (devel-
oped by K. Struhl and colleagues) that contains muta-
tions in the DNA-binding domain. We have shown
that changing the HIV-1 TATA box to TGTAAA in-
hibits basal transcription and Tat trans-activation and
that both can be restored by cotransfection of a vector
expressing the altered specificity TBP. We will now
test a series of mutations in the altered specificity
TBP.
Direct Interactions between
TBP and Tat
D.B. Morrison, P.S. Pendergrast, N. Hernandez
Tat has been reported to interact directly with TBP.
We are interested in determining whether mutated
TBPs that cannot support Tat trans-activation have
also lost the ability to interact directly with Tat. For
this purpose, we are generating GST-Tat and GST.
TBP affinity columns. Wild-type and mutant Tat and
TBP proteins will then be tested for their ability to be
retained on such columns.
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TELOMERASE AND TELOMERE LENGTH REGULATION
C.W. Greider C. Autexier
A.A. Avilion
M.A. Blasco
K. Collins
L.A. Harrington
L.L. Mantell
M. Scharring
S.K. Smith
Chromosome stability is essential for living cells.
Eukaryotes have linear chromosomes, and the telo-
meres that cap the ends protect chromosomes from
degradation and recombination. In the 1930s, Muller
and McClintock recognized that broken chromo-
somes that lack telomeres are unstable. Subsequently,
experiments in protozoa, yeast, and mammalian cells
have demonstrated the requirement for telomeres.
Telomeres are highly conserved in eukaryotes. The
DNA sequence contains simple tandem repeats of
specific GT-rich motifs. The exact sequences are
characteristic of a particular organism: for example,
d(TTGGGG) in Tetrahymena, I GGGG) in
Oxytricha, and d(TTAGGG) in humans. The number
of repeats on any given chromosome end may vary,
giving telomeres a characteristic heterogeneous or
"fuzzy" appearance on Southern blots.
Tetrahymena telomerase is a ribonucleoprotein
(RNP) containing an essential endogenous RNA
component. The enzyme synthesizes d(TTGGGG)
repeats de novo onto synthetic single-stranded
d(TTGGGG) primers. The nucleotides are added one
base at a time. The 159-nucleotide RNA component
contains within it the sequence CAACCCCAA,
which provides the template for d(TTGGGG) repeat
synthesis. Since the initial identification of the
Tetrahymena telomerase, telomerase activity has
been found in three other ciliates, as well as Xenopus
laevis, and immortalized human and mouse culture
cells. The properties of telomerase in these species
are very similar to those of the Tetrahymena enzyme.
However, the mouse and Xenopus enzymes do not
synthesize long products as do the other enzymes.
The telomerase RNA component has only been
cloned from one other organism: Euplotes telomerase
RNA contains the sequence CAAAACCCC-
AAAACC complementary to the d( ITITGGGG)
telomeric repeats in this ciliate.
Our model for the role of telomerase in telomere
replication suggests that an equilibrium is established
between telomere shortening and telomere lengthen-
ing during rounds of cell division. DNA replication
leads to telomere shortening because DNA poly-
merase cannot replicate the molecular end of double-
stranded DNA. Telomerase elongates the chromo-
some through de novo telomere sequence addition.
DNA polymerase and primers then fill in the com-
plementary C-rich strand.
Strikingly, length maintenance does not occur in
primary human somatic cells. We found that as pri-
mary human fibroblasts are passaged in culture,
telomere length decreases. Primary human cells have
a limited life span in culture, and telomere shortening
correlates with loss of replicative capacity. Cells
from older donors have shorter telomeres and go
through fewer divisions before senescence. Telomere
shortening in tissues in vivo has been demonstrated
for fibroblasts, leukocytes, and endothelial cells.
Sperm cell telomeres do not shorten with age, sug-
gesting that the germ line is protected from telomere
loss. Although telomere loss is correlated with cell
senescence, it is not clear whether shortening has any
direct role in this process.
Telomere shortening is also found in human can-
cer tissues. Telomeres in Wilms' tumors and mam-
mary and colon carcinomas were initially shown to
be shorter than those in normal neighboring tissues.
These data are consistent with the observation that
telomeres shorten with each round of cell division.
Tumor tissue has undergone many more rounds of
division than has the normal neighboring cells. Clear-
ly, telomere shortening cannot go on without major
consequences on the cell. To determine what happens
to cells when telomeres get very short, in collabora-
tion with Drs. Harley and Bacchetti at McMaster
University, we followed telomere length and telo-
merase activity throughout the process of cellular im-
mortalization. Human embryonic kidney cells were
transfected with SV40 T antigen and immortal
variants were selected. Telomeres shortened progres-
sively in the primary and extended life span clones.
Telomerase was not detected in these cultures. At
crisis, many of the cells died. However, in those
clones that survived crisis, telomeres were stabilized
at a very short length and telomerase activity was
detected. These results suggest that primary human
cells express little or no telomerase activity, but after
immortalization, the cells reactivate telomerase and
telomere length is maintained. If telomerase is re-
quired for the growth of immortalized cells,
telomerase inhibitors may be excellent anticancer
drugs. In the past year, our laboratory has focused on
the biochemistry of Tetrahymena telomerase and
regulation in mammalian cells and during develop-
ment in Xenopus.
Primer Binding by Tetrahymena
Telomerase RNP
L.A. Harrington, C.W. Greider [with undergraduate
researcher C. Hut and rotation student J. Crittenden]
To study the kinetic parameters associated with telo-
merase, one must be able to isolate the different steps
in the elongation cycle. All studies to date have used
primer elongation as a measure of primer-binding ef-
ficiency. However, if the rate-limiting step is elonga-
tion, the intrinsic affinity of telomerase for different
primers may not be measured by assaying elongation
products. To dissociate primer binding from elonga-
tion and to test the role of the RNA component in
binding, we identified and characterized a specific
telomerase gel shift. When partially purified
telomerase fractions were incubated with 32P-labeled
d(TTGGGG)3, a labeled band appeared near the top
of the gel (Fig. 1). Four lines of evidence indicated
that telomerase was responsible for this shift: (1) The
shift was competed by excess d(TTGGGG)3 but not
by nontelomeric oligonucleotides; (2) the shift co-
purified with telomerase more than 1000-fold and
cosedimented on a sucrose gradient; (3) the shift was
destroyed by preincubation of telomerase with RNase
or micrococcal nuclease; and (4) PCR analysis
showed that telomerase RNA was present at a posi-
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FIGURE 1 Identification of a d(TTGGGG)3-specific mobility
shift. Approximately 1 ng of the probe 32P-labeled
d(TTGGGG)3 was incubated with 10 [LI of partially purified
telomerase extract. For competition with unlabeled oligo-
nucleotides, the indicated amount of competitor was added
to the mobility shift mixture. (1) 32P-labeled 1 kbp marker;
(2-6) competition with unlabeled d(TTGGGG)3 from 2500
ng (lane 2) to no competitor (lane 6). (7-11) Competition
with oligo 3; ( 12-16) competition with pBR. A large arrow in-
dicates the position of the d(TTGGGG)3-specific complex.
The sequences of oligonucleotides used in this experiment
are as follows: pBR, 5' -AGCCACTATCGACTACGCGA
TCAT-3 ' , oligo 3, 5' -GCACTAGA lilt! GGGG.
32P-(7204)3
tion in the native gel containing the shifted complex.
The ability of RNase treatment to abolish the binding
in this gel-shift assay suggests that the telomerase
RNA is involved directly in primer binding or that
the integrity of the entire complex is needed for
stable binding.
UV Cross-linking of Telomerase
Components
L.A. Harrington
We used UV cross-linking to identify potential com-
ponents of the telomerase enzyme. After testing
several different nucleotide analogs for cross-linking,
we found that the aryl azide, N3RdUTP, gives high
cross-linking efficiency with telomerase. Telomerase
was incubated under reaction conditions with 32p
labeled dGTP and N3RdUTP. The analog was in-
corporated into reaction product in place of nip.
After cross-linking for 5-10 minutes, proteins Were
resolved on an SDS gel. Several radioactively labeled
bands were apparent; however, only the band at ap.
proximately 100 kD was specific to UV treatment.
RNase treatment either before or after telomerase
elongation with N3RdUTP abolished the labeling at
100 kD. We used our most highly purified telomerase
fractions and found that the 100-kD labeled product
peaked with activity in the final sucrose gradient
(Fig. 2). These data suggest that a polypeptide of ap-
proximately 100 kD is a component of telomerase.
Reconstitution of Active
Telomerase from
Proteins and RNA
C. Autexier
In the past year, we have developed a functional
reconstitution assay for telomerase. We have used
this assay to study mutations in the telomerase RNA
and to identify a previously unknown specialization
in the RNA template region. Using a method of RNP
"unfolding" with EDTA, we defined a specific com-
plex on an acrylamide/agarose gel that was competed
with unlabeled telomerase RNA but not with other
unlabeled RNAs. After defining salt and temperature
optima for this exchange reaction, we then used these
conditions in functional assays. Removal of endo-
genous RNA with micrococcal nuclease (MNase)
completely abolished telomerase activity. Incubation
of the enzyme with EDTA and a T7 transcript of the
telomerase RNA, followed by a brief heating step and
re-addition of Mg++, resulted in restoration of
telomerase activity. To examine the properties of the
reconstituted telomerase, we tested primer specificity
after reconstitution. Only telomeric sequence oligo-
nucleotides were elongated, the addition products
were similar to wild-type enzyme, and activity was
RNase-sensitive. Primers containing permuted ver-
sions of the telomeric sequence d(TTGGGG)3 were
elongated with the addition of the correct next
nucleotide in a manner identical to that of the wild-
type enzyme (Fig. 3). For example, d(TTGGGG) had
TTG added first, whereas d(GGGGTT) had GGG
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FIGURE 2 Copurification of the 100-kD cross-linked protein with telomerase elongation ac-
tivity. (Left) Telomerase was purified using five chromatographic steps, loaded onto a
sucrose gradient. Fractions were assayed for elongation and cross-linking in the presence of
N3RdUTP. (Lanes 1-11) Telomerase activity in the presence of N3RdUTP for the fraction
loaded onto the gradient (L), and gradient fractions 1-10 (fraction numbers are indicated at
the top of the figure, and lane numbers at the bottom). The peak in telomerase activity oc-
curred in fractions 4 and 5. (Lanes 12-22) The same samples as those in lanes 1-11, after
cross-linking and SDS-PAGE analysis. (Right) Arrow indictes the position of the 100-kD
cross-linked protein.
added first. To define the sequence added, ddTTP
was used to chain-terminate the elongation products.
These experiments demonstrated that the recon-
stituted telomerase has similar specificity to that of
the wild-type enzyme. Since the synthetic T7 tran-
script used does not contain any modified bases, any
modification that may be present in the wild-type
RNA must not be essential for activity.
We used the reconstituted enzyme to study the role
of nucleotides in the template region of the RNA.
Our initial experiments suggest that all nine nucleo-
tides in the template region 5' -CAACCCCAA-3 ' do
not provide templating information as previous
models had predicted. Five different mutations were
made in the "template region" by site-directed
mutagenesis: 5' -UAACCCCAA-3 ' (43U), 5' -
CAACCCUAA-3 ' (49U), 5 ' -UAACCCUAA-3 '
(4349U), 5' -CGGCCCCAA-3 ' (4445G), and 5' -
CAACCCCGG-3 ' (5051G). To define the sequence
added onto primer oligonucleotides, mutant
telomerase enzymes were subjected to a variety of
tests. First, since each mutation introduces a new
nucleotide into the template region, elongation was
carried out in the presence or absence of this
nucleotide. For example, the mutant 5' -
UAACCCCAA-3 ' (43U) did not generate long pro-
ducts when dATP was omitted from the reaction.
Second, the nucleotide specified by the template
mutation was added as a radioactive precursor. For
example, 32P-labeled dATP was incorporated by the
mutant 5' -UAACCCCAA-3 ' but not the wild-type
telomerase. Third, dideoxynucleotides were added to
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FIGURE 3 Reconstitution of primer specificity and cleavage.
Telomerase assays were performed with telomerase
pretreated as indicated. (Lane 1) Native telomerase; (2) na-
tive telomerase preincubated under similar buffer conditions
as reconstitution reactions; (3) telomerase treated with
nuclease. The primer d(GGGGTT)3 was used in lanes 1-3.
(Lanes 4-21) Permutations of Tetrahymena telomeric
oligonucleotides were used to assay the reconstituted
telomerase. The sequence of each oligo is shown in the fig-
ure. Elongation reactions were carried out in the presence of
[a-32P]dGTP and dTTP, [a-32P]dGTP and ddTTP, or [a-32P]
dGTP, dTTP and ddCTP as described in the figure. Lanes
19-21 are a darker exposure of the reactions in lanes 4-6 to
show that long products were synthesized. Numbers indi-
cate the number of nucleotides added onto the input
primers. (P) Size of the 18-mer input primer.
chain-terminate the elongation products at specific
sites so that the sequence of the added products could
be deduced. For example, addition of ddCTP to
elongation reactions with the mutant 5' -
CGGCCCCAA-3 ' (4445G) and the primer d(GGTT
GG)3 resulted in the addition of three nucleotides dG,
dG, and ddC. Wild-type enzyme was not effected by
the addition of ddCTP. A summary of the results ob-
tained with each type of mutant is shown in Figure
4A.
The mutant RNA we assayed in these reconstitu-
tion experiments fell into two classes: The two muta-
tions in the 3' -most three residues of the template
A
4911
AAIJCCCAAC
9--TTGGGGTTAGG
dA incorporated
ddA incorporated
43U
AACCCCAAU
-1TTGGGGTTGGG
dA not incorporated
ddA not incorporated
5051G
3AA' C44C45CCGGGC
s'-TTGGGGTTGGGGCCCCAAC
5'--TTGGGGTTGG
B
dC not incorporated
ddC not incorporated
ddT incorporated
dC incorporated
ddC incorporated
ddT not incorporated
Telomerase RNA template specialization
3'
taACIC.C.CLACi
Alignment Template
FIGURE 4 Template mutations in the telomerase RNA. (A)
Telomerase RNA template mutants. Incorporation of specific
nucleotides and dideoxynucleotides specifies the sequence
added onto the telomeric primer. (B) Model for template
specificity. In wild-type telomerase only the 5' -most six
residues provide template information.
region, CAACCCUAA-3 ' (49U) and CAACCCC
GG-3 ' (5051G), did not change the sequence added,
whereas the other mutations all resulted in incorpora-
tion of new nucleotides. On the basis of these results,
we suggest a model in which the 3' three residues
are involved only in primer alignment, whereas the
5' six residues provide the template information for
the enzyme (Fig. 4B). We are currently assaying fur-
ther template mutations to test this model of telo-
merase action.
Regulation of Telomerase
during Mouse Embryonic
Stem Cell Differentiation
M. Scharring
Our previous work with both human and mouse cells
suggested that telomerase is present in stem cells but
inactivated in many somatic cell lines. To examine
telomerase expression during differentiation, we
studied mouse embryonic stem (ES) cell lines. ES
cells that were grown in the presence of LIF and
remained undifferentiated had telomerase activity.
After the removal of LIF and the addition of retinoic
acid and cAMP analogs, the cells differentiated into a
neuronal cell type, and no telomerase activity was
detected in the differentiated cultures. These studies
indicate that telomerase is regulated during develop-
ment and differentiation and that ES cells offer a use-
ful system to study the regulatory pathways.
Identification of Telomerase
in Xenopus Oocytes
L.L. Mantell
Since telomerase is involved in the synthesis of
telomere repeats, telomerase activity is expected to
be present primarily in the nucleus. We manually dis-
sected nuclei, or germinal vesicles (GV), from stage
VI Xenopus oocytes and prepared nuclear lysate. A
specific telomere primer elongation activity was
found predominantly in the nuclear fraction. The ac-
tivity was specific for telomeric primers and was
abolished by RNase pretreatment of the extracts. The
elongation products synthesized were very short as
seen with the mouse telomerase, although permuted
sequence primers confirmed the specificity of the
added sequence. To further test if the sequence
TTAGGG was added onto the input telomeric pri-
mers, dideoxynucleotides were substituted for deoxy-
nucleotides to terminate the elongation reaction at
specific positions. These results confirmed that
Xenopus oocyte nuclear extracts contain telomerase
activity that synthesizes TTAGGG repeats de novo.
We assayed telomerase activity at each stage of
oogenesis. S-100 extracts were prepared from ap-
proximately 200 oocytes from stage I to stage VI and
purified over a DEAE-agarose column. Most of the
Xenopus telomerase activity was recovered in a 0.2 M
NaC1 wash from a DEAE-agarose column. Extracts
representing all stages of oocyte maturation had
telomerase activity. To determine whether telomerase
was active during Xenopus development, we obtained
fertilized oocytes and allowed development to occur.
S-100 extracts were prepared from embryos at dif-
ferent developmental stages and assayed for
telomerase; activity was detected in matured eggs and
at all stages of embryogenesis from blastula to
neurula.
To examine whether telomerase activity is regu-
lated during the cell cycle, S- and M-phase-specific
extracts were prepared from Xenopus eggs. For the S-
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FIGURE 5 (Top) Characterization of Xenopus telomerase
activity in cell-cycle-specific extracts. (Lanes 2-3) Telo-
merase activity assayed in S-phase extract. Telomerase as-
says were carried out with (+) and without (-) pretreatment
of the extract with RNase. (Lanes 4-5) Telomerase activity
assayed in the M-phase extract. Extracts from equivalent
cell numbers were assayed in each lane. (Lane 1) [a-32P]-
dideoxyATP end-labeled oligonucleotide (TTAGGG)3 was
included as a marker. (Bottom) Characterization of MPF ac-
tivity in cell cycle extracts. MPF activity was measured as
[y- 32P]ATP incorporation into the p34cdc2 protein-kinase-
specific polypeptide substrate. Series of dilutions were
made for both M- and S-phase extracts. (Open square) M-
phase extracts; (solid diamond) S-phase extracts.
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phase extract, cycloheximide was
added to the buffer
to prevent any new synthesis of cyclin
that may in-
duce MPF activity. Telomerase activity
was detected
in both S- and M-phase extracts that were purified
ei-
ther by DEAE-agarose
chromatography or by 15%
(NH4)2SO4 precipitation or after simple dilution
without further purification (Fig. 5, top). As a control
for the specificity of the S- and M-phase extracts,
MPF activity was tested in these extracts.
A synthetic
polypeptide substrate, specific for p34cdc2 protein
kinase, was used to assay MPF activity (courtesy of
Dr. Marshak, CSHL) (Fig. 5, bottom). As expected,
the M-phase extracts had significant MPF activity,
whereas the S-phase extracts had very little.
Telomerase activity was detected in total testes ex-
tracts. Xenopus testes are composed of primary and
secondary spermatocytes, spermatids, mature sperm,
and supporting somatic cells. To determine
if
telomerase activity is present in sperm cells, mature
sperm were separated from the testes tissue, the ma-
ture sperm were washed and pelleted five times, and
activity was detected in extracts prepared from ap-
proximately 106 mature sperm cells. Telomerase ac-
tivity was present also in the extract prepared from
testes after the removal of most mature sperm. The
telomerase activity detected in this extract may be
from somatic cells or from immature spermatocytes,
spermatids, and the remaining mature sperm.
Telomerase regulation in humans has suggested
that this enzyme may have a role in the development
and life span of mammalian tissues. The ability of
immortal cell types to divide indefinitely seems to re-
quire the presence of telomerase. It is not yet clear
whether this same regulation occurs in Xenopus Al_
though telomerase regulation may differ in some
respects between Xenopus and mammalian cells, by
understanding the differences and similarities, We
will gain insights into the essential components of
both systems.
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STRUCTURE AND COMPUTATION
This section includes two major groups that heavily use computers and networks to solve
important biological problems related to cell processes such as signal transduction,
growth control, and development. The structural and sequencing studies described below
are designed to benefit from and to complement the genetic and biochemical experiments
performed at the laboratory. Gene sequence analysis and atomic models of kinases,
phosphatases, DNA-binding enzymes, and other proteins will help us comprehend the
roles of genes and proteins in cell division and in cell transformation and will ultimately
lead to new and better treatments of human afflictions such as cancer, diabetes, AIDS,
and Alzheimers' disease.
The members of the W.M. Keck Structural Biology Laboratory elucidate the three-
dimensional atomic structures of proteins and protein-DNA complexes. Dr. Xiaodong
Cheng has solved the crystal structure of Hhal DNA methyltransferase in a binary complex
with S-adenosyl-L-methionine cofactor and in a ternary complex with both bound DNA and
cofactor. Astonishingly, in the latter structure, a 13-mer oligonucleotide has a cytosine
base flipped out of canonical base-pairing so that its C5 is positioned near the conserved
active site cysteine sulfhydryl and the bound cofactor. Dr. Jeff Kuret has been instrumen-
tal in the structure determinations of casein kinase 1 with Dr. Cheng and of cAMP-
dependent protein kinase with Dr. Jim Pflugrath. The collaborative efforts Dr. John Ander-
son and Dr. Cheng have yielded the structure of a Pvul I endonuclease/DNA complex. Dr.
David Barford, a CSHL Junior Fellow within the Keck Laboratory, determined the first
known structure of a protein tyrosine phosphatase. All the crystallography efforts used
data collection software developed by Dr. Pflugrath.
Members of the Computational Biology group also develop software and conduct
basic research to help molecular biologists, geneticists, and other scientists to determine,
map, and analyze the sequences and functions of genes and proteins. Dr. Tom Marr
leads a group that has created the Genome Topographer software, which is an integrated
and comprehensive tool to visualize and analyze genetic objects and databases. Dr. Dick
McCombie and colleagues develop sequencing technology as they sequence the
genome of Schizosaccharomyces pombe.
MACROMOLECULAR CRYSTALLOGRAPHY
J.W. Pflugrath J. Horton Y. Liu
J. Keller E. Yoo
Structural Studies of the
Neurotrophic Factor Sloop
Y. Liu, J.W. Pflugrath [in collaboration with
D. Marshak, Cold Spring Harbor Laboratory]
S10013 is a member of a family of dimeric acidic
Ca++-binding proteins involved in cell differentiation,
cell cycle progression, and calcium signal transduc-
tion. S100(3 is synthesized and released from
astrocytes in the brain, and its disulfide-linked
dimeric form has neurotrophic activity on cerebral
cortical neurons in vitro. S10013 is homologous to
proteins with EF-hand calcium-binding motifs, such
as calmodulin and intestinal calcium-binding protein.
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We are attempting to determine the crystal structures
of 510013 at pH 7 and pH 8 from existing crystals of
S10013 that diffract beyond 1.5 A resolution. Our at-
tempts to solve the structure by molecular replace-
ment with intestinal calcium-binding protein as a
model have failed. We have also failed to produce
any heavy atom derivatives by either soaking or
cocrystallization. Since these two conventional meth-
ods have failed, we have expressed S10013 in the Es-
cherichia coli strain DL41(DE3), a methionine
auxotroph. When these bacteria are grown in the
presence of selenomethionine (Se Met), the recom-
binant sloop expressed contains five selenium atoms
that scatter X-rays anomalously. Thus, a multi-
wavelength anomalous dispersion experiment can be
performed at a synchrotron to yield phases and an
electron density map. Up to now, the purified Se Met-
S10013 protein has not yielded crystals.
Yeast cAMP-dependent
Protein Kinase
J.W. Pflugrath, J. Kuret
Protein kinases, which catalyze the transfer of a
phosphate from ATP to serine, threonine, and
tyrosine residues of protein substrates, are key
regulatory enzymes that participate in many
biochemical pathways. As catalysts, they can amplify
intra- or extracellular signals. By virtue of their broad
yet limited substrate specificity, they are able to regu-
late more than one substrate protein at a time. We
wish to understand how protein kinases achieve the
specificity necessary to regulate cell processes, a fun-
damental problem in biology, and how kinases are
regulated at the structural level. The more than 200
known protein kinases share a common catalytic core
based on sequence comparison and recent structure
determinations. Despite the similarities in the cat-
alytic subunits, protein kinases exhibit several dif-
ferent modes of regulation.
We have crystallized and solved the structure of
the catalytic subunit of the Saccharomyces cerevisiae
cAMP-dependent protein kinase. The crystals belong
to space group P6522 with cell dimensions a = b =
61 A, c = 320 A. The structure has two domains with
a wide cleft between them where ATP binds. A shal-
low groove on the large domain was shown to be the
protein substrate-binding site (Knighton et al., Sci-
ence 253: 407 [1991]).
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Casein Kinase
J. Horton, J.W. Pflugrath [in collaboration with
D. Marshak, Cold Spring Harbor Laboratory]
Casein kinase II (CKII) is a highly conserved, ubiqui-
tous serine/threonine heterotetrameric protein kinase
composed of two catalytic (a and/or a ' ) and two
regulatory ((3) subunits. This kinase is found predorn_
inantly in cell nuclei and primarily, in mammals, in
the brain. It is believed that CKII is involved in the
phosphorylating cascade originated by M-phase-
specific kinase (Cdc2 kinase) and participates in
mitogenic signaling, particularly in neural develop-
ment.From similar conditions, we have grown three
different crystal forms of the regulatory subunit
(CKIII3) of this kinase. SDS-PAGE analysis suggests
that one is of the full-length protein (residues 1-215),
one of a truncated form (residues 1-189), and another
that probably contains a mixture of both full-length
and truncated proteins. Truncated CKII13 is found in
most preparations and copurifies with the full-length
protein; it is not obvious if the truncation is the result
of premature termination or proteolysis. The position
of the CKIII3 truncation was determined by carboxy-
terminal sequencing and mass spectrometry in col-
laboration with Applied Biosystems.
Presently, we are attempting to characterize these
small fragile crystals. All crystal forms appear to be
temperature-sensitive. We are searching for condi-
tions to stabilize them and/or to obtain new, better
crystals.
Cell Cycle Protein
Regulators
J.R. Horton, J.W. Pflugrath
We wish to understand the underlying molecular me-
chanisms of regulation and activity of proteins that
control the proliferation and differentiation of
eukaryotic cells. Toward this end, we hope to
determine the three-dimensional structure of com-
ponents of the cell cycle regulation system that con-
tain human CDK4 and cyclin D1. Importantly, aber-
rations of the protein subunits of this system have
been directly linked to human cancers. In normal
cells, cyclin D1 and CDK4 form quaternary com-
plexes with PCNA (proliferating cell nuclear
antigen), a known subunit of DNA polymerase 8, and
another protein, p16. (Recently, p16 has been named
INK4, for inhibitor of CDK4, since it binds specifi-
cally to CDK4 and inhibits in vitro its ability to
phosphorylate Rb.) However, in cells transformed by
the expression of viral oncoproteins, CDK4 is no
longer involved in the quaternary complex but in ei-
ther a binary complex with p16 and/or a ternary com-
plex with p16 and cyclin Dl. Thus, p16/INK4 may be
an important negative regulator of cell proliferation.
We have been working toward purifying and crys-
tallizing the protein subunits of the CDK4-cyclin
Dl-PCNA-INK4 complex. Unfortunately, although
the gene for p16 has been put into high-expression
systems in E. coli and the yeast, Pichia pastoris,
there is little or no evidence of a large amount of the
protein after induction. Additionally, the protein is
only partially soluble in E. coli; thus, only 0.25 mg of
the protein can be recovered per liter of bacterial cul-
ture. We have set up crystallization trials with what
little protein we have to no avail. We are investigat-
ing ways of increasing the amounts of p16 that can be
obtained in these systems.
In autumn 1993, during sequence analysis, we
noticed that p16 is almost entirely made up of four
ankyrin-like repeats. Ankyrins are a family of
proteins that are thought to coordinate interactions
between various integral membrane proteins and
cytoskeletal elements; some ankyrins have greater
than 20 repeats in a distinct domain. Several other
cell cycle proteins also have ankyrin-like repeats in
them, and we think that such repeats must have im-
portant functions in the regulation of the cell cycle.
To learn something about the three-dimensional
structure of p16, if we find that we cannot obtain
large enough amounts of p16 for crystallization, we
may design a protein with a number of ankyrin-like
repeats and crystallize it.
Although a large amount of cyclin D1 is expressed
in E. coli (40-50 mg per liter of culture), most, if not
all, of this protein is found in inclusion bodies. After
refolding procedures, nearly all of the protein
remains insoluble or forms soluble aggregates. We
have been successful in properly refolding very small
amounts of this insoluble cyclin Dl and have partial-
ly purified it; however, we think that this is not the
avenue for acquiring the large milligram quantities of
protein needed for crystallization studies and sub-
sequent structure determination. We are investigating
obtaining soluble, recombinant cyclin Dl from other
expression systems, either in a P. pastoris system or
in a baculoviral system. The E. coli strain harboring
the cdk4 gene expresses this protein nearly as robust-
ly as cyclin Dl. However, this protein is also found
entirely in inclusion bodies. In the coming year, we
will test the same avenues as those of cyclin D1, so
that we will obtain large soluble homogeneous
quantities of CDK4 for crystallization. Ultimately,
we wish to cocrystallize cyclin D1 and CDK4 as well
as their complexes with associated proteins found in
normal and transformed cells.
Structural Analysis of a Bifunctional
Enzyme: 6-Phosphofructo-2-Kinase/
Fructose-2,6-Bisphosphatase
J.W. Pflugrath, E. Yoo, J. Keller [in collaboration with
S. Pi lkis and Y. Lee, SUNY, Stony Brook]
Protein phosphorylation is the major mechanism by
which intracellular events are controlled by ex-
tracellular stimuli. We are studying protein kinases
(see above), but how phosphorylation modulates the
activity of protein substrates is just beginning to
emerge. The activity of 6-phosphofructo-2-kinase-
/fructose-2,6-bisphosphatase (6PF2K/F26BP) is con-
trolled by phosphorylation at Ser-32 by the cAMP-
dependent protein kinases. This single bifunctional
liver enzyme catalyzes both the synthesis and
degradation of fructose-2,6-bisphosphate (Fru-2,6-
P2). The 6PF2K activity is inhibited by phosphoryla-
tion, whereas the bisphosphatase activity is increased.
Fru-2,6-P2 is a regulatory metabolite whose steady-
state level determines glycolytic/gluconeogenic flux
in the hepatocyte and glycolytic flux in extrahepatic
tissue: When the concentration of Fru-2,6-P2 is low,
net glucose synthesis occurs in tissues capable of
gluconeogenesis. The homodimeric enzyme is com-
posed of 54.5-kD monomers of 470 amino acids
forming two discrete domains: an amino-terminal
kinase domain (residues 1-249) and a carboxy-
terminal bisphosphatase domain (residues 250-470).
Sequence and modeling analysis shows that the
amino-terminal kinase domain is similar to that of the
glycolytic enzyme 6-phosphofructo-l-kinase and that
the carboxy-terminal bisphosphatase domain is
similar to that of yeast phosphoglycerate mutase.
Work by Pilkis and colleagues has begun to elucidate
the chemical basis for catalysis and substrate/product
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binding of the bisphosphatase half of the enzyme.
A
three-dimensional model of this enzyme would be an
invaluable asset in interpreting the kinetic, muta-
tional, and phosphorylation results. A model would
also aid the design of inhibitors and/or activators that
could lead to the control of Fru-2,6-P2 levels which
in turn help regulate the glycolytic/gluconeogenic
pathway.
Both rat and human liver 6PF2K/F26BPs have
been cloned and expressed in E. coli by the Pilkis
laboratory. The rat liver bifunctional enzyme has
been expressed as the holoenzyme of 470 residues
and also as its distinct and active domains: the kinase
and the bisphosphatase. We have crystallized the
bisphosphatase domain in four different crystal
forms. Two forms grow in the presence of inorganic
phosphate and the other two forms grow in the ab-
sence of phosphate. The crystals diffract to 1.8 A
resolution, although they are very sensitive to
temperature changes and radiation damage. Native
data sets for two crystal forms to 2.8 A resolution
have been collected and heavy atom screening is un-
der way. To understand the enzyme mechanism in
atomic detail, we will soak in (or crystallize the
protein in the presence of) the substrate Fru-2,6-P2,
which can act as an inhibitor at high concentrations,
and the product fructose-6-phosphate. Numerous site-
directed mutants are available for crystallization as
well. Attempts are also under way to crystallize the
entire protein and the kinase domain separately.
Area Detector Software
J.W. Pflugrath [in collaboration E.M. Westbrook,
Argonne National Laboratory]
At its simplest, X-ray diffraction data collection con-
sists of producing a set of reflections from a crystal.
One mounts the crystal on the goniometer where it
will be bathed by the source. The source photons (or
neutrons!) are diffracted by the crystal rotated on the
goniometer. These diffracted photons are detected in
a detector that will be scanned or read periodically to
create images. The pixels in the images will he as-
signed to individual Bragg reflections and integrated
to yield an estimated intensity and standard deviation.
Thousands of diffracted intensities from numerous
crystals must be measured in order to determine
crystal structure of a macromolecule. To address this
problem, we have developed the device-independent
package MADNES to collect and process diffraction
images from many different types of area detectors.
MADNES is used widely in the crystallographic
community. In 1993, more than 60 publications cited
the use of the MADNES package.
MADNES is the application software used with
the 1024 by 1024 pixel CCD area detector developed
at Argonne National Laboratory and installed at
beamline X8C of the National Synchrotron Light
Source located at Brookhaven National Laboratory
(BNL) here on Long Island. In the past year, we have
maintained and extended the software at the X8C
beamline. For example, the device handlers for the
CCD detector hardware have been re-implemented in
a client-server mode; i.e., the detector hardware need
not share the same computer platform to which the
other system hardware such as shutter, goniometer
motors, and ion chamber counters are attached. This
is a forward-looking development for when larger
CCD detectors with more advanced electronics come
online. MADNES was also implemented on the High
Flux Beam Reactor neutron diffraction beamline at
BNL and on three different imaging plate diffrac-
tometers.
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MACROMOLECULAR CRYSTALLOGRAPHY
X. Cheng D. Alonso M. O'Gara
T. Malone R. Xu
K. Mc Cloy
During the year of 1993, two talented young sci-
entists arrived at this X-ray laboratory: Ruiming Xu
with a solid background in physics came from the In-
stitute for Theoretical Physics at Stony Brook, and
Margaret O'Gara with a background in chemistry
came from the University of Galway in Ireland.
Ruiming began working on yeast casein kinase-1 in
an effort to determine its three-dimensional structure.
Margaret started to work on Hhal methyltransferase
to illustrate further the mechanisms of DNA recogni-
tion and methylation on a detailed steric chemical
level. Diane Alonso, an URP from Scripps College at
California, also applied her energy on the methyl-
transferase using the techniques of molecular ge-
netics. The latest structure solved in this laboratory is
Pvull endonuclease. Our progress on three different
enzymes are described below.
Structure of Yeast Casein Kinase-1
R. Xu, T. Malone, X. Cheng [in collaboration with
J. Kuret, Cold Spring Harbor Laboratory; R.M. Sweet,
Brookhaven National Laboratory]
We have determined the crystal structure of the
catalytic domain of casein kinase-1 (CK1) from
Schizosaccharomyces pombe in complex with
MgATP at 2.0 A resolution. The current R-factor is
20.7%. The truncation consists of the amino-terminal
298 residues and is fully active in vitro. CK1 is a
family of protein kinases common to all eukaryotic
cells and phosphorylates many proteins in vitro, in-
cluding SV40 T antigen, p53, and glycogen synthase.
CK1 employs a catalytic domain that differs en-
zymologically from most other protein kinases. CK1
isoforms selectively recognize the sequence SpXXS,
where X is any amino acid, and the underlined serine
residue is the phosphate acceptor. The presence of
acidic residues amino-terminal to a phosphorylatable
hydroxyamino acid is the minimal requirement for
recognition of synthetic peptides by CK1. Replace-
ment of the acidic amino acid with phosphoserine at a
position three residues amino-terminal to the phos-
phorylatable serine results in a synthetic substrate
with far superior kinetics. Thus, the substrate selec-
tivity of CK1 appears to be directed toward phos-
phate groups rather than unmodified amino acids.
The structure contains nine a helices and seven p
strands, designated A to I for helices and 1 to 7 for
strands from the amino to the carboxyl terminus of
the amino acid sequence (Fig. 1). The loops are
designated by their flanking secondary structures.
The molecule folds into two parts, and we named
them the beta domain (amino acids 1-86) and the al-
pha domain (amino acids 91-298), connected by a
single loop L-5B (amino acids 86-91). There is a
deep cleft between the two domains, which binds
MgATP and peptide substrate. The overall architec-
ture of CK1 is quite similar to that of the cAMP-
dependent protein kinase and the cyclin-dependent
kinase-2.
The beta domain contains one third of the protein
from the amino terminus. It has five twisted
antiparallel strands ((31-135) and one helix (aA). A
characteristic glycine-rich sequence motif among
most protein kinases, G19-T-G21-S-F-G24-V, forms
a part of the (31- turn -(32 structure over the MgATP-
binding site. G19 is the last amino acid of strand pl,
and V25 is the first amino acid of strand 132. The
adenine base and ribose ring of ATP are inserted into
a hydrophobic pocket, whereas the triphosphate
group is covered by glycine-rich loop L-12. An Mg++
ion bridges the a and y phosphates.
The alpha domain contains five long helices
(C,E,F,H,I), three short helices (B,D,G), two short
strands (6,7), and one long loop (L-7D). Four of five
long helices (aC, aE, aH, and aI) form an antiparal-
lel bundle with the fifth long helix (aF) almost per-
pendicular to the bundle. These five helices form a
structural framework for this domain. The remainder
of the domain contains three short helices (aB, aD,
and aG) and two short strands (136 and (37) and loops
including the 10-residue loop L-C6, the 30-residue
long loop L-7D, and the 12-residue loop L-EF. These
short secondary structures and the loops containing
conserved residues are clustered around the surface
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Casein Kinase-1
FIGURE 1 Structure of the catalytic domain of the casein kinase-1.
of the cleft and may be crucial for the function of the
enzyme.
Structure of PvuII Endonuclease
X. Cheng, K. Balendiran, J.E. Anderson [in collaboration
with I. Schildkraut, New England Bio labs, Inc.]
We have determined the structure of the Pvull endo-
nuclease (RPvull) complexed with cognate DNA at
2.6 A resolution. The final crystallographic R-factor
is 18.9%. RPvull, which forms part of the restric-
tion-modification system of Proteus vulgaris, cleaves
duplex DNA with the sequence 5' -CAGC- TG -3'
between the central guanine and cytosine residues in
both strands to generate blunt-ended DNA products.
RPvull is the smallest restriction endonuclease
found so far, containing 157 amino acids. Two views
of the structure are shown in Figure 2.
The cleft between the U-shaped dimer of RPvull
provides the binding site for DNA. The DNA in the
structure is a 12-base duplex containing the recogni-
tion sequence (CAGCTG) with single-base (T) 5'
overhangs. Contacts between the protein and back-
bone phosphates span 12 base pairs of the duplex.
The bound duplex has the characteristic shape of B-
form DNA (Fig. 2, top). The minor groove of the
DNA faces the bottom of the cleft and the major
groove faces the open end (Fig. 2, bottom).
The monomer structure contains five a helices
and eight 13 strands, designated A to E for helices and
1 to 8 for strands from the amino to the carboxyl
terminus of the amino acid sequence (Fig. 2, bottom).
The molecule of the monomer is folded into three
parts, and we named them the protein-interface
region, the catalytic region, and the DNA-recognition
region.
The first 46 amino-terminal residues form the
dimer interface through two helices connected by a
loop (aA, loop L-AB, and aB). The 21-residue helix
aA is bent due to a proline. The two aA helices of
the dimer cross over each other, and as a result, the
amino terminus of one monomer is close to the car-
Pvull endonuclease
major
groove
FIGURE 2 Structure of Pvull endonuclease. Two subunits are shown with a
ball-and-stick model of the bound cognate DNA segment. (Top) Front view of
the protein-DNA complex. A hydrogen bond between the side chains of H85,
which both lie in the major groove of the DNA, closes off the DNA-binding
cleft. (Bottom) Side view of the protein-DNA complex from an angle as indi-
cated in the top drawing.
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boxyl terminus of the other monomer
(Fig. 2, bot-
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ti pa al lseel
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strands
bases in the major groove
torn). The 10-residue aB helices are aligned head-to- side chains of amino acids in the loop L-AB
mw oh incohm et wrs contactan
spans the minor groove, make water-mediated con_head in the dimer, as if there were a
single helix with
a kink in the middle. Thus, the two helix-loop-helix t
structures are arranged as a pseudo-three-helix
acts to the central G-C base pair and backbone
bundle, with the hydrophobic side chains from all
phosphates.
four helices packing into a hydrophobic
core in the
center of the bundle. The loop L-AB of each
monomer forms the bottom of the
DNA-binding cleft
with their main-chain atoms hydrogen bonded to
each Structure of Hhal Methyltransferase
other like two p strands. The only other contact
of the X. Cheng, K. McCloy, D. Alonso, M. O'Gara
two monomers is a hydrogen bond between the side [in collaboration with
R.J. Roberts, New England
chain of H85 in the major groove of the DNA (Fig. 2, Biolabs, Inc.]
top). This H85-H85 interaction wraps around the cen-
tral G-C base pairs and closes off the DNA-binding
We have solved the structure for a chemically
cleft and therefore must only occur after the DNA is
trapped covalent reaction intermediate between the
bound. This raises the possibility that the protein may
Hhal methyltransferase (M HhaI), S-adenosyl-L.
h
undergo a conformational change upon substrate
homocysteine (AdoHcy), and a duplex 13-mer DNA
bindin
oligonucleotide containing methylated 5-fluorocyto-
g. sine at its target. MHhal forms part of a type II re-The catalytic region consists of a mixed antiparal-
lel/parallel sheet formed by three short strands 031, striction-modification
system from Haemophilus
haemolyticus. The enzyme recognizes the specific
1:32, and (38) and three long strands 033, 135, and (36)
with one helix (aB or aE) on either side of the sheet. tetranucleotide sequence, 5' -GCGC-3 ' and methyl-
The sheet is twisted around strand /33, whose amino- ates the C5 position of the first cytosine residue.
terminal half forms hydrogen bonds with strand /32 We have crystallized a complex formed upon in-
and carboxy-terminal half pairs with strand /35. As a cubation of MHhaI, S-adenosyl-L-methionine (Ado-
result, the hairpin of 135 and (36 is almost per- Met), and a 13-mer oligonucleotide containing the
pendicular to the hairpin of p1 and 132. The potential recognition sequence GFGC in which the target
catalytic amino acids were identified in the vicinity cytosine was substituted by 5-fluorocytosine (F) (Fig.
of the reactive phosphodiester group. Among these 3a). The substrate forms a 12-base-pair duplex with
residues, E55 is located in loop L-12 and D58 is in single-base 5' overhangs. Reaction with this sub-
the amino-terminal end of strand 132, and the triplet strate results in the formation of an intermediate,
wE68-L69-K70 is situated in the middle of the twisted hich contains a covalent linkage between the sulfur
strand (33. Comparison of the catalytic site with that atom of Cys-81 of the enzyme and the C6 atom of the
of EcoRV and EcoRI endonucleases reveals the con- target cytosine ring. In this intermediate, the methyl
served triplet sequence and the conserved acidic pair group has transferred to the CS position of cytosine,
that presumably provide the ligands for the catalytic but elimination is inhibited because the fluorine on
cofactor Mg++. Despite their dissimilar primary se- C5 cannot be released as F+. During the course of this
quences, the structural similarity among the catalytic reaction, AdoMet is converted to AdoHcy, which is
regions of these three endonucleases is related to the still present in the complex. The structure has been
common feature of restriction enzymes-they cleave solved at 2.8 A resolution by molecular replacement.
both strands to produce 5' -phosphate and 3 ' - The final crystallographic R-factor is 17.4%.
hydroxyl groups. In contrast to the endonuclease that acts on the
The recognition region comprises two substruc- phosphate backbone, the methylase requires access to
tures from different locations in the primary se- a base in order to carry out its chemistry. How this is
quence, each containing one strand and one helix. accomplished is revealed remarkably by the structure.
Strand /34 and helix aC run antiparallel with helix MHha1 binds DNA as a monomer, and the cleft
aD and (37. The resulting two antiparallel 13 strands between the two domains provides the binding site
make specific interactions with DNA bases in the for DNA as predicted previously (see last year's An-
major groove. A similar mode of base-specific recog- nual Report) (Fig. 3b). Overall, the structure of the
nition was seen in the structure of Met repressor, in protein component is very similar to that in the ab-
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sence of DNA. The major difference lies in the 20-
residue active-site loop located in the large domain.
This loop contains the catalytic nucleophile Cys-81.
Upon DNA binding, this loop undergoes a large con-
formational change and moves toward the DNA-
binding cleft (Fig. 3c). The sulfhydryl group of Cys-
81 is brought into close proximity to the target
cytosine, allowing the formation of the covalent link.
Another significant shift in the protein is found in the
small domain, which undergoes a small concerted
movement toward the DNA-binding cleft (Fig. 3c).
The bound 13-mer DNA fragment has close to the
characteristic conformation of B-form DNA, with
standard Watson-Crick hydrogen bonds between the
base pairs, except for a completely disrupted G-C
base pair that contains the target cytosine. Remark-
ably, the target cytosine (both the base and sugar
rings) has flipped completely out of the DNA helix
(Fig. 3d). The exclusion of the cytosine from the
helix is accompanied by substantial distortions of the
phosphodiester backbone on the same strand. This
can be seen by comparing the oligonucleotide struc-
ture with that of an unbound DNA decanucleotide
containing the MHhal recognition sequence GCGC
(Fig. 3d). Both phosphates flanking the target cyto-
sine are shifted significantly away from their cor-
responding positions in the unbound oligonucleotide,
whereas further distortions extend along the phospho-
diester backbone in the 5' direction. These changes
increase the interstrand phosphorus-phosphorus dis-
tances and allow the target cytosine to flip through
the minor groove and out of the helix. The DNA is
contacted from both the major and the minor grooves,
but almost all base-specific interactions between the
enzyme and the recognition bases occur in the major
groove, through two glycine-rich loops from the
small domain.
The binding of MHhal to its DNA substrate
causes extensive conformational changes. The three
essential components of the methylation reaction, the
target cytosine, the catalytic nucleophile, and the
methyl donor, are brought into close proximity with
one another, allowing the methylation reaction to
proceed. Around the active site, the protein forms ex-
tensive contacts with both the DNA and the cofactor
mainly through well-conserved amino acids. The
complex offers a particularly clear example of the
induced-fit mechanism of enzyme-substrate interac-
tions. The entire story is of great interest in under-
standing protein-DNA interaction and the catalysis of
methylation.
In light of the dramatic structural change that has
occurred in forming the intermediate in DNA meth-
ylation, the mechanistic details of the reaction have
suddenly become much more complicated. The struc-
ture has raised more questions than it has answered.
For instance, it is not certain that the contacts be-
tween DNA and protein that are seen in this structure
are the ones responsible for sequence-specific recog-
nition during the initial binding event. It seems likely
that this initial recognition is tied to the mechanism
for flipping out the target cytosine and that both take
place as a concerted event. There is also the problem
of returning the methylated cytosine residue into the
helix. Clearly, studies either with mutant proteins or
with cytosine analogs that fail at some point in the
reaction pathway will be useful in dissecting the me-
chanism further. Currently, such studies are under
way.
Replacement of the catalytic Cys-81 of MHhal
methyltransferase with serine abolished catalysis (see
last year's Annual Report by S. Mi and R.J. Roberts
in the Nucleic Acid Chemistry section). This mutant
behaves as the sequence-specific DNA-binding
protein but loses the activity of methylation. The
mutant protein can be trapped as an intermediate with
DNA and cofactor due to the lack of subsequent
methylation. Crystals of this mutant protein com-
plexed with DNA have been obtained.
As mentioned above, two major changes take
place upon DNA binding: the complete disruption of
the target base pair and a conformational change of
the active-site loop. Gln-237 from the small domain
occupies the position left by the target cytosine after
it has flipped out of the helix. The polar groups along
the Watson-Crick pairing edge of the orphan guanine
are all involved in intermolecular hydrogen bonds
with the backbone and side chain atoms of Gln-237
whose alignment is stabilized through hydrogen bond
formation with Ser-87 from the large domain (Fig.
3e). The three glycines flanking Gln-237 appear to be
crucial in positioning the side chain of Gln-237 for its
deep penetration into the helix to ensure the stacking
and hydrogen bonding. Interestingly, Gln-237 and
Ser-87 are not conserved amino acids among the
cytosine-05-methyltransferases, establishing that hy-
drophobic interactions also contribute to these
protein-DNA interactions. For this reason, we exam-
ined the role of Gln-237 in DNA binding and sub-
strate specificity by site-directed mutagenesis. (For
detailed analysis and results, see report by S. Mi and
R.J. Roberts.)
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Gln-237 was replaced by all other amino
acids
except Ile and Tyr. The result of substitution
can be
divided into three classes. The first
class retains full
DNA-binding and methylation activities,
including
Glu, Lys, Arg, and Leu. The second class
greatly
reduced both activities, including Meth
Ser, His,
Thr, Ala, and Pro. Substituting with Met retained
slightly higher residual activities
than others in this
class. The third class completely abolished
the bind-
ing and methylation activity, including
Gly, Cys, Val,
Asp, Tyr, and Phe. The three substitutions with
charged amino acids in the first class retained the
potential to form hydrogen bonds with the orphan
guanine and/or Ser-87, consistent with the
fact that
Gln-237 functions by hydrogen bonding. Substituting
with Asp, however, abolished both activities com-
pletely, suggesting that the size and shape of the side
chain of Gln-237 may he critical for
hydrophobic interactions with the neighboring DNA
bases. This may also explain why substitution With
Leu retained full activities and Met retained partial
activities, whereas aromatic rings eliminated ac,
tivities.
In summary, the binding of the enzyme to sub.
strate DNA results in large conformational changes
of both the DNA and the protein. The first distortion
appears to be the flipping of the target cytosine, ac-
companied by a glutamine (Gln-237) occupying its
space and providing hydrogen bonds to its partner
guanine. Subsequent closing of the active-site loop
on the target brings an additional amino acid (Ser-87)
into the DNA helix to stabilize the conformation
of
Gln-237. The two amino acids restore the stack in the
DNA.
FIGURE 3 (See facing page for parts d and e and legend.)
190
eGln 237
m 3.02
FIGURE 3 Structure of Hhal methyltransferase. (a) Target cytosine base with a fluorine atom substituted for a hydrogen
atom at its C5-position. (b) Stereoview looking down the axis of DNA helix in which the DNA can be seen to lie between the
large domain (on the upper right) and the small domain (on the lower left). (c) Stereoview showing the superimposition of the
protein Ca chains from ternary complex of DNA-M Hhal-AdoHcy and the binary structure of MHhal-AdoMet. The Ca chains
of M Hhal are shown as a light line (binary complex) or a heavy line (ternary complex). The 20-residue active-site loop in the
large domain undergoes a large conformational change upon DNA binding. The extreme movement is about 25 A toward theA
cleft. The small domain is also shifted toward the cleft with a movement of about 3 . (a) Stereoview showing the DNA con-
formation (as heavy line) from the minor groove. The structure of normal B-DNA is shown as a light line. Excluding the
flipped-out target cytosine and the unpaired 5' bases, the average helical twist is 31.6° and the mean rise per base is 3.6 A,
implying 10.9 by per turn. (e) Gln-237 makes three hydrogen bonds (two from side chain atom 01 and one from main chain
amide) with Ni, N2, and 06 atoms of the orphan guanosine, which originally paired with the target cytosine. A hydrogen
bond links Gln-237 to Ser-87.
191
PUBLICATIONS
Cheng, X., S. Kumar, S. Klimasauskas, and
R.J. Robens-rts.
1993. Crystal structure of the
Hhal DNA methyltra
ferase. Cold Spring Harbor
Symp. Quant. Biol. 58:
331-338.
Cheng, X., S. Kumar, J. Posfai, J.W.
Pflugrath, and R.J.
Roberts. 1993. Crystal structure
of the Hhal DNA meth-
yltransferase complexed with
S-adenosyl-L-methionine.
Cell 74: 299-307.
PROTEIN CHEMISTRY
R. Kobayashi J. Murtha
B. Schwender
Our research goal has focused on developing meth-
ods for microcharacterization of biologically impor-
tant proteins. In the beginning of this year, James
Murtha joined the laboratory as a part-time assistant
and Brian Schwender joined in July. James helped to
synthesize amino acid derivatives for the modified
Edman degradation and to explore a new staining dye
for protein after gel electrophoresis. Brian has been
constructing a protein database for the yeast Sac-
charomyces cerevisiae as a part of the Quest Protein
Database Center. We have been identifying protein
spots on two-dimensional gels by analyzing their in-
ternal amino acid sequences (see the Quest Protein
Database Center section).
PROTEIN SEQUENCING
The collaboration with other scientists at Cold Spring
Harbor Laboratory has been extended lab-wide since
the end of 1992 and has been a major activity in our
laboratory. This year's collaborators were Drs. Arndt,
Bar-Sagi, Beach, Garrels, Greider, Hernandez,
Krainer, Kuret, Moran, Patterson, Spector, Stenlund,
Stillman, Tanaka, Tonks, and Wigler. Most of the
collaborations were for protein sequence analysis so
that each researcher could clone their genes for fur-
ther study and determine the phosphorylation sites of
the proteins. The technique for internal amino acid
sequence analysis of protein was improved this
spring. The change was to remove the SDS after
Klimasauskas,Prlimaessasuskas, S., S. Kumar, R.J. Roberts, and X. Cheng
1994. Hhal methyltransferase flips its target base
out 0)
the DNA helix. Cell 76: 357-369
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R.J.Roberts, and G.G. Wilson. 1994. The DNA (cytosine-5)
methyltransferases. Nucleic Acids Res. 22: 1-10.
polyacrylamide gel electrophoresis prior to enzymatic
digestion of the protein instead of using SDS in the
digestion and separating peptide fragments by high-
performance liquid chromatography (HPLC) using an
anion-exchange column. This change improved the
recovery of peptides when 1-2 .tg of protein is
studied.
This year, we successfully obtained amino acid
sequence information for more than 60 proteins those
of which were DNA replication factors, transcription
factors, including p300, RNA splicing factors, and
cell cycle control proteins including p21.
Cell cycle control protein p21 was found in
normal human cells but not in many transformed
cells. This protein was isolated and purified from 400
tissue culture dishes by Dr. Yue Xiong in the Beach
laboratory at Cold Spring Harbor. About 2 ug of p21
was finally obtained after polyacrylamide gel elec-
trophoresis. The protein band was excised and sub-
jected to in-gel digestion with Achromobacter prote-
ase I (lysylendopeptidase) in the presence of 0.1%
SDS. The peptide fragments after the digestion were
separated by HPLC. The HPLC profile is shown in
Figure 1. Each peptide fragment was sequenced by
automated sequencers. Based on the peptide se-
quence, oligonucleotide primers were designed and
synthesized, and the gene encoding p21 was then
cloned in the Beach laboratory. Excitingly, Dr. Beach
and his colleague found that p21 is a universal in-
hibitor of cyclin kinases and that overexpression of
p21 inhibits the proliferation of mammalian cells.
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FIGURE 1 HPLC profile of the Achromobacter protease I (lysylendopeptidase) digest of p21 (in
collaboration with Dr. David Beach, Cold Spring Harbor Laboratory).
METHODOLOGICAL STUDY OF PROTEIN SEQUENCE
ANALYSIS
We have been trying to develop a highly sensitive
method for protein sequencing by combining
modified Edman degradation and chemiluminescence
detection. However, this research has not progressed
much this year, although we synthesized and purified
many of the standard amino acid derivatives for a
new protein-sequencing method. We expect to spend
more time in the future in developing a new method
in 1994 in order to sequence peptides at the sub-
picomole level.
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PROTEIN KINASE STRUCTURE
AND FUNCTION
J. Kuret G. Carmel
W. Schaub
M. Ebert
P. Kearney
R.M. Xu
Casein kinase-1 (CK1) is a ubiquitous eukaryotic
protein kinase that phosphorylates acidic substrate
recognition sequences efficiently. Once
considered a
single entity, it is now known to consist of subspecies
that together comprise a distinct branch of the eu-
karyotic protein kinase family. Family members con-
sist of a highly conserved, ,-290-residue amino-
terminal catalytic domain, joined to a carboxy-ter-
minal region that is not conserved among family
members and that varies in size from 40 to 180 amino
acids. Although the full role of the carboxy-terminal
domain is not understood fully, part of its function is
to target the enzyme to specific regions of the cell.
Last year, we reported the isolation of four new
CK1 genes from fission yeast, their expression in
bacteria, and their enzymological properties in vitro.
We also reported the rational design and crystalliza-
tion of a carboxy-terminal deletion mutant of Ckil, a
cytoplasmic isoform of CK1. The truncation, termed
CkilA298, consists of the 298-residue catalytic core
of Ckil and is fully active in vitro. Three different
crystal lattices were obtained: one form of CK1 alone
and two different forms of the CK1/MgATP binary
complex. This year, the first of these structures, a
binary complex diffracting to 2.0 A resolution, was
solved.
Casein Kinase-1 Tertiary Structure
R.-M. Xu, G. Carmel, P. Kearney [in collaboration
with X. Cheng, Cold Spring Harbor Laboratory,
and R.M. Sweet, Brookhaven National Laboratory]
The methods used to determine the crystal structure
of CK1 are discussed in the Macromolecular Crystal-
lography section of this volume. The overall structure
of CK1 is described there as well. Here, we focus on
the functional aspects of structure.
On the basis of kinetic measurements, CK1 selec
tively binds synthetic peptide substrates containing a
phosphoamino acid located three residues amino-
terminal to the phosphate acceptor site (position P-3).
This requirement differs dramatically from that of
cAPK, which selectively binds a positively charged
residue in positions P-2 and P-3. Not surprisingly, the
key residues involved in substrate binding in cAPK
Glu-230, Glu-127, and Glu-170, are not conserved in
CK1, being replaced by Tyr-210, Ser-91, and Asp-
135, respectively. Despite these differences, the
peptide-substrate-binding cleft found on the face of
the a lobe of cAPK is found in a similar location
on
CK1. As described above, all known forms of CK1
are positively charged at neutral pH. Calculation of
the local electrostatic potential on the surface of CK1
reveals that the positive charge is enriched in the
substrate-binding cleft, in a position suitable to make
contact with the peptide substrate amino-terminal to
the phosphorylatable hydroxyamino acid.
Interestingly, we have identified a sulfate anion in
the positively charged peptide-substrate-binding re-
gion, where it may mimic the noncovalent binding of
a phosphate ion or phosphohydroxyamino acid re-
sidue as it does in the crystal structures of other
phosphoproteins (Fig. 1). Clearly, this sulfate does
not mediate crystal contacts. In CK1, sulfate binds
the main-chain nitrogen of Gly-220, the c-amino
nitrogen of Lys-229, and is approximately 3.4 A
away from the guanidino moiety of Arg-183. Each of
these residues is conserved throughout the CK1 fam-
ily of enzymes. Gly-220 and a lysine or arginine at
position 229 are found in subdomains IX and X of all
known CK1 isoforms, whereas Arg-183 is conserved
in all isoforms except mammalian CKI13. Although
Gly-220 flanks a kinase insert sequence unique to
CK1, Arg-183 occupies the same position as does
Glu-203 in cAPK. In cAPK, this position is an impor-
tant determinant of substrate selectivity that makes
contact with P-3 and P-6 of PKI. In addition to sug-
gesting the structural basis of substrate selectivity,
the S1 site may mediate the inhibition of CK1 by
phosphatidylinosito1-4,5-bisphosphate.
Our model of CK1 also suggests functions for
structural motifs conserved throughout the CK1 fam-
ily of kinases. First, the motif Asp-Leu-Leu-Gly-Pro-
Ser-Leu-Glu-Asp-94 found in subdomain V is con-
served in all CK1 isoforms because it makes direct
FIGURE 1 Structural basis of CK1 substrate selectivity. An a-carbon trace of CK1 is
shown. The side chains Arg-183 and Lys-229 come together with the main-chain
nitrogen of Gly-220 to create a high-affinity site for sulfate and presumably for
phosphate as well. This site suggests a mechanism whereby CK1 binds synthetic
peptide substrates containing phosphoamino acids in the P-3 position with an af-
finity greater than that of identical peptides containing simple acidic residues in this
position.
contact with the nucleotide substrate while spanning
a single-residue deletion relative to other protein
kinases. In addition to supplying a hydrophobic-
binding pocket, the backbone amide and carbonyl
groups of Asp-86 and Leu-88 hydrogen bond with
NI and N6 of the base. Moreover, this sequence
bridges the two lobes and spans the presumptive
hinge region. Although the CK1-bound conformation
of ATP is almost identical to that found in cAPK, the
side chains and water molecules that make contact
with it differ greatly between the two enzymes.
One Mg++ was identified on the basis of its
bonding distances and coordination geometry. The
ion makes direct contact with nucleotide, bridging its
a and y phosphates, and binding the side chain of
Asn-136. This position corresponds to the low-
affinity M1 site of cAPK. Although cAPK contains a
second Mg++ bridging the 1 and y phosphates (the
M2 site), no density for this site was observed in
CK1. It is possible that the M2 site exists in CK1 but
is obscured by dynamic motion. This appears unlike-
ly, because in the model of the protein kinase ERK2,
the y-phosphate of ATP is completely disordered and
yet the M2 site is well-resolved. In cAPK, occupation
of the low-affinity M1 site is accompanied by a
reduction in phosphotransferase velocity. Our results
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they may bind a phosphate moiety in mho
CK1
suggest that the primary role of Mg++ is to
provide an
homologous to Thr-197 of cA PK. Second, L..9D
electron sink for the y-phosphorus and that it can
supply this function by directly binding the
y- resembles the regulatory T-loop of Cdk2. However,
phosphate in either the M2 or M1 conformation. As
the T-loop in Cdk2 is rotated approximately 1800
demonstrated through kinetic measurements,
the with respect to L-9D in CK1, so that upon super-
binding of a second Mg++ increases the affinity of
imposition, the two loops lie opposite each other. $e_
ATP for kinase by decreasing its dissociation rate.
cause our model is of fully active CK1,
Because the dissociation rate of the ADP product is
Cdk2 is inactive, the two conformations may cor-
respond to the active versus inactive states of these
also reduced, and because this is the rate-limiting
step, the overall rate of phosphoryltransfer is dimin-
enzymes. Indeed, it has been suggested that upon
fished. Thus, the occupation of both M2 and M1 by
Cdk2 activation, the small helix amino-terminal to
Mg++ appears to be inhibitory. Our results suggest
the T-loop (aL12) unwinds, removing the T-loop
that it is the binding of the first Mg++ rather than the
from the active site, whence it may adopt a con_
occupation of a specific site that activates the protein
formation similar to that of L-9D in CK1. Similarly,
kinase and that the binding of additional ions to either an in vivo regulatory mechanism may exist for CK1
site may lead to inhibition through decreased product that stabilizes L-9D in a conformation similar to that
dissociation. Again, our results suggest that the loca- observed for the T-loop in inactive Cdk2. Interesting-
tion of the highest-affinity Mg++-binding site will ly, all CK1 isoforms retain a threonine residue (Thr-
vary among protein kinases. 166; Fig. 2) at the apex of the hairpin (L-9Da) that is
The most intriguing conserved feature of CK1 is homologous to a regulatory phosphorylation site in
the triplet Ser-Ile-Asn-188 of helix aD where it re- Cdk2 (Thr-160).
places the triplet Ala-Pro-Glu found in cAPK, Cdk2, Although CK1 and Cdk2 share similarities in
and most other protein kinases. In both cAPK and structure, they may be regulated in different ways.
Cdk2, the glutamic acid residue of the triplet forms a Our model points to a second potential mechanism
salt bridge with Arg-280 in cAPK and Arg-274 in for CK1 regulation. Included in L-9D is the sequence
Cdk2 that are located in loops homologous to L-HI. His-Ile-Pro-Tyr-Arg-Glu-Lys-175, a motif found in
Surprisingly, we find that the Ser- Ile/Val -Asn motif the head regions of kinesins, the motor proteins of
adopts the same secondary structure and is in the microtubules. The head region contains microtubule-
same location as the Ala-Pro-Glu-208 sequence of binding sequences, of which His-169-Lys-175 may
cAPK. However, major differences exist among the be a component. Isoforms of CK1 copurify with
kinases in the structure of L-HI. As a result, sub- cytoskeletal proteins and may associate with them in
domain VIII no longer makes direct contact with sub- part through the His-169-Lys-175 sequence. If this is
domain XI via a salt bridge as it is thought to do in all the case, then the role of L-9D may be to regulate the
other protein kinases. Instead, Ser-186 and Asn-188 reversible association of CK1 with the cytoskeletal
hydrogen bond to Arg-198 and Asp-199 of helix aE, fraction.
respectively, whereas the side chain of Ile-187 is In summary, CK1 is a conserved member of the
buried. In addition, the helices flanking L-HI are sta- eukaryotic protein kinase family despite its unusual
bilized by salt-bridging between Glu-202 of aE and primary structure. Its most divergent motifs appear to
Arg-261 of aH. Therefore, the Ser- Ile/Val -Asn motif shape its unique substrate specificity and participate
appears to be conserved in the CK1 family because of in its regulation. The genetically tractable CK1
the unique fold of L-HI, rather than adopting an un- homologs of fission yeast will prove useful in testing
usual conformation by itself. these hypotheses and correlating structure with in
If this is the case, what is the function of loop L- vivo function.
HI? We suspect that the conformation of L-HI is
unique because it interacts directly with the long loop
L-9D, in which are scattered several conserved
residues. Several features of L-9D suggest that it has New CK1 Crystal Forms
a regulatory role. First, as described above, Lys-159 G. Carmel, R.M. Xu
and Lys-176 form part of a potential phosphorylation
site. Although both of these lysine residues interact During the 1980s, a family of selective, low-
with Glu-194 in our dephospho structure of CK1, molecular-weight casein kinase inhibitors were de-
196
FIGURE 2 Potential mechanism of CK1 regulation. CK1 contains a loop (L-9D) that
resembles the T-loop of Cdk2. The loop begins with a 10-residue hairpin and
terminates with 15 residues in extended conformation. In the structure of inactive
Cdk2, the homologous loop (T-loop) rises from the a lobe to make contact with the
glycine-rich flap. Thus, the T-loop is positioned to control Cdk2 activity by reversibly
blocking its active site. In CK1, L-9D is in an open conformation, leaving the active
site unblocked. Shown here is the T-loop of Cdk2 superimposed on the backbone
trace of CK1. The view is rotated 120° relative to Fig. 1.
veloped. The first of these was N-(2-aminoethyl)-5-
choroisoquinoline-8-sulfonamide, also known as
CKI7. It is one of a large family of naphthalene and
isoquinoline sulfonamide derivatives that differ in
potency and specificity. Selectivity for individual
protein kinases has been achieved by varying the
chemical substituents at two locations on the iso-
quinoline ring. For example, CKI7, which has a
chlorine at ring position 5 and ethylamine sul-
fonamide at ring position 8, inhibits CK1 with a Ki of
9.5 tim but is weakly inhibitory for all other kinases
tested. As with other isoquinoline sulfonamides,
CKI7 is a competitive antagonist of the nucleotide
substrate, but it has weak activity against other ATP-
using enzymes such as ATPases and adenylate
cyclase. As a result, individual isoquinoline sul-
fonamides have emerged as important pharmacologi-
cal tools for dissecting signal transduction pathways.
To determine the structural basis of isoquinoline
sulfonamide specificity, we crystallized CK1 in com-
plex with CKI7. The crystals grow as hexagonal
bipyramids up to 0.8 mm in length (Fig. 3) and dif-
fract X-rays to at least 3.5 A resolution. This is our
most recent crystal, and as of this writing, its space
197
FIGURE 3 Crystals of CK1 in complex with an isoquinoline
sulfonamide inhibitor. The maximum dimension is 0.6 mm.
group has not been established. In the coming year,
we hope to obtain the structure of this and two other
crystal forms from our collaboration with X. Cheng.
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The "Open" Conformation of the
cAMP-dependent Protein Kinase
J. Kuret, G. Carmel
Last year, we described the preliminary structure of
the unliganded form of yeast cAMP-dependent
iprotein kinase, performed in collaboration with j.
Pflugrath (CSHL). This summer, its refinement was
completed, bringing the crystallographic portion of
the project to a conclusion after 4 years of effort. The
final model, which includes data to 2.8 A resolution,
has an R-factor of 20.9% and deviates from ideal
bond lengths and interbond angles by 0.018 A and
2.8°, respectively.
No electron density is apparent for the two
amino-terminal residues or for 18 residues located
carboxy-terminal to the catalytic core. The stereo-
chemical quality of the model is good: 73.1% of 264
nonproline, nonglycine residues fall within the most
favorable region of the Ramachandran plot, with an
additional 25.0% falling in additionally allowed
regions. The model is in excellent agreement with the
structure of unliganded mammalian cAPK, published
earlier in the year.
Comparison of this structure with its fully
liganded mammalian homolog reveals a highly con-
served protein fold composed of two globular lobes.
Within each lobe, root mean square deviations in Ca
positions average -0.8 A. In addition, a phospho-
threonine residue is found in the carboxy-terminal
domain of each enzyme. Further comparison reveals
that ligand binding is accompanied by two major
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FIGURE 4 Differences in backbone 4) and w angles between unliganded TPK1 and
fully liganded mammalian cAPK.
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conformational changes. The first consists of a 15.8°
rigid-body rotation of one lobe relative to the other
along an axis parallel to a large a-helix located in the
carboxy-terminal lobe (Helix E) and results in closure
of the active site cleft. The rotation is mediated in
part by the single strand that connects the two lobes
and can be described by rotations in backbone dihed-
ral angles 4) and v. The largest changes in this region
are a 65° increase in the (I) angle of Gly-126 ac-
companied by a 70° decrease in the to angle of Gly-
125 (Fig. 4). Because Gly-125 is highly conserved
throughout the protein kinase family, we suspect that
the hinge motion observed in cAPK will emerge as a
common feature of these enzymes. The second con-
formational change affects only the glycine-rich
nucleotide-binding loop, which moves A to fur-
ther close the active site and trap the nucleotide sub-
strate.
COMPUTATIONAL BIOLOGY
T. Marr L. Catapano
W. Chang
S. Cozza
D. Cuddihy
E. Cuddihy
W. Li
E.C. Reed
J. Salit
M. Zhang
Our group does basic research and computer software
development in a new emerging area often referred to
as "genomics" or "genome informatics." Through the
efforts of the international Human Genome program,
highly detailed molecular maps of human and model
organisms are rapidly becoming available to all re-
searchers in the broad areas of molecular cell biol-
ogy. Data are often released on a daily basis from the
large (by typical molecular biology standards) ge-
nome centers around the world, but primarily in the
United States, Great Britain, and France. It is our
thesis that gene finding and functional analysis could
be greatly accelerated if these data were provided to
the numerically dominant (and intellectually impor-
tant) small, hypothesis-driven research laboratories in
a simple, consistent, integrated, and timely manner.
Currently, one must use several different sources
of data to devise informative experiments, such as the
published scientific literature and scientific meetings,
and a myriad of often difficult-to-use computer pro-
grams to accomplish even relatively simple investiga-
tions. The consequence of the current situation is that
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most biologists are not able to analyze fully the sig-
nificance of their data and therefore are potentially
missing crucial new findings. This situation is ex-
acerbated by an ever-growing number of journals,
scientific meetings, and specialized databases using
ad hoc nomenclature and data representational and
computer access methods. A major goal of our soft-
ware development is to be able to move from genetic
map, to physical map, to sequence and function using
what appears to the user as one computer program.
This type of "virtual program" ultimately is intended
to be the primary source that an investigator can use
to plan the next experiment, rather than being depen-
dent on the relatively inefficient primary scientific lit-
erature and scientific meetings. The field is naturally
evolving in this direction and "publication" will take
on new meaning in the near future as fast, in-
expensive computers and high-speed, wide-area
networks become widely used.
We have a major computer software project in
our group that has been under development for
several years. This software package, called Genome
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pombe genome (to
tal side of genome mapping and genomic
analysis.
Topographer (GT) represents the results of many
Green, unpubl.). Our own work of mapping the fis-
years of studying and participating in the experimen-
sion yeast Schizosaccharomyce.s
13-kb resolution; Mizukami et al. 1993) was
cience Section), and on methods for gene function
-
We are in particular focusing on methods
that ac- bination of bottom-up
and top-down methods:
celerate finding genes involved in complex,
multi- hybridization data
that can be viewed either as
gene diseases, such as in what is
expected for bipolar STS/SCL (single-copy landmarks) content mapping
affective disorder (see H. Feilotter in the Neuros-
or more broadly as "multi-origin chromosome
ing" (Olson and Green 1993), integrated with genetic
prediction (using DNA and protein sequence analy-
and restriction maps of the genome. It is this diversity
sis). In this way, our system will provide continuity
of data that poses a challenge: The tools must "under-
to the process of gene mapping through directional
stand" the parameters of the underlying data types
cloning and functional analysis, which is currently
and origins (i.e., which laboratory), otherwise, they
lacking.
will Wnot fhuanvcet i n op t im
specific
pt ally.l y
areas of explosive
formation is essential in most cases to study gene
.
Since genetic, molecular, and biochemical in- growth where tools can be built that are likely to be
function and dysfunction, Genome Topographer pro-
of great help in the task of data integration. These in-
vides uniform representation (and database storage)
elude the Saccharomyces cerevisiae 3-kb resolution
of such data for human and major model organisms
EcoRIIHind111 restriction map (Riles et al., Genetics
(including mouse, fruit fly, nematode worm, and the 134: 81 [1993] and in
prep.), the complete sequences
fission and budding yeasts). The types of data that we of yeast chromosomes
(Oliver et al., Nature 57: 38
collect (and store) from multiple, independent data- [1992] and in prep.),
Caenorhabditis elegans genom-
bases from international computer networks and from
is sequencing (Waterston et al., Science 252: 1651
the scientific literature include (1) cytogenetic maps,
[1992]), and expressed sequence tag sequencing
(2) genetic linkage maps, (3) physical maps (clone (Adams et al., Nature Genet. 1: 114 [1992]). In addi-
contigs, restriction maps, PFG maps, genomic se- tion, such a tool that compares two maps locally can
quences), and (4) loci, including genetic markers be adapted into a search engine that localizes one
(mutations, polymorphism, genotype, disease state), region inside a much larger one if the commonhave high enough specificity. For example,
ele-
DNA sequence (eDNA, fragments, translated protein ments
sequence, alternate splicing, features unique to DNA when a restriction-digested clone or sequenced locus
sequences), protein sequence (features unique to is "drag-and-dropped" onto a restriction map or a
protein sequences, motifs), locus effects (cell cycle, genomic sequence, its precise location can be
tissue, development stage expression patterns), locus determined and displayed on the computer screen in
interactions (nucleic acid-nucleic acid, nucleic acid- "near real time" (i.e., without appreciable delay).
protein, protein-protein). The construction of novel, highly effective com-
The premise of Genome Topographer is that a puter tools for scientific discovery requires a solid
comprehensive, integrated presentation of the data be quantitative and theoretical understanding of the
essential for their understanding. Therefore, a need problems at hand. In our case, we are studying DNA
arises for tools that will automate certain aspects of at multiple levels of resolution and protein sequences,
this process. Two maps that share certain elements, including motifs. To gain insight into biological
for example, can generally be compared by eye (and mechanisms that might be responsible for generating
then annotated). However, this can become tedious if patterns we see in the data, we have initiated theoreti-
the amount of data grows exponentially. Simple tools cal studies in genome dynamics (e.g., gene splicing
that will compare two maps and highlight in- recognition sites, inheritance patterns of segments of
consistencies in the ordering of, or distance between, DNA that are identical by descent, and mechanisms
common elements can be of great help in many cir- that generate long-range statistical patterns in DNA
cumstances. Furthermore, "no single experimental sequences). We have a small group of theorists work-
procedure can be used to map a genetic object as ing on these problems, two of whom are physicists
complex as a mammalian chromosome. The most (one classical theorist, M. Zhang, and one complex
successful projects employ a variety of mapping tech- systems theorist, W. Li) and one theoretical computer
niques, some clone-based and others involving direct scientist (W. Chang), who specializes in the theory
analysis of genomic DNA" (M.V. Olson and P. and practice of complex combinatorial calculations.
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Below, we report on some of our new work in this
area.
Length Distribution of DNA
Segments That Are Identical
by Descent
W. Li, M. Zhang, T. Marr
It is well known that a child inherits half of the
genome from the father and half of the genome from
the mother and that two siblings on average have half
of their haploid genome identical by descent. These
estimates, however, are very rough and are not ade-
quate for many situations. The lengths of fragments
inherited and their statistical distribution within and
between individuals in an extended family unit are
fundamental quantities in genetics that must be un-
derstood. Understanding these fundamental quantities
has direct implications in many experimental
strategies for mapping complex genetic traits, for
biochemical difference cloning methods, and for
cytogenetic difference analysis. For example, several
new experimental methods under development are
able to take DNA from two (or more) individuals in a
family and pool them in a hybridization reaction, al-
lowing those pieces that are largely identical-by-
descent (IBD) to cross-hybridize. Such a reaction
could be highly effective when comparing normal
and, for example, transformed cells in the same per-
son, by removing the IBD segments by stringent
hybridization and selectively amplifying the dif-
ferences hypothesized to be primarily associated
with the transformed cell condition (see M. Wig ler in
the Molecular Genetics of Eukaryotic Cells Section).
In any case, it is of interest to know the probability of
two individuals sharing 100% IBD, 90% IBD, and so
on, because of the discrete (intact and/or recombined
segments from distinct chromosomes) nature of ge-
netic inheritance in sexually reproducing organisms.
The set of probabilities for each extent of IBD gives
us a statistical distribution. We have carried out ex-
tensive numerical simulations and mathematical
analyses on this topic.
In the simple situation, assuming there is only one
crossover event per chromosome per meiosis, the
IBD segments are always composed of contiguous
stretches of DNA originating from particular individ-
uals and matings. We have obtained the size distribu-
tion of such fragments for an arbitrary number of
generations. Mathematical analysis shows that this
distribution contains two discrete components (noth-
ing IBD or all IBD) and one continuous component
(0% < IBD segment < 100%). The distribution dens-
ity after N rounds of meiosis follows:
= 1 - ((N+2)/(N+1)) if x = 0%
p(x)N = (2 - x)^(N-2) (N)(N+3-x)(N+1) if 0% < x < 100%
= 1/(4^N) if x = 100%
For example, when N = 1, this equation says that
the probability of inheriting all of one particular
haploid chromosome is 1/4, that for inheriting zero of
that particular haploid chromosome is 1/4, and that
for inheriting x percent is proportional to a constant
value, 1/2. We have more general forms of this basic
equation and circumstance available that address is-
sues related to what we refer to as horizontal and
vertical IBD, which refer to siblings of arbitrary ge-
netic relation and of descendants of arbitrary genetic
relation. We also have an expression relating to the
question of the probability of inheriting a particular
segment, for example, a segment containing a disease
gene. We are continuing our work in this area by ex-
amination of the situation of multiple crossovers, the
nature of the genetic disease (e.g., autosomal domi-
nant, single gene vs. recessive expression, or quanti-
tative genetic traits).
Detecting Local Similarity
between Protein Sequences
W. Chang, T. Marr
The fundamental problem of protein sequence com-
parison is judging whether two or more sequences
share structural and/or functional features, based on
similarities observed in their amino acid sequences.
Current understanding of the underlying processes of
structure and function is not sufficient for a com-
pletely rigorous solution to this problem. Neverthe-
less, two developments in particular have combined
to produce methods that are reasonably rigorous and
successful. The first of these attacks the central prob-
lem of assigning a score to aligning a single pair of
residues, according to chemical properties or statisti-
cal analysis of allowed mutations in known homo-
logous sequences. The second is the rigorous treat-
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ment of optimal alignment of regions by dynamic
programming.
The widely used PAM matrices (Dayhoff et al.,
Atlas of Protein Sequence and Structure, vol. 5
[suppl. 3] 345-352 [1979]) were calculated on the
basis of 1600 accepted point mutations in 71 groups
of closely related proteins. This model of amino
acid
substitution assumes that the nonlethal mutations fol-
low the same rate and distribution as in the original
data, extrapolated to evolutionarily distant sequences
and beyond. Generally, 50% identity over a putative
domain (not the entire sequences) is considered ex-
tremely significant; in the PAM scale, this cor-
responds to about 90 PAMs. Occasionally, a particu-
lar 33% identity (120 PAMs) alignment is claimed to
be significant. Recent advances (Altschul, J. Moe'.
Biol. 219: 555 [1991]) have led to the important un-
derstanding that PAM-X scores measure the likeli-
hood that the aligned portion of two sequences are X
PAMs apart evolutionarily. Thus, one ought to use
the PAM 120 matrix to find 33% similar homologs.
Given a scoring matrix, one can find the highest
scoring local alignment between two sequences
(Smith and Waterman, J. Mol. Biol. 147: 195
[1981]). However, this alignment can have an ar-
bitrarily low (but positive) mean score per residue. If
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FIGURE 1 Overview of high-scoring local alignments. Query sequence is drawn along the top edge.
Top window shows identities (=) and conservative substitutions (+). Middle window displays non-
conservative substitutions in lowercase. Bottom window describes genes and gives both alignment
scores and score-per-residue. All windows scroll.
an alignment is significant, one would expect its
mean score per residue to be fairly high (indeed char-
acteristic of X PAMs). If the observed mean is much
lower than expected, then the two sequences must be
much more distant or unrelated, i.e., not what we are
looking for. What we want is a method that finds all
sufficiently long local alignments with a given mean
score per residue. We have devised such an algorithm
(Chang and Mari. 1994) and are currently implement-
ing and testing it in conjunction with other tools we
have built.
A Suite of Tools for the Analysis
and Visualization of Protein
Sequences
W. Chang, D. Cuddihy, T. Marr
A similarity search of a given protein sequence in a
large database can produce a massive amount of data
that must be scrutinized for useful information.
Therefore, the importance of a concise and effective
visual display of the data cannot be overstated. We
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FIGURE 2 Detail view of high-scoring local alignments.
Alignments are divided into
ten groups by score; in this example, scores below '3' are hidden. The window
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available; e.g., one can switch back and forth between
(1) showing only the data-
base gene residues plus (score:position) and (2) showing both query gene and
database gene residues.
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are developing an interactive display, with scrolling
windows and multiple views of the data, that uses
character-cell graphics. It works effectively through
both high-speed Ethernet and dial-up phone connec-
tions. The user-interface is kept simple, even
though
fairly powerful facilities are available for selectively
hiding portions of the data (such as low-scoring
alignments). Redundant data (such as identical align-
ments against several database entries) are combined
but not discarded. Such filtering can pare down a
BLAST or FASTA report by a factor of ten, without
losing any information. Access to databases and pow-
erful search facilities are available on-line as well.
For example, several alignments can be merged to
produce a PROSITE-type pattern, which is then com-
pared against the entire database in just seconds. Ver-
sion 1.0 (see Figs. 1 and 2) will be ready for release
the first week of March, 1994.
We also implemented a search engine based on
dynamic programming algorithms for finding high-
scoring local alignments (Smith and Waterman, J.
MoL Biol. 147: 195 [1981]; Gotoh, J. MoL Biol. 162:
705 [1982]; Waterman and Eggert, J. MoL Biol. 197:
723; Huang and Miller, Adv. Appl. Math. 12: 337
[1991]). Our highly efficient implementation of
Smith-Waterman-Gotoh (called GSW) is the fastest
available for a uniprocessor computer, taking just 10
minutes on a DEC Alpha to compare a 400-residue
sequence against the Swiss Prot database. (The fastest
Email-server, blitz@EMBL-Heidelberg.de by S.S.
Sturrock and J.F. Collins of the University of Edin-
burgh [1993], runs on a 4000-processor MasPar and
is 25 times faster.) Dynamic programming has ad-
vantages over the highly tuned heuristic method
GENOME SEQUENCE ANALYSIS
W.R. McCombie N. Kaplan
D. Lombardi
A. Melnikov
The comparison of the structures of different eukar-
yotic genomes will be important in our understanding
of the structure and function of the human genome.
In addition, the complete genome sequence of an
organism will have a dramatic impact on the under-
standing of that organism and on the way it is used as
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FASTA (Pearson, Genomics 11: 635 [1991]) in that
the latter has difficulty characterizing its findings and
nonfindings. GSW is about one-third the speed of
FASTA (most sensitive setting, -o and ktup=i). The
drawback of using BLAST is that it only finds gap-
less alignments. A search engine based on a new
method (Chang and Marr 1994) of finding alignments
with appropriately high score per residue is under de-
velopment.
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a model system. Yet, while the rate at which DNA
sequence data can be obtained and to a lesser extent
analyzed has changed rapidly in recent years, even
the smallest eukaryotic genome presents a major
challenge for DNA sequencing. One of the major
goals of our laboratory is to sequence and analyze the
genome of the fission yeast Schizosaccharomyces
pombe. Our other major goal is to develop the tech-
nology, strategies, and infrastructure required to ac-
complish this in a timely fashion.
Sequencing Technology
Development
D. Lombardi, N. Kaplan, W.R. McCombie
We are developing sequencing technology in three
primary areas: (1) development of computer software
tools and databases to facilitate the management of
large-scale sequencing projects, (2) implementation
of hexamer strings on automated sequencers, and (3)
optimization of double-stranded template-based se-
quencing strategies and technologies. Once these new
sequencing technologies are optimized, we will use
the database tools we have developed to compare
them with more traditional strategies.
An important capability in large-scale sequencing
projects is the ability to rapidly and accurately pro-
cess and store the large amounts of data generated by
automated sequencers. This requires the ability to
handle data generated from multiple types of instru-
ments in different formats and to reformat the data
into still other formats for assembly and analysis. Al-
though theoretically simple, the demands of this pro-
cess when the thousands of samples processed are
multiplied by several different formats can cause a
severe bottleneck in the sequencing process. We have
begun addressing this problem by developing and im-
plementing a series of software tools. This work has
been done in collaboration with Tom Marr (CSHL).
We have chosen to use several commercially or
academically available software packages and to de-
velop the necessary software to integrate them and
ultimately place them all under the control of a com-
mon graphics user interface. This will allow these
packages to be used by individuals who do not have
extensive computer experience. Software developed
this year allows data to be transferred to a central Sun
computer that functions as a file server from either a
Macintosh used for data acquisition by the ABI se-
quencer or the IBM compatible computer that the
Pharmacia sequencer employs. This is carried out by
a simple "drag and drop" function with the mouse.
Once on the Sun, a program has been written that
reformats the data to the format used by the ted and
Staden Xbap graphical assembly packages used on
the Sun and simultaneously transfers a copy of the
data to both a Sun (Xbap) and pc (Macintosh or IBM
native format) backup. A second program then
autoloads the data one directory at a time (currently
up to 36 sequence files) into the ted editor (developed
by La Deana Hillier at the C. elegans genome center
at Washington University). Once the ted editor is
used to remove poor-quality data at the 3' end of the
sequence and vector at the 5' end, the edited files are
stored on the Sun. After a group of sequences is pro-
cessed to this stage, programs written at CSHL are
used for the next steps, which are again carried out in
a batch mode on all the sequence files in a directory
simultaneously. Copies of the edited data are made in
Staden format, Intelligenetics format (IG), and Fasta
(Blast) format. These files are automatically moved
to separate directories for each format. This puts
copies of the data in a separate directory for Staden
assembly, IG assembly and homology searching of
Gen Bank, and the protein databases (Fasta format).
Furthermore, the data are automatically placed in
subdirectories based on what project it is a part of,
and a record of failed sequences is written out to a
separate directory location. Each project is typically a
cosmid being sequenced. The next phase of the soft-
ware development will be the implementation of user
interface screens that will be displayed on the
Macintosh and allow the above-described functions
to be carried out using the Macintosh graphics inter-
face. This will eliminate the need for directly logging
into the Sun and executing Unix commands to carry
out the data handling. The third phase will be the de-
velopment of software to transfer automatically vari-
ous statistical data derived from the sequencing pro-
cess into a Sybase database. This will enable us to
evaluate quantitatively the impact of technology ad-
vances made in the laboratory.
An important technology that we are testing in the
laboratory is the implementation on automated se-
quencers of sequencing using strings of contiguous
hexamers rather than a single 18 mer as a primer.
This has the potential of making low-redundancy
primer walking possible on a large scale with mini-
mal reagent and management costs associated with de
novo primer synthesis. This is because all 4096 pos-
sible hexamers can be synthesized in advance and
used when needed. This is made possible by the
presence in the reactions of saturating amounts of Es-
cherichia coli single-stranded DNA-binding protein
(SSB) (Kieleczawa et al., Science 258: 1787 [1992]).
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The reactions require an initial extension step
at 0°C
to stabilize the hexamers, followed by a termination
step in which fluorescent analogs of dideoxynucleo-
tides are incorporated at 37°C.
Last year, we were able to get some priming of
the reactions using ABI sequenase terminator
chemistry and hexamer primers, but there was a rela-
tively high error rate on M13 templates. This year,
we have made further progress in adapting this
chemistry to the ABI373. We found that a tenfold in-
crease in hexamer concentration relative to what we
used previously and what had been used for 35S se-
quencing by Kieleczawa et al. (Science 258: 1787
[1992]) appears to result in better, more reproducible
signals. We have tried four different hexamer strings
on M13. All of them worked and the best results to
date are read lengths of about 400 bases with slightly
over 1% errors in the range from 20 to 400 bases
from the priming. Our future efforts will be to
determine and ultimately improve the reproducibility
of these reactions using a wider range of templates.
In addition, we will be testing the reactions on
double-stranded templates and testing ways to
remove the SSB from the reactions other than the
organic extractions currently employed. While we are
working to improve the utility of hexamer primed
reactions, we have begun sequencing the S. pombe
genome using a nucleation and walk strategy. This
will allow flexible incorporation of primer-walking-
based sequencing (such as the use of hexamer
strings) into our overall sequencing strategy. We will
do this when hexamer-string-based reactions have
been further tested on control templates. In the
meantime, we have begun testing the effect of dif-
ferent variables of template isolation and sequencing
reactions on our S. pombe templates but have no con-
clusive results yet.
S. pombe Genome
Sequencing
N. Kaplan, A. Melnikov, D. Lombardi, W.R. McCombie
Previous work in David Beach's and Tom Marr's
laboratories has provided a high-resolution physical
map of the S. pombe genome and a set of mapped,
overlapping cosmid clones that represent virtually the
entire genome of the organism with only a few small
gaps (Mizukami et al., Cell 73: 121 [1993]). These
clones make the S. pombe genome ready for sequenc-
ing, and we have begun that project.
Cosmid 359 is the most telomeric cosmid mapped
to chromosome II of S. pombe. We subcloned cosmid
359 by randomly fragmenting the DNA with nebuli-
zation, which is a new technique that appears to give
more discrete fragmentation than sonication. Frag-
ments in the 1.5-3.0-kb range were subcloned into
pGEM vectors using blunt-end end-cutting enzymes
to prepare the vector. We began sequencing these
subclone libraries and found a large percentage of the
subclones had damage to the vector, which included
the sequencing primer-binding sites, that prevented
them from being successfully sequenced. We devel-
oped a polymerase chain reaction (PCR) assay to
screen for functional clones rapidly and continued se-
quencing cosmid 359 using the screened clones. Si-
multaneously, efforts continued to make libraries
with a higher percentage of sequenceable clones so
that screening would be unnecessary. The results of
the sequencing of cosmid 359 are not yet complete,
but several interesting genes have already been found
based on putative homology with previously known
genes.
As of February 1994, cosmid 359 is present in a
single contig of slightly over 38,000 base pairs. There
is a vector insert junction present at the centromeric
end of the insert, but a small amount of sequence, in-
cluding the vector-insert junction, is apparently miss-
ing at the telomeric end of the insert. This sequence
was probably transferred out of the assembly with the
vector sequences, and we are in the process of sear-
ching those data for the junction in order to recover
it. There are about 750 fragments of sequence data in
the cosmid 359 contig. Most of these are from the
shotgun phase of the project. However, a number of
gaps in the cosmid were filled by using custom
primers and either sequenase dye-deoxyterminators
or Taq dye-deoxyterminator chemistry. We are cur-
rently in what is commonly called the finishing phase
of a shotgun-sequencing project with cosmid 359. In
this stage, the disagreements between the multiple se-
quence fragments present at a given point in the con-
sensus sequence are resolved. It is also when regions
of insufficient redundancy are resequenced or se-
quenced on the complementary strand. When com-
pleted, we will have double-stranded coverage on all
of the cosmid, meaning that both strands are se-
quenced at least once at every base. In addition, dur-
ing the finishing phase, compressions and other prob-
lem areas are resolved. This involves picking custom
primers to resequence areas and sequencing areas
with sequenase rather than Taq (or vice versa) to
eliminate problems caused by the sequence at a par-
ticular site that interferes with sequencing by one of
the enzymes. When this phase is completed, the final
sequence will be analyzed for gene content in col-
laboration with Tom Marr's and David Beach's
laboratories. This will include using software to pre-
dict the presence of coding regions and splice sites.
Although the predictions of splice junctions and open
reading frames require accurate sequences with the
ambiguities resolved, the analysis of the sequence
based on homology with previously known genes
does not. We have begun this aspect of the analysis
and have identified potential homologs of eight genes
in cosmid 359. These are shown in Table 1 along
with their positions in the contig.
In other large-scale sequencing projects, includ-
ing both genomic sequencing and cDNA tagging, be-
tween 30% and 50% of the genes have detectable
homology with genes already identified in the various
protein and DNA databases. Assuming that a similar
percentage of S. pombe genes could be identified in
this manner, the eight detected putative homologs
would imply 16-24 genes present in this 38-kb
region of the S. pombe genome. This is in good
agreement with the estimate of one gene per 2 kb in
S. pombe. Once the sequence of cosmid 359 is fin-
ished, it will be analyzed not only for potential genes,
but also for compositional patterns and other features
that can be determined and compared to the results
from Saccharomyces cerevisiae.
TABLE 1 Potential Homo logs of Genes in Cosmid 359
Potential homolog Positive segments (kb)
Alanine racemase
Hypothetical protein permease
Agglutinin attachment subunit
Multidrug resistance gene
Inorganic phosphate transporter
AMP deaminase
Aminotriazole resistance
8-glucosidase
3-4
5-6
13
19-21
29-30
31-32
33-34
37-38
The 38-kb contig from cosmid 359 was divided into nonoverlap-
ping 1000-bp segments. Each of the segments was used to search a
nonredundant protein database at the National Center for Biotech-
nology Information using Blast. Potential homologies are noted
above, along with the segments in which they were found. Segment
distances are from the most telomeric end of cosmid 359; hence, the
potential homolog of alanine racemase is 3-4 kb from the telomeric
end of cosmid 359.
As the shotgun phase of cosmid 359 was being
completed, the next two cosmids toward the centro-
mere (cosmids 1198 and 1683) were begun. Due to
problems with the construction of subclone libraries
for cosmid 359, a new method of library construction
was tested. One of us (W.R.M.) traveled to Baylor
College of Medicine to learn new techniques in the
laboratory of Dr. Richard Gibbs, who has been work-
ing extensively on solving this subcloning problem.
The latest generation of these techniques are de-
scribed by Andersson et al. (Analytical Biochem., in
press). In addition to learning techniques at Baylor,
we were able to show them the nebulization tech-
nique and combine it with their subcloning proce-
dures. The modified procedure as we carried it out at
Baylor began with the fragmentation of the cosmid
with nebulization and the repair of the fragments to
make them blunt-ended. Adapters with a long single-
strand overhang were then ligated to the insert frag-
ments and 2-5-kb fragments were fractionated and
purified from an agarose gel. The vector was
prepared quite differently from that with cosmid 359
or other standard strategies. The vector DNA was cut
with two enzymes at positions in the universal clon-
ing site region to minimize the amount of intact vec-
tor in the preparation. The actual vector used for the
subcloning was then prepared by PCR amplification
of this doubly digested vector. A small (5 pgm)
amount of cut vector was amplified. The primers con-
sisted of sequences complementary to the forward
and reverse sequencing primers so that the amplifica-
tion began from those two points. In addition, each
primer had a 5' extension that produces the 3-base
repeating sequence found in the insert adapter over-
hang region. However, the vector primers included
uracil in place of thymidine in the repeat portion of
the primer. Amplification was carried out in the
presence of thymidine and no uracil in the dNTP mix
so that only the ends of one strand of the amplifica-
tion product contained uracil. In previous work done
at Baylor with M13 amplification, it was necessary to
purify the proper vector fragment from an agarose
gel. We found that the pBluescript that we amplified
was much more homogeneous and so we eliminated
the gel purification step. An aliquot of the amplified
vector was then treated with uracil-d-glycosylase,
which cleaved at the three uracils present on one
strand at each end of the vector, producing overhangs
complementary to the insert adapter overhang. The
vector and insert were then annealed in the absence
of ligase for 1 hour and used to transform E. coli
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strain XL1-Blue. The long overhang allows the prob-
lems associated with ligation of blunt-end fragments
of material purified from agarose gels to be elim-
inated. Cosmid 1198 and 1683 subclone libraries had
very few blue colonies when transformed, and test se-
quencing indicates that probably less than 5% of the
clones have damaged ends and will not sequence.
This compares with 60-70% of the cosmid 359
clones (prior to screening) that were made using vec-
tor prepared by Smal or EcoRV cleavage. We are
continuing the shotgun phase of both of these cos-
mids without screening. In addition to drastically im-
proving the efficiency of sequencing, this technique
also has increased the amount of useful data obtained
from each clone. In cosmid 359, insertion in the vec-
tor Smal site led to 60 bases of vector being se-
quenced with the forward primer and 90-100 bases
of vector being sequenced with the reverse primer.
With cosmids 1198 and 1683, the vector is only
amplified from the sequencing primer-binding sites;
hence, only the adapter (less than 20 bases) is present
between the primer-binding site and the insert. This
results in an extra 40 and 80 bases of useful se-
quence, respectively, when forward and reverse
primers are used. This improvement alone will result
in an extra 30,000 to 48,000 bases of raw sequence
being determined at no extra cost in the course of se-
quencing a typical cosmid. Cosmids 1198 and 1683
are well into the shotgun phase. In keeping with our
overall strategy to reduce gradually the amount of
random sequencing and increase the directed se-
quencing, the shotgun phase of cosmids 1198 and
1683 will be concluded when about 500-550 se-
quence fragments are obtained from each. Cosmid
DNA from the next two cosmids has been isolated
and is being tested. It will soon be used to make the
next set of subclone libraries according to the proce-
dure of Andersson et al. (1994).
NEUROSCIENCE
The Neuroscience Section is focused on molecular-genetic mechanisms of
neuronal events that underlie developmental and behavioral plasticity. Insight
into these processes promises effective therapeutic approaches to cognitive dys-
function, such as that associated with normal aging or with Alzheimer's disease.
This year marked the first full year of effort by members of this new section. Al-
ready significant progress has been made, driven in part by a growing synergy
of ideas among the neuroscientists: (1) The Enikolopov, Marshak, and Nawa
groups have discovered different aspects of gene expression or regulation of
protein phosphorylation that appear to mediate the effects of neurotrophic factors
on the growth and differentiation of neurons and neural circuits. (2) The Silva, Tul-
ly, and Zhong groups are pursuing various aspects of the regulation of gene ex-
pression, signal transduction and synaptic transmission that are involved with
animal learning and memory formation. (3) As part of the inter-institutional Dana
Consortium, the Feilotter, Marr, and Witkowski groups are pursuing the identifica-
tion of genes involved with bipolar affective disorder (manic depression) in hu-
mans.
To balance the departure of one neuroscientist, Dr. R. Davis, two new col-
leagues recently have accepted positions. Drs. R. Malinow and H. Cline will join
the Laboratory early in 1994 to contribute their expertise in vertebrate hip-
pocampal synaptic plasticity and vertebrate developmental plasticity, respective-
ly, to the fledgling Neuroscience effort.
NEURONAL GROWTH AND DIFFERENTIATION
D.R. Marshak N. Chester
J. Diaz-Nido
L. Pena
P. Recksiek
A. Rossomando
M. Vandenberg
This laboratory conducts research on the biochemical
basis of neuronal growth and differentiation. Overall,
the questions that we approach in our research in-
volve the decisions of neuroblasts to cease prolifera-
tion and subsequently to elaborate neuritic processes
prior to terminal differentiation. These questions thus
Involve understanding how signal transduction sys-
tems that control cell proliferation in the neuroblast
are altered upon becoming postmitotic, as well as
learning which growth factor molecules control these
switches within cells. Specifically, we are interested
in the action of a growth-stimulating protein, S10013,
that is produced by astrocytes in the brain. The in-
volvement of such neurotrophic factors in degenera-
tive diseases, such as Alzheimer's disease, has
prompted our interest in the role of such factors in
neuropathological processes.
Mechanism of Action
of S100(3
L. Pena, J. Diaz-Nido, D.R. Marshak
Our work on the action of S10013 in Alzheimer's dis-
ease and development has centered on studying
protein kinases. One avenue of investigation has been
to examine the direct influence of sloop on protein
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kinase C. We found that 510013 inhibited
the
phosphorylation of GAP43 by recombinant protein
kinase C (Sheu et al. 1994). These studies suggest
that protein kinase C might be a direct target of
S10013 action in neurons. Another effort grew out
of
the observations by members of this program that
S10013 can have mitogenic actions as well as differ-
entiative actions. Our studies have
focused on the in-
teractions between protein kinases
involved in
mitogenic pathways and those involved in differen-
tiative pathways. These protein kinases
include
casein kinase II, the cyclin-dependent kinases, MAP
kinases, MAP kinase kinases, and glycogen synthase
kinase 3.
Last year, we found that casein kinase II (CKII)
phosphorylated a cyclin-dependent kinase, p34cdc2, in
human cells on Ser-39. Since CKII is elevated in
normal differentiated tissue and decreased in
degenerating tissue, we sought to study the effects of
this phosphorylation event. On the basis of muta-
genesis data, it appears that phosphorylation of Ser-
39 in 3 4 cd 2 prevents cyclin binding, disabling the
activation of the enzyme. In Alzheimer's disease,
decreases in CKII may lead to inappropriate activa-
tion of p34cdc2 or other cyclin-dependent kinases. In
the developing rat brain, J. Diaz-Nido found that
CKII catalytic subunits are differentially expressed,
with the a' subunit appearing much later in develop-
ment and correlated with synaptogenesis in the
cortex. These observations suggest that CKII may
have an interesting developmental role in neuronal
function. Decreases in CKII in degenerative disease
might lead to neuronal dysfunction.
Regulation of cdc2 and
MAP Kinases in PC12 Cells
A. Rossomando, D.R. Marshak
Another area of signal transduction in developing
neurons is that which responds to growth factors
known as neurotrophins, such as nerve growth factors
(NGFs). Using rat pheochromocytoma (PC12) cells,
we examined the regulation of MAP kinase and
p34cdc2 kinase in response to NGFs. The p34cdc2 is
down-regulated as the cell differentiates. The MAP
kinase is rapidly activated and then deactivated but
not suppressed to zero levels during differentiation.
Epidermal growth factor, which promotes prolifera-
tion of these cells, has somewhat different effects on
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these protein kinases. These experiments suggested
that regulation occurs on some level between these
kinase pathways.
To further analyze this phenomenon in human
cells, we studied cycling HeLa cells. We found that
the cell cycle controlled the pathway that culminates
in the activation of MAP kinase (A.J. Rossomando et
al. 1994). This enzyme is stimulated by MAP kinase
kinase (also known as MEK). We found that both
MAP kinase and MEK were not active in mitosis in
human cells. Furthermore, MEK is phosphorylated
in a cell-cycle-dependent manner by p34cdc2, which
is most active during mitosis. The phosphorylation
was localized to threonine residues near the carboxy-
terminal end of MEK, and the phosphorylation of
those residues resulted in the complete inactivation of
MEK. These results indicate that cell division regu-
lates the MAP kinase pathway at the level of MEK.
This is significant to neuronal survival, since the ac-
tion of neurotrophins appears to act
A
kinases. Abnormal activation of p34cdc2 might lead to
neuronalinactivation of the pathways that support naPl
survival and subsequent cell death.
Regulation of S1000
by 3- amyloid
L. Pena, P. Recksiek, D.R. Marshak
Further work has been done on the basis of our obser-
vation that S10013 gene expression can be stimulated
by A13 peptides derived from amyloid precursor
protein (Pena et al. 1993). In Alzheimer's disease and
Down's syndrome, severely afflicted brain regions
exhibit up to 20-fold higher protein levels of S10013,
and astrocytes surrounding neuritic plaques exhibit
higher protein levels of S10013. A major constituent
of the plaques is 13-amyloid protein, which has been
reported to have both neurotrophic and neurotoxic ef-
fects in vitro. We examined the responses of central
nervous system glia to A13 peptide. Primary astrocyte
cultures, obtained from neonatal rats and rat C6
glioma cells, were synchronized by serum depriva-
tion and treated with APA(1-40), a synthetic frag-
ment of 13-amyloid. A weak mitogenic activity was
observed, as measured by [3H]thymidine incorpora-
tion. Northern blot analysis revealed increases in
S10013 mRNA within 24 hours, in a dose-dependent
manner. Nuclear run-off transcription assays showed
that PA(1-40) specifically induced new synthesis of
S10013 mRNA in cells maintained in serum but
caused a general elevation of several mRNA species
in cells maintained under serum-free conditions. At
the protein level, corresponding increases in sloop
protein synthesis were observed in response to the
PA(1-40) peptide, as measured by immunoprecipita-
tion of 35S-labeled cellular proteins. The data indicate
that S10013 expression can be influenced directly by
P-amyloid.
Phosphorylation of Amyloid
Precursor Proteins
D.R. Marshak [in collaboration with P. Greengard,
Rockefeller University]
Control of the processing of the amyloid precursor
protein (APP) is central to the generation of the PA4
peptide that is found in plaques. We studied cell divi-
sion cycle control of APP processing in He La and
PC12 cells (Suzuki et al. 1994). During mitosis, the
forms of APP produced are qualitatively different
from that during G1 phase. In particular, the imma-
ture form of APP is altered, the level of secreted,
amino-terminal domain is decreased, and the level of
the truncated, intracellular carboxy-terminal fragment
is increased. These events are correlated with
phosphorylation of the cytoplasmic domain of APP.
We demonstrated that Thr-668 of APP is phosphory-
lated in vivo in a cell-cycle-dependent manner and
that in vitro, the same site is phosphorylated by
p34cdc2 kinase. These data are consistent with our
working hypothesis that an abnormal mitogenic sig-
nal, resulting in the elevation of p34cdc2 kinase, can
contribute to the neuronal degeneration seen in
Alzheimer's disease.
Distribution of S10013 in
Human Brain Diseases
D.R. Marshak, M. Vandenberg [in collaboration
with W.S.T. Griffin, University of Arkansas]
The proximity of S100(3- containing astrocytes to
neuritic, amyloid plaques in the brains of Alzhei-
mer's disease patients suggests a functional role for
sloop in the pathology of the disease. Gliosis and
elevated S10013 accompany several neurodegenera-
tive diseases, and the elucidation of the role of this
growth factor in degeneration is important to our un-
derstanding of the etiology of the diseases. In addi-
tion, basic research in glial-neuronal interactions will
help us learn the fundamental processes that control
brain development and adult function. In collabora-
tion with W.S.T. Griffin, radioimmunoassays for
S1000 have been done on a variety of brain regions
from autopsy tissue of Alzheimer's disease patients
compared to age-matched controls. Temporal lobe
regions that are clearly affected by amyloid deposi-
tion and degeneration have elevated S10013 in reac-
tive glia. In a separate study, samples from patients
suffering from AIDS dementia were observed to have
increased S100p, but not to as high a level as in
Alzheimer's disease.
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MOLECULAR AND CELLULAR BIOLOGY OF
LEARNING
R. Davis G. Bolwig
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J. Cherry
C. Chromey
J. Crittenden
B. Dauwalder
J. Dezazzo
K. Han
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E. Skoulakis
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Our laboratory continues with its long-term goals of
probing the molecular and cellular biology of learn-
ing. We approach these goals using the techniques of
genetics, molecular biology, biochemistry, behavior,
and anatomy. In general, the techniques of genetics
and behavior are used to identify genes required for
normal learning/memory, the techniques of molecular
biology and biochemistry are used to clone the re-
quired genes and to characterize the gene products,
and anatomical methods are used to trace the flow of
information in the brain and to understand where the
genes are required to be expressed for normal learn-
ing/memory.
A major and important story contributed by our
laboratory in 1993 was the characterization of the
protein kinase A gene of Drosophila and an elabora-
tion of its role in learning and memory. With mo-
lecular and behavioral techniques, we demonstrated
that this gene is preferentially expressed in neural
centers called mushroom bodies and that mutations in
the gene cause dysfunction in olfactory learning.
Progress on other projects in the laboratory is de-
scribed below.
DROSOPHILA PROTEIN KINASE A
The fly stock, MB581, was isolated in an enhancer
detector screen to search for mushroom body genes
and was shown to contain a transposable element in
the unique gene for the catalytic subunit (dc0) of
protein kinase A (PKA). In situ hybridization to tis-
sue sections and immmunohistochemical analysis
demonstrated that dc0 is preferentially expressed in
the mushroom bodies. Thus, the preferential expres-
sion of PKA in the mushroom bodies, along with the
rutabaga-encoded adenylyl cyclase (AC) and the
dunce-encoded cAMP phosphodiesterase (PDE),
lends strong support for a role of the cAMP cascade
in these neurons to serve learning/memory processes.
Molecular characterization revealed that the
transposon in MB581 was inserted in exon 1, 71 by
downstream from the transcriptional start site of dc0,
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thus disrupting the gene. This disruption reduces the
amount of dc0 RNA to barely detectable levels as
as-
sayed by in situ hybridization with homozygous
mutant embryos. The insertion produces recessive
lethality and a 35-40% reduction in PKA activity in
heterozygous adults due to the reduction in the level
of the DCO protein. A similar decrease in activity and
a lethal phenotype are exhibited by a different
hypomorphic allele of this gene (B10) isolated in a
screen by EMS mutagenesis (D.K., unpublished).
The reduction in PKA activity in B10 is likely the ef-
fect of a missense mutation on the structure of the
protein and/or activity of DCO. Surprisingly, het-
eroallelic MB581/B10 animals can be obtained that
appear normal externally and normal with respect to
brain structure. However, they exhibit only 20-25%
of the PKA activity of control strains.
The effect of reduced PKA activity on behavior
was investigated by determination of the learn-
ing/memory phenotype of MB581 and B10 het-
erozygotes and the MB581/B10 heteroallelic animals
using an olfactory classical conditioning paradigm.
Initial learning of MB581 is slightly reduced com-
pared with the control strains and B10 heterozygotes.
Interestingly, memory assayed 30 minutes or later is
normal. Thus, the 35-40% reduction in PKA activity
may have a mild effect on learning but is not limiting
for memory. The MB581/B10 heteroallelic animals
exhibit a 50% reduction in both initial learning and
memory. This behavioral effect is not due to the in-
ability of the mutants to perceive the stimuli
demonstrated by control experiments in which both
heterozygotes and the heteroallelic animals are in-
distinguishable from the control strains. These results
demonstrate unambiguously that PKA plays a car-
dinal role in learning and memory processes medi-
ated by the mushroom bodies.
CELL ADHESION MOLECULES AND LEARNING
Among the enhancer detector lines, one line named
MB2225 has its P-element insertion site cytogeneti-
cally at 4AB. This is a locus housing the gene for a
Drosophila cell adhesion molecule, fasciclin II
(fasII), which was originally identified as a molecule
involved in the early development of the nervous sys-
tem. When tested for their ability to associate an odor
with electric shock, flies from this line showed defec-
tive association and memory at all time points tested
up to 3 hours after training.
To clarify the relationship between fasII and
MB2225, the genomic fragment next to the P-
element insertion site in MB2225 was obtained by
plasmid rescue. Using this fragment for Southern
hybridization and DNA sequence analysis, the inser-
tion site in MB2225 was mapped to the first exon of
the fasII gene at a position between the transcription
start site and the open reading frame. Therefore,
MB2225 was expected to be a fasl I mutant. To con-
firm this, the protein expression was analyzed by im-
munohistochemistry using antibodies raised against
the transmembrane form of the FasII protein. In head
sections of wild-type adult flies, the protein is ex-
pressed mainly in the mushroom bodies and the ellip-
soid body of the central complex. This expression is
missing in MB2225. Because of the hypothetical role
for mushroom bodies in learning, the FasII expres-
sion in these structures is consistent with the pos-
sibility that FasII functions in adult behavior in addi-
tion to its developmental functions.
Lightminded, A PUTATIVE NEW LEARNING AND
MEMORY MUTANT
Enhancer detector line 2063 shows preferential ex-
pression of 13-galactosidase in the mushroom bodies.
Flies homozygous for the P-element insert are defi-
cient in learning and memory in a classical negatively
reinforced learning paradigm. Initial learning and
retention over the 180 minutes tested are lower than
that of wild type. Control experiments confirmed that
mutant flies perceive the stimuli used for condition-
ing (olfactory cues and electrical shock) in a manner
indistinguishable from that of wild type, suggesting a
defect specific for the learning/memory process. An-
other P-element line with an insert only 200 by from
2063 has also been shown to be deficient in learn-
ing/early memory, and this may be allelic to the first.
We have isolated genomic DNA flanking the P-
element insertion site and used it to screen a head-
specific cDNA library. Two classes of transcripts
have been identified. Several head-specific RNAs are
detected by the cDNA probes, some of which are ab-
sent or strongly reduced in the mutant. Future work
will include characterizing these sequences and their
spatial expression pattern.
MAMMALIAN HOMOLOGS OF Dunce
The study of Drosophila has yielded much of our
current understanding of the cellular mechanisms un-
derlying behavior. A number of genes that appear to
be critical for the processes of learning and memory
formation have been identified in this species, includ-
ing the dunce gene which encodes a cAMP-specific
phosphodiesterase. We are now in a position to ask
whether these genes are structurally and functionally
conserved in other species. We have thus begun to
examine the mammalian homologs of the Drosophila
dunce gene. Four distinct dunce homologs have so far
been reported in mammals; we used polymerise
chain reaction (PCR) to partially clone three of the
mouse dunce homologs from rat clones obtained
from M. Wigler's laboratory (CSHL). Antibodies
have been generated to each of the mouse dunce gene
products, and we are now in the process of determin-
ing specifically where in the brain the Dunce proteins
occur.
The most advanced information is for mouse
dunce 2. This gene is exquisitely expressed in olfac-
tory receptor neurons as detected by RNA in situ
hybridization. Similarly, immunohistochemical re-
sults with isoform-specific antibodies have demon-
strated that the protein is expressed in the olfactory
receptor neurons but is compartmentalized in an in-
teresting way. The protein is found in the soma and
axon bundles that project to the olfactory bulb, but
not in the cilia, where the initial signal transduction
events have been proposed to occur. This suggests
that the protein is involved in the propagation of the
signal downstream from the initial signal transduc-
tion events. Thus, it may be involved in axon poten-
tial propagation by modulating ion channels, thus
participating in olfactory acuity, sensitization, or
adaptation processes.
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MOLECULAR NEUROBIOLOGY OF LEARNING
AND MEMORY IN DROSOPHILA
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Although significant progress continues all along a
wide front of molecular neurobiological analyses of
learning and memory in fruit flies, our most impor-
tant result is the discovery of a "molecular switch"
for long-term memory (LTM). The switch turns out
to be a transcription factor homologous to the verte-
brate CREB family. As in vertebrates, dCREB2 is ac-
tivated via phosphorylation by cAMP-dependent
protein that one or more
CREB family members also will be involved with
LTM in vertebrates. In a more general sense, our
results represent a clear example of the power that
gene discovery in Drosophila brings to the study of
complex, "emergent" organismal functions like learn-
ing and memory.
Long-term Memory
in Fruit Flies
T Tully, M Del Vecchio, S. Boynton
After one "standard" training cycle of Pavlovian con-
ditioning (CS+ for 60 sec, rest for 45 sec, CS- for 60
sec, rest for 45 sec), memory retention of conditioned
odor responses normally decays to about 18% of ini-
tial values within 24 hours and to 5% of initial values
within 4 days. Recently, with the automation of our
training apparatus, we have demonstrated much
longer-lasting memory after extended training (Fig.
1). Ten training cycles with a 15-minute rest interval
between each ("spaced" training) produced memory
that decayed only to 35% of initial values within 7
D. Wood
G. Hannon
N. Arora (Eton College)
days. Interestingly, ten cycles of training without a
rest interval between each cycle ("massed" training)
produced a moderate 24-hour memory, which
nevertheless decayed to zero within 4 days (as was
the case for one cycle of training; data not shown).
Thus, spaced training was required to produce long-
lasting memory-a property of memory formation
ubiquitously observed in vertebrates.
A second property of LTM in vertebrates is that
it is stable to disruption. To this end, we have ex-
posed third instar larvae to extended training proce-
dures and have demonstrated that conditioned
avoidance is retained through metamorphosis (Tully
et al. 1994). This retention of conditioned avoidance
was observed only for the group of larvae for which
odor and electric shock were temporally paired, in-
dicating that memory through metamorphosis derived
from associative learning. Moreover, memory
through metamorphosis was observed after eight, but
not three, training cycles, a property of long-lasting
memory also observed in adults (data not shown). In-
terestingly, adults were tested 8 days after larval
training and yielded a memory score similar to that
seen for 7-day retention in adults trained as adults.
Taken together, these data indicate that a stable LTM
survives substantial neuronal reorganization during
metamorphosis. The morphological questions raised
by this observation will be fun to address in future
experiments.
A third property of memory formation in verte-
brates is that the induction of LTM can be blocked by
protein synthesis inhibitors. Thus, we fed flies the
protein synthesis inhibitor cycloheximide (CXM; 35
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FIGURE 1 Memory retention after ten cycles of massed
(circles) or spaced (squares) training in wild-type Can-S
(closed) or mutant radish (open) flies. Some groups of Can-
S and radish flies also were fed the protein synthesis in-
hibitor cycloheximide (triangles). N = 6 Pls per group.
mm in glucose for 17 hr), trained them with either
massed or spaced procedures, put them back on
CXM-laced glucose for 24 hours, and then measured
memory retention. We found that 24-hour memory
after spaced training in CXM-fed wild-type flies was
only 60% that of glucose-fed controls, a level of
memory retention similar to that of glucose-fed flies
24 hours after massed training (see Fig. 1). In con-
trast, CXM had no effect on conditioned avoidance
immediately after one cycle of training (PIs = 81 ± 1
and 85 ± 2 for glucose- or CXM-fed flies, respective-
ly; N = 6 PIs each), demonstrating that the drug did
not produce any nonspecific performance deficits un-
der these feeding conditions. More interestingly,
CXM also had no effect on 24-hour memory after
massed training (data not shown), suggesting that the
massed training procedure induced only a "CXM-
insensitive" memory, whereas spaced training in-
duced both CXM-insensitive and CXM-sensitive
components of 24-hour retention.
The fact that CXM did not affect 24-hour
memory after massed training was remniscent of past
experiments, in which we showed that an earlier
anesthesia-resistant phase of memory (ARM) was not
disrupted in CXM-fed flies. This observation sug-
gested that 24-hour memory after massed training-or
after spaced training in CXM-fed flies-might be
ARM (and nothing else). Recently, Dr. E. Folkers in
W.G. Quinn's laboratory at the Massachusetts In-
stitute of Technology demonstrated that ARM is dis-
rupted in mutant radish flies (Folkers et al., Proc.
Natl. Acad. Sci. 90: 8123 [1993]). We therefore rea-
soned that if 24-hour memory after massed training
was ARM and radish disrupted ARM, then 24-houl-
memory after massed training in radish flies would
be zero. In fact, we found such to be the case (Fig. 1).
We then went on to show that the 24-hour retention
deficit after massed training and the ARM deficit
both "co-map" to the radish cytological region (data
not shown). Such a result indicates formally that the
radish mutation is responsible for both phenotypic
defects.
Surprisingly, spaced training of radish mutants
yielded completely normal memory retention 2-7
days afterward and 1-day retention 56% of normal.
Moreover, the 1-7-day decay rate for radish mutants
was zero (Fig. 1). The presence of such a memory
curve after spaced training of radish flies suggested
that LTM might be normal in these mutants even
though ARM was disrupted. We predicted that 24-
hour memory after spaced training in radish mutants
would be blocked completely by CXM. In fact, we
found such to be the case (Fig. 1). Taken together,
these results indicate the following:
1. ARM and LTM are genetically distinct, func-
tionally independent components of memory.
2. Spaced training of wild-type flies induces ARM
and LTM, which then act in an additive fashion
from 1 to 7 days after training to produce the ob-
served memory retention curve.
3. Massed training in wild-type flies induces only
ARM.
4. The radish mutation blocks ARM, leaving LTM
intact.
5. CXM blocks LTM, leaving ARM intact in wild-
type flies and yielding no 24-hour memory what-
soever in radish mutants.
A "Dominant-negative" Form of CREB
Transcription Factor Specifically
Blocks LTM in Adult Transgenic Flies
J. Yin, M. Del Vecchio, T. Tully [in collaboration with
J. Wallace and W. Quinn, Massachusetts Institute
of Technology; B. Wilder and N. Perrimon,
Harvard Medical School]
Early biochemical and molecular work in other
laboratories has established that the learning/memory
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genes dunce and rutabaga encode a cAMP phospho-
diesterase and a Ca++/CaM-dependent adenylyl
cyclase, respectively, thereby implicating the cAMP
signal transduction pathway in olfactory learning in
Drosophila. Subsequent work with transgenic flies
expressing a "dominant-negative" inhibitor of cAMP-
dependent protein kinase (PKA) or with mutants in
DCO, the gene encoding the catalytic subunit of PKA,
also has shown that disruptions of PKA produce
learning/memory defects. In the Aplysia model sys-
tem, blocking the PICA-dependent phosphorylation of
a potassium channel leads to learning defects. In
analogous fashion, fruit fly Shaker mutants have
defective potassium channels and abnormal learning
and memory. Given such clear evidence for the in-
volvement of the cAMP signal transduction pathway
with learning and memory in fruit flies and in Aplysia
and given the general observation from vertebrate
work that protein synthesis is required for LTM
formation, Dr. J. Yin cloned two Drosophila homo-
logs of the vertebrate transcription factor, cAMP
response element-binding protein (CREB). He dis-
covered that one of these genes, dCREB-2, produces
several different RNA isoforms, one of which
(CREB-A) acts as an activator of a CRE-activated (3-
galactosidase reporter gene and the other one of
which (CREB-B) acts as a "dominant-negative"
blocker of the activator form in cell culture (data not
shown). In a manner analogous to that of the mam-
malian CREM gene, the activator splice form differs
from the blocking form by the coordinate inclusion of
three exons (data not shown). Dr. Yin then generated
a transgenic strain carrying an hsp70-driven CREB-B
construct on a wild-type background.
We have outcrossed these CREB-B transgenic
flies to "equilibrate" their genetic background with
that of wild-type Canton-S flies and then have as-
sayed 24-hour memory retention after spaced or
massed training with or without a 30-minute heat
shock (37°C) 3 hours before training. Figure 2 shows
that 24-hour memory after spaced or massed training
was normal when hsp-CREB-B was not induced.
After heat-shock induction of hsp-CREB-B, 24-hour
memory after massed training was still normal in the
CREB-B transgenic flies, but 24-hour memory after
spaced training was disrupted to a level similar to that
of 24-hour memory after massed training. (This "pro-
file" of results for 24-hour memory after massed or
spaced training has been replicated with a second, in-
dependently derived lisp-CREB-B transgenic strain.
We also have shown that olfactory acuity, shock
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FIGURE 2 24-hr memory retention in control (Can-S) flies or
transgenic flies (17-2) carrying an hsp-driven 'dominant-
negative' blocker of CREB transcription factor (hsp-
dCREB2-B). Flies received spaced or massed training
without heat shock (uninduced) or 3 hr after a 30-min heat
shock at 37°C (induced). N = 6 Pls per bar.
reactivity, and immediate learning are normal in hsp-
dCREB2-B transgenic flies in the absence of heat
shock or 3 or 24 hours after heat shock; data not
shown.) That learning and memory after massed
training were normal and that memory after spaced
training was reduced to a level similar to that of
memory after massed training in the CREB-B trans-
genic flies is an outcome identical to that of CXM-
fed wild-type flies, suggesting therefore that heat-
shock-induced expression of the CREB dominant-
negative isoform blocked the formation of LTM.
We have corroborated this conclusion in two
ways: First, we have shown that 7-day memory after
spaced training in induced hsp-CREB-B transgenic
flies is zero, as expected if LTM is not present (cf.
Fig. 1). Second, in a manner analogous to that for
radish mutants fed CXM, we have shown that 24-
hour memory after spaced training is zero (PI = -4 ±
3, N = 6) in radish induced hsp-CREB-B "double
mutants." Third, the performance deficit in hsp-
dCREB2-B transgenic flies was not due to non-
specific effects of heat shock or of the hsp-driven
transformation vector (which includes a "miniwhite"
gene), since 24-hour memory after spaced training
was normal in induced alal transgenic flies carrying
a dominant-negative inhibitor of Ca++/CaM-kinase in
a similar hsp-driven vector. (Immediate learning and
3-hour retention after one cycle of training also were
normal in the alal transgenic flies, suggesting that
Ca++/CaM-kinase is not involved with olfactory
learning in flies; data not shown.)
Such phenotypic analyses of memory formation
in radish, transgenic hsp-CREB-B flies, and trans-
genic alai flies and past work on amnesiac, dunce,
and rutabaga (Tully and Gold 1993), latheo
(Boynton and Tully 1992), and linotte (Dura et al.
1993) have yielded a working model of memory
formation after Pavlovian conditioning (Fig. 3).
Experience-dependent information is acquired via as-
sociative learning (LRN) and then is processed
through as many as three memory phases-short-term
memory (STM), middle-term memory (MTM), and
anesthesia-resistant memory (ARM)-on its way to
becoming fully consolidated as long-term memory
(LTM). We have shown herein that (1) radish blocks
the formation (or expression) of ARM, leaving LTM
intact, and (2) CXM or the CREB-B blocker disrupts
the formation (or expression) of LTM, leaving ARM
intact. We have argued previously that amnesiac dis-
rupted MTM (Tully et al., Cold Spring Harbor Symp.
Quant. Biol. 55: 203 [19901), and we have shown
that such a disruption affects both ARM and LTM
(data not shown). Thus, MTM most likely is involved
with the induction of both ARM and LTM. Com-
parisons of the overall memory retention curves of
dunce and rutabaga with those of amnesiac, latheo,
or linotte suggest that these mutations first disrupt
STM. Finally, since initial learning levels are low,
but the memory decay rates of latheo and linotte
mutants appear to be normal, these mutations most
likely disrupt the initial acquisition of information.
This experimental and conceptual approach
toward a genetic dissection of learning and memory
formation is unique. We have developed all the be
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FIGURE 3 Working model of information flow from initial
Pavlovian olfactory learning (LRN) through short-term
memory (STM), middle-term memory (MTM), and anes-
thesia-resistant memory (ARM) or long-term memory (LTM).
Putative blocks in the pathway by mutations in different
learning/memory genes also are shown. In particular, we
have shown that the protein synthesis inhibitor cyclo-
heximide (CXM) or a heat-shock-induced CREB blocker
(CREB-B) disrupts LTM, leaving ARM intact, whereas the
radish mutation disrupts ARM, leaving LTM intact.
havioral assays and continue to test and to modify our
working model. Our discovery that LTM in radish
mutants forms normally in the absence of ARM
represents a fundamental contribution to the psychol-
ogy of memory. Behavior-pharmacological analyses
of memory formation in vertebrates led to the belief
that ARM represented the earliest appearance of
LTM. We have shown instead that ARM and LTM
are functionally independent and genetically distinct.
Our discovery that a dominant-negative form of
CREB blocks LTM is the first demonstration in any
intact animal that transcription factor regulation of
gene expression is involved in memory formation.
Germane to our model of memory formation is the
fact that such regulation of gene expression itself
must be induced by earlier learning/memory pro-
cesses. We believe that further understanding of the
molecular biology of extant and yet to be discovered
"upstream" genes promises to shed light on some
anatomical or biochemical aspects of these early in-
ductive events leading to the formation of LTM. In
addition, we now will be able to bring the full power
of Drosophila molecular genetics to bear on identify-
ing "downstream" CREB-regulated genes specifically
involved with the formation of LTM.
Molecular Genetics of latheo, linotte,
nalyot, golovan, and dNOS
R. Mihalek, S. Boynton, G. Hannon, D. Wood, G. Bolwig,
J. DeZazzo, M. Regulski, T. Tully
latheo AND linotte
We have cloned and sequenced cDNAs correspond-
ing to the putative messages for latheo and linotte. In
both cases, deduced amino acid sequence analyses
have revealed no convincing homologies with other
known proteins. To establish beyond doubt that we
have identified the correct messages, we have gen-
erated germ-line transformants carrying hsp70
promoter-driven lac' or lio+ transgenes. Currently,
we are breeding strains that carry these transgenes on
lat or lio mutant backgrounds to determine whether
the transgenes rescue the mutant learning deficits.
With such knowledge in hand, we will continue in
earnest the biological detective work necessary to un-
derstand how the Lat and Lio proteins function.
Phenogenetic analyses of latheo mutants have
provided some clues to the nature of this gene. We
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have shown that excision of the latP1 P element
results about 10% of the time in homozygous-lethal
mutations. Using the lethal excision alleles, we then
were able to identify one lethal complementation
group to which all of the lethal lat excisions mapped
and to which three independently isolated EMS-
induced lethal mutations mapped. Finally, we showed
by assaying memory retention in adult-viable
late' /lethal genotypes that the behavioral deficits as-
sociated with the original latP1 P-insert mutation also
co-mapped to the same complementation group
(Boynton and Tully, Genetics 131: 655 [1992]).
We also determined that homozygous-lethal
latheo genotypes died during the pupal stage of de-
velopment, thereby prompting us to look at larval
anatomy just before this lethal period. We discovered
that late third instar mutant larvae had no imaginal
discs and underdeveloped central nervous systems
(CNSs). Imaginal discs and CNSs from second instar
mutants were normal, however. Apparently, the third
instar defect was caused by a failure of cell prolifera-
tion, as determined from bromodeoxyuridine histo-
fluorescent labeling studies. Interestingly, we did see
some disorganized imaginal disc structures and ab-
normal cell proliferation patterns in mutants homo-
zygous for one (apparently hypomorphic) lethal exci-
sion allele. Immunocytochemical analysis using anti-
ELAV antibodies (which label all terminally differ-
entiated neurons in the Drosophila CNS and PNS)
revealed an overabundance of ELAV- cells in these
mutant CNSs. Taken together, these developmental
studies suggest that (1) latheo may be involved with
the differentiation of "adult-specific" cells during late
third instar and (2) a failure of cell division in late
third instar mutants may represent the null (neural)
phenotype of latheo.
These developmental results also prompted us to
take a closer look at neuroanatomical structures in the
adult brains of viable latheo mutants (cf. Boynton
and Tully, Genetics 131: 655 [1992]). Under the su-
pervision of Dr. M. Heisenberg at his laboratory in
Wiirzburg, we quantified the neuropilar volumes of
the mushroom body, the central complex, and the
medulla from frontal sections of adult heads using a
"planimetric" method with serial 7 [tm head sections
from adult-viable latheo genotypes (which show the
behavioral deficits). We detected a 20% (significant)
reduction in the mean volume of the mushroom body
but normal central complex and medulla neuropil in
learning-defective latPillatP1 mutants, compared to
learning-normal latP1 14- flies. These mean relative
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volumes were 80% reduced in mushroom body, 20%
reduced in central complex, and normal in medulla of
sluggish, behavior-defective latP11Df(1)vg56 mutants
(cf. Boynton and Tully, Genetics 131: 655 [1992]).
These anatomical data run parallel to our behav-
ioral data (cf. Boynton and Tully, Genetics 131: 655
[1992]). In general, the more severely mutant geno-
type produced more widespread anatomical defects.
Consideration of the specific structures, however, is
even more informative. Mushroom body is an ana-
tomical structure involved with olfactory learning in
bees and in fruit flies. Learning-defective latP1/latP1
mutants only show anatomical defects in the
mushroom body. Thus, the correspondence of behav-
ioral defects and anatomical defects in latheo variants
is consistent with the known functions of the affected
brain structures and with known anatomical defects
in other learning- or behavior-defective mutants.
Analysis of the deduced amino acid sequence of
the putative linotte message using BLASTA has
revealed a weak homology (25% identical, 40% con-
served) over a 130-amino-acid domain in the car-
boxy-terminal half the rutabaga adenylyl cyclase. In-
terestingly, this region of the rutabaga cyclase
presumably resides on the cytoplasmic side of the
cell membrane and shares no sequence homology
with vertebrate adenylyl cyclases (the common func-
tional domains of cyclase are in the amino-terminal
half of the rutabaga cyclase). On the basis of this se-
quence homology, we have bred a ruts; lio double
mutant. Such double mutants of two inessential genes
are themselves viable and yield a Pavlovian learning
score of 16 ± 4 (N = 4), suggesting that the rutabaga
and linotte genes lie in different "learning" pathways.
This result has prompted the breeding of a series of
double-mutant combinations with linotte and other
extant learning/memory mutants to generate addi-
tional data in support of the "two pathway" notion.
nalyot AND golovan
We most likely have identified two additional learn-
ing/memory genes, which we have named nalyot and
golovan from our P-element mutagenesis initiated at
Brandeis in 1987. The original P-insert mutants for
each gene have been outcrossed to a wild-type genet-
ic background for more than ten generations in a
manner that allows recombination around the sight of
the P insert. Such outcrossed mutants, homozygous
for either the nalyot or golovan P inserts, still yield
significantly lower 3-hour retention scores, indicating
beyond reasonable doubt that the P inserts are
responsible for the defective behaviors. Mutant
nalyot and golovan flies also show normal olfactory
acuity and shock reactivity; thus, the performance
deficits in the Pavlovian experiments most likely
result from defects in associative learning/memory.
Finally, we have mapped each P insert to cytological-
ly distinct locations using the P-element sequence as
a probe, and we have begun molecular cloning of
nalyot (lack of funds prevents us from pursuing gol-
ovan).
With these new discoveries, we now have identi-
fied four new autosomal genes (latheo, linotte,
nalyot, and golovan) from a total of 2200 P-element
transposant lines, yielding an empirical estimate for a
mutation frequency of 1/550, compared to a mutation
frequency of 1/500 from the EMS mutageneses of the
Benzer and Quinn groups (W.G. Quinn, pers.
comm.). This observation shows clearly that our be-
havioral screen for new genes involved with associa-
tive learning and memory is efficient.
dNOS
We have cloned the Drosophila homolog of the ver-
tebrate nitric oxide synthase (NOS), which also is the
first demonstration of a NOS in any invertebrate.
Conservation of the protein sequence and of the
splicing pattern suggests that we can expect broad
similarities in NO biochemical pathways between
vertebrates and invertebrates. Knowing the homol-
ogies in properties of learning and memory between
vertebrates and Drosophila, we intend to apply the
genetic tools available in fruit flies to an investigation
of the role of dNOS in learning and memory.
The dNOS message contains one long open read-
ing frame (ORF) of 4350 by encoding a protein of
1350 amino acids. This conceptual Drosophila
protein shows a significant degree of amino acid se-
quence homology with the vertebrate NOS proteins:
It is 38% identical to rat brain NOS, 36% identical to
bovine endothelial NOS, and 28% identical to mouse
macrophage NOS. The Drosophila sequence contains
all of the known functional domains of vertebrate
NOS: heme-, calmodulin-, FMN-, FAD-, NADPH-
binding. In the NADPH-binding domain, all amino
acids that have been shown to be contact points with
the dinucleotide in crystals of ferrodoxin NADP+
reductase are perfectly conserved in the putative
Drosophila protein. Moreover, the region between
the heme- and calmodulin-binding sites is 70%
identical between rat and Drosophila proteins and is
likely involved with binding of arginine and possibly
cofactor tetrahydrobiopterine.
Computer searches of protein sequence databases
with the deduced amino acid sequence of dNOS
revealed significant homologies only with other NOS
proteins and CPR. There were limited sequence
homologies with other nucleotide-binding proteins,
but such were restricted to those domains containing
a particular binding site. Comparisons of dNOS with
individual vertebrate NOS isoforms have revealed
that (1) the Drosophila protein does not contain a
myristylation site close to the amino terminus, which
is present in the endothelial NOS, (2) the fly protein
does not seem to have a deletion in the middle part of
a protein as is the case for macrophage NOS, (3)
DNOS contains a PKA consensus site that is absent
from the macrophage enzyme but present in brain
and endothelial forms, and (4) dNOS is expressed
predominantly in the head, which is analogous to the
vertebrate brain NOS.
There are at least two splice forms of brain NOS
transcripts in mice. One has a 315-bp fragment
spliced out that results in a protein 105 amino acids
shorter than the other. The deletion occurs in a region
that is highly conserved among different NOS genes
in vertebrates and likely contains the arginine-
binding site. It is not known at present whether the
shorter protein has NOS activity or what function it
could play. This region is very well conserved in
dNOS: It is 70% identical to the rat brain isoform,
67% to the macrophage isoform, and 65% to the
endothelial isoform. We have used RT-PCR technol-
ogy and appropriate primers against Drosophila head
mRNA to test if a similar shorter isoform is present
in fruit flies. We have obtained two DNA fragments:
one of the size of the unspliced form and another of
expected size similar to the shorter spliced form. Se-
quence data revealed that the shorter fragment
originates from Drosophila mRNA and would be
produced if the splicing pattern in fruit flies was
identical to that in mice, i.e., it has a 315-bp in-frame
deletion.
Behavioral Properties of
Learning and Memory
in Normal and Mutant Flies
N. Arora, S. Knabe, Z. Asztalos, C. Jones, T. Tully
In the past, we have described initial results from a
new procedure (and apparatus) that we developed to
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assay habituation of the jump reflex to olfactory cues
(cf. Boynton and Tully, Genetics 131: 655 [19921).
This year, we have succeeded in developing the com-
plementary behavioral assay: sensitization of the
jump reflex. In the habituation experiments, flies
were dishabituated by strong mechanical vibration in
a vortexer. In our new sensitization experiments, we
have used this same strong stimulus on naive flies to
induce a sensitized response to odors. Initially, this
has allowed us to compare dishabituation and sensi-
tization induced by the same stimulus. Preliminary
results suggest that vortexing naive flies produces
sensitization, whereas vortexing habituated flies pro-
duces dishabituation rather than (or in addition to)
sensitization. With assays for both forms of non-
associative learning (habituation and sensitization) in
hand-both using the odor-induced jump re-
flex-quantitative comparisons among normal and
mutant flies now are feasible. Moreover, we may be
able to use electric shock as a sensitizing stimulus,
thereby allowing us to study nonassociative forms of
learning with the same stimuli used in our Pavlovian
(associative) learning experiments. These three basic
learning tasks and their associated controls represent
an extremely powerful repertoire of integrated behav-
ioral assays with which to accomplish a genetic dis-
section of behavioral properties of learning and
memory.
To this end, we continue to study the genetic dis-
section of associative and nonassociative learning by
latheo mutations. Combined with our previous work
showing that habituation and the US pre-exposure ef-
fect were normal in latheo mutants, our discovery of
defective mushroom body brain structures in latheo
mutants suggests that conditioned odor avoidance
(associative) and habituation to olfactory cues (non-
associative) involve different anatomical regions of
the fly brain. We currently are evaluating this pos-
sible example of anatomical dissection.
We also continue to develop separate assays for
conditioned excitation and conditioned inhibition of
odor avoidance responses. At the moment, we have
two candidate learning/memory mutants showing
defective conditioned inhibition. More thorough anal-
yses of these and other mutants promise to yield
biochemical and/or anatomical distinctions among
these fundamental forms of associative learning.
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REGULATION OF NEUROTRANSMITTER EXPRESSION
AND ITS IMPLICATIUON IN NEURAL PLASTICITY
H. Nawa K. Mizuno
R. Lundsten
M. Waga
Neurons communicate with each other using a large
variety of neurotransmitters and neuropeptides.
Despite this enormous diversity, each functional
neural pathway can be recognized by the particular
set of transmitters, neuropeptides, and receptors
employed. Clearly, this "chemical coding" of path-
ways is critical for determining neural function and
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behavior. The long-term objective of our laboratory
is to define the molecular and cellular mechanisms
that regulate the synthesis and release of neurotrans-
mitters and neuropeptides in the nervous system. In
particular, we are interested in intercellular protein
factors such as cytokines and growth factors, which
can regulate the synthesis and release. The alteration
in neurotransmitter/peptide expression and release
presumably changes the mode of neurotransmission
at each neuron and consequently modulates neural
functions such as cognition and memory.
We have identified multiple neuronal differentia-
tion factors in heart-cell conditioned medium (CM),
which control neurotransmitter/peptide expression in
peripheral neurons. Our previous observations sug-
gest the possibility that many distinct, diffusible fac-
tors can influence the development of neurotransmit-
ter/peptide phenotypes in the peripheral nervous sys-
tem. Recently, we found that the heart cell CM also
has effects on neurotransmitter/peptide levels in cul-
tured neurons prepared from the central nervous sys-
tem (CNS). Subsequent biochemical analyses suggest
that the responsible component resembles brain-
derived neurotrophic factor (BDNF), which belongs
to the nerve growth factor family, named neuro-
trophin. BDNF increases and maintains the expres-
sion of putative inhibitory neuropeptides, neuropep-
tide Y, and somatostatin in cultured cerebral cortical
neurons. Our finding demonstrates that, as in the
peripheral nervous system, neurotransmitter pheno-
types in the CNS are plastic and can be regulated by
various diffusible protein factors.
Our current efforts have been focused on the four
projects: (1) regulation of BDNF protein production
in nerve and muscle, (2) characterization of neuro-
transmitter/peptide differentiation activity of neuro-
trophins in vivo, (3) physiological consequences of
regulated neurotransmitter production, and (4) identi-
fication of novel neurotransmitter differentiation fac-
tors. These studies will elucidate the mechanism of
how such a complex but highly ordered expression of
neurotransmitters/peptides is controlled during devel-
opment and how it contributes to neural plasticity
such as learning and memory processes.
Plastic Regulation of Neuropeptide
Expression in Neonatal Rat
Brain by BDNF
H. Nawa
We have shown that BDNF specifically enhances and
maintains the expression of neuropeptide Y and so-
matostatin in cultured neocortical neurons. As an ex-
tension of this research, we examined its effects in
vivo on neuropeptide expression in various brain
regions by injecting BDNF into the cerebroventricle
of newborn rats. Repeated administration (2x) of
BDNF increased the content of neuropeptide Y and
substance P most markedly in the anterior neocortex
by 11- and 24-fold, respectively, in comparison to
values in the animals receiving a control injection. A
smaller but significant increase was also observed in
immunoreactivity for somatostatin, enkephalin, and
cholecystokinin. mRNA for neuropeptide Y, sub-
stance P, and somatostatin was similarly up-regulated
in the anterior neocortex, suggesting that BDNF en-
hances peptide synthesis rather than inhibiting pep-
tide release or degradation. Among the brain regions
examined, however, peptidergic responses to BDNF
were different with respect to their spatial distribution
and time course. Induction of substance P, neuropep-
tide Y, and somatostatin around the injection site was
most pronounced in cortical layers layers IV-
VI, and layer VI, respectively. Peptidergic im-
munoreactivity was also enhanced in other brain
regions ipsilateral to the injection site, e.g., neuropep-
tide Y in the hippocampus, thalamic nuclei, and
striatum and somatostatin in the striatum. A single in-
jection of BDNF elevated substance P to a plateau
level within 12 hours, whereas neuropeptide Y and
somatostatin reached maximum levels at 48 hours
and then all returned to control levels at 68 hours. In
contrast, the same dose of nerve growth factor (NGF)
had no influence on the neuropeptide levels at 48
hours. These observations suggest that BDNF may
regulate development of peptidergic neurons in the
CNS.
Effects of BDNF on Neuropeptide
Expression in Adult Rat Brain
H. Nawa, M. Waga
Hippocampal neuropeptides are known to be altered
after brain seizure induction. BDNF mRNA is in-
creased following seizure but with an earlier time
course than that of the neuropeptides. Because the in-
crease in BDNF mRNA precedes the neuropeptide
changes after seizure, it is possible that BDNF
mediates the peptide alterations. To test this hypoth-
esis directly, BDNF was continuously infused into
the hippocampus of adult rats from an osmotic pump.
To test the regional specificity of any observed ef-
fects of BDNF administration on neuropeptide ex-
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pression, infusions into the neocortex and striatum
were also studied. To control for the specificity of
BDNF, NGF and vehicle were also infused into dif-
ferent animals. Peptide and mRNA alterations were
assessed by Northern analysis, immunohistochemis-
try, and radioimmunoassay. BDNF elevated peptide
and mRNA levels for neuropeptide Y and cholecys-
tokinin in hippocumpus and neocortex, and soma-
tostatin in cortex. BDNF increased mRNA only for
neuropeptide Y and cholecystokinin in striatum. In
contrast, BDNF decreased dynorphin peptide and
mRNA in hippocampus. NGF's effects were limited
to mRNA increases, without corresponding peptide
changes, for neuropeptide Y in hippocumpus and
striatum, substance P in neocortex, and cholecys-
tokinin in striatum. The distinct and more limited ef-
fects of NGF infusion demonstrate that BDNF's ef-
fects are not nonspecific results of protein infusion
into the brain. These findings indicate that BDNF
may have a regionally specific role in modulating
neuropeptide expression in the adult brain as well as
in various pathophysiological states.
Influence of Neurotrophins on
Development of Striatal
GABAergic Neurons
K Mizuno, H. Nawa
Striatal neurons are derived from a developmental
lineage different from that of neocortical neurons. In
our previous study, all neurotrophins failed to alter
GABA content in cultured neocortical neurons. How-
ever, we have found that neurotrophins can influence
GABAergic properties of the striatal neurons both in
vivo and in vitro. Among neurotrophins, BDNF and
neurotrophin-5 (NT-5) specifically elevated cellular
GABA content in striatal culture without altering
neuronal survival. An increase in GABA content in
the striatum was also observed following BDNF in-
jections into the cerebroventricle of neonatal rats.
The increase of GABA levels in culture resulted from
a ninefold increase in holo-enzyme activity of the
GABA synthetic enzyme glutamic acid decarboxy-
lase (GAD) and a threefold increase in GABA uptake
activity. In BDNF-treated striatal cultures, the newly
differentiated neurons extended elaborate neurites
and exhibited strong GAD immunoreactivity. These
alterations were reflected by the up-regulation of
mRNA encoding GAD67 and the neuronal GABA
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transporter GAT-1. BDNF treatment also promoted
other phenotypic differentiations of striatal neurons:
BDNF increased the frequency of parvalbumin-
immunoreactive neurons and calbindin-immuno-
reactive neurons and neuropeptide content of neu-
ropeptide Y and somatostatin. These observations
suggest that BDNF may contribute to phenotypic dif-
ferentiation of GABAergic neurons in the developing
striatum.
Production and Secretion
of BDNF Protein
M Waga, R Lundsten, H. Nawa
Despite numerous previous studies on BDNF mRNA,
regulation of the production and secretion of BDNF
protein has been poorly understood because of a lack
of its quantitative measurement. Recently, we at-
tempted to establish an ultrasensitive enzyme-linked
immunosorbent assay (ELISA) for BDNF protein.
The ELISA system enables us to measure trace
amounts of BDNF protein in tissues, cells, blood, and
cerebrospinal fluid. Using the ELISA system, we ad-
dress the question of how BDNF protein production
and secretion are regulated.
We purified anti-BDNF antibodies with a BDNF-
linked affinity column; half were biotinylated with
NHS-Biotin. Non labeled anti-BDNF antibody was
coated on a 96-well microtiter plate for ELISA, and
the biotinylated antibody was used for the detection
of BDNF in combination with avidin-labeled per-
oxidase. Determination of optimal concentrations of
the antibodies decreased the sensitivity of ELISA less
than 3 pg/sample. This ELISA system exhibits no ap-
parent immunocross-reactivity to other neurotrophins
(i.e., NGF, neurotrophin-3, and -5) nor other cyto-
kines (i.e., basic fibroblast growth factor, leukemia
inhibitory factor, tumor growth factor, interleukin lb,
stem cell factor, CNTF, insulin, and activin). BDNF
content was measured in various brain regions of
adult rats. The highest concentration was found in the
hippocampus. The striatum and septal area contained
lower levels of BDNF protein. This observation at the
protein level is quite consistent with the reported
regional distribution of BDNF mRNA, suggesting the
accuracy of the measurement. The BDNF level (20
ng/g tissue) is ten times higher than the NGF levels
(2 ng/g tissue) in the hippocampus (Korsching et al.,
EMBO J. 4: 1389 [1985]), although Maisonpierre et
al. (Neuron 5: 501 [1990]) reported almost equal
mRNA levels for NGF and BDNF in the hip-
pocampus. Controversial observations suggest that
production of each neurotrophin might also be regu-
lated at posttranslational levels.
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THE BIOLOGY OF LEARNING
A. Silva R. Burchuladze K. Peter Giese
B. Frenguelli Z. Wang
C.-M. Chen
The study of learning and memory is at a crossroads:
Much information is available on potentially relevant
behavioral, anatomical, physiological, and molecular
phenomena; still, the functional connections among
these findings remain illusive. Thus, we have devel-
oped a new strategy to integrate information pertinent
to learning and memory. The essence of this ap-
proach is the combined biochemical, physiological,
anatomical, and behavioral study of genetically
altered mice. The goal is to determine how mechan-
isms at all of these levels of analysis interact to pro-
cess and retrieve information.
In the past, much attention has focused on long-
term potentiation (LTP), a long-lasting increase in
synaptic strength, as a mechanism of memory. At the
center of this hypothesis is the idea that memories are
stored as patterns of strengthened synapses in the
brain. However, little is known about the mechanisms
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that determine what and how quickly we learn. Per-
haps other synaptic mechanisms, such as short-lived
changes in synaptic strength, are involved in the
filtering and processing of information to be stored.
Indeed, in the last year, we found evidence consistent
with this idea.
Our electrophysiological studies identified a novel
synaptic mechanism involving the a-calcium-
calmodulin kinase II (aCaMKII): Depending on the
frequency and intensity of activation, this kinase can
both enhance and dampen the potentiation of
neurotransmitter release. Mice heterozygous for a
targeted mutation of the aCaMKII gene lack this
fine-tuning mechanism. Strikingly, behavioral studies
of these mice showed that they can learn but that they
do it slower than normal controls. In contrast, our
previous studies of mice with impaired LTP showed
that they were simply unable to learn.
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aCAMKII: A BIDIRECTIONAL MODULATOR
OF PRESYNAPTIC PLASTICITY
Synaptic weight changes are at the core of informa-
tion processing and storage in neural networks. How-
ever, little is known about the biochemical machinery
that mediates these changes. Previous studies showed
that the a isoform of aCaMKII is required for LTP of
synapses in the CA1 region of the hippocampus. We
have found in the last year that this kinase also has a
crucial role in hippocampal short-term plasticity.
Field and whole-cell recordings in the CAl region of
mutants and controls indicate that the aCaMKII has
the surprising capacity to either potentiate or depress
synaptic function depending on the pattern of neur-
onal activation.
In the studies described below, we used mice both
homozygous and heterozygous for a targeted disrup-
tion of the aCaMKII gene (henceforth referred to
simply as homozygotes and heterozygotes). Bio-
chemical analysis of the homozygotes showed that
they completely lacked the aCaMKII protein and that
forebrain homogenates from these mutants had half
of the total Ca++-calmodulin-induced kinase function
measured in vitro. Western analysis showed that in
the heterozygotes, the amount of aCaMKII protein
isolated from forebrain synaptosomes is roughly half
of that in control littermates (Fig. 1). Similar results
were obtained with hippocampal protein isolated
from heterozygotes and controls. Consistent with the
loss of half of the aCaMKII in heterozygous mice, in
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FIGURE 1 Reduced amounts of aCaMKII in heterozygous
mice. Western analysis of synaptosomal forebrain homog-
enates from heterozygotes (+/-) and control mice (+/+) with
two monoclonal antibodies that recognize aCaMKII (a) and
synaptophysin (S). In each of the two samples in A, we used
1.5 mg of total synaptosomal protein and 3.0 mg in B. The
anti-synaptophysin antibody was used as a control for
amounts of presynaptic protein in each of the lanes shown.
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vitro kinase assays with hippocampal homogenates
revealed a proportional decrease (mean + s D of 71%
7.8%; n = 9) in the amount of kinase activity.
These protein studies were done with Alan Smith, a
visiting scientist in the laboratory.
To determine how the decrease in aCaMKII af-
fected synaptic function, Paul Chapman, another
visiting scientist in our laboratory,
i
started by study-
ing paired-pulse facilitation (PPF) n the CA1 region
of hippocampal slices maintained in vitro. PPF is a
presynaptic facilitation revealed by the second of a
pair of pulses. Figure 2A shows that heterozygous
fields, as well as homozygotes, have smaller PPF
than controls at all interpulse intervals tested.
Changes in synaptic inhibition could explain the
blunting of PPF in the mutants, a possibility that we
excluded by finding consistently depressed PPF in
recordings of mutant slices done in the presence of y-
amino-butyric-acid (GABA) channel inhibitors of the
A and B types.
Whole-cell recordings of CA1 cells, carried out
by Bruno Frenguelli, from heterozygotes and controls
confirmed these results. Thus, changes in membrane
potential in the mutants could not account for their
depressed PPF, since these recordings were done un-
der voltage clamp. Furthermore, our whole-cell
recordings mentioned above were also done under
conditions known to shut off all GABA-mediated in-
hibition. Altogether, these data strongly suggest that
the depression of PPF in the mutants is due to lower
neurotransmitter release in response to the second
pulse of the stimulus pair. Remarkably, this decrease
revealed during PPF does not appear to be associated
with a general blunting of synaptic transmission, be-
cause a range of stimulus intensities elicits similar
responses in heterozygotes, homozygotes, and con-
trols. These results show that the partial or complete
loss of aCaMKII does not shut off synaptic function.
Consistent with the observation that thiophos-
phorylated CaMKII increases synaptic release in the
squid giant synapse, the loss of aCaMKII led to a
decrease in synaptic release during PPF in the CAl
region of the hippocampus. This is evidence that
aCaMKII normally enhances short-term increases in
synaptic weights, perhaps by the phosphorylation of
synapsin I, a negative regulator of synaptic transmis-
sion. Interestingly, the loss of synapsin I, the most
abundant substrate for CaMKII, presynaptically leads
to an enhancement in PPF.
Since the loss of aCaMKII could have also af-
fected other short-lived enhancements of synaptic ef-
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FIGURE 2 Paired-pulse facilitation is blunted in aCaMKII
mutants, but augmentation is enhanced. (A) Percent
potentiation (slope of the second response divided by the
slope of the first response x 100) measured at interpulse in-
tervals of 50, 100, 150, and 250 msec was significantly dif-
ferent between heterozygous mutants and wild-type controls
(overall mean + S.E.M.) = 147 + 4 (wild type), 129 + 2
(heterozygotes); t = 4.745, df = 135, p < 0.001). (B) Aver-
age enhancement of synaptic responses produced by 10-
burst theta stimulation for homozygotes (n = 4) and
heterozygotes (n = 8) was significantly higher than wild-type
controls (n = 8), both in the first second after tetanus (255 +
25%, 217 + 12%, and 147 + 5%, respectively; F[2,17] =
18.01, p < .0001) and averaged over all 15 stimuli at 1 Hz
(163 + 5%, 160 + 3%, and 128 + 1%; F [2,17] = 11.23, p <
.001).
ficacy, we studied augmentation, a potentiation of
neurotransmitter release detected in the first 10-15
seconds following a tetanus. The tetanus used con-
sisted of a total of ten high-frequency bursts of four
stimuli delivered at the theta rhythm (5 Hz), a pattern
of hippocampal electrophysiological activity predom-
inant during exploration and during other behaviors
correlated with learning in rodents. We avoided the
potentially confounding superposition of LTP on
measurements of augmentation by using a pharma-
cological blocker of LTP induction in CA 1. Un-
expectedly, the degree of augmentation induced by
the tetanus in homozygous and heterozygous CA1
fields was significantly greater (p < .001) than in con-
trols (Fig. 2B). As little as eight pulses delivered at
the tetha frequency were sufficient to reveal a dif-
ference (p < .001) between the responses of mutants
and controls, even though with shorter tetani, the
levels of augmentation in mutants and controls were
smaller. The enhancement (p < 0.001) of augmenta-
tion in the mutants was also seen with longer tetani
(80 pulses). This shows that the enhanced posttetanic
responses of mutants are expressed throughout wide-
ly different presynaptic activation levels.
Even in the absence of GABA-mediated inhibi-
tion, augmentation in the heterozygotes was greater
than that in the controls. To determine whether the
enhancement in augmentation in the mutants was not
due to postsynaptic changes in membrane potential,
Bruno confirmed these results with whole-cell
recordings under voltage clamp. Again, the size of
responses immediately after the tetanus were greater
in mutants than in controls. Contrary to the predic-
tions of current models, the partial or complete loss
of aCaMKII does not reduce all synaptic transmis-
sion. Instead, the absence of this kinase resulted in
greater augmentation, implying that it normally
depresses synaptic responses to tetanic stimulation.
Previous experiments showed that CaMKII ac-
tivity can enhance neurotransmitter release in the
squid giant synapse. Thus, it is not surprising that the
partial or complete removal of aCaMKII from axonal
terminals depressed PPF in the mutant neurons. How-
ever, we did not expect to find enhanced augmenta-
tion in these cells. This shows that immediately after
tetanic stimulation, the aCaMKII does not promote
synaptic release as it seems to do during PPF; in-
stead, it inhibits synaptic responses. The high-
calcium conditions induced by a tetanus sharply in-
crease the autophosphorylation of this enzyme. Since
the autophosphorylated kinase is an efficient trap for
Ca++/calmodulin (Ca++/CaM) during and after high-
frequency stimulation, this kinase could serve as a
presynaptic calmodulin sink. This likely sequestering
of Ca++/CaM by the autophosphorylated kinase could
lead to the down-regulation of Ca++/CaM-dependent
processes required for neurotransmitter release.
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IMPAIRED LEARNING IN MICE HETEROZYGOUS
FOR THE aCAMKII
Studies of the physiological basis of learning have
focused on long-term synaptic plasticity. However,
short-lived changes in synaptic strength might also
have a role in learning. Consistent with
this
hypothesis, mice with a heterozygous targeted muta-
tion of the aCaMKII have abnormal hippocampal
short-term plasticity, and they are impaired in two
distinct hippocampally dependent learning tasks: the
spatial version of the water maze and contextual con-
ditioning. Importantly, other aspects of hippocampal
physiology, such as LTP and performance in hippo-
campally independent learning tasks, appeared much
less affected in the mutant mice. Unlike the homo-
zygous aCaMKII mutants, which have abnormal
LTP, the heterozygotes seem to master the hippo-
campus-dependent tasks with additional training,
suggesting that deficits in short-lived plasticity do not
prevent learning, as those in long-term plasticity
seem to do, but only slow it down.
Mice heterozygous for the aCaMKII have half of
the kinase present in control littermates. Field and
whole-cell recordings in the CA1 region of the hip-
pocampus showed that these mutants have increased
augmentation and decreased PPF, two forms of short-
lived presynaptic plasticity (see above). Since aCaM-
KII homozygotes have a profound LTP impairment
in the hippocampus, we also studied LTP in the
heterozygotes. Our studies show that LTP in the
heterozygotes, induced with a variety of tetanic pa-
rameters, is indistinguishable from that of control lit-
termates (Table 1). In conclusion, the aCaMKII
heterozygote mutants appear to have normal LTP but
abnormal short-term plasticity.
To determine the impact of deficits of short-term
plasticity in learning and memory, Diana Cioffi, an
undergraduate student in the laboratory, and Rusiko
Burchuladze started by studying the mice in the water
maze tasks. In this test, animals are placed in a round
pool, and they escape the water by learning to find a
platform. In the visible platform version of this task,
the location of the platform is marked, and the mice
simply have to learn to swim toward it. Figure 3A
shows that the performance of the heterozygotes in
this version, which does not require hippocampal
function, is indistinguishable from that of control lit-
termates, suggesting that motivation to escape the
water, vision, and motor coordination are normal in
the heterozygotes.
Next, we tested a different group of mice in the
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TABLE 1 Percent of Slices Showing LTP following Each
of Four Different Sets of Conditions
% of
No. LTP/No. slices baseline (LTP)
10-burst theta
wild type
heterozygous
10-burst theta + AP5
wild type
heterozygous
20-burst theta
wild type
heterozygous
100 pulse tetanus (100 Hz)
wild type
heterozygous
7/8
7/7
0/15
0/14
2/3
4/5
6/8
8/8
147 + 8
137 + 8
108 ± 1.9
108 ± 2.4
146 -± 11
146 ± 18
130 ± 8
132 ±5
Comparisons between heterozygous mutants and controls, taken as
t-tests contrasting 5-min time slices at t = 0, 15, 30, and 60 min after
tetanus revealed no significant differences, even in the '10-burst
theta tetanus' experiment (t = 0.9, 1.1, 0.7, and 0.3, respectively, df
13, p > 0.05 for all comparisons).
"spatial" version of the water maze. In this test, the
mice have to learn the position of a submerged plat-
form relative to distal objects in the pool room.
Strikingly, in this version requiring hippocampal
function, the performance of the heterozygotes is in-
ferior to that of controls (Fig. 3B). The heterozygotes
take considerably longer to locate the submerged
platform. This result was confirmed by a conven-
tional probe trial, in which after 3 days of training,
the platform was removed, and the mice were al-
lowed to search for it for 60 seconds. The controls
searched selectively for the absent platform, spending
53% of their time swimming in the quadrant of the
pool where the platform had been during training,
whereas the heterozygotes searched randomly in all
four quadrants of the pool (Fig. 3C).
In a second probe trial after two more days of
training (Fig. 3C), we found that the heterozygotes
learned to search selectively for the absent platform.
In contrast, the homozygotes still did not search se-
lectively for the platform, suggesting that they cannot
learn the spatial position of the platform. Similar
results were obtained using other assessments of
search selectivity, such as number of platform-site
crossings and the "Galagher measure," a platform-
proximity measure. However, despite normal swim-
ming speeds, the heterozygotes take longer than con-
trols to reach the platform, showing that their trajec-
tories are less direct than controls.
A)
60
50
40 -
co.4.4O 30 -a
4.4 20 -
P" 10-
0
WTI-4-aHets
C)
cu 50
E
40
4.
z 20
10
1 1 2 1 3 1 4 1 5
Blocks of 4 Trials
3 DAY PROBE
6
B)
0 11111111111111
1 2 3 4 5 6 7 8 9 10 11 1213 14 15
60
50
40
30
20
10
0 0
AR AL OP T AR AL OP
Quadrant
FIGURE 3 Water maze tests. (A) Wild-type controls (n = 10) and aCaMKII heterozygotes (n = 10)
were trained to navigate to a visible platform. Analysis of variance of all trials revealed no significant
difference between groups. (B) Performance of mice in the hidden platform version of the water
maze. Wild-type controls (n = 12) and aCaMKII heterozygotes (n = 15) were trained to find a hidden
platform located in a fixed position of the pool. (C) Probe trials without the platform given at the end
of the third and fifth days of training, respectively. (T) Training; (AR) adjacent right; (AL) adjacent left;
(OP) opposite quadrants.
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Even with hippocampal lesions, rodents can learn
the spatial version of the water maze after extended
training. However, unlike control subjects, hip-
pocampally lesioned animals are profoundly impaired
in relearning tests. These tests measure the ability of
trained animals to quickly learn to find the hidden
platform in a new position. Thus, it is possible that
the hippocampal short-term plasticity deficits of the
heterozygotes have the same impact on spatial learn-
ing as hippocampal lesions. To investigate this
hypothesis, we tested the heterozygotes in a relearn-
ing experiment. Both heterozygotes and controls
learned quickly to find the platform in a new loca-
tion, a result confirmed with a probe trial: The sear-
ches of both heterozygotes and controls were selec-
tive for the platform's new position. Together, the
evidence presented demonstrates that the hetero-
zygotes differ from the aCaMKII homozygotes,
which have LTP deficits, and from animals with hip-
pocampal lesions. Strikingly, heterozygotes learned
slower than controls to find the hidden platform.
To extend these findings, Rusiko Burchuladze
and Zachary Marowitz, an undergraduate in the
laboratory, tested a new group of mice on another
very different task known to require hippocampal
function: contextual conditioning. In this test, ani-
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FIGURE 4 Contextual conditioning in aCaMKII hetero-
zygotes and wild-type mice. (A) Mice (n = 10 in each group)
were given a single training trial consisting of an aversive
stimulus delivered to their paws. Twenty-four hours after
training, contextual conditioning was assessed by measur-
ing how long the mice remained immobile in the same en-
vironment in which they were trained. After extended
training (five training trials), the mice learned to recognize
the environment in which they were trained as well as con-
trols. Both mutants and controls remained immobile for the
same amount of time.
mals were aversively conditioned to a specific en-
vironment or context. Figure 4A shows that after a
single trial, controls are clearly conditioned since
they spent 40 + 5% of a 5-minute testing interval
without any perceptible movement (freezing), where-
as the heterozygotes showed little freezing (6 + 4%).
Omitting the sound during training, using another
aversive stimulus, pre-exposing the mice to the con-
ditioning environment for 15 minutes the day before
training, or testing them 1 hour after training failed to
reveal any contextual freezing in the heterozygotes.
However, the heterozygotes did freeze (43 + 6%)
when exposed to the sound, demonstrating that they
can be conditioned and that conditioning can be
studied in these mice by measuring freezing. Even
conditioning to sound, which is known to be
hippocampus-independent, seemed lower in heter-
ozygotes. This could be due to their threefold higher
levels of activity as reported by an open-field test.
Alternatively, other brain regions, such as the amyg-
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dala, might also be affected by the loss of half of the
aCaMKII in heterozygotes. Nevertheless, the heter-
ozygotes were once again profoundly impaired in an
hippocampus-dependent task, whereas in the version
not requiring hippocampal function, they were not.
Next, we tested whether similarly to the water
maze, extended training in this test could improve the
performance of the heterozygotes. Figure 4B shows
that with five trials, with 1-minute intertrial time, the
heterozygotes showed contextual conditioning (48 +
6%). To investigate the specificity of this response,
we trained another group of heterozygotes and con-
trols in one cage and tested them on a different con-
text (a different cage). In the novel context, both
groups of mice showed little freezing, attesting to the
specificity of the contextual freezing responses. Un-
like heterozygotes, homozygotes did not show any
contextual conditioning even after five trials, con-
firming the profound hippocampal impairment pre-
viously detected with water maze studies.
This work shows that despite abnormal short-term
plasticity in the CA1 region of the hippocampus,
mice heterozygous for the aCaMKII mutation appear
to have normal LTP there. These results suggest a
connection between learning and short-term plastic-
ity. However, it is important to note that we have not
yet checked LTP in other regions. Thus, it is still pos-
sible that deficits in LTP are underlying the slow
learning of the mutants. To address this problem, we
are currently testing LTP in other regions, and we are
also testing another mutant mouse with apparently
normal LTP but abnormal short-term plasticity.
CONCLUDING REMARKS
The studies described above are just the beginning of
a research program designed to use modern genetic
approaches to integrate information about molecules,
cells, circuits, and behavior. It is easy to see how the
suggestive richness of these results will continue to
generate testable models about how physiology con-
ditions learning. For example, the presence of this
kinase presynaptically and its uncanny ability to be
modified by interactions with Ca++ could be at the
heart of the surprising presynaptic responses ob-
served. Either its putative role in freeing synaptic
vesicles trapped in the cytoskeleton or its function as
a calmodulin trap could be underlying crucial
modulations of synaptic weights responsible for the
slow rate of learning in the heterozygous mutants.
Thus, indirectly, the intriguing biochemistry of the
aCaMKII might be an important component of the
dynamic process by which information continuously
fine tunes brain circuitry.
New developments in transgenic technology al-
low for subtler mutations, such as those that Karl
Peter Giese is carrying out in our laboratory. Amino
acid mutation in the various domains of the kinase
will enable us to correlate directly biochemistry with
physiology and behavior. Karl has set up the tech-
nique in the laboratory and he already has germ-line
transmission of embryonic stem cells.
The growing number of brain mutants will be an
important resource to further explore the issues raized
by these experiments. The pharmacological, elec-
trophysiological, neuroanatomical, and behavioral
analyses of these mutants should prove to be an im-
portant catalyst for a much sought-after biological
theory of brain function.
SIGNAL TRANSDUCTION IN NEURONS
G. Enikolopov N. Peunova
P. Krasnov
We are trying to understand the mechanisms that link
long-term changes in gene expression in a neuron
with long-term changes in its synaptic transmission.
We have developed new tools to dissect complex sig-
naling pathways; our particular focus is on the role of
protein kinases in regulatory cascades. This year, we
began experiments to design targeting vectors to
deliver chimeric protein kinase inhibitors to nerve
terminals and growth cones.
Recently, we have initiated studies on how gene
activity in neurons is modulated by gaseous messen-
gers, such as nitric oxide (NO) and carbon monoxide
(CO), which display properties similar to those of
both para- and autocrine effectors and have important
roles in the function of a neuron. This year, we have
extended our studies to primary cortical cells, show-
ing that NO is an integral part of the neuron's re-
sponse to glutamate. We have also shown that induc-
tion of nitric oxide synthase (NOS) acts as a switch
between mitogenic and cytostatic phases of neuronal
differentiation. This observation suggests that a
domain of adjacent cells might develop in coordina-
tion with a signal from a small group NO-producing
neurons or even a single NO-producing neuron.
NOS Acts as a Cytostatic Agent
during Neuronal Differentiation
N. Peunova, G. Enikolopov
Developmental mechanisms employ growth arrest to
define roughly the size of the cellular population that
is further committed to become a distinct domain of
differentiated neurons. Arrest of cell division is a pre-
requisite for cells to enter a program of terminal dif-
ferentiation. Differentiation of neuronal cells induced
by nerve growth factor (NGF) involves a mitogenic
phase followed by cytostasis and, later, by manifesta-
tion of the fully differentiated phenotype. We have
found that (1) NOS activity is strongly induced dur-
ing NGF-mediated differentiation of neuronal PC12
cells; (2) NO can act as an antimitogenic agent in
these cells, and (3) inhibition of NOS, whereas not
affecting the mitogenic component of NGF activity,
reverses the antiproliferative cytostatic action of NGF
and thereby prevents further development of the dif-
ferentiated phenotype. The crucial phase of NOS ac-
tion is cell-cycle-specific, and there is a critical time
window for NO action within the first 2-3 days of
NGF addition.
On the basis of our experimental evidence, we
propose that NO can act as a growth-arrest agent for
a population of proliferating neuronal precursor cells
and that it serves as a necessary prerequisite for the
full implementation of the differentiated phenotype.
Our data suggest a model for NGF action where, in
the first stages, NGF activates a cascade of genes,
eventually leading to mitogenesis and the induction
of the NOS gene. In the second stage, the accumu-
lated NOS enzyme produces enough NO to inhibit
DNA synthesis and probably alerts further check-
points, thereby slowing down the cell cycle. Finally,
when the cell processes the cytostatic signal, it starts
to implement the remainder of the differentiation pro-
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cesses such as neurite outgrowth, which can only oc-
cur once cell division has ceased.
Our data suggest that induction of NOS is an im-
portant step in the commitment of neuronal precur-
sors during development and that NOS serves as a
growth-arrest gene during differentiation of neuronal
cells, switching the differentiation program from
mitogenesis to cytostasis.
Does a similar NOS-mediated mechanism for
cytostasis exist in other systems (including but not
limited to the nervous system)? A positive answer to
this question could explain the mechanism of action
of other growth factors (and systems) during terminal
differentiation in which the initial mitogenic response
is replaced by a cytostatic phase. In the case of the
brain, this could include not only embryonal brain de-
velopment, but also regeneration and neuronal differ-
entiation in the adult brain. It also suggests that the
development of a domain of neighboring cells might
be coordinated under the command of, in principle, a
single activated NO-producing cell. Finally, because
NO is involved in synaptic plasticity, such mechan-
isms could provide a link between the activity of a
cell and the developmental fate of it and its nearest
neighbors.
Synergism between NO and Calcium
Is Part of the Cortical Neurons'
Response to Glutamate
G. Enikolopov [in collaboration with H. Nawa, Cold
Spring Harbor Laboratory]
We have recently found that NO can amplify weak
calcium signals in the neuronal PC12 cell line. To
test the relevance of these results for the brain
neurons, we have conducted experiments with pri-
mary cultures of rat cortical neurons. Two com-
plementary approaches were used: (1) We supple-
mented the action of various inducers (glutamate and
BayK8644 in particular) with NO to see if their ac-
tions can synergize, and (2) we specifically inhibited
the action of NOS to detect its input in neuronal sig-
nal transduction. Our major finding is that the
synergism between NO and calcium we had de-
scribed for PC12 cells is also present in rat cortical
neurons. Very importantly, this synergism is an in-
trinsic part of the response of the cortical neurons to
glutamate. This synergistic action is dependent on
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calcium influx through NMDA receptors. Calcium
activates NOS and the produced NO molecules
amplify calcium signals, thereby introducing an addi-
tional
overall
regulatory in the signaling network of the
ll esupotnosrey to glutamate. Thus, glutamate induc-
tion of gene transcription involves the participation of
rerg
the NOS system as an integral part of the response.
This indicates that the phenomenon, which we have
observed with cultured cells and an external source
on NO, has direct parallels in brain neurons, where
internally produced NO acts synergistically with
NMDA channel-delivered calcium.
We have made several predictions based on our
data with neuronal cells: (1) The effect of NO on sig-
naling might be particularly important at very low
levels of calcium action, at which this inducer acting
alone would have negligible effect; these very weak
signals, which would go unnoticed by the cell, might
be amplified by NO, resulting in pronounced
physiological changes for the cell. (2) Since NO dif-
fuses freely and readily leaves and enters cells
without need for a secretory system or a surface
receptor, nearby synapses that receive very weak im-
pulses simultaneously with exposure to NO might es-
tablish facilitated synaptic transmission. (3) NO and
Ca++ must act within a very narrow time window for
this enhancement to occur, suggesting that in the ner-
vous system, this synergistic effect might be re-
stricted to the recently active synapses, thereby coin-
ciding with transient elevations of calcium levels. (4)
Amplification of Ca++ action by NO, acting on sig-
naling machinery either directly or through re-
programming of gene activity, might be directly in-
volved in NO-mediated steps in LTP and similar
activity-dependent neuromodulation.
Important recent data confirm our hypothesis on
the NO/Ca++ synergism in the brain. It was recently
shown that hippocampal LTP can spread to the
nearby synapses and that this spreading is totally de-
pendent on the production of NO by the synapse with
established LTP; it also was demonstrated that addi-
tion of NO to hippocampal synapses strengthens only
those synapses that are already receiving nerve im-
pulses. The described phenomena can be explained
on a biochemical level by the mechanisms that we
have suggested based on our experiments with PC12
cells and cortical neurons, and we lap n experiments
to test whether these explanations are correct.
We will continue these experiments to study the
mechanisms of NO and calcium action in more detail
and also to search for the other patterns of NO action.
We are particularly interested in whether different
time coincidence requirements exist for different
types of cells; e.g., are there types of neurons where
noncoincident application of NO and Ca++ makes
neurons refractive to the action of the second agent?
Targeted Protein Kinase
Inhibitors
P. Krasnov, G. Enikolopov
Our earlier studies introduced pseudosubstrate-based
recombinant inhibitors (RPKI) as tools to study sig-
nal transduction pathways. We are now extending
this approach with a goal of directing chimeric in-
hibitory proteins to specialized structures and specific
compartments of the cell. Our aim with respect to
signal transduction in neurons is to manipulate the
events in the terminals without affecting the pro-
cesses in the nucleus and the soma. Potentially, this
could be achieved by targeting recombinant in-
hibitors to the nerve terminals as parts of larger
chimeric proteins containing domains of synaptic
vesicle proteins (synaptotagmins, synaptophysins), of
the GAP43 protein, or of other proteins that tend to
accumulate in the nerve terminals and growth cones.
As a first attempt to develop a targeting "protein vec-
tor," we tested the potential of synaptic vesicle
proteins to be transported to the terminals after the
transfection of constructs into cultured neuronal cells.
We have achieved best results with constructs con-
taining rat synaptotagmin II, fused to the influenza
virus HA epitope tag (to permit visualization by im-
munofluorescence in situ and on Western blots) and
an inhibitory pseudosubstrate peptide. We have
shown that chimeric molecules accumulate in the
growth cones of the neurites, with some fluorescence
being present in the cell body and almost no signal in
the nucleus. We are now testing whether, coordinate
with the location, the activity of the inhibitors is also
restricted to specific cellular compartments.
We will continue these experiments to (1) localize
the sequences in the synaptotagmin that are sufficient
for targeting the attached domains to the terminals
and growth cones; (2) test whether the activity of the
inhibitors is indeed restricted to the targeted compart-
ments of the neuronal cells; and (3) test other com-
ponents of synaptic vesicles and GAP43 for the pos-
sibility of targeting foreign polypeptides. We want to
narrow down the targeting sequence, to test their
potential as universal targeting vehicles (for RPKI as
well as for any other potentially interfering protein
domains) and to use them to introduce fine perturba-
tion in the processes in the terminal without affecting
the rest of the cell compartments.
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GENETIC ANALYSIS OF CELLULAR MECHANISMS OF LEARNING
AND MEMORY IN DROSOPHILA
Y. Zhong N.J.D. Wright
J. Shan ley
The goal of our research is to understand the cellular
mechanisms of learning and memory. We are taking
an approach of electrophysiological analysis of
Drosophila leaning and memory mutants. These
mutants have been isolated on the basis of poor per-
formance in learning.
Characterization of two such mutants dunce (dnc)
and rutabaga (rut) has shown that the dnc gene en-
codes cAMP-specific phosphodiesters, whereas the
rut gene encodes an adenylyl cyclase and that expres-
sion of both genes is enhanced in a brain region
called the mushroom body. Genetic or pharmacologi-
cal ablation of mushroom bodies has been
demonstrated to lead to diminished olfactory-as-
sociated learning. Therefore, our first mission was to
identify neurotransmitters that activate the cAMP
cascade involving Dnc and Rut proteins. We will
then determine how neuro-transmissions mediated by
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the identified transmitters are affected in learning and
memory mutants. In the past year, we have focused
on the peptide function in mushroom body neurons of
Drosophila learning and memory mutants. Neuropep-
tides comprise the largest single group of intercellular
messengers in the central nervous system (CNS), and
thus an understanding of their actions must be a
major part in the understanding of neuronal commu-
nication. We have chosen to study three neuropep-
tides: pituitary adenylyl cyclase-activating peptide
(PACAP), PACAP-related peptide (PRP), and proc-
tolin primarily for three reasons: First, PACAP and
proctolin are known, or are suggested, to stimulate
cAMP synthesis. Second, all three peptides appear to
act on Drosophila mushroom body neurons. Third,
the memory mutant amnisiac gene may code for a
PACAP-related peptide.
PACAP belongs to a VIP/secretin/glucogon
neuropeptide family. Two bioactive forms of
PACAP, PACAP38 and PACAP27, are derived from
the precursor protein and their peptide sequences are
identical in humans, rats, and sheep. PRP is also
derived from the same precursor, but its function has
not yet been identified. PACAP receptors are coupled
to both adenylyl cyclase and phospholipase C. The
receptors are widely distributed in vertebrate pc_
ripheral tissues and in the central brain, including the
hypothalamus and hippocampus. PACAPs have been
reported to regulate hormone or transmitter release,
neurite outgrowth, and gene expression. The presence
of PACAP and PRP-related neuropeptides in inverte-
brates has not yet been reported. Proctolin is one of
the best-characterized neuropeptides in insects, which
has been reported to modulate Ca++ currents in insect
muscle and stomatogastric neurons. Proctolin-like
immunoreactivity has also been observed in the
Drosophila CNS and at neuromuscular junctions. The
purified fraction from Drosophila extracts exhibits a
proctolin-like bioactivity in Drosophila and grass-
hopper.
FIGURE 1 PACAP38-like immunoreactivity in the Drosophila larval CNS and at the larval body-wall
neuromuscular junctions. (Left) Dorsal view of immunoreactivity of vertebrate PACAP38 in the
ganglion and brain lobes. Arrowheads point to a pair of stained neuronal soma. (Inset) Schematic
drawing of the distribution of stained soma in the CNS. (Right) Immunoreactivity in the motor nerve
terminals arborized onto larval body-wall muscle fibers 4, 6, 7, 12, and 13. Arrowsheads pointto
stained varicosities.
Immunohistochemical Analysis of
Neuropeptide Distribution
J. Shan ley, Y. Zhong
One of the major strategies for identifying new
neuropeptides is to utilize immunocross-reaction
among the conserved peptide families in different
organisms. Since the presence of PACAP-like
neuropeptides in invertebrates is unknown, we have
used vertebrate PACAP antisera to determine the dis-
tribution of the putative Drosophila PACAP. Using
antisera against the vertebrate PACAP38, we were
able to detect PACAP38-like immunoreactivity in the
larval CNS and at larval body-wall neuromuscular
junctions (Fig. 1). Figure 1 (left) shows the pattern of
immunoreactivity in the ganglion and brain lobes.
The number of the stained neurons in the ventral
ganglion is rather large, roughly about 500. The cate-
gories of the stained neurons remain to be deter-
mined. However, the distribution and morphology of
some of these neurons are very similar to those of
previous identified neurosecretory cells (e.g., T1 v-
T3v, SE2, and SP1) that express other neuropeptide
immunoreactivities, including FMRFamide-like im-
munoreactivity. However, the overall pattern of im-
munoreactivity is different from that of all previously
examined peptides, such as FMRFamide, proctolin,
and insulin-like immunoreactivity.
The PACAP38-like immunoreactivity was also
found at neuromuscular junctions of most body-wall
muscle fibers (about 30 in each hemisegment) in all
segments. Representative examples of such im-
munoreactivity in muscle fibers 6, 7, 12, and 13 are
shown in Figure 1 (right). Immunoreactivity of other
peptides examined including proctolin and insulin
was restricted to subsets of motor nerve terminals.
Immunoreactivity was abolished when the antiserum
was incubated with PACAP38, suggesting the
specificity of the immunoreactivity. However,
PACAP27 antisera did not stain Drosophila tissues.
Using an antiserum against vertebrate PRP, we
have found PRP-like immunoreactivity in the CNS
and neuromuscular junctions as well (data not
shown), but the pattern is very different from that of
PACAP-like immunoreactivity. Only a few cell
bodies including neurosecretory-like cells were
stained in the ventral ganglia. At the larval body-wall
neuromuscular junctions, only one nerve terminal
was stained in each hemisegment of abdominal seg-
ments 1-5.
Neuropeptide Functions at
Neuromuscular Junctions
Y. Zhong
The larval body-wall neuromuscular junction is prob-
ably the only preparation suitable for quantitative
analysis of synaptic transmission at identifiable
synapses in Drosophila. We chose this preparation to
carry out a rigorous analysis of the physiological
function of PACAP. Results of this analysis will pro-
vide a necessary theoretical foundation for proper in-
terpretation of results from our study of PACAP in
the CNS.
To investigate the physiological significance of
immunoreactivity, focal application of vertebrate
PACAP38 to neuromuscular junctions was analyzed
by intracellular and voltage-clamp recordings. Ap-
plication of PACAP38 (4 [im) to the neuromuscular
junctions induces a slow depolarization of 10-20 mV
lasting for tens of seconds (Fig. 2). After preincuba-
tion with its antiserum, PACAP38 failed to de-
polarize the muscle membrane. In contrast, 10 tim
VIP failed to induce any significant response. These
data indicate the specificity of the PACAP38
response. In addition to the PACAP38-induced
depolarization, two-electrode voltage-clamp analysis
revealed a second type of muscle response: modula-
tion of voltage-activated K+ currents, which occurred
5-8 minutes later after depolarization (Fig. 2). A
dramatic enhancement (50-100-fold) of the K+ cur-
rents is observed several minutes later after perfused
PACAP38 is removed. This enhancement of K+ cur-
rent lasts for about 3-5 minutes, and then the
amplitude of the K+ currents gradually decays to that
of the control.
In addition, this novel PACAP effect could also
be mimicked by higher-frequncy (60 Hz) stimulation
of motor axons. The stimulation evoked not only the
early slow depolarization, but also a dramatically en-
hanced K+ current several minutes after stimulation.
Taken together, these data suggest that PACAP38
and an endogenous neuropeptide released upon
stimulation of motor axons induce the same novel
muscle response.
When the vertebrate PRP was pressure ejected or
bath perfused to the neuromuscular preparations,
muscle membrane potential and K+ currents were not
significantly affected. However, synaptic transmis-
sion measured by excitatory junctional currents (ejcs)
was enhanced (data not shown). This enhancement of
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FIGURE 2 A typical time course of PACAP38-induced responses in larval body-wall
muscles recorded by voltage clamp. Muscle membrane is held at -80 mV. At 0 min
(0 minute), a pulse of 4 RNA PACAP38 (as indicated by the bar) is focally applied to
the neuromuscular junction, which induces an inward current as the early response.
This early inward current lasts for many seconds. The muscle K+ currents are also
monitored before the application and each minute after the application. The com-
mand voltages are stepped from -80 to -50 and 0 mV, respectively. Only a leakage
current is elicited by the voltage step to -50 mV, but voltage-dependent currents are
activated by depolarization to 0 mV. The amplitude of voltage-activated K+ currents
remains relatively stable during the period prior to the application and 6 min after the
application. A dramatic increase, as the late response, is seen at 7 min (7 ' ) after the
application, which peaks at 8' and returns to the control level at about 13 .
ejcs as examined in segments 3 through 6 was only
recorded from muscle 6 but not from muscle 12.
Characterization of K+
Currents in Identified
Mushroom Body Neurons
N.J.D. Wright, Y. Zhong
The adult Drosophila or third instar larval mushroom
body consists of about 2500 neurons and is located in
the dorsal and posterior cortex of each brain lobe.
Despite two decades of genetic, molecular, anatomi-
cal, and behavioral analyses of learning and memory
mutants, it has not been possible to determine the
functional defects of these mutants in the CNS, par-
ticularly in mushroom body neurons. A large part of
the problem has been due to the difficulty in record-
ing from the small-sized Drosophila brain and
neurons composing it. As a first step, we developed a
preparation that allows us to identify fluorescent-
stained mushroom body neurons in acutely dis-
sociated larval CNS cultures and to patch-clamp
these neurons. A Drosophila enhancer-trap line 221
(isolated by R. Davis' laboratory, CSHL) expresses
the lacZ reporter gene almost exclusively in the
mushroom body. When the 221 larval CNS is dis-
sociated in culture, individual lacZ- expressing
mushroom body neurons can be identified by fluores-
cent staining. Electrophysiological and pharma-
cological characterization of K+ currents (Fig. 3) re-
corded from these identified neurons demonstrates
that lacZ expression per se and the staining do not af-
fect these cells. These K+ currents essentially can be
grouped into two types based on the whole-cell K+
current observed. Type-1 current exhibits a slow in-
activating component and is mainly sensitive to the
drug TEA, whereas type-2 current exhibits a fast
transient A current and a sustained component and is
mainly blocked by the drug 4-AP. Both types of K+
currents can be modulated by cAMP. This suggests
that the staining did not significantly affect the
physiology of voltage-activated K+ currents.
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FIGURE 3 Representative examples of voltage-activated
whole-cell K+ currents recorded from acutely dissociated
larval CNS cultures. The family of current traces were
elicited by depolarizations to -60, -20, 20, 50 mV. (Left
column) Recorded from cells not subject to hypotonic
shock; (middle column) recorded from cells subjected to the
hypotonic shock and loaded with fluorogenic substrate of 3-
galactosidase but unmarked due to the lack of expression
of lacZ; (Right column) recorded from cells that are fluores-
cently labeled resulting from lacZ expression. The marked
neurons are derived from the mushroom body.
Modulation of K± Currents Induced
by Neuropeptides in Normal
and Mutant Flies
N.J.D. Wright, Y. Zhong
Figure 4 presents responses to the application of
PACAP38, PRP, and proctolin of type-1 current in
stained mushroom body neurons. The control current
was elicited by depolarization from the holding
potential -80 mV to -50 and +20 mV. The current
elicited by the -50 mV pulse represents leakage cur-
rent, whereas the +20 mV pulse triggers voltage-
activated K+ currents. After recording of control cur-
rents, peptides were perfused by pressure ejection for
30-60 seconds via a micropipette placed 50-100 [irn
away from the patched neuron. Leakage current was
not affected by these peptides. In contrast, type-1 cur-
rent was modulated by PACAP38, PRP, and proc-
tolin but each in a different fashion (Fig. 4). PRP
reduced the amplitude, whereas proctolin mainly
altered kinetics (the inactivating component becomes
faster). PACAP38 produced both a reduction in the
amplitude and an alteration of inactivation kinetics
(faster). Such peptide-induced responses were seen in
all type-1 neurons examined, but to different degrees.
One possible source of such interpatch variability
may have resulted from variation of the concentration
of peptides applied to the patched neuron, since the
tip diameter of the perfusion micropipette and the
distance of the micropipette from the patched neuron
most likely varied from preparation to preparation.
The ruts mutation completely abolishes Ca++/CaM-
activated adenylyl cyclase activity and significantly
but not completely disrupts olfactory learning and
memory. We bred ruts mutants, which also carried
nA
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0 80 ms
-100+20-I -60 mV L
FIGURE 4 Peptide-induced modulation of type-1 K+ current
in mushroom body neurons. Controls were recorded prior to
perfusion of proctolin (20 p.m), PRP (20 µm), and PACAP38
(8 pm). The current traces under 'Peptide' were recorded
immediately after ceasing the perfusion, which is usually
30-60 sec. Traces under 'Recovery' were recorded 2-4 min
after ceasing the perfusion.
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FIGURE 5 Effect of the rut mutation on PACAP38-induced
modulation in mushroom body neurons. The top lane shows
the normal response. The bottom two lanes indicate the rut
response from different mutant neurons. PACAP38 was per-
fused for 60 sec. Scale is in the range similar to that shown
in Fig. 4.
the enhancer-driven lacZ gene from 221, thereby al-
lowing the identification of ruts mutant mushroom
body neurons. When PACAP38 was perfused on
these mutant cells, the response was abnormal (Fig.
5). As indicated in Figure 5, application of PACAP38
induced modulation of both amplitude and inactiva-
tion kinetics in normal mushroom body neurons. In
contrast, all mutant neurons examined showed a
reduction in the amplitude of type-1 K+ current, but
the inactivation kinetics were not modulated by ap-
plication of PACAP38. Thus, our approach promises
to contribute to a better understanding of the elec-
trophysiological defects in the CNS of learning and
memory mutants.
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GENETICS OF HUMAN BEHAVIORAL DISORDERS
H. Feilotter S. Lincoln
R. Koskela
The Genetics of Manic
Depressive Illness
H. Feilotter, S. Lincoln, R. Koskela [in collaboration with
T Marr, Cold Spring Harbor Laboratory; J. Witkowski,
Banbury Center; R. De Paulo, S. Simpson, F. McMahon,
M. McInnes, D. Meyers, C. Stine and J. Xu at Johns Hopkins
University School of Medicine; and D. Botstein, C. Clark,
C. Friddle, M. Gschwend, and D. Cox at Stanford University
School of Medicine]
This year marked the beginning of a new research
direction for the Laboratory on the genetics of human
behavioral disorders. Because our involvment in the
Dana Consortium began in the last months of 1993,
this report will provide background about the project
236
and a summary of ongoing work. The specific objec-
tive of this consortium is the identification of the
gene or genes that are responsible for the disorder
known as manic depression. Drawing from the diag-
nostic and genotyping expertise at Johns Hopkins and
Stanford and the informatics expertise here at the
Laboratory, the long-term goal of this work is to de-
velop a novel informatics tool for use in studies of
complicated human genetic disorders.
Manic depression, or bipolar affective disorder,
is a prevalent disease, affecting roughly 1% of the
population of America. It is also a complicated one,
both from the point of view of the diagnostic un-
certainties that accompany it and the potential com-
plex genetics that may underlie it. Criteria for the
diagnosis of bipolar disorder are set out in the DSM-
III-R handbook to facilitate a standardized approach
among clinicians. However, the disorder is displayed
as a startling variety of phenotypes, which may be in-
fluenced by the underlying genetics, the environment,
or both. The continuum of phenotypes that may
denote the same genetic lesion ranges from bipolar 1
disorder, characterized by full-blown manias and
deep, lasting depressions, through to cyclothymia,
characterized by less severe mood swings. The dif-
ficulty lies in determining who is suffering from the
clinical manifestation of a specific genetic disorder
and who may be displaying a disorder of a non-
genetic nature.
There is evidence for a genetic component of
bipolar disorder from both twin and family studies.
However, these data have also demonstrated that
penetrance of the genetic component is less than
complete and have opened the possibility that the dis-
ease may be at least in part the result of complicated
genetics. For example, the interaction of a number of
mutant gene products might combine to produce the
various phenotypes. Mutations might be present in
more than one gene, each of which may be re-
sponsible for a subset of cases. Interactions of
specific genetic predispositions with environmental
factors might give rise to a variety of phenotypes.
The obvious difficulties in a genetic approach to a
disease that has no simple biochemical marker to flag
its presence, nor a simple Mendelian pattern of trans-
mission, have made studies on the genetics of manic
depression very frustrating.
Genetic studies on human disease are initiated by
attempting to find linkage between the disease
phenotype and specific chromosomal regions that are
tagged by polymorphic markers. These studies have
recently been enormously improved by the construc-
tion of a relatively high-density genetic map of the
human genome. Informative markers (i.e., those that
display a high degree of polymorphism in the general
population) are available at a resolution of about 1-2
cM over much of the genome. Rather than a methodi-
cal approach, researchers may look for candidate
genes that are linked to the disorder, which might
reasonably contribute to the observed phenotype
when mutated. A variation on this strategy is the use
of the candidate gene approach only after a general
chromosomal region has been shown to be linked to
the disease phenotype.
Our collaborative efforts toward understanding
the genetics of manic depressive illness implement
the same strategies. Following family selection,
rigorous and repeated screenings of family members
to maximize diagnostic accuracy have been carried
out by the psychiatric group at Johns Hopkins Hospi-
tal. Only families that are segregating the illness in a
unilineal pattern are chosen for study. Currently, 28
such families have been identified. Blood has been
drawn from each willing family member, and im-
mortalized lymphoblastoid cell lines have been creat-
ed to provide a constant source of DNA for use in
linkage analysis. Two hundred markers, spaced at
roughly 20 cM across the genome, have been chosen
for use by the genotyping group at Johns Hopkins to
do linkage analysis. An additional 200 markers have
been chosen by the genotyping group at Stanford for
use on the same DNAs. The markers have been
chosen such that approximately 10% of them are the
same in both groups and the others interdigitate to
create a 10 cM map across the genome.
The role of our group in the collaboration is to
maximize the information gained from these studies
and to facilitate data flow and data manipulation
through the application of computing power. Tom
Marr's laboratory has produced a new database
known as Genome Topographer (GT). GT was de-
signed to meet several specific needs of the biologi-
cal research community and exploited and
modified to be more useful for the psychiatric
genetics community in this collaboration. A complete
description of GT is given elsewhere in this Annual
Report (see T. Man in the Structure and Computation
Section), but a brief outline is relevant here. The con-
cept of GT stemmed from the realization that the vast
amount of information currently being produced on
the human and other genomes was being scattered
among various databases and literature sources in
forms that were largely incompatible with each other
and often inaccessible to the average biologist. GT
seeks to overcome this problem by integrating all
genome information in a standardized format in a
single easily accessible database. In addition to in-
formation on the human genome, GT stores data on
all other model systems. It also stores biochemical
and molecular data where these are known. The result
is a huge information repository that allows a user to
browse material and find relationships between
pieces of data that might not have been obvious by
using several different databases as sources. Re-
searchers can simply browse the remote database to
obtain information about specific regions of chromo-
somes, genes, contigs, probes, etc. Alternatively,
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users can also enter their own data in local projects.
These data can then be integrated into the publicly
accessible large database, or they can bypass the pub-
lic forum and make use of a number of the external
applications or tools which GT also maintains. These
tools allow manipulation of data using various pro-
grams such as sequence analysis or linkage analysis
programs. Because of the size of the computers on
which these programs are executed, the run time for
such manipulations is much reduced, making possible
complicated data analyses that laboratories with less
computing power could not have done previously.
Output from the external tools can then be used to
search for new relationships in the remote database.
The current effort from our group is toward mod-
ification of GT to provide a system that will be useful
in efforts to understand the genetic basis of manic
depression. This is taking place in several ways that
make use of the remote and local database setup, as
well as the external tools. Using the remote database,
we are currently entering information on available
markers and genetic maps. Other efforts involve ad-
ditions to the existing GT structure. These modifica-
tions are specifically designed to address some of the
major problems encountered during genetic analysis
of human disease. Therefore, initial emphasis is being
put on the following areas: (1) the design of programs
that allow researchers to input pedigree, genotyping,
and diagnostic data in a standardized format, (2) the
addition of currently available linkage analysis pro-
grams to the external tool selection in GT, (3) the
writing of new linkage analysis tools that implement
novel approaches to the linkage problem, (4) the writ-
ing of user interfaces for all the linkage analysis pro-
grams and for data input that are comprehensible to
the biologists using the linkage programs, and (5) the
construction of a survey database that incorporates
published data which may be helpful to current re-
search, including exclusion maps from previous
linkage analyses.
CSH LABORATORY JUNIOR FELLOWS
In 1986, Cold Spring Harbor Laboratory began a Junior Fellow program to en-
courage independent research by outstanding young scientists who, during their
graduate studies, displayed exceptional promise of becoming leading scientists
of the future. The purpose of this program is to provide an opportunity for each
Fellow to work independently at the Laboratory for a period of up to 3 years on
projects of their choice. The Fellow is provided with a salary, research support,
and technical assistance so that they can accomplish their goals free from other
distractions. The interaction among research groups at the Laboratory and the
program of courses and meetings on diverse topics in molecular biology contrib-
ute to a research environment that is ideal for innovative science by these Fel-
lows.
Three previous Cold Spring Harbor Fellows, Dr. Adrian Krainer (1987), Dr.
Carol Greider (1988), and Dr. Eric Richards (1989), are currently members of the
scientific staff at the Laboratory. Dr. David Barford is our most recent Fellow, hav-
ing joined us in 1991 from Professor Louise Johnson's laboratory at Oxford. Dr.
Barford is an X-ray crystallographer who has previously worked on glycogen
phosphorylase, but whose present interests lie in the area of protein-mediated
signal transduction. Dr. Barford's current focus is on the serine/threonine-specific
protein phosphatases. Immediately before coming to Cold Spring Harbor, Dr.
Barford spent some time in Dr. P. Cohen's laboratory in Dundee working on
protein phosphatase 2A (PP2A) from rabbit muscle.
D. Barford
We have been pursuing our crystallographic investi-
gations on protein phosphatases. Progress has been
made in obtaining better quality crystals of the
serine/threonine-specific protein phosphatase 1. Two
protein tyrosine phosphatases, namely, protein tyro-
sine phosphatase 1B and the T-cell protein tyrosine
phosphatase, have been crystallized, and their struc-
tures have been determined.
Protein phosphatases constitute a family of signal
transducing enzymes that catalyze protein dephos-
phorylation and are important in regulating a variety
of proteins. Two classes have been characterized on
the basis of substrate specificity and primary struc-
ture. The serine/threonine protein phosphatases act
specifically or preferentially on phosphoserine and
phosphothreonine residues, whereas the structurally
distinct protein tyrosine phosphatases specifically
dephosphorylate phosphotyrosine residues. A sub-
family of dual specificity phosphatases, characterized
by p8Ocdc25 and MAP kinase phosphatase-1 has been
characterized recently.
PROTEIN PHOSPHATASE 1 (PP1)
PP1 is a principal member of the serine/threonine
class of protein phosphatases and is important in con-
trolling a number of celluar processes including me-
tabolism, division and differentiation, and learning
and memory processes. The human isoform of PP1
has been crystallized. This year, better quality crys-
tals have been obtained that diffract to 2.2 A when
exposed to synchrotron radiation. The space group
and cell parameters have been characterized, and a
complete native dataset was collected at beam-line
X1 2C at the National Synchrotron Light Source,
Brookhaven National Laboratory. A considerable ad-
vance was made following the acquisition of a cryo-
239
FIGURE 1 A ribbons diagram of human protein tyrosine
phosphatase 1B showing the secondary
structure and the position of the invariant and catalytic residues
His-214, Cys-215, Arg-221, and Gln-
262 and the tungstate ion.
system cooling device, allowing us to freeze and
store crystals in liquid nitrogen and to collect crystal-
lographic data at cryogenic temperature. Heavy atom
screening is currently in progress.
HUMAN PROTEIN TYROSINE PHOSPHATASE 1B
This research was carried out in collaboration with
A.J. Flint and N.K. Tonks (CSHL). The cDNA en-
coding the amino-terminal 321 residues of human
PTP1B was cloned into the T7 polymerase expres-
sion vector, allowing the gene to be overexpressed in
E. coli (A.J. Flint). A purification procedure was de-
veloped, allowing more than 50 mg of protein to be
purified from a 4-liter culture. The protein is more
than 99% homogeneous and has been crystallized.
The structure was determined to 2.8 A from a
single heavy atom derivative with use of anomalous
scattering. All data were collected at beam-line X8C
at the National Synchrotron Light Source, Brook-
haven National Laboratory. The structure reveals a
novel protein fold and the position of the substrate
phosphate-binding site. The catalytic cysteine residue
(C215) interacts directly with the phosphate group lo-
cated at the catalytic site, consistent with its role as a
nucleophile in the catalytic reaction. Other residues
within the conserved PTP sequence signature motif
form the phosphate-binding site. The catalytic cleft is
the correct size to accommodate a phosphotyrosine-
containing residue and is probably too deep for
phosphoserine and phosphothreonine. The surface of
the protein surrounding the catalytic site is predomi-
nantly electro-positive, which may explain the prefer-
ence of PTP1B for dephosphorylating phospho-
tyrosine adjacent to acidic residues.
The structure reveals the position and roles of in-
variant residues shared among protein tyrosine
phosphatases and explains previous biochemical and
site-directed mutagenesis experiments performed by
other investigators.
A ribbons diagram showing the secondary struc-
ture and the position of the invariant and catalytic
residues His-214, Cys-215, Arg-221, and Gln-262
and the tungstate (phosphate analog) is shown in Fig-
ure 1.
HUMAN T-CELL PROTEIN TYROSINE PHOSPHATASE
This research was carried out in collaboration with
N.K. Tonks (CSHL). The cDNA encoding the human
T-cell PTP was cloned into a T7 expression vector,
and the overproduced protein was purified in a man-
ner similar to that used for PTP1B. Small crystals
were obtained in the presence of ammonium sulfate
and data to a resolution of 3.0 A were collected at
beam-line X12C. The sequence of T-cell PTP shares
50% sequence identity with PTP1B and the structure
of PTP1B was used as a model to determine the
structure of T-cell PTP using the molecular replace-
ment method. As expected, the structure is very
similar to that of PTP1B. The deletions in the T-cell
PTP sequence compared to the PTP1B sequence are
located in loops connecting elements of secondary
structure.
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ACADEMIC AFFAIRS
The academic program at Cold Spring Harbor Laboratory
in 1993 included a
i
series of advanced postgraduate laboratory
and lecture courses in molecular
genetics, structural biology, and neurobiology;
conferences and workshops in-
cluding the annual Symposium; and a summer
research program for un-
dergraduates. In an era of rapidly advancing scientific research, the courses and
meetings serve multiple functions, both in
teaching advanced state-of-the-art
techniques and methodologies and in bringing together
scientists in many areas
to exchange their latest results.
More than 5000 scientists came to the Laboratory
this year to attend or teach
in the various courses and conferences. In
1993, 25 laboratory courses and 14
meetings were held, starting with a spring session of courses held early in April
and extending through two sessions of fall courses ending in November. Several
new laboratory and workshop courses were held this year: Early Development of
Xenopus laevis, taught by Richard Harland and Hazel Sive; Arabidopsis
Molecular Genetics, taught by JoAnne Chory, Joseph Ecker, and Athanasiasus
Theologis; and Construction and Analysis of Two-dimensional Gel Protein Data-
bases, taught by B. Robert Franza, James Garrels, Gerald Latter, and Scott Pat-
terson. Two new Neurobiology lecture courses were also taught and were held at
the Laboratory's Banbury Center: Human Functional Neuroimaging, taught by
Francis Miezin, Steven Petersen, and Marcus Reich le; and Structure, Function,
and Development of the Visual System, taught by Tobias Bonhoeffer and David
Fitzpatrick. The entire program of courses and meetings is listed in detail on the
pages that follow. Clearly, it is due to the large number of scientists who serve
with great skill and enormous effort and goodwill that this very intensive program
is run so successfully.
The course program is supported by grants from both private and govern-
ment sources. This year, the grant to support the Advanced Bacterial Genetics
course was renewed by the National Institute of General Medical Sciences. This
grant, which entered its fourteenth year of funding, is crucial to the existence of
the course, and the efforts of the instructors, Stan Maloy, Valley Steward, and
Ron Taylor, in carrying on the tradition of the longest-running course at Cold
Spring Harbor are greatly appreciated. Grants from the National Institutes of
Health and the National Science Foundation support many of the molecular
genetics courses, and a grant from the National Institute of Mental Health covers
several neurobiology courses. More recently, awards from the Department of En-
ergy and the Department of Agriculture have helped in the funding of the courses
on Macromolecular Crystallography and Molecular Markers for Plant Breeding,
respectively. The education grant from the Howard Hughes Medical Institute,
now in its second year of renewal, continues to provide enormously important
stable funding for the neurobiology program as well as support for new courses,
a critically important area. The Laboratory is also fortunate to have an award from
the Esther and Joseph A. Klingenstein Fund for the support of the neurobiology
program as well as scholarship funds from the Grass Foundation for the support
of students taking neurobiology courses. In addition, the Laboratory courses
receive invaluable support from many companies that donate supplies and lend
large amounts of equipment (see Educational Activities Section).
The Symposium organized by Bruce Alberts and Bruce Stillman was again
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the highlight of the meetings this year. This year's topic, DNA and Chromosomes,
was chosen not only to recognize the 40th anniversary of the discovery of the
double helix, but also to celebrate the 25th anniversary of Jim Watson's tenure as
Director of the Laboratory. Thirteen additional conferences were held on topics
ranging from Neurobiology of Aplysia to Mechanisms of Eukaryotic Transcription.
The latter meeting and those covering Genome Mapping and Sequencing, RNA
Processing, Retroviruses, and Yeast Cell Biology, as well as the Symposium it-
self, had at least 400 participants each. Many of this year's meetings continue to
be held in alternate years and thus will return in 1995. Others, including the con-
ferences on Retroviruses and Genome Mapping and Sequencing, will be held
again next year. As in past years, support from the Laboratory's Corporate
Sponsor Program and from NIH, NSF, and the Department of Energy was impor-
tant in helping scientists at all levels of their careers to attend the meetings. Con-
tributors to the various meetings are listed in the pages that follow.
While graduate students, postdoctoral fellows, and faculty participate in the
courses and meetings, the Undergraduate Research Program (URP) provides an
opportunity for college undergraduates to spend 10 weeks at the Laboratory dur-
ing the summer. The program, headed by Winship Herr, allows students to do re-
search in the laboratories of staff scientists.
The large numbers of courses and meetings proceed with skill and efficiency,
thanks to the collaborative efforts of a large number of people at the Laboratory.
The staff of the Meetings Office, including Barbara Ward, Micki McBride, Diane
Tighe, Marge Stellabotte, Andrea Stephenson, and Nancy Weeks, coordinates
with both skill and tact the visits of the thousands of scientists who come here to
participate in the meetings and courses. A major change took place this year
with the early retirement of Barbara Ward, the Registrar for the courses and head
of the Meetings Office. Barbara presided over the office as the Academic
gram grew to a large and almost year-round effort and always played a major
part in the many aspects of managing the meetings and courses. David Stewart
joined the Laboratory this year as the new head of the Meetings Office. He
received his Ph.D. from the Institute of Biotechnology, University of Cambridge,
and comes to the Laboratory from Affinity Chromatography, Ltd., where he was a
Senior Scientist. David is the first scientist to head the Meetings Office and will be
exploring an expansion of the Meetings Program. Micki McBride, who has
worked in the Meetings Office for several years, has been promoted to Course
Registrar. The audiovisual staff headed by Herb Parsons manages with great ef-
ficiency and good humor the thousands of slides and projections provided by the
scientists at our meetings. The course instructors have come to depend on the
skills of Cliff Sutkevich and his staff in setting up and maintaining all of the neces-
sary equipment and supplies, as well as those of the Purchasing Office headed
by Sande Chmelev and the new Purchasing Agent in charge of the courses, Edie
Kappenberg. The many grants that support the academic program are ably coor-
dinated by Mary Horton of the Grants Office.
Terri Grodzicker
Assistant Director for Academic Affairs
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58th COLD SPRING HARBOR SYMPOSIUM
ON QUANTITATIVE BIOLOGY
DNA & Chromosomes
June 2-June 9, 1993
ARRANGED BY
Bruce Alberts, University of California, San Francisco
Bruce Stillman, Cold Spring Harbor Laboratory
413 participants
The 1993 Cold Spring Harbor Symposium on Quantitative Biology focused on
DNA and Chromosomes in the 40th year since the discovery by James Watson
and Francis Crick of the double helix of DNA. The central goal of the meeting was
to bring together scientists who work on all aspects of DNA structure and func-
tion, including those working on gene expression and the influence of chromatin
structure on this process. Other topics included chromosomal elements such as
telomeres, centromeres, origins of DNA replication, locus controlling elements,
and position effect elements. Chromosomal phenomena such as silencing, im-
printing, recombination, DNA repair, and transcription were also discussed.
There were a total of 93 invited speakers, 152 posters, and approximately 450
participants, the maximum Cold Spring Harbor Laboratory could accept.
The impact of these studies on understanding human disease was also ap-
parent. Alterations in DNA-repair processes frequently lead to higher rates of
cancer, and the loss of coordination between DNA replication and DNA damage
controls appeared to accelerate the rate of accumulation of genetic damage. For
S. Brenner, J. Watson, F. Jacob
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example, in cells lacking the p53 tumor suppressor protein, DNA amplification is
much more prevalent. New DNA mapping technologies, also
reported at the
meeting, have facilitated mapping of genes associated with
inherited diseases.
New advances in the human genome project were also highlighted at the meet-
ing, including the sequence of chromosome XII from Saccharomyces cerevisiae
and the T-cell receptor locus from humans.
Essential funds to hold such a meeting were provided by the National Cancer
Institute, the National Institute of Child Health and Human
Development, and the
National Institute of General Medical Sciences (all divisions of the National In-
stitutes of Health) and the National Science Foundation and U.S. Dept. of Energy,
Office of Health and Environmental Research. Additional funding came from our
Corporate Sponsors who provide increasingly essential funding: Akzo Pharma In-
ternational B.V., Alafi Capital Company, American Cyanamid Company, Amgen
Inc., Applied Biosystems, Inc., Armstrong Pharmaceuticals-Medeva PLC, BASF
Bioresearch Corporation, Becton Dickinson and Company, Boehringer Mannheim
Corporation, Bristol-Myers Squibb Company, Chugai Pharmaceutical Co., Ltd.,
Diagnostic Products Corporation, The Du Pont Merck Pharmaceutical Company,
Forest Laboratories, Inc., Genentech, Inc., Glaxo, Hoffmann-La Roche Inc.,
Johnson & Johnson, Kyowa Hakko Kogyo Co., Ltd., Life Technologies, Inc., Met-
Path, Millipore Corporation, Monsanto Company, New England BioLabs, Inc., On-
cogene Science, Inc., Pall Corporation, The Perkin-Elmer Corporation, Pfizer Inc.,
Sandoz Research Institute, Schering-Plough Corporation, SmithKline Beecham
Pharmaceuticals, Sterling Winthrop Inc., Sumitomo Pharmaceuticals Co., Ltd.,
Takeda Chemical Industries, Ltd., Toyobo Co., Ltd., The Upjohn Company,
Wyeth-Ayerst Research.
H. Varmus, M. Botchan
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S. Elgin, J. Crall
PROGRAM
Welcoming Remarks: Bruce Stillman
Introduction
Chairperson: B. Alberts, University of California, San Francisco
Chromosome Replication
Chairperson: B. Brewer, University of Washington, Seattle
Silencing and Variegation
Chairperson: S.C.R. Elgin, Washington University
Methylation and Imprinting
Chairperson: R.J. Roberts, New England Biolabs, Beverly, Massachusetts
Chromosome Machinery
Chairperson: E. Blackburn, University of California, San Francisco
Transcription and Chromatin
Chairperson: H. Varmus, University of California, San Francisco
Chromosome Domains
Chairperson: J. Gall, Carnegie Institution, Baltimore
Centromeres, Telomeres, and Replicators
Chairperson: D. Gottschling, University of Chicago, Illinois
DNA and Chromatin Structure
Chairperson: J. Thomas, University of Cambridge, United Kingdom
Chromosome Organization and Stability
Chairperson: R. Kahmann, Universitat Munchen, Germany
Dorcas Cummings Lecture: 'Mapping Genes and Genomes'
Speaker: Eric S. Lander, Whitehead Institute for Biomedical Research
and Massachusetts Institute of Technology, Cambridge
Transcription Activation
Chairperson: T. Maniatis, Harvard University
Recombination and Repair
Chairperson: C. Laird, University of Washington, Seattle
Genome Structure
Chairperson: G. Bernardi, Institut Jacques Monod, Paris, France
Gene Regulation
Chairperson: S.M. Tilghman, Howard Hughes Medical Institute,
and Dept. of Molecular Biology, Princeton University
Nuclear Structure
Chairperson: G. Felsenfeld, NIDDK, National Institutes of Health
Summary: H. Weintraub, Howard Hughes Medical Institute Laboratory,
Fred Hutchinson Cancer Research Center, Seattle, Washington
H. Weintraub, L. Hood
R. Tjian, B. Stillman
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MEETINGS
Neurobiology of Aplysia
April 21-April 25, 1993
ARRANGED BY
Wijnand Geraerts, Vrije Universiteit Amsterdam
Hersch Gerschenfeld, Ecole Norma le Superieure
Philip Haydon, Iowa State University
Leonard Kaczmarek, Yale University Medical School
Eric Kandel, Howard Hughes Medical Institute, Columbia University College of Physicians
& Surgeons
Irwin Levitan, Brandeis University
Richard Scheller, Stanford University
Micha Spira, Hebrew University
Felix Strumwasser, Uniformed Services, University of the Health Sciences
119 participants
The third international meeting on the Neurobiology of Aplysia was held at Cold
Spring Harbor April 21-25, 1993. Since neurobiology of Aplysia is deeply
entwined in the biology of other molluscs, the meeting has been progressively
expanded to include representations from other important molluscan prepara-
tions such as the squid, Heliosoma, Hermissenda, and various land snails.
Aplysia and related molluscs represent a distinctive niche in the cellular biologi-
cal study of the nervous system, especially the molecular mechanisms of synap-
tic transmission, synaptic plasticity, the neural circuitry of behavior, and the modi-
fication of behavior by learning. This is due to the fact that the nerve cells of
L. Kaczmaret, G. Augustine, R. Scheller
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these animals are large and identifiable and can be readily cultured, and their
synapses can be visualized. As a result, a variety of imaging
techniques make it
possible to study the distribution of calcium influx or cAMP within specific
neurons and even regions of neurons in a way that is not possible in other sys-
tems.
This meeting was funded in part by the National Institute of Neurological Dis-
orders and Stroke, a division of the National Institutes of Health.
T. Carew, E. Kandel
PROGRAM
J. Kehoe, S. Siegelbaum
Opening Remarks: Mechanisms of Exocytosis in the Squid Giant Synapse
Richard Scheller, Stanford University
George Augustine, Duke University
Molecular Imaging Approaches to Synapse Development and Function
Chairperson: H. Gerschenfeld, Ecole Norma le Superieure
Ion Channels and Their Modulation
Chairperson: M. Spira, Hebrew University
The Expression and Processing of Peptides
Chairperson: Philip Haydon, Iowa State University
Peptides and Behavior
Chairperson: W.P. Geraerts, Vrije Universiteit Amsterdam
Rhythms and Behavior
Chairperson: L. Kaczmarek, Yale University Medical School
Learning and Short-term Memory
Chairperson: T.J. Carew, Yale University
Learning and Long-term Memory
Chairperson: R. Scheller, Stanford University
Closing Remarks: L. Kaczmarek, Yale University Medical School
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The Cytoskeleton and Cell Function
April 28-May 2, 1993
ARRANGED BY
Elizabeth Raff, Indiana University
David Helfman, Cold Spring Harbor Laboratory
275 participants
The 1993 meeting on The Cytoskeleton and Cell Function covered all aspects of
the cytoskeleton, including actin filaments, intermediate filaments, and micro-
tubules. Talks focused on the function of the cytoskeleton in various biological
processes, including development and differentiation, pathological aspects of
contractile and cytoskeletal systems, cell communication, intracellular trafficking
and organelle movement, and cell shape and morphogenesis. The fundamental
importance of the cytoskeleton in cellular functions rendered the subject of the
conference of interest to investigators from a wide number of disciplines includ-
ing cell biologists, biochemists, molecular biologists, and developmental
biologists. A broad range of experimental systems were discussed including
yeast, Dictyostelium, flies, and vertebrates. A major theme of the meeting was the
increasing use in cell biology of multidisciplinary approaches including powerful
genetic and molecular tools. Another meeting on the cytoskeleton is scheduled
for 1995.
This meeting was funded by contributions from the CSHL Corporate Sponsors
Program, The March of Dimes Birth Defects Foundation, The U.S. Army Research
Office, Pierce Chemical Company, and The Council for Tobacco Research.
D. Helfman, E. Raff
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M. Way, J.V. Small
PROGRAM
Actin Filament Assembly and Dynamics
Chairperson: P. Matsudaira, Massachusetts Institute of Technology
Cell Movement
Chairperson: S. Zigmond, University of Pennsylvania
Microtubule Assembly and Dynamics
Chairperson: D. Cleveland, Johns Hopkins University
Cell Division
Chairperson: R. McIntosh, University of Colorado
Intermediate Filaments
Chairperson: E. Fuchs, University of Chicago
Molecular Motors: Intracellular Trafficking
Chairperson: M. Mooseker, Yale University
Signal Transduction: Membrane-cytoskeleton Interactions
Chairperson: B. Geiger, Weizmann Institute
The Role of the Cytoskeleton in Development and Differentiation
Chairperson: E. Raff, Indiana University
Closing Remarks: David Helfman, Cold Spring Harbor Laboratory
W. Franke, J. Vandekerckhove
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Regulation of Liver Gene Expression in Health and Disease
May 5-May 9, 1993
ARRANGED BY
Savio Woo, Baylor College of Medicine
Moshe Yaniv, Institut Pasteur
Robert Costa, University of Illinois
Barbara Knowles, The Wistar Institute
264 participants
The Regulation of Liver Gene Expression in Health and Disease meeting was
devoted to various aspects of regulation of hepatic gene expression, liver devel-
opment, and hepatic gene therapy. It was the fourth bi-annual international meet-
ing in a series focused on the liver, which is the major organ that controls many
metabolic processes and homeostasis under normal physiological state. The
meeting attracted 264 scientists from Europe, Asia, and North America who are
investigating various aspects of the cellular, molecular, and developmental biol-
ogy of the liver in health and disease. It had three main themes: (1) liver gene ex-
pression and regulation; (2) liver architecture, cellular growth, and differentiation;
and (3) liver diseases and gene therapy, including an update on the clinical trial
for familial hypercholesterolemia by hepatic gene therapy.
This meeting was funded in part by the National Institute of Diabetes and Di-
gestive and Kidney Diseases, a division of the National Institutes of Health,
Boehringer Mannheim Corporation, Miles Inc., Pharmacia Biotech Inc., Amgen
Inc., and Clontech Laboratories Inc.
PROGRAM
Liver-specific Gene Expression and Regulation
Chairperson: M. Yaniv, Institut Pasteur
Keynote Address: Regulation of Eukaryotic Transcription-General Factors, Activators, and
Co-Factors
R.G. Roeder, Rockefeller University, New York
R. Costa, S. Woo, B. Knowles, M. Yaniv
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M. Tomomura, A. Ichihara, S. Woo, H. Isom, N. Fausto, L. Reid
Genetic Control of Hepatic Gene Expression
Chairperson: M.C. Weiss, Institut Pasteur
Viral Hepatitis, Chirrosis, and Hepatocellular Carcinoma
Chairperson: B. Knowles, Wistar Institute
Temporal Regulation of Liver Gene Expression by Hormones and Cytokines
Chairperson: R.H. Costa, University of Illinois College of Medicine
Differentiation and Embryonic Development
Chairperson: K. Zaret, Brown University
Liver Regeneration and Growth Control
Chairperson: G.J. Darlington, Baylor College of Medicine
Cell Biology, Extracellular Matrix and Gene Expression
Chairperson: J.E. Darnell, Jr., Rockefeller University
Gene Therapy
Chairperson: S.L.C. Woo, Howard Hughes Medical Institute, Baylor College of Medicine
Overview of Hepatic Gene Therapy
S.L.C. Woo, Howard Hughes Medical Institute, Baylor College of Medicine
Update of Clinical Trials for Familial Hypercholesterolemia
J.M. Wilson, Institute for Human Gene Therapy, University of Pennsylvania and the Wistar
Institute, Philadelphia
N. Marceau, G. Brownlee, N. Bucher, S. Woo
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Genome Mapping and Sequencing
May 12-May 16, 1993
ARRANGED BY
Richard Myers, Stanford University
David Porteous, MRC, Western General Hospital, United Kingdom
Robert Waterston, Washington University
408 participants
The sixth annual Cold Spring Harbor Genome Mapping and Sequencing meeting
was held between May 12th and 16th. Attended by some 400 participants, drawn
largely from the United States, but with a strong showing from Europe and else-
where, the 300 abstracts provided a rich and lively forum for discussion of recent
advances and outstanding problems in the field. Sessions covered such topics
as recent advances in identifying and studying human disease genes, large-
scale physical mapping of genomes, meiotic mapping, megabase DNA se-
quencing, and cDNA clone isolation and mapping. In addition, there was a heavy
representation of new technologies for mapping and sequencing, as well as an
exciting session on how best to handle and interpret the wealth of new DNA se-
quence information and the complexity of data being generated by meiotic and
physical mapping efforts. This year, more than ever, the meeting highlighted the
vast contributions that studies of the genomes of "model organisms,' including
bacteria, yeast, worms, flies, and mice, have made to the rapid advances in
biological knowledge, genome structure, and technologies for sequencing and
mapping.
This meeting was funded in part by the National Center for Human Genome
Research, a branch of the National Institutes of Health.
D. Porteous, R. Myers, R. Waterston
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J. Weissenbach, S. Foote
PROGRAM
Human Diseases
Chairperson: D.R. Cox, Stanford University
Model Organisms
Chairperson: R. Rothstein, Columbia University
Sequencing Methods
Chairperson: G. Rubin, University of California, Berkeley
Informatics
Chairperson: R. Waterston, Washington University School of Medicine
Mapping Methods
Chairperson: B. Trask, University of Washington
cDNA Mapping and Other Methods
Chairperson: E. Green, Washington University Medical School
Large Maps
Chairpersons: R.M. Myers, Stanford University
D.J. Porteous, MRC Human Genetics Unit, Edinburgh, United Kingdom
L. Stuve, R. Gould, M. Polymerupoulos, V. Smith
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RNA Processing
May 19-May 23, 1993
ARRANGED BY
Adrian Krainer, Cold Spring Harbor Laboratory
Reinhard Lahrmann, Philipps-Universitat Marburg
Hugh Robertson, Cornell University Medical College
Jo Ann Wise, University of Illinois
470 participants
The 1993 RNA Processing meeting was oversubscribed, continuing the trend of
the past several years, and thus attendance had to be limited. There were 100
talks and 265 poster presentations, reporting exciting developments in several
areas. Of greatest potential for the field as a whole was the optimization of meth-
ods to obtain crystals of large RNA molecules, such as ribozymes, that diffract to
high resolution. Insights on ribozyme higher-order structure have been obtained
by cross-linking studies and by melting studies on ribozyme-substrate com-
plexes.
A complex network of dynamic RNA-RNA, RNA-protein, and protein-protein
interactions within the spliceosome has been studied in increasing detail. In par-
ticular, mutational studies of U6 snRNA have implicated the U6 snRNP in defini-
tion of the 5' splice site and in positioning this site near the catalytic center of the
spliceosome. Subunit interactions in a heterotrimeric U2 snRNP-associated es-
sential splicing factor were shown to be conserved between yeast and mammals.
The RS domains present in several splicing factors and alternative splicing
regulators were implicated in protein-protein interactions.
Studies of the cleavage and polyadenylation specificity factor showed that
this factor recognizes not only the AAUAAA element, but also adjacent context
sequences. Poly(A) polymerases from several species and their interactions with
other 3 ' -end-processing components were analyzed. Feedback regulation of U1
snRNP A protein expression was shown to be achieved by U1-A binding to the
3' -UTR of its own pre-mRNA and interacting with poly(A) polymerase to inhibit
polyadenylation. An apparent sequence of mRNA decay was defined, in which
deadenylation leads to cleavage near the 5' cap, which in turn leads to 5' to 3'
J. Steitz, A. Krainer
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W. Keller, R. Hallick
exonucleolytic degradation. The basis for the nuclear retention of U6 snRNA was
defined, and members of the yeast ras superfamily were implicated in mRNA ex-
port.
Selection and amplification approaches were employed to design new
ribozymes, to identify specific targets for RNA-binding proteins, and to identify
RNA sequences with affinity for small ligands. Small molecules that disrupt
ribozyme function or specific protein-RNA interactions were reported. New
protein motifs capable of binding RNA were also identified.
This meeting was funded in part by the National Science Foundation and the
National Institute of General Medical Sciences, a branch of the National Institutes
of Health.
PROGRAM
Regulation of mRNA Splicing
Chairperson: D.C. Rio, University of California, Berkeley
Ribozymes
Chairperson: J.M. Burke, University of Vermont, Burlington
Mechanisms of mRNA Splicing
Chairperson: T.W. Nilsen, Case Western Reserve University School of Medicine
3' End Processing and RNA Transport
Chairperson: W. Keller, University of Basel, Switzerland
Ribonucleoprotein Particles
Chairperson: J. Beggs, University of Edinburgh, United Kingdom
RNA Editing, Modification and Turnover
Chairperson: B.L. Bass, University of Utah
Nuclear Architecture, RNA-Protein Interactions, and RNA Structure
Chairperson: J.D. Keene, Duke University Medical Center
A. Lambowitz, J. Keene, N. Pace
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Retroviruses
May 25-May 30, 1993
ARRANGED BY
Stephen Hughes, ABL-Basic Research Program, Frederick Cancer Research Facility, NCI
Ron Swanstrom, University of North Carolina, Chapel Hill
445 participants
This year, the title of the meeting was changed from "RNA Tumor Viruses" to
"Retroviruses." This change of title reflects a significant change in the content of
the meeting and in the field itself. About ten to 15 years ago, a major focus of the
meeting was oncogenes and the role of retroviruses in oncogenesis. Today, the
primary focus of oncogene research is not in retroviruses. There are now sepa-
rate meetings for investigators whose primary interest is oncogenes. The dis-
covery of pathogenic human retroviruses has shifted our attention from the inter-
action of retroviruses and oncogenes to other disease mechanisms involving
retroviruses, including AIDS.
Rather than try to single out particular accomplishments, it is probably more
appropriate to point to the progress that has been made in the past 10 years in
understanding pathogenic human viruses. We do not yet have cures for retroviral
diseases; however, we have a broad and solid foundation on which to build. It is
also important to say that these 10 years of progress rests on the foundation pro-
vided by previous and ongoing work in animal retroviruses. It is therefore entirely
fitting that the Cold Spring Harbor meeting, once "RNA Tumor Viruses" now
"Retroviruses', is the focus of the interchange of information between human
retrovirus research and research in animal retroviruses, intimately related topics
that are all too often treated as separate fields.
Contributions from Corporate Sponsors provided core support for this meet-
ing.
R. Swanstrom, S. Hughes
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PROGRAM
Phylogeny and Receptors
Chairpersons: M. Sitbon, Institut Cochin de Genetique
Moleculaire, Paris, France
N. Rosenberg, Tufts University School of Medicine
env
Chairpersons: J. Overbaugh, University of Washington
G. Franchini, National Cancer Institute, Bethesda
gag
Chairpersons: A. Rein, NCI-Frederick Cancer Research Facility
S.P. Goff, Columbia University
Protease
Chairperson: H.-G. Krausslich, German Cancer
Research Center, Heidelberg, Germany
Reverse Transcription
Chairpersons: S.B. Sandmeyer, University of California, Irvine
M. Roth, University of Medicine and Dentistry of New Jersey/Robert Wood
Johnson Medical School
Integration
Chairpersons: J. Coffin, Tufts University School of Medicine
D. Grandgenett, St. Louis University Medical Center
Vectors/Mutation/Recombination
Chairperson: M. Linial, Fred Hutchinson Cancer Research Center
Pathology
Chairpersons: K. Radke, University of California, Davis
L. Ratner, Washington University School of Medicine
Tat/Rev
Chairpersons: N. Hernandez, Cold Spring Harbor Laboratory
A.I. Dayton, N/AID, National Institutes of Health
RNA
C.M. University of Iowa, Iowa City
Transcription
Chairpersons: J. Lenz, Albert Einstein College of Medicine
J. Dudley, University of Texas, Austin
Nontranscriptional Regulation
Chairpersons: A. Rabson, Center for Advanced Biotechnology and Medicine and
University of Medicine and Dentistry of New Jersey-Robert Wood Johnson
Medical School
F. Clavel, Institut Pasteur, Paris, France
F. Clavel
M. Linial, J. Overbaugh
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Yeast Cell Biology
August 17-August 22, 1993
ARRANGED BY
Trisha Davis, University of Washington
Michael Douglas, University of North Carolina, Chapel Hill
Mark Rose, Princeton University
392 participants
The conference on Yeast Cell Biology was the fourth bi-annual international meet-
ing devoted to major aspects of cell biology in yeast. Topics included the struc-
ture and function of the cytoskeleton, structure and biogenesis of organelles,
secretion, endocytosis, and protein targeting. Recent advances in studying the
cell cycle, signaling pathways, and developmental pathways were also de-
scribed. More than 400 scientists attended; 287 abstracts were presented includ-
ing 109 talks and 178 posters.
This meeting was funded in part by Labatt Breweries of Canada and
Anheuser-Busch Companies, Inc.
PROGRAM
Cell Polarity and the Actin Cytoskeleton
Chairperson: J. Pringle, University of North Carolina, Chapel Hill
Developmental Pathways and Mating
Chairperson: S. Michaelis, Johns Hopkins University School of Medicine
M. Rose, T. Davis
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R. Wright, M. Jaffe, T. Davis
Spindle Function and Microtubules
Chairperson: C. Holm, Harvard University
Cell Cycle
Chairperson: D. Botstein, Stanford University School of Medicine
Methodology
Chairperson: J. Cooper, Washington University, St. Louis
Calmodulin, Ion Pumps and Cyclophilins
Chairperson: E.W. Jones, Carnegie Mellon University
Secretion
Chairperson: T. Stevens, University of Oregon, Eugene
Endocytosis, Protein Retention, and Sorting
Chairperson: R. Fuller, Stanford University School of Medicine
Nuclear Structure, Targeting, and Telomeres
Chairperson: M. Yaffe, University of California, San Diego
Organelle Biogenesis
Chairperson: R. Butow, University of Texas Southwestern Medical Center
Signaling
Chairperson: J. Thorner, University of California, Berkeley
D. Botstein, S. El ledge, M. Austin
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Molecular Genetics of Bacteria and Phages
August 24-August 29, 1993
ARRANGED BY
Susan Gottesman, National Cancer Institute, National Institutes of Health
Peter Model, Rockefeller University
Jeffrey Roberts, Cornell University
194 participants
Attendance of the phage meeting stayed strong in 1993: 194 participants sub-
mitted 156 abstracts, gave 102 talks in 10 sessions, and explained 54 posters.
The usual abundance of foreign scientists included a Russian whose travel was
sponsored by International Science Foundation. The meeting was dedicated to
the memory of Hatch Echols, and one session contained reminiscences and
scientific talks from his family, students, and colleagues.
Some especially exciting reports described a novel mechanism of transcrip-
tion antitermination regulated through direct tRNA-mRNA interaction, character-
ized a new cell-surface sorting signal and mechanism in S. aureus, and present-
ed a remarkable technique for visualizing RNA polymerase sliding-and oc-
casionally jumping-along a single DNA molecule. Other presentations detailed
the role of DNA in transcriptional activation mediated by CRP protein and the a
subunit of RNA polymerase and reported the identification of an excreted peptide
in B. subtillis that regulates competence for DNA uptake by sensing cell density.
An unexpected discovery-that mutation of thioredoxin reductase allows in-
tracellular disulfide bond formation- has important implications for expressing
active, disulfide-containing foreign proteins in E. coll.
The meeting served to emphasize the continued value of bacteria in provid-
ing an increasingly complete description of basic mechanisms of cell physiology,
gene regulation, recombination, replication, and protein secretion.
This meeting will be held in Wisconsin in 1994, and the attendees look for-
ward to its return to Cold Spring Harbor in 1995 to celebrate the 50th anniversary
of the Cold Spring Harbor phage course.
Contributions from Corporate Sponsors provided core support for this meet-
ing.
L. Silver, M. Russel, P. Model
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J. Roth, N. Craig
PROGRAM
RNA Polymerase and Promoter Recognition
Chairperson: C.A. Gross, University of Wisconsin, Madison
Transcriptional Regulation: Regulatory Strategies
Chairperson: T.J. Silhavy, Princeton University
Remembrance of Hatch Echols/Mechanisms of Transcription
Chairperson: S. Adhya, National Cancer Institute, National Institutes of Health
Transcription Elongation, Termination, and Antitermination
Chairperson: C. L. Squires, Columbia University
Recombination and Transposition
Chairperson: N. Kleckner, Harvard University
Life Stories of Phage
Chairperson: M.M. Susskind, University of Southern California, Los Angeles
Structure and Folding
Chairperson: S. Wickner, National Cancer Institute, National Institutes of Health
Trans location/Replication
Chairperson: J. Beckwith, Harvard Medical School
Cell Surfaces and Transport
Chairperson: D. Dubnau, Public Health Research Institute, New York
Translation and Posttranslation Events
Chairperson: M. Springer, Institut de Biologie Physico-Chimique, Paris, France
S. Adhya
E. Witkin, J. Heimann
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Mechanisms of Eukaryotic Transcription
September 1-September 5, 1993
ARRANGED BY
Winship Herr, Cold Spring Harbor Laboratory
Robert Tjian, University of California, Berkeley
Keith Yamamoto, University of California, San Francisco
447 participants
The 1993 Cancer Cells meeting, Mechanisms of Eukaryotic Transcription, was
the third biennial meeting devoted to mechanisms of transcriptional regulation in
eukaryotes. It brought together scientists from all over the world that are best
characterized by their diversity. They study organisms as diverse as yeast and
humans and use biochemical, genetic, and cell biological approaches. Major ad-
vances in our understanding of how transcription is regulated were described, in-
cluding the description of a startling DNA conformation induced by the TATA-
box-binding protein TBP; a plethora of TBP-containing multiprotein complexes at
least one of which is targeted to a non-TATA-box regulatory element; the associa-
tion of TBP and RNA polymerase II in a large multisubunit holoenzyme that partic-
ipates in transcription initiation; and connections between proteins involved in
transcription and in DNA repair, DNA replication, and control of the cell cycle.
The meeting was elegantly summarized by Richard Losick, who brought the
diverse aspects of the meeting into coherent themes.
This meeting was funded in part by the National Institute of General Medical
Sciences, the National Institute of Child Health and Human Development, and the
National Cancer Institute, all branches of the National Institutes of Health; and the
National Science Foundation.
W. Dynan, K. Yamamoto
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I. Grummt, A. Sentenac
PROGRAM
TBP, TAFs, and Cofactors
Chairperson: C.A. Gross, University of Wisconsin, Madison
Basal Factors and RNA Polymerases
Chairperson: A. Sentenac, Centre d'Etudes de Sac lay, France
Activation
Chairperson: D. Reinberg, Robert Wood Johnson Medical School, University of
Medicine and Dentistry of New Jersey
Repression
Chairperson: A.D. Johnson, University of California, San Francisco
Structure and Function of Transcription Factors
Chairperson: C. Wu, National Cancer Institute, National Institutes of Health
Regulation of Transcription Factor Activity
Chairperson: S. Kustu, University of California, Berkeley
Chromatin Function and Regulation
Chairperson: M. Grunstein, University of California, Los Angeles
Factor/Factor Interplay
Chairperson: C. Prives, Columbia University, New York
Summary: R. Losick, Harvard University
R. Roeder, D. Reinberg
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D. Buhmann, R. Tjian
Eukaryotic DNA Replication
September 8-September 12, 1993
ARRANGED BY
Thomas Kelly, Johns Hopkins University
Bruce Stillman, Cold Spring Harbor Laboratory
317 participants
This year was the fourth bi-annual meeting on Eukaryotic DNA Replication that
brought together investigators who work on all aspects of the replication of the
genetic material from eukaryotes. As in past years, this meeting was an ex-
traordinarily productive gathering of most of the scientists throughout the world
interested in the replication of DNA in eukaryotes. Sessions included studies on
the replication of viruses that infect mammalian cells, and this year saw a very
strong program that included studies on the replication of the cells' chromosomal
DNA, including the proteins that replicate DNA. Other work discussed included
the identification of the elements in the chromosomes that are responsible for
maintaining chromosomal integrity, including replication origins and telomeres.
For the first time this year, the program also included research on DNA-repair,
which has now become intimately tied in with the understanding of the replication
of DNA due to the fact that many proteins are common to both processes of
replication and repair. At the meeting, there were 234 abstracts and a total of 317
participants.
This meeting was funded in part by the National Institutes of General Medical
Sciences, the National Institute of Child Health and Human Development and the
National Cancer Institute, all branches of the National Institutes of Health, as well
as funding from the National Science Foundation.
D. Clayton, B. Stillman, C. Greider
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W. Fangman, E. Fanning, B. Brewer
PROGRAM
Virus DNA Replication I
Chairperson: M.D. Challberg, National Institutes of Health
Chromosomal DNA Replication
Chairperson: B.K. Tye, Cornell University
Regulation of DNA Replication
Chairperson: C. Greider, Cold Spring Harbor Laboratory
Replication Proteins
Chairperson: D. Clayton, Stanford University School of Medicine
Origins of DNA Replication
Chairperson: T. Wang, Stanford University School of Medicine
DNA Repair/Telomeres
Chairperson: M. O'Donnell, Cornell University Medical College
The Replication Fork
Chairperson: T. Formosa, University of Utah School of Medicine
Virus DNA Replication II
Chairperson: E. Fanning, Institat fOr Biochemie der Universitat Miinchen, Germany
T. Formosa, J. Scott, D. Ray
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Modern Approaches to New Vaccines Including Prevention of AIDS
September 20-September 24, 1993
ARRANGED BY
Fred Brown, USDA, Plum Island Animal Disease Center
Robert Chanock, NIAID, National Institutes of Health
Harold S. Ginsberg, Columbia University College of Physicians & Surgeons
Er ling Norrby, Karolinska Institute
163 participants
The eleventh annual meeting on Modern Approaches to New Vaccines Including
Prevention of AIDS, like its predecessors, provided a forum for the discussion of
several advances in immunoprophylaxis. Of particular importance was the intro-
duction of several keynote speakers to address the issues involved in vaccination
against bacterial and parasitic diseases, areas that are frequently neglected.
The meeting in 1992 had included some papers on immunization by direct in-
oculation of the DNA coding for protective protein antigens. Sufficient expression
of the proteins had been obtained to afford protection against challenge infec-
tion. The increased activity in this approach to immunization in the interim re-
quired that an entire session was needed for its discussion at this year's meeting.
Clearly, much remains to be worked out, not least the efficiency of the method
compared with the more conventional approach. Nevertheless, the new ap-
proach is both exciting and fascinating.
A fundamental requirement in vaccination is the need to identify the immune
that afford protection against natural infection. These are not the same
for all diseases, but it is recognized that most infections take place via mucosal
surfaces. Consequently, it is gratifying that methods to achieve mucosal immunity
are being vigorously pursued and were described in several papers.
H. Ginsberg, E. Norrby, F. Brown
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R. Chanock
A. Austrian, J.B. Robbins, P.F. Spar ling, J.T. Poolman
The meeting continues to attract many contributions on vaccination against
AIDS. This task is beset with major problems such as antigenic variation and in-
tegration of the viral genome into the host cell. Nevertheless, an understanding of
the requirements for successful vaccination is gradually being reached.
Contributions from the Corporate Sponsors provided core support and in ad-
dition a generous gift from Leder le-Praxis and Pharmacia LKB Biotechnology al-
lowed the organizers to invite several keynote speakers.
PROGRAM
AIDS I: HIV-Vaccine
Chairperson: H. Ginsberg, Columbia University College of Physicians & Surgeons
Bacteriology Symposium I
Chairperson: R. Austrian, University of Pennsylvania School of Medicine, Philadelphia
Virology I
Chairperson: F. Brown, USDA Plum Island Animal Disease Center
Gene Vaccination
Chairperson. R. Chanock, NIAID, National Institutes of Health
AIDS II: SIV
Chairperson: P. Nara, National Cancer Institute, National Institutes of Health
Bacteriology and Parasitology II
Chairperson: J. Robbins, National Institute of Child Health and Human Development, Na-
tional Institutes of Health
Immunology
Chairperson: J. Berzofsky, National Cancer Institute, National Institutes of Health
Virology II
Chairperson: A. R. Neurath, Lindsley F. Kimball Research Institute, New York Blood Center,
New York
AIDS III: HIV-Pathogenesis and Immunology
Chairperson: E. Norrby, Karolinska Institute Stockholm, Sweden
Summary: E. Norrby, Karolinska Institute
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J. Berzofsky
Molecular and Cellular Biology of Plasminogen Activation
September 28-October 3, 1993
ARRANGED BY
Francesco Blasi, Dipartimento di Genetica, University di Milano, and DIBIT, H.S. Raffaele,
Milan, Italy
Keld Dano, Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark
James Quigley, State University of New York School of Medicine, Stony Brook
Daniel Rifkin, New York University School of Medicine, New York
Sidney Strickland, State University of New York School of Medicine, Stony Brook
227 participants
The fourth international meeting on the Molecular and Cellular Biology of Plas-
minogen Activation was held at Cold Spring Harbor Laboratory September 28,
1993; 227 people from Europe, North America, and Asia attended this meeting.
The varied functions of this enzymatic system in both normal and pathological
processes ranging from clot lysis to neural development were consideered. The
span of presentations went from physical-chemical analysis of structure to
phenotypic analysis of 'knock out mice for urokinase and tissue-type plas-
minogen activators. The primary foci of the presentations were (1) regulation of
plasminogen activation, (2) role of plasminogen activation in normal cellular and
tissue physiology, and (3) role of plasminogen activation in disease states.
This meeting was funded in part by American Diagnostica Inc.; National In-
stitutes of Health, National Institute of Child Health and Human Development;
Boehringer Mannheim Italia; Boehringer Mannheim GMBH; Miles Inc. Phar-
maceutical Division; Abbott Laboratories Pharmaceutical Products Division; and
the Genetics Institute.
K. Karito, D. Be lin, H. Chapman
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PROGRAM
Urokinase Receptor: Structure/Function
Chairpersons: E. Reich, State University of New York, Stony Brook
G.S. Lazarus, University of Pennsylvania, Philadelphia
Plasminogen Activator Inhibitors
Chairpersons: R. Miskin, Weizmann Institute of Science, Israel
D.C. Rijken, Gaubius Laboratory, The Netherlands
Cancer
Chairpersons: P. Verde, International Institute of Genetics and Biophysics, CNR, Naples,
Italy
T.D. Gelehrter, University of Michigan, Ann Arbor
Mechanisms of Regulation: Promoters
Chairpersons: D.B. Rifkin, New York University Medical Center
R.L. Medcalf, Central Hematology Laboratory, Lausanne, Switzerland
Proteolytic Cascades: Other Reactions
Chairpersons: M. Ploug, Finsen Laboratory, State University Hospital, Copenhagen,
Denmark
W.-D. Schleuning, Schering Research Laboratories, Berlin, Germany
Mechanisms of Internalization of PA and PA Inhibitors
Chairpersons: D.J. Loskutoff, Scripps Research Institute
K. Dane, Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark
Plasminogen Activator in Nontumor Systems
Chairpersons: J.P. Quigley, State University of New York, Stony Brook
E.L. Wilson, New York University Medical Center
Plasminogen Activator in Other Diseases
Chairpersons: F. Blasi, University of Milan, Italy, DIBIT, H.S. Raffaele, and
University of Copenhagen, Denmark
T. Ny, Umea University, Sweden
Transgenic Mice as Genetic Systems for PA Studies
Chairpersons: A. Vaheri, University of Helsinki, Finland
M. Johnsen, University of Copenhagen, Denmark
Transgenics (Continued)
Chairpersons: A. Vaheri, University of Helsinki, Finland
M. Johnsen, University of Copenhagen, Denmark
Discussion: Points of Contention
Chairpersons: D. Belin, University of Geneva Medical School, Switzerland
L. Ossowski, Mount Sinai School of Medicine, New York
Structural Studies
Chairpersons: S. Strickland, State University of New York, Stony Brook
J. Henkin, Abbott Laboratories, Illinois
R. Medcalf, D. Loskutoff
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M. Ploug
Neurobiology of Drosophila
October 6-October 10, 1993
ARRANGED BY
Ronald Davis, Cold Spring Harbor Laboratory
Larry Zipursky, University of California, Los Angeles
270 participants
The fifth meeting of the Neurobiology of Drosophila attracted some 270
participants from the United States, Europe, and Asia. A wide range of topics
were covered in the areas of development, neural function, and behavior. There
were seven formal lecture sessions and three excellent poster sessions. Whereas
in previous meetings, the rapid progress in dissecting developmental processes
and the isolation and characterization of ion chemicals dominated the highlights,
this year was noteworthy with exciting progress reported on the molecular and
genetic dissection of synaptic transmission. The convergence of these studies
with secretion in yeast and mammalian systems is a very important development
in the field. This year marked the occasion of the 2nd Elkins Lecture to honor an
outstanding Ph.D. thesis in the Neurobiology of Drosophila. This year's speaker
was Dr. Ilaria Rebay who described her studies on the Notch protein completed
in Dr. Spyro Artavanis-Tsakonas' laboratory at Yale University.
This meeting was funded in part by the National Science Foundation and the
National Institute of Neurological Disorders and Stroke, a branch of the National
Institutes of Health.
L. Zipursky, C. Goodman, P. Taghert, R. Davis, T. Schwartz
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J. Posakony
PROGRAM
Introductory Comments
Neurogenesis
Chairperson: J. Posakony, University of California, San Diego
Axon Guidance, Connectivity, and Synaptogenesis
Chairperson: C.S. Goodman, Howard Hughes Medical Institute and University of
California, Berkeley
Neurotransmitter Function, Metabolism, and Receptors
Chairperson: P.H. Taghert, Washington University Medical School, St. Louis, Missouri
Elkins Lecture
Excitability and Synaptic Transmission
Chairperson: T.L. Schwarz, Stanford University Medical Center
Sensory System Development
Chairperson: E. Hafen, Zoologisches Institut, Universitat Zurich, Switzerland
Sight, Smell, and Touch
Chairperson: J. O'Tousa, University of Notre Dame
Brain Structure and Behavior
Chairperson: M. Heisenberg, Lehrstuhl kir Genetik, Theodor-Boveri-lnstitut, Wurzburg,
Germany
L. Zipursky, C. Goodman
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POSTGRADUATE COURSES
The summer program of Postgraduate Courses at Cold Spring Harbor Laboratory
is aimed at meeting the special need for training in interdisciplinary subjects that
are either so new or so specialized that they are not adequately treated by uni-
versities. Our aim is to provide intensive study in the most recent developments
and techniques in these subjects and to prepare students to enter directly into
research in a particular area. To ensure up-to-date coverage of current research
work, we bring together a workshop staff from many laboratories around the
world and supplement this staff with a series of seminar speakers.
Construction and Analysis of Two-Dimensional Gel
Protein Databases
April 13-April 20
INSTRUCTORS
Franza Jr., B. Robert, Ph.D., Cold Spring Harbor Laboratory
Garrels, James I., Ph.D., Cold Spring Harbor Laboratory
Latter, Gerald I., Ph.D., Cold Spring Harbor Laboratory
Patterson, Scott D., Ph.D., Cold Spring Harbor Laboratory
This course presented the practical aspects of constructing and analyzing a
protein database through quantitative analysis of two-dimensional gels. The in-
structors lectured on methods of two-dimensional gel electrophoresis, strategies
and methodologies for database construction, analysis of protein databases, and
methods for characterization and identification of proteins in two-dimensional
gels. In the hands-on part of the course, students built and analyzed a protein
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database from existing two-dimensional gel images using the Quest II software.
Topics in database construction included data acquisition, protein quantitation,
and matching of proteins across sets of gels. Topics in database analysis in-
cluded retrieval of quantitative data, searches for common expression profiles,
and analysis to determine relatedness of protein samples. Guest speakers and
instructors covered applications in cell regulation, medical applications, protein
identifications in two-dimensional gels, and connections to genome sequencing
projects. This course was intended for those who have prior experience with two-
dimensional gels.
PARTICIPANTS
Amess, R., Ph.D., University of Oxford, England
Corbett, J., B.A., Harefield Hospital, Harefield, England
Dean, D., M.S., Pfizer Central Research, Groton, Con-
necticut
Kanitz, M., Ph.D., National Institute for Occupational Safety
and Health, Cincinnati, Ohio
Madden, B., Ph.D., University College, Dublin, Ireland
SEMINARS
Aebersold, R., University of British Columbia. Protein isola-
tion and microanalysis at the primary structure level.
Celis, J., University of Aarhus. Comprehensive two-
dimensional gel protein databases and cDNA cloning;
toward linking protein and DNA information.
Hanash, S., University of Michigan. Lymphoid protein data-
base.
Hochstrasser, D., University Hospital Geneva. Clinical ap-
Martzen, M., Ph.D., University of Rochester, New York
Pleissner, K.-P., Ph.D., Deutsches Herzzentrum, Berlin,
Germany
Smith, D., Ph.D., University of California, San Francisco
Tanzer, L., B.S., Lilly Research Laboratories, Indianapolis,
Indiana
Volker, U., Ph.D., University Greifswald, Germany
plications of 2D-PAGE.
Latham, K., Temple University. Construction and applica-
tions of a mouse embryo database.
McLaughlin, C., University of California, Irvine. Construction
of the yeast database.
Van Bogelen, R., Parke Davis Pharmaceutical Research.
The gene-protein database of E. coll.
Cloning and Analysis of Large DNA Molecules
April 13-April 26
INSTRUCTORS
Abderrahim, Nadi, M.D., Ph.D., Cell Genesys, Inc., Foster City, California
Birren, Bruce, Ph.D., California Institute of Technology, Pasadena
Klapholz, Sue, M.D., Ph.D., Cell Genesys, Inc., Foster City, California
Vollrath, Doug, M.D., Ph.D., Whitehead Institute, Cambridge, Massachusetts
ASSISTANTS
Mendez, Michael, Cell Genesys, Inc., Foster City, California
Van Bokklen, Gil, Stanford University, California
Wang, David, California Institute of Technology, Pasadena
This course covered the theory and practice of manipulating and cloning high-
molecular-weight DNA. The course focused on the use of yeast artificial
chromosome (YAC), bacterial artificial chromosome (BAC), and bacteriophage
P1 cloning systems for library construction and techniques of pulsed-field gel
electrophoresis (PFGE). Lectures and laboratory work included an introduction to
yeast genetics, the isolation and manipulation of high-molecular-weight DNA from
a variety of sources, and preparative and analytical PFGE. YAC, BAC, and P1
clones were produced and characterized by a number of approaches, including
hybridization, recovery of YAC ends, physical mapping, and PCR-based meth-
ods. A variety of size standards for PFGE were prepared, and their separations
on many different types of PFGE gel boxes were compared. Lectures byoutside
speakers on topics of current interest supplemented the laboratory work.
PARTICIPANTS
Baez-Camargo, M., B.S., Cinvestav-IPN, Mexico City, Mexico
Chen, H., Ph.D., Harvard Medical School, Boston, Massa-
chusetts
Dewar, K., M.S., University Laval, Ste-Foy, Canada
Funke, R., M.S., University of Tennessee, Knoxville
Gardner, J., Ph.D., Fox Chase Cancer Center, Philadelphia,
Pennsylvania
Iraqi, F., Ph.D., USDA, East Lansing, Michigan
Janaswami, P., Ph.D., Jackson Laboratory, Bar Harbor,
Maine
Kaur, G., Ph.D., New Jersey Medical School, Newark
SEMINARS
Beach, D., Cold Spring Harbor Laboratory. Genome map-
ping in fission yeast.
Ecker, J., University of Pennsylvania. Progress toward a
complete map of the Arabidopsis genome.
Foote, S., Whitehead Institute. Cloning human chromosomes
in YACs: Yesterday the Y, tomorrow the genome.
Gemmill, R., Eleanor Roosevelt Institute. Isolation and map-
Lapitan, N., Ph.D., Colorado State University, Fort Collins
Murty, V., Ph.D., Memorial Sloan-Kettering Cancer Center,
New York, New York
Sadowski, J., Ph.D., University of California, Davis
Sellar, G., Ph.D., Trinity College, Dublin, Ireland
Shah, K., Ph.D., Clark Atlanta University, Atlanta, Georgia
Stambolian, D., Ph.D., University of Pennsylvania, Philadel-
phia
Steggles, A., Ph.D., Northeastern Ohio Universities, Root-
stown
Yeung, R., M.D., Fox Chase Cancer Center, Philadelphia,
Pennsylvania
ping of YACs on human chromosome 3.
Lai, E., University of North Carolina. Pulsed-field gel techni-
ques for large DNA.
Shepherd, N., DuPont Merck Pharmaceutical. The P1 clon-
ing system.
Shizuya, H., California Institute of Technology. Large frag-
ment cloning with the BAC system.
Protein Purification and Characterization
April 13-April 26
INSTRUCTORS
Brennan, Jr., William, Ph.D., Penn State University, Hershey, Pennsylvania
Burgess, Richard, Ph.D., University of Wisconsin, Madison
Kadonaga, James, Ph.D., University of California, San Diego
Marshak, Daniel, Ph.D., Cold Spring Harbor Laboratory, New York
ASSISTANTS
Buckwalter, Elizabeth, Penn State University, Hershey, Pennsylvania
George, Catherine, University of California, San Diego
Knuth, Mark, Promega Corporation, Madison, Wisconsin
Paranjape, Suman, University of California, San Diego
This course was intended for scientists who are not familiar with techniques of
protein isolation and characterization. It was a rigorous program that included
laboratory work all day and a lecture with discussion session every evening.
Each student became familiar with each of the major techniques in protein
purification by actually performing four separate isolations including (1) a
regulatory protein from muscle tissue, (2) a sequence-specific, DNA-binding
protein, (3) a recombinant protein overexpressed in E. coli, and (4) a membrane-
bound receptor. A variety of bulk fractionation and electrophoretic and
chromatographic techniques were employed including precipitation by salts, pH,
and ionic polymers; ion exchange, gel filtration, hydrophobic interaction, and
reverse phase chromatography; lectin affinity, oligonucleotide affinity, and im-
munoaffinity chromatography; polyacrylamide gel electrophoresis, two-
dimensional gel electrophoresis, and electroblotting; and high-performance liq-
uid chromatography. Methods of protein characterization were utilized including
immunological and biochemical assays, peptide mapping, amino acid analysis,
protein sequencing, and mass spectrometry. Emphasis was placed on strategies
of protein purification and characterization, rather than on automated instrumen-
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tal analysis. Guest lecturers discussed protein structure, modifications of
proteins, methodologies for protein purification and characterization, chemical
synthesis of peptides, and applications of protein biochemistry to cell and
molecular biology.
PARTICIPANTS
Baserga, S., Ph.D., Yale University, New Haven Connecticut
Bockus, B., Ph.D., Tufts Medical School, Boston, Massachu-
setts
Cohn, M., Ph.D., University of California, San Francisco
DePinho, R., M.D., Albert Einstein College of Medicine, New
York, New York
Greenberg, M., Ph.D., Wayne State University, Detroit,
Michigan
Jin, P., Ph.D., Harvard Medical School, Boston, Massachu-
setts
Jordan, S., Ph.D., Trinity College, Dublin, Ireland
Joy, J., Ph.D., St. Elizabeth's Hospital, Washington, D.C.
SEMINARS
Aebersold, R., University of British Columbia. Methods for
protein microanalysis.
Burgess, R., University of Wisconsin, Madison. Protein
purification: Basic methods.
Guidotti, G., Harvard University. Membrane proteins.
Hart, G., Johns Hopkins University. Glycosylations of
proteins.
Kadonaga, J., University of California, San Diego. Chromatin
structure and gene activity.
Pace, C.N., Texas A&M University. Thermodynamics of
protein folding.
Paterson, Y., University of Pennsylvania. Preparation of
antipeptide antibodies.
Lazard, D., Ph.D., Institut Cochin, Paris, France
Martinez del Rio, C., Ph.D., Princeton, University, New Jer-
sey
Miller, M., B.S., University of California, Irvine
Myer, V., M.S., Yale University, New Haven, Connecticut
Rincon-Limas, D., M.S., Baylor College of Medicine, Hous-
ton, Texas
Sandmeyer, S., Ph.D., University of California, Irvine
Tetzloff, S., M.S., University of New Mexico, Albuquerque
Zack, D., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Patterson, S., Cold Spring Harbor Laboratory. Two-
dimensional gel electrophoresis.
Reinberg, D., University of Medicine and Dentistry of New
Jersey. Transcription by RNA polymerase II.
Rose, G., Washington University School of Medicine. Funda-
mentals of protein structure.
Rothman, J., Memorial Sloan Kettering Cancer Center.
Protein trafficking.
Stillman, B., Cold Spring Harbor Laboratory. DNA replication
in eukaryotes.
Tonks, N., Cold Spring Harbor Laboratory. Protein
phosphorylation.
Early Development of Xenopus laevis
April 14-April 22
INSTRUCTORS
Harland, Richard, Ph.D., University of California, Berkeley
Sive, Hazel, Ph.D., Whitehead Institute, Cambridge, Massachusetts
ASSISTANTS
Doniach, Tabitha, University of California, San Francisco
Wilson, Paul, Harvard University, Cambridge, Massachusetts
This course provided extensive laboratory exposure to the biology and manipula-
tion of embryos from the frog, Xenopus laevis. The course was particularly
suited
for investigators who have a current training in molecular biology and knowledge
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of developmental biology but had no experience with Xenopus. Intensive
laboratory sessions were supplemented by daily lectures from experts in both ex-
perimental and molecular embryology. Six main areas were covered: (1) care
and handling of adults and embryos, (2) stages of embryonic development and
anatomy, (3) whole-mount in situ hybridization and immunocytochemistry, (4) mi-
croinjection of eggs and oocytes, (5) micromanipulation of embryos, and (6) in-
duction assays.
PARTICIPANTS
Agus, N., M.S., Albert Einstein College of Medicine, New
York, New York
Cecchini, M., B.A., University of Colorado, Denver
Dompenciel, R., Ph.D., USUHS, Bethesda, Maryland
Howell, M., Ph.D., ICRF, London, England
Kondo, M., M.S., University of Tokyo, Japan
Lohmann, E., M.S., University of Essen, Germany
Mantell, L., Ph.D., Cold Spring Harbor Laboratory, New York
Martin, K., B.S., Duke University, Durham, North Carolina
Mead, P., Ph.D., University of Auckland, New Zealand
Pierceall, W., Ph.D., Yale University, New Haven, Con-
SEMINARS
Gerhart, J., University of California, Berkeley. Axis formation
in Xenopus laevis.
Harland, R., University of California, Berkeley. Expression
cloning of new cytokines, patterning of the mosederm, and
neural induction.
Harris, B., University of California, San Diego. Development
of the Xenopus nervous system.
necticut
Shuldiner, A., M.D., Johns Hopkins University, Baltimore,
Maryland
Seidman, S., M.S., Hebrew University, Jerusalem, Israel
Snider, L., Ph.D., Fred Hutchinson Cancer Center, Seattle,
Washington
Suzuki, K., Ph.D., Frederick Cancer Research Center,
Frederick, Maryland
Vignali, R., Ph.D., Universita Degli Studi di Pisa, Italy
Zuber, M., Ph.D., Colorado State University, Fort Collins
Keller, R., University of California, Berkeley. Gastrulation.
Sive, H., Whitehead Institute. Anteroposterior patterning of
the Xenopus embryo.
Whitman, M., Harvard University. Signal transduction during
mesoderm induction.
Wickens, M., University of Wisconsin, Madison. Translational
control and oogenesis.
Human Functional Neuroimaging
June 11-June 17
INSTRUCTORS
Francis Miezin, Washington University, St. Louis, Missouri
Steven Petersen, Washington University, St. Louis, Missouri
Marcus Raichle, Washington University, St. Louis, Missouri
In recent years, advances in neuroimaging have opened exciting new avenues in
the study of the human brain. In particular, there is growing interest in the area of
functional neuroimaging of indirect measures of neuronal activity related to dif-
ferent task states. Since this is a relatively recent development, there is consider-
able discussion on the ways in which neuroimaging can be applied to basic
neurobiological problems. This lecture course was designed to survey questions
at several levels, including a general overview of the performance characteristics
of the different technologies, focusing on positron emission tomography (PET)
and functional magnetic reasonance imaging (MRI); the way data are collected
and reconstructed into various image formats; assessment of image quality and
significance; applications of the different technologies to studies in the areas of
vision, attention, language, etc., in normal populations; and applications of func-
tional neuroimaging to abnormal populations. These subjects were presented in
lecture and discussion, as well as with hands-on manipulation of images on com-
puter workstations.
Since the course was designed as a survey with ample time for discussion of
problems and applications, both scientists with a direct in neuroimaging
approaches and systems and behavioral neuroscientists with an interest in un-
derstanding neuroimaging in relation to their current approaches were en-
couraged to apply.
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PARTICIPANTS
Anderson, M., Ph.D., University of Washington, Seattle
Baldo, J., B.S., University of California, Berkeley
Beauchamp, M., B.A., Salk Institute, San Diego, California
Brint, S., M.D., University of Illinois, Chicago
Burns, L., Ph.D., McLean Hospital, Belmont, Massachusetts
Cai, H-D., M.S., University of California, Los Angeles
Gold, I., Ph.D., Rutgers University, Newark, New Jersey
Huston-Lyons, D., Ph.D., Bowman Gray School of Medicine,
Winston-Salem, North Carolina
lsen, A., Ph.D., Cornell University, Ithaca, New York
SEMINARS
Duncan, G., University of Montreal. Neuroimaging of noc-
ception: Pictures of pain?
Evans, A., Montreal Neurological Institute. Recent advanced
in multimodality brain mapping.
Fiez, J., University of Iowa. PET studies of language pro-
cessing.
Fox, P., University of Texas, San Antonio. Database devel-
opment in human cognitive neuroscience.
Frackowiak, R., Hammersmith Hospital. Investigation of func-
tional neuroanatomy of the human brain with statistical
parametric mapping.
Friston, K., The Neurosciences Institute. Voxel-based image
analysis: Conceptual and practical issues.
Grady, C., National Institutes of Health. Functional
neuroimaging of the aging brain.
Advanced Bacterial Genetics
Marois, R., M.S., Yale University, New Haven, Connecticut
Martin, B., Ph.D., Stanford University, California
Savoy, R., Ph.D., Rowland Institute for Science, Cambridge,
Massachusetts
Servos, P., M.A., University of Western Ontario, Canada
Stratta, F., M.D., Vollum Institute, Portland, Oregon
Wessinger, C., B.S., University of California, Davis
West ling, G., Ph.D., University of Umea, Sweden
Wong, D., Ph.D., Indiana University, Indianapolis
Haxby, J., National Institutes of Health. The functional orga-
nization of human visual cortex.
Miezin, F., Washington University. Computer demonstration:
Image manipulation and display.
011inger, J., Washington University. Current issues in PET
image reconstruction.
Petersen, S., Washington University. Experimental design
considerations for functional neuroimaging.
Raichle, M., Washington University. (1) Introduction to func-
tional neuroimaging. (2) Tutorial on signals used in func-
tional neuroimaging.
Rosen, B., Massachusetts General Hospital. (1) Functional
neuroimaging with magnetic resonance. (2) Tutorial on
MRI.
June 11-July 1
INSTRUCTORS
Maloy, Stanley, Ph.D., University of Illinois, Urbana-Champaign
Stewart, Valley, Ph.D., Cornell University, Ithaca, New York
Taylor, Ronald, Ph.D., University of Tennessee, Memphis
ASSISTANTS
Brown, C., University of Tennessee, Memphis
Lin, J., Cornell University, Ithaca, New York
Ostrovsky de Spicer, P., University of Illinois, Urbana-Champaign
This laboratory course demonstrated genetic approaches that can be used to an-
alyze biological processes and their regulation, as well as detailed struc-
ture/function relationships of genes. Techniques included the isolation, character-
ization, and mapping of mutations; use of transposable genetic elements as
mutagens, linked selectable markers, and portable regions of homology; con-
struction and analysis of operon and gene fusions; use of bacteriophage in ge-
netic analysis; molecular cloning and restriction endonuclease mapping; allele
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exchange; Southern blot analysis; polymerase chain reaction; and site-specific
mutagenesis. The course consisted of a series of experiments that employed
these techniques in the genetic analysis of diverse bacterial and bacteriophage
species. Lectures and discussions concentrated on the application of genetic
analysis to contemporary questions in bacterial physiology, diversity, and
pathogenesis.
PARTICIPANTS
Anderson, P., B.A., University of California, Los Angeles
Andrews-Cramer, K., Ph.D., Washington University, St. Louis
Armitage, L., B.A., University of Texas, Houston
Cipriani, K., B.S., Purdue University, Lafayette, Indiana
Collazo-Custodio, C., B.S., SUNY at Stony Brook, New York
Flardh, K., M.S., University of Goteborg, Sweden
Gil, A., M.S., Kings College, London, England
Hammar, M., M.S., Washington University, St. Louis
Hansson, K., M.S., Uppsala University, Sweden
SEMINARS
Beckwith, J., Harvard Medical School. Pathways of disulfide
bond formation in vivo.
Grossman, A., Massachusetts Institute of Technology.
Genetics of signal transduction and development in
Bacillus subtilis.
Herskowitz, I., University of California, San Francisco. The
Mackenzie, R., Ph.D., University of Texas, Houston
Marini, P., Ph.D., Universidad Nacional de Rosario, Argen-
tina
Ramakrishnan, L., Ph.D., Stanford University, California
Toro, C., M.S., Universidad Catolica, Santiago, Chile
Tsolis, R., B.S., Oregon Health Sciences University, Portland
Vanet, A. M.S., Institut de Biologie, Paris, France
Webber, C., B.S., University of Virginia, Charlottesville
lysis-lysogeny decision of bacteriophage
Miller, V., University of California, Los Angeles. Isolation and
characterization of invasion-defective mutants of Sal-
monella enteritidis.
Trun, N., National Cancer Institute. Genetics of altered ploidy
in E. coll.
Molecular Embryology of the Mouse
June 11-July 1
INSTRUCTORS
Mann, Jeff, Ph.D., Beckman Research Institute, Duarte, California
Soriano, Philippe, Ph.D., Fred Hutchinson Cancer Research Center, Seattle, Washington
CO-INSTRUCTORS
Behringer, Richard, University of Texas, Houston
Papaioannou, Virginia, Tufts University, Boston, Massachusetts
Rastan, Sohaila, Clinical Research Centre, Middlesex, United Kingdom
ASSISTANTS
Gubbay, John, Rockefeller University
McLaughlin, John, City of Hope Medical Center, Duarte, California
This course was designed for molecular biologists, biochemists, and cell
biologists interested in applying their expertise to the study of mouse embryonic
development. Lecture and laboratory components of the course emphasized
both the practical aspects of working with mouse embryos and the conceptual
basis of current embryonic research. The following procedures and their potential
applications were described: isolation and culture of germ cells and pre-
implantation and postimplantation embryos, embryo transfer, establishment and
genetic manipulation of embryo-derived stem cell lines, germ layer separation,
chimera formation, nuclear transplantation, microinjection of DNA into eggs,
retroviral infection of embryos, microinjection of cell lineage tracers, in situ
hybridization, and immunohistochemistry. Guest lecturers discussed current re-
search in the field.
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PARTICIPANTS
Abel, T., M.S., Harvard University, Cambridge, Massachu-
setts
Heard, E., Ph.D., Institut Pasteur, Paris, France
Kampman, K., Ph.D., Mayo Clinic, Scottsdale, Arizona
Karsenty, G., M.D., University of Texas, Houston
Murphy, T., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Oakey, R., Ph.D., University of Pennsylvania, Philadelphia
Pekny, M., M.D., University Hospital, Uppsala, Sweden
Rappolee, D., Ph.D., Northwestern University, Chicago, II-
SEMINARS
Bradley, A., Baylor College of Medicine. (1) Introduction to
embryonic stem cells. (2) Homologous recombination in ES
cells.
Bronner-Fraser, M., University of California, Irvine. Cell
lineage in the neural crest.
Chapman, V., Roswell Park Cancer Institute. History of
mouse genetics.
Donovan, P., National Cancer Institute. Primordial germ cells,
embryonic germ cells.
Gridley, T., Roche Institute of Molecular Biology. Cloning
and analysis of mouse homologs of Drosophila neurogenic
genes; targeted disruption of genes implicated in hind-
brain development.
Hogan, B., Vanderbilt University. Extraembryonic mem-
branes.
Jaenisch. R., Whitehead Institute. The role of DNA methyla-
tion in mammalian development.
Jenkins, N., ABL-Basic Research Program. Mutations at the
micropthalmia cocus are associated with defects in a
novel basic-helix-loop-helix-zipper protein.
Jessell, T., Columbia University. Establishing symmetry and
pattern in the vertebrate nervous system.
Lovell-Badge, R., MRC National Institute for Medical Re-
search. (1) Introduction to sex determination. (2) Sex and
Sox genes in development.
linois
Swanson, B., B.S., University of Wisconsin, Madison
Urbanek, P., Ph.D., Institute of Molecular Pathology, Vienna,
Austria
Wang, Y., Ph.D., Salk Institute, La Jolla, California
Yun, K., B.S., California Institute of Technology, Pasadena
Zhao, B., Ph.D., Columbia University, New York, New York
Zhuang, Y., Ph.D., Fred Hutchinson Cancer Center, Seattle,
Washington
Mann, J., Beckman Research Institute. Genetic imprinting in
ES cells and embryos.
Papaioannou, G., Tufts University. Chimeras in experimental
embryology.
Parada, L., NCI-FCRDC. Receptor tyrosine kinases: Impor-
tant regulators of development.
Rastan, S., MRC Clinical Research Centre. X chromosome
inactivation.
Rinchik, G., Oak Ridge National Laboratory. Genetic
resources.
Rossant, J., Mount Sinai Hospital, Toronto. (1) Postimplanta-
tion development. (2) Anterior-posterior patterning in the
postimplantation embryo.
Schultz, R., University of Pennsylvania. Preimplantation de-
velopment.
Solter, D., Max Planck Institute, Freiburg. Genetic imprinting
and cellular and nuclear totipotency in mammals.
Soriano, P., Fred Hutchinson Cancer Center. Genetic analy-
sis of tyrosine kinases in mice.
Strickland, S., SUNY at Stony Brook. Oocyte maturation.
Wassarman, P., Roche Institute of Molecular Biology. Me-
chanisms of mammalian fertilization.
Wilkinson, D., National Institute for Medical Research. Seg-
mentation in the vertebrate embryo.
Molecular Approaches to Ion Channel Expression and Function
June 11-July 1
INSTRUCTORS
Enyeart, Jack, Ph.D., Ohio State University, Columbus
Goldin, Al, M.D., Ph.D., University of California, Irvine
Papazian, Diane, Ph.D., University of California, Los Angeles
Ruben, Peter, Ph.D., University of Hawaii, Honolulu
This intensive laboratory/lecture course was designed to introduce
students to
the combined use of molecular biological techniques and
electrophysiological
analysis for the study of neurotransmitter receptors and
voltage-gated ion chan-
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nels. The course covered expression of cloned channels and receptors in
Xenopus oocytes, including preparation of RNA transcripts in vitro, microinjection
in oocytes, in vitro mutagenesis, and characterization of channels and receptors
in oocytes using two-microelectrode voltage clamping and patch clamping. Ad-
ditional topics included using Baculovirus to express transiently voltage-gated
ion channels in insect cells and using patch clamp techniques to characterize
channels and receptors in cultured cells. Lectures covered the theory and analy-
sis of ionic currents.
PARTICIPANTS
Altan, N., B.A., Rockefeller University, New York, New York
Campo, M., Ph.D., University Extremadura, Caceres, Spain
Conley, P., Ph.D., COR Therapeutics, South San Francisco,
California
Cross, K., B.S., University of Southampton, England
Koch, B., Ph.D., Syntex Discovery Research, Palo Alto, Cali-
fornia
Kuziemko, G., B.S., University of California, Berkeley
SEMINARS
Adelman, J., Vollum Institute. A novel mechanism for ion
channel activation.
Andersen, 0., Cornell University. Kinetic analysis of ion
movement through channels.
Bezanilla, P., University of California, Los Angeles. Voltage-
dependent channels.
Enyeart, J., Ohio State University. A novel potassium current
that regulates steroid hormone secretion.
Goldin, A., University of California, Irvine. Molecular basis of
sodium channel inactivation.
Kallen, R., University of Pennsylvania. Striated muscle
voltage-sensitive sodium channel in health and disease.
Lindstrom, J., University of Pennsylvania. Structure and
function of the nicotinic acetylcholine receptor.
Laukkanen, M.-L., M.S., Technical Research Centre, Espoo,
Finland
Lautermilch, N., B.S., University of California, San Diego
Lieberman, M., B.S., University of Vermont, Burlington
Magoski, N., B.S., University of Calgary, Canada
Schulteis, C., B.S., University of California, Los Angeles
Witchel, H., Ph.D., University of Bristol, England
MacKinnon, R., Harvard Medical School. Structure/function
studies in voltage-activated potassium channels.
Mandel, G., SUNY at Stony Brook. Regulation of a neuron-
specific sodium channel.
Papazian, D., University of California, Los Angeles.
Biochemistry and activation of potassium channels.
Ruben, P., University of Hawaii. Sodium channels: Macro-
patches, mutations, mode switches, and more.
Sigworth, F., Yale University. Yet more stuff on Shaker
potassium channels.
Trimmer, J., SUNY at Stony Brook. Potassium channel ex-
pression in mammalian cells.
White, M., Medical College of Pennsylvania. Insites on the
acetylcholine receptor.
Structure, Function, and Development of the Visual System
June 20-July 3
INSTRUCTORS
Tobias Bonhoeffer, Ph.D., Max Planck Institute, Martinsried, Germany
David Fitzpatrick, Ph.D., Duke University Medical Center, Durham, North Carolina
This lecture/discussion course explored the functional organization and develop-
ment of the visual system as revealed by the use of a variety of anatomical,
physiological, and behavioral methods. It was designed for graduate students
and more advanced researchers who wish to gain a basic understanding of the
biological basis for vision and to share in the excitement of the latest develop-
ments in this field. Topics included phototransduction and neural processing in
the retina; gating functions of the lateral geniculate nucleus; functional architec-
ture of striate cortex; cellular basis of cortical receptive field properties; the
anatomy, physiology, and perceptual significance of parallel pathways; functional
parcellation of extrastriate cortex; sensory-motor integration in the superior col-
liculus; and role of patterned neuronal activity in the development of central
visual pathways.
PARTICIPANTS
Alonso, J., Ph.D., Rockefeller University, New York, New
York
Feller, M., Ph.D., AT&T Bell Laboratory, Murray Hill, New
Jersey
Freiwold, W., M.S., Max Planck Institut, Frankfurt, Germany
Gibson, J., B.A., Baylor College of Medicine, Houston,
Texas
Gustincich, S., Ph.D., C.I.B., Trieste, Italy
Jaworski, D., Ph.D., Yale Medical School, Con-
necticut
Mejia-Monasterio, N., M.S., Boston University, Massachu-
setts
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Moore, T., M.S., Princeton University, New Jersey
Niederer, J., B.A., Cornell University, Ithaca, New York
Pelah, A., M.S., University of Cambridge, England
Ringach, D., M.S., New York University, New York
Rudolph, K., B.A., University of Rochester, New York
Sanchez-Vives, M., Ph.D., Rockefeller University, New York,
SEMINARS
Baylor, D., Stanford University. Calcium ions and the regula-
tion of photoreceptor sensitivity.
Bonhoeffer, T., Max Planck Institute, Germany. Imaging the
functional architecture in visual cortex.
Borst, A., Max Planck Institute, Germany. (1) Principles of
visual motion detection. (2) Using the visual system of the
fly to examine theories of motion detection.
Constantine-Paton, M., Yale University. Patterned activity,
synaptic convergence, and the NMDA receptor in the de-
velopment of retino-tectal system.
Ferster, D., Northwestern University. The synaptic basis for
cortical receptive field properties.
Fitzpatrick, D., Duke University. Ascribing functions to cir-
cuits in visual cortex.
Hubel, D., Harvard Medical School. Functional organization
of striate cortex.
Humphrey, A., University of Pittsburgh. Information process-
ing mechanisms in the lateral geniculate nucleus.
Katz, L., Duke University. Development of local circuits in
visual cortex.
Logothetis, N., Baylor College of Medicine. Motion and form
analysis in extrastriate cortex.
Malpeli, J., University of Illinois. Paths of information flow
Arabidopsis Molecular Genetics
New York
Tang, C., M.S., New York University, New York
Tzonev, S., B.S., University of Illinois, Urbana
Usrey, W., M.S., Duke University, Durham, North Carolina
Woo, T.-U., M.D., Cornell University, Ithaca, New York
through visual cortex.
Martin, K., Medical Research Council. Modeling the micro-
circuitry of visual cortex.
Masland, R., Massachusetts General Hospital. Functional
organization of retinal circuitry.
Maunsell, J., Baylor College of Medicine. Cortical and sub-
cortical parallel visual pathways in primates.
McCormick, D., Yale University. Modulation of neuronal ex-
citability in the lateral geniculate nucleus.
Movshon, T., New York University. Cortical mechanisms of
motion perception.
Shatz, C., University of California, Berkeley. (1) Role of ac-
tivity in the development of connection between the retina
and the lateral geniculate nucleus. (2) Disappearing
neurons and transient networks in visual cortical develop-
ment.
Sparks, D., University of Pennsylvania. Sensory-motor in-
tegration in the superior colliculus.
Stryker, M., University of California, San Francisco. Activity-
dependent development of the visual cortex.
Van Essen, D., Washington University. Physiological and
computational aspects of form processing and visual at-
tention.
July 5-July 25
INSTRUCTORS
Chory, Joanne, Ph.D., Salk Institute, San Diego, California
Ecker, Joseph, Ph.D., University of Pennsylvania, Philadelphia
Theologis, Athanasios, Ph.D., University of California, Berkeley
ASSISTANTS
Abel, Steffen, University of California, Berkeley
Bell, Callum, University of Pennsylvania, Philadelphia
Poole, Dan, Salk Institute, San Diego, California
This course provided an intensive overview of current topics and techniques in
Arabidopsis biology, with an emphasis on molecular genetics. It also introduced
approaches used in yeast that have the potential to be utilized for the advance-
ment of Arabidopsis molecular genetics. It was designed for scientists with expe-
rience in molecular techniques who are working or wish to work with Arabidopsis.
The course consisted of a rigorous lecture series, a hands-on laboratory, and in-
formal discussions. Guest speakers provided both an in-depth discussion of their
work and an overview of their specialty. The laboratory sessions covered
Arabidopsis genetics and development; transient gene expression assays in
protoplasts; gene transplacement and complementation of yeast mutants for
cloning Arabidopsis genes; transformation by Agrobacterium; in situ detection of
RNA; pulsed-field gel electrophoresis and analysis of yeast artificial
chromosomes containing the Arabidopsis genome; use of PCR-based markers
for genetc mapping of mutations; and a tutorial on access and use of the
Arabidopsis resource databases available on the internet.
PARTICIPANTS
Batchelder, C., Ph.D., John Innes Centre, Norfolk, England
Belostotsky, D., Ph.D., University of Georgia, Athens
Bruggemann, E., Ph.D., National Institutes of Health,
Bethesda, Maryland
Grater, T., B.S., Ciba Seeds, Research Triangle Park, North
Carolina
Johnson, K., Ph.D., Dartmouth Medical School, Hanover,
New Hampshire
Kakutani, T., Ph.D., Washington University, St. Louis, Mis-
souri
Kniessl, M., B.S., Penn State University, University Park
Levy, Y., B.S., Brandeis University, Waltham, Massachusetts
Oliveira, R., B.S., New York University, New York
SEMINARS
Baker, B., Plant Gene Expression Center. Ac-Ds insertional
mutagenesis in Arabidopsis.
Bender, J., Whitehead Institute. Yeast complementation.
Bell, C., University of Pennsylvania. Physical mapping of the
Arabidopsis genome.
Benfey, P., New York University. A molecular genetic analy-
sis of root morphogenesis in Arabidopsis.
Pilgrim, M., B.A., Dartmouth College, Hanover, New Hamp-
shire
Ronemus, M., B.A., Yale University, New Haven, Con-
necticut
Shah, J., Ph.D., Waksman Institute, Piscataway, New Jersey
Siddiqi, I., Ph.D., Centre for Cellular & Molecular Biology,
Hyderabad, India
Snowden, K., M.S., University of Auckland, New Zealand
Trentmann, S., Ph.D., Michigan State University, East Lans-
ing
Zhong, H.-H., B.S., Dartmouth College, Hanover, New
Hampshire
Bowler, C., Rockefeller University. Phytochrome signal
transduction pathways.
Browse, J., Washington State University. Gathering grease
genes.
Callis, J., University of California, Davis. Proteolysis and the
ubiquitin pathway in higher plants.
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Chory, J., Salk Institute. Genetic interactions controlling
photomorphogenesis.
Drews, G., University of Utah. Application of in situ
hybridization for analysis of flower development.
Ecker, J., University of Pennsylvania. Genes controlling
ethylene signal transduction in Arabidopsis.
Estelle, M., Indiana University. Genetic analysis of hormone
action in Arabidopsis.
Fink, G., Whitehead Institute. Molecular genetics of growth
regulation in Arabidopsis.
Johnston, M., Washington University. (1) Precisely
manipulating genomes: Illustrations with yeast. (2)
Regulation of GAL genes in yeast.
Jurgens, G., University of Munich. Genes and pattern forma-
tion in the embryo.
Kay, S., University of Virginia. Molecular genetic analysis of
biological clocks.
Ma, H., Cold Spring Harbor Laboratory. G-protein functions
and their involvement in plant signal transduction.
Molecular Cloning of Neural Genes
Meyerowitz, E., California Institute of Technology. Genetic
and molecular studies of flower development in
Arabidopsis.
Poethig, S., University of Pennsylvania. Genetic regulation of
plant morphology.
Pruitt, R., Harvard University. Molecular genetics of fertiliza-
tion in Arabidopsis.
Quail, P., University of California, Berkeley. Phytochrome.
Schena, M., Stanford University. Master genes controlling
Arabidopsis development.
Signer, E., Massachusetts Institute of Technology. Interac-
tions based on DNA homology.
Staskawitz, B., University of California, Berkeley. Genetic re-
lationships specifying disease resistance in plant bacterial
interactions.
Sussex, I., University of California, Berkeley. Meristem orga-
nization.
Theologis, A., University of California, Berkeley. Molecular
aspects of plant hormone action.
July 5-July 25
INSTRUCTORS
Boulter, James, Ph.D., Salk Institute, La Jolla, California
Chao, Moses, Ph.D., Cornell University, New York, New York
Eberwine, James, Ph.D., University of Pennsylvania, Philadelphia
CO-INSTRUCTORS
Blake ley, Randy, Emory University, Atlanta, Georgia
Lai, Cary, Salk Institute, La Jolla, California
ASSISTANTS
Kong, Hae-Young, University of Pennsylvania, Philadelphia
Phillips, Jennifer, University of Pennsylvania, Philadelphia
This intensive laboratory/lecture course was intended to provide scientists with a
basic knowledge of the use of the techniques of molecular biology in examining
questions of neurobiological significance. Particular emphasis was placed on
using and discussing methods for circumventing the special problems posed in
the study of the nervous system, for example, examination of low abundance
mRNAs in extremely heterogeneous cell populations.
The laboratory work included mRNA quantitation methods (nuclease protec-
tion, etc.), preparation of hybridization probes, library construction (X. ZAP and
1ST procedures), plaque screening techniques (probe hybridization, antibody in-
teraction), DNA sequencing, PCR amplification, RNA amplification, and DNA-
mediated gene transfer. A portion of the laboratory work was devoted to charac-
terization and analysis of nucleic acids from single live neurons and glia. A major
portion of the course was devoted to in situ hybridization and in situ transcription
technologies. The lecture series, presented by invited speakers, focused on
emerging techniques and how they may be applied to the study of the nervous
system.
PARTICIPANTS
Amato, A., M.S., University College London, England
Connolly, J., Ph.D., University of Strathclyde, Glasgow, Scot-
land
Cooke, H., Ph.D., Ohio State University, Columbus
Corfas, G., Ph.D., Harvard Medical School, Boston, Massa-
chusetts
Galli, T., Ph.D., Yale University, New Haven, Connecticut
Hunter, K., Ph.D., Rockefeller University, New York, New
York
Levin, M., M.D., Cornell Medical Center, New York, New York
SEMINARS
Edwards, R., University of California, Los Angeles.
Molecular cloning by functional expression.
Ganetzky, B., University of Wisconsin-Madison. Genetic
analysis of ion channels in Drosophila: From mutants to
molecules and from molecules to mutants.
Julius, D., University of California, San Francisco. Molecular
biology of serotonin and ATP receptors.
Lemke, G., Salk Institute. Molecular genetics of myelination.
Mandel, G., SUNY at Stony Brook. Regulation of a neuron-
specific Na' channel gene.
Morgan, J., Roche Institute of Molecular Biology. Molecular
Lu, Q., Ph.D., Emory University, Atlanta, Georgia
Macagno, E., Ph.D., Columbia University, New York, New
York
Metcalf, A., M.S., University of Texas, Dallas
Murphy, T., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Olschowka, J., Ph.D., University of Rochester, New York
Oyesiku, N., M.D., Emory University, Atlanta, Georgia
Rehder, V. Ph.D., Colorado State University, Fort Collins
Streit, A., Ph.D., University of Oxford, England
Witchel, H., Ph.D., University of Bristol, England
biology of development and plasticity in the nervous sys-
tem.
Neve, R., McLean Hospital. Molecular mechanisms of
Alzheimer's disease neurodegeneration.
Poo, M., Columbia University. Reconstitution of transmitter
secretion in nonneuronal cells.
Reed, R., Johns Hopkins University. The molecular mechan-
isms of diversity in odorant recognition.
Silva, A., Cold Spring Harbor Laboratory. Gene targeting and
the biology of learning plus memory.
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Neurobiology of Drosophila
July 5-July 25
INSTRUCTORS
Bieber, Alan, Ph.D., Purdue University, West Lafayette, Indiana
Hardie, Roger, Ph.D., University of Cambridge, United Kingdom
Taghert, Paul, Ph.D., Washington University, St. Louis, Missouri
ASSISTANTS
Hall, Stephen, Purdue University, West Lafayette, Indiana
Silber, Judy, Washington University, St. Louis, Missouri
This laboratory/lecture course was a series of in-depth discussions with research-
ers active in genetic, physiological, cellular, molecular, and behavioral studies of
Drosophila neurobiology. It was organized around a core of seminars, extensive
informal discussion, and lab work. Lecturers often brought original preparations
for viewing and discussion and directed lab exercises and experiments in their
areas of special interest. The course was intended for researchers at all levels
who want to use Drosophila as an experimental system for studying neurobiol-
ogy.
The course covered basic electrophysiological techniques, as applied to
mutants with altered ion channels or sensory physiology. In addition, the course
familiarized students with various preparations, including the embryonic nervous
system, imaginal discs, and adult nervous system. Topics included Shaker and
the biophysics and diversity of potassium channels, the genetics and molecular
biology of excitability, the control of neurogenesis and neuronal diversity, em-
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bryonic and postembryonic development of the CNS and PNS, axonal pathfind-
ing, development of the nervous system, mesoderm and muscle development,
eye and optic lobe development, olfaction, learning, and the neural control of
flight.
PARTICIPANTS
Bates, D., Ph.D., University of Glasgow, Scotland
Brewster, R., M.S., University of Michigan, Ann Arbor
Ericsson, C., Ph.D., Karolinska Institutet, Stockholm,
Sweden
Kania, A., B.S., Baylor College of Medicine, Houston, Texas
Li, Q., M.S., Dalhousie University, Halifax, Canada
Lin, F., Ph.D., Salk Institute, La Jolla, California
SEMINARS
Bieber, A., Purdue University. Axon pathfinding.
Crews, S., University of California, Los Angeles.
Neurogenesis I.
Davis, R., Cold Spring Harbor Laboratory. Learning and
memory I.
Doe, C., University of Illinois. Neurogenesis II.
Ffrench-Constant, R., University of Wisconsin. Ligand-gated
receptors.
Ganetzky, B., University of Wisconsin. Ion channel studies.
Hardie, R., Cambridge University. (1) Visual systems. (2) In-
troductory electrophysiology.
Hartenstein, V., University of California, Los Angeles. Em-
bryogenesis early neurogenesis.
Isacoff, E., University of California, Berkeley. K+ channel
structure and function.
Jackson, R., Worcester Foundation. Drosophila circadian
rhythms.
Littleton, J., B.S., Baylor College of Medicine, Houston,
Texas
Sandstrom, D., B.A., University of Arizona, Tucson
The, I., M.S., Massachusetts General Hospital, Charlestown,
Massachusetts
Yeo, S., B.S., National University of Singapore
Zavitz, K., Ph.D., University of California, Los Angeles
Keshishian, H., Yale University. Synaptic development.
Patel, N., Carnegie Institution of Washington. Relationships
between Drosophila neurogenesis and segmentation.
Taylor, B., Oregon State University. Sexual dimorphism and
the brain.
Technau, G., University of Mainz. Neurogenesis.
Tomlinson, A., Columbia University. Eye development.
Truman, J., University of Washington. Metamorphosis of the
nervous system.
Tully, T., Cold Spring Harbor Laboratory. Learning and
memory II.
White, K., Brandeis University. Neurotransmitters I.
Wu, C.-F., University of Iowa. (1) Physiological studies of ex-
citable cells in Drosophila. (2) Functional and develop-
mental plasticity of Drosophila neurons.
Zhong, Y., Cold Spring Harbor Laboratory. Neuromodulation.
The Biology of Memory: From Molecules to Behavior
July 9-July 22
INSTRUCTORS
Byrne, Jack, Ph.D., University of Texas Medical School, Houston
Kandel, Eric, Ph.D., Columbia University College of Physicians & Surgeons, New York,
New York
Pearson, Keir, Ph.D., University of Alberta, Canada
Squire, Larry, Ph.D., University of California, San Diego
This lecture course provided an introduction to cell and molecular biological ap-
proaches to learning and memory. It was suited for graduate
students in
molecular biology, neurobiology, and psychology as well as research workers
who are interested in an introduction to this new field. The course
covered topics
ranging from behavioral considerations of learning and memory
to gene regula-
tion in the nervous system. The lectures provided an intensive coverage
of six
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selected areas: (1) an introduction to modern behavioral studies of learning and
memory; (2) an overview of the cell biology of neuronal plasticity and second
messenger systems; (3) the regulation of gene expression; (4) cellular and
molecular mechanisms of simple forms of learning and memory in invertebrates
and vertebrates; (5) cellular and molecular mechanisms of long-term potentiation
in various regions of the mammalian brain; and (6) neural approaches to human
learning and its abnormalities.
PARTICIPANTS
Ajima, A., Ph.D., Frontier Research Program, Saitama,
Japan
Borroni, A., Ph.D., Max Planck Institute, Frankfurt, Germany
Burwell, R., Ph.D., Salk Institute, San Diego, California
Gerlai, R., Ph.D., Mt. Sinai Hospital, Toronto, Canada
Gewirtz, J., M.S., Yale University, New Haven, Connecticut
Kim, J., Ph.D., University of Southern California, Los Angeles
Kornau, H.-C. , B.S., Zentrum fur Molekulare Biologie,
Heidelberg, Germany
Krupa, D., Ph.D., University of Southern California, Los
Angeles
Lopez-Garcia, J., M.S., Columbia University, New York, New
York
Rajachandran, L., Ph.D., Neurogen Corporation, Branford,
Connecticut
SEMINARS
Byrne, J., University of Texas, Houston. (1) Overview of
membranes and synaptic transmission I. (2) Overview of
membranes and synaptic transmission II. (3) Learning in
Aplysia III: Classical conditioning.
Crow, T., University of Texas, Houston. Cellular mechanisms
of associative learning in Hermissenda.
Davis, M., Yale University. Neural mechanisms of fear con-
ditioning.
Ramus, S., M.S., University of California, San Diego
Rogan, M., B.A., New York University, New York
Roy, R., Ph.D., Laval University, Quebec, Canada
Sheffield, L., M.S., University of Kansas, Kansas City
Stanhope, K., Ph.D., Wyeth Research Ltd., Berkshire, Eng-
land
Sun, W., B.S., University of California, San Diego
Van Praag, H., Ph.D., Robert Wood Johnson Medical
School, Piscataway, New Jersey
Wang, Y., B.S., University of Miami, Florida
Wicks, S., B.S., University of British Columbia, Vancouver,
Canada
Wood, E., Ph.D., University of Oregon, Eugene
Zhang, F., M.S., University of Texas, Houston
Davis, R., Cold Spring Harbor Laboratory. Genetic ap-
proaches to study associative learning in Drosophila.
Eichenbaum, H., University of North Carolina. Role of the hip-
pocampus and hippocampal long-term potentiation in
learning.
Ganetzky, B., University of Wisconsin. Introduction to the
study of genes and behavior: Genetic analysis of ion
channels and membrane excitability in Drosophila.
Gould, J., Princeton University. Ethological approaches to
learning.
Greenough, W., University of Illinois. Morphological corre-
lates of learning and experience.
Holland, P., Duke University. Introduction to learning theory.
Kaas, J., Vanderbilt University. Cortical plasticity and learn-
ing.
Kandel, E., Columbia University. (1) Introduction to the cel-
lular study of learning. (2) Learning in Aplysia I: Habitua-
tion. (3) Learning in Aplysia II: Sensitization. (4) Long-term
potentiation II.
Nicoll, R., University of California, San Francisco. Long-term
potentiation I.
Nottebohm, F., Rockefeller University. Bird-song learning.
Pearson, K., University of Alberta. Mechanisms of motor
learning.
Developmental Neurobiology
Pfaffinger, P., Baylor College of Medicine. (1) Cloning of
genes important to learning I. (2) Cloning of genes impor-
tant to learning II.
Raichle, M., Washington University. Neuropsychology of
cognition.
Rankin, C., University of British Columbia. Genes and
the behavior of C. elegans.
Schulman, H., Stanford University. Overview of second mes-
senger systems and their role in learning and memory.
Squire, L., University of California, San Diego. (1) Memory in
nonhuman primates. (2) Human memory and disorders of
memory.
Thompson, R., University of Southern California. Classical
conditioning of the nictitating membrane response.
July 24-August 6
INSTRUCTORS
Greg Lemke, Ph.D., The Salk Institute, San Diego, California
Dennis O'Leary, Ph.D., The Salk Institute, San Diego, California
The aim of this lecture course was to discuss established principles and recent
advances in developmental neurobiology. Major topics considered were
proliferation, migration, and aggregation of neurons; determination and differen-
tiation of neural cells; trophic interactions in neural development; patterns, gradi-
ents, and compartments; genetic programs for development; the guidance of
axons to targets; and the formation of synaptic connections. These topics were
considered within the context of the development of both invertebrate and verte-
brate neural systems. Students had a background in neurobiology or molecular
biology.
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PARTICIPANTS
Chen, M., Ph.D., Cambridge Neuroscience, Massachusetts
Dietz, G., B.S., Rockefeller University, New York, New York
Fernandes, J., M.S., Tata Institute of India, Bombay
Habecker, B., Ph.D., Case Western Reserve University,
Cleveland, Ohio
Heller, S., B.S., Max Planck Institute, Frankfurt, Germany
Heyman, I., M.S., Guy's Hospital, London, England
Hutson, L., B.A., University of Washington, Seattle
Jensen, A., Ph.D., University College London, England
Lawrence, A., B.S., University College London, England
McCullumsmith, C., B.S., University of Michigan, Ann Arbor
Orr Urtreger, A., Ph.D., Baylor College of Medicine, Hous-
ton, Texas
SEMINARS
Bronner-Fraser, M., University of California, Irvine. Neural
crest differentiation and specification.
Cagan, R., University of California, Los Angeles. Cell fate
specification in the Drosophila eye.
Chao, M., Cornell University. Neurotrophin receptors
(molecular biology).
Fraser, S., California Institute of Technology. Retino-tectal
development.
Goodman, C., University of California, Berkeley. Molecular
genetics of pathfinding in simple systems.
Jessell, T., Columbia University. Axial specification and
dorsal-ventral patterning of the vertebrate
neuroepithelium.
Kintner, C., Salk Institute. Neural induction and early pat-
terning of the vertebrate nervous system.
Kuwada, J., University of Michigan. Axonal development
and scaffolding in Zebrafish.
Yeast Genetics
Pignoni, F., Ph.D., University of California, Los Angeles
Pina, A., M.S., Universidad Nacional Autonoma de Mexico,
Mexico City
Redmond, L., B.A., Yale University, New Haven, Connecticut
Rosenthal, A., Ph.D., Genentech, Inc., South San Francisco,
California
Rowitch, D., Ph.D., Children's Hospital, Boston, Massachu-
setts
Rortocil, T., M.S., University of Geneva, Switzerland
Selfors, L., B.S., Yale University, New Haven, Connecticut
Wallis, J., B.A., Guy's Hospital, London, England
Yoon, S., Ph.D., Rockefeller University, New York, New York
Lemke, G., Salk Institute. Molecular genetics of myelination.
Lichtman, J., Washington University. Synapse formation and
elimination.
Lindsay, R., University of Pittsburgh. Neurotrophins (cell
biology).
O'Leary, D., Salk Institute. Cortical development.
Patterson, P., California Institute of Technology. Neural
cytokines and their receptors.
Pittman, R., University of Pennsylvania. Cell death in neural
development.
Raper, J., University of Pennsylvania. Inhibitory interactions
in axon guidance.
Sanes, J., Washington University. Synapse formation and
neuromuscular development.
Shatz, C., University of California, Berkeley. Electrical ac-
tivity and CNS development.
July 27-August 16
INSTRUCTORS
Kaiser, Chris, Ph.D., Massachusetts Institute of Technology, Cambridge
Michaelis, Susan, Ph.D., Johns Hopkins University, Baltimore, Maryland
Mitchell, Aaron, Ph.D., Columbia University, New York, New York
ASSISTANTS
Baker, Cary, Johns Hopkins University, Baltimore, Maryland
Hammer, Ruth, Massachusetts Institute of Technology, Cambridge
Smith, Harold, Columbia University, New York, New York
The major laboratory techniques used in the genetic analysis of yeast were
studied, including the isolation and characterization of mutants, tetrad analysis,
complementation, and mitotic recombination. Micromanipulation used in tetrad
analysis was carried out by all students. Molecular genetic techniques, including
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yeast transformation, gene replacement, analysis of gene fusions, and elec-
trophoretic separation of chromosomes, were applied to the analysis of yeast
DNA. Indirect immunofluorescence experiments were done to identify the
nucleus, microtubules, and other cellular components. Lectures on fundamental
aspects of yeast genetics were presented along with seminars given by outside
speakers on topics of current interest.
PARTICIPANTS
Arkowitz, R., Ph.D., University of California, Los Angeles
Ben Yaacov, R., M.S., Tel Aviv University, Israel
Caron, J., Ph.D., University of Connecticut, Farmington
Franssen, J.-H., M.D., Erasmus University, Rotterdam, The
Netherlands
Frydman, J., Ph.D., Memorial Sloan-Kettering Cancer Cen-
ter, New York, New York
Ghannoum, M., Ph.D., Harbor-UCLA Medical Center, Tor-
rance, California
Griffin, L., B.S., University of Massachusetts, Worcester
Izumi, T., Ph.D., University of Colorado, Denver
Laybourn, P., Ph.D., Colorado State University, Fort Collins
SEMINARS
Adams, A., University of Arizona. Genetic analysis of the ac-
tin cytoskeleton.
Carlson, M., Columbia University. Transcriptional control in
response to glucose.
El ledge, S., Baylor College of Medicine. Heterologous ex-
pression cloning.
Fink, G., Whitehead Institute. Control of pseudohYphal
growth.
Leidich, S., B.S., University of Illinois, Urbana
McMaster, C., Ph.D., Duke University Medical Center, Dur-
ham, North Carolina
Mukherjee, M., B.S., Johns Hopkins University, Baltimore,
Maryland
Okorokova, A., M.S., Federal University of Rio de Janeiro,
Brazil
Payvar, F., Ph.D., St. Louis University, Missouri
Reinero, A. Ph.D., American Cyanamid Company, Princeton,
New Jersey
Zaman, S., Ph.D., National University of Singapore
Futcher, B., Cold Spring Harbor Laboratory. Role of cyclins
in cell cycle control.
Herskowitz, I., University of California, San Francisco. Yeast
mating type.
Hieter, P., Johns Hopkins University. Molecular genetics of
the yeast kinetochore.
Kaiser, C., Massachusetts Institute of Technology. Genetic
analysis of early steps in secretion.
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Levin, D., Johns Hopkins University. Signal transduction by
protein kinase C.
Michaelis, S., Johns Hopkins University. Biogenesis of a-
factor.
Mitchell, A., Columbia University. Control of meosis.
Parker, R., University of Arizona. mRNA turnover in yeast.
Petes, T., University of North Carolina. Micro- and macro-
rearrangements of the yeast genome.
Roeder, S., Yale University. Genetic analysis of meiotic
recombination and chromosome synapsis.
Rose, M., Princeton University. Microtubules, motors, and
the spindle pole body in yeast mating and mitosis.
Sherman, F., University of Rochester. Modification,
mitochondrial import, and degradation of cytochrome c.
Sprague, G., University of Oregon. The mating response
pathway.
Winston, F., Harvard Medical School. Analysis of TATA-
binding protein, histones, and other transcription factors
of yeast.
Advanced Molecular Cloning and Expression of Eukaryotic Genes
July 27-August 16
INSTRUCTORS
Freedman, Len, Ph.D., Sloan Kettering Institute, New York, New York
Learned, Marc, Ph.D., University of California, Davis
Robbins, Alan, Ph.D., Tularik, Inc., South San Francisco, California
ASSISTANTS
Alroy, Iris, Sloan Kettering Institute, New York, New York
Connolly, Erin, University of California, Davis
Towers, Terri, Sloan Kettering Institute, New York, New York
This course focused on both the cloning and characterization of eukaryotic
genes to probe their structure, function, and expression. As a model system, stu-
dents examined cis- and trans-acting components involved in the regulation of
eukaryotic gene expression. Eukaryotic transcription factors were expressed in E.
coli and purified by affinity chromatography. Mutations were generated in the
DNA-binding domain of these factors by oligonucleotide-directed and random
mutagenesis procedures and characterized by DNA sequencing and DNA-
binding assays. Using both the wild-type and mutant proteins, students learned
the techniques and theory for detecting and characterizing the interaction be-
tween regulatory DNA sequences and trans-acting protein factors. In addition,
transfection was used to introduce cloned DNA molecules that had been manipu-
lated in vitro into mammalian tissue culture cells. The regulated expression of
these transfected DNAs were analyzed by nuclease protection and enzymatic
assays. Finally, expression libraries from various organisms were prepared and
screened with recognition site probes for specific DNA-binding proteins as a
means of learning the theoretical and practical aspects of constructing cDNA li-
braries. Guest lecturers discussed current problems in eukaryotic molecular biol-
ogy as well as technical approaches to their solutions. Experience with basic
recombinant DNA techniques was a prerequisite for admission to the course.
PARTICIPANTS
Amfo, K., M.S., Vrije University, Brussels, Belgium
Filler, S., M.D., Harbor-UCLA Medical Center, Torrance, Cali-
fornia
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Frostesjo, L., B.S., University of Umea, Sweden
Gadbut, A., Ph.D., Brigham & Women's Hospital, Boston,
Massachusetts
Gallo, R., Ph.D., Children's Hospital, Boston, Massachusetts
Gamberi, C., Ph.D., University of Verona, Italy
Hansen, R., B.S., Loma Linda University, California
Hardin, M., B.S., University of South Carolina, Columbia
Harris-Kerr, C., Ph.D., Medical College of Virginia, Rich-
mond
Lummis, S., Ph.D., University of Cambridge, England
Paulsen, R., Ph.D., Norwegian Defence Research Establish-
SEMINARS
Burdis, K., University of California, Davis. Structure and
function of double sex proteins of Drosophila.
De Lange, T., Rockefeller University. Remaking vertebrate
chromosome ends in vivo and in vitro.
Desplan, C., Rockefeller University. Molecular determinants
of homeoprotein specificity.
Ebright, R., Waksman Institute. Identification of contacts in
protein-DNA complexes by photocross-linking.
El ledge, S., Baylor College of Medicine. Genetics of cell
cycle checkpoints in yeast and the two-hybrid system.
Gilman, M., Cold Spring Harbor Laboratory. Mechanics and
ment, Kjeller
Pedersen, H., B.S., Maribo Seeds, Copenhagen, Denmark
Ragland, M., Ph.D., Monsanto Company, St. Louis, Missouri
Raventos, D., B.S., Conseil Superior d'Investigacions
Cientifiques, Barcelona, Spain
Skouv, J., Ph.D., Danish Cancer Society, Copenhagen
Soto, J., M.S., University of Santiago de Compostela, Spain
specificity of signal transduction to the nucleus.
Kingston, R., Massachusetts General Hospital. Gene ac-
tivators and transcription of nucleosomal templates.
Reinberg, D., Robert Wood Johnson Medical School.
Regulation of initiation of transcription by RNA polymerase
Rio, D., University of California, Berkeley. Mechanism and
regulation of Drosophila P element transposition.
Yamamoto, K., University of California, San Francisco. Com-
binatorial regulation at a composite response element.
Imaging Structure and Function in the Nervous System
July 27-August 16
INSTRUCTORS
Augustine, George, Ph.D., Duke University, Durham, North Carolina
Lichtman, Jeff, Ph.D., Washington University, St. Louis, Missouri
ASSISTANTS
Ba lice-Gordon, Rita, Washington University, St. Louis, Missouri
Delve, Matt, Duke University, Durham, North Carolina
Parsons, Tom, Max Planck Institute, Heidelberg, Germany
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Recent advances in optical, video, and computer-assisted microscopy, coupled
with the development of powerful new fluorescent probes, present unique op-
portunities for visualizing the structure and function of individual neurons and
neuronal assemblies. This intensive laboratory/lecture course provided
participants with the theoretical and practical tools to utilize these emerging tech-
nologies. Course topics included principles of fluorescence and video micros-
copy; image processing techniques; theory and practice of confocal microscopy;
the use of caged compounds to study intracellular and synaptic signaling,
voltage-sensitive dyes. Particular emphasis was placed on the use of calcium-
sensitive probes (e.g., fura-2, fluo-3) to monitor cell function in slices and in
single cells. Using state-of-the-art equipment, students explored a variety of
preparations, including mammalian brain slices, acutely dissociated neurons,
cultured cells, and even living animals.
PARTICIPANTS
Baier, H., B.S., Max Planck Institut, Tubingen, Germany
Hohn, A., Ph.D., University of California, Berkeley
Hsu, M., M.S., Rutgers University, Newark, New Jersey
Kirkpatrick, K., B.S., Montreal General Hospital, Canada
Kuner, T., University of Heidelberg, Germany
Maycox, P., Ph.D., Salk Institute, La Jolla, California
Phenna, S., B.S., University of Southampton, England
SEMINARS
Augustine, G., Duke University. (1) Laser confocal micro-
scopy. (2) Calibration of Ca indicator dyes. (3) Ca imaging
principles and problems.
Betz, W., University of Colorado. Fluorescence measure-
ments of synaptic vesicle cycling.
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Ray, K., M.S., Tata Institute, Bombay, India
Sekino, Y., Ph.D., Tokyo Metropolitan Institute, Japan
Simerly, R., Ph.D., Oregon Regional Primate Center,
Beaverton
Von Gersdorff, H., Ph.D., SUNY at Stony Brook, New York
Webb, B., M.S., University of Florida, Gainesville
Connor, J., Roche Institute of Molecular Biology. Ca imaging
in dendritic spines.
Fraser, S., California Institute of Technology. MRI imaging.
Grinvald, A., Weizmann Institute of Science. Voltage-
sensitive dyes and intrinsic optical signals.
Inoue, T., Universal Imaging Corporation. Image process-
ing.
Katz, L., Duke University. Living preparations for neuro-
science.
Lewis, R., Stanford University. Types of calcium indicator
dyes.
Lichtman, J., Washington University. (1) Structure and func-
tion of the light microscope. (2) Fluorescence microscopy.
(3) Introduction to confocal microscopy.
Nerbonne, J., Washington University. Caged compounds.
Ross, W., New York Medical College. Ca measurements
from central neurons in slices.
Smith, S., Stanford University. Limits in confocal microscopy.
Tsien, R.W., University of California, San Diego. Design and
function of indicator dyes.
Webb, W., Cornell University. 2-Photon excitation micros-
copy; fluorescence recovery after photobleaching.
Wick, R., Hamamatsu Photonic Systems. Detectors for imag-
ing.
Neurobiology of Human Neurological Disease
August 10-August 16
INSTRUCTORS
Choi, Dennis, M.D., Ph.D., Washington University, St. Louis, Missouri
Mobley, William, M.D., Ph.D., University of California, San Francisco
This lecture course focused on selected arenas where recent advances in
neuroscience have improved our understanding of a disease of the human ner-
vous system. Substantial time was allotted to discussions led by the invited lec-
turers, so that in-depth delineation of specific approaches, methods, and results
would be possible. An underlying general theme of the course was the explora-
tion of the highly dynamic interface between basic neuroscience and clinical
medicine. What can we learn certain disease mechanisms by studying
molecules, cells, and animals, and what must we learn by studying patients?
What experimental and clinical problems hinder the development of novel
therapeutic approaches? What can the study of neurological or psychiatric dis-
eases reveal about the nature of the normal nervous system? Applicants with ei-
ther neuroscience or clinical backgrounds were encouraged to apply.
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PARTICIPANTS
Bermingham-McDonogh, 0., Ph.D., Cambridge Neuro-
science, Massachusetts
Gordon, M., M.D., SUNY Downstate Medical Center, Brook-
lyn, New York
Green, S., D.V.M., University of California, Davis
Hochberg, L., B.S., Emory University, Atlanta, Georgia
Koh, J., M.D., Ph.D., Washington University, St. Louis, Mis-
souri
Kowallis, G., M.D., St. Vincent's Hospital, New York, New
York
Miller, P., B.S., Rutgers University, Newark, New Jersey
SEMINARS
Chalfie, M., Columbia University. Genetically determined
neurodegeneration.
Choi, D., Washington University. Excitotoxicity.
Ciaranello, R., Stanford University. Neural development and
psychiatric diseases.
Diamond, I., University of California, San Francisco. Alcohol
and the nervous system.
Fischbeck, K., University of Pennsylvania. Molecular
genetics of neuromuscular diseases.
Goate, A., Washington University. Genetics of familial
Alzheimer's disease and transgenic animal models.
Landis, D., Case Western Reserve University. Role of glia in
CNS injury.
Mazziotta, J., University of California, Los Angeles. (1) PET
Macromolecular Crystallography
Mozaffar, T., M.D., Washington University, St. Louis, Mis-
souri
Petrucci, T., Ph.D., Istituto Superiore di Sanita, Rome, Italy
Pribilla, I., Ph.D., Schering AG, Berlin, Germany
Quevedo, J., M.D., CINVESTAV, Mexico City, Mexico
Rosales, M., M.D., CINVESTAV, Mexico City, Mexico
Schmerler, M., M.D., Cincinnati Neurological Associates,
Ohio
Wells, J., Ph.D., VA Hospital, Bedford, Massachusetts
Ying, H., B.S., Washington University, St. Louis, Missouri
Yuen, E., M.D., University of California, San Francisco
neuroimaging. (2) Functional anatomy and neurological
disease.
McNamara, J., Duke University. Epilepsy.
Mobley, W., University of California, San Francisco.
Neuronal growth factors.
Monyer, H., University of Heidelberg. Glutamate receptors in
health and disease.
Prusiner, S., University of California, San Francisco. Prion
diseases of the nervous system.
Ptacek, L., University of Utah. Disorders of excitable mem-
branes.
Selkoe, D., Brigham & Women's Hospital. Alzheimer's dis-
ease.
October 13-October 26
INSTRUCTORS
Furey, William, Ph.D., V.A. Medical Center, Pittsburgh, Pennsylvania
Gilliland, Gary, Ph.D., Center for Advanced Research in Biotechnology,
Rockville, Maryland
McPherson, Alexander, Ph.D., University of California, Riverside
Pflugrath, James, Ph.D., Cold Spring Harbor Laboratory, New York
ASSISTANT
Ji, Xinhau, Center for Advanced Research in Biotechnology
Crystallography and X-ray diffraction yield a wealth of structural information un-
obtainable through other methods. This intensive laboratory/computational
course focused on the major techniques used to determine the three-dimensional
structures of macromolecules. It was designed for scientists with a working
knowledge of protein structure and function, but who are new to macromolecular
crystallography. Topics covered included protein crystallization, membrane
protein crystallization, crystal characterization, data collection, cryo-
crystallography, data reduction, anomalous dispersion, phase determination,
molecular replacement and averaging, electron density interpretation, structure
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refinement, molecular graphics, molecular dynamics, and multidimensional
nuclear magnetic resonance. Participants learned through extensive hands-on
experiments and informal discussions and lectures on current applications of
these and related procedures given by outside speakers.
PARTICIPANTS
Dan ley, D., M.S., Pfizer Central Research
Eger, B., Ph.D., University of Toronto
Fethiere, J., Ph.D., University of Alberta
Francklyn, C., Ph.D., University of Vermont
Hruza, A., B.A., Shering Plough Research Institute
Jewell, D., Ph.D., Scripps Research Institute
Jessen, S., Ph.D., Rutgers University
Kuyper, L., Ph.D., Burroughs-Wellcome Company
Parmentier Lesage, F., Ph.D., University of Montreal
SEMINARS
Aggarwal, A., Columbia University. The Application of MAD
to protein phasing.
Brunger, A., Yale University. Models of thermal motion and
bulk solvent for macromolecular crystal structures.
Burley, 5., Rockefeller University, HHMI. Co-crystal structure
of TBP recognizing the minor groove of a TATA element.
Clark, K., The Rockefeller University. Crystallography and
flash-freezing.
Clore, G.M., National Institutes of Health. Determination of
high-resolution structures of proteins by three- and four-
dimensional NMR.
Fitzgerald, P., Merck Sharp & Dohme Research Labs. HIV-
protease: A target for structure-based drug design.
Furey, W., V.A. Medical Center. Structure of the super-
antigen staphylococcal enterotoxin B.
Perrakis, A., B.S., European Molecular Biology Lab
Schaper, S., B.S., Max Planck Institute, Germany
Sridhar, V., Ph.D., National Institutes of Health
Vaughn, D., B.S., California Institute of Technology
Vasudevan, S., M.S., Princess Margaret Hospital, United
Kingdom
Verboven, C., B.S., Catholic University Leuven, Belgium
Yuvaniyama, J., B.S., University of Michigan
Gilliland, G., Center for Advanced Research in Biotechnol-
ogy. (1) Crystallographic studies of enzymatic and sub-
strate specificity of Mu-class glutathione S-transferase. (2)
Ribonuclease A revisited: Crystallographic evidence for
solvent modulated pyrimidine specificity and the high-
resolution anisotropic refinement at 1.04 A resolution.
Jurnak, F., University of California, Riverside. Structure and
function of pectate lyases, the secreted plant virulence
factors that fold into a new type of domain motif.
Kjeldgaard, M., Aarhus University. EF-Tu: A molecular flip-
flop device.
Kossiakoff, A., Genentech, Inc. Structure of the growth
hormone bound to its receptor: Implications for receptor
recognition and activation.
309
McPherson, A., University of California, Riverside. (1) Crys-
tallization of macromolecules. (2) The structure of pan-
creatic a-amylase and its complexes with polysac-
charides.
Otwinowski, Z., Yale University. Scaling and merging of data.
Pflugrath, J., Cold Spring Harbor Laboratory. Area detector
data collection.
Poljak, R., Center for Advanced Research in Biotechnology.
Structure and thermodynamics of an antigen-antibody
reaction.
Quiocho, F., Baylor College of Medicine, HHMI. Protein
plasticity in molecular recognition and signal transduction:
Calmodulin and transport/chemotactic proteins.
Sweet, R., Brookhaven National Laboratory. (1) X-ray
sources and optics. (2) Laue crystallography: A great way
to get data REALLY fast. Some results from dynamic
studies of catalysis.
Tronrud, D., University of Oregon. Macromolecular refine-
ment.
Steigemann, W., Max Planck Institute, Germany. Protein: A
program system for the crystal structure analysis of macro-
molecules.
Welte, W., Universitat Freiburg. Porin: Structure and function
of a membrane channel protein.
Advanced In Situ Hybridization and Immunocytochemistry
October 13-October 26
INSTRUCTORS
Hough, Paul, Ph.D., Brookhaven National Laboratory, Upton, New York
Jacobson, Ken, Ph.D., University of North Carolina, Chapel Hill
Spector, David, Ph.D., Cold Spring Harbor Laboratory, New York
Trask, Barbara, Ph.D., University of Washington School of Medicine, Seattle
ASSISTANTS
Derby, Robert, Cold Spring Harbor Laboratory, New York
Lipfert, Jennifer, University of North Carolina, Chapel Hill
Oliver, Tim, University of North Carolina, Chapel Hill
This course focused on specialized techniques and concepts in microscopy re-
lated to localizing nucleic acid sequences and proteins in cells and preparing
isolated nucleic acids for microscopic examination. The course was designed for
the molecular biologist who is in need of microscopic cell biological approaches
and for the cell biologist who is not familiar with the practical application of the
advanced techniques presented in the course. The course emphasized the use
of the latest techniques and methods in epifluorescence microscopy, confocal
laser scanning microscopy, and electron microscopy to localize nucleic acids
and proteins in mammalian cells. Among the methods presented were prepara-
tion of tagged nucleic acid probes, fixation methods, detection of multiple nucleic
acids in a single cell, chromosome spreads, use of a variety of reporter
molecules and non-antibody fluorescent tags, direct and indirect antibody label-
ing, and detection of multiple proteins in a single cell. In addition, electron micro-
scopic techniques to observe isolated nucleic acids and proteins were present-
ed. For each technique, several experimental protocols were presented allowing
the students to assess the relative merits of each and to relate them to their own
research. The students were encouraged to bring specific probes to the course
that could be used in addition to those provided by the instructors. The
laboratory portion of the course was supplemented by invited lecturers who gave
up-to-the-minute reports on current research using the techniques presented in
the course.
PARTICIPANTS
Aratake, H., Ph.D., Harvard Medical School
Bassnett, S., Ph.D., Uniformed Services University
Becker-Andre, M., Ph.D., Glaxo Institute, Geneva
Blencowe, B., Ph.D., Massachusetts Institute of Technology
Carver, E., B.S., Oak Ridge National Laboratory
Denison, K., B.A., Los Alamos National Laboratory
Fuentes, L., Ph.D., Agriculture Canada Research Station
Glencorse, T., Ph.D., University of Alberta
SEMINARS
Block, S., Rowland Institute for Science. Using optical
tweezers to study biological motors.
Brinkley, W., Baylor College of Medicine. Ultrastructural or-
ganization of the kinetochore.
Haaf, T., Yale University. Localizing DNA sequences at the
fluorescence level.
Hough, P., Brookhaven National Laboratory. Image produc-
tion in the electron microscope and a brief overview of dif-
ferent applications.
Jacobson, K., University of North Carolina. Basic introduc-
tion to light microscopy and fluorescence microscopy.
Murray, J., University of Pennsylvania. Use of confocal mi-
croscopy and deconvolution techniques.
Kaskel, F., Ph.D., SUNY at Stony Brook, New York
Kutchera, W., M.D., University of Utah
Lauer, P., B.S., University of California, Berkeley
Ma, N., Ph.D., Collaborative Research Incorporated
Niblock-Foxx, M., B.A., Bowman Gray School of Medicine
Schroeter, S., Ph.D., Emory University
Southard Smith, M., Ph.D., University of Michigan
Yaworsky, P., B.S., Mayo Clinic, Scottsdale
Oshiro, M. Hamamatsu Photonic Systems, N.J. Video mi-
croscopy.
Singer, R., University of Massachusetts. Cytoplasmic organi-
zation of mRNA.
Spector, D., Cold Spring Harbor Laboratory. (1) An in-
tegrated microscopic approach to examining nuclear or-
ganization. (2) Immunocytochemistry.
Trask, B., University of Washington School of Medicine.
Mapping chromosomes and interphase nuclei by in situ
hybridization.
Waggoner, A., Carnegie Mellon University. Development of
fluorochromes and filters for fluorescence microscopy.
311
Analysis and Genetic Manipulation of Yeast Artificial
Chromosomes
October 14-October 27
INSTRUCTORS
Green, Eric, M.D., Ph.D., Washington University, St. Louis, Missouri
Clare Huxley, Ph.D., St. Mary's Hospital, United Kingdom
Rothstein, Rodney, Ph.D., Columbia University, New York, New York
ASSISTANTS
Lisbeth Borbye, Washington University, St. Louis, Missouri
Amanda McGuigan, St. Mary's Hospital, United Kingdom
Sunjevaric, Ivana, Columbia University, New York, New York
Cloning in yeast artificial chromosomes (YACs) is rapidly being applied to a wide
variety of molecular genetic problems. This course provided basic scientific ex-
pertise in current techniques for the analysis and manipulation of YACs. In gener-
al, a blend of theoretical and practical information was provided, with the goal to
establish a strong foundation for applying YAC cloning to a diversity of scientific
problems. Topics included standard yeast genetic techniques (such as the
propagation and storage of cells, tetrad dissection, colony hybridization, and
DNA transformation), YAC library screening using both PCR- and genetic-based
strategies, characterizing YAC inserts by pulsed-field gel electrophoresis and
PCR, manipulating YAC clones by recombination-mediated disruption, targeted
integration, and YAC-YAC recombination, and techniques for introducing YACs
into mammalian cells. Participants learned through hands-on experience, in-
formal discussbns, and lectures given by prominent experts designed to com-
plement the experimental activities.
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PARTICIPANTS
Aksentijevich, I., M.D., National Institutes of Health
Ashworth, A., Ph.D., Chester Beatty Laboratories, United
Kingdom
Campbell, M., B.S., Los Alamos National Laboratory
Del-Favero, J., Vrije University Brussels, Belgium
Haub, 0., Ph.D., Sloan Kettering Institute
Herron, B., B.S., David Axelrod Institute
Koide, T., Ph.D., University of Cambridge, United Kingdom
Michalek, W., B.S., Technical University of Munich, Germany
SEMINARS
Carle, G., Universite de Nice, France. Practice and pitfalls of
pulsed-field gel electrophoresis in large DNA analysis.
Foote, S., Whitehead Institute. Overlapping YAC clone map-
ping of the human Y chromosome.
Green, E., Washington University. Application of YAC clon-
ing to the mapping of human chromosomes.
Hieter, P., Johns Hopkins University. Modification of YACs
using homologous recombination-based techniques.
Huxley, C., St. Mary's Hospital, United Kingdom. Transfer of
YACs into mammalian cells.
Pennetta, G., B.S., University of Geneva, Switzerland
Peterfy, M., Ph.D., Amgen, Inc.
Saeger, J., B.S., Princeton University
Schmitt-John, T., Ph.D., GSF Research Center, Germany
Schoenmakers, E., Ph.D., Center for Human Genetics, The
Netherlands
Stern, M., M.S., University of Texas
Street, V., B.S., University of Washington
Wagner, S., Ph.D., MRC, Cambridge, United Kingdom
Krizman, D., National Institutes of Health. Identifying genes in
genomic clones by exon trapping.
Lovett, M., University of Texas Southwestern Medical Cen-
ter. Identifying genes in genomic clones by direct selec-
tion.
Olson, M., University of Washington. YACs: Past, present,
and future.
Trask, B., University of Washington. FISHing with YACs.
Rothstein, R., Columbia University. Exploring genome
stability in Saccharomyces cerevisiae.
Molecular Genetics, Cell Biology, and Cell Cycle of Fission Yeast
November 2-November 15
INSTRUCTORS
Chappell, Tom, Ph.D., Duke University, Durham, North Carolina
McLeod, Maureen, Ph.D., State University of New York, Brooklyn
Young, Paul, Queens University, Canada
ASSISTANTS
Edwards, Kevin, Duke University, Durham, North Carolina
Schettino, Annette, State University of New York, Brooklyn
Recent advances in cell cycle research, largely due to studies on the fission
yeast Schizosaccharomyces pombe, have prompted much interest in this
organism. Although cell cycle studies continue to flourish, S. pombe is in-
creasingly being chosen as a model organism for investigations
into other
aspects of cell biology and genetics using the powerful molecular
and genetical
techniques available. The content of the course reflected all these areas
of inter-
est and provided participants with the skills necessary to pursue their own
inves-
tigations. Topics covered included mutagenesis and analysis of mutants,
trans-
formation and gene transplacement techniques, isolation
of nuclei, preparation of
nuclear DNA, plasmid recovery from yeast into bacteria, cell cycle
methods,
cytology, and immunological techniques. In addition to hands-on
experience,
participants had the opportunity to learn through informal group
discussions and
formal lectures given by prominent S. pombe researchers drawn
from the ex-
panding international community.
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PARTICIPANTS
Atkins, D., Ph.D., R.W. Johnson Pharmaceutical Research In-
stitute
Birse, C., Ph.D., University of Oxford, United Kingdom
Bonneville, J.-M., Ph.D., CNRS/ISV, France
Bureik, M., Ph.D., Universitat des Saarlandes, Germany
Causton, H., Ph.D., University of Uppsala, Sweden
Clyne, R., B.A., Johns Hopkins University
Erpel, T., M.S., EMBL, Germany
Hildebrandt, V., Ph.D., University of California, Los Angeles
SEMINARS
Beach, D., Cold Spring Harbor Laboratory. Cell cycle.
Dunphy, W., California Institute of Technology. Biochemical
characterizations of cell cycle control.
Enoch, T., Harvard University Medical School. Why don't
cells divide until DNA replication is complete?
Gould, K., Vanderbilt University. Genetic analysis of
cytokinesis.
Hoffman, C., Boston College. Trials and tribulations of clon-
ing git+ genes in S. pombe.
Klar, A., NCI Frederick Cancer Facility. Cellular differentia-
Jensen, I., B.S., University of Illinois, Urbana
Kanipes, M., B.S., Carnegie Mellon Mellon Institute
Morse, D., Ph.D., University of Utah
Ocampos, M., M.S., University of Cambridge, United King-
dom
Ortiz, J., Ph.D., Universidad de Cantagria, Spain
Scocca, J., Ph.D., Johns Hopkins School of Medicine
Tonkin, E., Ph.D., University of Wales, United Kingdom
Zhang, M., Ph.D., Cold Spring Harbor Laboratory
tion and the fission yeast mating-type interconversion.
Marks, J., Queens University, Canada. Integration of mitosis
and cytokinesis: The role of cal 16.
Potashkin, J., University of Health Sciences, Chicago. Pre-
RNA splicing.
Russell, P., Scripps Research Institute. Cell cycle control.
Singer, C., Singer Instrument Company, Inc. S. pombe
tetrad dissection.
Wig ler, M., Cold Spring Harbor Laboratory. Studies of RAS in
yeast.
Monoclonal Antibodies from Combinatorial Libraries
November 2-November 15
INSTRUCTORS
Barbas, Carlos, Ph.D., Scripps Research Institute
Burton, Dennis, Ph.D., Scripps Research Institute
ASSISTANTS
Bastidas, Raiza, Scripps Research Institute
Briones, Amelia, Scripps Research Institute
Pilkington, Glenn, American Bio-Technologies
Recent advances in the generation and selection of antibodies from com-
binatorial libraries allow for the rapid production of antibodies from immune and
nonimmune sources. This laboratory/lecture course focused on the construction
of combinatorial antibody libraries expressed on the surface of phage and selec-
tion of desired antibodies from pre-existing libraries by panning. Students
learned the theoretical and practical aspects of constructing combinatorial librar-
ies from immune and nonimmune sources as well as the construction of synthetic
antibody libraries. Production, purification, and characterization of Fab fragments
expressed in E. coli were also covered. The lecture series, presented by a num-
ber of invited speakers focused on the biology of filamentous phage and the utili-
ty of surface expression libraries, expression of antibodies in E. coli and mam-
malian cells, antibody structure and function, antibody diversity, catalytic
antibodies, and recent results on the use of antibodies in therapy.
PARTICIPANTS
Kanjilal, S., Ph.D., Dartmouth Medical School
Karrasch, M., Ph.D., Hoffman-La Roche
Kufer, P., M.D., Institut fur lmmunologie, Germany
Lidell, E., Ph.D., University of Wales, United Kingdom
Linney, E.A., Ph.D., Duke University
Mueller, E., Ph.D., University of Bern, Switzerland
Hiroyoshi, 0., Ph.D., Science University of Tokyo, Japan
Rosell Vives, E., Ph.D., MERCK-IGODA, S.A., Spain
SEMINARS
Barbas, C., Scripps Research Institute. Antibodies from
synthetic libraries.
Burton, D., Scripps Research Institute. Antibodies from im-
mune libraries.
Clackson, T., Genentech, Inc. Phage display of proteins.
Dimmock, N., University of Warwick. Neutralization of
animal viruses by antibody.
Janda, K., Scripps Research Institute. Catalytic antibodies.
Scarselli. E., M.D., I.R.B.M., Rome, Italy
Schlager, J., Ph.D., U. S. Army Medical Research Institute
Steinberger, P., M.S., University of Vienna, Austria
Valdivia, M., Ph.D., University of Cadiz, Spain
Vieira, J.G., Ph.D., Escola Paulista de Medicina, Spain
Walker, J., B.S., Bristol, United Kingdom
Wang, Y., M.D., Beijing Institute for Cancer Research, China
Yokoyama, I., Ph.D., Public Health Research Institute, New
York
Larrick J., Palo Alto Institute for Molecular Biology. An over-
view of antibodies in biotechnology.
Model, P., Rockefeller University. Phage biology.
Sanz, I., University of Texas Health Science Center. Genera-
tion and features of antibody diversity.
Wilson, I., Scripps Research Institute. Structural basis of
antigen recognition by antibody.
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Molecular Markers for Plant Breeding
November 2-November 15
INSTRUCTORS
Burr, Ben, Ph.D., Brookhaven National Laboratory,
Upton, New York
Helentjaris, Tim, Ph.D., University of Arizona, Tucson
Tingey, Scott, Ph.D., DuPont Experimental Station, Wilmington, Delaware
ASSISTANTS
Doerge, Rebecca, Cornell University, Ithaca, New York
Krespan, William, DuPont Experimental Station, Wilmington, Delaware
Stevenson, Becky, University of Arizona, Tucson
This course was designed to train scientists in the use of molecular markers in
plant breeding. It was taught through both a theoretical and practical approach
to the subject, including lectures and extensive laboratory work. Participants
learned a variety of techniques that can be used to approach problems such as
single gene introgression, analysis of genetic diversity, gene mapping, and
quantitative trait analysis. These techniques included DNA preparation, non-
radiosotopic Southern analysis, PCR, RAPDs, and DNA sequencing. The course
included training in computational analysis of both RFLP and RAPD data and
taught methods from a variety of plant and animal systems with an emphasis on
potential future strategies. Course participants were expected to have knowledge
of, but not necessarily practical experience with, the basic principles of
molecular biology and genetics.
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PARTICIPANTS
Bohac, J., Ph.D, USDA, ARS, South Carolina
Carson, S., Ph.D., New Zealand Forest Research Institute,
New Zealand
Di Stilio, V., B.S., University of Massachusetts, Amherst
Garcia Garcia, P., Ph.D., Universidad de Leon, Spain
Hookstra, G., Linkage Genetics, Utah
Kindinger, B., Ph.D., USDA, ARS, Oklahoma
Kump, B., Center for Plant Biotechnology & Breeding,
SEMINARS
Beavis, W., Pioneer Hi-Bred International. Comparative
mapping with molecular markers.
Beckmann, J., Centre d'Etude du Polymorphism Humain,
France. Utilization of microsatellites as molecular markers.
Dudley, J., University of Illinois, Urbana. Application of
molecular markers to plant breeding.
Gayle, M., John Innes Center, Cambridge Laboratory, United
Kingdom. Synteny and polyploidy considerations
in plant genomic studies.
Gibson, S., Michigan State University. Use of physical map-
ping methods in plant genomic studies.
Slovenia
Legg, E., M.S., Monterey Laboratories, California
Oliveira, A., M.S., Purdue University
Orjeda, G., M.S., Genetic Resources, Peru
Sutherland, K., M.S., Agriculture Canada, Canada
Van Toai, T., Ph.D., USDA, ARS, Ohio
Wilcox, P., North Carolina State University
Woeste, K., Ph.D., University of Massachusetts, Amherst
Michelmore, R., University of California, Davis. Future direc-
tions with the application of molecular markers.
Rafalski, A., DuPont Experimental Station. New technologies
and the application of molecular markers.
Romero-Severson, J., Agrigenetics. Statistical considera-
tions in the use of molecular markers.
Sederoff, R., North Carolina State University. Application of
molecular markers to perennial crops.
Weir, B., North Carolina State University. Use of molecular
markers in analyzing populations.
Essential Computational Genomics for Biologists
November 3-November 12
INSTRUCTORS
Branscomb, Elbert, Ph.D., Lawrence Livermore Laboratory
Goodman, Nat, Ph.D., Massachusetts Institute of Technology
Marr, Tom, Ph.D., Cold Spring Harbor Laboratory
This course was intended primarily for molecular biologists and geneticists who
are mounting large-scale projects that require informatics components. No prior
experience with the use of computers or mathematics is assumed. Lectures
and
computer work delved deeply into both the theoretical issues and practical ap-
proaches to a number of important computational problems in genomic
analysis.
The course included an overview of informatics systems analysis and design
principles. Topics included such basics as database design and data modeling
to more complex analytical methods. Technical issues relating to
the analysis of
raw data such as image analysis, sequence assembly, physical
mapping,
genetic-linkage analysis, and data integration were covered.
Students were intro-
duced to, and gained hands-on experience with, a variety of software
tools used
In computer systems design and data acquisition and
analysis running on
Macintosh computers. It was intended that students gain
sufficient knowledge
and experience from this course to enable them to initiate
active collaborations
with computational scientists at their home institutions.
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PARTICIPANTS
Acland, G., B.S., Cornell University
Bottu, G., Ph.D., Universite Libre de Bruxelles, Belgium
Burk, R., M.D., Albert Einstein College of Medicine
Chiapello, H., M.D., I.N.R.A., France
Cozzani, F., B.S., C.R.I.B.I., Italy
De Vicente, C., Ph.D., I.R.T.A., Spain
Ellis, L., Ph.D., Texas A&M University
Ismailov, I., Ph.D., University of Alabama, Birmingham
Knecht, M., Ph.D., Biocenter Basel, Switzerland
SEMINARS
Altschul, S., National Library of Medicine. Statistical theory of
sequence searching.
Branscomb, E., Lawrence Livermore Laboratory. (1) An in-
tegrated relational database to support genome mapping.
(2) Physical mapping of genomes.
Chang, W., Cold Spring Harbor Laboratory. Physical map-
ping of genomes.
Cinkowsky, M., Los Alamos National Laboratory. Relational
database to support genome mapping and analysis.
Davison, D., University of Houston. Unix and biological
resources on the INTERNET and various data servers.
Fasman, K., Johns Hopkins University. The genome data-
bases.
Goodman, N., Massachusetts Institute of Technology. Data-
Leung, M., B.S., Tulane University Medical Center
Pouliot, Y., Ph.D., Genethon, France
Saxon, M., Ph.D., Mount Sinai School of Medicine
Shechter, I., Ph.D., University of Colorado
Snoddy, J., Ph.D., Department of Energy, Washington D.C.
Stassen, A., M.S., The Netherlands Cancer Institute, Nether-
lands
Warwar, V., M.S., University of Nebraska
Worley, K., B.S., Baylor College of Medicine
base technologies: Relational, object oriented, etc.
Green, P., Washington University Medical School. (1) Basic
statistics and probability. (2) The Worm sequencing pro-
ject: Gene finding.
Lincoln, S., Whitehead Institute. Genetic Linkage, Map-
Maker/QTL.
Marr, T., Cold Spring Harbor Laboratory. Physical mapping
of genomes.
Pearson, W., University of Virginia. (1) Protein evolution. (2)
Sequence analysis, FASTA, Smith-Waterman.
Schuler, G., National Institutes of Health. MACAW/BLAST
and other NCB! tools.
Smith, R., Dana-Farber Cancer Institute. PIMA, PAUP, se-
quence clustering.
SEMINARS
Cold Spring Harbor Seminars were initiated to provide a semiformal avenue for
communication between the various research groups at the Laboratory. They are
particularly useful for research personnel who have joined the Laboratory during
the summer. The seminars also afford a necessary opportunity for the graduate
students and postgraduate staff to develop their skills in defending, organizing,
and presenting their research.
1993
January
Roberto Malinow, University of Iowa. Long-term synaptic
potentiation: Cellular mechanisms of learning and
memory. (Host: Alcino Silva)
Hank Sadowski, Cold Spring Harbor Laboratory (Gilman
Laboratory). Cell-free activation of a DNA-binding protein
by epidermal growth factor.
Gian Luigi Russo, Cold Spring Harbor Laboratory (Marshak
Laboratory). Interaction between casein kinase II and
p34cdc2 in He La cell division cycle.
Mu-Ming Poo, Columbia University. Plasticity of developing
synapse and molecular mechanisms. (Host: Yi Zhong)
Paul Bingham, SUNY Stony Brook. Nuclear organization and
regulated pre-mRNA processing in Drosophila. (Host:
David Helfman)
Roberto Mariani, Cold Spring Harbor Laboratory
(Skowronski Laboratory). CD4 down-regulation by nef al-
leles isolated from HIV-1-infected individuals.
Richard Treisman, Imperial Cancer Research Fund, London.
Building a growth-factor-responsive transcription com-
plex. (Host: Michael Gilman)
Jiann-Shiun Lai, Cold Spring Harbor Laboratory (Herr
Laboratory). Protein-protein interaction in transcriptional
regulation: Homeodomains do more than just bind DNA.
February
Eric Olson, Baylor College of Medicine. Regulatory networks
controlling myogenin. (Host: David Helfman)
Maria Zapp, University of Massachusetts Medical Center.
Small molecules that selectively block binding of the HIV-
1 Rev protein to its viral RNA site. (Host: Nouria
Hernandez)
Gideon Dreyfuss, HHMI/University of Pennsylvania School of
Medicine. Ribonucleoprotein structures along the pathway
of mRNA formation. (Host: Adrian Krainer)
Akila Mayeda, Cold Spring Harbor Laboratory (Krainer
Laboratory). Factors that regulate alternative splice site
selection.
Seth Grant, HHMI/Columbia University, Center for
Neurobiology and Behavior. Analysis of nonreceptor
tyrosine kinases in synaptic plasticity using targeted gene
disruption. (Host: Winship Herr)
Makis Skoulakis, Cold Spring Harbor Laboratory (Davis
Laboratory). Preferential expression of the catalytic sub-
unit of PKA in mushroom bodies and its role in learning
and memory.
March
Eileen White, Center for Advanced Biotechnology and Medi-
cine, Piscataway, New Jersey. Regulation of programmed
cell death (apoptosis) by the products of oncogenes and
tumor suppressor genes. (Host: Bruce Stillman)
Yukiko Mizukami, Cold Spring Harbor Laboratory (Ma
Laboratory). Manipulating flower structure: Functional
analysis of the Arabidopsis homeotic gene Agamous in
transgenic plants.
Don McCarty, University of Florida, Gainesville. Structure
and function of the Vp1 gene product: A novel transcrip-
tional activator/repressor that regulates seed maturation
and germination. (Host: V. Sundaresan)
Peter Yaciuk, Cold Spring Harbor Laboratory (Moran
Laboratory). Characterization of the E1A-associated 300-
kD host cell protein and its associated cell growth regulat-
ing activity.
Susan Lobo, Cold Spring Harbor Laboratory (Hernandez
Laboratory). The role of the TATA-binding protein in RNA
polymerase III transcription.
April
Pat Hearing, SUNY Stony Brook. Viral-cellular protein inter-
actions involved in activation of adenovirus transcription.
(Host: Winship Herr)
Mike Tyers, Cold Spring Harbor Laboratory (Futcher
Laboratory). How S. cerevisiae cell cycles are started,
stopped, and coupled.
Barbara Meyer, University of California, Berkeley. Molecular
themes in C. elegans sex determination and dosage com-
pensation. (Host: Hong Ma)
Andrew Tomlinson, Columbia University. Organization of the
proximodistal axis of Drosophila appendages: The com-
bined action of wingless and dpp. (Host: Rob Martiens-
sen)
Robert Mihalek, Cold Spring Harbor Laboratory (Tully
Laboratory). Progress toward clong latheo, a new gene in-
volved in learning in Drosophila.
October
Tony Pawson, Samuel Lunenfeld Research
Center, Mt. Sinai
Hospital, Toronto. SH2 and SH3 domains control protein
interactions in signal transduction. (Host: Dafna Bar-Sagi)
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October (continued)
Linda Van Aelst, Cold Spring Harbor Laboratory (Wig ler
Laboratory). Ras function and map kinase cascade.
Tim Mitchison, University of California, San Francisco.
Cytoskeletal dynamics in vivo and in vitro. (Host: Dave
Casso)
Xiaodong Cheng, Cold Spring Harbor Laboratory. How does
DNA become methylated? The crystal structure of Hhal
methylase in complex with DNA.
Stanley Korsmeyer, HHMI/Washington University. BcI-2/Bax:
A rheostat that regulates cell death. (Host: Carol Greider)
Cindy Sadowski, Cold Spring Harbor Laboratory
(Hernandez Laboratory). Targeting TBP to the PSE, a non-
TATA box cis-regulatory element present in snRNA
promoters.
November
William Stet ler-Stevenson, Extracellular Matrix Pathology
Section, National Cancer Institute. Tumor invasion and
metastasis: Role of matrix metalloproteinases and their in-
hibitors. (Host: David Casso)
Carol Greider, Cold Spring Harbor Laboratory. Telomerase
mechanism, reconstitution, and potential role in cellular
immortalization.
Laura Manuelidis. Yale University, Section of Neuropathol-
ogy. Elements of chromosome structure. (Host: David
Spector)
Anthony Rossomando, Cold Spring Harbor Laboratory (Mar-
shak Laboratory). Negative regulation of map kinase
kinase (MKK).
December
Roland Kannar, University of California, Berkeley. Biochemi-
cal and genetic analysis of pre-mRNA splicing factors in
Drosophila. (Host: Carol Greider)
Hong Sun, Cold Spring Harbor Laboratory. MKP-1, a
phosphatase that dephosphorylates and inactivates MAP
kinases in vivo.
Sung-Hou Kim, University of California, Berkeley.The struc-
ture and its functional implications of CDK2, a cell cycle
kinase. (Host: James Pflugrath)
Yi Zhong, Cold Spring Harbor Laboratory. Genetic analysis
of a neuropeptide action in Drosophila.
Howard Eichenbaum, SUNY Stony Brook. Rhyme and
rhythm in the hippocampus: Linking neural coding and
neural plasticity. (Host: Alcino Silva
Dafna Bar-Sagi, Cold Spring Harbor Laboratory. The Ras
signaling complex.
UNDERGRADUATE RESEARCH
An important aspect of the summer program at the Laboratory is the participation
of college undergraduate students in active research projects under the supervi-
sion of full-time laboratory staff members. The program was initiated in 1959.
Since that year, 397 students have completed the course, and many have gone
on to creative careers in biological science.
The objectives of the program are to provide (1) a greater understanding of
the fundamental principles of biology; (2) an increased awareness of major prob-
lem areas under investigation; (3) a better understanding of the physical and in-
tellectual tools for modern research and the pertinence of this information to fu-
ture training; and (4) a personal acquaintance with research, research workers,
and centers for study.
The following students, selected from more than 170 applicants, took part in
the program, which was supported by Bio-Rad Laboratories, Burroughs-
Wellcome Fund, C. Bliss Memorial Fund, The Garfield Internship, Hanson In-
dustries, Libby Internship, National Science Foundation, Philips Petroleum Foun-
dation., Inc., William Shakespeare Internship, Frederica von Stade Internship,
and Zeneca.
Diane Alonso, Scripps College
Advisor: Xiaodong Cheng
Sponsor: National Science Foundation
Determining the role of the glutamine residue in the binding
and sequence recognition by the Hhal methyltransferase.
Nadine Bewry, Tennessee State University
Advisor: David Helfman
Sponsor: National Science Foundation
Role of the polypyrimidine-tract-binding protein (PTB) in the
regulation of alternative splicing in the rat 13 -tropomyosin
gene.
John (Ewan) Birney, Oxford University
Advisor: Adrian Krainer
Sponsor: Olney/Garfield Internship
mRNA splicing in mammalian cells.
Keith Brennan, Cambridge University
Advisor: Michael Gilman
Sponsor: Hanson Industries
Activation specificity of SRF and Phox1.
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Julie Carruthers, University of California, Santa Cruz
Advisor: Hong Ma
Sponsor: Burroughs-Wellcome Fund
Assay for function of the AGAMOUS gene of Arabidopsis
thaliana in yeast using a fusion construct of the AGAMOUS
DNA-binding domain and the GAL4 activation domain.
Andrea Castillo, Albertson College
Advisor: Robert Martienssen
Sponsor: National Science Foundation
A simple method for cloning mutator suppressible mutants
in maize using PCR.
Howard Chang, Harvard University
Advisor: Kim Arndt
Sponsor: Burroughs-Wellcome Fund
Genetic dissection of the signaling pathways that activate
G1 cyclin expression.
Nupur Ghoshal, Iowa State University
Advisor: Robert McCombie
Sponsor: National Science Foundation
Applications of automated fluorescence sequencing in a
large-scale random and directed sequencing project.
Stephanie Knabe, Pomona College
Advisor: Tim Tully
Sponsor: Burroughs-Wellcome Fund
Effects of dunce mutations on habituation of a jump reflex in
Drosophila melanogaster.
Frank Lee, Duke University
Advisor: Alcino Silva
Sponsor: National Science Foundation
Study of spatial learning and synaptic plasticity in von Reck-
linghausen's neurofibromatosis type 1 (NF1) mutant mice
and a-Ca++-calmodulin-dependent kinase II (a-CaMKII)/
NF1 double-mutant mice.
Eric Liao, Stanford University
Advisor: Yi Zhong
Sponsor: National Science Foundation
Immunocytochemical mapping of PACAP-like neuropeptide
distribution in the third instar larval and adult CNS and PNS
of Drosophila melanogaster.
Laurie Littlepage, University of Texas, Austin
Advisor: Bruce Futcher
Sponsors: Bliss Internship; Bio-Rad Laboratories, Inc.; Phil-
lips Petroleum Foundation, Inc.
Use of the two-hybrid screen to find proteins associated
with Cln2, Cln3, and other cell cycle proteins.
Michele Pierre-Louis, Brown University
Advisor: Winship Herr
Sponsor: National Science Foundation
Protein-protein interactions between virion protein-16 and
the Oct-1 transcription factor as a study in the role of a
DNA-binding domain in regulating transcription.
Marko Piirsoo, Tartu University
Advisor: Arne Stenlund
Sponsor: Libby Internship
Studies on the functions of M protein in BPV-1 replication.
Marta Rosario, University of Glasgow
Advisor: Michael Wig ler
Sponsor: Shakespeare Internship
Detection of specific protein-protein interactions in the mam-
malian Ras signal transduction pathway using the two-
hybrid system.
Carolyn Ruddell, University of Liverpool
Advisor: David Beach
Sponsor: von Stade Internship
Identification of novel proteins that physically interact with
cell cycle regulators, using the two-hybrid screen in Sac-
charomyces cerevisiae.
Wendy Schaub, Beloit College
Advisor: Jeff Kuret
Sponsor: National Science Foundation
Determining the functional role of members of the casein
kinase 1 family of proteins.
Patricia Sung, University of Texas, Austin
Advisor: Venkatesan Sundaresan
Sponsor: Burroughs-Wellcome Fund
Use of inverse polymerase chain reaction for amplifying
Arabidopsis genomic sequences flanking transposed Ds
elements.
Fiona Thistlethwaite, Cambridge University
Advisor: Bruce Stillman
Sponsor: Zeneca
Subcloning and expression of Mcm2.
NATURE STUDY PROGRAM
The Nature Study Program gives elementary and secondary school students the
opportunity to acquire a greater knowledge and understanding of their environ-
ment. Through a series of specialized field courses, younger students can
engage in introductory programs such as Nature Bugs and Nature Detectives I
and II, and older students can enroll in more advanced programs such as Marine
Biology and Nature Photography.
During the summer of 1992, a total of 420 students participated in 29 courses
within the program; 17 of these courses were filled to capacity. The classes were
held outdoors, weather permitting, at the Uplands Farm Preserve, the head-
quarters of the Long Island Chapter of the Nature Conservancy. The Laboratory
has equipped and maintains classroom and laboratory facilities as well as a
darkroom at Uplands Farm. This facility is used as a base for the students' ex-
ploration of the local environment. Field classes are held on Laboratory grounds,
St. John's Preserve, Fire Island National Seashore, Caumsett State Park, the Cold
Spring Harbor Fish Hatchery and Aquarium, as well as other local preserves and
sanctuaries.
In addition to the three 2-week sessions, the Adventure Education course
meets on two Saturdays for trips. The students go on a 10-mile bicycle hike to
Sagamore Hill and a 12-mile canoe trip on the Nissequogue River.
PROGRAM DIRECTOR
William M. Payoski, M.A., Adjunct Professor, Nassau Community College
REGISTRAR
Catherine Schratwieser, M.A., Dowling College
INSTRUCTORS
Kimberly Hamilton, B.S., Colgate University
Michael Manfredonia, Teaching Candidate, Marist College
Linda Payoski, B.A., Science Teacher, Uniondale High School
Marjorie Pizza, B.A., Science Teacher, Bayville School District
Donna Stokes, Teaching Candidate
Sarah Whiteside, Photography Undergraduate
COURSES
Nature Bugs
Nature Detectives I and II
Advanced Nature Study
Ecology Explorers
Frogs, Flippers, and Fins
Pebble Pups
Rock Hounds
Bird Study
Freshwater Life
Seashore Life
Marine Biology
Nature Photography
Adventure Education
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The Laboratory would like to acknowledge the generosity of the following com-
panies who loaned equipment and reagents to the various courses:
Adams & List
Ambion, Inc.
Amersham
AMRESCO
Applied Biosystems, Inc.
Axon Instruments
Baxter Scientific
Beckman Instruments, Inc.
Bio 101, Inc.
Biometra
Bio-Rad Laboratories
Biosynth International
Bio-Whittaker
Boehringer Mannheim Biochemicals
Brinkmann Instruments, Inc.
CBS Scientific
Calbiochem
Cell Genesys, Inc.
Chroma Technology Corp.
Clontech Laboratories, Inc.
Costar
Drummond Scientific
Epicentre Technologies
Eppendorf
Fisher Scientific
FMC Corporation
Fotodyne, Inc.
Fuji Medical Systems
General Valve Corporation
GIBCO/BRL
Hamamatsu Photonic Systems Corp.
Hewlett Packard
Hoefer Scientific
Hyclone Laboratories
IntelliGenetics, Inc.
Intermountain Scientific
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International Biotechnologies,
Inc. (IBI)
Invitrogen Corp.
ISCO
Kramer Scientific
Micro Video Instruments
Millipore Corp.
MJ Research, Inc.
Molecular Probes
Narishige, Inc.
New England Biolabs, Inc.
Newport
Nikon, Inc.
Nissei Sangyo America, LTD
Noran Instruments
Olympus Corporation
Omega Optical
Oncor
Operon Technologies
Perkin Elmer Cetus
Pharmacia LKB
Photometrics
Promega Corporation
Qiagen, Inc.
SAS Institute
Savant Instruments, Inc.
Sigma Chemical
Stoelting Autogenics
Stratagene Cloning Systems
Sutter Instruments Co.
Techne-Walter
United States Biochemical Corp.
Vector Laboratories, Inc.
Wallac, Inc.
Warner
Carl Zeiss, Inc.
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BANBURY CENTER
DIRECTOR'S REPORT
Banbury Center continues to be one of the premier sites in the world for small,
workshop-style meetings. In 1993, there were 16 meetings at the Center, at-
tended by 506 participants. In addition, five neurobiology courses were held over
the summer months, and the Center was used for eight other meetings. As usual,
the topics of the scientific meetings were diverse, ranging from highly technical
subjects in molecular biology to Lyme disease to the genetics of manic-
depressive illness.
Participants
We made some refinements to our database at the beginning of 1993, so for the
first time, we can provide information about the geographical distribution of our
visitors. Participants from the United States came from 31 states. California sup-
plied the largest number (65), followed closely by New York (63), Massachusetts
(44), and Maryland (40). These four states alone accounted for 42% of visitors to
Banbury Center in 1993. Ninety participants (18%) came from 14 foreign coun-
tries. Most came from the United Kingdom, and it is striking that Japanese
participants ranked joint second with those from France. This is due in part to the
very strong support Japanese companies are providing to the Cold Spring Har-
bor Laboratory Corporate Sponsor Program. We would like to increase the num-
bers of scientists from abroad, especially from countries more distant than
Europe; however, travel expenses weigh very heavily on the Center's finances.
Molecular Biology
One feature of Banbury Center meetings that contributes to their value and suc-
cess is that they are interdisciplinary. We make a special effort to bring
together
scientists working on related topics from different points of view and in
different
organisms. The advantages of this approach were exemplified in the meeting
Epigenetic Mechanisms of Gene Regulation. Originally intended to discuss
some recent fascinating research in plants, it became clear that to do the subject
justice, the meeting would have to include research on other organisms. In the
end, maize, petunia, tobacco, yeast, fungi, fruit flies, mice, and
human beings
were included! It was a pleasure to have Amar Klar returning to
his old haunts.
Once the amino acids of a protein have been put together in
accordance with
the instructions in its gene, the protein has still to assume its final
three-
dimensional shape. For a long while it was thought that the newly
synthesized
amino acid chain did this spontaneously, with no additional help.
However, it be-
came clear that other proteins were needed and these were
called chaperones.
Subsequent research has shown that chaperones are involved
in many if not all
stages of the life of a protein and have a key role in cellular
metabolism. The
Molecular Chaperones meeting discussed what is known
of the roles of cellular
chaperones and of how they function. How, for
example, does a chaperone
recognize its target protein? And having done so, how
does it interact with the
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Robertson House provides dining and housing accommodations at Banbury Center
protein? This was one of three 1993 Banbury Center meetings organized by Cold
Spring Harbor Laboratory alumni. In this case it was Mary-Jane Gething who did
the hard work of choosing the participants and preparing the program.
The Apoptotic Cell Death: Functions and Mechanisms meeting was
notable on three counts. First, apoptosis is being recognized as a key
phenomenon in an ever-increasing number of biological systems. It occurs as a
programmed event during development in the nervous and immune systems and
in response to agents such as radiation and cytotoxic drugs. Second, a number
of genes, including genes involved in cancers, have been discovered that induce
or suppress apoptosis, and this should speed understanding of the cellular me-
chanisms involved. Third, it is a striking example of the way in which an area of
research can suddenly become a very "hot" topic. This was evident in the
presence of a BBC film crew shooting material for a forthcoming program on cell
death! The timing of the meeting was again just right, and we were able to attract
all the top researchers in the field, including Andrew Wylie, who was the first to
describe the phenomenon as long ago as 1972.
One of the great challenges in biology is to learn how the transcription of
genes is regulated. An ever-increasing number of DNA sequences are being
found that, when bound by specific proteins, control expression of genes. One of
the best characterized of these elements is the KB element that is associated with
a large number of viral and cellular genes. The Banbury Center meeting KB-
binding Proteins: Their Role in Development and Growth Control was
designed to examine this element, especially its control by Rel-related proteins.
The In Vitro Selection from Combinatorial Libraries meeting examined the
latest strategies for producing molecules with new properties. This is very impor-
tant for those searching for new drugs, but unfortunately it is difficult to do so sys-
tematically, in part because we do not know enough about the relationship be-
tween structure and function to make predictions from first principles. An alterna-
tive strategy makes use of combinatorial libraries of molecules together with se-
lection of those forms that have enhanced function. And recently a mutational
step has been included so that the process has parallels with Darwinian evolu-
tion. This was a fascinating meeting in the interplay of theoretical treatments of
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generating molecular diversity and the experimental results of those trying to pro-
duce molecules.
Just a few years ago, the idea that nitric oxide could act as a messenger
molecule would have seemed preposterous. But now it is clear that nitric oxide is
a key intermediate in a variety of physiological processes, including mediating
blood vessel relaxation and functioning as a novel form of neurotransmitter. It
may even be involved in the development of long-term memory. There remain
many interesting and perplexing features of nitric oxide and this meeting, Nitric
Oxide: Molecular Mechanisms of Synthesis and Action, examined some of
them, especially the regulation of nitric oxide synthase, the enzyme that makes
nitric oxide.
Angiogenesis is the process by which new blood vessels are formed. This is
a crucial part not only of normal development, but also of tumor growth. The Me-
chanisms of Developmental and Tumor Angiogenesis meeting reviewed the
latest findings on how angiogenesis is controlled. A major emphasis of the meet-
ing was on the evolving knowledge of proteins that influence normal and
pathological angiogenesis. These include a variety of stimulatory growth factors
as well as inhibitory factors such as thrombospondin. In addition, cell surface
and extracellular matrix molecules have a role in determining how endothelial
cells proliferate and form new blood vessels. This was the second of the Cold
Spring Harbor Laboratory alumni meetings, and in this case, Doug Hanahan was
one of the principal organizers.
Developments in Human Genetics
Diagnostic tests using DNA probes are proving to be extremely powerful be-
cause of their specificity, accuracy, and speed. The real impact of DNA-based
diagnosis will come only when the tests can be used in routine clinical chemistry,
microbiology, and pathology laboratories. This meeting, The Future of DNA-
based Diagnosis, funded by Helix Partners Inc., was held to review some of the
new research strategies being developed to move these mutation detection sys-
tems into routine large-scale application. Thus, a numberof talks discussed the
use of robot systems to increase the reliability and speed of tests, and there was
a critical evaluation of advances in DNA sequencing by hybridization. It was a
particular pleasure to have Ed Southern presenting his work in this area.
DNA-based diagnostics are all very well, but the ultimate goal of clinical
geneticists is to treat individuals afflicted with genetic disorders. This goal
has
been achieved for the immunodeficiency caused by adenosine deaminase,
where gene therapy is being used successfully. Duchenne muscular dystrophy
(DMD) is a genetic disorder, affecting boys, in which the muscles degenerate.
There is no treatment or cure and the boys die in their late teens or
early twenties.
We explored in this meeting, Gene Reactivation as a Therapeutic
Strategy for
Duchenne and Becker Muscular Dystrophies, a novel approach to
treating
DMD in which a muscle protein that is normally turned
off in adult life might be
turned on again and so take the place of the mutant
protein that fails to work in
DMD. The meeting included the world's authorities on the molecular
biology of
DMD and scientists who have been working on a similar strategy
for treating the
thalassemias. In part as a result of these deliberations, the
Laboratory has enter-
ed into a collaboration with Oncogene Science, Inc., to search
for drugs that
could switch on the second protein.
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The monies from the William Stamps Farish Fund are being used for the sup-
port of Banbury Center meetings on complex, polygenic disorders and the 1993
meeting in the series was the Polygenic Basis of Cancer. For many years,
epidemiological data had suggested that cancers were the result of mutations in
a number of genes, a prediction confirmed by the molecular analysis of muta-
tions in oncogenes. We decided that the time was ripe to bring together
scientists working on a wide variety of cancers to see what common themes are
emerging as regards the mechanisms underlying the origin and selection of mul-
tiple genetic alterations in primary human tumors. A session of special interest
was that discussing how the products of tumor suppressor genes were related to
control of the cell cycle. The meeting was notable also for beginning on the day
of the worst snow storm of the 1992-1993 winter. One participant made three at-
tempts to come here from Boston before succeeding and arriving at the end of
the first day!
Lyme Disease
Banbury Center was the site of a very successful meeting on Lyme disease in
1991. Since that time, the pace of research on all aspects of the causative agent,
a spirochaete called Borrelia burgdorferi, has accelerated, and the time was right
to review what has and has not been achieved. For this reason, the meeting,
Molecular and Immunologic Aspects of Lyme Disease, covered a wide range
of topics, from molecular biology and immunology, through pathogenesis, detec-
tion, and diagnosis, to vaccine development. Unfortunately, many issues, espe-
cially in relation to diagnosis and treatment, remain unresolved.
Science Policy Meeting
One of the keys to the success of the Banbury Center is that we have the
flexibility to put on meetings at very short notice. This is important for scientific
meetings but even more so for meetings discussing science policy: We are able
to respond very rapidly to new developments. An example of such a meeting was
that on Industrial Sponsorship of Research in Academic Institutions, which
was prompted by the controversy raised by the research agreement between the
Scripps Research Institute and Sandoz. However, this controversy was not the
focus of the meeting which reviewed and discussed the different types of ar-
rangements being made between academic institutions and companies and the
merits and demerits of these agreements. The meeting was notable in having
representatives of academic institutions, large and small companies, congress-
ional staff (including staff from the Congressional committee that is pursuing this
matter and from the Vice President's office), the NSF Inspector-General, a deputy
commissioner from the FDA, and eminent scientists. It is always hard to measure
the success of such a meeting, but it was clear that the participants welcomed
the opportunity to discuss the issues in a nonadversarial situation.
Baring Brothers/Dillon Read/Cold Spring Harbor Laboratory Meeting
This was the eighth in the series of Banbury Center meetings for senior execu-
tives of pharmaceutical, biotechnology, and venture capital companies. They are
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Baring Bros./CSHL Conference (Francis Collins at dais)
extraordinary meetings and this year's meeting, The Human Genome Project In-
cluding Its Commercial Application, was no exception. We were fortunate to
have as speakers eminent scientists who not only are at the forefront of their dis-
cipline, but are wonderful speakers as well. The meeting began with a talk by
Francis Collins on the revolution that molecular human genetics is bringing about
in clinical practice and finished with a vision of the future with a presentation by
Kenneth Culver on gene therapy. This is the last of the present series to be
funded by the London merchant bank Baring Brothers & Co. and Dillon Read, its
American partner. It was especially pleasing that our collaboration ended on
such a high note.
Charles A. Dana Foundation Project on Manic Depressive Illness
The Charles A. Dana Foundation made a very substantial grant to Cold Spring
Harbor Laboratory as part of a new Dana initiative on research
on the genetic
basis of manic depressive illness. Our partners in the project are Johns Hopkins
Medical School and Stanford University Medical School. Part of the Cold
Spring
Harbor Laboratory effort is to promote research through having meetings.
The
first of these, The Genetics of Manic Depressive Illness,
held in December,
brought together psychiatrists and geneticists who are working on this
difficult
problem to review current progress, to examine what makes
this research so dif-
ficult, to suggest new strategies for genetic analysis,
and to look to the future. It
was very helpful in orientating the Cold Spring Harbor Laboratory
database pro-
ject and will, we hope, promote closer cooperation between all
the grou rps pusu-
ing this research.
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Human Genetics and Genome Analysis Workshops
We held the last of the current series of Genetics Workshops for Nonscientists,
funded by the Department of Energy, in February. These workshops, styled after
the Sloan Foundation workshops but dealing exclusively with human genetics
and doing so in more detail, have been very successful. A total of 92 participants
from 28 states took part in the four workshops. They included teachers, Congres-
sional staff, theologians, bioethicists, journalists, lawyers, and patient advocates.
The workshops provided an opportunity for individuals with a special interest in
human genetics to learn about the science of genetics and its application to hu-
man beings and what the consequences might be of our increasing knowledge
of human genetics. Fortunately, the Department of Energy agrees with our as-
sessment of the workshops and has decided to fund a further two workshops. We
are going to hold the first of these for a section of society that needs to be
brought up to speed on human genetics, namely, primary care physicians. Our
first workshop will be for the directors of continuing medical education in local
hospitals. We hope that they will be so enthused by modern human genetics that
they will return to their colleagues and encourage them to take the same course.
Other Meetings
The Center has been used by local groups throughout the year. The Village of
Lloyd Harbor held two seminars for residents in February and March. In May, the
Cold Spring Harbor School District came here, and in August, West Side School
held a faculty meeting here. The Board of Huntington Hospital held their annual
review at Banbury in September, and the Lloyd Harbor Conservation Board
hosted the North Shore Environmental Conference here in November.
Funding
Unfortunately, the costs of travel and board and lodging continue to rise.
Fortunately, the generosity of the members of the Cold Spring Harbor Laboratory
Corporate Sponsor Program, and other companies and foundations, enables us
to continue our exciting program at Banbury Center. There is no doubt in my
mind that this program would not survive if we had to rely on federal funding; the
funding is not there and I would be buried under a mountain of grant applica-
tions. The Corporate Sponsors provided support for six meetings in 1993: Nitric
Oxide: Molecular Mechanisms of Synthesis and Action; Mechanisms of De-
velopmental and Tumor Angiogenesis; KB-binding Proteins: Their Role in
Development and Growth Control; Apoptotic Cell Death: Functions and Me-
chanisms; Molecular Chaperones; and Epigenetic Mechanisms of Gene
Regulation. An average of six scientists from Corporate Sponsor companies at-
tended each of these meetings. Smith-Kline Beecham Pharmaceuticals very
kindly allowed us to use funds remaining from an earlier meeting for the 1993
meeting In Vitro Selection from Combinatorial Libraries. Companies were es-
pecially generous in their support of the meeting Molecular and Immunologic
Aspects of Lyme Disease. Abbott Laboratories, Allen & Hanburys, Connaught
Laboratories, Med Immune Inc., and Pfizer Laboratories all helped to make this a
successful meeting. Helix Partners Inc. sponsored The Future of DNA-based
Diagnosis, a meeting of special interest in that we designed it to cover basic re-
search and potential applications.
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Foundations continue to be supportive of Banbury Center meetings. The Wil-
liam Stamps Farish Fund provided support for the second of the series of meet-
ings on complex human genetics, and the Charles A. Dana Foundation funded
the first in the series of meetings related to the genetics of manic depressive ill-
ness. Last year, I wrote a special tribute to the Alfred P. Sloan Foundation, which
had, after 12 years, reluctantly declined to provide us with further support. How-
ever, the good that foundations do lives on after they are gone, and in this case,
we had sufficient funds left to hold one last meeting, that on Industrial Sponsor-
ship of Research in Academic Institutions. It was among the most interesting
of the Sloan meetings that we have held. The Association Francaise contre Les
Myopathies and the Muscular Dystrophy Association both contributed to the
meeting, Gene Reactivation as a Therapeutic Strategy for Duchenne and
Becker Muscular Dystrophies. Finally, the Office of Health and Environmental
Research of the Department of Energy funded The Workshop on Human
Genetics and Genome Analysis, a Genetic Workshop for Nonscientists. These
have been very successful and we look forward to the new series of workshops
funded by D.O.E.
Banbury Center Meeting House
Banbury Center Meeting Room and Library
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Looking Forward to 1994
The 1994 Banbury Center program looks to be as interesting and varied as in
previous years. We will continue to have meetings on topics that are at the cut-
ting edge of research as well as meetings that deal with wider issues of research.
I am looking forward especially to continuing the meetings related to manic
depressive illness sponsored by the Charles A. Dana Foundation. The program
includes public education, and this year we will be holding a workshop for jour-
nalists and Congressional staff. A second project of great promise is being sup-
ported by the Robert Wood Johnson Foundation. Gordon Hargraves (Develop-
ment Office) and I persuaded the Foundation that human genetics should be a
part of its health care program. Banbury Center has held many meetings on re-
search aspects of human molecular genetics and now we are going to look at the
provision of genetic services and the role of genetics in the modern health care
system.
Finally, my thanks to Bea To liver and Ellie Sidorenko in my office and to Katya
Davey in Robertson House. They, as usual, have kept the whole operation run-
ning smoothly. Danny Miller and Andy Sauer have kept the Banbury Center
grounds looking wonderful, one of the features of the Center that makes it unique.
Jan A. Witkowski
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MEETINGS
The Future of DNA-based Diagnosis
January 10-January 13
FUNDED BY
Helix Partners
ARRANGED BY
C.T. Caskey, Howard Hughes Medical Institute, Baylor College of Medicine, Houston,
Texas
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
SESSION 1: Technical Advances I
Chairperson: E.M. Southern, University of Oxford, United Kingdom
J. Gordon, Abbott Laboratories, North Chicago, Illinois: The
marriage of immunoassay technology to DNA-based diag-
nostics.
E.S. Winn-Dean, Applied Biosystems, Inc., Foster City, Cali-
fornia: Applications of DNA probe ligation detection tech-
nology.
F.W. Studier, Brookhaven National Laboratory, Upton, New
York: DNA sequencing by priming with strings of con-
tiguous hexamers.
J. Quint, Beckman University, Fullerton, California: Robotic
automation of dot blots.
M. Bywater-Ekegard, Pharmacia LKB Biotechnology AB,
Uppsala, Sweden: Sequence-based diagnostics: A stan-
dardized system for the handling of multiple clinical
samples.
SESSION 2: Technical Advances II
Chairperson: C.T. Caskey, Howard Hughes Medical Institute, Baylor College of Medicine,
Houston, Texas
M.N. Kronick, Applied Biosystems, Inc., Foster City, Califor-
nia: Application of four-color fluorescent sequencing
technology to new methods of mutation screening.
S.P.A. Fodor, Affymax, Palo Alto, California: Oligonucleotide
arrays and parallel hybridization analysis.
E.M. Southern, University of Oxford, United Kingdom: Analy-
sis of sequence differences by hybridization to array of
D. Yardell, R. Gibbs
oligonucleotides.
R. Crkvenjakov, Argonne National Laboratory, Illinois: Se-
quencing by hybridization (SHB) format I and DNA diag-
nostics: Present and future applications.
M. Eggers, Houston Advanced Research Center, The Wood-
lands, Texas: Microfabricated detection devices for
automated diagnosis by hybridization (DbH).
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SESSION 3: Implementation: Consequences of Different Disorders I
Chairperson: A.G. Motulsky, University of Washington, Seattle
A. Cao, Universita Studi Cagliari, Sardinia, Italy: Application
of DNA technology for screening and prenatal diagnosis
of p-thalassemia in Sardinia.
D.R. Witt, Kaiser Permanente, San Jose, California: The
status of population screening for cystic fibrosis.
B. Weber, Howard Hughes Medical Institute, University of
Michigan, Ann Arbor: Breast cancer DNA-based diag-
nosis: Moving from research to practice.
R.A. Gibbs, Baylor College of Medicine, Houston, Texas:
Diagnostic DNA sequencing for genetics and infectious
diseases.
C.T. Caskey, Howard Hughes Medical Institute, Baylor Col-
lege of Medicine, Houston, Texas: Screening for
premutation parents.
SESSION 4: Implementation: Consequences of Different Disorders II
Chairperson: C.T. Caskey, Howard Hughes Medical Institute, Baylor College of Medicine,
Houston, Texas
A.G. Motulsky, University of Washington, Seattle: Late onset
diseases.
S.T. Reeders, Howard Hughes Medical Institute, Yale Uni-
versity, New Haven, Connecticut: Adult polycystic kidney
disease: Need for a test in a common late-onset disease.
D.W. Yandell, Massachusetts Eye & Ear Infirmary, Boston:
DNA-based diagnostic testing for cancer predisposition:
Experience to date with p53 and RB.
S.H. Friend, Massachusetts General Hospital Cancer Cen-
ter, Charlestown: Functional assays of tumor suppressor
genes.
D.C. Ward, Yale University School of Medicine, New Haven,
Connecticut: Fluorescence in situ hybridization (FISH) as
a tool for DNA-based diagnostics.
SESSION 5: Implementation: Economic Factors
Chairperson: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
M. Wig ler, Cold Spring Harbor Laboratory, New York: Ge-
netic analysis of disease.
J.L. Cova, Health Insurance Association of America, Wash-
ington D.C.: Insurance companies coverage policy deci-
sions: Present and future.
E.R.B. McCabe, Baylor College of Medicine, Houston,
Texas: Regulation, certification, and public health.
E. Southern
P.G. Debenham, Cellmark Diagnostics, Abingdon, Oxon,
United Kingdom: Development and experience with test
trials of CF kits in Europe.
T.M. Tsakeris, FDA Office of Biotechnology, Rockville,
Maryland: The FDA and DNA diagnostic kits.
T.J. White, Roche Molecular Systems, Inc., Alameda, Cali-
fornia: Impact of FDA actions on diagnostic testing.
Workshop on Human Genetics and Genome Analysis
February 4-February 7
FUNDED BY
Ethical, Legal, and Social Issues Program of the Department of Energy Human Genome
Initiative (Office of Health & Environmental Research)
ARRANGED BY
M. Bloom, DNA Learning Center, Cold Spring Harbor Laboratory, New York
D. Mick los, DNA Learning Center, Cold Spring Harbor Laboratory, New York
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
SESSION 1
D. Mick los, DNA Learning Center, Cold Spring Harbor
Laboratory, New York: Mendelian view of the gene.
M. Saxton, Massachusetts Office on Disability, Boston:
Genetics and cultural attitudes to disability.
J.A. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory, New York: Modern view of the gene.
SESSION 2
M. Bloom, DNA Learning Center, Cold Spring Harbor
Laboratory, New York: Cloning genes.
D. Mick los, DNA Learning Center, Cold Spring Harbor
Laboratory, New York: Using restriction enzymes and
constructing chromosome maps.
SESSION 3
J.A. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory, New York: RFLPs and PCR: What they are;
what they do.
P. Ward, Institute of Molecular Genetics, Baylor College of
Medicine, Houston, Texas: DNA-based diagnosis for hu-
man genetic diseases.
N. Holtzman, Johns Hopkins Medical Institute, Baltimore,
Maryland: Map or maze: The future of human genetics.
SESSION 4
M. Bloom, DNA Learning Center, Cold Spring Harbor
Laboratory, New York: Laboratory: Human DNA finger-
printing by polymerase chain reaction.
M. Bloom, DNA Learning Center, Cold Spring Harbor
Laboratory, New York: Laboratory: Inserting DNA into
bacteria and making gene libraries.
SESSION 5
M. Bloom, DNA Learning Center, Cold Spring Harbor
Laboratory, New York: Laboratory results: Inserting DNA
into bacteria and human DNA fingerprinting.
B. Weber, Howard Hughes Medical Institute, University of
Michigan, Ann Arbor: Breast cancer genetics: Moving
from research to practice.
K. Culver, National Institutes of Health, Bethesda, Maryland:
The first human gene therapy trials.
337
Polygenic Basis of Cancer
February 21-February 24
FUNDED BY
The William Stamps Farish Fund
ARRANGED BY
E.R. Fearon, Yale University School of Medicine, New Haven, Connecticut
SESSION 1: Rate-limiting Mutations, Penetrance of Inherited Mutations, Cell Senescence,
and Other Things We Do Not Understand About Carcinogenesis
J.C. Barrett, National Institute of Environmental Health
Sciences, Research Triangle Park, North Carolina: Ge-
netic basis for cell senescence, aging, and cancer.
SESSION 2: Multiple Genetic Alterations in Human Cancers
J.D. Minna, University of Texas, Dallas: Lung cancer re-
quires multiple genetic lesions to become clinically evi-
dent.
B.J. Reid, University of Washington, Seattle: Barrett's
esophagus: A human model of genetic instability in
neoplastic progression.
W. Isaacs, Johns Hopkins Hospital, Baltimore, Maryland:
Molecular and cellular biology of prostate cancer.
J. Yokota, National Cancer Center Research Institute, Tokyo,
Japan: Biological significance of multiple genetic altera-
tions in human cancer.
E.J. Stanbridge, University of California, Irvine, School of
Medicine: Suppression of tumorigenicity by single
chromosome transfer: Why are multiple genetic altera-
tions selected for in human cancers?
SESSION 3: Role and Mechanisms of Tumor Suppressor Gene Inactivation in Human
Cancers I
C.C. Harris, National Cancer Institute, Bethesda, Maryland:
Mutational spectra of tumor suppressor genes: Hypoth-
esis-generating clues to cancer etiology and mechanism.
S.H. Friend, Massachusetts General Hospital Cancer Cen-
ter, Charlestown: Why Rb and p53 germ-line mutations
are rate-limiting in only certain tissues.
Y. Nakamura, Cancer Institute, Tokyo, Japan: Role of APC
inactivation in human cancer.
J. Groden, Howard Hughes Medical Institute, University of
Utah Medical Center, Salt Lake City: Relationship be-
tween APC germ-line mutations and the polyposis
phenotype: Addressing APC function.
J. Witkowski, E. Lee, E. Fearon
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SESSION 4: Analysis of Tumor Suppressor Gene Function
D.W. Yandell, Massachusetts Eye & Ear Infirmary, Boston: A
comprehensive analysis of mutations in retinoblastoma:
Does the two-hit model fit?
T. Jacks, Massachusetts Institute of Technology, Cam-
bridge: Analysis of mouse strains carrying mutations in
the tumor suppressor genes Rb, p53, and NF-1.
A. Bradley, Baylor College of Medicine, Houston, Texas:
Mutational analysis of tumor suppressor genes in mice.
E.Y.-H. Lee, University of Texas, San Antonio: Mechanism of
the tissue-specific function of the retinoblastoma gene.
D. Haber, Massachusetts General Hospital, Charlestown:
Mutational analysis and functional studies of WT-1.
F.J. Rauscher, The Wistar Institute, Philadelphia, Pennsyl-
vania: Regulation of transcription by tumor suppressor
gene products: Can a common set of target genes regu-
lated by WT1, p53, and Rb be identified whose deregula-
tion accompanies cell transformation?
SESSION 5: Genetic Instability and Alterations in Cell Cycle Control and Checkpoints in
Cancer
T.A. Weinert, University of Arizona, Tucson: Speculation on
compromised checkpoints and genetic instability.
D. Beach, Cold Spring Harbor Laboratory, New York: Cyclin
D and cancer.
G.M. Wahl, The Salk Institute, San Diego, California: Altered
G1 control mediated by tumor suppressor genes: A
prelude to chromosome instability.
T.D. Tlsty, University of North Carolina, Chapel Hill: The ge-
netic regulation of genomic instability in normal and
neoplastic cells.
M.B. Kastan, Johns Hopkins Hospital, Baltimore, Maryland:
Consequences of abnormalities in p53 and other controls
of a mammalian G1 checkpoint.
Epigenetic Mechanisms of Gene Regulation
March 7-March 10
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
R. Jorgensen, University of California, Davis
A. Klar, National Cancer Institute-Frederick Cancer Research and Development Center,
Maryland
R. Martienssen, Cold Spring Harbor Laboratory, New York
SESSION 1: Methylation
Chairperson: R. Martienssen, Cold Spring Harbor Laboratory, New York
setts: Regulation of DNA modification during mammalian
development.
E. Richards, Washington University, St. Louis, Missouri:
Plant DNA methylation mutants.
R. Holliday, CSIRO Laboratory for Molecular Biology, North
Ryde, Australia: Epigenetic inheritance based on DNA
methylation.
T.H. Bestor, Harvard Medical School, Boston, Massachu-
SESSION 2: Repeated Genes and Gene Silencing I
Chairperson: V.E.A. Russo, Max-Planck-Institute for Molecular
Genetics, Berlin, Germany
M. Matzke, Austrian Academy of Sciences, Salzburg,
Austria: Interactions between unlinked, partially
homologous transgene loci leading to inactivation
and
methylation of transgenes in tobacco.
E. Selker, University of Edinburgh, United Kingdom: DNA
methylation and gene inactivation in neurospora.
Rossignol, Universite Paris-Sud, France: Epimutation in
the fungus A. immerses: Cytosine methylation and DNA
repeats.
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SESSION 3: Repeated Genes and Gene Silencing II
Chairperson: M. Matzke, Austrian Academy of Sciences, Salzburg, Austria
0. Mittelsten Scheid, The Friedrich Miescher Institute, Basel, R. Fray, University of Nottingham, Loughborough, United
Switzerland: Interactions between multiple transgene Kingdom: Are sense inhibition and antisense down- regula-
copies in A. thaliana. tion manifestations of the same phenomenon?
E. Signer, Massachusetts Institute of Technology, Cam- D. Inze, Laboratorium Voor Genetica, Gent, Belgium: Post-
bridge: Epigenetic repeat-induced gene silencing in A. transcriptional co-suppression of endogenous and trans-
thaliana. gene p-glucanase gene expression.
SESSION 4: Nuclear Organization and Chromatin Structure I
Chairperson: S.C.R. Elgin, Washington University, St. Louis, Missouri
J.S.P. Hes lop-Harrison, John Innes Center, Norwich, United Hutchinson Cancer Research Center, Seattle, Washington:
Kingdom: Nuclear domains, gene expression, and trans- Variegation phenomena involving somatic pairing in
mission of expression patterns. Drosophila.
S. Henikoff, Howard Hughes Medical Institute, Fred
N. Fedoroff, F. Meins
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SESSION 5: Nuclear Organization and Chromatin Structure II
Chairperson: V. Pirrotta, University of Geneva, Switzerland
B. Stillman, Cold Spring Harbor Laboratory, New York: Pos-
sible epigenetic inheritance of the origin of recognition
complex.
S.C.R. Elgin, Washington University, St. Louis, Missouri:
Heterochromatic protein 1, a known participant in
position-effect variegation in Drosophila, is a highly con-
served chromosomal protein.
P. Avner, Institut Pasteur, Paris, France: X-inactivation and
the X-inactivation center.
L. Hirschbein, Universite Paris-Sud, France: Archived DNA:
Imprinting-like phenomenon in prokaryotic cells.
SESSION 6: Trans-acting Regulators
Chairperson: A. Klar, National Cancer Institute-Frederick Cancer Research and Develop-
ment Center, Maryland
N.V. Fedoroff, Carnegie Institution of Washington, Baltimore,
Maryland: Molecular dissection of the Spm transposable
element's epigenetic control system in transgenic tobac-
co.
V. Pirrotta, University of Geneva, Switzerland: Zest and
polycomb group genes: Relationship between transec-
ion, PEV, and maintenance of gene repression.
SESSION 7: Paramutation
Chairperson: E.R. Signer, Massachusetts Institute of Technology, Cambridge
J. Kermicle, University of Wisconsin, Madison: Gene
duplication and maize R-locus paramutation.
V.L. Chandler, University of Oregon, Eugene: Paramutation
at the b and pl loci in maize: A heritable alteration in the
gene expression of one allele caused by the presence of
SESSION 8: Imprinting
Chairperson: J. Kermicle, University of Wisconsin, Madison
A. Surani, University of Cambridge, United Kingdom: Mech-
anism of gene regulation by chromosomal imprinting in
mice.
D.P. Barlow, Research Institute of Molecular Pathology,
Vienna, Austria: Methylation is the imprinting signal at the
SESSION 9: Epigenetic Patterns in Development
Chairperson: V.L. Chandler, University of Oregon, Eugene
V.E.A. Russo, Max-Planck-Institute for Molecular Genetics,
Berlin, Germany: Methylation and reversible inactivation of
a foreign gene in N. crassa.
K. Cone, University of Missouri, Columbia: Molecular genet-
ic analysis of an antholyanin regulatory gene of maize
that leads to variegated pigmentation.
R. Martienssen, Cold Spring Harbor Laboratory, New York:
Developmental patterns of Mu transposon activity in
maize.
M. Donoghue, Washington University Medical School, St.
another allele.
P. Meyer, Max-Delbruck-Laboratorium, Koln, Germany: A
paramutation phenomenon in transgenic petunia associ-
ated with differences in DNA-methylation.
mouse Igf2r locus.
A. Klar, National Cancer Institute-Frederick Cancer Re-
search and Development Center, Maryland: Regulation
of cell-type switching and silencing the mating type
genes in fission yeast.
Louis, Missouri: Methylation as an imprint of rostrocaudal
position in mice.
F. Meins, Jr., The Friedrich Miescher Institute, Basel,
Swit-
zerland: Developmental and environmental regulation of
homologous gene expression in plants transformed with
plant-defense-related genes.
R. Jorgensen, University of California,
Davis: Novel flower
color patterns can be elicited by pigment transgenes
and reprogrammed by transmissible developmental
im-
prints.
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Molecular and Immunologic Aspects of Lyme Disease
March 28-March 31
FUNDED BY
Allen & Hansburys, Pfizer Labs, Abbott Laboratories, Connaught Laboratories, Inc.,
and Medlmmune Inc.
ARRANGED BY
S.E. Schutzer, UMDNJ-New Jersey Medical School, Newark
J.J. Dunn, Brookhaven National Laboratory, Upton, New York
SESSION 1: Molecular Biology
Chairperson: J.J. Dunn, Brookhaven National Laboratory, Upton, New York
W.M. Huang, University of Utah Medical Center, Salt Lake
City: The chromosome and gene organization of B. burg-
dorferi.
P. Rosa, National Institute of Allergy and Infectious Dis-
eases, Hamilton, Montana: Molecular mechanisms of out-
er surface protein variation.
I. Schwartz, New York Medical College, Valhalla: Ribosomal
genes of B. burgdorferi.
A. Sadziene, University of Texas Health Science Center, San
Antonio: Resistant variants and application to immunity
and pathogenesis.
J.L. Benach, State University of New York, Stony Brook:
Point mutations in OspB result in escape variants and dif-
ferent monoclonal antibody reactivity.
D.E. Dykhuizen, State University of New York, Stony Brook:
Genetic diversity and clonality.
SESSION 2: Immunology
Chairperson: P.K. Coyle, State University of New York, Stony Brook
R.J. Dattwyler, State University of New York, Stony Brook: In-
fluence of antimicrobials on the immune response.
S.E. Schutzer, UMDNJ-New Jersey Medical School,
Newark: Early antibody response to OspA.
F.S. Kantor and L.K. Bockenstedt, Yale University School of
Medicine, New Haven, Connecticut: Mapping T-cell
epitopes of OspA N40.
S.E. Malawista, Yale University School of Medicine, New
Haven, Connecticut: The fate of B. burgdorferi in mouse
macrophages: Destruction, survival, recovery.
SESSION 3: Vaccine
Chairperson: R.A. Flavell, Yale University School of Medicine, New Haven, Connecticut
L.E. Erdile, Connaught Laboratories, Inc., Swiftwater,
Pennsylvania: Protective immune responses to OspA.
E. Fikrig, Yale University, New Haven, Connecticut: Im-
munization against tick-borne Lyme borreliosis.
G. Bansal, Medlmmune Inc., Gaithersburg, Maryland: Pro-
tective response elicited by recombinant BCG express-
ing OspA lipoprotein: dA candidate Lyme disease vac-
cine.
J. Radolf, University of Texas Southwestern Medical Center,
Dallas: New insights into the molecular architecture of B.
burgdorferi relevant to Lyme disease pathogenesis and
vaccine development.
SESSION 4: Animal Models
Chairperson: S.W. Barthold, Yale University School of Medicine, New Haven, Connecticut
J.L. Goodman, University of Minnesota, Minneapolis: Guinea
pig model.
J.N. Miller, University of California, Los Angeles, School of
Medicine: Erythema migrans-rabbit model.
J.J. Weis, University of Utah, Salt Lake City: Quantitation of
spirochete number in severely and mildly arthritic con-
genic mice and mapping of an arthritis susceptibility
locus.
M.T. Phillip, Tulane Regional Primate Research Center,
Covington, Louisiana: Early Lyme disease in the rhesus
monkey.
Participant, S. Schutzer
SESSION 5: Pathogenesis
Chairpersons: S.E. Schutzer, UMDNJ-New Jersey Medical School, Newark
F.S. Kantor, Yale University School of Medicine, New Haven, Connecticut
A. Spielman, Harvard School of Public Health, Boston, Mass-
achusetts: Mode of transmission of the Lyme disease
spirochete.
A.C. Steere, New England Medical Center, Boston, Massa-
chusetts: Pathogenetic factors in chronic Lyme arthritis.
S. Batsford, Institute of Medical Microbiology, Freiburg,
Germany: A role for outer surface proteins in Lyme
arthritis.
J. Leung, New England Medical Center Hospital, Boston,
Massachusetts: Adhesion of B. burgdorferi in
pathogenesis.
A.R. Pachner, Georgetown University Hospital, Washington,
D.C: Parallels between human and animal CNS B. burg-
dorferi infection.
L.H. Sigal, UMDNJ-Robert Wood Johnson Medical School,
New Brunswick, New Jersey: Molecular mimicry in
neurologic B. burgdorferi infection.
P.K. Coyle, State University of New York, Stony Brook: Evi-
dence for early and persistent infection in neurologic Lyme
disease.
SESSION 6: Detection and Diagnostics
Chairperson: B.J. Luft, State University of New York, Stony Brook
D.H. Persing, Mayo Clinic, Rochester, Minnesota: Molecular
diagnosis and monitoring of Lyme disease.
J.C. Hunt, Abbott Laboratories, Abbott Park, Illinois: Recom-
binant antigens as IgM and IgG serologic targets for
detection of B. burgdorferi.
L.W. Mayer, Centers for Disease Control and Prevention,
Fort Collins, Colorado: Design of new diagnostic tests for
Lyme disease.
C.A. Norton-Hughes, University of Minnesota Medical
School, Minneapolis: Scanning and quantification of
Western blot staining.
DISCUSSION AND FUTURE DIRECTIONS
Chairperson: R.L. Quackenbush, National Institute of
Allergy and Infectious Diseases, Bethesda, Maryland
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Coffee break
Molecular Chaperones
April 4-April 7
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
M.-J.H. Gething, Howard Hughes Medical Institute, University of Texas Southwestern
Medical Center, Dallas
SESSION 1: Chaperones: Cooperation and Interactions
Chairperson: M.-J.H. Gething, Howard Hughes Medical Institute, University of Texas
Southwestern Medical Center, Dallas
F.U. Hartl, Sloan-Kettering Institute, New York, New York:
Cooperation of molecular chaperones in protein folding.
S. Wickner, National Cancer Institute, National Institutes of
Health, Bethesda, Maryland: The function of DnaJ, DnaK,
and GrpE in the monomerization of P1 RepA protein.
M. Zylicz, University of Gdansk, Poland: Different mecha-
nisms for reactivation of heat-treated RNAP by two E. coli
chaperone systems.
M.G. Douglas, University of North Carolina, Chapel Hill:
Specificity and mechanism for regulation of polypeptide
hsp70 by Ydj1p.
SESSION 2: Other Chaperones/Protein Folding 'Catalysts'
Chairperson: L.M. Gierasch, University of Texas Southwestern Medical Center, Dallas
D.B. Williams, University of Toronto, Ontario, Canada: Partic- C.S. Zuker, Howard Hughes Medical Institute, University of
ipation of the chaperone-like molecule, p88 (calnexin) in California, San Diego, La Jolla: The in vivo role of the
the biogenesis of class I MHC molecules. cyclophilin homolog, ninaA, in rhodopsin biogenesis.
K. Nadeau, Harvard Medical School, Boston, Massachu- A.A. Gatenby, DuPont Company, Wilmington, Delaware:
setts: hsp90: Partner protein recognition and peptide in- Novel chaperones involved in the biosynthesis of
teraction. cytosolic photoreceptors and plastids.
Relaxing/working during coffee break
A. Horwich, R. Morimoto
SESSION 3: Chaperone: Protein Interactions
Chairperson: F.U. Hart!, Sloan-Kettering Institute, New York, New York
L.M. Gierasch, University of Texas Southwestern Medical
Center, Dallas: Chaperone/substrate recognition.
A. Gragerov, Columbia University, New York, New York: In-
teraction of DnaK and DnaJ with newly formed proteins
and model peptides.
M.-J.H. Gething, Howard Hughes Medical Institute, Univer-
sity of Texas Southwestern Medical Center, Dallas: Pep-
tide binding specificity of BiP.
L.E. Hightower, University of Connecticut, Storrs: Identifica-
tion of hsc70-binding peptides selected from phage dis-
play libraries.
J.F. Dice, Tufts University School of Medicine, Boston, Mas-
sachusetts: A role for hsc70 in lysosomal degradation of
intracellular proteins.
SESSION 4: Chaperones: Structure/Function Studies I
Chairperson: A. Horwich, Howard Hughes Medical Institute, Yale University School of
Medicine, New Haven, Connecticut
D. MacKay, Stanford University School of Medicine, Califor-
nia: Structure and mechanism of a 70-kD heat shock
cognate protein.
A.L. Fink, University of California, Santa Cruz: Molecular
mechanism of hsp70: Substrate protein dissociation
precedes ATP hydrolysis.
SESSION 5 Chaperones: Structure/Function Studies II
R.I. Morimoto, Northwestern University, Evanston, Illinois:
Role of the carboxyl domain of hsp70 in substrate recogni-
tion and oligomerization.
L. Hendershot, St. Jude Children's Research Institute,
Memphis, Tennessee: Characterization of the protein
binding and dimerization domain of BiP.
Chairperson: L. Hendershot, St. Jude Children's Research Institute,
Memphis, Tennessee
R. McMacken, Johns Hopkins University, Baltimore, Mary-
land: Mechanistic studies of the ATPase activity of DnaK
and its modulation by peptides, DnaJ and GrpE.
M. Sherman, Harvard Medical School, Boston, Massachu-
setts: Heat-shock-induced phosphorylation of molecular
chaperones DnaK and GroEL in E. coli.
G. Flynn, University of Oregon, Eugene: GroEL
and protein
assembly.
A. Norwich, Howard Hughes Medical
Institute, Yale Univer-
sity School of Medicine, New Haven,
Connecticut: Func-
tional analyses of mutant forms of the
GroEL chaperone,
in vivo and in vitro.
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Gene Reactivation as a Therapeutic Strategy for Duchenne and
Becker Muscular Dystrophies
April 25-April 27
FUNDED BY
Association Francaise contre Les Myopathies and the Muscular Dystrophy
Association
ARRANGED BY
K.P. Campbell, Howard Hughes Medical Institute, The University of Iowa College of
Medicine, Iowa City
K.E. Davies, University of Oxford, United Kingdom
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
SESSION 1: Factors in DMD Gene Therapy
Chairperson: L. Charash, Muscular Dystrophy Association Medical Advisory Committee,
Hicksville, New York
T. Partridge, Charing Cross & Westminster Medical School, H. Gilgenkrantz, INSERM 0129, Paris, France: Phenotype re-
London, United Kingdom: Myogenesis and myogenic stem version of mdx muscle fibers, consecutive to a long-
cells. term adenovirus-mediated expression of minidystrophin.
A.H.M. Burghes, Ohio State University, Columbus: Dys- I. Danko, University of Wisconsin, Madison: Direct injection
trophin production when it is not expected: Revertants in of genes into muscle.
frame Duchennes and exon 3-7 deletions. R.H. Brown, Jr., Massachusetts General Hospital East,
M. Perricaudet, Institut Gustave Roussy, CNRS, Villejuif, Charlestown: Approaches to cell therapy in muscular
France: Adenovirus-mediated gene transfer to muscle dystrophy.
fibers.
SESSION 2: Regulation of Dystrophin and Dystrophin-related Protein Gene Expression
Chairperson: D.A. Fischman, Cornell University Medical College, New York, New York
D. Helfman, Cold Spring Harbor Laboratory, New York:
Alternative RNA processing in the control of gene ex-
pression in muscle and nonmuscle cells.
K.P. Campbell, Howard Hughes Medical Institute, The Uni-
versity of Iowa College of Medicine, Iowa City: Dystro-
phin and utrophin: Functional and comparative aspects.
K.E. Davies, University of Oxford, United Kingdom: Utrophin
regulation in skeletal muscle.
R.G. Worton, Hospital for Sick Children, Toronto, Ontario,
Canada: The DMD gene: Aspects of gene expression.
J.S. Chamberlain, University of Michigan Medical School,
Ann Arbor: Dystrophin expression in wild-type, mdx, and
transgenic mice.
G. Foulks, K. Davies
SESSION 3: Reactivation of Genes as a Therapeutic Strategy
Chairperson: S. Hauschka, University of Washington, Seattle
J.G. Foulkes, Oncogene Science, Inc., Uniondale, New
York: Gene transcription as an approach to drug dis-
covery.
M.D. Schneider, Baylor College of Medicine, Houston,
Texas: Activation of a generic fetal program in cardiac
myocytes by peptide growth factors.
P.A. Jones, University of Southern California, Los Angeles:
Gene activation by 5-azacytidine.
F. Grosveld, National Institute for Medical Research,
London, United Kingdom: Control of globin gene expres-
sion.
G.D. Ginder, University of Minnesota Medical School, Min-
neapolis: Pharmacologic activation of embryonic globin
genes in adult erythroid cells.
G.J. Dover, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Reactivation of a fetal gene.
S. Perrine, Children's Hospital, Oakland, California: Activat-
ing fetal globin genes with arginine butyrate.
Industrial Sponsorship of Research in Academic Institutions
May 23-May 25
FUNDED BY
The Alfred P. Sloan Foundation
ARRANGED BY
J.D. Watson, Cold Spring Harbor Laboratory, New York
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
SESSION 1: Development of Technology Transfer and Biotechnology Policy
Chairperson: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New
York
H. Etzkowitz, Columbia University, New York, New York:
Review of biotech technology and transfer.
E. Beutler, The Scripps Research Institute, La Jolla, Califor-
nia: Lessons from clinical science.
M.L.Williamson, Preston, Thorgrimson, Shidler, Gates and
Ellis, Seattle, Washington: Development of federal tech-
nology transfer policy.
S. Brenner, The Scripps Research Institute, La Jolla, Califor-
nia: Biotechnology transfer in the United Kingdom.
R. Herdman, K. Hudson, C. Scheman
SESSION 2: Current Models for Large-scale Industrial-Academic Interactions I
Chairperson: D. Brown, Carnegie Institution of Washington, Baltimore, Maryland
D. Korn, Stanford University School of Medicine, California: cine.
Stanford University Medical School. G.R. Galluppi, Monsanto Company, St. Louis, Missouri:
J.I. Gordon, Washington University School of Medicine, St. Monsanto Company.
Louis, Missouri: Washington University School of Medi-
SESSION 3: Current Models for Large-scale Industrial-Academic Interactions II
Chairperson: B. Stillman, Cold Spring Harbor Laboratory, New York
R.A. Lerner, The Scripps Research Institute, La Jolla, Cali-
fornia: Scripps Research Laboratory.
G.G. Dellenbaugh, Robert Wood Johnson Pharmaceutical
Research Institute, Raritan, New Jersey: Johnson &
Johnson.
D.M. Livingston, Dana-Farber Cancer Institute, Cambridge,
Massachusetts: Dana-Farber Cancer Institute.
T.O. Poehler, Johns Hopkins University, Baltimore,
Maryland: Johns Hopkins University.
R.B. Shelton, University of California, Davis: University of
California.
J. Pratt, H. Halpern
D. Brown, R. Lerner
SESSION 4: Perspectives by Interested Parties I: Funding Bodies
Chairperson: J. Halpern, University of Chicago, Illinois
L.G. Sundro, National Science Foundation, Washington,
D.C.: National Science Foundation.
G.J. Galasso, National Institutes of Health, Bethesda,
Maryland: National Institutes of Health.
C.A. Alexander, Howard Hughes Medical Institute, Chevy
Chase, Maryland: Howard Hughes Medical Institute.
SESSION 5: Perspectives by Interested Parties II: Scientists
Chairperson: R.C. Herdman, Office of Technology Assessment, Washington, D.C.
Discussants:
F. Grinnell, Southwestern Medical School, Dallas, Texas
D. Nathans, Johns Hopkins Medical School, Baltimore
D. Brown, Carnegie Institute, Washington, D.C.
SESSION 6: Perspectives by Interested Parties III: Biotechnology Companies
Chairperson: R.C. Herdman, Office of Technology Assessment, Washington, D.C.
Discussant:
B.S. Conte, Regeneron Pharmaceuticals, Inc., Tarrytown, New York
SESSION 7: Perspectives by Interested Parties IV: Washington
Chairperson: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New
York
Discussant:
S. Denning, House Subcommittee on Regulation, Business Opportunities, and
Technology,
Washington, D.C.
Pane/ Discussion:
K Hudson, Office of the Assistant Secretary of Health, Washington, D.C.
cheman, Food and Drug Administration, Rockville, Maryland
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Apoptotic Cell Death: Functions and Mechanisms
October 12-October 15
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
G. Evan, Imperial Cancer Research Fund, London, United Kingdom
D. Hockenbery, Fred Hutchinson Cancer Research Center, Seattle, Washington
M.C. Raff, M.R.C. Laboratory for Molecular Cell Biology, London, United Kingdom
SESSION 1: Endonucleases and Other Nuclear Events during Apoptosis
Chairperson: A.H. Wyllie, University Medical School, Edinburgh, United Kingdom
M.K.L. Collins, Chester Beatty Laboratories, London, United
Kingdom: Characterization of an apoptotic nuclease from
mouse bone marrow cells.
W.C. Earnshaw, Johns Hopkins University School of Medi-
cine, Baltimore, Maryland: Nuclear events of apoptosis in
a cell-free mitotic extract.
D. Ucker, Medical Biology Institute, La Jolla, California:
Physiological cell death is an abortive mitosis.
SESSION 2: Cell Cycle Control
Chairperson: A.H. Wyllie, University Medical School, Edinburgh, United Kingdom
R.T. Schimke, Stanford University, California: A nested cell
cycle progression as a signal for apoptosis: Potential
mechanisms.
G. Evan, Imperial Cancer Research Fund, London, United
Kingdom: c-myc: An oncogene and a tumor suppressor
gene.
P. Neiman, Fred Hutchinson Cancer Research Center,
Seattle, Washington: Apoptotic cell death during normal
and neoplastic B-cell development in the bursa of
fabrius.
SESSION 3: p53
Chairperson: G. Evan, Imperial Cancer Research Fund, London, United Kingdom
M.B. Kastan, Johns Hopkins Hospital, Baltimore, Maryland:
Activation of a p53-dependent pathway by irradiation.
M. Oren, The Weizmann Institute, Rehovot, Israel: Role of
p53 in apoptosis: Relevance to survival factor depen-
dence.
T. Jacks, Massachusetts Institute of Technology Center for
Cancer Research, Cambridge: On p53, cell death, and
cancer.
A.H. Wyllie, University Medical School, Edinburgh, United
Kingdom: Regulation of apoptosis by p53 in vitro and in
vivo.
E. White, Rutgers University, Piscataway, New Jersey:
Regulation of apoptosis by the transforming gene prod-
ucts of adenovirus.
SESSION 4: bc1-2 and Related Genes
Chairperson: M.C. Raff, M.R.C. Laboratory for Molecular Cell Biology, London, United
Kingdom
D. Hockenbery, Fred Hutchinson Cancer Research Center,
Seattle, Washington: Bcl -2: A regulator of oxidant stress
in programmed cell death pathways.
S.J. Korsmeyer, Howard Hughes Medical Institute, Washing-
ton University School of Medicine, St. Louis, Missouri:
Regulation of programmed cell death: An endogenous
rheostat of bc/-2/Bax.
D. Loh, Howard Hughes Medical Institute, Washington Uni-
versity School of Medicine, St. Louis, Missouri: T-cell de-
velopment and cell death.
C.B. Thompson, Howard Hughes Medical Institute, Univer-
sity of Chicago, Illinois: bcl-x, a be / -2- related gene that
functioned as a dominant regulator of apoptotic cell death.
M. Hengartner, Massachusetts Institute of Technology,
Cambridge: Molecular genetics of programmed cell
death in C. elegans.
SESSION 5: Cooperative Gene Effects in Lymphoid Cells
Chairperson: M.C. Raff, M.R.C. Laboratory for Molecular Cell Biology, London, United
Kingdom
S. Cory, The Walter and Eliza Hall Institute of Medical Re-
search, Victoria, Australia: be / -2 in lymphopoiesis and
lymphomagenesis.
A.B. Rickinson, The University of Birmingham Medical
School, United Kingdom: Epstein-Barr virus genes pro-
tecting B cells from apoptosis.
SESSION 6: Social Controls
Chairperson: S.J. Korsmeyer, Howard Hughes Medical Institute, Washington University
School of Medicine, St. Louis, Missouri
M.C. Raff, M.R.C. Laboratory for Molecular Cell Biology,
London, United Kingdom: Social controls of cell survival
and death.
J. Savill, Royal Postgraduate Medical School, London, United
Kingdom: Phagocyte recognition and clearance
of cells undergoing apoptosis.
SESSION 7: Apoptotic Signals in T- lymphocyte Interactions
Chairperson: S.J. Korsmeyer, Howard Hughes Medical Institute, Washington University
School of Medicine, St. Louis, Missouri
S. Nagata, Osaka Bioscience Institute, Japan: Fas antigen-
mediated cell death and death of animals.
J.H. Russell, Washington University School of Medicine, St.
Louis, Missouri: fas/gld pathway couples TCR/CD3
stimulation to T-cell suicide in mature T cells.
P. Golstein, Centre d'Immunologie de Marseille-Luminy,
Marseille, France: Molecular mechanisms of T-cell-
mediated cell death.
SESSION 8: Effectors and Inhibitors in Cytolytic Pathways
Chairperson: D. Hockenbery, Fred Hutchinson Cancer Research Center,
Seattle, Wash-
ington
J.A. Ledbetter, Bristol-Myers Squibb Pharmaceutical Re-
search Institute, Seattle, Washington: Superantigen-
induced death of human T-cell clones requires adhesion
mediated by 02-integrins.
P. Anderson, Dana-Farber Cancer Institute, Boston, Massa-
chusetts: Cytotoxic-granule-associated RNA-binding
proteins as mediators of apoptotic cell death.
M. Rothe, Genentech, Inc., South San Francisco,
California:
Individual roles and signaling mechanisms of the two
TNF receptors.
V.M. Dixit, University of Michigan Medical School,
Ann Arbor:
A20, a novel cytokine inducible zinc finger protein
that inhibits apoptosis.
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SESSION 9: Developmental Control of Cell Death
Chairperson: D. Hockenbery, Fred Hutchinson Cancer Research Center, Seattle, Wash-
ington
H. Steller, Howard Hughes Medical Institute, Massachusetts
Institute of Technology, Cambridge: Programmed cell
death in Drosophila.
J. Morgan, Roche Institute of Molecular Biology, Nutley,
New Jersey: Role of immediate-early genes in pro-
grammed cell death.
N.M. Bonini and S. Benzer, California Institute of Technol-
ogy, Pasadena: Cell death in the developing Drosophila
eye.
In Vitro Selection from Combinatorial Libraries
October 17-October 20
FUNDED IN PART BY
SmithKline Beecham Pharmaceuticals
ARRANGED BY
G.F. Joyce, The Scripps Research Institute, La Jolla, California
SESSION 1: Theoretical Aspects
Chairperson: L.E. Orgel, The Salk Institute, San Diego, California
L.A. Loeb, University of Washington, Seattle: Evolution of
herpes thymidine kinases for gene therapy.
S. Kauffman, The Santa Fe Institute, New Mexico: Search on
high-dimensional molecular fitness landscapes.
J. McCaskill, Institute for Molecular Biotechnology, Jena,
Germany: Spatially resolved amplification and selection.
P. Schuster, Institute for Molecular Biotechnology, Jena,
Germany: The search for RNA structures.
G.D. Stormo, University of Colorado, Boulder: Nucleic acid
libraries.
D.C. Youvan, Massachusetts Institute of Technology, Cam-
bridge: Computational optimization of combinatorial
mutagenesis.
SESSION 2: Nucleic Acid Libraries
Chairperson: J. Szostak, Massachusetts General Hospital,
L. Gold, University of Colorado, Boulder: Novel oligonuc-
leotides.
D.J. Ecker, ISIS Pharmaceuticals, Carlsbad, California: Ra-
tional screening of oligonucleotide combinatorial libraries
for drug discovery.
A. Ellington, Indiana University, Bloomington: In vitro selec-
tion of aptames that bind to viral proteins.
J.D. Keene, Duke University Medical Center, Durham, North
SESSION 3: Selection of Ribozymes
Chairperson: L.A. Loeb, University of Washington, Seattle
J.M. Burke, University of Vermont, Burlington: In vitro selec-
tion of hairpin ribozymes.
C. Drlica, Public Health Research Institute, New York, New
York: Biological considerations concerning hammerhead
ribozyme selection.
R. Green, University of California, Santa Cruz: Ribozyme se-
SESSION 4: Phage Presentation Libraries
Chairperson: L. Gold, University of Colorado, Boulder
C.F. Barbas, The Scripps Research Institute, La Jolla, Cali-
fornia: Synthetic antibodies and their use as scaffolds for
the design of conformationally constrained peptides.
H.R. Hoogenboom, Cambridge Antibody Technology
Limited, United Kingdom: Antibodies without immunization
from phage display libraries.
R.C. Ladner, Protein Engineering Corporation, Cambridge,
Massachusetts: Selection of binding proteins.
SESSION 5: Selection of Peptides and Small Organics
Chairperson: R.A. Lerner, The Scripps Research Institute, La Jolla,
California
San Diego, California: The broad utility
in in vitro and
in vivo assays of soluble combinatorial
libraries.
K.S. Lam, Arizona Cancer Center, Tucson:
Application of
selective technology in various model systems.
M. Gallop, Affymax Research Institute, Palo Alto,
California:
Encoded synthetic libraries.
Boston
Carolina: Selection of nucleic acid epitopes to the
antigen-combining sites of antibodies.
L. Leung, Gilead Sciences, Foster City, California: Discovery
and development of a thrombin inhibitor selected from a
combinatorial ssDNA library.
L.E. Orgel, The Salk Institute, San Diego, California: In vitro
selection of DNAs with unusual reactivity.
lections as structural probes.
G.F. Joyce, The Scripps Research Institute, La Jolla, Califor-
nia: Better ribozymes through evolutionary chemistry.
O.C. Uhlenbeck, University of Colorado, Boulder: Using in
vitro selection to study tRNA folding.
R.A. Lerner, The Scripps Research Institute, La Jolla, Califor-
nia: Direct selection for catalytic mechanisms.
H. Lowman, Genentech, Inc., South San Francisco, Califor-
nia: Affinity maturation of human growth hormone using
additive and combinatorial strategies.
G. Zhong, University of Missouri, Columbia: Conformational
mimicry of a chlamydia neutralization epitope on
filamentous phage.
A. Schwienhorst, Max-Planck-Institute for Biophysical
Chemistry, Gottingen, Germany: Experimental ap-
proaches to function space.
P. Schatz, Affymax Research Institute, Palo Alto, California:
Peptide libraries linked to DNA-binding proteins.
R.A. Houghten, Torrey Pines Institute for Molecular Studies,
KB-binding Proteins: Their Role in Development and
Growth Control
October 25-October 28
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
P.A. Baeuerle, Gene Center, Martinsried, Germany
R. Franza, Cold Spring Harbor Laboratory, New York
G.J. Nabel, Howard Hughes Medical Institute, University of Michigan, Ann Arbor
SESSION 1: NF-KB/REL Subunits: Biochemistry and Transcriptional Regulation I
Chairperson: P.A. Baeuerle, Gene Center, Martinsried, Germany
T. Maniatis, Harvard University, Cambridge, Massachusetts:
The role of NF-KB in virus induction of the human B-
interferon gene and the involvement of the high-mobility-
group-protein HMG I (Y).
A. Israel, Institut Pasteur, Paris, France: The RBP-JK family
represents KB-site-specific transcriptional activators.
R. Franza, Cold Spring Harbor Laboratory, New York: Altera-
tion of Rel in a disease model.
G.J. Nabel, Howard Hughes Medical Institute, University of
Michigan, Ann Arbor: NF-KB and HIV replication.
D.W. Ballard, Vanderbilt University School of Medicine,
Nashville, Tennessee: A novel NF-KB complex containing
p65 homodimers: Implications for transcriptional control at
the level of subunit dimerization.
SESSION 2: NF-KB/REL Subunits: Biochemistry and Transcriptional Regulation II
Chairperson: T. Maniatis, Harvard University, Cambridge, Massachusetts
M.J. Lenardo, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, Bethesda,
Maryland: NF-KB regulation of differentiation genes that
control early T-cell development in the mouse thymus.
S. Ghosh, Yale University, New Haven, Connecticut: Regula-
tion of NF-KB during B- lymphocyte differentiation.
I.M. Verma, The Salk Institute, San Diego, California: Regula-
tion of KB/IKB protein and direct association of Rel
with TBP required for KB-driven transcription.
E. Serf ling, University of Wurzburg, Germany: The KB-like
site of the interleukin-2 promoter is a target of suppres-
sion of IL-2 transcription in T cells by agonists of protein
kinase A.
C. Scheidereit, Max-Planck-Institute for Molecular Genetics,
Berlin, Germany: Nuclear translocation control of NE-KB:
Functional domains and role of phosphorylation.
Coffee break
SESSION 3: Dorsal Development and Signal Transduction
Chairperson: G.J. Nabel, Howard Hughes Medical Institute, University of Michigan, Ann
Arbor
S.A. Wasserman, University of Texas Southwestern Medical
Center, Dallas: Regulation of dorsal nuclear import.
R. Steward, Princeton University, New Jersey: Function of
the cactus and dorsal protein.
B. Sha, The Rockefeller University, New York, New York:
Analysis of mice deficient in NF-IKB.
R. Bravo, Bristol-Myers Squibb Pharmaceutical Research In-
stitute, Princeton, New Jersey: ReIB: Role in mouse de-
velopment?
M. Levine, University of California, San Diego, La Jolla:
Characterization of DAF: A Rel protein in Drosophila that
mediates an acute phase response.
Y. Engstrom, Stockholm University, Sweden: KB-binding
proteins regulate the immune response in Drosophila
and other insects.
SESSION 4: REL, p65, and Oncogenesis I
Chairperson: R.G. Roeder, The Rockefeller University, New York, New York
U. Schindler, Tularik, Inc. South San Francisco, California:
The involvement of NF-KB in cytokine induction of cell
adhesion molecules.
A. Manning, The Upjohn Company, Kalamazoo, Michigan:
Inhibition of NF-KB activation in endothelial cells: Inhibi-
tion of leukocyte adhesion.
U.K. Siebenlist, National Institutes of Health, Bethesda,
Maryland: Bcl -3, IKB-2 regulation of KB-binding com-
plexes.
SESSION 5: REL, p65, and Oncogenesis II
Chairperson: R. Franza, Cold Spring Harbor Laboratory, New York
T.D. Gilmore, Boston University, Massachusetts: v-re/ trans-
formation: Functions required for transformation of chick-
en spleen cells by the v-rel oncogene.
P.J. Enrietto, State University of New York, Stony Brook: The
role of c-rel in normal avian development and cell
growth.
R. Dalla-Favera, Columbia University, New York, New York:
Chromosomal translocations involving the NF-KB-2/LYT-
10 gene in lymphoid neoplasia.
SESSION 6: IKB, Structural Motif, Protein/Protein Interactions
Chairperson: P.J. Enrietto, State University of New York, Stony Brook
P.A. Baeuerle, Gene Center, Martinsried, Germany: How is
IKB released from NF-KB?
A.S. Baldwin, University of North Carolina, Chapel Hill:
Regulation of NE-KB activity by cytoplasmic and nuclear
mechanisms.
N.R. Rice, National Cancer Institute-Frederick Cancer Re-
search and Development Center, Maryland: IKB.
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Baring Brothers/Cold Spring Harbor Laboratory Executive
Conference on The Human Genome Project Including Its
Commercial Application
October 29-October 31
ARRANGED BY
J.D. Watson, Cold Spring Harbor Laboratory, New York
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
SESSION 1: Overview of Human Molecular Genetics
F.C. Collins, National Center for Human Genome Research,
National Institutes of Health, Bethesda, Maryland: Human
molecular genetics and its impact on clinical genetics.
SESSION 2: Mapping, Sequencing, and Cloning Genes
E. Lander, Whitehead Institute for Medical Research, Cam-
bridge, Massachusetts: How to find genes.
J. Sulston, Sanger Centre, Cambridge, United Kingdom: Se-
SESSION 3: Genomes and Computers
T. Marr, Cold Spring Harbor Laboratory, New York: Genome
informatics: What it does and a hands-on experiment.
quencing DNA and why do it for a worm?
M.-C. King, University of California, Berkeley: The molecular
genetics of human cancers.
SESSION 4: Applications and Consequences of Molecular Human Genetics
C.T. Caskey, Howard Hughes Medical Institute, Baylor Col-
lege of Medicine, Houston, Texas: DNA-based diag-
nostics: Technical advances and commercial develop-
ments.
K. Culver, Gene Therapy Institute, Iowa City, Iowa: Human
gene therapy: Present status and future developments.
N. Wexler, Columbia University, New York, New York:
Society aspects of human genetics.
Roundtable Discussion:
The human genome and biotechnology.
T. Perkins, E.W. Roberts, J.D. Watson, J.C. Chambers
Mechanisms of Developmental and Tumor Angiogenesis
November 7-November 10
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
D. Hanahan, University of California, San Francisco
J. Folkman, Children's Hospital, Boston, Massachusetts: Introduction.
SESSION 1: Developmental Angiogenesis
Chairperson: R. Auerbach, University of Wisconsin, Madison
F. Dieter len, Institut d'embryologie cellulaire et moleculaire
du CNRS, Nogent Sur Marne, France: Ontogenic emer-
gence of the endothelial network analyzed in the avian
model.
W. Risau, Max-Planck-Institute, Bad Nauheim, Germany:
Molecular mechanisms of vasculogenesis and em-
bryonic brain angiogenesis.
M.L. Breitman, Mount Sinai Hospital, Toronto, Canada: The
Tek endothelial receptor tyrosine kinase is required for
mouse development.
D. Coffin, McLaughlin Research Institute, Great Falls,
Montana: Growth factors in vascular morphogenesis.
SESSION 2: Positive Controls of Angiogenesis I
Chairperson: H.F. Dvorak, Harvard Medical School, Boston, Massachusetts
E. Keshet, The Hebrew University, Jerusalem, Israel: Role of
VEGF in ischemia-induced angiogenesis.
N. Ferrara, Genentech, Inc., South San Francisco, Califor-
nia: VEGF: A paracrine mediator of tumor growth in vivo.
K.H. Plate, Philipps-Universitat Marburg, Germany: Mole-
cular mechanisms involved in glioma angiogenesis.
P.A. D'Amore, Harvard Medical School, Boston, Massa-
chusetts: Endothelial cell-pericyte interactions in the
vasculature.
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SESSION 3: Positive Controls of Angiogenesis II
Chairperson: M. Klagsbrun, Harvard Medical School, Boston,
T. Maciag, American Red Cross, Rockville, Maryland: Mech-
anisms of fibroblast growth factor action.
G. Christofori, University of California, San Francisco: The
angiogenic switch: Angiogenic factors and molecular
events in multistage tumor development.
K. Alitalo, University of Helsinki, Finland: Roles of Tie and
SESSION 4: Complex Controls of Angiogenesis
Chairperson: S.M. Schwartz, University of Washington, Seattle
E.H. Sage, University of Washington, Seattle: Regulation of
angiogenesis by SPARC and type I collagen.
E.F. Wagner, IMP Research Institute, Vienna, Austria:
Polyoma middle T expression and the control of
endothelial cell growth.
Massachusetts
FLT4 receptor tyrosine kinases in megakaryoblastic dif-
ferentiation and angiogenesis.
M. Bernfield, Harvard Medical School, Boston, Massachu-
setts: The Syndecans: A family of cell surface co-
receptors for matrix and growth factors.
V. Bautch, University of North Carolina, Chapel Hill: Trans-
genic mouse models of angiogenesis.
M.S. Pepper, University of Geneva, Switzerland: Angio-
genesis in vitro: Cytokine interactions and extracellular
proteolysis.
SESSION 5: Negative Control of Angiogenesis
Chairperson: D. Hanahan, University of California, San Francisco
N.P. Bouck, Northwestern University, Chicago, Illinois:
Tumor suppressor gene control of thrombospondin and
angiogenesis.
R. Weiner, University of California, San Francisco: The 16-kD
amino-terminal fragment of prolactin: An inhibitor of
angiogenesis.
J. Folkman, Children's Hospital, Boston, Massachusetts: Cir-
culating endothelial inhibitors.
Nitric Oxide: Molecular Mechanisms of Synthesis and Action
November 14-November 17
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
M.A. Marietta, University of Michigan College of Pharmacy, Ann Arbor
SESSION 1: NOS: Regulation and Expression
Chairperson: S.R. Tannenbaum, Massachusetts Institute of Technology, Cambridge
C.F. Nathan, Cornell University Medical College, New York,
New York: Inducible NOS: Molecular aspects of regula-
tion.
T. Michel, Brigham & Women's Hospital, Boston, Massachu-
setts: Biosynthesis and molecular regulation of
endothelial nitric oxide synthase.
T.R. Billiar, Presbyterian University Hospital, Pittsburgh,
Pennsylvania: From rodents to humans: Characterization
of hepatic inducible NOS.
J. Cohen, Royal Postgraduate Medical School, London,
United Kingdom: Cytosine interactions with the inducible
NOS.
J.M. Cunningham, Brigham & Women's Hospital, Boston,
Massachusetts: Regulation of arginine transport.
T. Michel, S. Tannenbaum, M. Marietta, J. Corbin
SESSION 2: NOS: Mechanism
Chairperson: T. Michel, Brigham & Women's Hospital, Boston, Massachusetts
M.A. Marietta, University of Michigan College of Pharmacy,
Ann Arbor: Current studies on NOS.
S. Kaufman, National Institute of Mental Health, National In-
stitutes of Health, Bethesda, Maryland: Studies on mech-
anisms of rat brain NOS.
B.M. Mayer, Universitat Graz, Austria: Characterization of
NOS-binding domains for L-arginine and tetrahydrobiop-
terin.
B.S.S. Masters, The University of Texas Health Science Cen-
ter at San Antonio: Molecular aspects of the constitutive
cerebellar NOS.
D.J. Stuehr, Cleveland Clinic, Ohio: Characteristics of mac-
rophage NOS subunits and their assembly into functional
dimeric enzyme.
SESSION 3: In Vivo Reactions of NO
Chairperson: C.F. Nathan, Cornell University Medical College, New York, New York
B. Demo le, Harvard School of Public Health, Boston, Mass-
achusetts: An NO-sensing gene regulator controlling
resistance to activated macrophages.
S.R. Tannenbaum, Massachusetts Institute of Technology,
Cambridge: The chemistry of NO in relation to toxicity
and carcinogenesis.
LK, Keefer, National Cancer Institute, National Institutes of
Health, Frederick, Maryland: Genotoxicity of NO and its
progenitors: An update.
E.M. Schuman, California Institute of Technology, Pasadena:
NO, ADP ribosyltransferase activity, and intercellular sig-
naling in long-term potentiation.
J. Moss, National Heart, Lung, and Blood
Institute, National
Institutes of Health, Bethesda, Maryland: Effects of NO
on modification of proteins by NAD
and ADP-ribose.
G. Enikopoiov, Cold Spring Harbor
Laboratory, New York:
NO and gene expression in neuronal cells.
SESSION 4: NO/Guanylate Cyclase System
Chairperson: M.A. Marietta, University of Michigan College of Pharmacy,
Ann Arbor
F. Murad, Molecular Geriatrics, Lake Bluff, Illinois: The NO-
cGMP signal transduction system.
J. Burstyn, University of Wisconsin, Madison: Mechanisms
of activation of soluble guanylyl cyclase.
J.R. Stone, University of Michigan, Ann Arbor: Purification of
soluble guanylate cyclase from bovine lung and initial
spectral characterization.
J. Corbin, Vanderbilt University,
Nashville, Tennessee:
Specificity and mechanisms of cGMP
receptors.
J.M.C. Ribeiro, University of Arizona,
Tucson: NO synthesis,
storage, and delivery in the salivary
glands of a blood
sucking bug, Rhodnius prolixus.
SESSION 5: NO: Metal Complexes
Chairperson: L.K. Keefer, National Cancer Institute, National Institutes of Health,
Frederick, Maryland
F.T. Bonner, State University of New York, Stony Brook:
Aspects of aqueous NO chemistry.
W.B. Tolman, University of Minnesota, Minneapolis: Chemical
modeling of the interactions of NO with copper sites
in biology: Binding and activation of NO by biomimetic
copper complexes.
V.S. Sharma, University of California, San Diego, La Jolla:
Reactions of NO with heme-proteins.
D.J. Singel, Harvard University, Cambridge, Massachusetts:
Magnetic resonance studies of NO biochemistry.
The Genetics of Manic Depressive Illness
December 8-December 11
FUNDED BY
The Charles A. Dana Foundation
ARRANGED BY
J.R. De Paulo, The Johns Hopkins Hospital, Baltimore, Maryland
K.R. Jamison, The Johns Hopkins Hospital, Baltimore, Maryland
J. Mallet, Centre National de la Recherche Scientifique, Cedex, France
P. McGuffin, University of Wales College of Medicine, Cardiff, United Kingdom
R.M. Post, National Institute of Mental Health, National Institutes of Health, Bethesda,
Maryland
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York.
SESSION 1: Brief Reports of Current Genetic Studies
Chairperson: D. Botstein, Stanford University School of Medicine, California
W.F. Byer ley, University of Utah School of Medicine, Salt
Lake City
N.B. Freimer, University of California, San Francisco
D.S. Gerhard, Washington University School of Medicine, St.
Louis, Missouri
E.S. Gershon, National Institute of Mental Health, National
Institutes of Health, Bethesda, Maryland
C. Gilliam, New York State Psychiatric Institute, Columbia
University, New York
J.R. Kelsoe, University of California, San Diego, La Jolla
J. Mallet, Centre National de la Recherche Scientifique, Gif-
sur-Yvette Cedex, France
P. McGuffin, University of Wales College of Medicine, Car-
diff, United Kingdom
J.I. Nurnberger, Indiana University School of Medicine, In-
dianapolis
R.A. Price, University of Pennsylvania, Philadelphia
O.C. Stine, The Johns Hopkins Hospital, Baltimore,
Maryland
SESSION 2: Issues in Diagnosis
Chairperson: R.M. Post, National Institute of Mental Health, National Institutes of Health,
Bethesda, Maryland
S. Simpson, The Johns Hopkins Hospital, Baltimore,
Maryland: Defining the bipolar phenotype.
J.A. Egeland, University of Miami North Research Office,
Hershey, Pennsylvania: Variable age of onset and diag-
nostic stability for BP1 disorder.
K.R. Jamison, The Johns Hopkins Hospital, Baltimore,
Maryland: Clinical description of manic-depressive ill-
ness.
V. Reus, University of California, San Francisco: Children of
bipolar probands: A longitudinal high-risk study.
W.C. Drevets, Washington University School of Medicine, St.
Louis, Missouri: PET imaging of mood disorders: Implica-
tions for family studies.
R.M. Post, National Institute of Mental Health, National In-
stitutes of Health, Bethesda, Maryland: Roundtable dis-
cussion.
SESSION 3: Candidate Gene Approach
Chairperson: C. Gilliam, New York State Psychiatric Institute, Columbia University, New
York
A.J. Lewy, Oregon Health Sciences University, Portland:
Biological markers in circadian phase disorders.
R.R. Crowe, University of Iowa Hospitals and Clinics, Iowa
City: Discuss candidate gene approaches.
D. Schaid, Mayo Clinic, Rochester, Minneapolis: Relative
risk methods for candidate genes using cases and their
parents.
J.C. Hall, Brandeis University, Waltham, Massachusetts:
Rhythm disorders in Drosophila.
T.A. Wehr, National Institute of Mental Health, National In-
stitutes of Health, Bethesda, Maryland: Biological
rhythms.
SESSION 4: Genetic Strategies I
Chairperson: N.J. Risch, Yale University School of Medicine, New Haven, Connecticut
M. Wig ler, Cold Spring Harbor Laboratory, New York: New
approaches to genetic analysis.
D.R. Cox, Stanford University School of Medicine, California:
Development of efficient strategies for linkage analysis
using meiotic maps spanning the human genome.
J. Ott, Columbia University, New York, New York: Linkage
analysis with multilocus diseases.
L.A. Sandkuijl, Delft, The Netherlands: Exclusion of linkage
under heterogeneity: Measuring informativeness before
testing.
T. Reich, Jewish Hospital, St. Louis, Missouri: The power
of
the genebank database to detect genes of moderate
ef-
fect (oligogenes).
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N. Risch, D. Cox
SESSION 5: Genetic Strategies II
Chairperson: J. Mallet, Centre National de la Recherche Scientifique, Gif-sur-Yvette
Cedex, France
R. Plomin, Pennsylvania State University, University Park:
Quantitative trait loci: Is manic-depression a dimension
or disorder?
R.A. Price, University of Pennsylvania, Philadelphia
Polygenic (QTL) approaches to identifying genes for
depression.
D.W. Fulker, University of Colorado, Boulder: A sib-pair ap-
proach to interval mapping of quantitative trait loci.
SESSION 6: Future Developments
Chairpersons: D.R. Cox, Stanford University School of Medicine, California
P. McGuffin, University of Wales College of Medicine, Cardiff, United Kingdom
J. Egeland
DNA LEARNING CENTER

DNA LEARNING CENTER
David A. Mick los, Director
Mark V. Bloom, Assistant Director
Susan M. Lauter, Designer
Jane P. Conigliaro, Education Manager
Diane S. Jedlicka, Laboratory Instructor
Diane Esposito, Laboratory Instructor
Flavio Della Seta, Laboratory Instructor
Judy L. Cumella, Administrative Assistant
Science museums and centers occupy an important position in American
science education, providing "informal" learning opportunities that usually cannot
be found within the formal school context. Science museums tend to accentuate
technology and physical phenomena, which are amenable to hands-on exhibits
that can stand up to use by large numbers of young people. With the exception
of natural history, biology content is underrepresented, primarily because its sub-
ject matter does not translate well into interactive exhibits-living things by and
large are not very amenable to manipulation by large numbers of students.
Molecular genetics has proved a particularly difficult topic, because it deals al-
most entirely with phenomena that cannot be seen or manipulated in the usual
sense. Our institution is unique in its focus on this difficult subject area. Our solu-
tion to the problem of dealing with things invisible has been to concentrate on
providing high-level laboratories that help students learn about genes using the
same modes of inference employed by research biologists. This emphasis on lab
work places us in the company of a handful of science centers, notably the
Lawrence Hall of Science, in Berkeley, California, and Fernbank Science Center,
in Atlanta, Georgia.
Another unique attribute is our building, which was constructed in 1925 as
Union Free School, the first "modern" elementary school in the village of Cold
Spring Harbor. Designed by the noted New York architectural firm, Peabody, Wil-
son & Brown, the building's symmetrical brick facade and details, such as
dentil
moldings and quoins, echo the Georgian revival architecture popular among
builders of Long Island's "Gold Coast" estates of the period. It is likely not coin-
cidence that school board member and patron of construction of the
building
Jean Brown Jennings lived at the large Georgian -style estate "Burrwood"
in
nearby Lloyd Harbor with her husband Walter Jennings, a founder
of Standard
Oil Company. We think that Mrs. Jennings and others who were
responsible for
the construction of this beautiful building, as well as those who spent
a good por-
tion of their childhoods here, would be happy to see it preserved
and tastefully
updated as a showcase of modern science. In an
architectural sense, the
DNALC is truly a house of science, unlike most science centers,
which typically
strive to look futuristic. Many of these facilities are out of context
with the architec-
ture of their urban surroundings and appear unstuck in time,
perhaps in a subtle
Way Perpetuating the stereotype of science as an ivory
tower out of touch with
mainstream culture. We believe that our antique-style
building sends the healthier
message that science is forward looking, yet
rooted in time and culture.
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We Own a Completely Refurbished Facility
The DNALC has gone through several rounds of renovations, totaling $1.5 million,
since we took lease of the facility from the Cold Spring Harbor Central School
District in September 1987. Initial renovations in 1987-1989 included installing
new heating/air-conditioning and electrical systems and converting a former
classroom into the Bio2000 Biochemistry Laboratory, the teacher's lounge into a
bookstore, and the unfinished basement into staff offices and a research/prep
laboratory. Other former classrooms, a library, and auditorium were converted
into galleries in which were installed The Search for Life, a multimedia exhibit on
the history of genetic technology loaned by the National Museum of American
History.
Bridge financing by the Banbury Fund and tax-exempt financing from the
Nassau/Suffolk County Industrial Development Agency made possible the pur-
chase of the DNALC property in January 1993. A concept design study funded
by longtime friends Mary Jeanne and Henry Harris provided a guide for the
redevelopment of the main floor and exterior of the building in 1993. Prior to be-
ginning renovations in April was the arduous task of clearing the building of some
9000 cubic feet of exhibit materials and hardware from The Search for Life exhib-
it, including two tractor trailers of parts! Major entrances were rebuilt and auto-
matic fire sprinklers were installed to bring the building into full compliance with
all handicap access, fire, and safety codes. Three galleries were renovated for
future exhibits on human genetics and research at Cold Spring Harbor
Laboratory. A BioMedia Computing Laboratory, equipped with 13 Macintosh
computers and video projection, was installed in renovated space adjacent to the
existing Bio2000 Biochemistry Laboratory. This project, as well as renovation of a
(Left to right) General contractor Bill Baldwin, DNALC Director David Mick los, CSHL Buildings and Groui
Director Jack Richards, and Centerbrook architect Jim Childress discuss renovation plans.
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Demolition and reconstruction of
front porch of DNALC.
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(Top) Refurbishment of front hall. (Bottom) Cellarium under construction, during painting and set for Corporate Advisory dinner.
computation/design office in the last remaining undeveloped basement space (in
1994), will be the final phase in the development of the DNALC as a model Hu-
man Genome Education Center. Planned for 1995 is construction of a 3500 -
square -foot BioMedia addition to the south side of the building, which will include
a genetics laboratory and research library. The addition will also include modern
lavatory facilities and an atrium/lunchroom-practical features needed to effec-
tively handle our growing numbers of student visitors.
Multitorium under construction-looking toward screen area and rear-projection booth (left top), and before and after views of
seat risers (bottom and right).
The 18 by 50-foot Cellarium, a room-size mural of the interior of a human cell,
creates a splendid backdrop in the main gallery. This cell mural was completed
during the summer by five art students from The Cooper Union for the Advance-
ment of Science and Art (Hope Gangloff, Marius Jaskowski, and Jackie O'Neill)
and the New York Institute of Technology (Donna Conversano and Elvia
Reynolds), working under the direction of staff designer Susan Lauter. A 1/12th
scale master drawing was divided into a 2 by 2-inch grid, and a corresponding
2
by 2-foot grid was chalked onto the ceiling and walls of the
gallery. Each grid
square on the master was scaled up on a 2-foot square of drafting tissue.
Then,
the back of each tissue drawing was rubbed with graphite and traced into
its ap-
propriate grid position in the gallery. The variety of colors seen in the
mural were
obtained by mixing only 12 colors of latex interior house paint. Twenty-five
gal-
lons of paint were applied using brushes and natural sea sponges.
The centerpiece of the renovation is a 104-seat multimedia auditorium,
or
Multitorium. The vaulted ceilings and plaster moldings of th e original
1925
auditorium were preserved and complemented with a bold
color scheme of
blues, rust, and terra cotta. A frieze carries the names of 35 Nobel
laureates who
have contributed to our understanding of genetics and the
molecular basis of
heredity. Deeply banked seating provides a superb view
for all, and the wide
aisles provide a uncommon feeling of spaciousness. A remote
control allows one
to shift easily between all major types of visual presentation-video,
laser disk,
Computer
tem
compact disk, slides, and overhead/opaque
projection. The audio sys-
makes use of JBL power amplifiers and three-way
JBL studio monitors, com-
puterized feedback control, and wireless radio-frequency
microphones.
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Cablevision CEO Charles
Dolan and CSHL President
James Watson at a preview
of Long Island Discovery
Long Island Discovery
The Multitorium is the venue for Long Island Discovery, which opened in Septem-
ber and received 6400 viewers during its first quarter of operation. This 28-minute
"electronic field trip" was especially designed to help students explore the rich
history of Long Island. Beginning with the mammoth glaciers that created the
unique 118-mile-long landscape, the production presents a collage of the Long
Islanders who shaped its history, including Indians, settlers, and whalers; Cap-
tain Kidd, the pirate; Anna Strong, the Revolutionary War spy; Jupiter Hammon,
the first published African-American poet; Charles Lindbergh, the first trans-
Atlantic aviator; and William Levitt, the architect of suburban living. The fast-
paced presentation makes full use of the Multitorium's audiovisual capabilities.
Thousands of images from 18 slide projectors and 3 video projectors are trained
on three 5 by 7-foot glass screens and three 32-inch television monitors. Digital
stereo surround sound is provided through ten JBL speakers, including an 18-
inch sub-woofer.
Long Island Discovery was produced by Cablevision Systems Corporation,
one of the nation's largest cable operators. The project was conceived by
Charles Dolan, Cablevision Chairman/CEO and Cold Spring Harbor Laboratory
Trustee, after seeing a similar presentation in Ireland. Charles recognized a fit
between the DNALC's desire for a state-of-the-art auditorium and Cablevision's
need for a dedicated facility to make its production widely available to local
school children. Cablevision provided major funding for the renovation of the Mul-
titorium and galleries, and the urgency to bring Long Island Discovery quickly to
the public provided the impetus to complete construction in only 5 months+.
Renewal of National Science Foundation Support
The new year brought news of the renewal of key National Science Foundation
(NSF) support of our training programs for high school and college faculty. A 3-
year grant of $854,150 continues support for the DNA Science Workshop for high
school teachers, which has received NSF funding since 1987. Through 1993,
DNALC staff have instructed 1639 teachers at 74 workshops held in 31 states,
Canada, and Puerto Rico. Building upon our past success, the new NSF program
provides a two-tier model for organizing a critical mass of leadership teachers in
molecular genetics at the national level and for disseminating genetics instruction
at the local level. At the first level, Targeted DNA Science Workshops provide
first-order training activity for underserved teachers and act as a screen for
teachers with leadership potential. At the second level, the Leadership Institute in
Human and Molecular Genetics provides recognition and super-order training for
innovative leaders among the estimated 3500 high school teachers who have
taken training workshops on molecular genetics/biotechnology. The aim is to util-
ize super-lead teachers as regional educational resources to ramify new teaching
technologies in their regions and provide liaison between school systems and
genetic information sources (such as genetic disease foundations/support
groups and the National Institutes of Health). Following their training, lead
teachers are pledged to provide a minimum of 30 hours in-service instruction for
elementary and secondary teachers in their regions.
Our analysis of databases assembled by the National Academy of Science
indicates that there are approximately 30 major, ongoing training programs for
precollege teachers in genetics/biotechnology that are administered through
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Leadership Institute participants (left) recreate a vintage photo of an early class at the Biological Laboratory (right, circa 1895).
academic institutions in the United States. However, most high-caliber institutes
are offered in major urban centers of the east, midwest, and far west, thus effec-
tively excluding rural and nonurban teachers in the south, midwest, southwest,
Rocky Mountains, northwest, and Puerto Rico. Thus, the targeted workshops are
designed to provide educational equity to underserved teachers in
rural/nonurban areas by offering them the same high-quality instruction available
to their urban peers. The first round of targeted workshops was held at
John
McDonogh High School in New Orleans and the University of Utah in Salt Lake
City.
The Leadership Institute, held July 6-30, drew together 23 innovative
teachers from 16 states. The participants' previous experiences included
teach-
ing advanced laboratory units in molecular genetics, leading teacher-training
workshops, developing model curriculum materials, administering equipment-
sharing consortia, and conducting a state-wide surveyof biotechnology
educa-
tion. To build upon this expertise, the institute provided 160 hours
of advanced
laboratory experimentation, scientist seminars, computer explorations, leadership
training, classroom observations, and independent projects. One
highlight was
an informal question-and-answer period with the Laboratory's
Director James D.
Watson, who shared the Nobel prize for the discovery of the structure
of DNA.
Others were "high-technology rotations" through the
laboratories of Cold Spring
Harbor scientists working in the technology-intensive
areas of X-ray crystal-
lography, protein biochemistry, and two-dimensional protein
electrophoresis.
Leadership teachers were free to attend seminars
of three of the Laboratory's
Postgraduate training courses, which were scheduled concurrently.
Leadership
teachers were housed along with visiting scientists on
the Laboratory's 100-acre
in-
formally
A summer stay at Cold Spring Harbor, and
the chance to interact n-
a ly with staff and visiting scientists in residence, was
a fitting honor for the
leadership teachers, who represent the top 1% of high
school biology instructors
nationwide.
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The continuation of our successful Advanced DNA Science Workshop for col-
lege faculty was assured upon renewal of our NSF grant, which provides
$291,275 of support during the next 2 years. The workshop curriculum articu-
lates with and extends that of the DNA Science Workshop to include more
sophisticated techniques such as restriction mapping; Southern hybridization
(nonradioactive); genomic library construction and analysis, cloning by
polymerase chain reaction (PCR); and human DNA fingerprinting by PCR. The
curriculum will be formally published in 1994 as Laboratory DNA Science: An In-
troduction to Recombinant DNA Technology and Methods of Genome Analysis.
During the summer, a pair of 2-week Advanced DNA Science Workshops
were conducted at the University of Puerto Rico, Rio Piedras (July 26-August 6),
and the University of Washington, Seattle (August 16-27). The program attracted
43 faculty from predominately teaching institutions in seven states and Puerto
Rico. An additional 34 faculty from six different states were trained at a pair of
workshops (Columbia University, May 24-June 1, and California State University,
Northridge, June 14-25) sponsored by the Department of Education's Fund for
the Improvement of Postsecondary Education.
Human Genome Diversity and Genetic Sensitivity
The rapid proliferation of screening tests to detect the genetic basis of human
diseases ultimately may lead to social and legal judgments about what is geneti-
cally normal versus abnormal. Reducing predictive medicine to pinpointing often
tiny genetic variances from the norm may also produce a mindset that overly
focuses on the genetic differences between people. This runs counter to
scientific evidence from the study of population genetics, which concludes that
human beings are more alike genetically than they are different. Embodied in
each person's genes is an unbroken flow of human evolution dating back millions
of years. Noted human geneticist Luca Cavalli-Sforza has said that understand-
ing the common ancestry of all human beings may be the best inoculation
against racism for young people growing up in a world that increasingly empha-
sizes cultural, racial, and ethnic differences.
In addition to fostering formal genetic literacy, biology educators also will be
faced with the task of turning out compassionate citizens who understand that, as
Laboratory Director James Watson has said, "Some people get a bad start in life
because they are born into poverty, and some people get a bad start in life be-
cause they are born with a bad set of genes." Most teachers attempt to stimulate
this type of higher-order social and ethical analysis through case studies, role-
playing, and panel discussion. Each of these methods essentially asks students
to identify with an abstract situation largely removed from their own experiences.
These methods often require a "briefing" of the "facts" of a case or technology,
which can be substantially colored by the teacher's presentation or selection of
materials.
As a remedy to this situation, we began in earnest in 1993 to develop plans
for a Human Genome Diversity-Student Allele Database (HGD-SAD) project that
will provide an experiment-based means for high school and college students to
investigate human genome diversity. The project centers around a hands-on
laboratory that enables students to produce a personal "DNA fingerprint" of the
alleles (DNA variations) they have inherited on chromosome 1 (D1S80). Students
then have the option of submitting their results to a Student Allele Database
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maintained at the DNALC. Via computer, students can perform various statistical
tests to compare their own alleles with those of students from around the United
States and Europe. The exercise of making a personal DNA fingerprint and then
comparing it to the fingerprints of other students challenges students to consider
their place in the family of humankind, thus opening the door to genetic
sensitivity. Students' questions about their own participation in the project
engender much of the ethical and personal decision making of DNA typing and
genetic data banking:
Should I submit my alleles to the Student Allele Database?
Does it matter if my anonymity is safeguarded?
Are my alleles rare or frequent (in my class, in the world)?
Do I share alleles with people of other races?
Are the allele frequencies in my class different from those in other parts of
the world?
How genetically alike or different are people of (different countries, dif-
ferent races)?
What if my DNA fingerprint was a diagnosis of disease susceptibility?
HGD-SAD also offers an example of the interdisciplinary nature of human
genome research, which blends genetics, biochemistry, statistics, computational
science, and social science. The commitment to map and sequence the human
genome has called attention to the need for efficient computer strategies to col-
lect, organize, store, and access the billions of nucleotides of DNA sequence to
be generated over the next decade. HGD-SAD provides a simple analog of the
growing use of computers in human genome research and illustrates a means to
link together experimental and computer resources to encourage understanding
of biological concepts. The project also provides an unprecedented opportunity
for biology students and teachers to work in concert with genome researchers as
they develop computational systems for genetic research.
The Student Allele Experiment
The student allele experiment is based on a forensic DNA typing kit optimized
for
educational use by DNALC staff member Mark Bloom. The
object of the student
allele experiment is to amplify and visualize a locus on the short arm
of
chromosome 1, termed D1S80, at which varying numbers
of copies of a repeated
DNA sequence create polymorphisms. These variable
numbers of tandem
repeats (VNTRs) are inherited in a Mendelian fashion as
distinguishable alleles.
The  VNTR polymorphism at D1S80 has a repeat unit of 16 base
pairs and dis-
plays 29 alleles that determine 435 possible genotypes.
The size of a D1S80 al-
lele depends on the number of VNTR copies present on
the chromosome 1 in-
from the mother or father. For example, the maternally
inherited allele may
have 21 copies of the repeat unit, whereas the paternally
inherited allele may
have 14 copies. These different alleles can be separated by
size using elec-
trophoresis.
The experiment consists of three parts: sample isolation,
amplification by
PCR, and analysis by polyacrylamide gel electrophoresis
(PAGE). Participating
schools receive a kit that contains two simple reagents
(sterile saline and 10%
helex) and supplies for a class of students to prepare
DNA extracts from their
Own Cells. Students obtain cheek epithelial cells by a
10-second rinse with saline
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mouthwash (bloodless and noninvasive). Incubation at boiling temperature lyses
the cheek cells and releases the DNA into solution. Cellular debris is separated
from the crude DNA extract by centrifugation with Chelex, a chelating agent that
binds inhibitors of the PCR.
The student DNA samples, identified only by number, are then passed on to a
partner institution for PCR amplification and allele separation. A sample of this
crude DNA extract is added to a "cocktail" of amplification reagents, including
Taq polymerise, the four nucleotide phosphates, magnesium, and primers that
identify the D1S80 locus on chromosome 1. Polymerase chain reaction is used to
amplify the D1S80 locus of each student sample, and the amplification products
are electrophoresed on a polyacrylamide gel, together with an allelic ladder of 27
amplified D1S80 alleles. A photostat of the stained gel is then provided to the
participating teacher. Comparison of bands present in each lane with the allelic
ladder allows students to determine their own D1S80 genotypes. Students have
the choice of submitting their genotypes and demographic information, without
personal identifiers, to the Student Allele Database.
HGD-SAD offers an appropriate point of collaboration for high schools and
genome research centers. Electrophoretic analysis of human alleles is the next
logical step for the growing numbers of high school biology teachers who are
conversant in modern molecular genetics and currently perform electrophoretic
analysis of viral DNA with their students. Preparation of student DNA samples re-
quires only a clinical centrifuge and hotplate, which are available at most high
schools or can be borrowed from a partner genome research center. Although
the equipment needed for human allele detection-a DNA thermal cycler and
polyacrylamide electrophoresis apparatus-is currently beyond the means of
even the most advanced high school teachers, it is commonplace in any genome
research center. A several hour commitment by a technical staff member at a
genome research center is all that is required to generate the student genotypes.
Several options are open to high school teachers who would like to do more
in-class experimentation. Amplified alleles can be separated in agarose using
mini-gel apparatuses common in high schools. Although agarose systems can
differentiate a number of alleles, they do not offer resolution great enough to
score alleles for submission to the archival portion of the Student Allele Data-
base. Efficient amplification of D1S80 alleles from crude extracts requires an
automated DNA thermal cycler, the least expensive of which now costs approxi-
mately $2800. Therefore, we are working with the biocomputing center at the Uni-
versity of Chicago to develop a "washing machine" thermal cycler that will pro-
vide a low-cost alternative for amplifying student samples. Working from a design
used in early efforts to automate thermal cycling at Cetus Corporation, teachers
Washing machine thermal cycler built by leadership teachers successfully amplified human
DNA polymorphisms.
at the 1993 Leadership Institute built a prototype machine, essentially composed
of a washer valve and plumbing supplies, that successfully amplified the D1S80
alleles. We are currently working with the University of Chicago biocomputing
center to construct a computer controller that can be distributed with a ready-to-
assemble kit.
With funds from the Stone Foundation, we have equipped a Student Allele
Reference Laboratory to qualify all allele submissions to the archival Student Al-
lele Database. The reference laboratory will also process student samples
referred from teachers in rural and nonurban areas nationwide who lack a nearby
partner institution. The laboratory is equipped for large-format
PAGE and a com-
puterized documentation system that allows submitted students' gels to be
auto-
matically read and digitized for archival storage. Tom White, Vice President
of
Research & Development of Roche Molecular Systems, has
agreed to donate
750 PCRs and provide 750 reactions at a reduced price each year over
the next
5 years to support the reference laboratory and activities to "seed"
the project in
different regions of the country.
The Student Allele Database
The Student Allele Database program software is being jointly
developed here
and in collaboration with Helen Donis-Keller atWashington
University and John
Kruper at the University of Chicago. Program software will
be developed to run
on three platforms: Macintosh, UNIX, and MS-DOS. Initial applications
are being
developed to run on Macintosh computers, which are common
in high schools,
followed by DOS/MS Windows versions. Several applications
that will be part of
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the package have already been developed in the Donis-Keller laboratory for use
in a UNIX environment, which is common in genome research centers. These util-
ities will be the starting points for designing a robust and scalable client-server
application to administrate SAD materials. The database will be composed of
four major utilities, all of which make use of a user-friendly graphical interface:
On the client side, a Public Data Utility (PDU) is accessible to all users and
provides data entry forms for recording allele data and demographic iden-
tifiers. The PDU also provides a workspace where data can be temporarily
stored and evaluated, or compared to data stored in the archive. The PDU
operates both in "stand-alone' mode (allowing entry, display, and analysis
of local data) and in a 'networked client" mode (allowing data submission
to the archived dataset and comparison of local data to archival data).
On the server side, an Archival Data Utility (ADU) is accessed through the
PDU on a "read only' basis for users. The archival database contains sub-
mitted student cases that have been refereed to meet standards for
scientific use and incorporates relational database technology to allow fast
and efficient processing of simultaneous queries. The ADU can be ac-
cessed by the system administrator to enter and/or edit refereed cases.
The ADU incorporates key features of research databases, including
scalability, data integrity, and disaster recovery.
A Statistics Utility is accessible to all users to enable data analysis using
files from the PDU and ADU. A number of statistical and graphical tools will
be added over time, including allele frequency estimation, heterozygosity
and polymorphic information content (PIC), Hardy-Weinberg equilibrium,
single allele isoclines, analysis of variance, and genetic distance.
A Bulletin Board is accessible to all users, allowing students and teachers
to share findings, interpretations, lesson plans, and curricular materials. In
addition, the Bulletin Board operates an Internet Relay Chat (IRC) system
to provide interactive dialogue between participants. With this, teachers
and students can discuss in real time their local efforts and ask questions
of designated professor 'mentors' (drawn from the partner regional
genome research centers) during scheduled on-line 'seminars."
The Bulletin Board and Archival Data Utility reside on a Sun Sparcstation
10-30 server with one gigabyte SSCI disk storage currently available at the
DNALC. A fiber optic line will link the DNALC to the main Laboratory
campus, providing high-speed access to national and international
networks. Partner research institutions here and abroad will likely prefer to
access the database through Internet. However, secondary biology
teachers will likely tie into the system via Access Excellence, a biology ed-
ucation network that is reached through America Online.
International Collaborations
Although human genome diversity is not a large element of the Human Genome
Initiatives of the National Institutes of Health and the Department of Energy, it is
an important component of research funded by the international Human Genome
Organization (HUGO). Our Italian collaborator, Marcel lo Siniscalco is active in the
HUGO project, and his institution, Porto Conte Research and Training
Laboratories (PCRTL) in Sardinia, has been the site of planning workshops for the
HUGO-sponsored project, The People ofEurope. As a reference laboratory in the
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HUGO genome diversity project, PCRTL maintains a high-speed Internet connec-
tion. Thus, it was appropriate that Dr. Siniscalco agreed that PCRTL will serve as
the European node for the Human Genome Diversity-Student Allele Database,
(HGD-SAD), mirroring the SAD on its system and qualifying European submis-
sions to the archival database.
To cement the new collaboration, a pilot Human Genome Diversity Training
Workshop was conducted at the PCRTL as part of the European Week of Science
in November. Funded by the Italian Ministry of University and Scientific and Tech-
nological Research, the workshop built upon previous DNALC collaborations with
PCRTL to develop activities for the Italian Week of Science in 1991 and 1992. The
pilot workshop was attended by 19 secondary science teachers (representing 11
European countries) who produced their own D1S80 fingerprints and tested a
new method of preparing DNA from saliva. Highlights of the workshop were talks
by Luca Cavalli-Si.orza and Alberto Piazza, both authorities on human genetic
diversity. They showed the participants methods for analysis of genetic distance
using D1S80 data from Asian Indians, American Blacks, American Caucasians,
and Sardinian school students (obtained by Dr. Siniscalco's group). Several al-
leles were found among the Sardinian students that had never been seen among
sample populations in North America.
Local Activities and Training Workshops
The Bio2000 Laboratory was kept very busy during the academic year, with 3200
precollege students participating in lab field trips on Variability and Inheritance;
Corn Genetics and Mendelian Inheritance; Cells, Chromosomes, and Mutations;
DNA Structure and Recombination; Bacterial Transformation; DNA Restriction
Analysis; and Human DNA Fingerprinting. The Great Moments in DNA Science
Lecture Series, held in the spring, continued as a popular element of our annual
calendar of events, drawing the attendance of 730 local students and
teachers:
Michael Gilman, Cold Spring Harbor Laboratory: To Grow or Not
to Grow-How a Cell Decides.
Seth Grant, Columbia University: How Do Genes Control
the Way
the Brain Stores Memories?
William Lennarz, SUNY at Stony Brook: Sperm Meets Egg.
David Mick los, Cold Spring Harbor Laboratory: Eugenics-From
Science
to Social Quackery.
In February, we conducted the final in a series of four
Human Genetics and
Genome Analysis Workshops funded by the Department of
Energy. This program
draws together opinion leaders and policy makers who must
help society make
sense and proper use of genetic technology. The program
has provided an op-
portunity to formalize the existing strong ties between the
DNALC and our sister
organization, Banbury Center. The combination of high-level
seminars and col-
legial exchange in beautiful surroundings at Banbury
and hands-on labs at the
DNALC has proven a winning formula for our
bright, but nonscientist,
clientele of
government administrators, lawyers, ethicists, reporters,
educators, and mem-
bers of patient support groups. Jan Witkowski's
keen scientific insight and
broad
contacts in basic/clinical molecular genetics
ensure an extremely high
caliber of
featured speakers from around the country.
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Kenneth Culver, National Institutes of Health: The First Human Gene
Therapy Trials.
Neil Holtzman, John Hopkins Medical Institute: Map or Maze-The
Future of Human Genetics.
Marsha Saxton, Massachusetts Office on Disability: Genetics and
Cultural Attitudes to Disability.
Patricia Ward, Baylor College of Medicine: DNA-based Diagnosis for
Human Genetic Diseases.
Barbara Weber, University of Michigan: Breast Cancer Genetics-Moving
from Research to Practice.
Our summer workshop schedule took on added intensity with the addition of
the month-long Leadership Institute for 23 high school faculty, as well as in-
creased offerings for precollege students. Summer has traditionally been our
Corporate Advisory Board open house: Middle school student Matthew Bentz explains DNA extraction
experiment. DNALC intern Chris Como demonstrates the Genetic Computer Arcade to his parents,Judy and Tom.
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season for teacher-training workshops, and Mark Bloom continued his hectic
schedule of four 2-week Advanced DNA Science Workshops, reaching 79 col-
lege faculty at workshops held in New York, Seattle, Los Angeles, and San Juan.
Dave Mick los instructed a lightened load of DNA Science Workshops, reaching
67 high school faculty at workshops in New Orleans, Salt Lake City, and the
DNALC. Demand for student spaces in the two local DNA Science Workshops
has been increasing over the last several years, with 37 high-ability students par-
ticipating in summer 1993. Seventy-eight minority/disadvantaged students (5-6th
grade) were instructed, free of charge, at four Fun With DNA Workshops taught
by Robert Willis at the DNALC and A. Phillip Randolph High School in Harlem. To
satisfy the high demand for our 'kiddie camps," we entered into a new collabora-
tion to administer five 'Fun With DNA' camps at Port ledge School in Locust Val-
ley. This arrangement allowed us to accommodate an additional 101 5-6th grade
students. In addition, 23 7-8th graders attended the pilot of the new World of En-
zymes Workshop, designed for past 'graduates' of Fun With DNA.
Corporate Advisory Board
Under the strong leadership of Doug Fox, Vice President of Marketing for the
Times Mirror newspaper group, the Corporate Advisory Board has risen to the
challenge of increasing unrestricted annual support from the Long Island busi-
ness community. In 1993, the Board raised a total of $66,650. Corporate Advisory
Board members help explain the DNALC's role as a center of educational ex-
cellence and key element of the community infrastructure to support high-
technology industry on Long Island. Board members are drawn from a gamut of
Long Island businesses, including communications, banking, accounting, insur-
ance, law, real estate, retail sales, and health care/biotechnology. Guiding the ef-
fort, and working closely with DNALC and Laboratory staff, are members of the
executive committee:
Douglas B. Fox, Chairman
Rocco S. Barrese, Dilworth and Barrese
Thomas J. Calabrese, NYNEX
Gary E. Frashier, Oncogene Science, Inc.
Patricia Peterson, Dale Gale Agency
Paul A. Vermylen, Jr., Meenan Oil Company
Michael Aboff
Howard M. Blankman
Harry G. Charlston
Richard M. Clark
Kenneth Daley
Robert E. Diller
Mrs. Sinclair Hatch
Aurther D. Herman
John J. Lack
Ralf Lange
Mrs. Lilo Leeds
Ms. Shelia Mahony
Glenn Prestwich, Ph.D.
Francis Roberts, Ph.D.
Peter G. Schiff
John Smith
Michael Vittorio
Lawrence Waldman
Staff and Interns
We were disappointed when Robert Willis left his position as
Special Programs
Manager at the end of the summer to return to a
teaching position in Maryland.
Robert helped to expand our programs for minority and
disadvantaged students
in the New York metropolitan area, a task to which we
remain committed. The
vacuum created by Robert's departure was filled ably
and cost-effectively by
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three part-time laboratory instructors: Diane Jedlicka of Roslyn Public Schools
and Drs. Diane Esposito and Flavio Della Seta, who have research positions at
Cold Spring Harbor Laboratory. With degrees in elementary and special educa-
tion, Diane Jedlicka administers the Roslyn OMNI Gifted Program with DNALC
Education Manager Jane Conigliaro. Diane Esposito is a staff associate in the
laboratory of Michael Wig ler and has had research experience at Columbia Uni-
versity, Memorial Sloan-Kettering Cancer Institute, and North Shore Community
Hospital. Diane also brings strong ties to our Italian collaborator Marcel lo Sinis-
calco, with whom she worked for several years. A native of Italy, Flavio is a post-
doctoral fellow in the laboratory of Kim Arndt. Flavio has research experience in
DNA structure and transcription at the University of Rome, University of Paris,
and University of Nancy, where he holds a faculty position. We also rely on the
collaboration of Twana Adams, an energetic minority educator with strong ties to
community action groups in Harlem.
We were further frustrated when Administrative Assistant Sandra Ordway left
at the end of the year to accept a position at the law firm Scheine, Fusco,
Brandenstein, and Rada. Sandy first came to the DNALC in 1988 to organize a
corps of neighborhood volunteers, joining the staff in 1989 to orchestrate our in-
creasingly complex schedule of visiting schools and off-site workshops. We
moved quickly to hire new Administrative Assistant Judy Cumella, who was a pur-
chasing agent at Medical Sterilization, Inc. Additional administrative help was
provided by part-time employee Margot Kohler and volunteer Katya Davey.
We continued to get excellent laboratory, computational, and administrative
support from our growing staff of student interns drawn from neighboring school
districts. Mark Staudinger, of Cold Spring Harbor High School, assisted Mark
Bloom with Advanced DNA Science Workshops in Los Angeles, Seattle, and San
Juan prior to beginning his freshman year at Muhlenberg College. Cold Spring
Harbor senior David Holtman focused primarily on the development of multimedia
computer programs and assisted Leadership Institute participants with computer
projects, leaving at the end of summer for his freshman year in the College of
Engineering at Cornell University. Ken Bassett, of Massapequa High School, as-
sisted Dave Mick los with the DNA Science Workshop in Salt Lake City and as-
sumed the position of senior intern at the beginning of the 1993-1994 school
year. Assisting at Fun With DNA summer camps were lab aides Tara Marathe of
Colby College, Daryn Berger of Walt Whitman High School, Andrea Conigliaro of
St. Anthony's High School, and Michael Conigliaro of Cold Spring Harbor High
School. New interns were Jessica Hinton of Huntington High School, Chris Como
of Cold Spring Harbor High School, and Andy Diller of Sachem High School.
Andy brought with him considerable lab experience and represents the fruition of
our efforts to stimulate advanced biology instruction on Long Island. He had the
opportunity to take two molecular genetics electives at Sachem, where instructor
Fred Gil lam runs the nation's largest precollege program in laboratory molecular
genetics. Andy's father Bob is a member of the DNALC's Corporate Advisory
Board and as Vice President of Marketing for Brinkmann Instruments has been
instrumental in obtaining many gifts of Eppendorf pipets and centrifuges.
PUBLICATIONS
Bloom, M., G. Freyer, and D. Mick los. 1994. Laboratory DNA Science: An Introduction to
Recombinant DNA Technology and Methods of Genome Analysis. (In press.)
Mick los, D. 1994. Genetic Testing: An Educational Imperative to Our Schools. In Proceed-
ings of the Committee on Assessing Genetic Risks, Institute of Medicine. (In press.)
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1993 Workshops,
January 9-10
January 16-17
January 23-24
January 26
February 4-6
February 8-11
February 13-14
February 15-17
February 19
February 23
February 27-28
March 4
March 8-10
March 13-14
March 30
March 31-April 1
April 5
April 27
May 4
May 7
May 10-12
May 11
May 13-15
May 18
May 20
May 24-June 4
June 1
June 7-11
June 14-25
June 28-July 2
June 28-July 2
June 28-July 2
June 29-July 1
Meetings, and Collaborations
National Science Foundation Follow-up Workshop, DNA Science, University of Nevada,
Reno, Nevada
National Science Foundation Follow-up Workshop, Advanced DNA Science, University
of Puerto Rico, Mayaguez, Puerto Rico
National Science Foundation Follow-up Workshop, DNA Science, University of Puerto
Rico, Mayaguez, Puerto Rico
Site visit to Biotechnology Teaching Laboratory, State University of New York,
Stony Brook
Department of Energy Workshop, Human Genetics and Genome Analysis, DNALC and
Banbury Center
Department of Energy Contractors Workshop, Santa Fe, New Mexico
Department of Education Follow-up Workshop, Advanced DNA Science, University of
Chicago, Chicago, Illinois
Coalition for Education in the Life Sciences Meeting, Marine Biological Laboratory,
Woods Hole, Massachusetts
Biology Teachers Inservice Training Committee Meeting, National Research Council,
Washington D.C.
Site visit by Dennert 0. Ware, Boehringer Mannheim Corporation
National Science Foundation Follow-up Workshop, Advanced DNA Science, DNALC
Corporate Advisory Board Meeting and Reception, DNALC
Site visit by Ian Muchamore, Wellcome Centre for Medical Science, London, England
Howard Hughes Medical Institute Follow-up Workshop, DNA Science, Edison Career
Center, Montgomery County, Maryland
Site visit by Dennis Bittisnich, Australian National University,
Canberra, Australia
Scholar in Residence Program, SUNY, Purchase, New York
Site visit by Tom Zinnen and Michael Patrick, University
of Wisconsin, Madison,
Wisconsin
Great Moments in DNA Science Honors Student Seminar, DNALC
Great Moments in DNA Science Honors Student Seminar, DNALC
Corporate Advisory Board Meeting, DNALC
Collaboration with Ray Gladden, Carolina
Biological Supply Company, Burlington,
North Carolina
Great Moments in DNA Science Honors
Student Se
Un
minar,
ver
DNALC
St. Louis, Missouri
Collaboration with Helen Donis-Keller, Washingisity,
Great Moments in DNA Science Honors
Student Seminar, DNALC
Corporate Advisory Board Meeting and Reception,
DNALC
Deartment of Education, Advanced DNA
Science Workshop, Columbia University,
p
New York, New York
Corporate Advisory Board Meeting
and Reception, DNALC
ience Foundation Workshop, DNA
Science, John McDonogh High School,
National Sc
New Orleans, Louisiana
Department of Education Workshop,
Advanced DNA Science, University
of California,
Northridge, California
National Science Foundation, DNA Science
Workshop, University of Utah,
Salt Lake City, Utah e School, Locust Valley,
New York
Fun With DNA Workshop, Portledg
DNA Science Workshop, DNALC
National Science Foundation Workshop,
Exploring Human Genetics, Titusville
Middle School, Poughkeepsie,
New York
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July 6-30
July 12-16
July 19-23
July 26-30
July 26-August 6
August 2-6
August 9-13
August 16-20
August 16-27
August 24-26
August 23-27
August 30-September 2
September 8
September 15
September 30
October 8-9
October 15
October 24-27
October 29
November 11
November 18-21
November 29-December 3
December 15-17
National Science Foundation Leadership Institute in Human and Molecular
Genetics, DNALC
Barker Welfare Foundation Minority Workshop, Fun With DNA, A. Phillip
Randolph High School, New York
Fun With DNA Workshop, Port ledge School, Locust Valley, New York; Barker
Welfare Foundation Minority Workshop, Fun With DNA, A. Phillip Randolph
High School, New York
Fun With DNA Workshop, Port ledge School, Locust Valley, New York
National Science Foundation Workshop, Advanced DNA Science, University of
Puerto Rico, Rio Piedras, Puerto Rico
Fun With DNA Workshop, Port ledge School, Locust Valley, New York
National Science Foundation Workshop, DNA Science, University of Puerto Rico,
Rio Piedras, Puerto Rico; Fun With DNA, Port ledge School, Locust Valley,
New York; Barker Welfare Foundation Minority Workshop, Fun With DNA,
DNALC
Advanced Placement Workshop, Stanford University, Palo Alto, California;
Barker Welfare Foundation Minority Workshop, Fun With DNA, DNALC
National Science Foundation Workshop, Advanced DNA Science, University of
Washington, Seattle, Washington
National Science Foundation Workshop, Exploring Human Genetics, DeWitt
Middle School, Ithaca, New York
High School Student/Faculty Workshop, DNALC
Microbes, Meteorites, and the Mind Workshop, DNALC
Premiere, Long Island Discovery, DNALC
Site visit by Kyle Vermillion, Westminster School, Atlanta, Georgia
Corporate Advisory Board Meeting/Museum preview and Open House, DNALC
National Science Foundation Follow-up Workshop, DNA Science, John
McDonogh High School, New Orleans, Louisiana
Site visit by Greg Baird and Laura Leber, Genentech, South San
Francisco, California
International Conference on Public Understanding of Science and
Technology, Chicago Academy of Sciences, Chicago, Illinois
Baring Brothers Workshop, Cold Spring Harbor, New York
Eugenics lecture, Banbury Center, Cold Spring Harbor, New York
National Association of Biology Teachers National Meeting, Boston,
Massachusetts
Human Genome Diversity Training Workshop, Porto Conte Research and
Training Laboratories, Sardinia, Italy
National Science Teachers Association Annual Meeting, Orlando, Florida
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1993 PUBLICATIONS
General Books
Experiments with Fission Yeast: A Laboratory
Course Manual
C. Alfa, P. Fantes, J. Hyams, M. McLeod, and E. Warbrick
Genetic Maps, 6th Edition
S.J. O'Brien (ed.)
Molecular Probes of the Nervous System: Selected
Methods for Antibody and Nucleic Acid Probes, Vol. 1
S. Hockfield, S. Carlson, C. Evans, P. Levitt, J. Pintar,
and L. Silberstein
The Cell Surface
Symposia on Quantitative Biology 57
The Development of Drosophila melanogaster
M. Bate and A. Martinez Arias (eds.)
Double Talking Helix Blues
J. Herskowitz and I. Herskowitz (illustrated
by J. Cuddihy)
The Early Days of Yeast Genetics
M.N. Hall and P. Linder (eds.)
Vaccines 93: Modern Approaches to New Vaccines
Including Prevention of AIDS
H.S. Ginsberg, F. Brown, R.M. Chanock, and R.A. Lerner
(eds.)
CSHL Monograph Series
Molecular and Cellular Biology of the Yeast Saccharomyces,
Vol. 2: Gene Expression
E.W. Jones, J.R. Pringle, and J.R. Broach (eds.)
Transcriptional Regulation, Book 2
S.L. McKnight and K.R. Yamamoto (eds.)
Reverse Transcriptase
A.M. Skalka and S.P. Goff (eds.)
The RNA World
R.F. Geste land and J.F. Atkins (eds.)
Nucleases, 2nd Edition
S.M. Linn, R.S. Lloyd, and R.J. Roberts (eds.)
Current Communications in Cell & Molecular
Biology Series
Superantigens: A Pathogen's View of the
Immune System
B. Huber and E. Palmer (eds.)
Video Tapes
Targeted Mutagenesis in Mice: A Video Guide
R.A. Pedersen, V. Papaioannou, A. Joyner,
and J. Rossant
Winding Your Way Through DNA
University of California, San Francisco
Cancer Surveys Series
Vol. 16: The Molecular Pathology of Cancer
N. Lemoine and N.A. Wright (eds.)
Vol. 17: Pharmacokinetics and Cancer Chemotherapy
P. Workman and M.A. Graham (eds.)
Vol. 18: Breast Cancer
I.S. Fentiman and J. Taylor-Papadimitriou (eds.)
Genome Analysis Series
Vol. 5: Regional Physical Mapping
K.E. Davies and S.M. Tilghman (eds.)
Vol. 6: Genome Maps and Neurological Disorders
K.E. Davies and S.M. Tilghman (eds.)
Vol. 7: Genome Rearrangement and Stability
K.E. Davies and S.T. Warren (eds.)
Journals
Genes & Development (Volume 7, 14 issues)
T. Grodzicker and N. Hastie (eds.)
PCR Methods and Applications (Volume 2, 2 issues;
Volume 3, 3 issues)
D. Bentley, R. Gibbs, E. Green, and R. Myers (eds.)
Other
A Limner's View
F. McCurdy and E. Watson
CSHL Annual Report 1992
Banbury Center Annual Report 1992
Administration and Financial Annual Report 1992
Abstract/program books for 14 CSHL meetings
COLD SPRING HARBOR LABORATORY PRESS
The Press continued its ambitious publishing program in 1993 by adding 20 new
books and 2 new videotapes, bringing its total titles in print to more than 120, by
deciding to increase the frequency of both its current journals, and by announc-
ing plans for the launch of a third journal in 1994. Sales increased by 16%, to
over $4.3 million, and the balance after expenses, including significant one-time
charges, rose by 25%.
Book Publishing
New titles were added in nearly all categories of the book catalog. Sales of
laboratory manuals continued to flourish, particularly the perennial bestsellers
Molecular Cloning by Joe Sambrook, Ed Fritsch, and Tom Maniatis; Ed Harlow
and David Lane's Antibodies; and the recent success by Jeffrey Miller, A Short
Course in Bacterial Genetics. There were new manuals on molecular probes of
the nervous system and fission yeast biology. Like many of our most successful
books of this kind, both were based on popular courses recently taught at the
Laboratory. The techniques they describe thus have the robust reliability that
only comes from repeated use by people with varying degrees of inexperience.
The Symposium volume, The Cell Surface, published in the 60th anniversary
year of the Symposium's founding, was a colorful addition to the famous book
series and marked the start of Bruce Stillman's stewardship of this
prestigious an-
nual meeting. The second volume of the authoritative monograph Transcriptional
Regulation, edited by Steve McKnight and Keith Yamamoto, was
published, and
the entire book was almost immediately reprinted in paperback in response
to
the strong demand for an edition affordable by graduate students.
A paperback
edition of the widely appreciated memoir of Barbara McClintock, The
Dynamic
Genome, edited by Nina Fedoroff and David Botstein, was published
with the
elegant cover that won a national design award.
Not every new title can be mentioned here (see opposite page
for a complete
list), but two new books made a particularly dramatic impact both visually
and
scientifically. The RNA World, edited by Ray Gesteland and John Atkins,
revisited
a prebiotic era in which evolution may have depended on
replicating RNA and
reviewed current ideas about the structure and function of this
ancient molecule.
The introductory articles by James Watson and Francis Crick
reminded us how
quickly their attention focused on the other nucleic acid after they
deduced the
structure of DNA exactly 40 years ago. A notable
feature of this book was the
frontispiece-a hologram derived from the computerized
construction of an RNA-
protein complex. The book was widely and enthusiastically
reviewed, and its
originality was rewarded with strong sales.
Equally arresting was the lavish artwork in The Development
of Drosophila
melanogaster, a monograph on the molecular analysis of
fruit fly embryology
edited by Michael Bate and Alfonso Martinez Arias.
This two-volume set includes
114 color plates plus a separate 50-page color
atlas of the developmental
stages
of the insect's growth created entirely with stunning
computer graphics by
Volker
Hartenstein. In printing terms, this was the most complex
scientific monograph
Yet published at Cold Spring Harbor, and necessarily the
most highly priced. Yet
it has been warmly welcomed as an essential resource
by the world's expanding
Population of fly labs.
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Publishing is a vital element in the Laboratory's program of professional edu-
cational activities, and our books have helped make Cold Spring Harbor's name
an honored one among scientists worldwide. In 1993, however, we embarked on
two projects with appeal beyond our customary audience. A series of six
videotapes, entitled Winding Your Way Through DNA, was produced in col-
laboration with the University of California at San Francisco, from a meeting at
which a group of distinguished scientists, led by Harold Varmus, spoke to the
public about the perils and possibilities of genetic technology. The tape set has
been recognized as a unique teaching tool and a stimulus to classroom discus-
sion of these important issues among college students.
Yet an understanding of how genes and cells work should begin earlier in a
child's life, at middle or elementary school level. The children's books from the
United Kingdom on these topics, by Fran Balkwill and Mic Rolph, which we have
distributed in the United States for several years, have proved lastingly popular.
Encouraged by their success, we published this year our own contribution to this
genre-a remarkable audio tape and book combination entitled Double Talking
Helix Blues. As written and performed by Joel and Ira Herskowitz and beautifully
illustrated by Judy Cuddihy, the basis of heredity is spelled out in song and
words, in a style that appeals to 8-12 year olds.
Both of these projects are experiments, undertaken in a controlled way, part-
ly in fulfillment of our educational mission, but with the quite serious intention of
examining the market potential for future publications of this kind. They also il-
lustrate what no observer of our book publishing operation can fail to miss-the
remarkable growth in the number of new titles produced annually and the in-
creased complexity of those titles in production terms. Nancy Ford and her
editorial and production staff in the book division have, as always, met the many
challenges changes have presented while maintaining the for
high quality our books earned long ago.
Journal Publishing
It was a year of expansion for our journals. Genes & Development, now in its
seventh year, consistently published papers of high quality. The number of
papers submitted to the journal increased and the scope of those published con-
tinued to broaden. G&D was again the most cited journal in genetics and in de-
velopmental biology and, as in previous years, showed a steady increase in cir-
culation. Because of the rising demand to publish in the journal and to avoid
creating issues that were discouragingly thick, the decision was taken to produce
issues semimonthly in 1994.
The success of PCR Methods and Applications, launched in 1991, prompted
an acceleration from quarterly to bimonthly publication with the start of Volume 3
in August. A series of articles was commissioned as a primer on getting started in
this powerful but still tricky technology, and these articles will later be reas-
sembled in the form of a laboratory manual. The journal's circulation continued to
rise and its vigorous financial health was again greatly aided by the impressive
advertising revenues mustered by Nancy Kuhle.
As always, the success of our journals owes a great deal to the editors, ad-
visory board members, and expert reviewers whose willingness to make critical,
often difficult judgments on the papers offered is the basis for the quality of thejournals' content.
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New journals continue to proliferate in the biomedical sciences despite
shrinking library budgets, the escalating costs of serial publishing, and a weary
sense among many that there are more than enough journals already. Yet
science continues to evolve and bud off new fields of enquiry, some of which be-
come vigorous and visible enough to support a specialist journal.
The growing tide of interest in the biological analysis of learning prompted us
to consult a number of experts on whether their field had yet reached this stage
of development. We were delighted to find that the consensus view was en-
couraging. The decision was therefore taken to launch a new journal, Learning &
Memory, in 1994. A distinguished group of editors and advisors was readily as-
sembled, attracted by the idea of a journal devoted exclusively to papers on this
broad and fascinating topic.
Throughout the year, Judy Cuddihy and her colleagues in the journal division
have succeeded in meeting the demands of producing flawless issues on an ac-
celerated schedule.
Marketing, Fulfillment, and Finance
The expansion of our publishing program into new fields was complemented by
vigorous marketing activities efficiently managed by Ingrid Benirschke. These ac-
tivities centered on a series of attractive, subject-specific catalogs designed by
Jim Suddaby that were mailed to targeted recipients worldwide. New titles were
announced in three editions of the Notebook, and a New Year's sale of older titles
at reduced prices was highly successful. As always, the Press participated
in the
trade shows associated with the national meetings of societies for genetics,
cell
biology, neuroscience, and microbiology. In addition, we exhibited at internation-
al conferences in virology and genetics that took place back-to-back in the
United Kingdom in August.
Closer to home, our bookstore in Grace Auditorium managed by Connie
Hal-
laran and Nancy Hodson extended our marketing activities to the several
thou-
sand visitors who attended the Laboratory's meetings and courses.
Despite its
narrow confines, the bookstore attracted more business than ever
in 1993, with
its eclectic mix of science books from Cold Spring Harbor and
elsewhere, gifts,
and travel necessities.
Vital support for book and journal sales in the form of customer
service, order
processing, and distribution was ably provided by Guy Keyes
and his staff in our
Plainview facility, from which more than 50,000 books were
dispatched during
the course of the year. Their computer system was ever
more finely tuned to our
needs, and by applying her ingenuity on a personal
computer to the sales data,
Nancy Hodson initiated many kinds of financial analysis
that helped us make bet-
ter and more timely business decisions.
New Projects
The development of projects for publication in 1995 and beyond
continued un-
abated. More than 20 new publications of various
kinds were initiated and
will be
describedn
in-
ternal
in future reports. We also began a new
serial publication for purely -
ernal use. Pressing News is a bimonthly roundup of news from
each Press de-
partment and has significantly improved communication
among the departments
in our four separate locations.
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It was a year in which communications technology moved from obscurity to
the front pages, and terms such as the information superhighway, CD-ROMs,
and multimedia became commonplace. Wary of the hype but intrigued by the
potential of these technologies, we have begun to explore their utility in our
marketplace. Our aim will be to adopt whatever of the new technologies are best-
suited to the goal of keeping our Press at the forefront of scientific communica-
tion worldwide.
John R. Inglis
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FINANCIAL STATEMENTS
BALANCE SHEET
Year ended December 31, 1993
with comparative amounts for 1992
ASSETS
co
Operating Funds
Endowment &
Similar Funds
Land,
Building, &
Equipment Funds
Total All FundsUnrestricted
RestrictedUndesignated Designated 1993 1992
o
Cash and cash equivalents $1,893,860 1,350,000 2,016,511 5,798,669 5,862,899 16,921,939 8,281,707
Marketable securities 1,892,645 - - 27,716,710 81,563 29,690,918 26,918,931
Accounts receivable:
Publications (less allowance for doubtful accounts
of $20,500 in 1993 and $34,700 in 1992) 436,288 - - - - 436,288 508,890
Other 138,252 - - - - 138,252 187,455
Grants receivable - - 1,883,040 - - 1,883,040 2,518,157
Accrued interest receivable 4,505 - - 255,012 - 259,517 306,586
Publications inventory 1,439,940 - - - - 1,439,940 1,369,223
Other assets, principally deferred expenses 357,554 - - - 873,046 1,230,600 705,538
Investment in employee residences - - - - 2,009,967 2,009,967 2,079,639
Land, buildings, and equipment:
Land and improvements
- - - - 5,825,328 5,825,328 4,585,228
Buildings
- - - - 56,621,938 56,621,938 51,185,656
Furniture, fixtures, and equipment
- - - - 2,961,229 2,961,229 2,763,071
Laboratory equipment
- - - - 8,839,803 8,839,803 7,638,616
Library books and periodicals
- - - - 365,630 365,630 365,630
- - - - 74,613,928 74,613,928 66,538,201
Less accumulated depreciation and amortization
- - - - 19,182,465 19,182,465 16,858,050
Land, buildings, and equipment, net
- - - - 55,431,463 55,431,463 49,680,151
Construction in progress
- - - - 1,326,536 1,326,536 2,372,078
Total assets $6,163,044 1,350,000 3,899,551 33,770,391 65,585,474 110,768,460 94,928,355
LIABILITIES AND FUND BALANCES
Operating Funds
Endowment &
Similar Funds
Land,
Building, &
Equipment Funds
Total All FundsUnrestricted
RestrictedUndesignated Designated 1993 1992
Liabilities:
Accounts payable and accrued expenses $ 915,125 _ - 353,749 1,268,874 2,282,838
Notes payable _ - 1,008,364 1,008,364 1,227,037
Bonds payable _ - 30,000,000 30,000,000 20,000,000
Deferred revenue 1,773,543 - 3,899,551 5,673,094 3,559,120
Total liabilities 2,688,668 - 3,899,551 31,362,113 37,950,332 27,068,995
Fund balances:
Unrestricted-undesignated 3,474,376 - - - - 3,474,376 3,652,272
Unrestricted-designated - 1,350,000 - - - 1,350,000 1,350,000
Endowment and similar funds - - 33,770,391 - 33,770,391 29,276,357
Land, buildings, and equipment:
Expended - - - - 31,970,878 31,970,878 31,209,369
Unexpended-Donor restricted - - - - 242,786 242,786 291,723
Unexpended-Board authorized - - - - 2,009,697 2,009,697 2,079,639
Total fund balances 3,474,376 1,350,000 - 33,770,391 34,223,361 72,818,128 67,859,360
Total liabilities and fund balances $6,163,044 1,350,000 3,899,551 33,770,391 65,585,474 110,768,460 94,928,355
STATEMENT OF SUPPORT, REVENUE AND EXPENSES,
AND CHANGES IN FUND BALANCES
Year ended December 31, 1993
with comparative amounts for 1992
Operating Funds
Endowment &
Similar Funds
Land,
Building, &
Equipment Funds
Total All FundsUnrestricted
Undesignated Designated Restricted 1993 1992
Support and revenue:
Public support $1,804,344 - 6,327,427 1,898,789 347,400 10,377,960 17,357,007
Government grant awards - - 11,550,559 - - 11,550,559 8,680,512
Indirect cost allowances 8,510,065 - - - - 8,510,065 8,508,920
c.)
coN Other revenue:
10,314,409 - 17,877,986 1,898,789 347,400 30,438,584 34,546,439
Program fees 1,535,762 - - - - 1,535,762 1,332,830
Rental income 289,891 - - - 289,891 298,104
Publications 4,319,267 - - - - 4,319,267 3,709,326
Dining services 1,661,674 - - - - 1,661,674 1,464,949
Rooms and apartments 1,451,719 - - - - 1,451,719 1,320,424
Distribution from Robertson Funds 490,000 - 1,085,000 - - 1,575,000 1,560,000
Investment income 204,790 - - 2,543,577 301,171 3,049,538 2,116,036
Royalty & licensing 283,870 - - - - 283,870 291,841
Miscellaneous 146,282 - - - - 146,282 198,054
Total other revenue 10,383,255 - 1,085,000 2,543,577 301,171 14,313,003 12,291,564
Total support and revenue 20,697,664 18,962,986 4,442,366 648,571 44,751,587 46,838,003
Expenses:
Program services:
Research - - 14,630,971 - - 14,630,971 12,985,969
Summer programs 1,155,025 - 3,505,060 - - 4,660,085 4,753,586
Publications 4,134,244 - - - - 4,134,244 3,547,638
Banbury Center conferences 239,149 - 340,309 - - 579,458 451,001
DNA Education Center programs 28,491 - 420,937 - - 449,428 497,721
Total program services 5,556,909 18,897,277 24,454,186 22,235,915
Supporting services:
Direct research support 1,196,259 - - - - 1,196,259 1,290,609
Library 505,105 - - - - 505,105 468,569
Operation and maintenance of plant 5,008,217 - - - - 5,008,217 4,575,804
General and administrative 3,387,597 - - 134,539 - 3,522,136 3,216,025
Dining services 1,659,112 - - - 1,659,112 1,604,098
Interest - - - 926,162 926,162 689,118
Total supporting services 11,756,290 134,539 926,162 12,816,991 11,844,223
Depreciation and amortization
Total expenses
Excess (deficiency) of support and
2,521,642 2,521,642 2,357,815
17,313,199 18,897,277 134,539 3,447,804 39,792,819 36,437,953
revenue over (under) expenses $3,384,465 65,709 4,307,827 (2,799,233) 4,958,768 10,400,050
Other changes in fund balances:
Capital expenditures (3,165,731) - (712,075) - 3,877,806 - -
Transfer to restricted funds (425,000) - 837,873 (412,873) - -
Transfer to endowment funds (586,233) - (191,507) 1,213,683 (435,943) - -
Transfer to unrestricted funds 614,603 - (614,603) - - -
Net increase (decrease) in fund balances (177,896) - - 4,494,034 642,630 4,958,768 10,400,050
Fund balances at beginning of year 3,652,272 1,350,000 29,276,357 33,580,731 67,859,360 57,459,310
Fund balances at end of year $3,474,376 1,350,000 33,770,391 34,223,361 72,818,128 67,859,360
Copies of our complete, audited financial statements, certified by the independent auditing firm
of KPMG, Peat, Marwick & Co., are available upon request from the Comptroller, Cold Spring
Harbor Laboratory.
COLD SPRING HARBOR LABORATORY
SOURCES OF REVENUE
YEAR ENDED DECEMBER 31, 1993
Federal Grants 44.1
Endowments and Similar Funds 9.2 %
Foundation and Private
Contributions and Grants 18.9 %
Interest and Miscellaneous 2.1
Corporate Contributions and Grants 5.0 %
Auxiliary Activities 20.7
COMPARATIVE OPERATING HISTORY
1989-1993
(Dollars in Thousands)
1989 1990 1991 1992 1993
Income:
Main Lab:
Grants & contracts 13,062 13,535 15,172 16,800 18,136
Indirect cost reimbursement 6,412 6,558 7,170 8,388 8,383
Other 4,034 3,976 5,056 5,520 6,049
CSH Press 4,450 4,223 3,079 3,709 4,319
Banbury Center 1,012 1,120 1,090 1,104 1,281
co
co
41
DNA Learning Center 662 585 744 822 796
Total income 29,592 29,997 32,311 36,343 38,964
Expenses:
Main Lab:
Grants & contracts 13,062 13,535 15,172 16,800 18,136
Operation & maintenance of plant 3,412 3,759 3,904 4,241 4,777
General & administrative 2,377 2,414 2,468 2,634 2,785
Other 3,165 2,973 3,375 4,141 4,385
CSH Press 3,934 3,708 3,488 3,548 4,134
Banbury Center 1,038 1,125 1,063 1,070 1,226
DNA Learning Center 635 615 752 843 768
Total expenses 27,623 28,129 30,222 33,277 36,211
Excess before depreciation and designation of funds 1,969 1,868 2,089 3,066 2,753
Depreciation (1,399) (1,485) (1,898) (2,358) (2,522)
Designation of funds (1) (400) (250) (100) (600) 0
Net operating excess $ 170 133 91 108 231
The above amounts are presented on a combined basis for all funds for which Cold Spring Harbor Laboratory prepares operating budgets.
(1) Funds designated to underwrite future direct and indirect expenses of the neuroscience and other research programs.
mit
Cold Spring Harbor Laboratory is a nonprofit research and educational institution
chartered by the University of the State of New York. Less than half (44.1%) of
our annual support is derived from Federal grants and contracts, and thus we
rely heavily on support from the private sector: foundations, corporations, and in-
dividuals. Contributions from the private sector are tax exempt under the provi-
sions of Section 501(c)(3) of the Internal Revenue Code. In addition, the
Laboratory has been designated a "public charity" and therefore may receive
funds resulting from the termination of "private foundations."
METHODS OF CONTRIBUTING TO COLD SPRING HARBOR LABORATORY
Gifts of money can be made directly to Cold Spring Harbor Laboratory.
Securities: You can generally deduct the full amount of the gift on your income tax return,
and, of course, you need pay no capital gains tax on the stock's appreciation.
We recommend any of the following methods:
(1) Have your broker sell the stock and remit the proceeds to Cold Spring Harbor
Laboratory.
(2) Deliver the stock certificates to your broker with instructions to open an account for
Cold Spring Harbor Laboratory and hold the securities in that account pending in-
structions from Cold Spring Harbor Laboratory.
(3) Send the unendorsed stock certificates directly to the Laboratory: Comptroller, Cold
Spring Harbor Laboratory, One Bungtown Road, Post Office Box 100, Cold Spring
Harbor, New York 11724. In a separate envelope, send an executed stock power.
Pooled Income Funds: Combine gifts from a number of donors in a pool for attractive in-
vestment and tax purposes.
Appreciated real estate or personal property: Sizable tax benefits can result from such
donations; the Laboratory can use some in its program and can sell others.
Life insurance and charitable remainder trusts can be structured to suit the donor's
specific desires as to extent, timing, and tax needs.
Bequests: Most wills probably need to be updated. Designating Cold Spring Harbor Labo-
ratory as beneficiary ensures that a bequest will be utilized as specified for continuing
good.
Conversion of private foundation to "public" status on termination: This may be done
by creating a separate fund within Cold Spring Harbor Laboratory whereby the assets of
the private foundation are accounted for as a separate fund and used for the purposes
specified by the donor. Alternatively, the private foundation can be established as a sup-
porting organization of Cold Spring Harbor Laboratory.
For additional information, please contact the Director of Development, Cold Spring Harbor
Laboratory, One Bungtown Road, Post Office Box 100, Cold Spring Harbor, NY 11724, or
call 516-367-8840.
FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the DNA Learning Center receive a substan-
tial portion of their funding through grants from the Federal Government and through grants, capital
gifts, and annual contributions from private foundations, corporations, and individuals. The follow-
ing section summarizes funding that occurred during 1993.
GRANTS January 1, 1993-December 31, 1993
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant 1993 Funding+
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Program Projects Cancer Research Center, Dr. Mathews 1/92 -12/96 $3,415,962
Cancer Center Support, Dr. Stillman 8/90 -7/95 4,478,704
Oncogene Program Project, Dr. Wig ler 3/88 -2/93 187,088
Research Support Dr. Anderson
Dr. Arndt
Dr. Arndt
Dr. Bar-Sagi
Dr. Beach
Dr. Beach
Dr. Beach
Dr. Beach
Dr. Cheng
Dr. Davis
Dr. Davis
Dr. Franza
Dr. Franza
Dr. Futcher
Dr. Futcher
Dr. Garrels
Dr. Gilman
Dr. Greider
Dr. Greider
Dr. Helfman
Dr. Helfman
Dr. Hernandez
Dr. Hernandez
Dr. Herr
Dr. Krainer
Dr. Kuret
Dr. Kuret
Dr. Marr
Dr. Martienssen
Dr. Mathews
Dr. Mathews
Dr. Moran
Dr. Moran
Dr. Peterson
Dr. Roberts
Dr. Roberts
Dr. Skowronski
Dr. Spector
Dr. Stillman
4/90 -3/93
4/88 -3/93
1/91 -12/94
7/91 -6/96
12/84 -1/93
9/86 -8/94
7/88 -6/93
8/90 -7/93
4/93 -3/97
9/91 -8/93
7/92 -11/93
9/85 -11/94
10/91 -8/94
1/91 -12/94
4/93 -3/97
1/85 -12/94
9/92 -8/97
12/89 -11/94
8/91 -7/96
9/85 -3/94
8/93 -5/98
7/92 -6/96
9/91 -8/96
3/92 -2/96
7/89 -6/94
7/89 -6/94
5/91 -4/95
8/91 -7/94
8/92 -7/94
2/92 -1/97
9/93 -8/98
8/91 -6/96
8/91 -5/95
4/88 -3/93
4/91 -3/94
7/88 -6/93
12/93 -11/97
4/90 -3/95
7/83 -5/96
53,188
36,090
371,931
445,726
90,411
298,491
57,153
210,663
195,847 *
134,572
267,774
289,165
553,112
141,245
226,514 *
904,703
501,836
412,183
410,446
534,055
181,580*
487,837
426,221
254,299
400,528
425,413
274,495
595,889
178,562
302,439
327,392 *
448,092
500,818
16,750
259,039
3,815
306,825 *
278,086
461,761
* New Grants Awarded in 1993
+ Includes direct
and indirect cost 397
Program/Principal Investigator Duration of Grant 1993 Funding+Grantor
Dr. Stillman
Dr. Tonks
Dr. Tully
Dr. Wig ler
Dr. Wig ler
7/91 -6/95
8/91 -5/96
9/91 -1/93
7/92 -6/99
8/90 -7/93
323,860
381,525
9,863
2,404,594
119,998
Equipment Support Dr. Marshak 6/92 -6/93 120,910
Fellowships Dr. Del Vecchio
Dr. Grueneberg
12/91 -11/93
10/90 -9/93
26,323
21,970
Dr. Jones 10/91 -9/94 53,731
Dr. Prowse 9/92 -2/93 4,834
Dr. Rossomondo 5/93 -12/93 19,570 *
Dr. Skoulakis 9/92 -8/93 15,100
Dr. Hwei-Gene Wang 8/92 -12/93 28,600
Dr. Kwang-Ai Won 5/92 -4/93 7,567
Dr. Michael Zhang 9/92 -8/97 39,298
Training Support Institutional, Dr. Grodzicker 7/78 -4/94 398,282
Course Support Advanced Bacterial Genetics,
Dr. Grodzicker 5/93 -4/98 57,016 *
Cancer Research Center Workshops,
Dr. Grodzicker 4/92 -3/97 246,645
Neurobiology Short-term Training,
Dr. Hockfield 5/82 -4/96 152,664
CSHL Analysis Large DNA Molecules,
Dr. Grodzicker 1991 -1996 96,908
Essential Computational Genomics for
Molecular Biologists, Dr. Marr 1991 -1996 27,606
Advanced In Situ Hybridization
and Immunocytochemistry, Dr. Spector 1992 -1997 57,760
Molecular Biology and Development
of Xenopus laevis, Dr. Grodzicker 4/93 -3/96 12,489 *
Meeting Support Genome Mapping and Sequencing Conference 1993 29,950 *
RNA Processing 1993 2,929 *
Third International Meeting on the Cell
and Molecular Biology of Aplysia 1993 13,322 *
Regulation of Liver Gene
Expression in Health and Disease 1993 11,000 *
Regulation of Eukaryotic mRNA Transcription 1993 5,500*
Eukaryotic DNA Replication 1993 5,500*
Molecular and Cell Biology
of Plasiminogen Activation Workshop 1993 2,000 *
Molecular Neurobiology Conference 1993 19,435 *
RNA Processing 4/82 -3/94 2,000
58th Symposium: DNA and Chromosomes 4/89 -5/95 8,500
NATIONAL SCIENCE FOUNDATION
Research Support Dr. Anderson 9/90 -8/93 47,169
Dr. Ma 5/91 -4/93 155,010
Dr. Ma 8/91 -7/94 178,322
Dr. Martienssen 2/93 -1/94 100,000 *
* New Grants Awarded in 1993
+ Includes direct and indirect cost
398
Grantor Program/Principal Investigator Duration of Grant 1993 Funding+
Dr. Peterson/Stillman
Dr. Sundaresan
Fellowship Support Dr. Pena
Dr. Springer
Training Support Undergraduate Research Program,
Dr. Herr
Course Support Plant Molecular Biology, Dr. Grodzicker
Construction Support Greenhouse
Meeting Support RNA Processing
57th Symposium: DNA and Chromosomes
Eukaryotic DNA Replication
Molecular Neurobiology of Drosophila
Regulation of Eukaryotic mRNA
DEPARTMENT OF ENERGY
Research Support Dr. Marr
Dr. Martienssen
Dr. Peterson
Meeting Support 58th Symposium: DNA and Chromosomes
U.S. DEPARTMENT OF AGRICULTURE
Research Support Dr. Ma
Dr. Sundaresan
Workshop Support CSHL Workshop on Molecular
Markers for Plant Breeding,
Dr. Sundaresan
NONFEDERAL GRANTS
Research Support
Academy of Natural Science Muscular Dystrophy Research
Allied Signal Dr. Greider
Alzheimer's Association Dr. Nawa
American Cancer Society Dr. Gilman
Dr. Marshak
Dr. Mathews (Scholar Award)
Dr. Sutton
Dr. Wig ler, Professorship
Dr. Wig ler
American Heart Association Dr. Helfman
11/91 -10/94
7/92 -7/95
6/92 -5/95
12/93 -11/95
6/91-5/94
8/86 -3/94
12/92 -5/95
4/91 -3/94
4/93 -3/94
4/93 -3/94
7/93 -6/94
7/93 -6/94
7/91 -2/94
8/91 -8/93
5/92 -5/93
1993
9/92 -9/94
8/91 -8/94
10/93 -9/94
11/93 -10/94
11/92 -10/93
12/93 -11/94
7/91 -5/94
7/93 -6/95
1/93 -12/93
1/92 -12/94
1986 -2012
4/92 -12/93
7/91-6/96
170,972
225,223
6,588
32,755*
50,000
73,063
140,000
10,661
15,000 *
10,000 *
6,460 *
5,000 *
571,805
83,698
25,941
20,000 *
124,650
1Q1,773
6,000 *
3,000 *
200,000
30,000 *
149,314
103,000 *
38,575 *
110,013
51,755
9,379
56,438
New Grants Awarded in 1993
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Duration of Grant 1993 Funding+
Grantor Program /Principal Investigator
American Foundation for
AIDS Research
Argonne National Laboratorie
Baxter Foundation
Sara Chait Foundation
J.W. Cleary
Council for Tobacco
Research
Dr. Laspia
Dr. Mathews
Dr. Pflugrath
Dr. Skowronski
Dr. Marshak
Muscular Dystrophy Research
Dr. Greider
Dr. Helfman
Dr. Spector
12/91 -6/93
10/91-9/93
2/91-8/93
6/92 -5/95
12/91 -11/96
11/93 -10/94
7/92 -6/94
7/91 -6/94
7/92 -6/94
42,321
47,651
46,449
78,375 *
25,000
26,899 *
95,200
113,029
121,204
Charles E. Culpepper
Foundation
Ford Foundation
Geron Corporation
Dr. Spector
Dr. Pena
Dr. Greider
5/93 -4/95
3/93 -2/94
8/92 -8/95
60,000 *
2,500 *
244,175
Greenwall Foundation Dr. Marshak 7/92 -6/94 81,179
Irving A. Hansen Memorial
Foundation Dr. Tonks 7/92 -6/94 17,569
Hitachi Foundation Dr. Nawa 3/92 -2/94 16,909
Human Frontier Science Dr. Davis 5/92 -8/93 64,127
Program Dr. Futcher 6/92 -5/96 108,247
Dr. Tully 5/92 -8/94 101,548
ICOS Corporation Dr. Futcher 7/92 -6/94 236,862
Dr. Tonks 4/92 -3/94 234,818
ICI Seeds Dr. Martienssen 1/92 -6/94 25,228
IFI Dr. Marshak 6/93 -6/94 48,000 *
ISIS Pharmaceuticals, Inc. Dr. Franza 8/93 -3/94 57,500 *
Dr. Spector 9/93 -3/94 12,500 *
Johnson & Johnson Dr. Skowronski 5/92 -4/95 107,354
Esther A. and Joseph Dr. Nawa 7/92 -6/95 46,632
Klingenstein Fund, Inc. Dr. Silva 7/93 -6/96 33,334 *
Theodore N. Kaplan Dr. Tobin 1993 -1994 3,000 *
March of Dimes Dr. Barker 7/93 -6/94 40,436*
Lucille P. Markey
Charitable Trust Neurobiology Support 7/90 -6/96 536,918
MSCl/US Agency for
International Development Dr. Marshak 11/91 -10/94 82,923
Mathers Charitable Foundation Neurobiology Research Support 8/91 -7/94 286,235
Mellam Family Foundation Dr. Tonks 12/93 -11/95 50,000 *
John Merck Fund Dr. Tully 9/91 -5/94 160,000
Muscular Dystrophy
Association Dr. Helfman 1/91 -12/93 53,585
NYU Consortium with NIH Dr. Marshak 5/92 -4/97 214,784
Oncogene Science, Inc. Monoclonal Agreement 6/92 -5/95 190,365
Oxnard Foundation Dr. Gilman 2/91 -1/94 102,785
Pall Corporation Swiss Project 4/93 -12/93 50,000*
Pew Memorial Trust Dr. Greider 7/90 -6/94 73,147
Dr. Krainer 7/92 -6/96 97,091
Dr. Tonks 7/91 -6/95 95,333
Pioneer Hi-Bred
International Inc. Dr. Peterson 8/91 -7/93 26,785
Rita Allen Foundation Dr. Hernandez 10/89 -9/94 107,446
Samuel Freeman Charitable Freeman Laboratory of Cancer 7/89 -6/94 2,000,000
Trust Cell Biology
Owen Smith Muscular Dystrophy Research 11/93 -10/94 5,000*
Whitehall Foundation Dr. Silva 9/93 -8/96 45,000*
* New Grants Awarded in 1993
+ Includes direct and indirect cost
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Grantor Program/Principal Investigator Duration of Grant 1993 Funding+
Wellcome Trust
World Business Council/
Meltzer Fund for Cancer Research
Equipment Support
Geron Corporation
The Perkin Fund
J.P. Morgan Trust
Fannie E. Rippel
Foundation
Fellowships
American Cancer Society
American Foundation for
AIDS Research
American Heart Association
Association
Cancer Research
Institute
Cancer Research Fund of the
Damon Runyon-Walter Winchell
Foundation
Jane Coffin Childs
CSHL Associates
The Charles A. Dana Foundation
Eppley Foundation
Fulbright Scholar Program
Helen Hay Whitney
Foundation
Human Frontier Science
Program
Life Science Research
Foundation
Wellcome Trust
Training Support
Bio-Rad Laboratories
Bliss Fund
Dr. Silva
Dr. Stillman
Equipment (Dr. Greider)
Equipment
Equipment
Equipment
Dr. Flanagan
Dr. Hinkley
Dr. Marcus
Dr. Mi Sha Jung
Dr. Scheppler
Dr. Yung-Chih Wang
Dr. Kazzaz
Dr. Flint
Dr. Conklin
Dr. Hannon
Dr. Hardy
Dr. Horton
Dr. V. Jung
Dr. Ruppert
Dr. Sun
Dr. Walworth
Dr. Wilson
Dr. Mirzayan
Fellowship and Research Support
Dr. Witkowski
Dr. Silva
Dr. J. Diaz Nido
Dr. Bell
Dr. Alexandre
Dr. Clarke
Dr. Della Seta
Dr. Hanamura
Dr. Mayeda
Dr. Tansey
Dr. Watakabe
Dr. Collins
Dr. Kaufman
Dr. Frenguelli
Summer Undergraduate
Program
Summer Undergraduate
Program
11/93 -10/94
3/93 -2/95
1/93 -12/93
1/93 -12/95
11/93 -10/94
12/93 -12/94
7/92 -6/95
9/92 -8/95
7/93 -6/96
8/92 -7/94
7/91 -6/93
7/93 -6/95
1/92 -12/94
1/92 -12/94
11/93 -10/96
1/92 -12/94
9/92 -8/93
9/92 -8/95
5/92 -4/95
8/91 -7/93
5/92 -4/95
9/90 -8/93
1/91 -12/93
7/93 -6/96
4/92 -3/95
1993 -1996
11/93 -10/94
11/92 -10/93
7/91 -6/94
1/92 -6/93
7/91 -6/93
4/93 -3/95
7/93 -6/95
7/91 -6/93
9/92 -9/94
12/93 -11/95
6/92 -5/95
7/92 -6/95
11/93 -10/95
1993
1993
12,403*
32,861 *
70,650*
50,000*
300,000 *
250,000 *
38,449
72,000
78,000 *
54,000
20,400
30,000 *
30,000
30,500
25,000 *
29,465
10,583
45,333
37,214
4,042
36,835
21,000
25,044
25,500 *
150,000
670,000 *
10,000 *
6,300 *
38,729
36,749
24,561
38,974 *
40,500 *
17,543
60,672
46,700 *
57,988
57,439
35,566 *
1,000 *
3,500 *
* New Grants Awarded in 1993
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Duration of Grant 1993 Funding+
Grantor Program/Principal Investigator
1993
1993
1993
1993
3/93 -2/96
9/90 -5/94
1991 -1995
3/91 -2/94
25,600 *
6,400*
1,000*
1,605*
50,000 *
107,302
511,584
62,413
Burroughs Wellcome
Foundation
Hanson White Industries
Phillips Petroleum Co.
Rockefeller Foundation
St. Giles Foundation
Andrew Seligson Memorial
Fellowships
Course Support
Howard Hughes Medical
Institute
Esther A. and Joseph
Klingenstein Fund, Inc.
Summer Undergraduate Program
Summer Undergraduate Program
Summer Undergraduate Program
Plant Course Scholarship Support
Leukemia Fellowship Support
Postdoctoral Fellowship Support
Advanced Neurobiology Courses
Advanced Neurobiology Courses
Meeting Support
Abbott Laboratories Molecular and Cell Biology 1993 2,500*
Plasminogen Activation
American Diagnostica Molecular and Cell Biology 1993 5,000*
Plasminogen Activation
American Cyanamid Co. Vaccines 1993 10,000 *
Amgen, Inc. Liver Gene 1993 2,000*
Anheuser-Busch Co. Yeast Cell Biology 1993 500*
Becton Dickinson Labware Liver Gene 1993 100*
Boehringer Mannheim Molecular and Cell Biology 1993 1,000*
Company, Germany Plasminogen Activation
Behringwerke/Hoechst Molecular and Cell Biology 1993 1,000*
Plasminogen Activation
Boehringer Mannheim Molecular and Cell Biology 1993 1,000 *
Company, Italy Plasminogen Activation
Chiron Corporation Liver Gene 1993 500*
Cohen Foundation Molecular and Cell Biology 1993 5,000*
Plasminogen Activation
Genetics Institute Molecular and Cell Biology 1993 1,000*
Plasminogen Activation
Labatt Brewing Co. Yeast Cell Biology 1993 100*
Miles, Inc. Molecular and Cell Biology 1993 1,000*
Plasminogen Activation
Pharmacia Biotech, Inc. Liver Gene 1993 100*
Pharmacia Laboratory Vaccines 1993 11,988*
Pierce Chemical Co. Cytoskeleton and Cell Function 1993 1,000*
The Upjohn Company Liver Gene 1993 500*
U.S. Army Research Cytoskeleton and Cell Function 1993 3,000"
Wellcome Trust Gene Therapy 1993 7,200*
* New Grants Awarded in 1993
+ Includes direct and indirect cost
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DNA LEARNING CENTER
Grantor Program/Principal Investigator
FEDERAL GRANTS
NATIONAL SCIENCE FOUNDATION
Duration of Grant 1993 Funding+
U.S. DEPARTMENT OF EDUCATION
NONFEDERAL GRANTS
Barker Welfare Foundation
William Randolph Hearst Foundation
Howard Hughes Medical Institute
New York State Legislature
Stone Foundation
Commack Union Free School District
Great Neck Public Schools
Half Hollow Hills Central School District
Locust Valley Central School District
Plainedge Union Free School District
Commack Union Free School District
East Williston Union Free School District
Elwood Union Free School District
Garden City Union Free School District
Great Neck Public Schools
Half Hollow Hills Central School District
Harborfields Central School District
Herricks Union Free School District
Island Trees Union Free School District
Jericho Union Free School District
Kings Park Central School District
Lawrence Union Free School District
Lindenhurst Union Free School District
Locust Valley Central School District
Manhasset Union Free School District
Massapequa Union Free School District
Northport-East Northport Union Free
School District
North Shore Central School District
Oyster Bay-East Norwich Central
School District
Plainedge Union Free School District
Plainview-Old Bethpage Central
School District
Port ledge School
Port Washington Union Free
School District
Roslyn Public Schools
Sachem Central School District
South Huntington Union
Free School District
Syosset Central School District
Middle School Faculty Enhancement
High School Faculty Enhancement
High School Faculty Enhancement
College Faculty Enhancement
College Faculty Enhancement
College Faculty Enhancement
Minority Programs
Middle School Program
High School Faculty Enhancement
Middle School Program
Equipment
Genetics as Whole Learning Program
Genetics as Whole Learning Program
Genetics as Whole Learning Program
Genetics as Whole Learning Program
Genetics as Whole Learning Program
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
Curriculum Study
1990 -1993
1990 -1993
1993 -1996
1991 -1993
1993 -1995
1991 -1993
1992 -1993
1991 -1994
1990 -1993
1993
1991 -1994
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
1993
80,430
25,254
281,607*
47,169
97,092 *
75,282
5,000
15,927
8,926
50,000
83,333
5,000 *
5,000*
5,000 *
5,000"
5,000*
850*
850*
850*
850*
850*
850*
850*
850*
850*
850*
850*
850*
850*
850*
850*
850*
850*
850*
850*
850 *
850*
850 *
850*
850*
850*
850*
850*
' New Grants Awarded in 1993
+ Includes direct and indirect cost
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BANBURY CENTER
Grantor
NONFEDERAL SUPPORT
Meeting Support
Abbott Laboratories
Allen & Hanburys
(Glaxo, Inc.)
Baring Brothers &
Company, Limited
Connaught Laboratories
Helix, Inc.
Pfizer Inc.
Medlmune, Inc.
Muscular Dystrophy
Association
Muscular Dystrophy
Association (French)
State of New York
Alfred P. Sloan Foundation
SmithKline Beecham
Pharmaceuticals
The William Stamps
Farish Fund
* New Grants Awarded in 1993
+ Includes direct and indirect cost
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Program/Principal Investigator
Lyme Disease Symposium
Lyme Disease Symposium
Human Genome Project
Lyme Disease Symposium
Future of Genetic Diagnosis
Lyme Disease Symposium
Lyme Disease Symposium
Neuromuscular Disease Special
Grant
Dystrophin and DMD Gene
DNA Forensic Fingerprinting
Industrial Sponsorship
In Vitro Selection
Meetings on Complex
Genetic Diseases
Duration of Grant 1993 Funding+
1993
1993
5,000 *
10,000*
1993 77,209*
1993 3,000*
1993 32,318*
1993 10,000 *
1993 5,000*
1993 10,000 *
1993 10,000
1993 2,500*
1993 15,555*
1993 14,052*
1991 -1993 126,030
CAPITAL AND PROGRAM CONTRIBUTIONS
January 1, 1993-December 31, 1993
Contributions of $5000 and above
During 1993, the Laboratory received capital and program contributions from
foundations, individuals, and corporations totaling $4,092,050.
Capital contributions were composed of gifts to the Cancer Research Fund,
the William J. Matheson Chair, the Charles S. Robertson Chair, and the Second
Century Unrestricted Fund, each of which are individual components of the
Laboratory's permanent endowment. Capital contributions also include planned
gifts, the principal of which will accrue to the Laboratory upon the death of the
donor.
Program contributions were composed of gifts to the Genetic Diseases Fund
and to the William Maxwell Cowan and Henry Wendt Neuroscience Fellowships.
Program contributions are gifts intended to be used in their entirety to fund ongo-
ing Laboratory programs.
Sherburn Becker
The Banbury Fund
Booth Ferris Foundation
John Cleary
Maxwell Cowan
Daphne Seybolt Culpeper
Foundation
Fort Hill Foundation
Robert B. Gardner, Jr. *
Townsend and Elise Knight *
David H. Koch Foundation
Charles Henry Leach II "
Total $4,092,050
* Planned Gift
George and Mary Lindsay
William R. Miller
Oncor
Dr. David B. Pall
Edward L. Palmer "
Perkin Fund
Rippel Foundation
Alan and Edith Seligson
Owen Smith
James Watson
Henry Wendt
Taggart Whipple *
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ANNUAL CONTRIBUTIONS
Corporate Sponsor Program
The Corporate Sponsor Program provides
support for the meetings held in both
Grace Auditorium on the main Laboratory campus and
Banbury Center. 1993
marked the 10th year of the Program, and it is the long-term
financial stability
provided through the generosity of the Program's members
that enables us to
keep our meetings exciting and at the cutting
edge of modern biological re-.
search. In 1993, there were 37 members (see below) of the Corporate
Sponsor
Program, and the meetings that they supported were
attended by 4600
scientists.
The members of the Program receive special privileges in acknowledgment
of their contributions. We waive all on-site fees
for eight representatives of each
company at our meetings. Three of these scientists may
attend meetings at Ban-
bury Center, where attendance is otherwise only by invitation of the organizers.
Corporate Sponsors receive gratis copies of Cold Spring Harbor Laboratory
Press publications including the journals Genes & Development and PCR. Begin-
ning in 1994, we will make Grace Auditorium available to Corporate Sponsor Pro-
gram members for sponsorship of scientific meetings on topics of their own
choice. These meetings will be of the same excellent standard as the regular
meetings and will garner kudos from being held here at the Laboratory. They will
be strictly limited in number.
We also acknowledge our Sponsors in all relevant publications, including the
books of abstracts given to all meeting participants. The names of the sponsoring
companies are listed on the poster describing the meetings. This is mailed to ap-
proximately 7000 scientists throughout the world.
Akzo Pharma International B.V.
Alafi Capital Company
American Cyanamid Company
Amgen Inc.
Applied Biosystems, Inc.
Armstrong Pharmaceuticals-
Medeva PLC
BASF Bioresearch Corporation
Becton Dickinson and Company
Boehringer Mannheim Corporation
Bristol-Myers Squibb Company
Chugai Pharmaceutical Co., Ltd.
Diagnostic Products Corporation
Total $737,750
The Du Pont Merck
Pharmaceutical Company
Forest Laboratories, Inc.
Genentech, Inc.
Glaxo
Hoffmann-La Roche Inc.
Johnson & Johnson
Kyowa Hakko Kogyo Co., Ltd.
Life Technologies, Inc.
Met Path
Millipore Corporation
Monsanto Company
New England BioLabs, Inc.
Oncogene Science, Inc.
Pall Corporation
The Perkin-Elmer Corporation
Pfizer Inc.
Sandoz Research Institute
Schering-Plough Corporation
SmithKline Beecham
Pharmaceuticals
Sterling Winthrop Inc.
Sumitomo Pharmaceuticals Co., Ltd.
Takeda Chemical Industries, Ltd.
Toyobo Co., Ltd.
The Upjohn Company
Wyeth-Ayerst Research
Cold Spring Harbor Laboratory Association (CSHLA)
Officers
Mrs. George N. Lindsay, President
James L. Spingarn, Vice President
Mrs. Edward Greenberg, Treasurer
Mrs. E. Maxwell Geddes, Jr., Secretary
G. Morgan Browne, Asst. Secretary/Treasurer
Directors
Mrs. Joseph S. Augusciak
Mrs. Harry A. Brooks
Mrs. Harry G. Charlston
David C. Clark
John P. Cleary
John Grace
Mrs. Henry U. Harris, Jr.
Mrs. Sinclair Hatch
Donald S. Kent, M.D.
E. Coe Kerr
Alan M. Kisner, M.D.
Gordon E. Lamb
Mrs. James M. Large
Edward F. McCann
Mrs. Walter Meier
Douglas Morris
Mrs. Vincent Nesi
Arthur M. Rogers, Jr.
Douglas E. Rogers
Phillip M. Satow
Mrs. Thomas A. Saunders Ill
Mrs. Peter G. Schiff
Mrs. Philip R. von Stade
James D. Watson, Ph.D.
President's Report
It was not easy to step into the shoes of my respected predecessors, Ed Pulling
and George Cutting. In another way, it was very easy because Ed and George
had attracted a large membership of Laboratory supporters. I also inherited a su-
per board of directors, Joan Pesek who knows all the ropes, a good staff, and a
calendar of events half full.
With the mandate of the Association in mind, we planned the year to provide
information to our directors, as well as our membership, about the Laboratory so
that they could expand their scientific knowledge and be good ambassadors in
the community. Each of our four Director's Meetings included an update of
science plus a special report from a young investigator. We wished to reach out
to as many new people as possible to attract them to and acquaint them with the
science being done here. To accomplish this, we needed to arrange varied
events, some informational, some entertaining, and some to raise funds, all fol-
lowed by tours of the Laboratory. Finally, we hoped that our present members
would continue their support and that our outreach would bring in new members
who would support the Annual Fund.
Looking beyond basic research to scientific environmental studies, at the an-
nual meeting in January, Dr. George M. Woodwell of the Woods Hole Research
Center spoke on global warming, alarming us with his view of the future of our
ecosystems. In conjunction with the American Museum of Natural History, Dr.
Melanie L.J. Stiassny gave a lecture on tropical cichlid fish, an interesting op-
portunity for our community to appreciate a little known threat to aquatic species.
Subsequent panel discussions focused on diseases related to the latest
basic genetic research of Cold Spring Harbor scientists: Breast Cancer,
Alzheimer's Disease, and Manic Depression. We hope to offer more of these dis-
cussions in the future, making the public lecture concurrent with a Banbury meet-
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ing on the same subject where the same panelists are participating. Because
of
its prevalence in this community, two evenings were
devoted to Lyme disease.
Music has always been part of the CSHLA's calendar.
This year, we were
most fortunate to have a concert of lolanthe performed by the Blue Hill Troupe.
George Cutting had made the arrangements with our neighbor Jay Whitman,
who
not only brought the Troupe, but was a star performer as
well. Mary Ann and
Harry Charlston, with Wendy Hatch, chaired an enthusiastic
committee that had
the pre-performance dinner and the auditorium filled
before the invitations were
mailed. It was a delightful evening for which we were extremely
grateful to the
members of the Troupe. The benefit netted $19,995 for the Annual Fund.
The opportunity for another special art occasion came in the fall. To benefit
the Laboratory and to celebrate Faith McCurdy's birthday, her family and friends
attended "A Limner's View," the architectural drawings of Faith McCurdy. To com-
plement the show, Liz Watson prepared a catalog that described in a charming
way each drawing. Again, on that weekend, the show was enjoyed by many new-
comers to the grounds.
Annually, at the renowned Cold Spring Harbor Symposium, the Association
invites one of the most distinguished attendees to be the speaker for the Dorcas
Cummings Memorial Lecture. Dr. Eric S. Lander (Director, MIT Center for
Genome Research) gave an illuminating talk on DNA, one that was highly under-
standable to our audience which came away with a fresh awareness of the part
proteins play in activating genes. Perhaps some referred to the Franny Elder
Glossary after the lecture? The following members deserve special thanks for
hosting the traditional dinners in their homes in honor of the selected worldwide
scientists attending the Symposium:
Mr. and Mrs. Henry Babcock
Mr. and Mrs. Loren Berry
Mr. and Mrs. David Clark
Mr. and Mrs. John Cleary
Dr. and Mrs. Paul Cushman
Mr. and Mrs. W. Tucker Dean
Mr. and Mrs. Donald Deming
Mr. and Mrs. Duncan Elder
Mr. and Mrs. Edward Gerry
Mr. and Mrs. John Grace
Mr. and Mrs. Henry U. Harris
Mrs. Sinclair Hatch
Mr. and Mrs. James Large
Mr. and Mrs. George Lindsay
Mr. and Mrs. David L. Luke III
Dr. and Mrs. Larry Nathanson
Mrs. Francis T.P. Plimpton
Mr. and Mrs. John Reese
Mr. and Mrs. Thomas Saunders
Mr. and Mrs. Owen Smith
Mr. and Mrs. James Spingarn
Mr. and Mrs. John Stevenson
On a stifling hot evening, June 19th, some 400 guests assembled on the lawn
of Watson's house, Airs lie, for the "Secret of Life" Garden Party. Although I was
unable to attend, I have been informed of the wonderful success of this event. It
was perfectly planned by Chairpersons Lisa Schiff and Laurie Nesi, working with
Jane Greenberg and Joan Pesek. DNA tee shirts, posters to clarify the scientific
"secret," decorations with a science theme-every part of the evening introduced
the Laboratory to those who attended. Following the reception, all 400 guests
were entertained by hosts and hostesses who had previously toured the
Laboratory. They were:
Mrs. Daniel Barbiero Mrs. Edward Greenberg
Mrs. Joseph B. Conolly, Jr. Mrs. Stuart Hartmeyer
Mrs. Anthony Duke, Jr. Mrs. Michael Held
Mrs. Raymond Fahs Mrs. Charles Holcomb
Dr. Barry Michael Gaines Mrs. Alan Kisner
Mrs. John Garver Mrs. Lawrence Lippert
Mrs. Thomas Gimbel
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Ms. Alison G. McCall
Mrs. Randall McIntyre
Mrs. Vincent Nesi
Mrs. Peter Schiff
Mrs. Robert Sheridan
Mrs. Douglas Warner
Mrs. Jonathan Warner
1993 'Secret of Life' Garden Party.
Heartfelt thanks go to all who worked on this evening. It brought 140 new mem-
bers to the Association, netted $23,985, and gave everyone a marvelous time.
As discussed above, outreach events are part of our agenda. John and
Joyce Phelan gave a lovely cocktail party at Airs lie for their friends from Garden
City. In November, Price Waterhouse provided their new auditorium and held a
reception in New York City for "An Evening with Jim Watson, The Genetics of
Cancer." The program included Dr. Bayard Clarkson (Honorary Trustee), Dr. Jim
Watson, and Dr. Michael Gilman, for the purpose of introducing New Yorkers to
the Cold Spring Harbor Laboratory. Those in attendance were excited by what
they heard and the event generated several new members for the Association.
Add all the above events to the information and publicity disseminated by the
news articles (and local) reporting new discoveries at Cold Spring Harbor
Laboratory, the 40th Anniversary of the Discovery of the Structure of DNA by Drs.
Watson and Crick, and finally the glorious Nobel prize won by Dr. Rich Roberts,
whom we all know, and you have the elements that have made the year 1993 so
successful. When our Association Directors wrote to the membership in the fall,
358 members renewed their support and 160 new members joined overall, bring-
ing the total to a high of 889 members. With Jim Spingarn heading up the Major
Gifts Committee and Carol Large in charge of membership, working with Wendy
Hatch, Mary Ann Charlston, John Cleary, and other Directors, the Annual Fund
grew to a record total of $526,241.
These unrestricted Annual Funds that support science are critical, enabling
the Laboratory to attract and retain the most desirable young scientists and assist
them with start-up money. At a time when federal grants are extremely competi-
tive and slow to come through, our newcomers, although qualified, may have to
wait months to receive their grants. It was extremely rewarding to find that the ad-
ministration was able to allocate $100,000 over budget for scientific support this
year because of the generosity of the Association Members! I thank all of our
members for their wonderful gifts.
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So it is with anticipation that I embark on
1994, ready to work with Bruce and
Grace Stillman while Jim and Liz have a
sabbatical in England. There are plans
to offer more tours and many events,
and in addition, the Scientific Support Com-
ortunities to scientific staff and their
mittee expects to offer more social opp
spouses. Should anyone have extra tickets
for concerts or theatre, they would be
much appreciated.
Warm thanks are extended to all the
Directors who have made my first year
easy. Of course I will miss Wendy
Hatch, a gem whom we will keep working with
us, and I look forward to having Coe Kerr, Vernon Merrill,
and oug M
you
remarkable Administrative and Development staff.
Mary D. Lindsay
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Research Staff
John Anderson
Kim Arndt
Dafna Bar-Sagi
David Beach*
Xiaodong Cheng
Grigori Enikolopov
Harriet Feilotter
Robert Franza
Bruce Futcher
James Garrels
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Carol Greider
David He lfman
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Ryuji Kobayashi
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Jeffrey Kuret
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Koji Okamoto
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Wolfgang Seufert
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Stefan Stamm
Barbara Steiner
Hong Sun
William Tansey
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Marie-Luce Vignais
Shou Waga
Yung-Chih (Judy) Wang
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Shaohui Zhang
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Alexander Melnikov
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Rui-Ming Xu
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Philip Renna
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Technical Programming
Thomas Boutell
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Xuejun (Adam) Chi
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Elisabeth Cuddihy
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Edwin (Corp) Reed
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Karen Otto
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Madeline Wisnewski
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Richard Freiman
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Linda Graziadei
Chong (Chris) Huang
John lafrate
Jiann-Shiun Lai
Kenneth La Montagne
Benjamin Lee
Betty Lee
Gary Lee
Yuliang (Frank) Ma
York Marahrens
Robert Mihalek
George Mulligan
Raymond O'Keefe
Kathy O'Neill
Frank Pessler
Hai Rao
Peter Rubinelli
Ann Ryan
Cynthia Sadowski
Ahmed Samatar
Christian Schmedt
Meenakshi Selvakumar
Kenneth Simon
Deborah Taylor
William Thomann
George Tokiwa
Tzu-Ling Tseng
Qinghong Yang
Shao-Song Yang
Tao Zhong
Research Assistants
Neeraj Arora
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Gigi Asouline
Deborah Aufiero
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Lynn Borzillo
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Maria Del Vecchio
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Paul Kearney
James Keller
Da-Wei Liao
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Bei Ma
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Jason Shanley
Stephanie Kaplan Smith
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Ikuko Watakabe
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Research Associates
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Linda Rodgers
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June Blanchford
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Salvador Henriquez
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John Santoro
Margaret Wallace
Isabelle Weeks
Xiu-xia Zhang
Electronic Data
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Fred Stellabotte
Jim Bense
Elizabeth O'Connor
Bobbie Peters
David Ruderman
Environmental Health
and Safety
Arthur Brings
Safety
Christopher Hubert
Randal Jones
John Pisciotta
Donald Rose, Sr.
Marlene Rubino
Harris Research Support Facility
Lisa Bianco
Charlene De Poto
Halina Swidzinski
Richard Swidzinski
Security
Robert Gensel
Frank Carberry
Donald Rose, Jr.
CSHL Press
Acquisition
Phyllis Chen
Advertising
Nancy Kuhle
Editorial/Production Books
Nancy Ford
Patricia Barker
Dorothy Brown
Mary Cozza
Maryliz Dickerson
Joan Ebert
Elaine Gaveglia
Annette Kirk
Lee Martin
Eileen Paetz
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Inez Sialiano
Marie Sullivan
Editorial/Production Journals
Judy Cuddihy
Nadine Dumser
Doris Lawrence
Valerie Nicolette
Lori Olsewski
Fulfillment/Distribution
Guy Keyes
Kathleen Cirone
Ann Felten
Jacqueline Matura
Penny Sheppard
Barbara Terry
Finance
Nancy Hodson
Connie Hallaran
Marketing
Ingrid Benirschke
James Suddaby
Library/Public Affairs/Development
Susan Cooper
Clare Bunce
Laura Hyman
Library
Margaret Henderson
Leigh Johnson
Kelly Kasso
Wanda Stolen
Public Affairs
Margot Bennett
Edward Campodonico
Nathaniel Comfort
Lynn Hardin
Herb Parsons
Development
Jill Clark
Claire Fairman
Gordon Hargraves
Gisela Jennings
Debra Mullen
Joan Pesek
Accciunting
Amy Anderson
Julie Belfiore
Sharon Bense
Jennifer Blovsky
Guy Cozza
Karen Fabian
Mary Ellen Goldstein
Patricia Maroney
Alison McDermott
Carlos Mendez
Mary Ann Miceli
Robert Pace
Patricia Urena
Barbara Wang
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Jan Eisenman
Kim Gronachan
Barbara Purcell
Merilyn Simkins
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James Hope
Dwayne Blackman
Francis Bowdren
Todd Brummer
Donna Corbett
Michael Corral
Joan Doxey
Donna Dykeman
Julie Ehrlich
Alec Firestone
Katherine Names
Renee Le Strange
Michael Manfredonia
Ronald Padden
Teresa Purcell
Mauricio Rodriguez
William Suescun
Cathy Van Deurs
Cesar Vera
Leslie Wenzel
Keith Wieczorek
Meetings
David Stewart
Sharon Faber
James Koziol
Michela McBride
Nancy Spatafora
Margaret Stellabotte
Andrea Stephenson
Diane Tighe
Nancy Weeks
Purchasing
Sandra Chmelev
Bruce Fahlbusch
Maryellen Fredriksen
Patricia Hinton
Edith Kappenberg
Susan Rose
Mary Smith
Barbara Zane
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Maureen Berejka
Delia Costello
Roberta Sa lant
Banbury Center
Katya Davey
Eleanor Sidorenko
Beatrice To liver
DNA Learning Center
Mark Bloom
Jane Conigliaro
Diane Jedlicka
Margot Kohler
Susan Lauter
Sandra Ordway
Buildings and Grounds
Jack Richards
Peter Stahl
Administration
Leslie Allen
Margaret Chellis
Charles Schneider
Carpentry and Painting
Michael Demers
Jeffrey Goldblum
John Meyer
Joseph Pirnak
Peter Rohde
Frank Russo
Peter Schwind
Harry Wozniak
Equipment and Repair/Machine Shop
Danielle Bruno
Gus Du lis
George Newell
Cliff Sutkevich
Custodial
Stephen Gay
David Gomez
Daniel Jusino
Morgan Kelly
Pino Kos
George Leedham
Aldo Leo
Wayne Pay
Peter Prianti
Ronald Romani
Jaroslaw Swidzinski
Steven Tang
Yew Teo
Mario Testani
Jorge Valdes
Curtis Williams
Electrical and Mechanical
Maintenance
Russell Allen
Richard Gallagher
Steven Guy
Louis Jagoda
John Kopyta
Stanley Miecnikowski
Grounds
Robert Arena
Vincent Carey
Joseph Ellis
Keith Falkowski
Edward Haab
William Kearney
Allen Lerch
Christopher McEvoy
Daniel Miller
Andrew Sauer
Eric Schlitter
Darius Slodkowski
Hans Trede
Christopher Williams
Jeremiah Young
Housekeeping
Rita Abrams
Elizabeth Botti
Catherine Burke
Carol Caldarelli
Patricia Carroll
Dessie Carter
Mary Genova
Patricia Mc Adams
Susanne McPherson
Dora Merlino
Claudia Schmid
Danuta Slodkowska
Dorothy Youngs
Plumbing
Lane Smith
Keith Spooner
Shipping and Receiving
Scott Nitz
Christopher Oravitz
James Sabin
Randy Wilfong
Uplands
Timothy Mulligan
Stanley Schwarz
Scientific Staff Departures
During 1993
Research Staff
Roymarie Ballester
Ronald Davis
Michael Laspia
Gilbert Morris
Scott Patterson
Thomas Peterson
Staff Associates
Graeme Bolger
James Cherry
Susan Lobo
Postdoctoral Fellows
Cyrille Alexandre
Prasanna Athma
Ricardo Attar
Kanagasabapathy Balendran
James Bischoff
Christian Brandes
Paul Clarke
Mubasher Dar
Brigitte Dauwalder
Salah-Ud Din
Ahmed Ebrahim
an Fitch
Simon Green
Kyung-An Han
Christopher Hardy
Luis Jimenez-Garcia
Betty Leichus
Maarten Linskens
Yu Liu
Karen Lundgren
Victoria Meller
Alan Nighorn
Arne Ostman
Karen Prowse
Anthony Rossomando
Michael Ruppert
Gian Luigi Russo
Efthimios Skoulakis
Robert Swanson
Michael Tyers
Ales Vancura
Nancy Walworth
Heidi Wang
Pi-Chao Wang
Yue Xiong
Peter Yaciuk
Qing Yang
Visiting Scientists
Jacques Camonis
Javier Diaz-Nido
Igor Garkavtsev
Kikuo Sen
Huan-Ran Tan
Graduate Students
Jill Crittenden
Lea Harrington
Robert Nash
Michael Sheldon
Kwok-Hang Wu
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